/DisorderList/Disorder/DisorderType/Name,/DisorderList/Disorder/Name,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceClass/Name,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceGeographic/Name,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceType/OrphaNumber,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceType/OrphaNumber/#agg,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceValidationStatus/@id,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceValidationStatus/@id/#agg,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceValidationStatus/Name/@lang,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceValidationStatus/Name,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceValidationStatus/OrphaNumber,/DisorderList/Disorder/PrevalenceList/Prevalence/PrevalenceValidationStatus/OrphaNumber/#agg,/DisorderList/Disorder/PrevalenceList/Prevalence/Source,/DisorderList/Disorder/PrevalenceList/Prevalence/ValMoy,/DisorderList/Disorder/PrevalenceList/Prevalence/ValMoy/#agg
Disease,"Multiple epiphyseal dysplasia, Al-Gazali type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11389160[PMID]_9689990[PMID]_ [EXPERT],4,4
Disease,"Multiple epiphyseal dysplasia, Al-Gazali type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11389160[PMID]_9689990[PMID],0,0
Disease,Alexander disease,<1 / 1 000 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,21533827[PMID]_[EXPERT],0.037,0.037
Disease,Alexander disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Multiple epiphyseal dysplasia, with miniepiphyses",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15523498[PMID],2,2
Disease,"Multiple epiphyseal dysplasia, with miniepiphyses",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15523498[PMID],0,0
Disease,Alpha-mannosidosis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2005[INST],0.1,0.1
Disease,Alpha-mannosidosis,<1 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.09,0.09
Disease,Alpha-mannosidosis,1-9 / 1 000 000,Norway,409968,409968,25965,25965,en,Not yet validated,410294,410294,7900112[PMID],0.13,0.13
Disease,Alpha-mannosidosis,<1 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.09,0.09
Disease,Alpha-mannosidosis,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.12,0.12
Disease,Alpha-mannosidosis,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.38,0.38
Disease,Alpha-mannosidosis,<1 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.07,0.07
Disease,"Multiple epiphyseal dysplasia, with severe proximal femoral dysplasia",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15523498[PMID],3,3
Disease,"Multiple epiphyseal dysplasia, with severe proximal femoral dysplasia",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15523498[PMID],0,0
Disease,"Metaphyseal chondrodysplasia, Kaitila type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6979929[PMID],2,2
Disease,"Metaphyseal chondrodysplasia, Kaitila type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6979929[PMID],0,0
Disease,Aspartylglucosaminuria,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.2,0.2
Disease,Aspartylglucosaminuria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Aspartylglucosaminuria,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.62,0.62
Disease,Aspartylglucosaminuria,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,27906067[PMID],3.35,3.35
Malformation syndrome,Brachydactyly-short stature-retinitis pigmentosa syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7252997[PMID]_28285769[PMID],12,12
Malformation syndrome,Brachydactyly-short stature-retinitis pigmentosa syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7252997[PMID]_28285769[PMID],0,0
Disease,Multiple sulfatase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:9780071363228[OTHER],50,50
Disease,Multiple sulfatase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:9780071363228[OTHER],0,0
Disease,Beta-mannosidosis,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID]_10480370[PMID]_20490927[PMID],0.14,0.14
Disease,Beta-mannosidosis,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.16,0.16
Disease,Beta-mannosidosis,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.13,0.13
Disease,Beta-mannosidosis,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.12,0.12
Disease,Beta-mannosidosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Pontocerebellar hypoplasia type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16470708[PMID],3,3
Malformation syndrome,Pontocerebellar hypoplasia type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16470708[PMID],0,0
Disease,Canavan disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Canavan disease,1-9 / 100 000,Specific population,409967,409967,25958,25958,en,Validated,410293,410293,20301412[PMID]_ORPHANET,7,7
Disease,Canavan disease,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Malformation syndrome,Pontocerebellar hypoplasia type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Malformation syndrome,Pontocerebellar hypoplasia type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20952379[PMID],0,0
Clinical subtype,Von Willebrand disease type 1,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pontocerebellar hypoplasia type 6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25809939[PMID],10,10
Malformation syndrome,Pontocerebellar hypoplasia type 6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25809939[PMID],0,0
Disease,Cystinosis,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,12110740[PMID]_18008091[PMID]_11562417[PMID],0.75,0.75
Disease,Cystinosis,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Cystinosis,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,1018302[PMID],0.31,0.31
Disease,Cystinosis,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,3921756[PMID],0.59,0.59
Disease,Cystinosis,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,9610798[PMID],2.1,2.1
Disease,Cystinosis,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.52,0.52
Disease,Cystinosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],1.5,1.5
Disease,Cystinosis,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,975942[PMID]_27102039[PMID],0.87,0.87
Disease,Cystinosis,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID]_27102039[PMID],0.38,0.38
Disease,Cystinosis,1-9 / 100 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,1937486[PMID]_25274184[PMID],1.6,1.6
Clinical subtype,Von Willebrand disease type 2A,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Farber disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29048419[PMID],96,96
Disease,Farber disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29048419[PMID],0,0
Disease,Farber disease,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],0,0
Clinical subtype,Von Willebrand disease type 2,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fucosidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10094192[PMID],100,100
Disease,Fucosidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10094192[PMID],0,0
Disease,Fucosidosis,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.1,0.1
Clinical subtype,Von Willebrand disease type 2M,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.8,0.8
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.17,0.17
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],0.83,0.83
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID]_10482961[PMID],2.25,2.25
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.37,0.37
Disease,Glycogen storage disease due to acid maltase deficiency,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,22133539[PMID],11.5,11.5
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,9738873[PMID],2.5,2.5
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.68,0.68
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 100 000,China,409968,409968,25958,25958,en,Validated,410293,410293,3106710[PMID],2,2
Disease,Glycogen storage disease due to acid maltase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.72,0.72
Disease,Glycogen storage disease due to acid maltase deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],3,3
Clinical subtype,Von Willebrand disease type 2B,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glycogen storage disease due to glycogen debranching enzyme deficiency,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,9412782[PMID],1,1
Disease,Glycogen storage disease due to glycogen debranching enzyme deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Von Willebrand disease type 2N,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glycogen storage disease due to muscle glycogen phosphorylase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Von Willebrand disease type 3,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glycogen storage disease due to glycogen branching enzyme deficiency,1-9 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,23285490[PMID],0.1,0.1
Disease,Glycogen storage disease due to glycogen branching enzyme deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Autosomal dominant otospondylomegaepiphyseal dysplasia,,,,,,,,,,,,,
Disease,Glycogen storage disease due to muscle phosphofructokinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18421897[PMID],100,100
Disease,Glycogen storage disease due to muscle phosphofructokinase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18421897[PMID],0,0
Disease,FASTKD2-related infantile mitochondrial encephalomyopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18771761[PMID]_28499982[PMID],3,3
Disease,FASTKD2-related infantile mitochondrial encephalomyopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18771761[PMID]_28499982[PMID],0,0
Disease,Glycogen storage disease due to liver glycogen phosphorylase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Paroxysmal nocturnal hemoglobinuria,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,Hill_Platts_Smith 2006[AUTHOR],0.13,0.13
Disease,Paroxysmal nocturnal hemoglobinuria,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,Hill_Platts_Smith 2006[AUTHOR],1.59,1.59
Disease,Paroxysmal nocturnal hemoglobinuria,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2016[INST],2,2
Disease,"Intellectual disability, Birk-Barel type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18678320[PMID],1,1
Disease,"Intellectual disability, Birk-Barel type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18678320[PMID],0,0
Disease,Bazex syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18775590[PMID],145,145
Disease,Bazex syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18775590[PMID],0,0
Clinical group,Rare cutaneous lupus erythematosus,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2007[INST],50,50
Clinical group,Rare cutaneous lupus erythematosus,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,19289752[PMID],4.3,4.3
Clinical group,Rare cutaneous lupus erythematosus,6-9 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,19289752[PMID],73,73
Clinical group,Rare cutaneous lupus erythematosus,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,21574972[PMID],4,4
Disease,Isolated osteopoikilosis,,,,,,,,,,,,,
Disease,Krabbe disease,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22991292[PMID]_26795590[PMID],0.327,0.327
Disease,Krabbe disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Krabbe disease,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.7,0.7
Disease,Krabbe disease,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301416[PMID],1,1
Disease,Krabbe disease,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.7,0.7
Disease,Krabbe disease,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.71,0.71
Disease,Krabbe disease,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],1.35,1.35
Disease,Krabbe disease,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],1.21,1.21
Disease,Krabbe disease,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,9286459[PMID],0.6,0.6
Disease,Krabbe disease,1-9 / 100 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],1,1
Disease,Krabbe disease,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.4,0.4
Disease,Krabbe disease,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,5409293[PMID],1.9,1.9
Clinical subtype,Dentinogenesis imperfecta type 2,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],14.6,14.6
Clinical subtype,Dentinogenesis imperfecta type 3,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.16,0.16
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,16435194[PMID],0.23,0.23
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.15,0.15
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.42,0.42
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID]_25274184[PMID],0.23,0.23
Disease,Mucopolysaccharidosis type 6,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],3.3,3.3
Disease,Mucopolysaccharidosis type 6,<1 / 1 000 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],0.07,0.07
Disease,Mucopolysaccharidosis type 6,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],2.2,2.2
Disease,Mucopolysaccharidosis type 6,<1 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],0.05,0.05
Disease,Mucopolysaccharidosis type 6,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],3.7,3.7
Disease,Mucopolysaccharidosis type 6,<1 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.05,0.05
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,16600651[PMID]_14608657[PMID],0.37,0.37
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10617747[PMID],0.1,0.1
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,19396827[PMID],0.14,0.14
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,22480138[PMID],0.27,0.27
Disease,Mucopolysaccharidosis type 6,<1 / 1 000 000,Colombia,409966,409966,25958,25958,en,Validated,410293,410293,22550061[PMID],0.059,0.059
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2001[INST],0.16,0.16
Disease,Mucopolysaccharidosis type 6,1-9 / 100 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,16435194[PMID],2.3,2.3
Disease,Mucopolysaccharidosis type 6,<1 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,25472774[PMID],0.0132,0.0132
Disease,Mucopolysaccharidosis type 6,1-9 / 100 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,20622343[PMID],7.85,7.85
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2014.12.082[OTHER],0.31,0.31
Disease,Mucopolysaccharidosis type 6,<1 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.03,0.03
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.11,0.11
Disease,Mucopolysaccharidosis type 6,1-9 / 1 000 000,Tunisia,409968,409968,25958,25958,en,Validated,410293,410293,20209839[PMID],0.3,0.3
Disease,Mucopolysaccharidosis type 6,<1 / 1 000 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,25364648[PMID],0.019,0.019
Disease,Mucopolysaccharidosis type 6,<1 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2016.11.285[OTHER],0.05,0.05
Malformation syndrome,Odontochondrodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18241073[PMID],11,11
Malformation syndrome,Odontochondrodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18241073[PMID],0,0
Disease,Mucolipidosis type II,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID]_10480370[PMID]_20301728[PMID]_ORPHANET,0.84,0.84
Disease,Mucolipidosis type II,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mucolipidosis type II,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.81,0.81
Disease,Mucolipidosis type II,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.16,0.16
Disease,Mucolipidosis type II,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,2998652[PMID],0.4,0.4
Disease,Mucolipidosis type II,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,20301728[PMID],1.56,1.56
Disease,Mucolipidosis type II,1-5 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,18190596[PMID]_1937486[PMID],16.2,16.2
Disease,Mucolipidosis type II,<1 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.05,0.05
Malformation syndrome,Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10544232[PMID],3,3
Malformation syndrome,Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10544232[PMID],0,0
Disease,Sialidosis type 1,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Sialidosis type 1,<1 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial sick sinus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,11,11
Disease,Familial sick sinus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mucolipidosis type IV,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mucolipidosis type IV,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.1,0.1
Disease,Mucolipidosis type IV,1-9 / 100 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,20159435[PMID]_16287144[PMID]_16645217[PMID],2.5,2.5
Disease,Porokeratotic eccrine ostial and dermal duct nevus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21393947[PMID],45,45
Disease,Porokeratotic eccrine ostial and dermal duct nevus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21393947[PMID],0,0
Disease,Mucolipidosis type III,<1 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.08,0.08
Disease,Mucolipidosis type III,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],1.89,1.89
Disease,Mucolipidosis type III,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mucolipidosis type III,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID]_14685153[PMID],1,1
Disease,Dirofilariasis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Benign non-familial infantile seizures,,,,,,,,,,,,,
Disease,Benign infantile focal epilepsy with midline spikes and waves during sleep,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20822975[PMID],36,36
Disease,Benign infantile focal epilepsy with midline spikes and waves during sleep,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20822975[PMID],0,0
Disease,Benign infantile seizures associated with mild gastroenteritis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24125788[PMID],100,100
Disease,Benign infantile seizures associated with mild gastroenteritis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24125788[PMID],0,0
Disease,Poliomyelitis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Poliomyelitis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011[INST],0,0
Disease,Benign partial epilepsy with secondarily generalized seizures in infancy,,,,,,,,,,,,,
Disease,Benign partial epilepsy of infancy with complex partial seizures,,,,,,,,,,,,,
Disease,Sandhoff disease,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],1.49,1.49
Disease,Sandhoff disease,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.34,0.34
Disease,Sandhoff disease,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.19,0.19
Disease,Sandhoff disease,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.26,0.26
Disease,Sandhoff disease,1-9 / 1 000 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,15275696[PMID],0.95,0.95
Disease,Sandhoff disease,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,2955697[PMID],0.3,0.3
Disease,Sandhoff disease,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.67,0.67
Disease,Sandhoff disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sandhoff disease,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.38,0.38
Disease,Photosensitive epilepsy,,,,,,,,,,,,,
Clinical group,Scleroderma,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1.41,1.41
Clinical group,Scleroderma,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],42,42
Clinical group,Scleroderma,1-9 / 100 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,11456035[PMID],1.5,1.5
Clinical group,Scleroderma,1-5 / 10 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,11456035[PMID],23,23
Clinical group,Scleroderma,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,8702445[PMID],469,469
Clinical group,Benign partial infantile seizures,,,,,,,,,,,,,
Disease,Recessive X-linked ichthyosis,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET,15,15
Disease,Recessive X-linked ichthyosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,16.6,16.6
Disease,Recessive X-linked ichthyosis,1-9 / 100 000,Italy,409967,409967,25965,25965,en,Not yet validated,410294,410294,12920363[PMID]_ORPHANET,9.9,9.9
Disease,Orgasm-induced seizures,,,,,,,,,,,,,
Disease,Eating reflex epilepsy,,,,,,,,,,,,,
Disease,Audiogenic seizures,,,,,,,,,,,,,
Disease,Mucopolysaccharidosis type 7,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],0.01,0.01
Disease,Mucopolysaccharidosis type 7,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.24,0.24
Disease,Mucopolysaccharidosis type 7,<1 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,25060283[PMID],0.02,0.02
Disease,Mucopolysaccharidosis type 7,<1 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.02,0.02
Disease,Mucopolysaccharidosis type 7,<1 / 1 000 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.038,0.038
Disease,Mucopolysaccharidosis type 7,<1 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.047,0.047
Disease,Mucopolysaccharidosis type 7,<1 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2016.11.285[OTHER],0.05,0.05
Disease,Mucopolysaccharidosis type 7,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.29,0.29
Disease,Hot water reflex epilepsy,,,,,,,,,,,,,
Disease,Reading seizures,,,,,,,,,,,,,
Disease,Micturation-induced seizures,,,,,,,,,,,,,
Malformation syndrome,Turner syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1985-2010[REG],5.5,5.5
Malformation syndrome,Turner syndrome,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1985-2009[REG],7.5,7.5
Malformation syndrome,Turner syndrome,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1980-2010[REG],7.9,7.9
Malformation syndrome,Turner syndrome,1-5 / 10 000,Bulgaria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1996-1999[REG],10.5,10.5
Malformation syndrome,Turner syndrome,1-9 / 100 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1983-2010[REG],3.6,3.6
Malformation syndrome,Turner syndrome,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1980-2010[REG],10.4,10.4
Malformation syndrome,Turner syndrome,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1980-2010[REG],7.1,7.1
Malformation syndrome,Turner syndrome,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1987-2010[REG],8,8
Malformation syndrome,Turner syndrome,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1998-2010[REG],3.2,3.2
Malformation syndrome,Turner syndrome,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1980-2010[REG],7.1,7.1
Malformation syndrome,Turner syndrome,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1980-2010[REG],3.4,3.4
Malformation syndrome,Turner syndrome,1-9 / 100 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1986-2009[REG],1.1,1.1
Malformation syndrome,Turner syndrome,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1981-2010[REG],14,14
Malformation syndrome,Turner syndrome,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1999-2010[REG],4.2,4.2
Malformation syndrome,Turner syndrome,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1999-2010[REG],3.6,3.6
Malformation syndrome,Turner syndrome,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1990-2010[REG],2.8,2.8
Malformation syndrome,Turner syndrome,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1980-2009[REG],2.8,2.8
Malformation syndrome,Turner syndrome,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1989-2010[REG],22.4,22.4
Malformation syndrome,Turner syndrome,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1980-2010[REG],10.1,10.1
Malformation syndrome,Turner syndrome,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2010[REG],2.3,2.3
Malformation syndrome,Turner syndrome,6-9 / 10 000,Japan,409968,409968,25965,25965,en,Not yet validated,410294,410294,ISBN:444897208[OTHER],70,70
Malformation syndrome,Turner syndrome,1-5 / 10 000,Singapore,409968,409968,25958,25958,en,Validated,410293,410293,19551311[PMID],42.5,42.5
Malformation syndrome,Turner syndrome,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Startle epilepsy,,,,,,,,,,,,,
Disease,Thinking seizures,,,,,,,,,,,,,
Disease,Friedreich ataxia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20301458[PMID]_23859338[PMID],2,2
Disease,Friedreich ataxia,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,9207112 [PMID]_23859338[PMID],2.3,2.3
Disease,Friedreich ataxia,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,2225525[PMID]_7793232[PMID],2.8,2.8
Disease,Friedreich ataxia,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,2225525[PMID]_7793232[PMID],1.1,1.1
Disease,Friedreich ataxia,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,2043954[PMID]_7898602[PMID],6.2,6.2
Disease,Friedreich ataxia,1-9 / 100 000,Spain,409966,409966,25965,25965,en,Not yet validated,410294,410294,2043954[PMID]_7898602[PMID],4.3,4.3
Disease,Friedreich ataxia,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,11810294[PMID],1,1
Disease,Friedreich ataxia,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,11810294[PMID]_23859338[PMID],0.13,0.13
Disease,Friedreich ataxia,1-9 / 1 000 000,Denmark,409966,409966,25965,25965,en,Not yet validated,410294,410294,2096315[PMID],0.7,0.7
Disease,Friedreich ataxia,1-9 / 1 000 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,23609960[PMID],0.9,0.9
Disease,Friedreich ataxia,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19347027[PMID],1.8,1.8
Disease,Friedreich ataxia,1-9 / 1 000 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,24209901[PMID],0.9,0.9
Disease,Friedreich ataxia,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,1126051[PMID],1,1
Disease,Friedreich ataxia,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,9187683[PMID]_23859338[PMID],2.1,2.1
Disease,Friedreich ataxia,1-9 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,11810294[PMID]_23859338[PMID],0.24,0.24
Disease,Friedreich ataxia,1-9 / 1 000 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,15726025[PMID]_23859338[PMID],0.27,0.27
Disease,Friedreich ataxia,1-9 / 100 000,Russian Federation,409966,409966,25958,25958,en,Validated,410293,410293,15559155[PMID]_23859338[PMID],3.03,3.03
Category,Neurocutaneous syndrome with epilepsy,,,,,,,,,,,,,
Disease,Beta-thalassemia,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Beta-thalassemia,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Beta-thalassemia,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Beta-thalassemia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Chromosomal anomaly with epilepsy as a major feature,,,,,,,,,,,,,
Disease,Alpha-thalassemia,>1 / 1000,France,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,100,100
Disease,Alpha-thalassemia,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cystic fibrosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_European Medicines Agency 2019[INST],7.4,7.4
Disease,Cystic fibrosis,1-5 / 10 000,France,409967,409967,25958,25958,en,Validated,410293,410293,16916626[PMID],21.7,21.7
Disease,Cystic fibrosis,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],21.3,21.3
Disease,Cystic fibrosis,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],7.5,7.5
Disease,Cystic fibrosis,1-5 / 10 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,15481678[PMID],23.6,23.6
Disease,Cystic fibrosis,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],23.8,23.8
Disease,Cystic fibrosis,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],8.7,8.7
Disease,Cystic fibrosis,6-9 / 10 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,17955689[PMID],73.9,73.9
Disease,Cystic fibrosis,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,19403164[PMID],25,25
Disease,Cystic fibrosis,1-5 / 10 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,16182667[PMID],27.7,27.7
Disease,Cystic fibrosis,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],30.3,30.3
Disease,Cystic fibrosis,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],8.3,8.3
Disease,Cystic fibrosis,1-9 / 100 000,Ecuador,409967,409967,25958,25958,en,Validated,410293,410293,17432547[PMID],8.9,8.9
Disease,Cystic fibrosis,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],21.3,21.3
Disease,Cystic fibrosis,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],7.6,7.6
Disease,Cystic fibrosis,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],35,35
Disease,Cystic fibrosis,1-5 / 10 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],10.3,10.3
Disease,Cystic fibrosis,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,19403164[PMID]_Cystic Fibrosis Foundation 2010[OTHER]_22914736[PMID],8.5,8.5
Disease,Cystic fibrosis,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22766612[PMID],19.9,19.9
Disease,Cystic fibrosis,1-5 / 10 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,21978347[PMID]_19403164[PMID],33.3,33.3
Disease,Cystic fibrosis,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,9161949[PMID]_8533810[PMID],0.28,0.28
Disease,Cystic fibrosis,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,16236889[PMID]_19403164[PMID],22,22
Disease,Cystic fibrosis,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,16236889[PMID]_19403164[PMID],7.8,7.8
Disease,Cystic fibrosis,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],16.7,16.7
Disease,Cystic fibrosis,1-9 / 100 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],2.7,2.7
Disease,Cystic fibrosis,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],27,27
Disease,Cystic fibrosis,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],5.46,5.46
Disease,Cystic fibrosis,1-5 / 10 000,Israel,409968,409968,25958,25958,en,Validated,410293,410293,19403164[PMID],33.3,33.3
Disease,Cystic fibrosis,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,17182652[PMID]_19403164[PMID],41.7,41.7
Disease,Cystic fibrosis,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,17182652[PMID]_19403164[PMID],13.7,13.7
Disease,Cystic fibrosis,1-5 / 10 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,2243313[PMID]_19403164[PMID],17.3,17.3
Disease,Cystic fibrosis,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,2243313[PMID]_19403164[PMID],4,4
Disease,Cystic fibrosis,1-5 / 10 000,Greece,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],28.6,28.6
Disease,Cystic fibrosis,1-9 / 100 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],5.2,5.2
Disease,Cystic fibrosis,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],4,4
Disease,Cystic fibrosis,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],1.2,1.2
Disease,Cystic fibrosis,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],28.6,28.6
Disease,Cystic fibrosis,1-5 / 10 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,19403164[PMID],40,40
Disease,Cystic fibrosis,1-5 / 10 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,31241292[PMID],16.9,16.9
Disease,Cystic fibrosis,1-5 / 10 000,Mexico,409968,409968,25958,25958,en,Validated,410293,410293,19403164[PMID],11.8,11.8
Disease,Cystic fibrosis,1-5 / 10 000,New Zealand,409968,409968,25958,25958,en,Validated,410293,410293,19403164[PMID],31.3,31.3
Disease,Cystic fibrosis,1-5 / 10 000,Slovakia,409968,409968,25958,25958,en,Validated,410293,410293,19403164[PMID],55.56,55.56
Disease,Cystic fibrosis,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,19403164[PMID],18.2,18.2
Disease,Cystic fibrosis,1-5 / 10 000,Romania,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],48.63,48.63
Disease,Cystic fibrosis,1-5 / 10 000,Bulgaria,409968,409968,25958,25958,en,Validated,410293,410293,19403164[PMID],40,40
Disease,Cystic fibrosis,>1 / 1000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,19403164[PMID],0,0
Disease,Cystic fibrosis,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,19403164[PMID],111,111
Disease,Cystic fibrosis,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],29.8,29.8
Disease,Cystic fibrosis,1-9 / 100 000,Austria,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],8.39,8.39
Disease,Cystic fibrosis,1-9 / 100 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],5.56,5.56
Disease,Cystic fibrosis,1-9 / 100 000,Slovakia,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],6.27,6.27
Disease,Cystic fibrosis,1-9 / 100 000,Romania,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],1.06,1.06
Disease,Cystic fibrosis,1-9 / 100 000,Lithuania,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],1.3,1.3
Disease,Cystic fibrosis,1-9 / 100 000,Luxembourg,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],4.31,4.31
Disease,Cystic fibrosis,1-9 / 100 000,Malta,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],5.79,5.79
Disease,Cystic fibrosis,1-9 / 100 000,Latvia,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],1.04,1.04
Disease,Cystic fibrosis,1-9 / 100 000,Slovenia,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],3.28,3.28
Disease,Cystic fibrosis,1-5 / 10 000,Slovenia,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],33.33,33.33
Disease,Cystic fibrosis,1-9 / 100 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],2.56,2.56
Disease,Cystic fibrosis,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],20,20
Disease,Cystic fibrosis,1-9 / 100 000,Estonia,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],6.18,6.18
Disease,Cystic fibrosis,1-5 / 10 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],22.22,22.22
Disease,Cystic fibrosis,1-9 / 100 000,Cyprus,409966,409966,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],3.35,3.35
Disease,Cystic fibrosis,1-5 / 10 000,Cyprus,409968,409968,25958,25958,en,Validated,410293,410293,18442953[PMID]_19403164[PMID],12.64,12.64
Category,Epilepsy syndrome,,,,,,,,,,,,,
Clinical group,Duchenne and Becker muscular dystrophy,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.23,0.23
Clinical group,Duchenne and Becker muscular dystrophy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Duchenne and Becker muscular dystrophy,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,25687144[PMID],0,0
Category,Cerebral malformation with epilepsy,,,,,,,,,,,,,
Category,Metabolic diseases with epilepsy,,,,,,,,,,,,,
Category,Monogenic disease with epilepsy,,,,,,,,,,,,,
Category,Idiopathic or cryptogenic familial epilepsy syndrome with identified loci/genes,,,,,,,,,,,,,
Disease,Emery-Dreifuss muscular dystrophy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.3,0.3
Category,Infectious disease with epilepsy,,,,,,,,,,,,,
Category,Inflammatory and autoimmune disease with epilepsy,,,,,,,,,,,,,
Category,Cerebral diseases of vascular origin with epilepsy,,,,,,,,,,,,,
Disease,MELAS,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,21443929[PMID],0.18,0.18
Disease,MELAS,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,MELAS,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0.6,0.6
Disease,MELAS,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,9371917[PMID],1.63,1.63
Disease,MELAS,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,17300999[PMID],236,236
Disease,Facioscapulohumeral dystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,19320656[PMID]_22217918[PMID]_19767415[PMID]_[EXPERT]_ORPHANET,4.5,4.5
Disease,Facioscapulohumeral dystrophy,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,19320656[PMID],4.4,4.4
Disease,Facioscapulohumeral dystrophy,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],3.95,3.95
Disease,Facioscapulohumeral dystrophy,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,1745328[PMID],2,2
Disease,Facioscapulohumeral dystrophy,1-5 / 10 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,25122204[PMID],12,12
Disease,Facioscapulohumeral dystrophy,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,25122204[PMID],0.3,0.3
Disease,Kearns-Sayre syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_17886296[PMID],2,2
Disease,Kearns-Sayre syndrome,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,15781811[PMID],0.8,0.8
Disease,Kearns-Sayre syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,17886296[PMID],1,1
Disease,Classic paraneoplastic limbic encephalitis,,,,,,,,,,,,,
Category,Myofibrillar myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Paraneoplastic limbic encephalitis,,,,,,,,,,,,,
Disease,Limbic encephalitis with LGI1 antibodies,,,,,,,,,,,,,
Category,Limbic encephalitis associated with antibodies to cell membrane antigens,,,,,,,,,,,,,
Disease,MERRF,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Central core disease,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.4,0.4
Disease,Central core disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Nemaline myopathy,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_15221447[PMID],2,2
Clinical group,Nemaline myopathy,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.2,0.2
Clinical group,Limbic encephalitis,,,,,,,,,,,,,
Disease,Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Dr Véronique PINGAULT[EXPERT],40,40
Disease,Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Paramyotonia congenita of Von Eulenburg,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Paramyotonia congenita of Von Eulenburg,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23516313[PMID],0.17,0.17
Disease,Paramyotonia congenita of Von Eulenburg,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,29606556[PMID],0.94,0.94
Disease,Paramyotonia congenita of Von Eulenburg,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23516313[PMID]_29606556[PMID],0,0
Disease,Acrodermatitis continua of Hallopeau,,,,,,,,,,,,,
Disease,Steinert myotonic dystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Disease,Steinert myotonic dystrophy,1-5 / 10 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ISBN:702021520[OTHER]_21364698[PMID],12.5,12.5
Disease,Steinert myotonic dystrophy,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],10.4,10.4
Disease,Steinert myotonic dystrophy,1-9 / 100 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,16264243[PMID],7.9,7.9
Disease,Steinert myotonic dystrophy,1-9 / 100 000,Serbia,409966,409966,25958,25958,en,Validated,410293,410293,16713671[PMID]_21364698[PMID],5.3,5.3
Disease,Steinert myotonic dystrophy,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,1745328[PMID],9.13,9.13
Disease,Steinert myotonic dystrophy,1-9 / 1 000 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,12902623[PMID]_21364698[PMID],0.46,0.46
Disease,Steinert myotonic dystrophy,1-5 / 10 000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,3992413[PMID],14.3,14.3
Disease,Steinert myotonic dystrophy,6-9 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,4973215[PMID],76.3,76.3
Disease,Steinert myotonic dystrophy,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,2924205[PMID]_21364698[PMID],210.5,210.5
Disease,Steinert myotonic dystrophy,1-9 / 1 000 000,Serbia,409967,409967,25958,25958,en,Validated,410293,410293,16713671[PMID],0.2,0.2
Disease,Steinert myotonic dystrophy,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,11359466[PMID]_21364698[PMID],9.31,9.31
Disease,Steinert myotonic dystrophy,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,14960839[PMID]_21364698[PMID],11.95,11.95
Disease,Steinert myotonic dystrophy,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,12784291[PMID]_21364698[PMID],20,20
Disease,Steinert myotonic dystrophy,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,12784291[PMID]_21364698[PMID],5.7,5.7
Disease,Steinert myotonic dystrophy,1-5 / 10 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,9088385[PMID]_21364698[PMID],18.1,18.1
Disease,Pustulosis palmaris et plantaris,,,,,,,,,,,,,
Disease,"X-linked intellectual disability, Najm type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,35,35
Disease,"X-linked intellectual disability, Najm type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Atopic keratoconjunctivitis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2009[INST],15,15
Category,Non-paraneoplastic limbic encephalitis,,,,,,,,,,,,,
Disease,Non-herpetic acute limbic encephalitis,,,,,,,,,,,,,
Disease,Thomsen and Becker disease,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,1822774[PMID],1,1
Disease,Thomsen and Becker disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Thomsen and Becker disease,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,9598722[PMID],7.3,7.3
Disease,Thomsen and Becker disease,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,7161034[PMID],0.9,0.9
Disease,Thomsen and Becker disease,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23516313[PMID],0.52,0.52
Disease,Thomsen and Becker disease,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,29606556[PMID],0.75,0.75
Particular clinical situation in a disease or syndrome,Posttransplant acute limbic encephalitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"X-linked dominant chondrodysplasia, Chassaing-Lacombe type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16001442[PMID]_[EXPERT],10,10
Disease,"X-linked dominant chondrodysplasia, Chassaing-Lacombe type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"X-linked intellectual disability, Cilliers type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17369115[PMID],0,0
Disease,"X-linked intellectual disability, Cilliers type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17369115[PMID],4,4
Malformation syndrome,"X-linked intellectual disability, Van Esch type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16053905[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Van Esch type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16053905[PMID],7,7
Disease,X-linked intellectual disability-craniofacioskeletal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17853486[PMID],0,0
Disease,X-linked intellectual disability-craniofacioskeletal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17853486[PMID],9,9
Disease,"X-linked intellectual disability, Nascimento type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20412111[PMID],8,8
Disease,"X-linked intellectual disability, Nascimento type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20412111[PMID],0,0
Disease,X-linked cerebral-cerebellar-coloboma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15887274[PMID],0,0
Disease,X-linked cerebral-cerebellar-coloboma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15887274[PMID],3,3
Category,Middle ear anomaly,,,,,,,,,,,,,
Disease,Acute myeloid leukemia and myelodysplastic syndromes related to radiation,,,,,,,,,,,,,
Disease,Fabry disease,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.22,0.22
Disease,Fabry disease,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.85,0.85
Disease,Fabry disease,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.21,0.21
Disease,Fabry disease,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.12,0.12
Disease,Fabry disease,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.52,0.52
Disease,Fabry disease,<1 / 1 000 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,15275696[PMID],0.015,0.015
Disease,Fabry disease,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,11732485[PMID],0.15,0.15
Disease,Fabry disease,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,22790789[PMID],0.25,0.25
Disease,Fabry disease,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fabry disease,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],1.11,1.11
Disease,Hyperekplexia-epilepsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30078784[PMID],4,4
Disease,Hyperekplexia-epilepsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30078784[PMID],0,0
Disease,Rett syndrome,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,12378695[PMID]_21878110[PMID],5,5
Disease,Rett syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2019[INST],10,10
Disease,Rett syndrome,1-9 / 100 000,France,409966,409966,25965,25965,en,Not yet validated,410294,410294,16647997[PMID]_ORPHANET,0,0
Disease,Rett syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Rett syndrome,1-9 / 100 000,Sweden,409966,409966,25965,25965,en,Not yet validated,410294,410294,3571139[PMID]_ORPHANET,5,5
Disease,Rett syndrome,1-9 / 100 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,2803793[PMID],0,0
Disease,Rett syndrome,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,2063900[PMID],0,0
Disease,Rett syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,National Congenital Anomaly and Rare Disease Registration Service 2017[INST]_3087206[PMID],1.6,1.6
Disease,Rett syndrome,1-9 / 100 000,Australia,409968,409968,25965,25965,en,Not yet validated,410294,410294,21587099[PMID]_ORPHANET,3.05,3.05
Disease,Rett syndrome,1-9 / 100 000,Australia,409966,409966,25965,25965,en,Not yet validated,410294,410294,21587099[PMID],0,0
Disease,Rett syndrome,1-9 / 100 000,Hong Kong,409966,409966,25965,25965,en,Not yet validated,410294,410294,18174559[PMID],0,0
Category,Rare odontal or periodontal disorder,,,,,,,,,,,,,
Malformation syndrome,Angelman syndrome,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20301323[PMID]_21587322[PMID]_[EXPERT]_ORPHANET,7.5,7.5
Malformation syndrome,Angelman syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],1.3,1.3
Malformation syndrome,Angelman syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2009[REG],0,0
Malformation syndrome,Angelman syndrome,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,16492624[PMID],2.5,2.5
Malformation syndrome,Angelman syndrome,1-9 / 100 000,Australia,409966,409966,25965,25965,en,Not yet validated,410294,410294,16492624[PMID],0,0
Malformation syndrome,Angelman syndrome,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,12373673[PMID],5,5
Malformation syndrome,Angelman syndrome,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,12373673[PMID],8.3,8.3
Malformation syndrome,Angelman syndrome,1-9 / 100 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,16906556[PMID],1.8,1.8
Malformation syndrome,Angelman syndrome,1-9 / 100 000,Estonia,409966,409966,25965,25965,en,Not yet validated,410294,410294,16906556[PMID],0,0
Malformation syndrome,Angelman syndrome,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,7573182[PMID],10,10
Malformation syndrome,Angelman syndrome,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,23913711[PMID],0.5,0.5
Malformation syndrome,Angelman syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21152085[PMID],4,4
Category,Genetic pancreatic disease,,,,,,,,,,,,,
Disease,Juvenile myoclonic epilepsy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic gastro-esophageal disease,,,,,,,,,,,,,
Category,Genetic intestinal disease,,,,,,,,,,,,,
Category,Rare genetic gastroenterological disease,,,,,,,,,,,,,
Disease,Juvenile absence epilepsy,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,8275976[PMID]_ORPHANET,7.5,7.5
Disease,Juvenile absence epilepsy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Gabrielle Rudolf[EXPERT],0,0
Disease,Von Hippel-Lindau disease,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,20082463[PMID]_[EXPERT],2.3,2.3
Disease,Von Hippel-Lindau disease,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,20082463[PMID]_[EXPERT],1.1,1.1
Disease,Von Hippel-Lindau disease,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Von Hippel-Lindau disease,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,27966541[PMID],2.13,2.13
Disease,Von Hippel-Lindau disease,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,27966541[PMID],3.66,3.66
Category,Rare acquired aplastic anemia,,,,,,,,,,,,,
Disease,Autosomal recessive polycystic kidney disease,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_9511976[PMID],5,5
Disease,Autosomal recessive polycystic kidney disease,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial advanced sleep-phase syndrome,,,,,,,,,,,,,
Malformation syndrome,CHARGE syndrome,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,15637722[PMID],3.5,3.5
Malformation syndrome,CHARGE syndrome,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,16959034[PMID],6.5,6.5
Malformation syndrome,CHARGE syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,CHARGE syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2019[INST],9,9
Disease,Marfan syndrome,1-5 / 10 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,16325700[PMID]_ORPHANET,25,25
Disease,Marfan syndrome,1-5 / 10 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301510[PMID],15,15
Disease,Marfan syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Marfan syndrome,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,8151638[PMID],10.2,10.2
Disease,Marfan syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,8151638[PMID],7,7
Disease,Marfan syndrome,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,3788757[PMID],10,10
Disease,Familial mesial temporal lobe epilepsy with febrile seizures,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21922598[PMID],4,4
Disease,Familial mesial temporal lobe epilepsy with febrile seizures,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21922598[PMID],0,0
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,19710046[PMID]_[EXPERT],2.2,2.2
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,19192301[PMID]_[EXPERT],5.2,5.2
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,21665992[PMID],3.85,3.85
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,21665992[PMID],1.35,1.35
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,17898523[PMID]_17219036[PMID],1.06,1.06
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,17898523[PMID],4.9,4.9
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,10025778[PMID],2.1,2.1
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,10025778[PMID],4.7,4.7
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,6601351[PMID],2.4,2.4
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,6601351[PMID],6.4,6.4
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Canada,409967,409967,25965,25965,en,Not yet validated,410294,410294,3762972[PMID]_19494548[PMID]_ ORPHANET,2,2
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,3762972[PMID],4.9,4.9
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,25298019[PMID],1.46,1.46
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Uruguay,409967,409967,25958,25958,en,Validated,410293,410293,18334826[PMID],1.37,1.37
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Uruguay,409966,409966,25958,25958,en,Validated,410293,410293,18334826[PMID],1.9,1.9
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,2786160[PMID],1.4,1.4
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,2786160[PMID],3.1,3.1
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,19237701[PMID],3,3
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Italy,409966,409966,25965,25965,en,Not yet validated,410294,410294,19237701[PMID],7.9,7.9
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,19452307[PMID],2,2
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,23286747[PMID],1.4,1.4
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,23286747[PMID],5.4,5.4
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,21860251[PMID],2.2,2.2
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,21860251[PMID],4,4
Disease,Amyotrophic lateral sclerosis,1-9 / 1 000 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,DOI:10.1016/j.jfma.2013.01.008[OTHER],0.51,0.51
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,DOI:10.1016/j.jfma.2013.01.008[OTHER],1.97,1.97
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Faroe Islands,409967,409967,25958,25958,en,Validated,410293,410293,22034926[PMID],2.6,2.6
Disease,Amyotrophic lateral sclerosis,1-9 / 1 000 000,"Iran, Islamic Republic of",409967,409967,25958,25958,en,Validated,410293,410293,20214678[PMID],0.42,0.42
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,"Iran, Islamic Republic of",409966,409966,25958,25958,en,Validated,410293,410293,20214678[PMID],1.57,1.57
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Specific population,409967,409967,25958,25958,en,Validated,410293,410293,23052600[PMID],2.5,2.5
Disease,Amyotrophic lateral sclerosis,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,23052600[PMID],10.8,10.8
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Specific population,409967,409967,25958,25958,en,Validated,410293,410293,22409362[PMID],1.4,1.4
Disease,Amyotrophic lateral sclerosis,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,22409362[PMID],6,6
Category,Rare abdominal surgical disease,,,,,,,,,,,,,
Category,Syndromic urogenital tract malformation,,,,,,,,,,,,,
Disease,Ataxia-telangiectasia,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,19339254[PMID],10,10
Disease,Ataxia-telangiectasia,1-9 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,19339254[PMID],0.4,0.4
Disease,Ataxia-telangiectasia,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20301790[PMID]_21569628[PMID],1.7,1.7
Disease,Ataxia-telangiectasia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19339254[PMID]_23609960[PMID]_19440741[PMID]_1512613[PMID],0.49,0.49
Disease,Ataxia-telangiectasia,1-9 / 1 000 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,23609960[PMID],0.15,0.15
Disease,Ataxia-telangiectasia,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,19440741[PMID],0.25,0.25
Disease,Ataxia-telangiectasia,1-9 / 1 000 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,Ataxia Telangiectasia Society 2014[OTHER],0.25,0.25
Disease,Ataxia-telangiectasia,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,1512613[PMID],1.19,1.19
Category,Non-syndromic urogenital tract malformation,,,,,,,,,,,,,
Disease,Familial adenomatous polyposis,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial adenomatous polyposis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],6,6
Disease,Familial adenomatous polyposis,1-5 / 10 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,12692062[PMID],19,19
Disease,Familial adenomatous polyposis,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,12692062[PMID],4.65,4.65
Disease,Familial adenomatous polyposis,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,10636071[PMID],8.6,8.6
Disease,Familial adenomatous polyposis,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,10636071[PMID],3.2,3.2
Disease,Familial adenomatous polyposis,1-5 / 10 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,1314763[PMID],15.8,15.8
Disease,Familial adenomatous polyposis,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,1314763[PMID],2.63,2.63
Disease,Familial adenomatous polyposis,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,20082463[PMID],11.6,11.6
Disease,Familial adenomatous polyposis,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,20082463[PMID],5.3,5.3
Disease,Familial adenomatous polyposis,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,2556632[PMID],0.24,0.24
Disease,Familial adenomatous polyposis,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,2556632[PMID],2.8,2.8
Disease,Huntington disease,1-9 / 100 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,21166788[PMID],4,4
Disease,Huntington disease,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,22692795[PMID],0.38,0.38
Disease,Huntington disease,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,22692795[PMID],2.7,2.7
Disease,Huntington disease,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2019[INST],12,12
Disease,Huntington disease,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,20880124[PMID],10.6,10.6
Disease,Huntington disease,1-9 / 1 000 000,United Kingdom,409967,409967,25965,25965,en,Not yet validated,410294,410294,22133668[PMID]_ORPHANET,0.61,0.61
Disease,Huntington disease,1-9 / 100 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,22133668[PMID]_21088431[PMID]_7994530[PMID]_9231935[PMID],5.4,5.4
Disease,Huntington disease,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,15716522[PMID],0.47,0.47
Disease,Huntington disease,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,2151397[PMID],0.11,0.11
Disease,Huntington disease,1-9 / 100 000,Italy,409966,409966,25965,25965,en,Not yet validated,410294,410294,2151397[PMID]_25689972[PMID],6.35,6.35
Disease,Huntington disease,1-9 / 1 000 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,11595021[PMID],0.69,0.69
Disease,Huntington disease,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,8018043[PMID],0.3,0.3
Disease,Huntington disease,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,8018043[PMID],1.9,1.9
Disease,Huntington disease,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,8700304[PMID],0.65,0.65
Disease,Huntington disease,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,11008591[PMID],0.65,0.65
Disease,Huntington disease,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,11008591[PMID],6.3,6.3
Disease,Huntington disease,<1 / 1 000 000,China,409967,409967,25958,25958,en,Validated,410293,410293,7586664[PMID],0.046,0.046
Disease,Huntington disease,1-9 / 1 000 000,China,409966,409966,25958,25958,en,Validated,410293,410293,7586664[PMID],0.37,0.37
Disease,Huntington disease,1-9 / 100 000,Slovenia,409966,409966,25958,25958,en,Validated,410293,410293,18976322[PMID],5.2,5.2
Disease,Huntington disease,<1 / 1 000 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,7586664[PMID],0.08,0.08
Disease,Huntington disease,1-9 / 1 000 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,7586664[PMID],0.42,0.42
Disease,Huntington disease,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,22722209[PMID],0.14,0.14
Disease,Huntington disease,1-9 / 100 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,22722209[PMID],1,1
Disease,Huntington disease,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,2938203[PMID],6.7,6.7
Disease,Huntington disease,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,22722209[PMID],4.7,4.7
Disease,Huntington disease,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,21166788[PMID],0.33,0.33
Disease,Huntington disease,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,2889026[PMID],0.5,0.5
Disease,Huntington disease,1-5 / 10 000,Egypt,409966,409966,25958,25958,en,Validated,410293,410293,7969703[PMID],21,21
Disease,Huntington disease,1-9 / 100 000,Cyprus,409966,409966,25958,25958,en,Validated,410293,410293,29105741[PMID],4.64,4.64
Disease,Huntington disease,1-9 / 1 000 000,Cyprus,409967,409967,25958,25958,en,Validated,410293,410293,29105741[PMID],0.12,0.12
Disease,Huntington disease,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,28155235[PMID],5.8,5.8
Disease,Wound myiasis,,,,,,,,,,,,,
Disease,Lafora disease,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Lafora disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lafora disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25217339[PMID],300,300
Disease,Lafora disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25217339[PMID],0,0
Malformation syndrome,Down syndrome,6-9 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,World Health Organization[INST],95,95
Malformation syndrome,Down syndrome,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization[INST],0,0
Malformation syndrome,Down syndrome,6-9 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2012[REG],97.7,97.7
Malformation syndrome,Down syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2012[REG],0,0
Malformation syndrome,Down syndrome,6-9 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,Institut de Veille Sanitaire 2011[INST],63.7,63.7
Malformation syndrome,Down syndrome,6-9 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],98.3,98.3
Malformation syndrome,Down syndrome,6-9 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],70,70
Malformation syndrome,Down syndrome,6-9 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],74,74
Malformation syndrome,Down syndrome,6-9 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],91.2,91.2
Malformation syndrome,Down syndrome,>1 / 1000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],110,110
Malformation syndrome,Down syndrome,6-9 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],69,69
Malformation syndrome,Down syndrome,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],38,38
Malformation syndrome,Down syndrome,6-9 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],91.6,91.6
Malformation syndrome,Down syndrome,6-9 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],98,98
Malformation syndrome,Down syndrome,6-9 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],66,66
Malformation syndrome,Down syndrome,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],59,59
Malformation syndrome,Down syndrome,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],44,44
Malformation syndrome,Down syndrome,6-9 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],75,75
Malformation syndrome,Down syndrome,>1 / 1000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],235,235
Malformation syndrome,Down syndrome,>1 / 1000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],100,100
Malformation syndrome,Down syndrome,>1 / 1000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,18412274[PMID],174,174
Malformation syndrome,Down syndrome,6-9 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23321618[PMID],66,66
Malformation syndrome,Down syndrome,>1 / 1000,United States,409968,409968,25958,25958,en,Validated,410293,410293,25822844[PMID],126,126
Malformation syndrome,Down syndrome,>1 / 1000,South Africa,409968,409968,25958,25958,en,Validated,410293,410293,9373864[PMID],130,130
Disease,Cavitary myiasis,,,,,,,,,,,,,
Disease,Metachromatic leukodystrophy,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,21496291[PMID]_[EXPERT]_European Medicines Agency 2010[INST],1.47,1.47
Disease,Metachromatic leukodystrophy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,21496291[PMID]_[EXPERT]_European Medicines Agency 2010[INST],0.1,0.1
Disease,Metachromatic leukodystrophy,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],1.42,1.42
Disease,Metachromatic leukodystrophy,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],1.85,1.85
Disease,Metachromatic leukodystrophy,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,9286459[PMID],0.6,0.6
Disease,Metachromatic leukodystrophy,1-9 / 100 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],1.43,1.43
Disease,Metachromatic leukodystrophy,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],1.09,1.09
Disease,Metachromatic leukodystrophy,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.69,0.69
Disease,Metachromatic leukodystrophy,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,21695197[PMID],0.38,0.38
Disease,Metachromatic leukodystrophy,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,19380076[PMID],2.5,2.5
Disease,Metachromatic leukodystrophy,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_21695197[PMID]_20490927[PMID]_19380076[PMID]_9918480[PMID]_9286459[PMID]_14685153[PMID]_10480370[PMID],0,0
Disease,Metachromatic leukodystrophy,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],1.73,1.73
Disease,"Multiple epiphyseal dysplasia, Beighton type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,699354[PMID],1,1
Disease,"Multiple epiphyseal dysplasia, Beighton type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_699354[PMID],0,0
Malformation syndrome,22q11.2 deletion syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],9.6,9.6
Malformation syndrome,22q11.2 deletion syndrome,1-5 / 10 000,France,409968,409968,25965,25965,en,Not yet validated,410294,410294,8863171[PMID],10.3,10.3
Malformation syndrome,22q11.2 deletion syndrome,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,21570089[PMID]_ORPHANET,37.5,37.5
Malformation syndrome,22q11.2 deletion syndrome,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,12837874[PMID],16.8,16.8
Malformation syndrome,22q11.2 deletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,22q11.2 deletion syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2019[INST],0,0
Disease,"Multiple epiphyseal dysplasia, Lowry type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8723087[PMID],2,2
Disease,"Multiple epiphyseal dysplasia, Lowry type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8723087[PMID],0,0
Disease,Sickle cell anemia,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,Institut de Veille Sanitaire 2010[INST],42,42
Disease,Sickle cell anemia,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,24398797[PMID],25,25
Disease,Sickle cell anemia,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,20331952[PMID]_Center for Diseases Control and Prevention[INST],30,30
Disease,Sickle cell anemia,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,10321364[PMID],47.5,47.5
Disease,Sickle cell anemia,1-5 / 10 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,Sickle Cell Society 2008[OTHER],41.7,41.7
Disease,Sickle cell anemia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2019[INST],10,10
Disease,Sickle cell anemia,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,17183567[PMID],32.8,32.8
Disease,Sickle cell anemia,>1 / 1000,Guadeloupe,409968,409968,25965,25965,en,Not yet validated,410294,410294,Institut de Veille Sanitaire 2015[INST],344.8,344.8
Disease,Sickle cell anemia,>1 / 1000,Martinique,409968,409968,25965,25965,en,Not yet validated,410294,410294,Institut de Veille Sanitaire 2015[INST],248.75,248.75
Disease,Sickle cell anemia,>1 / 1000,Guyana,409968,409968,25965,25965,en,Not yet validated,410294,410294,Institut de Veille Sanitaire 2015[INST],467.3,467.3
Disease,Sickle cell anemia,1-5 / 10 000,Reunion,409968,409968,25965,25965,en,Not yet validated,410294,410294,Institut de Veille Sanitaire 2015[INST],20.15,20.15
Disease,Systemic lupus erythematosus,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,25172239[PMID]_28968809[PMID],47,47
Disease,Systemic lupus erythematosus,6-9 / 10 000,Martinique,409966,409966,25958,25958,en,Validated,410293,410293,11859691[PMID]_28968809[PMID],64.2,64.2
Disease,Systemic lupus erythematosus,1-5 / 10 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,6929995[PMID]_28968809[PMID],14.7,14.7
Disease,Systemic lupus erythematosus,1-5 / 10 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,24322455[PMID]_28968809[PMID],20.6,20.6
Disease,Systemic lupus erythematosus,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,15333286[PMID]_28968809[PMID],53.6,53.6
Disease,Systemic lupus erythematosus,1-5 / 10 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,22899470[PMID]_28968809[PMID],37,37
Disease,Systemic lupus erythematosus,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Systemic lupus erythematosus,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,4001877[PMID]_28968809[PMID],28,28
Disease,Multiple epiphyseal dysplasia due to collagen 9 anomaly,,,,,,,,,,,,,
Malformation syndrome,Oculocerebrorenal syndrome of Lowe,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,16722554[PMID],0.2,0.2
Malformation syndrome,Oculocerebrorenal syndrome of Lowe,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,16722554[PMID]_[EXPERT],0.2,0.2
Malformation syndrome,Oculocerebrorenal syndrome of Lowe,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21152085[PMID],0.2,0.2
Clinical group,Diazoxide-resistant diffuse hyperinsulinism,,,,,,,,,,,,,
Disease,Retinoblastoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.05,0.05
Disease,Retinoblastoma,1-9 / 100 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,19373260[PMID],4.6,4.6
Disease,Retinoblastoma,1-9 / 100 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,24692122[PMID],5.9,5.9
Disease,Retinoblastoma,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.05,1.05
Disease,Retinoblastoma,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,22414599[PMID]_19704035[PMID]_ [EXPERT],6,6
Disease,Retinoblastoma,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,1513060[PMID],5.05,5.05
Disease,Retinoblastoma,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Retinoblastoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Retinoblastoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.073,0.073
Disease,Retinoblastoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.035,0.035
Disease,Retinoblastoma,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.04,0.04
Disease,Retinoblastoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Retinoblastoma,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.053,0.053
Disease,Retinoblastoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.033,0.033
Disease,Retinoblastoma,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Retinoblastoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.071,0.071
Disease,Retinoblastoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Retinoblastoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Retinoblastoma,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Retinoblastoma,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.094,0.094
Disease,Retinoblastoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.071,0.071
Disease,Retinoblastoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.038,0.038
Disease,Retinoblastoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.047,0.047
Disease,Retinoblastoma,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.042,0.042
Disease,Retinoblastoma,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.038,0.038
Disease,Retinoblastoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.048,0.048
Disease,Retinoblastoma,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Retinoblastoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.071,0.071
Disease,Retinoblastoma,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.107,0.107
Disease,Exercise-induced hyperinsulinism,,,,,,,,,,,,,
Disease,Multiple endocrine neoplasia type 1,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20301710[PMID]_17014705[PMID]_ [EXPERT],3.3,3.3
Clinical group,Diazoxide-sensitive diffuse hyperinsulinism,,,,,,,,,,,,,
Malformation syndrome,Fragile X syndrome,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,18413371[PMID]_[EXPERT]_ ORPHANET,32.5,32.5
Malformation syndrome,Fragile X syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],20,20
Malformation syndrome,Fragile X syndrome,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,19804849[PMID]_23765048[PMID],9.7,9.7
Malformation syndrome,Fragile X syndrome,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22925539[PMID],1.3,1.3
Malformation syndrome,Fragile X syndrome,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,19460941[PMID],19,19
Malformation syndrome,Fragile X syndrome,1-5 / 10 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,19863547[PMID],16.11,16.11
Malformation syndrome,Fragile X syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],2.4,2.4
Disease,Rheumatic fever,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,21386976[PMID]_[EXPERT],5,5
Disease,Rheumatic fever,1-5 / 10 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,21386976[PMID]_[EXPERT]_ ORPHANET,12.5,12.5
Disease,Rheumatic fever,1-5 / 10 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,21386976[PMID]_[EXPERT]_ ORPHANET,12.5,12.5
Disease,Rheumatic fever,>1 / 1000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,21386976[PMID]_[EXPERT],100,100
Disease,Rheumatic fever,1-5 / 10 000,India,409967,409967,25958,25958,en,Validated,410293,410293,21386976[PMID]_[EXPERT]_ ORPHANET,30,30
Disease,Rheumatic fever,>1 / 1000,Mexico,409967,409967,25958,25958,en,Validated,410293,410293,21386976[PMID]_[EXPERT],100,100
Disease,Rheumatic fever,1-9 / 100 000,Latin America,409967,409967,25958,25958,en,Validated,410293,410293,21386976[PMID]_[EXPERT],5,5
Disease,Rheumatic fever,1-9 / 100 000,New Zealand,409967,409967,25958,25958,en,Validated,410293,410293,23254495[PMID]_21386976[PMID]_ [EXPERT],7.6,7.6
Disease,Rheumatic fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Prader-Willi syndrome,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Prader-Willi syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Prader-Willi syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],3.1,3.1
Disease,Prader-Willi syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0,0
Disease,Prader-Willi syndrome,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,14679397[PMID],3.7,3.7
Disease,Prader-Willi syndrome,1-9 / 100 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,14679397[PMID],1.3,1.3
Disease,Prader-Willi syndrome,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,11732491[PMID],3.4,3.4
Disease,Prader-Willi syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,11732491[PMID],1.9,1.9
Disease,Prader-Willi syndrome,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,8579217[PMID],6.6,6.6
Disease,Prader-Willi syndrome,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,8579217[PMID],0,0
Disease,Prader-Willi syndrome,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,12598399[PMID],4,4
Disease,Prader-Willi syndrome,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,12598399[PMID],0,0
Disease,Prader-Willi syndrome,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,2240051[PMID],6.2,6.2
Disease,Prader-Willi syndrome,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,2240051[PMID],0,0
Disease,Prader-Willi syndrome,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,28659150[PMID],4.76,4.76
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,19419768[PMID],0.1,0.1
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.22,0.22
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.18,0.18
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.21,0.21
Clinical subtype,X-linked agammaglobulinemia,<1 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.08,0.08
Clinical subtype,X-linked agammaglobulinemia,<1 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.06,0.06
Clinical subtype,X-linked agammaglobulinemia,<1 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.03,0.03
Clinical subtype,X-linked agammaglobulinemia,<1 / 1 000 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.09,0.09
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.13,0.13
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,Hungary,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.16,0.16
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,"Macedonia, the former Yugoslav Republic of",409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.25,0.25
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,Slovenia,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.1,0.1
Clinical subtype,X-linked agammaglobulinemia,<1 / 1 000 000,Serbia,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.09,0.09
Clinical subtype,X-linked agammaglobulinemia,<1 / 1 000 000,Ukraine,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.04,0.04
Clinical subtype,X-linked agammaglobulinemia,<1 / 1 000 000,Belarus,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.06,0.06
Clinical subtype,X-linked agammaglobulinemia,<1 / 1 000 000,Romania,409966,409966,25958,25958,en,Validated,410293,410293,19419768[PMID],0.03,0.03
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,16862044[PMID],0.26,0.26
Clinical subtype,X-linked agammaglobulinemia,<1 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,16862044[PMID],0.07,0.07
Clinical subtype,X-linked agammaglobulinemia,1-9 / 1 000 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,22787376[PMID],0.11,0.11
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.7,0.7
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID]_25274184[PMID],0.31,0.31
Disease,Mucopolysaccharidosis type 2,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID]_[EXPERT],9.1,9.1
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID]_[EXPERT],0.43,0.43
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,9439667[PMID]_[EXPERT],0.71,0.71
Disease,Mucopolysaccharidosis type 2,1-9 / 100 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,19396827[PMID]_[EXPERT],1.07,1.07
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID]_[EXPERT],0.74,0.74
Disease,Mucopolysaccharidosis type 2,1-9 / 100 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,22480138[PMID]_[EXPERT],2.16,2.16
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10617747[PMID]_[EXPERT],0.1,0.1
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018 [INST],0.2,0.2
Disease,Mucopolysaccharidosis type 2,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID]_[EXPERT],1.09,1.09
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,16435194[PMID]_[EXPERT],0.64,0.64
Disease,Mucopolysaccharidosis type 2,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID]_[EXPERT],1.21,1.21
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID]_[EXPERT],0.67,0.67
Disease,Mucopolysaccharidosis type 2,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID]_[EXPERT],6.5,6.5
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID]_[EXPERT],0.13,0.13
Disease,Mucopolysaccharidosis type 2,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID]_[EXPERT],4.4,4.4
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID]_[EXPERT],0.27,0.27
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.68,0.68
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,25472774[PMID],0.46,0.46
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.84,0.84
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.46,0.46
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,25364648[PMID],0.74,0.74
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Tunisia,409968,409968,25958,25958,en,Validated,410293,410293,20209839[PMID],0.29,0.29
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2016.11.285[OTHER],0.29,0.29
Disease,Mucopolysaccharidosis type 2,1-9 / 1 000 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2014.12.082[OTHER],0.38,0.38
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,16435194[PMID],0.69,0.69
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],1.33,1.33
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],1.19,1.19
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID]_25274184[PMID],0.67,0.67
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],8.7,8.7
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],1.85,1.85
Disease,Mucopolysaccharidosis type 1,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],31,31
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],0.54,0.54
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],7.4,7.4
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,18463126[PMID],3.8,3.8
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,18796143[PMID],1.07,1.07
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Tunisia,409968,409968,25958,25958,en,Validated,410293,410293,20209839[PMID],0.63,0.63
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,19396827[PMID],0.11,0.11
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10617747[PMID],0.58,0.58
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],1.14,1.14
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.72,0.72
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],0.5,0.5
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.82,0.82
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,25472774[PMID],0.22,0.22
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.23,0.23
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.19,0.19
Disease,Mucopolysaccharidosis type 1,1-9 / 100 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,20622343[PMID],3.62,3.62
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,25364648[PMID],0.21,0.21
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2014.12.082[OTHER],0.24,0.24
Disease,Mucopolysaccharidosis type 1,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2016.11.285[OTHER],0.34,0.34
Disease,Wilson disease,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,17276780[PMID],2.2,2.2
Disease,Wilson disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],6,6
Disease,Wilson disease,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,DOI:10.1016/S0168-8278(85)80013-1[OTHER]_17276780[PMID],3.3,3.3
Disease,Wilson disease,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,28648494[PMID],1.5,1.5
Disease,Wilson disease,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],0.94,0.94
Disease,Wilson disease,1-5 / 10 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,7338703[PMID]_17276780 [PMID],3,3
Disease,Wilson disease,1-5 / 10 000,China,409966,409966,25958,25958,en,Validated,410293,410293,20301685[PMID],10,10
Disease,Wilson disease,1-5 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],13.5,13.5
Disease,Wilson disease,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,23486543[PMID],37.04,37.04
Disease,Wilson disease,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,8459248[PMID],1.37,1.37
Disease,Wilson disease,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,542546[PMID]_17276780[PMID],2.9,2.9
Category,Non-syndromic cerebral malformation due to abnormal neuronal migration,,,,,,,,,,,,,
Malformation syndrome,X-linked retinoschisis,1-9 / 100 000,Denmark,409966,409966,25965,25965,en,Not yet validated,410294,410294,17172462[PMID]_ORPHANET,5,5
Malformation syndrome,X-linked retinoschisis,1-9 / 100 000,Netherlands,409966,409966,25965,25965,en,Not yet validated,410294,410294,17172462[PMID]_ORPHANET,5,5
Malformation syndrome,X-linked retinoschisis,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Malformation syndrome,X-linked retinoschisis,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,1918822[PMID],3.6,3.6
Malformation syndrome,X-linked retinoschisis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,17172462[PMID]_1918822[PMID]_ ORPHANET,4.5,4.5
Disease,Subacute cutaneous lupus erythematosus,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,19289752[PMID],0.63,0.63
Disease,Stargardt disease,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],13,13
Category,Rare bacterial infectious disease,,,,,,,,,,,,,
Clinical group,Chronic cutaneous lupus erythematosus,,,,,,,,,,,,,
Disease,Wiskott-Aldrich syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],0.1,0.1
Disease,Wiskott-Aldrich syndrome,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.18,0.18
Disease,Wiskott-Aldrich syndrome,1-9 / 1 000 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,3065352[PMID],0.2,0.2
Disease,Wiskott-Aldrich syndrome,1-9 / 1 000 000,Norway,409966,409966,25965,25965,en,Not yet validated,410294,410294,11202238[PMID]_ORPHANET,0.55,0.55
Disease,Wiskott-Aldrich syndrome,<1 / 1 000 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,9314356[PMID],0.07,0.07
Disease,Wiskott-Aldrich syndrome,<1 / 1 000 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,22787376[PMID],0.03,0.03
Disease,Wiskott-Aldrich syndrome,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,7381651[PMID],0.2,0.2
Malformation syndrome,Williams syndrome,1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,10.8,10.8
Malformation syndrome,Williams syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.8,1.8
Malformation syndrome,Williams syndrome,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,12088082[PMID],13.3,13.3
Malformation syndrome,Williams syndrome,1-9 / 100 000,Hong Kong,409968,409968,25958,25958,en,Validated,410293,410293,14967851[PMID],4.2,4.2
Malformation syndrome,Williams syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Wolf-Hirschhorn syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,11480768[PMID]_[EXPERT],2,2
Malformation syndrome,Wolf-Hirschhorn syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,11480768[PMID]_[EXPERT],0,0
Malformation syndrome,Isolated congenital nasal pyriform aperture stenosis,,,,,,,,,,,,,
Disease,Achondroplasia,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_30606190[PMID],4,4
Disease,Achondroplasia,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_30606190[PMID],0,0
Disease,Achondroplasia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_31294928[PMID],3,3
Disease,Achondroplasia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Achondroplasia,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,2785882[PMID],6.4,6.4
Disease,Achondroplasia,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,3071354[PMID]_[EXPERT],3.7,3.7
Disease,Achondroplasia,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,8449630[PMID]_[EXPERT],2.8,2.8
Disease,Achondroplasia,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,2.6,2.6
Disease,Achondroplasia,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,2783977[PMID]_[EXPERT],1.3,1.3
Disease,Achondroplasia,1-9 / 1 000 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,22375084[PMID],0.7,0.7
Disease,Achondroplasia,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,18698630[PMID]_22461456[PMID]_[EXPERT],3.5,3.5
Disease,Achondroplasia,1-9 / 100 000,Latin America,409968,409968,25958,25958,en,Validated,410293,410293,22407836[PMID]_[EXPERT],4.4,4.4
Disease,Achondroplasia,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,458831[PMID]_[EXPERT],3.8,3.8
Disease,Ataxia with vitamin E deficiency,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.33,0.33
Morphological anomaly,Isolated congenital auditory ossicle malformation,,,,,,,,,,,,,
Disease,Dentatorubral pallidoluysian atrophy,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,18418674[PMID]_[EXPERT],0.48,0.48
Disease,Dentatorubral pallidoluysian atrophy,1-9 / 1 000 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,17965145[PMID],0.71,0.71
Disease,Dentatorubral pallidoluysian atrophy,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Rubinstein-Taybi syndrome,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,2118773[PMID],0.9,0.9
Malformation syndrome,Rubinstein-Taybi syndrome,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,2118773[PMID],0,0
Malformation syndrome,Rubinstein-Taybi syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.7,0.7
Malformation syndrome,Rubinstein-Taybi syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Spondyloepiphyseal dysplasia, Nishimura type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9557884[PMID],4,4
Disease,"Spondyloepiphyseal dysplasia, Nishimura type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9557884[PMID],0,0
Disease,Non-acquired isolated growth hormone deficiency,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,22851490[PMID],0,0
Disease,T-B+ severe combined immunodeficiency due to gamma chain deficiency,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Spondyloepiphyseal dysplasia, Cantu type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17515304[PMID],4,4
Disease,"Spondyloepiphyseal dysplasia, Cantu type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17515304[PMID],0,0
Disease,Kennedy disease,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,11949733[PMID]_[EXPERT],0.09,0.09
Disease,Kennedy disease,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11949733[PMID]_[EXPERT],1.6,1.6
Disease,Kennedy disease,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,11949733[PMID]_[EXPERT],0,0
Disease,Kennedy disease,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,9724012[PMID],7.6,7.6
Disease,Ornithine transcarbamylase deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],1,1
Disease,Ornithine transcarbamylase deficiency,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],1.4,1.4
Disease,Ornithine transcarbamylase deficiency,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,15050980[PMID],1.29,1.29
Disease,Ornithine transcarbamylase deficiency,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,18616627[PMID],1.6,1.6
Disease,Ornithine transcarbamylase deficiency,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,12788994[PMID]_10617747[PMID]_ORPHANET_[EXPERT],0.88,0.88
Disease,Ornithine transcarbamylase deficiency,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,23972786[PMID],1.77,1.77
Disease,Ornithine transcarbamylase deficiency,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,23972786[PMID]_[EXPERT],1.77,1.77
Malformation syndrome,"Spondyloepiphyseal dysplasia, MacDermot type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3681905[PMID],4,4
Malformation syndrome,"Spondyloepiphyseal dysplasia, MacDermot type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3681905[PMID],0,0
Disease,"Spondyloepiphyseal dysplasia, Reardon type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7747755[PMID],1,1
Disease,"Spondyloepiphyseal dysplasia, Reardon type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7747755[PMID],0,0
Disease,Classic homocystinuria,1-9 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,10328723[PMID],0.3,0.3
Disease,Classic homocystinuria,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2001[INST],1.65,1.65
Disease,Classic homocystinuria,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,9587032[PMID],1.5,1.5
Disease,Classic homocystinuria,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,9587032[PMID],0.77,0.77
Disease,Classic homocystinuria,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,15192637[PMID],15.6,15.6
Disease,Classic homocystinuria,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,10328723[PMID],5,5
Disease,Classic homocystinuria,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,646432[PMID],1.7,1.7
Disease,Classic homocystinuria,1-5 / 10 000,Qatar,409968,409968,25958,25958,en,Validated,410293,410293,19914636[PMID],55.5,55.5
Disease,Classic homocystinuria,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,9587032[PMID],0.11,0.11
Disease,"Spondyloepiphyseal dysplasia tarda, Kohn type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3612708[PMID],3,3
Disease,"Spondyloepiphyseal dysplasia tarda, Kohn type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3612708[PMID],0,0
Malformation syndrome,Leprechaunism,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Leprechaunism,<1 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,9128805[PMID],0,0
Category,Rare mycosis,,,,,,,,,,,,,
Disease,Hypophosphatasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT]_21488855[PMID],0,0
Clinical subtype,Hb Bart's hydrops fetalis,>1 / 1000,South East Asia,409968,409968,25958,25958,en,Validated,410293,410293,19459517[PMID]_2351917[PMID]_ [EXPERT],275,275
Clinical subtype,Hb Bart's hydrops fetalis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Hb Bart's hydrops fetalis,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,21167500[PMID],7.6,7.6
Category,Rare viral disease,,,,,,,,,,,,,
Disease,Hypochondroplasia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3.3,3.3
Category,Rare parasitic disease,,,,,,,,,,,,,
Clinical group,Hypophosphatemic rickets,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,"Rare disorder related with pregnancy, childbirth and puerperium",,,,,,,,,,,,,
Disease,Leber hereditary optic neuropathy,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,16564802[PMID],2.6,2.6
Disease,Leber hereditary optic neuropathy,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],4.3,4.3
Disease,Leber hereditary optic neuropathy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,21928272[PMID],2.3,2.3
Disease,Leber hereditary optic neuropathy,1-9 / 100 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,12518276[PMID],3.22,3.22
Disease,Leber hereditary optic neuropathy,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,17406640[PMID],2,2
Disease,Leber hereditary optic neuropathy,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,27007794[PMID],1.85,1.85
Category,Bile acid synthesis defect with cholestasis and malabsorption,,,,,,,,,,,,,
Clinical subtype,Hydrocephalus with stenosis of the aqueduct of Sylvius,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,22344793[PMID]_20301657[PMID],1.7,1.7
Clinical subtype,Hydrocephalus with stenosis of the aqueduct of Sylvius,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,22344793[PMID]_20301657[PMID],1.7,1.7
Disease,Maffucci syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,250,250
Disease,Maffucci syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Benign familial mesial temporal lobe epilepsy,,,,,,,,,,,,,
Disease,Cryptogenic late-onset epileptic spasms,,,,,,,,,,,,,
Disease,Neurofibromatosis type 1,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,20082463[PMID]_2511318[PMID],21,21
Disease,Neurofibromatosis type 1,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,29215653[PMID],24.46,24.46
Disease,Neurofibromatosis type 1,1-5 / 10 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,2518509[PMID],47.5,47.5
Disease,Neurofibromatosis type 1,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,10991696[PMID]_20082463[PMID]_2511318[PMID]_6807042[PMID]_ORPHANET,21.3,21.3
Disease,Neurofibromatosis type 1,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:039800370X[OTHER]_ORPHANET,36.65,36.65
Disease,Neurofibromatosis type 1,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,20082463[PMID],36.9,36.9
Disease,Neurofibromatosis type 1,1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20301288[PMID],33.3,33.3
Disease,Neurofibromatosis type 1,1-5 / 10 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,25354145[PMID],50,50
Disease,Neurofibromatosis type 1,1-9 / 100 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,1685193[PMID],6.7,6.7
Disease,Neurofibromatosis type 1,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,6807042[PMID],20,20
Disease,Febrile infection-related epilepsy syndrome,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,20345937[PMID]_[EXPERT],0.1,0.1
Disease,Febrile infection-related epilepsy syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20345937[PMID]_22911482[PMID]_ [EXPERT],1,1
Malformation syndrome,Norrie disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16052165[PMID],400,400
Malformation syndrome,Norrie disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10072049[PMID],1,1
Disease,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10072049[PMID],0,0
Disease,Rolandic epilepsy-speech dyspraxia syndrome,,,,,,,,,,,,,
Disease,Leukoencephalopathy-dystonia-motor neuropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,16685654[PMID],0,0
Disease,Leukoencephalopathy-dystonia-motor neuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_16685654[PMID],2,2
Disease,Cortical dysplasia-focal epilepsy syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.46,0.46
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,10844935[PMID],0.5,0.5
Disease,Chronic granulomatous disease,1-9 / 1 000 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,10844935[PMID],0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.5,0.5
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,18410635[PMID],0.75,0.75
Disease,Chronic granulomatous disease,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,18410635[PMID],0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,20700078[PMID],0.57,0.57
Disease,Chronic granulomatous disease,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,20700078[PMID],0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,8645957[PMID],0.22,0.22
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,8645957[PMID],0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,18037347[PMID],0.1,0.1
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,18037347[PMID],0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,18708296[PMID],0.7,0.7
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,18708296[PMID],0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,18708296[PMID],0.48,0.48
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,18708296[PMID],0,0
Disease,Chronic granulomatous disease,<1 / 1 000 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,9314356[PMID],0.08,0.08
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,10530081[PMID],0.35,0.35
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,10530081[PMID],0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,22787376[PMID],0.34,0.34
Disease,Chronic granulomatous disease,1-9 / 1 000 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,22787376[PMID],0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Latin America,409968,409968,25958,25958,en,Validated,410293,410293,17191150[PMID]_ORPHANET,0.99,0.99
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Latin America,409966,409966,25958,25958,en,Validated,410293,410293,17191150[PMID]_ORPHANET,0,0
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Israel,409968,409968,25958,25958,en,Validated,410293,410293,18708296[PMID],0.53,0.53
Disease,Chronic granulomatous disease,1-9 / 1 000 000,Israel,409966,409966,25958,25958,en,Validated,410293,410293,18708296[PMID],0,0
Disease,Blue cone monochromatism,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:9780521004398[OTHER]_[EXPERT],1,1
Disease,Blue cone monochromatism,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:9780521004398[OTHER]_[EXPERT],1,1
Disease,Alveolar soft tissue sarcoma,,,,,,,,,,,,,
Disease,NARP syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Neurofibromatosis type 2,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],1.7,1.7
Disease,Neurofibromatosis type 2,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,20082463[PMID],3,3
Disease,Neurofibromatosis type 2,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,20082463[PMID],1.78,1.78
Disease,Neurofibromatosis type 2,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,25354145[PMID],2.56,2.56
Disease,Action myoclonus-renal failure syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26677510[PMID],38,38
Disease,Action myoclonus-renal failure syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26677510[PMID],0,0
Etiological subtype,X-linked hypohidrotic ectodermal dysplasia,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0.75,0.75
Etiological subtype,X-linked hypohidrotic ectodermal dysplasia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0,0
Etiological subtype,X-linked hypohidrotic ectodermal dysplasia,1-5 / 10 000,Denmark,409966,409966,25965,25965,en,Not yet validated,410294,410294,23416623[PMID]_ORPHANET,12.7,12.7
Disease,2p21 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11524703[PMID],7,7
Disease,2p21 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11524703[PMID],0,0
Disease,Hypotonia-cystinuria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hypotonia-cystinuria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23794250[PMID],22,22
Disease,Fibrodysplasia ossificans progressiva,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,22133093[PMID]_[EXPERT],0.05,0.05
Disease,Fibrodysplasia ossificans progressiva,<1 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,7069743[PMID],0.061,0.061
Disease,Fibrodysplasia ossificans progressiva,<1 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,22796417[PMID],0.087,0.087
Disease,Fibrodysplasia ossificans progressiva,<1 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22796417[PMID],0.036,0.036
Disease,Fibrodysplasia ossificans progressiva,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22796417[PMID]_28666455[PMID]_7069743[PMID],0.078,0.078
Disease,Fibrodysplasia ossificans progressiva,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,28666455[PMID],0.136,0.136
Malformation syndrome,Gorlin syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],2,2
Malformation syndrome,Gorlin syndrome,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,20082463[PMID],5.3,5.3
Malformation syndrome,Gorlin syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,20082463[PMID],3.2,3.2
Malformation syndrome,Gorlin syndrome,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,10066029[PMID],0.39,0.39
Malformation syndrome,Gorlin syndrome,1-9 / 1 000 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,8042673[PMID],0.61,0.61
Malformation syndrome,Gorlin syndrome,<1 / 1 000 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,15183409[PMID],0.007,0.007
Malformation syndrome,Gorlin syndrome,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24403894[PMID]_[EXPERT],1.1,1.1
Malformation syndrome,Noonan syndrome,6-9 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,3895929[PMID]_ORPHANET,70,70
Malformation syndrome,Noonan syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Monosomy 5p,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,2092586[PMID],7,7
Malformation syndrome,Monosomy 5p,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,365706[PMID],2.22,2.22
Malformation syndrome,Monosomy 5p,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,"46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency",1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10599740[PMID],0.68,0.68
Disease,"46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency",>1 / 1000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,8626842[PMID],665,665
Disease,Cystinuria,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,19096983[PMID],50,50
Disease,Cystinuria,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,19096983[PMID],8,8
Disease,Cystinuria,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,19096983[PMID],5.5,5.5
Disease,Cystinuria,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],40,40
Disease,Cystinuria,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,22480232[PMID]_[EXPERT],14,14
Disease,Cystinuria,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Cystinuria,1-5 / 10 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,19096983[PMID],25,25
Disease,Cystinuria,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,19096983[PMID],5.9,5.9
Disease,Cystinuria,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],5,5
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],0.43,0.43
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0.34,0.34
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,18067674[PMID],0.42,0.42
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,Spain,409966,409966,25965,25965,en,Not yet validated,410294,410294,18067674[PMID],0,0
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,4558815[PMID],0.18,0.18
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,Canada,409966,409966,25965,25965,en,Not yet validated,410294,410294,4558815[PMID],0,0
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,11953730[PMID],0,0
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,21152085[PMID]_21126241[PMID],0.18,0.18
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21152085[PMID]_21126241[PMID],0.5,0.5
Disease,Lesch-Nyhan syndrome,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Li-Fraumeni syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23939697[PMID],7,7
Disease,Li-Fraumeni syndrome,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,19556618[PMID],5,5
Disease,Li-Fraumeni syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,6,6
Disease,Pearson syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26016877[PMID],0,0
Disease,Pearson syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26016877[PMID],95,95
Malformation syndrome,Hereditary neuropathy with liability to pressure palsies,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_24646194[PMID],3.5,3.5
Malformation syndrome,Hereditary neuropathy with liability to pressure palsies,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,9447611[PMID],16,16
Disease,Alpha-1-antitrypsin deficiency,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,21752289[PMID],47.5,47.5
Disease,Alpha-1-antitrypsin deficiency,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2016[INST],20,20
Disease,Alpha-1-antitrypsin deficiency,1-5 / 10 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,18855308[PMID],25,25
Disease,Alpha-1-antitrypsin deficiency,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,10954251[PMID]_18565211[PMID],17,17
Disease,Alpha-1-antitrypsin deficiency,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,18565211[PMID],33,33
Disease,Alpha-1-antitrypsin deficiency,6-9 / 10 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,1083485[PMID]_18565211[PMID],63.5,63.5
Clinical subtype,Waardenburg syndrome type 2,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Véronique PINGAULT[EXPERT],0,0
Clinical subtype,Waardenburg syndrome type 3,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Véronique PINGAULT[EXPERT],0,0
Malformation syndrome,Townes-Brocks syndrome,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,10083645[PMID],0.42,0.42
Malformation syndrome,Townes-Brocks syndrome,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Waardenburg syndrome type 1,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Waardenburg syndrome type 1,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Véronique PINGAULT[EXPERT],0,0
Disease,Hyperkalemic periodic paralysis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20301669[PMID]_[EXPERT],0.5,0.5
Disease,Hyperkalemic periodic paralysis,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23516313[PMID],0.17,0.17
Disease,Hyperkalemic periodic paralysis,<1 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,29606556[PMID],0.06,0.06
Disease,Schwartz-Jampel syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26436077[PMID],129,129
Disease,Schwartz-Jampel syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26436077[PMID],0,0
Disease,Diastrophic dwarfism,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.2,1.2
Disease,Diastrophic dwarfism,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.3,0.3
Disease,Diastrophic dwarfism,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,1948373[PMID],3.03,3.03
Disease,Malaria,6-9 / 10 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,73,73
Disease,Malaria,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency2015[INST],3,3
Disease,Malaria,1-5 / 10 000,France,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,12,12
Disease,Malaria,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.2,1.2
Disease,Malaria,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.62,1.62
Disease,Malaria,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2016-2017[INST],0.75,0.75
Disease,Malaria,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.8,0.8
Disease,Malaria,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],2.1,2.1
Disease,Malaria,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.16,0.16
Disease,Malaria,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.1,0.1
Disease,Malaria,1-9 / 1 000 000,Cyprus,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.52,0.52
Disease,Malaria,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.32,0.32
Disease,Malaria,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.2,0.2
Disease,Malaria,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.74,0.74
Disease,Malaria,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.68,0.68
Disease,Malaria,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.14,0.14
Disease,Malaria,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.7,1.7
Disease,Malaria,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.18,0.18
Disease,Malaria,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.22,0.22
Disease,Malaria,1-9 / 1 000 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.84,0.84
Disease,Malaria,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.54,1.54
Disease,Malaria,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.84,1.84
Disease,Malaria,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.08,0.08
Disease,Malaria,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.44,1.44
Disease,Malaria,1-9 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.16,0.16
Disease,Malaria,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.06,0.06
Disease,Malaria,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.28,0.28
Disease,Malaria,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.5,1.5
Disease,Malaria,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.88,1.88
Disease,Malaria,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.38,2.38
Disease,Malaria,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.62,1.62
Disease,Hypokalemic periodic paralysis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20301512[PMID]_[EXPERT],1,1
Disease,Hypokalemic periodic paralysis,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23516313[PMID],0.13,0.13
Disease,Hypokalemic periodic paralysis,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,29606556[PMID],0.53,0.53
Malformation syndrome,Blepharophimosis-ptosis-epicanthus inversus syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,BOR syndrome,1-9 / 100 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,7468659[PMID]_[EXPERT],2.5,2.5
Malformation syndrome,BOR syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary hemorrhagic telangiectasia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,30111344[PMID]_[EXPERT]_European Medicines Agency 2018[INST],16,16
Disease,Hereditary hemorrhagic telangiectasia,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,12157905[PMID],43.5,43.5
Disease,Hereditary hemorrhagic telangiectasia,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,1518020[PMID],2.5,2.5
Disease,Hereditary hemorrhagic telangiectasia,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,10095814[PMID],15.6,15.6
Disease,Hereditary hemorrhagic telangiectasia,1-5 / 10 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,11793473[PMID]_ORPHANET,16.25,16.25
Disease,Hereditary hemorrhagic telangiectasia,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,7802026[PMID],6.1,6.1
Disease,Hereditary hemorrhagic telangiectasia,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,8242961[PMID],19.4,19.4
Malformation syndrome,Saethre-Chotzen syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,15923834[PMID]_8988166[PMID]_[EXPERT],3,3
Malformation syndrome,Saethre-Chotzen syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,15923834[PMID]_[EXPERT],0,0
Malformation syndrome,Pfeiffer syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,16740155[PMID]_[EXPERT],1,1
Malformation syndrome,Pfeiffer syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Peutz-Jeghers syndrome,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301443[PMID],2.2,2.2
Disease,Peutz-Jeghers syndrome,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.4,0.4
Disease,Peutz-Jeghers syndrome,1-9 / 1 000 000,Uruguay,409968,409968,25958,25958,en,Validated,410293,410293,24260271[PMID],0.65,0.65
Malformation syndrome,WAGR syndrome,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20301534[PMID],0.2,0.2
Disease,Zellweger syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Zellweger syndrome,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,22894767[PMID]_[EXPERT],8.2,8.2
Disease,Aicardi syndrome,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,18182643[PMID],1.07,1.07
Disease,Aicardi syndrome,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,18182643[PMID],0.95,0.95
Disease,Aicardi syndrome,1-9 / 1 000 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,18182643[PMID],0,0
Disease,Aicardi syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Albers-Schönberg osteopetrosis,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301306[PMID],1,1
Malformation syndrome,Albers-Schönberg osteopetrosis,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,3829443[PMID],5.5,5.5
Malformation syndrome,Albers-Schönberg osteopetrosis,1-9 / 1 000 000,Brazil,409966,409966,25958,25958,en,Validated,410293,410293,14496532[PMID],0.2,0.2
Malformation syndrome,Albers-Schönberg osteopetrosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Disease,Abetalipoproteinemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30358967[PMID],0,0
Disease,Abetalipoproteinemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30358967[PMID],100,100
Malformation syndrome,Alagille syndrome,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,559475[PMID]_[EXPERT],1.4,1.4
Malformation syndrome,Alagille syndrome,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,559475[PMID]_[EXPERT],0,0
Malformation syndrome,Alagille syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.8,0.8
Malformation syndrome,Alagille syndrome,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,14684686[PMID],2.7,2.7
Malformation syndrome,Alagille syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chédiak-Higashi syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23541537[PMID]_10527680[PMID]_18043242[PMID],500,500
Disease,Chédiak-Higashi syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Cat-eye syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,17001329[PMID]_Dr Catherine TURLEAU[EXPERT],1.35,1.35
Malformation syndrome,Cat-eye syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Catherine TURLEAU[EXPERT],0,0
Malformation syndrome,Crouzon disease,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.9,0.9
Malformation syndrome,Crouzon disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0,0
Malformation syndrome,Crouzon disease,1-9 / 100 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,1633640[PMID],1.65,1.65
Disease,Crigler-Najjar syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Crigler-Najjar syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],1,1
Disease,Cap polyposis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24949613[PMID],67,67
Disease,Cap polyposis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24949613[PMID],0,0
Disease,Cowden syndrome,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,10234502[PMID],0.45,0.45
Disease,Cowden syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Malformation syndrome,Coffin-Lowry syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,19888300[PMID],1.5,1.5
Malformation syndrome,Coffin-Lowry syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,1.5,1.5
Clinical group,X-linked lymphoproliferative disease,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20301580[PMID]_[EXPERT],0.05,0.05
Clinical subtype,Mild hemophilia A,,,,,,,,,,,,,
Category,Congenital vitamin K-dependent coagulation factors deficiency,,,,,,,,,,,,,
Clinical subtype,Severe hemophilia A,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2.8,2.8
Clinical subtype,Moderately severe hemophilia A,,,,,,,,,,,,,
Disease,McCune-Albright syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,18489744[PMID]_[EXPERT],0.55,0.55
Disease,Menkes disease,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,1999344[PMID],0.33,0.33
Disease,Menkes disease,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,15902550[PMID],0.28,0.28
Disease,Menkes disease,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,15902550[PMID],2.5,2.5
Disease,Menkes disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,9,9
Malformation syndrome,Jeune syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],1.4,1.4
Malformation syndrome,Jeune syndrome,1-9 / 1 000 000,Australia,409968,409968,25965,25965,en,Not yet validated,410294,410294,931421[PMID]_ORPHANET,0.89,0.89
Malformation syndrome,Jeune syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial hemophagocytic lymphohistiocytosis,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,9561910[PMID]_[EXPERT],2,2
Disease,Familial hemophagocytic lymphohistiocytosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"Microphthalmia, Lenz type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Meckel syndrome,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22925539[PMID],1.3,1.3
Malformation syndrome,Meckel syndrome,<1 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22925539[PMID],0,0
Malformation syndrome,Meckel syndrome,1-5 / 10 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,6486168[PMID]_[EXPERT],11,11
Malformation syndrome,Meckel syndrome,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Malformation syndrome,Meckel syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,Meckel syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 1990-2011[REG]_25182137[PMID],2.6,2.6
Malformation syndrome,Ellis Van Creveld syndrome,>1 / 1000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,10700162[PMID],500,500
Malformation syndrome,Ellis Van Creveld syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.4,0.4
Malformation syndrome,Ellis Van Creveld syndrome,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ISBN:9780313387135[OTHER]_ORPHANET,1.1,1.1
Malformation syndrome,Ellis Van Creveld syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Laminin subunit alpha 2-related congenital muscular dystrophy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.3,0.3
Malformation syndrome,Laminin subunit alpha 2-related congenital muscular dystrophy,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.6,0.6
Disease,Schistosomiasis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,18445419[PMID],0,0
Disease,Schistosomiasis,>1 / 1000,Africa,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Bartter syndrome,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Bartter syndrome,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,3421146[PMID],0.12,0.12
Disease,Bartter syndrome,1-9 / 100 000,Kuwait,409968,409968,25958,25958,en,Validated,410293,410293,10365582[PMID],1.7,1.7
Disease,Bartter syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Specific antibody deficiency with normal immunoglobulin concentrations and normal numbers of B cells,,,,,,,,,,,,,
Malformation syndrome,Partial chromosome Y deletion,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301513[PMID],20.8,20.8
Malformation syndrome,Partial chromosome Y deletion,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Primary CD59 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23149847[PMID]_16631367[PMID],6,6
Disease,Primary CD59 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Autosomal dominant cerebellar ataxia,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24603320[PMID],2.7,2.7
Category,Autosomal dominant cerebellar ataxia,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,11889231[PMID],3,3
Category,Autosomal dominant cerebellar ataxia,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,7793232[PMID],0.9,0.9
Category,Autosomal dominant cerebellar ataxia,1-9 / 100 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,23609960[PMID],5.6,5.6
Category,Autosomal dominant cerebellar ataxia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23609960[PMID],5.6,5.6
Category,Autosomal dominant cerebellar ataxia,1-5 / 10 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,19169038[PMID],12.6,12.6
Malformation syndrome,Beckwith-Wiedemann syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],3.5,3.5
Malformation syndrome,Beckwith-Wiedemann syndrome,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,10199027[PMID],1.3,1.3
Malformation syndrome,Beckwith-Wiedemann syndrome,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,2092586[PMID]_7424972[PMID]_ORPHANET,5.25,5.25
Malformation syndrome,Beckwith-Wiedemann syndrome,1-9 / 100 000,Jamaica,409968,409968,25958,25958,en,Validated,410293,410293,5434588[PMID],7.4,7.4
Malformation syndrome,Beckwith-Wiedemann syndrome,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,23918458[PMID],10,10
Malformation syndrome,Beckwith-Wiedemann syndrome,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Apert syndrome,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Apert syndrome,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Apert syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Apert syndrome,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,10666902[PMID],1.1,1.1
Malformation syndrome,Apert syndrome,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,10666902[PMID],1.1,1.1
Malformation syndrome,Apert syndrome,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,9375719[PMID],1.2,1.2
Malformation syndrome,Apert syndrome,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,9375719[PMID],1.2,1.2
Malformation syndrome,Apert syndrome,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,1303629[PMID]_1602157[PMID],1.47,1.47
Malformation syndrome,Apert syndrome,1-9 / 100 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,1303629[PMID]_1602157[PMID],1.47,1.47
Etiological subtype,Secondary central precocious puberty,,,,,,,,,,,,,
Etiological subtype,Idiopathic central precocious puberty,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28890442[PMID],0,0
Disease,Familial paroxysmal ataxia,1-9 / 1 000 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301674[PMID],0,0
Disease,Familial paroxysmal ataxia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Recurrent Neisseria infections due to factor D deficiency,,,,,,,,,,,,,
Disease,Lamellar ichthyosis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22000705[PMID]_[EXPERT],0.55,0.55
Disease,Lamellar ichthyosis,1-9 / 1 000 000,Spain,409966,409966,25965,25965,en,Not yet validated,410294,410294,21668430[PMID]_22000705[PMID]_ ORPHANET,0.96,0.96
Disease,Lamellar ichthyosis,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9887377[PMID],1.1,1.1
Clinical subtype,Mild hemophilia B,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.6,0.6
Clinical subtype,Moderately severe hemophilia B,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.6,0.6
Clinical subtype,Severe hemophilia B,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.8,0.8
Morphological anomaly,Rectal duplication,,,,,,,,,,,,,
Disease,Ocular albinism with late-onset sensorineural deafness,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6542750[PMID]_10330347[PMID],9,9
Disease,Ocular albinism with late-onset sensorineural deafness,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10330347[PMID],0,0
Malformation syndrome,Ermine phenotype,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3055988[PMID]_19449401[PMID],6,6
Malformation syndrome,Ermine phenotype,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3055988[PMID]_19449401[PMID],0,0
Disease,Severe congenital nemaline myopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Intermediate nemaline myopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Typical nemaline myopathy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Childhood-onset nemaline myopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Oculocutaneous albinism,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,17980020[PMID]_[EXPERT],5.9,5.9
Clinical group,Oculocutaneous albinism,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,19060277[PMID],3.9,3.9
Clinical group,Oculocutaneous albinism,1-5 / 10 000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,17620156[PMID],45,45
Disease,Adult-onset nemaline myopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Muscle filaminopathy,,,,,,,,,,,,,
Disease,X-linked spastic paraplegia type 34,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1084423[PMID],24,24
Disease,X-linked spastic paraplegia type 34,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1084423[PMID],0,0
Malformation syndrome,Bruck syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25238597[PMID],60,60
Malformation syndrome,Bruck syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25238597[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 37,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17605047[PMID],13,13
Disease,Autosomal dominant spastic paraplegia type 37,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17605047[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 38,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18401025[PMID],1,1
Disease,Autosomal dominant spastic paraplegia type 38,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18401025[PMID],0,0
Malformation syndrome,Mitochondrial DNA-related cardiomyopathy and hearing loss,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8651277[PMID],2,2
Malformation syndrome,Mitochondrial DNA-related cardiomyopathy and hearing loss,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8651277[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 32,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17515546[PMID],1,1
Disease,Autosomal recessive spastic paraplegia type 32,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17515546[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 35,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24359114[PMID],38,38
Disease,Autosomal recessive spastic paraplegia type 35,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24359114[PMID],0,0
Malformation syndrome,Treacher-Collins syndrome,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22925539[PMID],0.63,0.63
Malformation syndrome,Treacher-Collins syndrome,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22925539[PMID],0,0
Malformation syndrome,Treacher-Collins syndrome,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,7424972[PMID],6.9,6.9
Malformation syndrome,Treacher-Collins syndrome,1-9 / 100 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,7424972[PMID],0,0
Malformation syndrome,Treacher-Collins syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,6024864[PMID]_14198411[PMID]_21131976[PMID]_[EXPERT],2,2
Malformation syndrome,Treacher-Collins syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,6024864[PMID]_14198411[PMID]_ [EXPERT],0,0
Malformation syndrome,Unverricht-Lundborg disease,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,17028542[PMID]_[EXPERT],0.2,0.2
Malformation syndrome,Unverricht-Lundborg disease,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,20301321[PMID],5,5
Malformation syndrome,Unverricht-Lundborg disease,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,20301321[PMID],4,4
Malformation syndrome,Unverricht-Lundborg disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Cleft lip with or without cleft palate,6-9 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20507242[PMID],0,0
Clinical group,Cleft lip with or without cleft palate,>1 / 1000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,22374000[PMID],190.5,190.5
Clinical group,Cleft lip with or without cleft palate,6-9 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22374000[PMID],77.5,77.5
Malformation syndrome,Cornelia de Lange syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.9,1.9
Malformation syndrome,Cornelia de Lange syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],1.3,1.3
Malformation syndrome,Cornelia de Lange syndrome,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22925539[PMID],0.65,0.65
Malformation syndrome,Cornelia de Lange syndrome,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,961413[PMID],0.5,0.5
Malformation syndrome,Cornelia de Lange syndrome,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,9608092[PMID],0.97,0.97
Morphological anomaly,High isolated anorectal malformation,,,,,,,,,,,,,
Malformation syndrome,Holoprosencephaly,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,20104599[PMID]_[EXPERT]_EUROCAT European surveillance of congenital anomalies[REG],13.4,13.4
Malformation syndrome,Holoprosencephaly,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,9409876[PMID]_ORPHANET,5.5,5.5
Malformation syndrome,Holoprosencephaly,1-5 / 10 000,Latin America,409968,409968,25958,25958,en,Validated,410293,410293,17987642[PMID],21.6,21.6
Malformation syndrome,Holoprosencephaly,1-5 / 10 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,11349198[PMID]_17286306[PMID]_8818944[PMID]_ORPHANET,15,15
Malformation syndrome,Holoprosencephaly,6-9 / 10 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,15844779[PMID],60.6,60.6
Malformation syndrome,Holoprosencephaly,>1 / 1000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,15329827[PMID],502,502
Malformation syndrome,Holoprosencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Holoprosencephaly,1-5 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,10703035[PMID],10.9,10.9
Disease,Idiopathic achalasia,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,23871090[PMID],0,0
Disease,Idiopathic achalasia,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,11319059[PMID],8,8
Disease,Idiopathic achalasia,1-5 / 10 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,20465592[PMID],10.82,10.82
Disease,Idiopathic achalasia,1-9 / 100 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,24753707[PMID],6.29,6.29
Disease,Idiopathic achalasia,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,3423207[PMID],13.5,13.5
Disease,Idiopathic achalasia,1-9 / 100 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,17420933[PMID],8.7,8.7
Disease,Idiopathic achalasia,1-9 / 100 000,Singapore,409966,409966,25958,25958,en,Validated,410293,410293,10482430[PMID],1.8,1.8
Disease,Idiopathic achalasia,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,21116729[PMID],1.59,1.59
Disease,Idiopathic achalasia,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,17420933[PMID],0.73,0.73
Disease,Idiopathic achalasia,1-9 / 1 000 000,Singapore,409967,409967,25958,25958,en,Validated,410293,410293,10482430[PMID],0.3,0.3
Disease,Idiopathic achalasia,1-9 / 1 000 000,"Korea, Republic of",409967,409967,25958,25958,en,Validated,410293,410293,24753707[PMID],0.39,0.39
Disease,Idiopathic achalasia,1-9 / 100 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,20465592[PMID],1.63,1.63
Disease,Idiopathic achalasia,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,11319059[PMID],0.77,0.77
Morphological anomaly,Low isolated anorectal malformation,,,,,,,,,,,,,
Malformation syndrome,Albinism-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14469778[PMID],1,1
Malformation syndrome,Albinism-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14469778[PMID],0,0
Morphological anomaly,Intermediate isolated anorectal malformation,,,,,,,,,,,,,
Malformation syndrome,22q11.2 microduplication syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cernunnos-XLF deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Disease,Cernunnos-XLF deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal trisomy 18q,,,,,,,,,,,,,
Malformation syndrome,Trisomy 18p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26042156[PMID],25,25
Malformation syndrome,Trisomy 18p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26042156[PMID],0,0
Malformation syndrome,Trisomy 18,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,23088440[PMID],16.7,16.7
Malformation syndrome,Trisomy 18,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2007[REG],9.8,9.8
Malformation syndrome,Trisomy 18,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],4.4,4.4
Malformation syndrome,Trisomy 18,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],25.3,25.3
Malformation syndrome,Trisomy 18,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],4.1,4.1
Malformation syndrome,Trisomy 18,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.4,11.4
Malformation syndrome,Trisomy 18,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.2,11.2
Malformation syndrome,Trisomy 18,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,22713804[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2009[REG],10.4,10.4
Malformation syndrome,Trisomy 18,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2009[REG],0,0
Malformation syndrome,Trisomy 18,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.8,5.8
Malformation syndrome,Trisomy 18,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],8.9,8.9
Malformation syndrome,Trisomy 18,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.8,5.8
Malformation syndrome,Trisomy 18,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],48.2,48.2
Malformation syndrome,Trisomy 18,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],4.4,4.4
Malformation syndrome,Trisomy 18,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.5,9.5
Malformation syndrome,Trisomy 18,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.9,1.9
Malformation syndrome,Trisomy 18,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],24.6,24.6
Malformation syndrome,Trisomy 18,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,20384468 [PMID]_ORPHANET,13,13
Malformation syndrome,Trisomy 18,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],6.5,6.5
Malformation syndrome,Trisomy 18,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],14.6,14.6
Malformation syndrome,Trisomy 18,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],38.8,38.8
Malformation syndrome,Trisomy 18,1-5 / 10 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,2092586[PMID],18,18
Malformation syndrome,Trisomy 18,1-5 / 10 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,2092586[PMID],0,0
Malformation syndrome,Trisomy 18,1-5 / 10 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET_18348276[PMID]_20878909[PMID],19.1,19.1
Malformation syndrome,Trisomy 18,1-5 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,10627940[PMID],12.6,12.6
Malformation syndrome,CLAPO syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18798326[PMID],6,6
Malformation syndrome,CLAPO syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18798326[PMID],0,0
Etiological subtype,Distal trisomy 15q,,,,,,,,,,,,,
Disease,Malignant melanoma of the mucosa,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.26,0.26
Disease,Malignant melanoma of the mucosa,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Malignant melanoma of the mucosa,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG],1.5,1.5
Disease,Malignant melanoma of the mucosa,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,Belgium Cancer registry[INST],0.32,0.32
Disease,Malignant melanoma of the mucosa,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer Institute[INST]_24272143[PMID],0.23,0.23
Malformation syndrome,Trisomy 13,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2009[REG],3.7,3.7
Malformation syndrome,Trisomy 13,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],2.9,2.9
Malformation syndrome,Trisomy 13,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2007[REG],4.8,4.8
Malformation syndrome,Trisomy 13,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],7.2,7.2
Malformation syndrome,Trisomy 13,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],24.1,24.1
Malformation syndrome,Trisomy 13,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],4.8,4.8
Malformation syndrome,Trisomy 13,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],2.2,2.2
Malformation syndrome,Trisomy 13,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5,5
Malformation syndrome,Trisomy 13,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.3,3.3
Malformation syndrome,Trisomy 13,1-5 / 10 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,2092586[PMID]_7424972[PMID],18,18
Malformation syndrome,Trisomy 13,1-5 / 10 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,2092586[PMID]_7424972[PMID]_ ORPHANET,15.9,15.9
Malformation syndrome,Trisomy 13,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20878909[PMID]_Center for Diseases Control and Prevention[INST],12.6,12.6
Malformation syndrome,Trisomy 13,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.9,1.9
Malformation syndrome,Trisomy 13,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],9.8,9.8
Malformation syndrome,Trisomy 13,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.1,1.1
Malformation syndrome,Trisomy 13,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.4,1.4
Malformation syndrome,Trisomy 13,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.4,11.4
Malformation syndrome,Trisomy 13,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],5.2,5.2
Malformation syndrome,Trisomy 13,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],2.5,2.5
Malformation syndrome,Trisomy 13,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2007[REG],13.2,13.2
Malformation syndrome,Trisomy 13,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Immunoglobulin heavy chain deficiency,,,,,,,,,,,,,
Disease,Immunodeficiency due to CD25 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17196245[PMID]_9096364[PMID],2,2
Disease,Immunodeficiency due to CD25 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17196245[PMID]_9096364[PMID],0,0
Disease,Good syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20149753[PMID],0,0
Disease,Good syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20149753[PMID],241,241
Disease,Combined immunodeficiency due to CRAC channel dysfunction,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Combined immunodeficiency due to CRAC channel dysfunction,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Trisomy 9p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25526829[PMID],150,150
Malformation syndrome,Trisomy 9p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25526829[PMID],0,0
Disease,Severe combined immunodeficiency due to FOXN1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28077132[PMID],9,9
Disease,Severe combined immunodeficiency due to FOXN1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28077132[PMID],0,0
Disease,Combined immunodeficiency due to CD3gamma deficiency,,,,,,,,,,,,,
Disease,Susceptibility to respiratory infections associated with CD8alpha chain mutation,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary peritoneal carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Peritoneal cystic mesothelioma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],150,150
Disease,Peritoneal cystic mesothelioma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency",Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Triose phosphate-isomerase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10916682[PMID]_[EXPERT],50,50
Disease,Triose phosphate-isomerase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Malignant peritoneal mesothelioma,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.2,0.2
Disease,Malignant peritoneal mesothelioma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2016[INST],0,0
Disease,Malignant peritoneal mesothelioma,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Category,Primary malignant peritoneal tumor,,,,,,,,,,,,,
Category,Primary peritoneal tumor,,,,,,,,,,,,,
Disease,Darier disease,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,1390140[PMID]_11841374[PMID],3,3
Disease,Darier disease,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,13835928[PMID],1,1
Disease,Darier disease,1-9 / 100 000,Slovenia,409966,409966,25958,25958,en,Validated,410293,410293,16001099[PMID],3.8,3.8
Disease,Darier disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,1390140[PMID]_11841374[PMID]_16001099[PMID],3.4,3.4
Malformation syndrome,"Heart-hand syndrome, Slovenian type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15996213[PMID]_27723096[PMID],14,14
Malformation syndrome,"Heart-hand syndrome, Slovenian type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15996213[PMID]_27723096[PMID],0,0
Malformation syndrome,Coffin-Siris syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22711679[PMID]_11170086[PMID]_23906836[PMID]_24092917[PMID]_23929686[PMID],190,190
Malformation syndrome,Coffin-Siris syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Childhood disintegrative disorder,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2,2
Malformation syndrome,Distal monosomy 9p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23824832[PMID]_24330994[PMID],89,89
Malformation syndrome,Distal monosomy 9p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23824832[PMID]_24330994[PMID],0,0
Disease,Composite lymphoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Refractory anemia with excess blasts in transformation,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.04,0.04
Malformation syndrome,"47,XYY syndrome",1-5 / 10 000,Denmark,409966,409966,25965,25965,en,Not yet validated,410294,410294,20509956[PMID],0,0
Malformation syndrome,"47,XYY syndrome",1-5 / 10 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,22893477[PMID],50,50
Malformation syndrome,"47,XYY syndrome",1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,20509956[PMID],14.1,14.1
Malformation syndrome,"47,XYY syndrome",1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,22893477[PMID],0,0
Malformation syndrome,Distal monosomy 7q36,,,,,,,,,,,,,
Clinical group,Hypereosinophilic syndrome,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,20639012[PMID],0.027,0.027
Clinical group,Hypereosinophilic syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2004[INST],1.5,1.5
Clinical group,Hypereosinophilic syndrome,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,20639012[PMID]_[EXPERT],3.3,3.3
Clinical group,Hypereosinophilic syndrome,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement,,,,,,,,,,,,,
Malformation syndrome,Monosomy 18q,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,21977138[PMID]_1614460[PMID],2.5,2.5
Disease,Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement,,,,,,,,,,,,,
Disease,Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement,,,,,,,,,,,,,
Disease,Monosomy 18p,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Monosomy 18p,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,18284672[PMID]_[EXPERT],2,2
Category,"Myeloid/lymphoid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB or FGFR1",,,,,,,,,,,,,
Disease,Chronic eosinophilic leukemia,,,,,,,,,,,,,
Malformation syndrome,Osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7515752[PMID],2,2
Malformation syndrome,Osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7515752[PMID],0,0
Malformation syndrome,Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,728577[PMID],3,3
Malformation syndrome,Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_728577[PMID],0,0
Disease,Isolated complex I deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15190193[PMID]_20818732[PMID],0,0
Category,Immune dysregulation disease with immunodeficiency,,,,,,,,,,,,,
Disease,Large congenital melanocytic nevus,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,21139903[PMID]_[EXPERT]_ ORPHANET,2.75,2.75
Disease,Refsum disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20301527[PMID]_[EXPERT],0.1,0.1
Disease,Refsum disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN 13:9789350901885[OTHER]_[EXPERT],60,60
Malformation syndrome,Pentasomy X,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency,,,,,,,,,,,,,
Clinical group,Glycogen storage disease due to phosphorylase kinase deficiency,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Clinical group,Glycogen storage disease due to phosphorylase kinase deficiency,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Immunodeficiency due to a late component of complement deficiency,,,,,,,,,,,,,
Disease,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,,,,,,,,,,,,,
Clinical group,Neurodegeneration with brain iron accumulation,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_European Medicines Agency 2018[INST],0.2,0.2
Disease,T-B+ severe combined immunodeficiency due to CD45 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9068311[PMID]_10700239[PMID]_22689986[PMID],0,0
Disease,T-B+ severe combined immunodeficiency due to CD45 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9068311[PMID]_10700239[PMID]_22689986[PMID],3,3
Disease,Transient hypogammaglobulinemia of infancy,,,,,,,,,,,,,
Disease,"Progressive epilepsy-intellectual disability syndrome, Finnish type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Immunodeficiency due to a classical component pathway complement deficiency,,,,,,,,,,,,,
Disease,Recurrent infection due to specific granule deficiency,,,,,,,,,,,,,
Category,Galactosemia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,2,2
Category,Galactosemia,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,2.1,2.1
Category,Galactosemia,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22766612[PMID],1.3,1.3
Category,Galactosemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,X-linked centronuclear myopathy,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,18817572[PMID]_[EXPERT],1,1
Disease,X-linked centronuclear myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,X-linked centronuclear myopathy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0.2,0.2
Clinical group,Immuno-osseous dysplasia,,,,,,,,,,,,,
Category,DNA repair defect other than combined T-cell and B-cell immunodeficiencies,,,,,,,,,,,,,
Category,Immunodeficiency syndrome with autoimmunity,,,,,,,,,,,,,
Disease,Bethlem myopathy,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.77,0.77
Disease,Bethlem myopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal recessive centronuclear myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Incontinentia pigmenti,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_Texas Birth Defect Registry[REG],0.62,0.62
Malformation syndrome,Incontinentia pigmenti,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],1.2,1.2
Malformation syndrome,Incontinentia pigmenti,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Tetrasomy 18p,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Familial scaphocephaly syndrome,,,,,,,,,,,,,
Disease,Autosomal dominant centronuclear myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Neonatal adrenoleukodystrophy,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],1.2,1.2
Disease,Neonatal adrenoleukodystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Alkaptonuria,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Alkaptonuria,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2003[INST],0,0
Disease,Alkaptonuria,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,21927854[PMID],0.15,0.15
Disease,Alkaptonuria,1-9 / 1 000 000,France,409966,409966,25965,25965,en,Not yet validated,410294,410294,21927854[PMID],0,0
Disease,Alkaptonuria,1-9 / 1 000 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301627[PMID],0.25,0.25
Disease,Alkaptonuria,1-9 / 1 000 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301627[PMID],0,0
Disease,Alkaptonuria,1-9 / 100 000,Slovakia,409968,409968,25958,25958,en,Validated,410293,410293,12051967[PMID],5.3,5.3
Disease,Alkaptonuria,1-9 / 100 000,Slovakia,409966,409966,25958,25958,en,Validated,410293,410293,12051967[PMID],0,0
Disease,Acromegaly,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,17893253[PMID]_26792654[PMID]_ORPHANET_[EXPERT],0.47,0.47
Disease,Acromegaly,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,15476442[PMID],3.6,3.6
Disease,Acromegaly,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,20621957[PMID],9.7,9.7
Disease,Acromegaly,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19650784[PMID],8.6,8.6
Disease,Acromegaly,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,17893253[PMID],0.19,0.19
Disease,Acromegaly,1-5 / 10 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_17893253[PMID],12,12
Disease,Acromegaly,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,2349750[PMID],0.4,0.4
Disease,Acromegaly,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,2349750[PMID],6.3,6.3
Disease,Acromegaly,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,20534753[PMID],0.34,0.34
Disease,Acromegaly,1-9 / 1 000 000,"Korea, Republic of",409967,409967,25958,25958,en,Validated,410293,410293,22909047[PMID],0.39,0.39
Disease,Acromegaly,1-9 / 100 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,22909047[PMID],2.79,2.79
Disease,Acromegaly,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,25893613[PMID],0.77,0.77
Disease,Acromegaly,1-5 / 10 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,25893613[PMID],13.4,13.4
Disease,Acromegaly,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,26792654[PMID],7.8,7.8
Disease,Acromegaly,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,26792654[PMID],1.1,1.1
Disease,Acromegaly,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,27280374[PMID],8.5,8.5
Disease,Acromegaly,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,23239049[PMID],0.31,0.31
Disease,Acromegaly,1-5 / 10 000,Malta,409966,409966,25958,25958,en,Validated,410293,410293,23239049[PMID],12.5,12.5
Disease,Acromegaly,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,25084775[PMID],0.35,0.35
Disease,Acromegaly,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,27280374[PMID],0.38,0.38
Disease,Acromegaly,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,Blue rubber bleb nevus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Malformation syndrome,Blue rubber bleb nevus,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Alopecia antibody deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,978318[PMID],3,3
Disease,Alopecia antibody deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_978318[PMID],0,0
Malformation syndrome,Lethal hemolytic anemia-genital anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7726230[PMID],2,2
Malformation syndrome,Lethal hemolytic anemia-genital anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7726230[PMID],0,0
Disease,Succinic semialdehyde dehydrogenase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301374[PMID],450,450
Disease,Succinic semialdehyde dehydrogenase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301374[PMID],0,0
Disease,Mevalonic aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16722536[PMID],30,30
Disease,Mevalonic aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Nager syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:1437725562[OTHER],100,100
Malformation syndrome,Nager syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:1437725562[OTHER],0,0
Malformation syndrome,Nager syndrome,1-9 / 1 000 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,17119427[PMID],0.3,0.3
Disease,Hereditary orotic aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25757096[PMID],20,20
Disease,Hereditary orotic aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25757096[PMID],0,0
Malformation syndrome,Acrocallosal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22696705[PMID],38,38
Malformation syndrome,Acrocallosal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22696705[PMID],0,0
Malformation syndrome,Aarskog-Scott syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.5,0.5
Malformation syndrome,Aarskog-Scott syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Nail-patella syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,DOI:10.1111/j.1469-1809.1965.tb00492.x[OTHER]_10972657[PMID]_[EXPERT],2.2,2.2
Malformation syndrome,Nail-patella syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10972657[PMID],0,0
Malformation syndrome,Nail-patella syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.2,0.2
Disease,Isovaleric acidemia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Isovaleric acidemia,1-9 / 100 000,Germany,409968,409968,25965,25965,en,Not yet validated,410294,410294,12777559[PMID]_21335445[PMID],1.55,1.55
Disease,Isovaleric acidemia,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,12788994[PMID],0.28,0.28
Disease,Isovaleric acidemia,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,18956250[PMID],0.63,0.63
Disease,Isovaleric acidemia,1-9 / 1 000 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,16601872[PMID]_16735252[PMID]_ ORPHANET,0.53,0.53
Category,Rare cardiac tumor,,,,,,,,,,,,,
Malformation syndrome,Smith-Magenis syndrome,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,17468296[PMID],0,0
Malformation syndrome,Smith-Magenis syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,17468296[PMID],4,4
Malformation syndrome,Smith-Magenis syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,5.35,5.35
Malformation syndrome,Smith-Magenis syndrome,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,1746552[PMID]_16354942[PMID],0,0
Malformation syndrome,Smith-Magenis syndrome,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,1746552[PMID]_16354942[PMID]_ ORPHANET,5.35,5.35
Malformation syndrome,Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8456839[PMID]_1251844[PMID],2,2
Malformation syndrome,Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8456839[PMID]_1251844[PMID],0,0
Malformation syndrome,Tetrasomy X,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23494840[PMID],50,50
Malformation syndrome,Tetrasomy X,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23494840[PMID],0,0
Biological anomaly,Hereditary persistence of alpha-fetoprotein,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21116028[PMID],19,19
Biological anomaly,Hereditary persistence of alpha-fetoprotein,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21116028[PMID],0,0
Biological anomaly,Congenital deficiency in alpha-fetoprotein,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18854864[PMID],22,22
Biological anomaly,Congenital deficiency in alpha-fetoprotein,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18854864[PMID],0,0
Malformation syndrome,Ring chromosome 18 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21333764[PMID],70,70
Malformation syndrome,Ring chromosome 18 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Dysplasia of head of femur, Meyer type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Cleidocranial dysplasia,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Malformation syndrome,Cleidocranial dysplasia,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.4,0.4
Malformation syndrome,Cleidocranial dysplasia,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22461456[PMID]_[EXPERT],1.2,1.2
Clinical subtype,Autosomal dominant coarctation of aorta,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Autosomal thrombocytopenia with normal platelets,,,,,,,,,,,,,
Malformation syndrome,"Familial scaphocephaly syndrome, McGillivray type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16061565[PMID],11,11
Malformation syndrome,"Familial scaphocephaly syndrome, McGillivray type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16061565[PMID],0,0
Malformation syndrome,Cohen syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_20301655[PMID],200,200
Malformation syndrome,Cohen syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301655[PMID],0,0
Category,Rare pervasive developmental disorder,,,,,,,,,,,,,
Malformation syndrome,Cooper-Jabs syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3572627[PMID],2,2
Malformation syndrome,Cooper-Jabs syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3572627[PMID],0,0
Morphological anomaly,Isolated corpus callosum agenesis,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,18642362[PMID],1.37,1.37
Morphological anomaly,Isolated corpus callosum agenesis,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_21555052[PMID],3.2,3.2
Disease,Generalized basaloid follicular hamartoma syndrome,,,,,,,,,,,,,
Disease,Chronic mucocutaneous candidiasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Hereditary North American Indian childhood cirrhosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,36,36
Clinical subtype,Hereditary North American Indian childhood cirrhosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22284826[PMID],40,40
Disease,Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary cryohydrocytosis with reduced stomatin,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22492876[PMID],3,3
Disease,Hereditary cryohydrocytosis with reduced stomatin,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22492876[PMID],0,0
Malformation syndrome,Sudden infant death-dysgenesis of the testes syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15273283[PMID],21,21
Malformation syndrome,Sudden infant death-dysgenesis of the testes syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15273283[PMID],0,0
Malformation syndrome,Charlie M syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_940017[PMID],0,0
Malformation syndrome,Charlie M syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,940017[PMID],4,4
Malformation syndrome,Hyperandrogenism due to cortisone reductase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,11,11
Malformation syndrome,Hyperandrogenism due to cortisone reductase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital enteropathy due to enteropeptidase deficiency,,,,,,,,,,,,,
Disease,Cholestasis-lymphedema syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25039919[PMID],47,47
Disease,Cholestasis-lymphedema syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25039919[PMID],0,0
Disease,Brain demyelination due to methionine adenosyltransferase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8770875[PMID],2,2
Disease,Brain demyelination due to methionine adenosyltransferase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8770875[PMID],0,0
Disease,Seborrhea-like dermatitis with psoriasiform elements,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,44,44
Disease,Seborrhea-like dermatitis with psoriasiform elements,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Axial spondylometaphyseal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26974433[PMID],13,13
Disease,Axial spondylometaphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26974433[PMID],0,0
Disease,Spondylometaphyseal dysplasia-bowed forearms-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12503112[PMID],2,2
Disease,Spondylometaphyseal dysplasia-bowed forearms-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12503112[PMID],0,0
Malformation syndrome,Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Spondylometaphyseal dysplasia, A4 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9637426[PMID]_15517830[PMID],3,3
Disease,"Spondylometaphyseal dysplasia, A4 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9637426[PMID]_15517830[PMID],0,0
Disease,"46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21880796[PMID],9,9
Disease,"46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21880796[PMID],0,0
Malformation syndrome,"46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22209139[PMID],5,5
Malformation syndrome,"46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22209139[PMID],0,0
Disease,Blackfan-Diamond anemia,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,20824457[PMID]_[EXPERT],0.67,0.67
Disease,Blackfan-Diamond anemia,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,8826887[PMID],0.5,0.5
Disease,Blackfan-Diamond anemia,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,10192448[PMID],0.65,0.65
Disease,Blackfan-Diamond anemia,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,18671700[PMID],0.75,0.75
Disease,Blackfan-Diamond anemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25037205[PMID],7,7
Disease,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25037205[PMID],0,0
Malformation syndrome,Caffey disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Caffey disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_22855962[PMID],100,100
Malformation syndrome,H syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24172204[PMID],100,100
Malformation syndrome,H syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24172204[PMID],0,0
Malformation syndrome,Native American myopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Bloom syndrome,1-9 / 100 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,10464606[PMID]_9758720[PMID]_10464671[PMID],2.08,2.08
Disease,Bloom syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301572[PMID],300,300
Disease,Bloom syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Argininemia,<1 / 1 000 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,18616627[PMID],0.04,0.04
Disease,Argininemia,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,8794176[PMID],0.27,0.27
Disease,Argininemia,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2016[INST],0,0
Disease,Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2363424[PMID],5,5
Disease,Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2363424[PMID],0,0
Malformation syndrome,Aniridia-cerebellar ataxia-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27108797[PMID],22,22
Malformation syndrome,Aniridia-cerebellar ataxia-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27108797[PMID],0,0
Disease,Spondyloepimetaphyseal dysplasia-abnormal dentition syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9018411[PMID],2,2
Disease,Spondyloepimetaphyseal dysplasia-abnormal dentition syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9018411[PMID],0,0
Malformation syndrome,Arrhinia-choanal atresia-microphthalmia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,672092[PMID]_8723126[PMID],4,4
Malformation syndrome,Arrhinia-choanal atresia-microphthalmia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_672092[PMID]_8723126[PMID],0,0
Disease,"Spondyloepimetaphyseal dysplasia, Geneviève type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27213289[PMID],6,6
Disease,"Spondyloepimetaphyseal dysplasia, Geneviève type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27213289[PMID],0,0
Malformation syndrome,Digitotalar dysmorphism,1-5 / 10 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20045868[PMID]_3978933[PMID],10,10
Disease,Neurogenic arthrogryposis multiplex congenita,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,23050160[PMID]_22005589[PMID],4.3,4.3
Disease,Neurogenic arthrogryposis multiplex congenita,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital neuronal ceroid lipofuscinosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16670177[PMID],10,10
Disease,Congenital neuronal ceroid lipofuscinosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16670177[PMID],0,0
Disease,Late infantile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Late infantile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,1609834[PMID]_[EXPERT],0.46,0.46
Disease,Late infantile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,23374165[PMID],0.78,0.78
Disease,Late infantile neuronal ceroid lipofuscinosis,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,9151309[PMID]_[EXPERT],5,5
Disease,Late infantile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID]_[EXPERT],0.26,0.26
Disease,Late infantile neuronal ceroid lipofuscinosis,<1 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,9151309[PMID]_[EXPERT],0,0
Disease,Late infantile neuronal ceroid lipofuscinosis,<1 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID]_[EXPERT],0.06,0.06
Disease,Late infantile neuronal ceroid lipofuscinosis,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,18684116[PMID],9,9
Disease,Late infantile neuronal ceroid lipofuscinosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Late infantile neuronal ceroid lipofuscinosis,<1 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],0.07,0.07
Disease,Late infantile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],0.38,0.38
Disease,"Spondylometaphyseal dysplasia, Golden type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Golden 1977[AUTHOR],3,3
Disease,"Spondylometaphyseal dysplasia, Golden type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Sheldon-Hall syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Postaxial acrofacial dysostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Postaxial acrofacial dysostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,XY type gonadal dysgenesis-associated anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6158563[PMID],2,2
Malformation syndrome,XY type gonadal dysgenesis-associated anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6158563[PMID],0,0
Disease,Dyskeratosis congenita,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Familial dysautonomia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial dysautonomia,1-5 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,27317387[PMID]_3652488[PMID]_4322121[PMID]_ORPHANET,18.5,18.5
Malformation syndrome,Dubowitz syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.2,0.2
Malformation syndrome,Dubowitz syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Dyggve-Melchior-Clausen disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Disease,Dyggve-Melchior-Clausen disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Category,Rare disease with dentinogenesis imperfecta,,,,,,,,,,,,,
Disease,Diencephalic syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Hereditary dentin defect,,,,,,,,,,,,,
Disease,Encephalopathy due to sulfite oxidase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Disease,Encephalopathy due to sulfite oxidase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Unclassified acute myeloid leukemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.49,0.49
Disease,Scleromyxedema,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25814746[PMID],250,250
Disease,Scleromyxedema,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25814746[PMID],0,0
Disease,Pyruvate dehydrogenase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pyruvate dehydrogenase deficiency,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0,0
Disease,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Isolated glycerol kinase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Multiple carboxylase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Carbamoyl-phosphate synthetase 1 deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Carbamoyl-phosphate synthetase 1 deficiency,1-9 / 1 000 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,18616627[PMID],0.19,0.19
Disease,Carbamoyl-phosphate synthetase 1 deficiency,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20142522[PMID]_[EXPERT],0,0
Disease,Carbamoyl-phosphate synthetase 1 deficiency,<1 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,23972786[PMID],0.077,0.077
Disease,Carbamoyl-phosphate synthetase 1 deficiency,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,2063931[PMID],0.125,0.125
Disease,Argininosuccinic aciduria,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,23972786[PMID],0.46,0.46
Disease,Argininosuccinic aciduria,1-9 / 1 000 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,18616627[PMID],0.69,0.69
Disease,Argininosuccinic aciduria,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2019[INST]_[EXPERT],1,1
Disease,Argininosuccinic aciduria,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,20236848[PMID],1.05,1.05
Disease,Adenosine monophosphate deaminase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Disease,Adenosine monophosphate deaminase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare hemorrhagic disorder due to an acquired coagulation factor defect,,,,,,,,,,,,,
Clinical subtype,Dihydropteridine reductase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14705166[PMID],150,150
Clinical subtype,Dihydropteridine reductase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Isolated Dandy-Walker malformation,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,1,1
Morphological anomaly,Isolated Dandy-Walker malformation,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,2.1,2.1
Malformation syndrome,Cutis marmorata telangiectatica congenita,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,300,300
Malformation syndrome,Cutis marmorata telangiectatica congenita,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8266990[PMID],4,4
Malformation syndrome,Craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8266990[PMID],0,0
Disease,Corpus callosum agenesis-neuronopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301546[PMID],0,0
Disease,Corpus callosum agenesis-neuronopathy syndrome,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,20301546[PMID],47,47
Disease,Neonatal severe primary hyperparathyroidism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hypogonadism-mitral valve prolapse-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2502012[PMID],2,2
Disease,Hypogonadism-mitral valve prolapse-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2502012[PMID],0,0
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,27409588[PMID]_30661430[PMID]_2339046[PMID]_ORPHANET,18,18
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,2339046[PMID],16.2,16.2
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],15.1,15.1
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],49.1,49.1
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],29.1,29.1
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],56.8,56.8
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.3,21.3
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],11.8,11.8
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],23.8,23.8
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],19.9,19.9
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],18.1,18.1
Morphological anomaly,Hypoplastic left heart syndrome,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],9.9,9.9
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],49.8,49.8
Morphological anomaly,Hypoplastic left heart syndrome,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.8,5.8
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],16.4,16.4
Morphological anomaly,Hypoplastic left heart syndrome,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.2,9.2
Morphological anomaly,Hypoplastic left heart syndrome,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],5.5,5.5
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],12.5,12.5
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],16.6,16.6
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],22.3,22.3
Morphological anomaly,Hypoplastic left heart syndrome,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.9,1.9
Morphological anomaly,Hypoplastic left heart syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Hypoplastic left heart syndrome,1-9 / 100 000,China,409968,409968,25958,25958,en,Validated,410293,410293,27409588[PMID],8,8
Morphological anomaly,Hypoplastic left heart syndrome,1-5 / 10 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,30661430[PMID],11.6,11.6
Disease,Neonatal hemochromatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21247995[PMID]_16237701[PMID],35,35
Disease,Neonatal hemochromatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Hennekam-Beemer syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19764024[PMID],3,3
Malformation syndrome,Hennekam-Beemer syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19764024[PMID],0,0
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,8982563[PMID]_[EXPERT]_ ORPHANET,30,30
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],21.2,21.2
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],39.3,39.3
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],14.6,14.6
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.4,11.4
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],19.8,19.8
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],23.6,23.6
Morphological anomaly,Congenital diaphragmatic hernia,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.9,5.9
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],23.2,23.2
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.7,21.7
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],22.6,22.6
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],49.8,49.8
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],29.2,29.2
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],22.9,22.9
Morphological anomaly,Congenital diaphragmatic hernia,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],8.2,8.2
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],18.9,18.9
Morphological anomaly,Congenital diaphragmatic hernia,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.4,9.4
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],38.9,38.9
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],19.7,19.7
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],22.3,22.3
Morphological anomaly,Congenital diaphragmatic hernia,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,1290156[PMID],33,33
Morphological anomaly,Congenital diaphragmatic hernia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Congenital hydrocephalus,6-9 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,21763944[PMID],59,59
Malformation syndrome,Congenital hydrocephalus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Congenital hydrocephalus,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,19410489[PMID],46.5,46.5
Disease,Hartnup disease,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:79130356[OTHER]_[EXPERT],4.2,4.2
Disease,Hartnup disease,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:79130356[OTHER],3.3,3.3
Disease,Hartnup disease,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:79130356[OTHER]_17555458[PMID],3.85,3.85
Disease,Hartnup disease,1-9 / 100 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:79130356[OTHER],1.9,1.9
Disease,Hartnup disease,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,909480[PMID],4,4
Disease,Hawkinsinuria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hawkinsinuria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11073718[PMID],5,5
Category,Rare cardiomyopathy,,,,,,,,,,,,,
Disease,Galactosialidosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Galactosialidosis,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.14,0.14
Disease,Galactosialidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23915561[PMID],100,100
Malformation syndrome,Goldenhar syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,24398798[PMID]_EUROCAT European surveillance of congenital anomalies 1990-2009[REG]_[EXPERT],3.8,3.8
Malformation syndrome,Goldenhar syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,Goldenhar syndrome,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,2092586[PMID],3.6,3.6
Malformation syndrome,Goldenhar syndrome,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,2092586[PMID],0,0
Disease,Congenital fiber-type disproportion myopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,Freeman-Sheldon syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Freeman-Sheldon syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19309503[PMID]_[EXPERT]_23277889[PMID],100,100
Clinical subtype,Frontal encephalocele,,,,,,,,,,,,,
Malformation syndrome,Fetal parvovirus syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2738799[PMID],2,2
Disease,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2738799[PMID],0,0
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,1.25,1.25
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.5,3.5
Morphological anomaly,Ebstein malformation,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],7.8,7.8
Morphological anomaly,Ebstein malformation,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],19.5,19.5
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2007[REG],3.1,3.1
Morphological anomaly,Ebstein malformation,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005[REG],16.5,16.5
Morphological anomaly,Ebstein malformation,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005[REG],18.2,18.2
Morphological anomaly,Ebstein malformation,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.6,11.6
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.1,1.1
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.6,3.6
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],4.1,4.1
Morphological anomaly,Ebstein malformation,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],24.1,24.1
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.7,5.7
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1,1
Morphological anomaly,Ebstein malformation,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.6,0.6
Morphological anomaly,Ebstein malformation,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2006[REG],27.2,27.2
Morphological anomaly,Ebstein malformation,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.5,3.5
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],6.5,6.5
Morphological anomaly,Ebstein malformation,1-9 / 100 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,20138303[PMID],4.7,4.7
Morphological anomaly,Ebstein malformation,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,21465650[PMID]_19818453[PMID]_18657826[PMID],6,6
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,15535817[PMID],6.6,6.6
Morphological anomaly,Ebstein malformation,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.8,9.8
Clinical group,Dopa-responsive dystonia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0.3,0.3
Clinical group,Dopa-responsive dystonia,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,8420194[PMID]_19533203[PMID],0.5,0.5
Malformation syndrome,Fetal alcohol syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.6,1.6
Malformation syndrome,Fetal alcohol syndrome,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],9.8,9.8
Malformation syndrome,Fetal alcohol syndrome,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.8,5.8
Malformation syndrome,Fetal alcohol syndrome,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],14.8,14.8
Malformation syndrome,Fetal alcohol syndrome,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.1,1.1
Malformation syndrome,Fetal alcohol syndrome,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],8.1,8.1
Malformation syndrome,Fetal alcohol syndrome,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2006[REG],1.4,1.4
Malformation syndrome,Fetal alcohol syndrome,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],1.6,1.6
Malformation syndrome,Fetal alcohol syndrome,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2007[REG],13.2,13.2
Malformation syndrome,Fetal alcohol syndrome,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.9,1.9
Malformation syndrome,Fetal alcohol syndrome,>1 / 1000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,17127017[PMID],6800,6800
Malformation syndrome,Fetal alcohol syndrome,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],13.6,13.6
Malformation syndrome,Fetal alcohol syndrome,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.5,0.5
Malformation syndrome,Fetal alcohol syndrome,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],1.2,1.2
Malformation syndrome,Fetal alcohol syndrome,6-9 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],80.8,80.8
Malformation syndrome,Fetal alcohol syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Isolated ectopia lentis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Isolated ectopia lentis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],90,90
Morphological anomaly,Multicystic dysplastic kidney,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,19171687[PMID],23.26,23.26
Morphological anomaly,Omphalocele,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG],11.7,11.7
Morphological anomaly,Omphalocele,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],19.6,19.6
Morphological anomaly,Omphalocele,1-5 / 10 000,Austria,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],14.6,14.6
Morphological anomaly,Omphalocele,1-5 / 10 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],10.9,10.9
Morphological anomaly,Omphalocele,1-5 / 10 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],19.8,19.8
Morphological anomaly,Omphalocele,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],13.6,13.6
Morphological anomaly,Omphalocele,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.6,11.6
Morphological anomaly,Omphalocele,1-5 / 10 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],6.6,6.6
Morphological anomaly,Omphalocele,1-9 / 100 000,Hungary,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],25.3,25.3
Morphological anomaly,Omphalocele,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11,11
Morphological anomaly,Omphalocele,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],48.2,48.2
Morphological anomaly,Omphalocele,1-5 / 10 000,Malta,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],22.9,22.9
Morphological anomaly,Omphalocele,1-5 / 10 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.2,11.2
Morphological anomaly,Omphalocele,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],12.1,12.1
Morphological anomaly,Omphalocele,1-5 / 10 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],6.9,6.9
Morphological anomaly,Omphalocele,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],12.3,12.3
Morphological anomaly,Omphalocele,1-5 / 10 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.6,11.6
Morphological anomaly,Omphalocele,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],16.2,16.2
Morphological anomaly,Omphalocele,1-5 / 10 000,Ukraine,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,23116348[PMID],10,10
Morphological anomaly,Omphalocele,1-5 / 10 000,Czech Republic,409966,409966,25965,25965,en,Not yet validated,410294,410294,23116348[PMID],0,0
Morphological anomaly,Omphalocele,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,10646777[PMID],6.3,6.3
Morphological anomaly,Omphalocele,1-9 / 100 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,10646777[PMID],0,0
Morphological anomaly,Omphalocele,1-5 / 10 000,China,409968,409968,25958,25958,en,Validated,410293,410293,15498248[PMID],15.2,15.2
Morphological anomaly,Omphalocele,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention 2010[INST],18.6,18.6
Morphological anomaly,Omphalocele,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention 2010[INST],0,0
Category,Rare vulvovaginal tumor,,,,,,,,,,,,,
Disease,Neuroblastoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],11,11
Disease,Neuroblastoma,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,16919772[PMID],5.8,5.8
Disease,Neuroblastoma,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,21108439[PMID],2.5,2.5
Disease,Neuroblastoma,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,11932471[PMID],14,14
Disease,Neuroblastoma,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,22796286[PMID],1.26,1.26
Disease,Linear nevus sebaceus syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Metatropic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_24223250[PMID],81,81
Disease,Metatropic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Metatropic dysplasia,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.2,0.2
Disease,Thanatophoric dysplasia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],3.5,3.5
Disease,Thanatophoric dysplasia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Thanatophoric dysplasia,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,2785882[PMID],2.8,2.8
Disease,Thanatophoric dysplasia,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,3071354[PMID],3.5,3.5
Disease,Thanatophoric dysplasia,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,8449630[PMID],1.7,1.7
Disease,Thanatophoric dysplasia,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,2783977[PMID],3.8,3.8
Disease,Thanatophoric dysplasia,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,22375084[PMID],8,8
Disease,Thanatophoric dysplasia,1-9 / 100 000,Latin America,409968,409968,25958,25958,en,Validated,410293,410293,22407836[PMID],4.7,4.7
Disease,Thanatophoric dysplasia,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22461456[PMID],4.3,4.3
Category,Rare non-malformative uterine adnexal disease,,,,,,,,,,,,,
Disease,Proximal myotonic myopathy,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,12921797[PMID]_12970845[PMID],1,1
Disease,Proximal myotonic myopathy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Proximal myotonic myopathy,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,16684600[PMID]_22995693[PMID],10,10
Disease,Proximal myotonic myopathy,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.17,0.17
Malformation syndrome,Pendred syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],7,7
Category,Syndromic diaphragmatic or thoracic malformation,,,,,,,,,,,,,
Category,Non-syndromic diaphragmatic or thoracic malformation,,,,,,,,,,,,,
Malformation syndrome,Juvenile Paget disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Malformation syndrome,Juvenile Paget disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Tetrasomy 12p,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Malformation syndrome,Tetrasomy 12p,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Category,Rare disease with autism,,,,,,,,,,,,,
Category,Malformative syndrome with dentinogenesis imperfecta,,,,,,,,,,,,,
Disease,Osteopetrosis with renal tubular acidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Disease,Osteopetrosis with renal tubular acidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Horizontal gaze palsy with progressive scoliosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Opsismodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23273569[PMID],30,30
Disease,Opsismodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Peroxisomal acyl-CoA oxidase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Disease,Peroxisomal acyl-CoA oxidase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Prune belly syndrome,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,22506933[PMID]_ORPHANET,2.4,2.4
Malformation syndrome,Prune belly syndrome,1-9 / 1 000 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,8876090[PMID]_ORPHANET,0.38,0.38
Malformation syndrome,Prune belly syndrome,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,6454342[PMID],3.42,3.42
Malformation syndrome,Prune belly syndrome,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20381841[PMID],3.8,3.8
Malformation syndrome,Prune belly syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Proteus syndrome,<1 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,21793738[PMID]_[EXPERT],0,0
Malformation syndrome,Proteus syndrome,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,21793738[PMID]_[EXPERT]_European Medicines Agency 2018[INST],0,0
Disease,Familial spontaneous pneumothorax,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,22643181[PMID]_21364698[PMID],54.64,54.64
Disease,Neuralgic amyotrophy,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,2996415[PMID]_[EXPERT],1.64,1.64
Disease,Neuralgic amyotrophy,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Neuralgic amyotrophy,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,10733998[PMID],3,3
Disease,Neuralgic amyotrophy,1-5 / 10 000,United Kingdom,409969,409969,25958,25958,en,Validated,410293,410293,10733998[PMID],30,30
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,6626822[PMID],0,0
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22925539[PMID],8,8
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22925539[PMID],0,0
Malformation syndrome,Isolated Pierre Robin syndrome,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,24433508[PMID],12.4,12.4
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,14697070[PMID],3.5,3.5
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,Denmark,409966,409966,25965,25965,en,Not yet validated,410294,410294,14697070[PMID],0,0
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,8897214[PMID],4.5,4.5
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,Sweden,409966,409966,25965,25965,en,Not yet validated,410294,410294,8897214[PMID],0,0
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,6626822[PMID],5.9,5.9
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,7.9,7.9
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,Isolated Pierre Robin syndrome,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,25994858[PMID],6.4,6.4
Category,Rare gastroesophageal tumor,,,,,,,,,,,,,
Category,Rare tumor of pancreas,,,,,,,,,,,,,
Category,Catecholamine-producing tumor,,,,,,,,,,,,,
Category,Rare disorder with hypogonadotropic hypogonadism,,,,,,,,,,,,,
Disease,Congenital rubella syndrome,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_World Health Organization 2005[INST],0,0
Disease,Congenital rubella syndrome,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22178098[PMID],0.29,0.29
Disease,Congenital rubella syndrome,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,22178098[PMID],0.24,0.24
Disease,Congenital rubella syndrome,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,22178098[PMID],0.8,0.8
Disease,Congenital rubella syndrome,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,22178098[PMID],0.64,0.64
Disease,Congenital rubella syndrome,1-9 / 1 000 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,22178098[PMID],0.27,0.27
Disease,Congenital rubella syndrome,1-9 / 100 000,Romania,409968,409968,25958,25958,en,Validated,410293,410293,22178098[PMID],2.18,2.18
Disease,Congenital rubella syndrome,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,22178098[PMID],0.22,0.22
Disease,Congenital rubella syndrome,<1 / 1 000 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,22178098[PMID],0.02,0.02
Disease,Congenital rubella syndrome,<1 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,22178098[PMID],0.03,0.03
Disease,Congenital rubella syndrome,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,22178098[PMID],0.35,0.35
Disease,Congenital rubella syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Costello syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301680[PMID],300,300
Malformation syndrome,Costello syndrome,<1 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,22495831[PMID],0.08,0.08
Malformation syndrome,Costello syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Hypogonadotropic hypogonadism associated with other endocrinopathies,,,,,,,,,,,,,
Category,Other rare diabetes mellitus,,,,,,,,,,,,,
Category,Rare hypothalamic or pituitary disease,,,,,,,,,,,,,
Category,Rare diabetes mellitus type 1,,,,,,,,,,,,,
Disease,Pycnodysostosis,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,21569238[PMID],0.13,0.13
Disease,Pycnodysostosis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Category,Rare diabetes mellitus type 2,,,,,,,,,,,,,
Disease,Disorder of sex development-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2098045[PMID]_8031539[PMID],3,3
Disease,Disorder of sex development-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2098045[PMID]_8031539[PMID],0,0
Category,"46,XX disorder of sex development",,,,,,,,,,,,,
Category,Rare insulin-resistance syndrome,,,,,,,,,,,,,
Category,Rare non-malformative breast disease,,,,,,,,,,,,,
Morphological anomaly,Congenital short bowel syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21042453[PMID]_22155368[PMID]_27352967[PMID],43,43
Morphological anomaly,Congenital short bowel syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21042453[PMID]_22155368[PMID],0,0
Category,Rare non-malformative gynecologic or obstetric disease,,,,,,,,,,,,,
Disease,Hereditary fructose intolerance,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Disease,Hereditary fructose intolerance,1-9 / 100 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,15880727[PMID],5,5
Disease,Hereditary fructose intolerance,1-9 / 100 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,15880727[PMID],0,0
Disease,Hereditary fructose intolerance,1-9 / 100 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,12042775[PMID]_15880727[PMID]_8933337[PMID],5,5
Disease,Hereditary fructose intolerance,1-9 / 100 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,12042775[PMID]_15880727[PMID]_8933337[PMID],0,0
Disease,Hereditary fructose intolerance,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,15880727[PMID],3.8,3.8
Disease,Hereditary fructose intolerance,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,15880727[PMID],0,0
Disease,Hereditary fructose intolerance,1-9 / 100 000,Poland,409968,409968,25965,25965,en,Not yet validated,410294,410294,16406649[PMID],0,0
Disease,Hereditary fructose intolerance,1-9 / 100 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,16406649[PMID],3.2,3.2
Disease,Hereditary fructose intolerance,1-9 / 100 000,Finland,409966,409966,25965,25965,en,Not yet validated,410294,410294,14565820[PMID]_ORPHANET,7.5,7.5
Category,Anomaly of puberty or/and menstrual cycle,,,,,,,,,,,,,
Malformation syndrome,Jacobsen syndrome,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_19267933[PMID],1.5,1.5
Malformation syndrome,Jacobsen syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Category,Rare non-malformative uterovaginal or vulvovaginal disease,,,,,,,,,,,,,
Malformation syndrome,Joubert syndrome with oculorenal defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Joubert syndrome with oculorenal defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23845172[PMID],17,17
Disease,Foveal hypoplasia-presenile cataract syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,11,11
Disease,Foveal hypoplasia-presenile cataract syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Isolated congenital breast hypoplasia/aplasia,,,,,,,,,,,,,
Morphological anomaly,Supernumerary breasts,,,,,,,,,,,,,
Category,Syndromic breast hypoplasia/aplasia,,,,,,,,,,,,,
Morphological anomaly,Multiple intestinal atresia,,,,,,,,,,,,,
Disease,Embryonal carcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Malformation syndrome,Trichorhinophalangeal syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26269715[PMID],0,0
Malformation syndrome,Trichorhinophalangeal syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26269715[PMID],100,100
Disease,Polyembryoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Malformation syndrome,Larsen-like osseous dysplasia-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12784294[PMID]_1916762[PMID],3,3
Malformation syndrome,Larsen-like osseous dysplasia-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ 12784294[PMID]_1916762[PMID],0,0
Disease,KID syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:0723436657[OTHER],100,100
Disease,KID syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:0723436657[OTHER],0,0
Morphological anomaly,Isolated cloverleaf skull syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,120,120
Morphological anomaly,Isolated cloverleaf skull syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare uterine adnexal tumor,,,,,,,,,,,,,
Disease,Angioosteohypertrophic syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.8,0.8
Disease,Angioosteohypertrophic syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Vaginal carcinoma,,,,,,,,,,,,,
Clinical group,Leigh syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2.8,2.8
Clinical group,Leigh syndrome,1-9 / 100 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,8602753[PMID],1.3,1.3
Clinical group,Leigh syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Leigh syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],2,2
Category,Rare breast tumor,,,,,,,,,,,,,
Malformation syndrome,Congenital macroglossia,,,,,,,,,,,,,
Category,Rare benign breast tumor,,,,,,,,,,,,,
Disease,Congenital pulmonary lymphangiectasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:019974808X[OTHER],100,100
Disease,Congenital pulmonary lymphangiectasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Congenital laryngomalacia,,,,,,,,,,,,,
Disease,Mixed germ cell tumor,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Benign tumor of fallopian tubes,,,,,,,,,,,,,
Malformation syndrome,Laurence-Moon syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Congenital laryngeal web,,,,,,,,,,,,,
Disease,Malignant tumor of fallopian tubes,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2009[INST],1,1
Disease,Malignant tumor of fallopian tubes,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,16263546[PMID],0.11,0.11
Disease,Malignant tumor of fallopian tubes,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,2706135[PMID],0.15,0.15
Disease,Malignant tumor of fallopian tubes,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,18027113[PMID],0.16,0.16
Clinical subtype,MASA syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Paget disease of the nipple,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.51,0.51
Disease,Paget disease of the nipple,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.065,0.065
Disease,Paget disease of the nipple,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.096,0.096
Disease,Paget disease of the nipple,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.179,0.179
Disease,Paget disease of the nipple,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.433,0.433
Disease,Paget disease of the nipple,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.235,0.235
Disease,Paget disease of the nipple,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.192,0.192
Disease,Paget disease of the nipple,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.287,0.287
Disease,Paget disease of the nipple,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.434,0.434
Disease,Paget disease of the nipple,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.29,0.29
Disease,Paget disease of the nipple,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.682,0.682
Disease,Paget disease of the nipple,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.487,0.487
Disease,Paget disease of the nipple,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.421,0.421
Disease,Paget disease of the nipple,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.254,0.254
Disease,Paget disease of the nipple,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.215,0.215
Disease,Paget disease of the nipple,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.345,0.345
Disease,Paget disease of the nipple,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.709,0.709
Disease,Paget disease of the nipple,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.209,0.209
Disease,Paget disease of the nipple,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.21,0.21
Disease,Paget disease of the nipple,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.457,0.457
Disease,Paget disease of the nipple,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.415,0.415
Disease,Paget disease of the nipple,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.394,0.394
Disease,Paget disease of the nipple,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.335,0.335
Disease,Paget disease of the nipple,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.637,0.637
Malformation syndrome,Marshall syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17236192[PMID]_19449424[PMID],17,17
Malformation syndrome,Marshall syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17236192[PMID]_19449424[PMID],0,0
Disease,Muir-Torre syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16321766[PMID],205,205
Disease,Muir-Torre syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Moebius syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,300,300
Disease,Moebius syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Moebius syndrome,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,12913192[PMID],2.12,2.12
Clinical group,Short rib-polydactyly syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare malignant breast tumor,,,,,,,,,,,,,
Disease,Phyllodes tumor of the breast,,,,,,,,,,,,,
Disease,Central bilateral macrogyria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2500888[PMID],4,4
Disease,Central bilateral macrogyria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2500888[PMID],0,0
Disease,Giant adenofibroma of the breast,,,,,,,,,,,,,
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],8.2,8.2
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],2.9,2.9
Malformation syndrome,Congenital pulmonary airway malformation,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],17.7,17.7
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.9,5.9
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],1,1
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],7.2,7.2
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],1.4,1.4
Malformation syndrome,Congenital pulmonary airway malformation,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],17.1,17.1
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],4.9,4.9
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.7,0.7
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.8,3.8
Malformation syndrome,Congenital pulmonary airway malformation,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],12.3,12.3
Malformation syndrome,Congenital pulmonary airway malformation,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],18.1,18.1
Malformation syndrome,Congenital pulmonary airway malformation,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],3.2,3.2
Clinical group,Potassium-aggravated myotonia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Obesity due to leptin receptor gene deficiency,,,,,,,,,,,,,
Disease,Phenylketonuria,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,11641035[PMID]_17616847[PMID]_[EXPERT]_Haute Autorité de Santé 2010[INST],6,6
Disease,Phenylketonuria,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,11641035[PMID]_17616847[PMID]_[EXPERT]_Haute Autorité de Santé 2010[INST],0,0
Disease,Phenylketonuria,1-5 / 10 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,20971365[PMID]_17616847[PMID],10,10
Disease,Phenylketonuria,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20971365[PMID]_17616847[PMID]_European Medicines Agency 2016[INST],0,0
Disease,Phenylketonuria,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,16690699[PMID],8,8
Disease,Phenylketonuria,1-9 / 100 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,16690699[PMID],0,0
Disease,Phenylketonuria,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,9254847[PMID]_[EXPERT],22,22
Disease,Phenylketonuria,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,9254847[PMID]_[EXPERT],0,0
Disease,Phenylketonuria,1-9 / 1 000 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,8825928[PMID]_[EXPERT],0,0
Disease,Phenylketonuria,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,8825928[PMID]_[EXPERT],0,0
Disease,Phenylketonuria,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,11581453[PMID]_21659675[PMID]_22766612[PMID],2.9,2.9
Disease,Phenylketonuria,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,11581453[PMID]_21659675[PMID],0,0
Disease,Phenylketonuria,1-9 / 100 000,Latin America,409968,409968,25965,25965,en,Not yet validated,410294,410294,17701285[PMID]_ORPHANET,3,3
Disease,Phenylketonuria,1-9 / 100 000,Latin America,409966,409966,25965,25965,en,Not yet validated,410294,410294,17701285[PMID]_ORPHANET,0,0
Disease,Phenylketonuria,1-9 / 100 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,19068582[PMID],4.9,4.9
Disease,Phenylketonuria,1-9 / 100 000,Brazil,409966,409966,25965,25965,en,Not yet validated,410294,410294,19068582[PMID],0,0
Disease,Phenylketonuria,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,10617747[PMID],7.5,7.5
Disease,Phenylketonuria,1-9 / 100 000,Australia,409966,409966,25965,25965,en,Not yet validated,410294,410294,10617747[PMID],0,0
Disease,Phenylketonuria,1-5 / 10 000,Iceland,409968,409968,25958,25958,en,Validated,410293,410293,21659675[PMID],11.9,11.9
Disease,Phenylketonuria,1-5 / 10 000,Iceland,409966,409966,25965,25965,en,Not yet validated,410294,410294,21659675[PMID],0,0
Disease,Phenylketonuria,1-9 / 100 000,Japan,409968,409968,25965,25965,en,Not yet validated,410294,410294,6468444[PMID]_20971365[PMID]_ ORPHANET,1.16,1.16
Disease,Phenylketonuria,1-9 / 100 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,6468444[PMID]_20971365[PMID]_ ORPHANET,0,0
Disease,Phenylketonuria,1-9 / 100 000,China,409968,409968,25965,25965,en,Not yet validated,410294,410294,23430943[PMID]_19718537[PMID]_15906732[PMID]_ORPHANET,4.8,4.8
Disease,Phenylketonuria,1-9 / 100 000,China,409966,409966,25965,25965,en,Not yet validated,410294,410294,23430943[PMID]_19718537[PMID]_15906732[PMID]_ORPHANET,0,0
Disease,Phenylketonuria,1-9 / 1 000 000,Thailand,409968,409968,25958,25958,en,Validated,410293,410293,15906730[PMID],0.46,0.46
Disease,Phenylketonuria,1-9 / 1 000 000,Thailand,409966,409966,25965,25965,en,Not yet validated,410294,410294,15906730[PMID],0,0
Disease,Phenylketonuria,1-5 / 10 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,11432505[PMID]_[EXPERT],24,24
Disease,Phenylketonuria,1-5 / 10 000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,11432505[PMID]_[EXPERT],0,0
Disease,Phenylketonuria,1-9 / 100 000,United Arab Emirates,409968,409968,25958,25958,en,Validated,410293,410293,15751925[PMID],5,5
Disease,Phenylketonuria,1-9 / 100 000,United Arab Emirates,409966,409966,25958,25958,en,Validated,410293,410293,15751925[PMID],0,0
Disease,Phenylketonuria,1-9 / 100 000,Jordan,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI:10.1007/978-3-642-05080-0_11[OTHER],0,0
Disease,Phenylketonuria,1-9 / 100 000,Jordan,409968,409968,25958,25958,en,Validated,410293,410293,DOI:10.1007/978-3-642-05080-0_11[OTHER],2.6,2.6
Etiological subtype,Obesity due to congenital leptin resistance,,,,,,,,,,,,,
Clinical group,Unilateral aplasia of the Müllerian ducts,,,,,,,,,,,,,
Clinical group,Partial bilateral aplasia of the Müllerian ducts,,,,,,,,,,,,,
Category,Non-syndromic uterovaginal malformation,,,,,,,,,,,,,
Disease,Classical Ehlers-Danlos syndrome,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20301422[PMID]_20847697[PMID]_[EXPERT],5,5
Category,Uterovaginal malformation,,,,,,,,,,,,,
Clinical subtype,Bicervical bicornuate uterus and blind hemivagina,,,,,,,,,,,,,
Morphological anomaly,Didelphys uterus,,,,,,,,,,,,,
Morphological anomaly,Pseudounicornuate uterus,,,,,,,,,,,,,
Morphological anomaly,True unicornuate uterus,,,,,,,,,,,,,
Clinical group,Septate uterus,,,,,,,,,,,,,
Morphological anomaly,Cordiform uterus,,,,,,,,,,,,,
Clinical group,Unicervical bicornuate uterus,,,,,,,,,,,,,
Clinical subtype,Bicervical bicornuate uterus with patent cervix and vagina,,,,,,,,,,,,,
Clinical group,Bicornuate uterus,,,,,,,,,,,,,
Morphological anomaly,Uterine hypoplasia,,,,,,,,,,,,,
Morphological anomaly,Complete septate uterus,,,,,,,,,,,,,
Morphological anomaly,Partial septate uterus,,,,,,,,,,,,,
Category,Syndromic uterovaginal malformation,,,,,,,,,,,,,
Disease,Early-onset autosomal dominant Alzheimer disease,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare vaginal malformation,,,,,,,,,,,,,
Disease,Alport syndrome,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Alport syndrome,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,8955456[PMID],1.9,1.9
Disease,X-linked recessive ocular albinism,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0.58,0.58
Disease,X-linked recessive ocular albinism,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0,0
Disease,X-linked recessive ocular albinism,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,9887374[PMID]_[EXPERT],0.84,0.84
Disease,X-linked recessive ocular albinism,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,9887374[PMID]_[EXPERT],0,0
Disease,X-linked recessive ocular albinism,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20301517[PMID],1,1
Disease,X-linked recessive ocular albinism,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301517[PMID],0,0
Morphological anomaly,Absence of uterine body,,,,,,,,,,,,,
Morphological anomaly,Uterine cervical aplasia and agenesis,,,,,,,,,,,,,
Clinical subtype,Transverse vaginal septum,,,,,,,,,,,,,
Disease,Familial isolated dilated cardiomyopathy,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,16839424[PMID]_[EXPERT]_ ORPHANET,2.91,2.91
Disease,Familial isolated dilated cardiomyopathy,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,16839424[PMID]_[EXPERT]_ ORPHANET,17.5,17.5
Disease,Familial isolated dilated cardiomyopathy,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,2766509[PMID],6,6
Category,Rare breast malformation,,,,,,,,,,,,,
Malformation syndrome,Fanconi anemia,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,7492758[PMID],3.3,3.3
Malformation syndrome,Fanconi anemia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20824457[PMID]_European Medicines Agency 2018[INST],0.3,0.3
Malformation syndrome,Fanconi anemia,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,11389461[PMID]_ORPHANET,0.3,0.3
Malformation syndrome,Fanconi anemia,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.62,0.62
Malformation syndrome,Fanconi anemia,1-9 / 100 000,Israel,409968,409968,25958,25958,en,Validated,410293,410293,20435624[PMID],2.2,2.2
Malformation syndrome,Fanconi anemia,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,11344308[PMID],2.5,2.5
Malformation syndrome,Fanconi anemia,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,15522956[PMID],2.5,2.5
Morphological anomaly,Septate vagina,,,,,,,,,,,,,
Disease,Proximal spinal muscular atrophy,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],2.6,2.6
Disease,Proximal spinal muscular atrophy,1-5 / 10 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,23107878[PMID],20,20
Disease,Proximal spinal muscular atrophy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Amyloidosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Amyloidosis,1-9 / 100 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,28877709[PMID],1.91,1.91
Clinical subtype,Longitudinal vaginal septum,,,,,,,,,,,,,
Category,Deficient breast volume or number,,,,,,,,,,,,,
Morphological anomaly,Familial juvenile hypertrophy of the breast,,,,,,,,,,,,,
Disease,Cockayne syndrome,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Cockayne syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.2,0.2
Disease,Cockayne syndrome,<1 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.09,0.09
Disease,Cockayne syndrome,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.18,0.18
Disease,Cockayne syndrome,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.2,0.2
Disease,Cockayne syndrome,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.45,0.45
Disease,Cockayne syndrome,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.38,0.38
Disease,Cockayne syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,21820100[PMID]_20301532[PMID]_ ORPHANET,25,25
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-5 / 10 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,21984771[PMID]_8026104[PMID]_ ORPHANET,15.95,15.95
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,6-9 / 10 000,Norway,409966,409966,25965,25965,en,Not yet validated,410294,410294,20482598[PMID]_4430158[PMID]_ ORPHANET,61,61
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-5 / 10 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,3472423[PMID],28.2,28.2
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,12207152[PMID],17.5,17.5
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-5 / 10 000,Sweden,409966,409966,25965,25965,en,Not yet validated,410294,410294,6576612[PMID]_8333247[PMID]_ ORPHANET,19.55,19.55
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,2096315[PMID],6.1,6.1
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-5 / 10 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,19893324[PMID],12,12
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-5 / 10 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,12207153[PMID],10.8,10.8
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-5 / 10 000,Cyprus,409966,409966,25958,25958,en,Validated,410293,410293,20571287[PMID],16,16
Category,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,1-9 / 100 000,Serbia,409966,409966,25958,25958,en,Validated,410293,410293,21546779[PMID],9.7,9.7
Category,Excess breast volume or number,,,,,,,,,,,,,
Clinical group,Aggressive primary cutaneous T-cell lymphoma,,,,,,,,,,,,,
Clinical group,Indolent primary cutaneous T-cell lymphoma,,,,,,,,,,,,,
Disease,Free sialic acid storage disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16584062[PMID],0,0
Disease,Free sialic acid storage disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16584062[PMID],130,130
Clinical group,Indolent primary cutaneous B-cell lymphoma,,,,,,,,,,,,,
Clinical group,Aggressive primary cutaneous B-cell lymphoma,,,,,,,,,,,,,
Malformation syndrome,Familial Scheuermann disease,,,,,,,,,,,,,
Disease,Schizencephaly,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,21647999[PMID],1.48,1.48
Disease,Schizencephaly,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,16059942[PMID],1.54,1.54
Disease,Schizencephaly,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Schizencephaly,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,26545857[PMID],1,1
Category,Primary cutaneous B-cell lymphoma,,,,,,,,,,,,,
Disease,Multiple sclerosis-ichthyosis-factor VIII deficiency syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8336172[PMID],2,2
Disease,Multiple sclerosis-ichthyosis-factor VIII deficiency syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8336172[PMID],0,0
Clinical group,Mycosis fungoides and variants,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET,0.59,0.59
Clinical group,Mycosis fungoides and variants,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Silver-Russell syndrome,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,15.5,15.5
Disease,Silver-Russell syndrome,1-9 / 100 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,16128241[PMID],0,0
Disease,Silver-Russell syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,16128241[PMID],1,1
Disease,Silver-Russell syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.7,0.7
Disease,Silver-Russell syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,22002878[PMID],0.98,0.98
Malformation syndrome,Sirenomelia,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.01,0.01
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.71,0.71
Malformation syndrome,Sirenomelia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.009,0.009
Malformation syndrome,Sirenomelia,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],1.04,1.04
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],0.62,0.62
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],0.64,0.64
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],0.54,0.54
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],0.7,0.7
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,Slovakia,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],0.31,0.31
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],0.33,0.33
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],0.74,0.74
Malformation syndrome,Sirenomelia,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],1.6,1.6
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,China,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],0.83,0.83
Malformation syndrome,Sirenomelia,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],0.79,0.79
Malformation syndrome,Sirenomelia,1-9 / 100 000,Mexico,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],2.36,2.36
Malformation syndrome,Sirenomelia,1-9 / 100 000,Latin America,409968,409968,25958,25958,en,Validated,410293,410293,22002878[PMID],1.36,1.36
Malformation syndrome,Sirenomelia,1-5 / 10 000,Colombia,409968,409968,25958,25958,en,Validated,410293,410293,22030798[PMID],12,12
Disease,Sjögren-Larsson syndrome,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,7273467[PMID],0.6,0.6
Disease,Sjögren-Larsson syndrome,1-5 / 10 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,22899470[PMID],16,16
Disease,Sjögren-Larsson syndrome,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sotos syndrome,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301652[PMID],7.1,7.1
Disease,Sotos syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301652[PMID],0,0
Disease,Sotos syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.5,0.5
Disease,Sotos syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2010[REG],0,0
Disease,Infantile spasms-broad thumbs syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2335044[PMID],2,2
Disease,Infantile spasms-broad thumbs syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2335044[PMID],0,0
Disease,Stormorken-Sjaastad-Langslet syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25044882[PMID]_25577287[PMID],17,17
Disease,Stormorken-Sjaastad-Langslet syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25044882[PMID]_25577287[PMID],0,0
Malformation syndrome,Sturge-Weber syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,24275166[PMID],3.5,3.5
Malformation syndrome,Sturge-Weber syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Thrombocytopenia-absent radius syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.5,0.5
Malformation syndrome,Thrombocytopenia-absent radius syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Acquired neutropenia,,,,,,,,,,,,,
Morphological anomaly,Tracheal agenesis,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,2,2
Morphological anomaly,Tracheal agenesis,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Primary immunodeficiency due to a defect in adaptive immunity,,,,,,,,,,,,,
Disease,Congenital toxoplasmosis,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],33,33
Disease,Congenital toxoplasmosis,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,20587361[PMID],30,30
Disease,Congenital toxoplasmosis,1-9 / 100 000,Greece,409968,409968,25958,25958,en,Validated,410293,410293,23173875[PMID],1,1
Disease,Congenital toxoplasmosis,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,16547084[PMID],2.2,2.2
Disease,Congenital toxoplasmosis,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,11561964[PMID],7.3,7.3
Disease,Congenital toxoplasmosis,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,10359408[PMID],30,30
Disease,Congenital toxoplasmosis,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,7597405[PMID],50,50
Disease,Congenital toxoplasmosis,>1 / 1000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,23173875[PMID],130,130
Disease,Congenital toxoplasmosis,>1 / 1000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,11326012[PMID],113,113
Disease,Congenital toxoplasmosis,1-5 / 10 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,22974376[PMID],40,40
Disease,Congenital toxoplasmosis,>1 / 1000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,19430667[PMID],138,138
Disease,Congenital toxoplasmosis,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention[INST]_ORPHANET,55,55
Disease,Congenital toxoplasmosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital toxoplasmosis,>1 / 1000,"Iran, Islamic Republic of",409968,409968,25958,25958,en,Validated,410293,410293,31096746[PMID],640,640
Malformation syndrome,VACTERL/VATER association,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,21846383[PMID]_[EXPERT]_ ORPHANET,6.25,6.25
Malformation syndrome,VACTERL/VATER association,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital varicella syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26965725[PMID],130,130
Disease,Congenital varicella syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26965725[PMID],0,0
Disease,Cerebrotendinous xanthomatosis,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,16157755[PMID]_[EXPERT],2,2
Disease,Cerebrotendinous xanthomatosis,<1 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,21645175[PMID],0.056,0.056
Disease,Cerebrotendinous xanthomatosis,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,16157755[PMID],4,4
Disease,Cerebrotendinous xanthomatosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Weaver syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24214728[PMID],48,48
Malformation syndrome,Weaver syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24214728[PMID],0,0
Malformation syndrome,Chondrodysplasia-disorder of sex development syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1342874[PMID],2,2
Malformation syndrome,Chondrodysplasia-disorder of sex development syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1342874[PMID],0,0
Clinical subtype,Infant botulism,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.2,0.2
Clinical subtype,Infant botulism,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_Center for Diseases Control and Prevention[INST]_ ORPHANET,0.3,0.3
Clinical subtype,Infant botulism,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2.1,2.1
Clinical subtype,Infant botulism,1-9 / 100 000,Argentina,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2.2,2.2
Clinical subtype,Infant botulism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Intestinal botulism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Autosomal dominant non-syndromic intellectual disability,,,,,,,,,,,,,
Etiological subtype,Wound botulism,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_Center for Diseases Control and Prevention[INST]_ ORPHANET,0.1,0.1
Etiological subtype,Wound botulism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,X-linked myopathy with postural muscle atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19687455[PMID],7,7
Disease,X-linked myopathy with postural muscle atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19687455[PMID],0,0
Disease,Hereditary myopathy with early respiratory failure,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10407851[PMID]_10053013[PMID]_2376753[PMID],10,10
Disease,Hereditary myopathy with early respiratory failure,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10407851[PMID]_10053013[PMID]_2376753[PMID],0,0
Disease,Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19483159[PMID],4,4
Disease,Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19483159[PMID],0,0
Disease,Distal myopathy with anterior tibial onset,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11198284[PMID],4,4
Disease,Distal myopathy with anterior tibial onset,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11198284[PMID],0,0
Morphological anomaly,Congenital vertical talus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Osteopetrosis-hypogammaglobulinemia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18606301[PMID],8,8
Disease,Osteopetrosis-hypogammaglobulinemia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18606301[PMID],0,0
Disease,Alpha-sarcoglycan-related  limb-girdle muscular dystrophy R3,<1 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.07,0.07
Disease,Alpha-sarcoglycan-related  limb-girdle muscular dystrophy R3,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Syndromic microphthalmia type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Syndromic microphthalmia type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Glycogen storage disease due to muscle phosphorylase kinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Disease,Glycogen storage disease due to muscle phosphorylase kinase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Osteosclerosis-developmental delay-craniosynostosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15940380[PMID],13,13
Malformation syndrome,Osteosclerosis-developmental delay-craniosynostosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15940380[PMID],0,0
Disease,"Fructose-1,6-bisphosphatase deficiency",1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],0.67,0.67
Disease,"Fructose-1,6-bisphosphatase deficiency",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Aromatase excess syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24716396[PMID],30,30
Disease,Aromatase excess syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24716396[PMID],0,0
Disease,Smith-McCort dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23042644[PMID]_28127940[PMID],16,16
Disease,Smith-McCort dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28127940[PMID],0,0
Disease,UV-sensitive syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19329487[PMID]_7264357[PMID]_9777763[PMID]_22466610[PMID],7,7
Disease,UV-sensitive syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19329487[PMID]_7264357[PMID]_9777763[PMID]_22466610[PMID],0,0
Disease,Alpha-N-acetylgalactosaminidase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Alpha-N-acetylgalactosaminidase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Inflammatory myofibroblastic tumor,,,,,,,,,,,,,
Disease,"Primary cutaneous diffuse large B-cell lymphoma, leg type",,,,,,,,,,,,,
Disease,Primary cutaneous follicle center lymphoma,,,,,,,,,,,,,
Disease,Behçet disease,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,10743812[PMID],0.66,0.66
Disease,Behçet disease,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,17266063[PMID],0.24,0.24
Disease,Behçet disease,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,19405011[PMID],5.2,5.2
Disease,Behçet disease,1-9 / 1 000 000,"Iran, Islamic Republic of",409967,409967,25958,25958,en,Validated,410293,410293,21199472[PMID],0.58,0.58
Disease,Behçet disease,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,19035493[PMID],7.1,7.1
Disease,Behçet disease,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,17266063[PMID],3.8,3.8
Disease,Behçet disease,1-9 / 1 000 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,19035493[PMID]_10519357[PMID],0.5,0.5
Disease,Behçet disease,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,7904097[PMID],1.2,1.2
Disease,Behçet disease,1-9 / 100 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,10519357[PMID],1.5,1.5
Disease,Behçet disease,1-5 / 10 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,19035493[PMID]_[EXPERT],10,10
Disease,Behçet disease,>1 / 1000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,19035493[PMID]_[EXPERT],225,225
Disease,Behçet disease,1-5 / 10 000,"Iran, Islamic Republic of",409966,409966,25958,25958,en,Validated,410293,410293,10519357[PMID],16.7,16.7
Disease,Behçet disease,1-5 / 10 000,Israel,409966,409966,25958,25958,en,Validated,410293,410293,16897122[PMID],15.2,15.2
Disease,Behçet disease,1-9 / 100 000,"Taiwan, Province of China",409966,409966,25965,25965,en,Not yet validated,410294,410294,22899470[PMID],1.4,1.4
Disease,Behçet disease,1-9 / 1 000 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,22899470[PMID],0.8,0.8
Disease,Behçet disease,1-5 / 10 000,Saudi Arabia,409966,409966,25958,25958,en,Validated,410293,410293,10519357[PMID],20,20
Disease,Behçet disease,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Polymyositis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET,0.585,0.585
Disease,Polymyositis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],7.1,7.1
Disease,Polymyositis,1-9 / 1 000 000,Argentina,409967,409967,25958,25958,en,Validated,410293,410293,23965482[PMID],0.75,0.75
Disease,Polymyositis,1-9 / 100 000,Argentina,409966,409966,25958,25958,en,Validated,410293,410293,23965482[PMID],7.2,7.2
Disease,Polymyositis,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,23981756[PMID],0.41,0.41
Disease,Polymyositis,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,23981756[PMID],7.2,7.2
Disease,Polymyositis,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,18053482[PMID],0.39,0.39
Disease,Polymyositis,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,9137324[PMID],0.76,0.76
Disease,Primary cutaneous marginal zone B-cell lymphoma,,,,,,,,,,,,,
Disease,Primary cutaneous gamma/delta-positive T-cell lymphoma,,,,,,,,,,,,,
Disease,Dermatomyositis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.55,0.55
Disease,Dermatomyositis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,6,6
Disease,Dermatomyositis,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,23981756[PMID],0.1,0.1
Disease,Dermatomyositis,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,23981756[PMID],1.97,1.97
Disease,Dermatomyositis,1-9 / 1 000 000,Argentina,409967,409967,25958,25958,en,Validated,410293,410293,23965482[PMID],0.32,0.32
Disease,Dermatomyositis,1-5 / 10 000,Argentina,409966,409966,25958,25958,en,Validated,410293,410293,23965482[PMID],10.2,10.2
Disease,Dermatomyositis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,20083689[PMID],0.96,0.96
Disease,Dermatomyositis,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,18053482[PMID],0.49,0.49
Disease,Multiminicore myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma,,,,,,,,,,,,,
Disease,Sporadic Creutzfeldt-Jakob disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Sporadic Creutzfeldt-Jakob disease,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,22516048[PMID],0.13,0.13
Disease,Sporadic Creutzfeldt-Jakob disease,1-9 / 1 000 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,Canada Public Health Agency 2012[INST]_ORPHANET,0.48,0.48
Disease,Sporadic Creutzfeldt-Jakob disease,1-9 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.15,0.15
Disease,Sporadic Creutzfeldt-Jakob disease,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention[INST],0.1,0.1
Disease,Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma,,,,,,,,,,,,,
Disease,Localized pagetoid reticulosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Folliculotropic mycosis fungoides,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Perry syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],53,53
Disease,Perry syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Brain calcification, Rajab type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19161147[PMID],8,8
Disease,"Brain calcification, Rajab type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19161147[PMID],0,0
Disease,Inclusion body myositis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],0.5,0.5
Disease,Inclusion body myositis,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,8191875[PMID],0.22,0.22
Disease,Inclusion body myositis,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,11087787[PMID],0.49,0.49
Disease,Inclusion body myositis,1-9 / 100 000,Australia,409966,409966,25965,25965,en,Not yet validated,410294,410294,10842277[PMID]_18815046[PMID]_ ORPHANET,1.2,1.2
Disease,Inclusion body myositis,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,11552086[PMID],1.1,1.1
Disease,Inclusion body myositis,1-9 / 1 000 000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,21842592[PMID],0.1,0.1
Disease,Myopic macular degeneration,,,,,,,,,,,,,
Clinical subtype,Adult intestinal botulism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],19,19
Clinical subtype,Adult intestinal botulism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Symptomatic form of hemophilia A in female carriers,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.87,0.87
Disease,Mucopolysaccharidosis type 3,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,16435194[PMID],1.57,1.57
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.84,0.84
Disease,Mucopolysaccharidosis type 3,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],1.89,1.89
Disease,Mucopolysaccharidosis type 3,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],1.42,1.42
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.91,0.91
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID]_25274184[PMID],0.84,0.84
Disease,Mucopolysaccharidosis type 3,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],1.63,1.63
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],0.27,0.27
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],0.88,0.88
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],0.43,0.43
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],0.92,0.92
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,9439667[PMID],0.36,0.36
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10617747[PMID],0.29,0.29
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,19396827[PMID],0.39,0.39
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Tunisia,409968,409968,25958,25958,en,Validated,410293,410293,20209839[PMID],0.7,0.7
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],0.3,0.3
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,25472774[PMID],0.86,0.86
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.26,0.26
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.38,0.38
Disease,Mucopolysaccharidosis type 3,1-9 / 100 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,20622343[PMID],1.8,1.8
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,25364648[PMID],0.25,0.25
Disease,Mucopolysaccharidosis type 3,1-9 / 100 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,22480138[PMID],1.62,1.62
Disease,Mucopolysaccharidosis type 3,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2016.11.285[OTHER],0.38,0.38
Clinical subtype,Symptomatic form of hemophilia B in female carriers,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Non-acquired combined pituitary hormone deficiencies without extrapituitary malformations,,,,,,,,,,,,,
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2043954[PMID]_19339254[PMID]_19039240[PMID]_23609960[PMID]_1512613[PMID],4.8,4.8
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,2043954[PMID]_24603320[PMID],9.6,9.6
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,23609960[PMID]_24603320[PMID],4.1,4.1
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Sweden,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1.3,1.3
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24603320[PMID],4.2,4.2
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Tunisia,409966,409966,25958,25958,en,Validated,410293,410293,19438933[PMID]_24603320[PMID],5.75,5.75
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,19339254[PMID]_24603320[PMID],7.4,7.4
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,1512613[PMID]_3759416[PMID]_7793232[PMID],2.7,2.7
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Estonia,409966,409966,25958,25958,en,Validated,410293,410293,19039240[PMID]_24603320[PMID],4.4,4.4
Clinical group,Hereditary spastic paraplegia,1-9 / 100 000,Libyan Arab Jamahiriya,409966,409966,25958,25958,en,Validated,410293,410293,4075075[PMID]_24603320[PMID],2.1,2.1
Disease,Osteogenesis imperfecta,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],10,10
Disease,Osteogenesis imperfecta,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,2785882[PMID],6.7,6.7
Disease,Osteogenesis imperfecta,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,12389865[PMID],6.7,6.7
Disease,Osteogenesis imperfecta,1-9 / 1 000 000,Latin America,409968,409968,25958,25958,en,Validated,410293,410293,22407836[PMID],0.74,0.74
Disease,Osteogenesis imperfecta,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,22375084[PMID],1.5,1.5
Disease,Osteogenesis imperfecta,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22461456[PMID],7.9,7.9
Disease,Osteogenesis imperfecta,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25944380[PMID],7.4,7.4
Disease,Central diabetes insipidus,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Etiological subtype,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,,,,,,,,,,,,,
Disease,Malignant hyperthermia of anesthesia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,,,,,,,,,,,,,
Clinical group,Congenital adrenal hyperplasia,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,13.35,13.35
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],10,10
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,15964450[PMID]_15554889[PMID],6.7,6.7
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,10079883[PMID],8.6,8.6
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,Italy,409968,409968,25965,25965,en,Not yet validated,410294,410294,8784357[PMID]_15818055[PMID]_ ORPHANET,6.65,6.65
Clinical group,Congenital adrenal hyperplasia,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,20148377[PMID],12.8,12.8
Clinical group,Congenital adrenal hyperplasia,1-5 / 10 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,9521977[PMID],10.2,10.2
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,22241917[PMID]_3259306[PMID],5.6,5.6
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,Netherlands,409968,409968,25965,25965,en,Not yet validated,410294,410294,15554889[PMID]_11731654[PMID]_ ORPHANET,7.65,7.65
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,15554889[PMID],4,4
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,12213856[PMID],9.3,9.3
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,Japan,409968,409968,25965,25965,en,Not yet validated,410294,410294,23330248[PMID]_ORPHANET,5.35,5.35
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,New Zealand,409968,409968,25958,25958,en,Validated,410293,410293,3259306[PMID],6.9,6.9
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,Cuba,409968,409968,25958,25958,en,Validated,410293,410293,23481450[PMID],6.3,6.3
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,12517042[PMID],6.7,6.7
Clinical group,Congenital adrenal hyperplasia,1-5 / 10 000,India,409968,409968,25958,25958,en,Validated,410293,410293,15053381[PMID],38.8,38.8
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,21641615[PMID]_15964450[PMID]_22766612[PMID],4.8,4.8
Clinical group,Congenital adrenal hyperplasia,1-9 / 100 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,31241292[PMID],7.98,7.98
Etiological subtype,Prader-Willi syndrome due to translocation,,,,,,,,,,,,,
Etiological subtype,Prader-Willi syndrome due to imprinting mutation,,,,,,,,,,,,,
Clinical group,Neuronal ceroid lipofuscinosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,23374165[PMID],0.12,0.12
Clinical group,Neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,23374165[PMID],0.98,0.98
Clinical group,Neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,7668318[PMID],0.56,0.56
Clinical group,Neuronal ceroid lipofuscinosis,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,17092455[PMID],4,4
Clinical group,Neuronal ceroid lipofuscinosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],2,2
Disease,Glycogen storage disease due to glucose-6-phosphatase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glycogen storage disease due to glucose-6-phosphatase deficiency,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,21599942[PMID]_[EXPERT],1,1
Category,Rare adult hypothyroidism,,,,,,,,,,,,,
Disease,Gaucher disease,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1.7,1.7
Disease,Gaucher disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Gaucher disease,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,23046562[PMID],1.3,1.3
Disease,Gaucher disease,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22429443[PMID],0.67,0.67
Disease,Gaucher disease,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,22133539[PMID],5.7,5.7
Disease,Gaucher disease,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,23046562[PMID],2.6,2.6
Disease,Gaucher disease,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,23046562[PMID],2,2
Disease,Gaucher disease,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,23046562[PMID],0.74,0.74
Disease,Gaucher disease,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],1.7,1.7
Disease,Gaucher disease,1-9 / 100 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],1.13,1.13
Disease,Gaucher disease,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],1.35,1.35
Disease,Gaucher disease,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],1.16,1.16
Disease,Gaucher disease,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,23430949[PMID],7.5,7.5
Disease,Gaucher disease,1-9 / 1 000 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,15275696[PMID],0.45,0.45
Disease,Gaucher disease,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],2.11,2.11
Disease,Hirschsprung disease,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,25066220[PMID]_EUROCAT European surveillance of congenital anomalies 1980-2009[REG],10.9,10.9
Disease,Hirschsprung disease,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hirschsprung disease,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.8,5.8
Disease,Hirschsprung disease,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],13.1,13.1
Disease,Hirschsprung disease,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],19.8,19.8
Disease,Hirschsprung disease,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],13.6,13.6
Disease,Hirschsprung disease,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.6,11.6
Disease,Hirschsprung disease,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.5,5.5
Disease,Hirschsprung disease,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],18.1,18.1
Disease,Hirschsprung disease,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],23.3,23.3
Disease,Hirschsprung disease,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.4,11.4
Disease,Hirschsprung disease,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1,1
Disease,Hirschsprung disease,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.5,9.5
Disease,Hirschsprung disease,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],6.9,6.9
Disease,Hirschsprung disease,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],12.3,12.3
Disease,Hirschsprung disease,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],16.2,16.2
Disease,Hirschsprung disease,1-5 / 10 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,6240474[PMID]_19777544[PMID],24.3,24.3
Disease,Hirschsprung disease,1-5 / 10 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,15868585[PMID],18.7,18.7
Disease,Hirschsprung disease,1-5 / 10 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,4049274[PMID],22.6,22.6
Disease,Hirschsprung disease,1-5 / 10 000,Oman,409968,409968,25958,25958,en,Validated,410293,410293,9165461[PMID],32.6,32.6
Disease,Hirschsprung disease,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Disease,Hirschsprung disease,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.8,9.8
Disease,Hirschsprung disease,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],24.1,24.1
Disease,Hirschsprung disease,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.2,11.2
Disease,Hirschsprung disease,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],15.5,15.5
Disease,Hirschsprung disease,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,15921246[PMID],33,33
Disease,Hirschsprung disease,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,27307146[PMID],1.91,1.91
Category,Syndromic hypothyroidism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Hemophilia,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,6.25,6.25
Clinical group,Hemophilia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,7.7,7.7
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20507631[PMID]_[EXPERT],1.8,1.8
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2.2,2.2
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20507631[PMID]_[EXPERT],1.9,1.9
Clinical group,Epidermolysis bullosa simplex,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,20507631[PMID]_[EXPERT],0,0
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,6203284[PMID],1.51,1.51
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Finland,409966,409966,25965,25965,en,Not yet validated,410294,410294,6203284[PMID],0,0
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,1419751[PMID],2.8,2.8
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Ireland,409966,409966,25965,25965,en,Not yet validated,410294,410294,1419751[PMID],0,0
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:801812658[OTHER],2.43,2.43
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:801812658[OTHER],0,0
Clinical group,Epidermolysis bullosa simplex,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,2601109[PMID],0.4,0.4
Clinical group,Epidermolysis bullosa simplex,1-9 / 1 000 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,2601109[PMID],0,0
Clinical group,Epidermolysis bullosa simplex,<1 / 1 000 000,South Africa,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:951563203[OTHER],0.08,0.08
Clinical group,Epidermolysis bullosa simplex,1-9 / 1 000 000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:951563203[OTHER],0,0
Clinical group,Epidermolysis bullosa simplex,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,20566927[PMID],0.56,0.56
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,20566927[PMID],1.05,1.05
Clinical group,Epidermolysis bullosa simplex,1-9 / 1 000 000,New Zealand,409968,409968,25958,25958,en,Validated,410293,410293,20566927[PMID],0.29,0.29
Clinical group,Epidermolysis bullosa simplex,1-9 / 1 000 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,20566927[PMID],0,0
Clinical group,Epidermolysis bullosa simplex,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,9155958[PMID]_[EXPERT],2.86,2.86
Category,Congenital hypogonadotropic hypogonadism,,,,,,,,,,,,,
Disease,GM1 gangliosidosis,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.75,0.75
Disease,GM1 gangliosidosis,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,9323577[PMID]_[EXPERT],27,27
Disease,GM1 gangliosidosis,1-9 / 100 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,10517258[PMID]_[EXPERT],5.9,5.9
Disease,GM1 gangliosidosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,GM1 gangliosidosis,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.34,0.34
Clinical syndrome,Acute lung injury,1-5 / 10 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,15659944[PMID]_15166842[PMID],25,25
Clinical syndrome,Acute lung injury,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],0,0
Clinical syndrome,Acute lung injury,1-5 / 10 000,Australia,409967,409967,25965,25965,en,Not yet validated,410294,410294,15659944[PMID]_15166842[PMID],25,25
Clinical syndrome,Acute lung injury,6-9 / 10 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,15659944[PMID]_20073554[PMID]_9468178[PMID],65,65
Disease,Undifferentiated embryonal sarcoma of the liver,,,,,,,,,,,,,
Disease,Åland Islands eye disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17525176[PMID],5,5
Disease,Åland Islands eye disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Purine nucleoside phosphorylase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30885031[PMID],72,72
Disease,Purine nucleoside phosphorylase deficiency,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30885031[PMID],0,0
Disease,Oculopharyngeal muscular dystrophy,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,9392014[PMID],167,167
Disease,Oculopharyngeal muscular dystrophy,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,9392013[PMID]_2204987[PMID],1,1
Disease,Oculopharyngeal muscular dystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Oculopharyngeal muscular dystrophy,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,7795598[PMID],100,100
Malformation syndrome,8q22.1 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22821852[PMID],6,6
Malformation syndrome,8q22.1 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary ciliary dyskinesia,1-5 / 10 000,Pakistan,409966,409966,25958,25958,en,Validated,410293,410293,19720631[PMID],44,44
Disease,Primary ciliary dyskinesia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,23871404[PMID],5,5
Clinical subtype,Antenatal multiminicore disease with arthrogryposis multiplex congenita,,,,,,,,,,,,,
Disease,Isolated sternocostoclavicular hyperostosis,,,,,,,,,,,,,
Disease,Reticulate acropigmentation of Kitamura,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23666529[PMID],130,130
Disease,Reticulate acropigmentation of Kitamura,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Myasthenia gravis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,20130418[PMID]_[EXPERT]_ ORPHANET,1.7,1.7
Disease,Myasthenia gravis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,17986328[PMID]_[EXPERT]_European Medicines Agency 2018[INST],20,20
Disease,Myasthenia gravis,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20565885[PMID],7.77,7.77
Disease,Myasthenia gravis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,8909435[PMID],0.9,0.9
Disease,Myasthenia gravis,1-5 / 10 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,14664466[PMID],20,20
Disease,Myasthenia gravis,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,12654975[PMID],2.1,2.1
Disease,Myasthenia gravis,1-5 / 10 000,United Kingdom,409969,409969,25958,25958,en,Validated,410293,410293,10733998[PMID],40,40
Disease,Myasthenia gravis,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,9771771[PMID],1.11,1.11
Disease,Myasthenia gravis,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,9771771[PMID],15,15
Disease,Myasthenia gravis,1-9 / 100 000,Serbia,409967,409967,25958,25958,en,Validated,410293,410293,23363926[PMID],1.33,1.33
Disease,Myasthenia gravis,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,8909435[PMID],17,17
Disease,Myasthenia gravis,1-5 / 10 000,Serbia,409966,409966,25958,25958,en,Validated,410293,410293,23363926[PMID],31.8,31.8
Disease,Myasthenia gravis,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,21757957[PMID]_20623298[PMID]_ ORPHANET,1.94,1.94
Disease,Myasthenia gravis,1-5 / 10 000,Austria,409966,409966,25958,25958,en,Validated,410293,410293,23129486[PMID],15.7,15.7
Disease,Myasthenia gravis,1-9 / 100 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,22469211[PMID],2.5,2.5
Disease,Myasthenia gravis,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,21757957[PMID]_22377708[PMID]_ ORPHANET,18.5,18.5
Disease,Myasthenia gravis,1-9 / 100 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,20523074[PMID],2.1,2.1
Disease,Myasthenia gravis,1-5 / 10 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,22469211[PMID],11.7,11.7
Disease,Myasthenia gravis,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,11511710[PMID],0.74,0.74
Disease,Myasthenia gravis,1-5 / 10 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,20523074[PMID],14,14
Disease,Myasthenia gravis,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,9705586[PMID],0.65,0.65
Disease,Myasthenia gravis,1-9 / 100 000,Estonia,409966,409966,25958,25958,en,Validated,410293,410293,14638881[PMID],7.8,7.8
Disease,Myasthenia gravis,1-9 / 100 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,11511710[PMID],7.1,7.1
Disease,Myasthenia gravis,1-9 / 100 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,9705586[PMID],9.9,9.9
Disease,Myasthenia gravis,1-9 / 100 000,Egypt,409966,409966,25958,25958,en,Validated,410293,410293,20948236[PMID],3.2,3.2
Disease,Myasthenia gravis,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,20565885[PMID],0.53,0.53
Disease,Tuberous sclerosis complex,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,2012513[PMID]_[EXPERT],0.46,0.46
Disease,Tuberous sclerosis complex,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Tuberous sclerosis complex,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,16700943[PMID],4,4
Disease,Tuberous sclerosis complex,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,9605811[PMID],8.8,8.8
Disease,Tuberous sclerosis complex,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,2039137[PMID],17.2,17.2
Disease,Tuberous sclerosis complex,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,2012513[PMID],6,6
Disease,Tuberous sclerosis complex,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,2012513[PMID],6.9,6.9
Disease,Tuberous sclerosis complex,1-9 / 100 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,19887839[PMID],1.05,1.05
Disease,Tuberous sclerosis complex,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],10,10
Disease,Tuberous sclerosis complex,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,30016967[PMID],5.62,5.62
Disease,Usher syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Usher syndrome,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Usher syndrome,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,9212179[PMID],5,5
Disease,Usher syndrome,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,12107518[PMID],6.2,6.2
Disease,Usher syndrome,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,9135408[PMID],6.2,6.2
Disease,Usher syndrome,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,3594933[PMID],3.6,3.6
Disease,Usher syndrome,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,15178965[PMID],4.2,4.2
Disease,Usher syndrome,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,5516287[PMID],3.5,3.5
Disease,Usher syndrome,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,6885960[PMID],4.4,4.4
Disease,Usher syndrome,1-9 / 100 000,Colombia,409966,409966,25958,25958,en,Validated,410293,410293,1756603[PMID],3.2,3.2
Disease,Usher syndrome,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,14569126[PMID],3,3
Clinical subtype,Moderate multiminicore disease with hand involvement,,,,,,,,,,,,,
Disease,Waardenburg syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.37,0.37
Disease,Waardenburg syndrome,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,9279758[PMID]_ORPHANET,1.74,1.74
Disease,Waardenburg syndrome,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,9279758[PMID],2.4,2.4
Disease,Waardenburg syndrome,1-9 / 100 000,Netherlands,409966,409966,25965,25965,en,Not yet validated,410294,410294,9279758[PMID],0,0
Disease,Waardenburg syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare peripheral precocious puberty,,,,,,,,,,,,,
Disease,Pelizaeus-Merzbacher disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.25,0.25
Disease,Pelizaeus-Merzbacher disease,1-9 / 1 000 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301361[PMID]_ORPHANET,0.35,0.35
Disease,Pelizaeus-Merzbacher disease,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,9286459[PMID],0.13,0.13
Clinical group,Porphyria,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,15652607[PMID]_ORPHANET,5.25,5.25
Clinical group,Porphyria,1-9 / 1 000 000,Japan,409969,409969,25958,25958,en,Validated,410293,410293,15239394[PMID],0.7,0.7
Clinical group,Porphyria,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,27139922[PMID],0.52,0.52
Clinical group,Familial long QT syndrome,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,18606002[PMID]_[EXPERT],40,40
Clinical group,Familial long QT syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Transient congenital hypothyroidism,,,,,,,,,,,,,
Disease,Retinitis pigmentosa,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],30,30
Disease,Retinitis pigmentosa,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],26.7,26.7
Disease,Retinitis pigmentosa,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,11921605[PMID],25.4,25.4
Disease,Retinitis pigmentosa,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,3594933[PMID],22.5,22.5
Disease,Retinitis pigmentosa,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,6702974[PMID],21,21
Disease,Retinitis pigmentosa,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,6512829[PMID],20.5,20.5
Disease,Retinitis pigmentosa,1-5 / 10 000,China,409966,409966,25958,25958,en,Validated,410293,410293,3500313[PMID],26.4,26.4
Disease,Retinitis pigmentosa,1-5 / 10 000,Slovenia,409966,409966,25958,25958,en,Validated,410293,410293,1395082[PMID],16.7,16.7
Disease,Retinitis pigmentosa,1-5 / 10 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,28130043[PMID],11.09,11.09
Disease,Anti-glomerular basement membrane disease,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0.08,0.08
Disease,Anti-glomerular basement membrane disease,1-9 / 1 000 000,New Zealand,409967,409967,25958,25958,en,Validated,410293,410293,22032242[PMID],0.179,0.179
Disease,Anti-glomerular basement membrane disease,<1 / 1 000 000,China,409967,409967,25958,25958,en,Validated,410293,410293,15056270[PMID],0.06,0.06
Disease,Anti-glomerular basement membrane disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Anti-glomerular basement membrane disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018 [INST],0.2,0.2
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25805746[PMID],1.56,1.56
Disease,Eosinophilic granulomatosis with polyangiitis,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,19797309[PMID],0.09,0.09
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,20039171[PMID]_25805746[PMID],1.13,1.13
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,17553910[PMID]_25805746[PMID],1.4,1.4
Disease,Eosinophilic granulomatosis with polyangiitis,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,21798892[PMID]_25805746[PMID],0.09,0.09
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9805179[PMID],1.3,1.3
Disease,Eosinophilic granulomatosis with polyangiitis,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,11156552[PMID],0.09,0.09
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,18771432[PMID]_25805746[PMID],2.23,2.23
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_19797309[PMID]_18565978[PMID]_11156552[PMID],0.18,0.18
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,18771432[PMID]_9805179[PMID]_17553910[PMID]_14872461[PMID],1.5,1.5
Disease,Eosinophilic granulomatosis with polyangiitis,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,11760724[PMID]_25805746[PMID],0.05,0.05
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,15696553[PMID]_25805746[PMID],0.11,0.11
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,15647446[PMID]_25805746[PMID],0.13,0.13
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,20039171[PMID]_25805746[PMID],0.12,0.12
Disease,Eosinophilic granulomatosis with polyangiitis,<1 / 1 000 000,Turkey,409967,409967,25958,25958,en,Validated,410293,410293,25805746[PMID],0.06,0.06
Disease,Eosinophilic granulomatosis with polyangiitis,<1 / 1 000 000,Peru,409967,409967,25958,25958,en,Validated,410293,410293,25805746[PMID],0.014,0.014
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,24425780[PMID]_25805746[PMID],2.4,2.4
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,24289197[PMID]_25805746[PMID],1.78,1.78
Disease,Eosinophilic granulomatosis with polyangiitis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,28881446[PMID],0.4,0.4
Disease,Allergic bronchopulmonary aspergillosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Locked-in syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,33,33
Disease,Locked-in syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Leptospirosis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.12,0.12
Disease,Leptospirosis,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Leptospirosis,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,23337900[PMID],0.92,0.92
Disease,Leptospirosis,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.12,0.12
Disease,Leptospirosis,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.12,0.12
Disease,Leptospirosis,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.18,0.18
Disease,Leptospirosis,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2015[INST],1.13,1.13
Disease,Leptospirosis,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.22,0.22
Disease,Leptospirosis,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.12,0.12
Disease,Leptospirosis,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.24,0.24
Disease,Leptospirosis,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.02,0.02
Disease,Leptospirosis,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.12,0.12
Disease,Leptospirosis,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.22,0.22
Disease,Leptospirosis,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.16,0.16
Disease,Leptospirosis,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.36,0.36
Disease,Leptospirosis,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.1,0.1
Disease,Leptospirosis,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.14,0.14
Disease,Leptospirosis,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.3,0.3
Disease,Leptospirosis,<1 / 1 000 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.04,0.04
Disease,Leptospirosis,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.42,0.42
Disease,Leptospirosis,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.36,0.36
Disease,Leptospirosis,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.38,0.38
Disease,Leptospirosis,1-9 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.38,0.38
Disease,Leptospirosis,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.12,0.12
Disease,Leptospirosis,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.52,0.52
Disease,Leptospirosis,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.04,0.04
Disease,Leptospirosis,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.1,0.1
Disease,Immunoglobulin A vasculitis,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9805179[PMID],3.3,3.3
Disease,Immunoglobulin A vasculitis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Alternating hemiplegia of childhood,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,24100174[PMID],0.94,0.94
Disease,Alternating hemiplegia of childhood,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Primary cutaneous T-cell lymphoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG]_21493798[PMID],5.2,5.2
Category,Primary cutaneous T-cell lymphoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],24,24
Category,Primary cutaneous T-cell lymphoma,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.09,0.09
Category,Primary cutaneous T-cell lymphoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.097,0.097
Category,Primary cutaneous T-cell lymphoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.577,0.577
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.539,0.539
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.158,0.158
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.341,0.341
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.185,0.185
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.326,0.326
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.767,0.767
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.647,0.647
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.323,0.323
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.431,0.431
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.355,0.355
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.273,0.273
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.225,0.225
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.594,0.594
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.231,0.231
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.441,0.441
Category,Primary cutaneous T-cell lymphoma,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.197,0.197
Category,Primary cutaneous T-cell lymphoma,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.163,1.163
Category,Primary cutaneous T-cell lymphoma,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.57,1.57
Disease,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Disease,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Category,B-cell non-Hodgkin lymphoma,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],17.45,17.45
Disease,Glycogen storage disease due to aldolase A deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Myeloid hemopathy,,,,,,,,,,,,,
Category,Lymphoid hemopathy,,,,,,,,,,,,,
Malformation syndrome,Fibrous dysplasia of bone,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Congenital myopathy with cores,,,,,,,,,,,,,
Disease,Autosomal dominant keratitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,T-cell non-Hodgkin lymphoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.99,0.99
Disease,Leydig cell hypoplasia,,,,,,,,,,,,,
Malformation syndrome,Trisomy 10p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Malformation syndrome,Trisomy 10p,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Citrullinemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adenylosuccinate lyase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18830228[PMID],56,56
Disease,Adenylosuccinate lyase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],38,38
Category,Congenital hypothyroidism,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,15807875[PMID],10,10
Category,Congenital hypothyroidism,1-5 / 10 000,France,409966,409966,25965,25965,en,Not yet validated,410294,410294,15807875[PMID],0,0
Category,Congenital hypothyroidism,6-9 / 10 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,10102157[PMID]_21048833[PMID]_16595645[PMID],57,57
Category,Congenital hypothyroidism,1-5 / 10 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,10102157[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,23025761[PMID]_23426615[PMID],45.5,45.5
Category,Congenital hypothyroidism,6-9 / 10 000,Greece,409968,409968,25958,25958,en,Validated,410293,410293,20591982[PMID]_23426615[PMID],57,57
Category,Congenital hypothyroidism,1-5 / 10 000,Cyprus,409968,409968,25958,25958,en,Validated,410293,410293,15921174[PMID],55.5,55.5
Category,Congenital hypothyroidism,1-5 / 10 000,Latvia,409968,409968,25958,25958,en,Validated,410293,410293,11400783[PMID],15.5,15.5
Category,Congenital hypothyroidism,1-5 / 10 000,Latvia,409966,409966,25965,25965,en,Not yet validated,410294,410294,11400783[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,China,409968,409968,25958,25958,en,Validated,410293,410293,23430943[PMID],49.1,49.1
Category,Congenital hypothyroidism,1-5 / 10 000,China,409966,409966,25965,25965,en,Not yet validated,410294,410294,23430943[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,16318620[PMID],30.2,30.2
Category,Congenital hypothyroidism,1-5 / 10 000,Germany,409966,409966,25965,25965,en,Not yet validated,410294,410294,16318620[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,9782755[PMID],29.4,29.4
Category,Congenital hypothyroidism,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,12762638[PMID],25,25
Category,Congenital hypothyroidism,1-5 / 10 000,Poland,409966,409966,25965,25965,en,Not yet validated,410294,410294,12762638[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,9575454[PMID],35,35
Category,Congenital hypothyroidism,1-5 / 10 000,Estonia,409966,409966,25965,25965,en,Not yet validated,410294,410294,9575454[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Lebanon,409968,409968,25958,25958,en,Validated,410293,410293,17146215[PMID],54.8,54.8
Category,Congenital hypothyroidism,>1 / 1000,"Iran, Islamic Republic of",409968,409968,25958,25958,en,Validated,410293,410293,23060475[PMID],150,150
Category,Congenital hypothyroidism,6-9 / 10 000,Brazil,409968,409968,25965,25965,en,Not yet validated,410294,410294,23033178[PMID]_22911283[PMID]_ ORPHANET,73.35,73.35
Category,Congenital hypothyroidism,1-5 / 10 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,15857333[PMID],43,43
Category,Congenital hypothyroidism,1-5 / 10 000,Turkey,409966,409966,25965,25965,en,Not yet validated,410294,410294,15857333[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,12031004[PMID],35.4,35.4
Category,Congenital hypothyroidism,1-5 / 10 000,Australia,409966,409966,25965,25965,en,Not yet validated,410294,410294,12031004[PMID],0,0
Category,Congenital hypothyroidism,6-9 / 10 000,United Arab Emirates,409968,409968,25958,25958,en,Validated,410293,410293,15751925[PMID],63.7,63.7
Category,Congenital hypothyroidism,6-9 / 10 000,Bangladesh,409968,409968,25958,25958,en,Validated,410293,410293,15906726[PMID],76.9,76.9
Category,Congenital hypothyroidism,6-9 / 10 000,Pakistan,409968,409968,25958,25958,en,Validated,410293,410293,19904471[PMID],62.5,62.5
Category,Congenital hypothyroidism,1-5 / 10 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,23291568[PMID],50.2,50.2
Category,Congenital hypothyroidism,1-5 / 10 000,Mexico,409968,409968,25958,25958,en,Validated,410293,410293,18782254[PMID],43,43
Category,Congenital hypothyroidism,1-5 / 10 000,Mexico,409966,409966,25965,25965,en,Not yet validated,410294,410294,18782254[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Bosnia and Herzegovina,409968,409968,25958,25958,en,Validated,410293,410293,18668261[PMID],25.3,25.3
Category,Congenital hypothyroidism,1-5 / 10 000,Bosnia and Herzegovina,409966,409966,25965,25965,en,Not yet validated,410294,410294,18668261[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Bahrain,409968,409968,25958,25958,en,Validated,410293,410293,20432804[PMID],33.7,33.7
Category,Congenital hypothyroidism,1-5 / 10 000,Bahrain,409966,409966,25965,25965,en,Not yet validated,410294,410294,20432804[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,New Zealand,409968,409968,25958,25958,en,Validated,410293,410293,22723332[PMID],36,36
Category,Congenital hypothyroidism,1-5 / 10 000,New Zealand,409966,409966,25965,25965,en,Not yet validated,410294,410294,22723332[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,Thailand,409968,409968,25958,25958,en,Validated,410293,410293,11400774[PMID],16,16
Category,Congenital hypothyroidism,1-5 / 10 000,Thailand,409966,409966,25965,25965,en,Not yet validated,410294,410294,11400774[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,17512233[PMID]_16509526[PMID],0,0
Category,Congenital hypothyroidism,1-5 / 10 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,17512233[PMID]_16509526[PMID]_ ORPHANET,44,44
Category,Congenital hypothyroidism,1-5 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,21632812[PMID],37.3,37.3
Category,Congenital hypothyroidism,1-5 / 10 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,31241292[PMID],34.76,34.76
Category,Congenital hypothyroidism,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,30242075[PMID],45,45
Disease,X-linked adrenoleukodystrophy,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20301491[PMID]_22889154[PMID]_ [EXPERT],5,5
Disease,X-linked adrenoleukodystrophy,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,8272182[PMID],0.5,0.5
Disease,X-linked adrenoleukodystrophy,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,9286459[PMID],0.8,0.8
Disease,X-linked adrenoleukodystrophy,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,23419472[PMID],1.6,1.6
Disease,X-linked adrenoleukodystrophy,1-9 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,23419472[PMID],0.8,0.8
Disease,X-linked adrenoleukodystrophy,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,10933453[PMID],1.8,1.8
Disease,X-linked adrenoleukodystrophy,1-9 / 100 000,Oceania,409968,409968,25958,25958,en,Validated,410293,410293,9556302[PMID],1.6,1.6
Disease,X-linked adrenoleukodystrophy,1-9 / 100 000,Japan,409968,409968,25965,25965,en,Not yet validated,410294,410294,12436195[PMID]_ORPHANET,1.35,1.35
Disease,X-linked adrenoleukodystrophy,1-9 / 100 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,19269120[PMID],1.4,1.4
Disease,X-linked adrenoleukodystrophy,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Disease,X-linked adrenoleukodystrophy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sialuria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11486897[PMID],5,5
Disease,Sialuria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11486897[PMID],0,0
Disease,Sitosterolemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18441155[PMID],100,100
Disease,Sitosterolemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18441155[PMID],0,0
Disease,Shigellosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Shigellosis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.68,1.68
Disease,Shigellosis,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.78,0.78
Disease,Shigellosis,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],8.18,8.18
Disease,Shigellosis,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2015[INST],0.33,0.33
Disease,Shigellosis,<1 / 1 000 000,Cyprus,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.04,0.04
Disease,Shigellosis,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.6,1.6
Disease,Shigellosis,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],2.08,2.08
Disease,Shigellosis,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.38,1.38
Disease,Shigellosis,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.82,1.82
Disease,Shigellosis,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],2.54,2.54
Disease,Shigellosis,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.7,0.7
Disease,Shigellosis,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.74,0.74
Disease,Shigellosis,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.38,0.38
Disease,Shigellosis,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.12,1.12
Disease,Shigellosis,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.34,0.34
Disease,Shigellosis,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.12,1.12
Disease,Shigellosis,1-9 / 100 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],2.6,2.6
Disease,Shigellosis,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.34,0.34
Disease,Shigellosis,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],2.4,2.4
Disease,Shigellosis,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.02,0.02
Disease,Shigellosis,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.08,0.08
Disease,Shigellosis,1-9 / 100 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.18,1.18
Disease,Shigellosis,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],6.1,6.1
Disease,Shigellosis,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.02,1.02
Disease,Shigellosis,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.44,0.44
Disease,Shigellosis,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],3.68,3.68
Disease,Shigellosis,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],3.32,3.32
Disease,Shigellosis,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.3,0.3
Disease,Shigellosis,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],2.06,2.06
Disease,Eosinophilic fasciitis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Eosinophilic fasciitis,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,29526049[PMID],1.4,1.4
Disease,Primary pulmonary lymphoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Microscopic polyangiitis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Microscopic polyangiitis,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,15696553[PMID]_25805746[PMID],0.26,0.26
Disease,Microscopic polyangiitis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Microscopic polyangiitis,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,11156552[PMID],1.16,1.16
Disease,Microscopic polyangiitis,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,17553910[PMID],9.4,9.4
Disease,Microscopic polyangiitis,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,18771432[PMID],0.5,0.5
Disease,Microscopic polyangiitis,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,14872461[PMID],2.5,2.5
Disease,Microscopic polyangiitis,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,11760724[PMID],0.27,0.27
Disease,Microscopic polyangiitis,1-9 / 100 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,16368729[PMID],3.7,3.7
Disease,Microscopic polyangiitis,1-9 / 1 000 000,United Kingdom,409967,409967,25965,25965,en,Not yet validated,410294,410294,11156552[PMID]_22258386[PMID]_10693883[PMID]_ORPHANET,0.74,0.74
Disease,Microscopic polyangiitis,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,22258386[PMID]_25805746[PMID],6.3,6.3
Disease,Microscopic polyangiitis,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,24425780[PMID]_25805746[PMID],2.8,2.8
Disease,Microscopic polyangiitis,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,18771432[PMID]_25805746[PMID],3.91,3.91
Disease,Microscopic polyangiitis,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,17699321[PMID]_25805746[PMID],1.38,1.38
Disease,Microscopic polyangiitis,1-9 / 100 000,Kuwait,409967,409967,25958,25958,en,Validated,410293,410293,9306338[PMID]_25805746[PMID],2.4,2.4
Disease,Microscopic polyangiitis,1-9 / 100 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,21798892[PMID]_25805746[PMID],1.82,1.82
Disease,Microscopic polyangiitis,1-9 / 1 000 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,23838025[PMID]_25805746[PMID],0.71,0.71
Disease,Microscopic polyangiitis,1-9 / 100 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,19604432[PMID]_25805746[PMID],1.02,1.02
Disease,Microscopic polyangiitis,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,15647446[PMID]_25805746[PMID],0.3,0.3
Disease,Microscopic polyangiitis,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,19797309[PMID]_25805746[PMID],1.01,1.01
Disease,Microscopic polyangiitis,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,28881446[PMID],1.6,1.6
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,16859601[PMID],0.85,0.85
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,16859601[PMID],9,9
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,10693883[PMID]_11156552[PMID]_22258386[PMID]_19790134[PMID],1,1
Disease,Granulomatosis with polyangiitis,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,17553910[PMID]_25805746[PMID],16,16
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,15696553[PMID]_25805746[PMID],0.86,0.86
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,14872461[PMID]_25805746[PMID],2.37,2.37
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,16960922[PMID]_25805746[PMID],1.19,1.19
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,11156552[PMID],0.49,0.49
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,11083271[PMID]_25805746[PMID],9.51,9.51
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,11760724[PMID]_11083271[PMID]_ ORPHANET,1,1
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,18771432[PMID]_25805746[PMID],9.5,9.5
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,16368729[PMID]_25805746[PMID],9.35,9.35
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,18799060[PMID],0.93,0.93
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,8546743[PMID],2.6,2.6
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,China,409966,409966,25958,25958,en,Validated,410293,410293,26989646[PMID],1.94,1.94
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,15647446[PMID]_25805746[PMID],0.21,0.21
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,19604432[PMID]_25805746[PMID],0.66,0.66
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,24932888[PMID]_25805746[PMID],0.24,0.24
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,23838025[PMID]_25805746[PMID],0.46,0.46
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,21798892[PMID]_25805746[PMID],0.21,0.21
Disease,Granulomatosis with polyangiitis,<1 / 1 000 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,24560699[PMID]_25805746[PMID],0.037,0.037
Disease,Granulomatosis with polyangiitis,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,17699321[PMID]_25805746[PMID],0.23,0.23
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,24932888[PMID]_25805746[PMID],3.43,3.43
Disease,Granulomatosis with polyangiitis,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,17582741[PMID]_25805746[PMID],10,10
Disease,Granulomatosis with polyangiitis,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,28881446[PMID],1.3,1.3
Disease,Trichinellosis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Trichinellosis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.06,0.06
Disease,Trichinellosis,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.48,0.48
Disease,Trichinellosis,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2015[INST],0.067,0.067
Disease,Trichinellosis,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.04,0.04
Disease,Trichinellosis,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.04,0.04
Disease,Trichinellosis,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.06,1.06
Disease,Trichinellosis,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.6,0.6
Disease,Trichinellosis,1-9 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.64,0.64
Disease,Trichinellosis,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.08,0.08
Disease,Parkinsonian-pyramidal syndrome,,,,,,,,,,,,,
Disease,Beta-ketothiolase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Beta-ketothiolase deficiency,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,10626578[PMID]_[EXPERT],0.72,0.72
Disease,Beta-ketothiolase deficiency,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,21669895[PMID]_[EXPERT],0.43,0.43
Disease,Beta-ketothiolase deficiency,1-9 / 1 000 000,China,409968,409968,25958,25958,en,Validated,410293,410293,31156707[PMID]_[EXPERT],0.98,0.98
Disease,Beta-ketothiolase deficiency,1-9 / 1 000 000,Viet Nam,409968,409968,25958,25958,en,Validated,410293,410293,28220263[PMID]_[EXPERT],0.53,0.53
Disease,Diffuse panbronchiolitis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Pulmonary agenesis,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-polymicrogyria-corpus callosum agenesis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17353897[PMID],4,4
Malformation syndrome,Microcephaly-polymicrogyria-corpus callosum agenesis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17353897[PMID],0,0
Disease,Short stature-delayed bone age due to thyroid hormone metabolism deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Male infertility due to globozoospermia,,,,,,,,,,,,,
Disease,Amish infantile epilepsy syndrome,,,,,,,,,,,,,
Malformation syndrome,Cutis laxa-Marfanoid syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1864606[PMID],0,0
Malformation syndrome,Cutis laxa-Marfanoid syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1864606[PMID],18,18
Disease,Aspergillosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,White sponge nevus,,,,,,,,,,,,,
Disease,Hereditary xanthinuria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,150,150
Disease,Hereditary xanthinuria,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,9.05,9.05
Disease,Hereditary xanthinuria,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Limbal stem cell deficiency,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],20,20
Particular clinical situation in a disease or syndrome,Periventricular leukomalacia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Maple syrup urine disease,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.67,0.67
Disease,Maple syrup urine disease,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20307994[PMID],0.78,0.78
Disease,Maple syrup urine disease,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],0.79,0.79
Disease,Maple syrup urine disease,1-9 / 100 000,Tunisia,409968,409968,25958,25958,en,Validated,410293,410293,22481200[PMID],7.3,7.3
Disease,Maple syrup urine disease,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,6468444[PMID],0.19,0.19
Disease,Maple syrup urine disease,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,20466570[PMID],1.15,1.15
Disease,Maple syrup urine disease,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,12788994[PMID],0.6,0.6
Disease,Maple syrup urine disease,1-9 / 1 000 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,2056791[PMID],0.86,0.86
Disease,Maple syrup urine disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],0,0
Disease,Maple syrup urine disease,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,31241292[PMID],0.34,0.34
Malformation syndrome,Lissencephaly due to TUBA1A mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,15,15
Malformation syndrome,Lissencephaly due to TUBA1A mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Glutathione synthetase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26984560[PMID],70,70
Disease,Glutathione synthetase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26984560[PMID],0,0
Disease,Idiopathic bilateral vestibulopathy,,,,,,,,,,,,,
Disease,Metabolic myopathy due to lactate transporter defect,,,,,,,,,,,,,
Disease,Methylmalonic acidemia with homocystinuria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16714133[PMID]_[EXPERT],500,500
Disease,Methylmalonic acidemia with homocystinuria,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant spastic paraplegia type 42,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19061983[PMID],1,1
Disease,Autosomal dominant spastic paraplegia type 42,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19061983[PMID],0,0
Disease,Intellectual disability-cataracts-kyphosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18781183[PMID],3,3
Disease,Intellectual disability-cataracts-kyphosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18781183[PMID],0,0
Clinical subtype,Renal pseudohypoaldosteronism type 1,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Exstrophy-epispadias complex,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Spondyloepimetaphyseal dysplasia, aggrecan type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19110214[PMID],3,3
Disease,"Spondyloepimetaphyseal dysplasia, aggrecan type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19110214[PMID],0,0
Morphological anomaly,Gastroschisis,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010-2016[REG]_[EXPERT],16.9,16.9
Morphological anomaly,Gastroschisis,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],29.4,29.4
Morphological anomaly,Gastroschisis,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],14.6,14.6
Morphological anomaly,Gastroschisis,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],22.7,22.7
Morphological anomaly,Gastroschisis,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.3,21.3
Morphological anomaly,Gastroschisis,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],17.7,17.7
Morphological anomaly,Gastroschisis,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],41.6,41.6
Morphological anomaly,Gastroschisis,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],6.2,6.2
Morphological anomaly,Gastroschisis,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],18.1,18.1
Morphological anomaly,Gastroschisis,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],9.9,9.9
Morphological anomaly,Gastroschisis,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2006[REG],25.8,25.8
Morphological anomaly,Gastroschisis,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],17.5,17.5
Morphological anomaly,Gastroschisis,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],36,36
Morphological anomaly,Gastroschisis,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.6,11.6
Morphological anomaly,Gastroschisis,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],11,11
Morphological anomaly,Gastroschisis,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.6,5.6
Morphological anomaly,Gastroschisis,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],12.3,12.3
Morphological anomaly,Gastroschisis,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],36.3,36.3
Morphological anomaly,Gastroschisis,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],9.5,9.5
Morphological anomaly,Gastroschisis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Cap myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25079567[PMID],21,21
Disease,Cap myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25079567[PMID],0,0
Etiological subtype,Autosomal recessive primary microcephaly,1-9 / 1 000 000,Specific population,409967,409967,25958,25958,en,Validated,410293,410293,21668957[PMID],0.1,0.1
Etiological subtype,Autosomal recessive primary microcephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Autosomal recessive primary microcephaly,1-9 / 100 000,Pakistan,409967,409967,25958,25958,en,Validated,410293,410293,21668957[PMID],1,1
Category,Non-syndromic polydactyly,,,,,,,,,,,,,
Clinical subtype,Generalized pseudohypoaldosteronism type 1,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare form of salmonellosis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Myopathy with hexagonally cross-linked tubular arrays,,,,,,,,,,,,,
Disease,Sarcoidosis,6-9 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,2750915[PMID]_[EXPERT],60,60
Disease,Sarcoidosis,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET_DOI:10.1016/B978-0-323-54429-0.00001-X[OTHER],0,0
Disease,Sarcoidosis,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_DOI:10.1016/B978-0-323-54429-0.00001-X[OTHER],48.1,48.1
Disease,Sarcoidosis,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,21906764[PMID],3.3,3.3
Disease,Sarcoidosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2007[INST]_DOI:10.1016/B978-0-323-54429-0.00001-X[OTHER],20,20
Disease,Sarcoidosis,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,16844727[PMID],5,5
Disease,Sarcoidosis,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,28775045 [PMID]_[EXPERT],30.2,30.2
Disease,Sarcoidosis,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,21546016[PMID],4.5,4.5
Disease,Sarcoidosis,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,7617979[PMID],28.2,28.2
Disease,Sarcoidosis,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,18983653[PMID],4.68,4.68
Disease,Sarcoidosis,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,19897550[PMID],7,7
Disease,Sarcoidosis,6-9 / 10 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,DOI:10.1016/B978-0-323-54429-0.00001-X[OTHER]_[EXPERT],0,0
Disease,Sarcoidosis,1-9 / 100 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,19345567[PMID],1.07,1.07
Disease,Sarcoidosis,1-9 / 100 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,19345567[PMID],5.89,5.89
Disease,Sarcoidosis,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,17277405[PMID],3.84,3.84
Disease,Sarcoidosis,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,7809493[PMID],4,4
Disease,Sarcoidosis,6-9 / 10 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,7809493[PMID],63,63
Disease,Sarcoidosis,1-9 / 100 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,17535377[PMID]_ORPHANET_[EXPERT],5.35,5.35
Disease,Sarcoidosis,1-9 / 100 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,17959635[PMID],1.01,1.01
Disease,Sarcoidosis,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,7617979[PMID],3.7,3.7
Disease,Sarcoidosis,1-9 / 1 000 000,"Korea, Republic of",409967,409967,25958,25958,en,Validated,410293,410293,11436538[PMID],0.125,0.125
Disease,Sarcoidosis,1-9 / 1 000 000,Singapore,409967,409967,25958,25958,en,Validated,410293,410293,17539838[PMID],0.56,0.56
Disease,Sarcoidosis,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,28475583[PMID],49,49
Disease,Sarcoidosis,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,28775045 [PMID]_[EXPERT],4.9,4.9
Disease,Sarcoidosis,>1 / 1000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,27471207[PMID],160,160
Disease,Sarcoidosis,1-5 / 10 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,27471207[PMID],11.5,11.5
Disease,Sarcoidosis,1-9 / 100 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,27786368 [PMID],2.17,2.17
Disease,Sarcoidosis,1-9 / 1 000 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,5884467[PMID],0.2,0.2
Disease,Sarcoidosis,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,5884453[PMID],26.7,26.7
Disease,Sarcoidosis,1-5 / 10 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,5884453[PMID],14.4,14.4
Disease,Sarcoidosis,1-5 / 10 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,5884470[PMID],10.5,10.5
Disease,Sarcoidosis,1-5 / 10 000,Guadeloupe,409966,409966,25958,25958,en,Validated,410293,410293,24962008[PMID],21,21
Disease,Sarcoidosis,1-9 / 100 000,Guadeloupe,409967,409967,25958,25958,en,Validated,410293,410293,24962008[PMID],2.3,2.3
Disease,Sarcoidosis,1-9 / 1 000 000,Uruguay,409967,409967,25958,25958,en,Validated,410293,410293,5884475[PMID],0.4,0.4
Disease,Cylindrical spirals myopathy,,,,,,,,,,,,,
Clinical group,Juvenile idiopathic arthritis,1-5 / 10 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,17181917[PMID],13,13
Clinical group,Juvenile idiopathic arthritis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,1.5,1.5
Clinical group,Juvenile idiopathic arthritis,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,Haute Autorité de Santé 2009[INST]_ORPHANET_16821272[PMID],4.7,4.7
Clinical group,Juvenile idiopathic arthritis,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,23588938[PMID]_ORPHANET,8.9,8.9
Clinical group,Juvenile idiopathic arthritis,1-5 / 10 000,Czech Republic,409966,409966,25965,25965,en,Not yet validated,410294,410294,17181917[PMID]_ORPHANET,21,21
Clinical group,Juvenile idiopathic arthritis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,6q16 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24038875[PMID],12,12
Disease,6q16 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],16,16
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Latin America,409968,409968,25958,25958,en,Validated,410293,410293,10951457[PMID],12.9,12.9
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Latin America,409966,409966,25965,25965,en,Not yet validated,410294,410294,10951457[PMID],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,8303613[PMID]_15313597[PMID],28,28
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,8303613[PMID]_15313597[PMID],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],9,9
Morphological anomaly,Atresia of small intestine,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],11,11
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],10,10
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],14,14
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Reunion,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],22,22
Morphological anomaly,Atresia of small intestine,1-9 / 100 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],9,9
Morphological anomaly,Atresia of small intestine,1-9 / 100 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],10,10
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Austria,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],14,14
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],19,19
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],12,12
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],18,18
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],20,20
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Reunion,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Malta,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],15,15
Morphological anomaly,Atresia of small intestine,1-5 / 10 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Malformation syndrome,Blindness-scoliosis-arachnodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18990988[PMID],4,4
Malformation syndrome,Blindness-scoliosis-arachnodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18990988[PMID],0,0
Malformation syndrome,Craniosynostosis-hydrocephalus-Arnold-Chiari malformation type I-radioulnar synostosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19022412[PMID],2,2
Malformation syndrome,Craniosynostosis-hydrocephalus-Arnold-Chiari malformation type I-radioulnar synostosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19022412[PMID],0,0
Malformation syndrome,Larynx atresia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,22247246[PMID]_EUROCAT European surveillance of congenital anomalies[REG],24.3,24.3
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22247246[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],19.5,19.5
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],17.5,17.5
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.4,11.4
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],42.5,42.5
Morphological anomaly,Esophageal atresia,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],11.8,11.8
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],23.8,23.8
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],26.6,26.6
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],10.8,10.8
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],18.4,18.4
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],24.9,24.9
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],17.1,17.1
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],34.4,34.4
Morphological anomaly,Esophageal atresia,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.7,9.7
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],18.9,18.9
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],15.7,15.7
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],25.1,25.1
Morphological anomaly,Esophageal atresia,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],22.4,22.4
Morphological anomaly,Esophageal atresia,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],22.3,22.3
Morphological anomaly,Esophageal atresia,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,8013895[PMID]_15826889[PMID],21,21
Disease,MEDNIK syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23423674[PMID],5,5
Disease,MEDNIK syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23423674[PMID],0,0
Disease,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23490117[PMID],19,19
Disease,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Brucellosis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.09,0.09
Disease,Brucellosis,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,27717526[PMID]_European Centre for Disease prevention and Control 2013-2017[INST],0.03,0.03
Disease,Brucellosis,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.04,0.04
Disease,Brucellosis,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.05,0.05
Disease,Brucellosis,1-9 / 100 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.13,1.13
Disease,Brucellosis,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.03,0.03
Disease,Brucellosis,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.22,0.22
Disease,Brucellosis,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.01,0.01
Disease,Brucellosis,<1 / 1 000 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.03,0.03
Disease,Brucellosis,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.05,0.05
Disease,Brucellosis,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.05,0.05
Disease,Brucellosis,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.35,0.35
Disease,Brucellosis,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.12,0.12
Disease,Brucellosis,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.15,0.15
Disease,Brucellosis,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.02,0.02
Disease,Brucellosis,<1 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.01,0.01
Disease,Brucellosis,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.02,0.02
Disease,Brucellosis,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.02,0.02
Disease,Brucellosis,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.02,0.02
Disease,Brucellosis,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.01,0.01
Disease,Brucellosis,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.04,0.04
Disease,Brucellosis,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.11,0.11
Disease,Brucellosis,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.02,0.02
Disease,Brucellosis,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.004,0.004
Disease,Brucellosis,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2016[INST],0.008,0.008
Disease,Cholera,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],0,0
Disease,Cholera,<1 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],0,0
Disease,Cholera,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Cholera,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Familial chondromalacia patellae,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14083144[PMID],5,5
Disease,Familial chondromalacia patellae,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14083144[PMID],0,0
Clinical group,Paroxysmal dystonia,,,,,,,,,,,,,
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,22078432[PMID],34,34
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG],29.3,29.3
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],39.3,39.3
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],40.8,40.8
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.4,11.4
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],39.7,39.7
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],13.8,13.8
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],11.9,11.9
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],34.3,34.3
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],14.5,14.5
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],26.8,26.8
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],48.2,48.2
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],29.2,29.2
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],31.1,31.1
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],16.2,16.2
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],23.7,23.7
Malformation syndrome,Tetralogy of Fallot,6-9 / 10 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,20138303[PMID],63,63
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.9,11.9
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],25.1,25.1
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],32,32
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],25.4,25.4
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,18657826[PMID],47,47
Malformation syndrome,Tetralogy of Fallot,1-5 / 10 000,China,409968,409968,25958,25958,en,Validated,410293,410293,23350618[PMID],40,40
Disease,Immunodeficiency with factor I anomaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22710145[PMID],35,35
Disease,Immunodeficiency with factor I anomaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant polycystic kidney disease,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,27325254[PMID]_European Medicines Agency 2018[INST],39.6,39.6
Disease,Immunodeficiency with factor H anomaly,,,,,,,,,,,,,
Disease,Autosomal dominant severe congenital neutropenia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2012[REG],4.2,4.2
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2012[REG],5.9,5.9
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2012[REG],2.8,2.8
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.8,9.8
Morphological anomaly,Tricuspid atresia,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],10.5,10.5
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2012[REG],4.3,4.3
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2012[REG],5.7,5.7
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],3.3,3.3
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],1.5,1.5
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],1.9,1.9
Morphological anomaly,Tricuspid atresia,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],11.1,11.1
Morphological anomaly,Tricuspid atresia,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],12.6,12.6
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2012[REG],6.2,6.2
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.7,9.7
Morphological anomaly,Tricuspid atresia,1-9 / 100 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,20138303[PMID],4.6,4.6
Morphological anomaly,Isolated encephalocele,,,,,,,,,,,,,
Disease,Autosomal recessive spastic ataxia of Charlevoix-Saguenay,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301432[PMID],0,0
Disease,Autosomal recessive spastic ataxia of Charlevoix-Saguenay,6-9 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,8472930[PMID],51.76,51.76
Morphological anomaly,Interatrial communication,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital factor XII deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Gonococcal conjunctivitis,,,,,,,,,,,,,
Disease,Evans syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Alveolar echinococcosis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,23301116[PMID]_ORPHANET,0.16,0.16
Disease,Alveolar echinococcosis,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,17553227[PMID],0.26,0.26
Disease,Alveolar echinococcosis,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,23301116[PMID],0.014,0.014
Disease,Alveolar echinococcosis,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,23628138[PMID],2.8,2.8
Disease,Alveolar echinococcosis,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,FrancEchino[REG]_Institut de Veille Sanitaire 2010[INST],0.026,0.026
Disease,Alveolar echinococcosis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Early-onset cerebellar ataxia with retained tendon reflexes,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,8330454[PMID],2.08,2.08
Disease,Early-onset cerebellar ataxia with retained tendon reflexes,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,8330454[PMID],1,1
Disease,Early-onset cerebellar ataxia with retained tendon reflexes,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Stickler syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],1,1
Disease,Stickler syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0,0
Disease,Stickler syndrome,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22925539[PMID],0.65,0.65
Disease,Stickler syndrome,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22925539[PMID],0,0
Disease,Stickler syndrome,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301479[PMID],12.2,12.2
Clinical group,Paroxysmal dyskinesia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital herpes simplex virus infection,1-9 / 100 000,Sweden,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,6.6,6.6
Disease,Congenital herpes simplex virus infection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital herpes simplex virus infection,1-9 / 100 000,United Kingdom,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1.6,1.6
Disease,"Muscular dystrophy, Selcen type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22734908[PMID],12,12
Disease,"Muscular dystrophy, Selcen type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pancreatic insufficiency-anemia-hyperostosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19268275[PMID],5,5
Disease,Pancreatic insufficiency-anemia-hyperostosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19268275[PMID],0,0
Disease,Dubin-Johnson syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Thiamine-responsive encephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19387023[PMID],2,2
Disease,Thiamine-responsive encephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19387023[PMID],0,0
Disease,Takayasu arteritis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_27159262[PMID],0.084,0.084
Disease,Takayasu arteritis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27159262[PMID],1.34,1.34
Disease,Takayasu arteritis,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_19542212[PMID],0.06,0.06
Disease,Takayasu arteritis,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,9119531[PMID],4,4
Disease,Takayasu arteritis,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_6133485[PMID]_25774057[PMID],0.1,0.1
Disease,Takayasu arteritis,1-9 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6133485[PMID]_25774057[PMID],0.98,0.98
Disease,Takayasu arteritis,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19542212[PMID],0.47,0.47
Disease,Takayasu arteritis,<1 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,21385546[PMID],0.04,0.04
Disease,Takayasu arteritis,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Takayasu arteritis,<1 / 1 000 000,Germany,409967,409967,25965,25965,en,Not yet validated,410294,410294,15696553[PMID]_ORPHANET,0.07,0.07
Disease,Takayasu arteritis,1-9 / 1 000 000,Kuwait,409966,409966,25958,25958,en,Validated,410293,410293,7563255[PMID],0.78,0.78
Disease,Takayasu arteritis,1-9 / 1 000 000,Japan,409967,409967,25965,25965,en,Not yet validated,410294,410294,1360971[PMID]_ORPHANET,0.15,0.15
Disease,Takayasu arteritis,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,15647446[PMID],0.13,0.13
Disease,Takayasu arteritis,1-9 / 1 000 000,Kuwait,409967,409967,25958,25958,en,Validated,410293,410293,7563255[PMID],0.22,0.22
Disease,Takayasu arteritis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,2858047[PMID],0.26,0.26
Disease,Takayasu arteritis,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,27159262[PMID],0.15,0.15
Disease,Takayasu arteritis,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,27159262[PMID],2.56,2.56
Disease,Takayasu arteritis,1-9 / 100 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,28283361[PMID],2.82,2.82
Disease,Takayasu arteritis,1-9 / 1 000 000,"Korea, Republic of",409967,409967,25958,25958,en,Validated,410293,410293,28283361[PMID],0.24,0.24
Disease,Takayasu arteritis,1-9 / 1 000 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,30260188[PMID],0.46,0.46
Disease,Takayasu arteritis,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,30260188[PMID,0.092,0.092
Disease,EAST syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27500072[PMID],26,26
Disease,EAST syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27500072[PMID],0,0
Disease,Extramammary Paget disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Isolated autosomal dominant hypomagnesemia, Glaudemans type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19307729[PMID],21,21
Disease,"Isolated autosomal dominant hypomagnesemia, Glaudemans type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Endophthalmitis,,,,,,,,,,,,,
Morphological anomaly,Congenital lobar emphysema,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,24068262[PMID],4,4
Morphological anomaly,Congenital lobar emphysema,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24068262[PMID]_ORPHANET_[EXPERT],0,0
Malformation syndrome,Endocrine-cerebro-osteodysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19185282[PMID]_27069622[PMID],7,7
Malformation syndrome,Endocrine-cerebro-osteodysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19185282[PMID]_27069622[PMID],0,0
Disease,"Congenital myopathy, Paradas type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19084402[PMID],2,2
Disease,"Congenital myopathy, Paradas type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19084402[PMID],0,0
Disease,Congenital mesoblastic nephroma,,,,,,,,,,,,,
Disease,Wolfram syndrome,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,7490992[PMID],0.13,0.13
Disease,Wolfram syndrome,1-9 / 1 000 000,India,409966,409966,25958,25958,en,Validated,410293,410293,21726277[PMID],0.12,0.12
Disease,Wolfram syndrome,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7490992[PMID]_21726277[PMID]_25211237[PMID],0.13,0.13
Disease,Wolfram syndrome,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,24497219[PMID],1.83,1.83
Disease,Wolfram syndrome,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,25211237[PMID],0.13,0.13
Disease,Wolfram syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.62,0.62
Disease,Cryptosporidiosis,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention 2010[INST],2.9,2.9
Disease,Cryptosporidiosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cryptosporidiosis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011[INST],1.96,1.96
Category,Non-syndromic cerebral malformation,,,,,,,,,,,,,
Malformation syndrome,Isolated congenital microcephaly,,,,,,,,,,,,,
Category,Syndrome with corpus callosum agenesis/dysgenesis as a major feature,,,,,,,,,,,,,
Disease,Legionellosis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.4,1.4
Disease,Legionellosis,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,21109475[PMID],2.5,2.5
Disease,Legionellosis,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.82,1.82
Disease,Legionellosis,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.38,1.38
Disease,Legionellosis,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2014-2017[INST],0.8,0.8
Disease,Legionellosis,1-9 / 1 000 000,Cyprus,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.42,0.42
Disease,Legionellosis,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.24,1.24
Disease,Legionellosis,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],3.18,3.18
Disease,Legionellosis,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.84,0.84
Disease,Legionellosis,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.32,0.32
Disease,Legionellosis,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.18,1.18
Disease,Legionellosis,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.3,0.3
Disease,Legionellosis,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.5,0.5
Disease,Legionellosis,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2014-2017[INST],0.83,0.83
Disease,Legionellosis,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.28,0.28
Disease,Legionellosis,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.72,2.72
Disease,Legionellosis,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.5,1.5
Disease,Legionellosis,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.28,0.28
Disease,Legionellosis,1-9 / 100 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.02,1.02
Disease,Legionellosis,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.88,1.88
Disease,Legionellosis,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.48,2.48
Disease,Legionellosis,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.96,0.96
Disease,Legionellosis,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.06,0.06
Disease,Legionellosis,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.42,2.42
Disease,Legionellosis,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.26,0.26
Disease,Legionellosis,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],4.38,4.38
Disease,Legionellosis,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.16,2.16
Disease,Legionellosis,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.52,1.52
Disease,Legionellosis,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.62,0.62
Disease,Legionellosis,<1 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.02,0.02
Disease,Legionellosis,1-9 / 100 000,New Zealand,409967,409967,25958,25958,en,Validated,410293,410293,31294928[PMID],5.4,5.4
Disease,Pemphigus vulgaris,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,7829889[PMID],0.13,0.13
Disease,Pemphigus vulgaris,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],18,18
Disease,Pemphigus vulgaris,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,18614511[PMID],0.7,0.7
Disease,Pemphigus vulgaris,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,6187153[PMID],0.076,0.076
Disease,Pemphigus vulgaris,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,10692058[PMID],0.47,0.47
Disease,Pemphigus vulgaris,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,7416755[PMID],0.42,0.42
Disease,Pemphigus vulgaris,1-9 / 1 000 000,Tunisia,409967,409967,25958,25958,en,Validated,410293,410293,7829889[PMID],0.25,0.25
Disease,Pemphigus vulgaris,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,27456755[PMID],9.482,9.482
Disease,CARASIL,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adult-onset dystonia-parkinsonism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18570303[PMID]_20938027[PMID],14,14
Disease,Adult-onset dystonia-parkinsonism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Gerstmann-Straussler-Scheinker syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Gerstmann-Straussler-Scheinker syndrome,<1 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,16903147[PMID],0.0055,0.0055
Disease,Fatal familial insomnia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,27,27
Disease,Fatal familial insomnia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Isolated cerebellar vermis hypoplasia,,,,,,,,,,,,,
Disease,Atypical autism,,,,,,,,,,,,,
Morphological anomaly,Congenital microgastria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28361011[PMID],0,0
Disease,Whipple disease,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Whipple disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Whipple disease,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,25804189[PMID],0.29,0.29
Disease,Whipple disease,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,30488239[PMID],0.98,0.98
Disease,Harlequin syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28018464[PMID],100,100
Disease,Harlequin syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28018464[PMID],0,0
Disease,Hereditary hypercarotenemia and vitamin A deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Kawasaki disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial multiple lipomatosis,,,,,,,,,,,,,
Clinical subtype,GTP cyclohydrolase I deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,16,16
Clinical subtype,GTP cyclohydrolase I deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial angiolipomatosis,,,,,,,,,,,,,
Disease,Calcifying aponeurotic fibroma,,,,,,,,,,,,,
Disease,Immune thrombocytopenic purpura,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2007[INST],25,25
Disease,Immune thrombocytopenic purpura,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,19200301[PMID],9.5,9.5
Disease,Immune thrombocytopenic purpura,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,19245432[PMID],3.9,3.9
Disease,Immune thrombocytopenic purpura,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ISBN:70703868[OTHER]_ORPHANET,6.75,6.75
Disease,Immune thrombocytopenic purpura,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,10419881[PMID],2.68,2.68
Disease,Immune thrombocytopenic purpura,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,20066507[PMID],45,45
Disease,Immune thrombocytopenic purpura,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,25305203[PMID],2.9,2.9
Disease,Infantile digital fibromatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23157779[PMID],200,200
Disease,Infantile digital fibromatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Familial clubfoot with or without associated lower limb anomalies,,,,,,,,,,,,,
Morphological anomaly,Congenital respiratory-biliary fistula,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21516501[PMID]_19586763[PMID],35,35
Morphological anomaly,Congenital respiratory-biliary fistula,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,15q13.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25077648[PMID]_[EXPERT],246,246
Malformation syndrome,15q13.3 microdeletion syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Tetragametic chimerism,,,,,,,,,,,,,
Morphological anomaly,Bronchogenic cyst,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Bernard-Soulier syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17109744[PMID]_24051937[PMID],100,100
Disease,Bernard-Soulier syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17109744[PMID],0,0
Disease,Congenital atransferrinemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19696475[PMID]_23888904[PMID],16,16
Disease,Congenital atransferrinemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Isolated cleft lip,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,Pr Marie-Paule VAZQUEZ_Dr Eva GALLIANI[EXPERT],0,0
Morphological anomaly,Cleft lip/palate,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,Pr Marie-Paule VAZQUEZ_Dr Eva GALLIANI[EXPERT],0,0
Morphological anomaly,Cleft lip/palate,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,25399767[PMID],56,56
Morphological anomaly,Cleft lip/palate,6-9 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,1842671[PMID],98,98
Morphological anomaly,Cleft lip/palate,6-9 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,22374000[PMID],80,80
Disease,Acatalasemia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3.2,3.2
Disease,Ramsay Hunt syndrome,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,23763077[PMID]_24799517[PMID],5,5
Disease,Ramsay Hunt syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital isolated ACTH deficiency,,,,,,,,,,,,,
Category,Craniosynostosis,1-5 / 10 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,EUROCAT European surveillance of congenital anomalies 2012[REG],24.3,24.3
Category,Craniosynostosis,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,7762595[PMID],47.6,47.6
Category,Craniosynostosis,1-5 / 10 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,10232748[PMID],50.6,50.6
Category,Craniosynostosis,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,18344207[PMID],43,43
Category,Craniosynostosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Late-onset isolated ACTH deficiency,,,,,,,,,,,,,
Disease,Dihydropyrimidine dehydrogenase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cushing syndrome due to macronodular adrenal hyperplasia,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.08,0.08
Disease,Adenine phosphoribosyltransferase deficiency,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.5,1.5
Disease,Adenine phosphoribosyltransferase deficiency,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3.7,3.7
Disease,Adenine phosphoribosyltransferase deficiency,1-9 / 100 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],6.7,6.7
Disease,Adenine phosphoribosyltransferase deficiency,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sarcosinemia,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,6207480[PMID],0.28,0.28
Disease,Sarcosinemia,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,2,2
Disease,Sarcosinemia,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Sarcosinemia,1-9 / 100 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:79092543[OTHER],2.3,2.3
Disease,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25874378[PMID],0,0
Disease,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2013[INST],0,0
Disease,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25874378[PMID],111,111
Disease,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,<1 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,23972786[PMID],0,0
Clinical subtype,6-pyruvoyl-tetrahydropterin synthase deficiency,1-9 / 1 000 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,11916314[PMID],0.1,0.1
Clinical subtype,6-pyruvoyl-tetrahydropterin synthase deficiency,1-9 / 1 000 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,11916314[PMID],0.76,0.76
Clinical subtype,6-pyruvoyl-tetrahydropterin synthase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Superficial fibromatosis,,,,,,,,,,,,,
Disease,Ménétrier disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary sclerosing cholangitis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,21351115[PMID]_[EXPERT],0.77,0.77
Disease,Primary sclerosing cholangitis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9489916[PMID]_18433916[PMID]_23775876[PMID]_7890895[PMID]_20683956[PMID],7.84,7.84
Disease,Primary sclerosing cholangitis,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,22245904[PMID],8.1,8.1
Disease,Primary sclerosing cholangitis,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,22245904[PMID],0.65,0.65
Disease,Primary sclerosing cholangitis,1-9 / 1 000 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,14598252[PMID]_21351115[PMID],0.77,0.77
Disease,Primary sclerosing cholangitis,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,14598252[PMID]_ORPHANET,8.81,8.81
Disease,Primary sclerosing cholangitis,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,9489916[PMID],1.3,1.3
Disease,Primary sclerosing cholangitis,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9489916[PMID],8.5,8.5
Disease,Primary sclerosing cholangitis,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,22098097[PMID],1.22,1.22
Disease,Primary sclerosing cholangitis,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,20683956[PMID],16.2,16.2
Disease,Primary sclerosing cholangitis,1-9 / 1 000 000,United Kingdom,409967,409967,25965,25965,en,Not yet validated,410294,410294,18433916[PMID]_15188211[PMID]_ ORPHANET,0.66,0.66
Disease,Primary sclerosing cholangitis,1-9 / 100 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,18433916[PMID]_15188211[PMID]_ ORPHANET,8.28,8.28
Disease,Primary sclerosing cholangitis,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,23775876[PMID],0.5,0.5
Disease,Primary sclerosing cholangitis,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,23775876[PMID],6,6
Disease,Primary sclerosing cholangitis,1-9 / 1 000 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,17313496[PMID],0.9,0.9
Disease,Primary sclerosing cholangitis,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,7890895[PMID],0.07,0.07
Disease,Primary sclerosing cholangitis,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,7890895[PMID],0.22,0.22
Disease,Primary sclerosing cholangitis,1-9 / 100 000,Singapore,409966,409966,25958,25958,en,Validated,410293,410293,12164967[PMID]_22245904[PMID],1.3,1.3
Disease,Ledderhose disease,,,,,,,,,,,,,
Clinical group,Congenital primary lymphedema without systemic or visceral involvement,,,,,,,,,,,,,
Disease,Corticosteroid-binding globulin deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical syndrome,Nelson syndrome,,,,,,,,,,,,,
Disease,Pulmonary capillary hemangiomatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24493495[PMID],100,100
Disease,Pulmonary capillary hemangiomatosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24493495[PMID],0,0
Disease,Atypical hemolytic uremic syndrome,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,15168377[PMID]_21902819[PMID],0.2,0.2
Disease,Atypical hemolytic uremic syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],1,1
Clinical subtype,Familial isolated hypoparathyroidism due to impaired PTH secretion,,,,,,,,,,,,,
Disease,Fatal infantile lactic acidosis with methylmalonic aciduria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary pigmented nodular adrenocortical disease,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.04,0.04
Disease,Pyridoxine-dependent epilepsy,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.2,0.2
Disease,Pyridoxine-dependent epilepsy,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,10519720[PMID],0.13,0.13
Disease,Pyridoxine-dependent epilepsy,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,16159904[PMID],0.25,0.25
Disease,Pyridoxine-dependent epilepsy,1-9 / 100 000,Germany,409968,409968,25965,25965,en,Not yet validated,410294,410294,10356240[PMID]_ORPHANET,5,5
Disease,Pyridoxine-dependent epilepsy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Rhabdomyosarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.59,0.59
Disease,Rhabdomyosarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Rotor syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Rotor syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Lennox-Gastaut syndrome,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Lennox-Gastaut syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_European Medicines Agency 2004[INST],15,15
Disease,Subacute sclerosing leukoencephalitis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Subacute sclerosing leukoencephalitis,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_22277189[PMID],0.003,0.003
Disease,Subacute sclerosing leukoencephalitis,1-9 / 100 000,India,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],2,2
Clinical group,Systemic mastocytosis,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,8645532[PMID],0.3,0.3
Clinical group,Systemic mastocytosis,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0,0
Clinical group,Systemic mastocytosis,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,24761987[PMID],0.9,0.9
Clinical group,Systemic mastocytosis,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,24761987[PMID],9.6,9.6
Clinical group,Systemic mastocytosis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,24761987[PMID]_8645532[PMID],0.6,0.6
Clinical group,Systemic mastocytosis,1-5 / 10 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,23219169[PMID],13,13
Clinical group,Systemic mastocytosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23219169[PMID]_24761987[PMID],11.3,11.3
Category,Non-rare developmental anomalies during embryogenesis,,,,,,,,,,,,,
Category,Non-rare genetic disease,,,,,,,,,,,,,
Clinical syndrome,Early infantile epileptic encephalopathy,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,19828294[PMID],1,1
Clinical syndrome,Early infantile epileptic encephalopathy,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,23252366[PMID]_[EXPERT],2,2
Clinical syndrome,Early infantile epileptic encephalopathy,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Tay-Sachs disease,1-5 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,20301397[PMID],27.8,27.8
Disease,Tay-Sachs disease,1-9 / 1 000 000,Specific population,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.5,0.5
Disease,Tay-Sachs disease,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.31,0.31
Disease,Tay-Sachs disease,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],3.13,3.13
Disease,Tay-Sachs disease,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.3,0.3
Disease,Tay-Sachs disease,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.5,0.5
Disease,Tay-Sachs disease,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:0870684507[OTHER],0.28,0.28
Disease,Tay-Sachs disease,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.41,0.41
Disease,Tay-Sachs disease,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10617747[PMID],0.29,0.29
Disease,Tay-Sachs disease,1-9 / 1 000 000,United Arab Emirates,409968,409968,25958,25958,en,Validated,410293,410293,23430803[PMID],0.74,0.74
Disease,Tay-Sachs disease,1-9 / 1 000 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,15275696[PMID],0.23,0.23
Disease,Tay-Sachs disease,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.48,0.48
Disease,Myoclonic-astastic epilepsy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical syndrome,Early myoclonic encephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20821848[PMID],80,80
Clinical syndrome,Early myoclonic encephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20821848[PMID],0,0
Disease,Early-onset progressive encephalopathy with migrant continuous myoclonus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8737801[PMID],3,3
Disease,Early-onset progressive encephalopathy with migrant continuous myoclonus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8737801[PMID],0,0
Clinical syndrome,West syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2017[INST],6,6
Clinical syndrome,West syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_11701251[PMID]_8082625[PMID]_7555969[PMID],3.5,3.5
Clinical syndrome,West syndrome,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,3.7,3.7
Clinical syndrome,West syndrome,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,11701251[PMID]_8082625[PMID],2.5,2.5
Clinical syndrome,West syndrome,1-9 / 100 000,Iceland,409968,409968,25958,25958,en,Validated,410293,410293,11701251[PMID]_8082625[PMID],2.5,2.5
Clinical syndrome,West syndrome,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,7555969[PMID],4.5,4.5
Clinical syndrome,West syndrome,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,10368073[PMID],2.9,2.9
Clinical syndrome,West syndrome,1-5 / 10 000,Singapore,409968,409968,25958,25958,en,Validated,410293,410293,11701260[PMID],31,31
Clinical syndrome,West syndrome,1-5 / 10 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,11701256[PMID],25,25
Clinical syndrome,West syndrome,1-9 / 100 000,Japan,409968,409968,25965,25965,en,Not yet validated,410294,410294,11701258[PMID]_17633081[PMID]_ORPHANET,3.25,3.25
Disease,Tetanus,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.014,0.014
Disease,Tetanus,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.024,0.024
Disease,Tetanus,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.044,0.044
Disease,Tetanus,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.01,0.01
Disease,Tetanus,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.014,0.014
Disease,Tetanus,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.028,0.028
Disease,Tetanus,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.004,0.004
Disease,Tetanus,<1 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.014,0.014
Disease,Tetanus,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.032,0.032
Disease,Tetanus,<1 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.036,0.036
Disease,Tetanus,<1 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.024,0.024
Disease,Tetanus,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.016,0.016
Disease,Tetanus,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.076,0.076
Disease,Tetanus,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.07,0.07
Disease,Tetanus,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.008,0.008
Disease,Tetanus,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.012,0.012
Disease,Tetanus,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.032,0.032
Disease,Tetanus,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.008,0.008
Disease,Tetanus,<1 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.032,0.032
Disease,Tetanus,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.118,0.118
Disease,Tetanus,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.016,0.016
Disease,Tetanus,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.02,0.02
Disease,Tetanus,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.01,0.01
Disease,Tetanus,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Non-rare urogenital disease,,,,,,,,,,,,,
Category,Non-rare hematologic disease,,,,,,,,,,,,,
Disease,Asbestos intoxication,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Rabies,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Rabies,<1 / 1 000 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,22699971[PMID],0,0
Disease,Rabies,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2017[INST],0,0
Category,Non-rare skin disease,,,,,,,,,,,,,
Category,Non-rare tumor,,,,,,,,,,,,,
Disease,American trypanosomiasis,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,1-9 / 1 000 000,France,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,<1 / 1 000 000,Germany,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,1-9 / 1 000 000,Italy,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,<1 / 1 000 000,Netherlands,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,<1 / 1 000 000,Portugal,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,1-9 / 100 000,Spain,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,1-9 / 100 000,Switzerland,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,<1 / 1 000 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,1-9 / 1 000 000,Belgium,409966,409966,25965,25965,en,Not yet validated,410294,410294,21944556[PMID],0,0
Disease,American trypanosomiasis,6-9 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,19640226[PMID]_Center for Diseases Control and Prevention [INST],95,95
Category,Non-rare eye disease,,,,,,,,,,,,,
Category,Non-rare systemic and rhumatologic disease,,,,,,,,,,,,,
Category,Non-rare endocrinologic disease,,,,,,,,,,,,,
Disease,Calpain-3-related  limb-girdle muscular dystrophy R1,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2006[INST],1,1
Disease,Calpain-3-related  limb-girdle muscular dystrophy R1,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.6,0.6
Disease,Calpain-3-related  limb-girdle muscular dystrophy R1,1-9 / 100 000,Reunion,409966,409966,25958,25958,en,Validated,410293,410293,8624690[PMID],4.8,4.8
Disease,Calpain-3-related  limb-girdle muscular dystrophy R1,1-9 / 100 000,Italy,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_15725583[PMID]_16141003[PMID],1.65,1.65
Category,Non-rare renal disease,,,,,,,,,,,,,
Morphological anomaly,Complete atrioventricular canal,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Complete atrioventricular canal,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,16722604[PMID]_[EXPERT],20,20
Category,Non-rare disease,,,,,,,,,,,,,
Disease,Mucopolysaccharidosis type 4,<1 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],0.07,0.07
Disease,Mucopolysaccharidosis type 4,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],7.6,7.6
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],0.76,0.76
Disease,Mucopolysaccharidosis type 4,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],24.2,24.2
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],0.48,0.48
Disease,Mucopolysaccharidosis type 4,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],31,31
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,16435194[PMID],0.38,0.38
Disease,Mucopolysaccharidosis type 4,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,9439667[PMID],1.31,1.31
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.73,0.73
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10617747[PMID],0.39,0.39
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Tunisia,409968,409968,25958,25958,en,Validated,410293,410293,20209839[PMID],0.45,0.45
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,19396827[PMID],0.33,0.33
Disease,Mucopolysaccharidosis type 4,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.36,0.36
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,25472774[PMID],0.14,0.14
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.15,0.15
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],0.38,0.38
Disease,Mucopolysaccharidosis type 4,1-9 / 100 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,20622343[PMID],3.62,3.62
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,25364648[PMID],0.13,0.13
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.59,0.59
Disease,Mucopolysaccharidosis type 4,<1 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2016.11.285[OTHER],0.09,0.09
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2014.12.082[OTHER],0.11,0.11
Disease,Mucopolysaccharidosis type 4,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.6,0.6
Category,Non-rare orthopedic disease,,,,,,,,,,,,,
Disease,Autoimmune hepatitis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autoimmune hepatitis,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET_24326217[PMID],1.2,1.2
Disease,Autoimmune hepatitis,1-5 / 10 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_24326217[PMID],23.5,23.5
Disease,Autoimmune hepatitis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.75,0.75
Disease,Autoimmune hepatitis,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,9489916[PMID],1.9,1.9
Disease,Autoimmune hepatitis,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9489916[PMID],16.9,16.9
Disease,Autoimmune hepatitis,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,18609163[PMID],0.85,0.85
Disease,Autoimmune hepatitis,1-5 / 10 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,20880179[PMID],24.5,24.5
Disease,Autoimmune hepatitis,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,15056409[PMID]_20163033[PMID]_ORPHANET,0.95,0.95
Disease,Autoimmune hepatitis,1-5 / 10 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,15056409[PMID],11.6,11.6
Disease,Autoimmune hepatitis,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,18609163[PMID],10.7,10.7
Disease,Autoimmune hepatitis,1-9 / 1 000 000,Israel,409967,409967,25958,25958,en,Validated,410293,410293,23815477[PMID],0.67,0.67
Disease,Autoimmune hepatitis,1-5 / 10 000,Israel,409966,409966,25958,25958,en,Validated,410293,410293,23815477[PMID],11,11
Disease,Autoimmune hepatitis,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,24326217[PMID],1.68,1.68
Disease,Autoimmune hepatitis,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,24326217[PMID],23.9,23.9
Disease,Autoimmune hepatitis,1-9 / 100 000,Singapore,409966,409966,25958,25958,en,Validated,410293,410293,11851837[PMID],4,4
Disease,Autoimmune hepatitis,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,12358264[PMID],42.9,42.9
Disease,Primary biliary cholangitis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,2.57,2.57
Disease,Primary biliary cholangitis,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_22245904[PMID],21.05,21.05
Disease,Primary biliary cholangitis,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,22245904[PMID],3,3
Disease,Primary biliary cholangitis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,17873609[PMID]_22562114[PMID]_24387641[PMID]_17918011[PMID]_22961000[PMID]_10421645[PMID]_9279616[PMID]_20347176[PMID]_24502439[PMID],25,25
Disease,Primary biliary cholangitis,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,20347176[PMID],0.9,0.9
Disease,Primary biliary cholangitis,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,17873609[PMID],1.7,1.7
Disease,Primary biliary cholangitis,1-5 / 10 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,17873609[PMID],19.5,19.5
Disease,Primary biliary cholangitis,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,22562114[PMID],2.5,2.5
Disease,Primary biliary cholangitis,1-5 / 10 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,22562114[PMID],38.3,38.3
Disease,Primary biliary cholangitis,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,24387641[PMID],1.1,1.1
Disease,Primary biliary cholangitis,1-5 / 10 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,24387641[PMID],13.2,13.2
Disease,Primary biliary cholangitis,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,17918011[PMID],1.7,1.7
Disease,Primary biliary cholangitis,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,17918011[PMID],12,12
Disease,Primary biliary cholangitis,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,17918011[PMID],1.7,1.7
Disease,Primary biliary cholangitis,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,17918011[PMID],18,18
Disease,Primary biliary cholangitis,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,22961000[PMID]_9279616[PMID]_10421645[PMID],25,25
Disease,Primary biliary cholangitis,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,11113084[PMID],4.5,4.5
Disease,Primary biliary cholangitis,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,11113084[PMID],40.2,40.2
Disease,Primary biliary cholangitis,1-9 / 100 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,19821525[PMID],3,3
Disease,Primary biliary cholangitis,1-5 / 10 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,19821525[PMID],22.7,22.7
Disease,Primary biliary cholangitis,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,15300579[PMID],5.1,5.1
Disease,Primary biliary cholangitis,1-9 / 100 000,Israel,409966,409966,25958,25958,en,Validated,410293,410293,16308995[PMID],5.5,5.5
Disease,Primary biliary cholangitis,1-9 / 100 000,China,409966,409966,25958,25958,en,Validated,410293,410293,20815889[PMID],4.9,4.9
Disease,Primary biliary cholangitis,1-9 / 100 000,Brunei Darussalam,409967,409967,25958,25958,en,Validated,410293,410293,21134832[PMID],1,1
Disease,Primary biliary cholangitis,1-9 / 100 000,Brunei Darussalam,409966,409966,25958,25958,en,Validated,410293,410293,21134832[PMID],2.6,2.6
Disease,Primary biliary cholangitis,1-5 / 10 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,24502439[PMID],36.5,36.5
Disease,Primary biliary cholangitis,1-9 / 100 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,24502439[PMID],2.1,2.1
Disease,Primary biliary cholangitis,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,10421645[PMID]_9279616[PMID],2.3,2.3
Morphological anomaly,Arnold-Chiari malformation type II,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Giant cell arteritis,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,11136884[PMID],8.9,8.9
Disease,Giant cell arteritis,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9805179[PMID],27.9,27.9
Disease,Giant cell arteritis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,6626279[PMID],0.35,0.35
Disease,Giant cell arteritis,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,2003856[PMID],2.8,2.8
Disease,Giant cell arteritis,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,10587547[PMID],7.7,7.7
Disease,Giant cell arteritis,1-5 / 10 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,25132663[PMID],11.2,11.2
Disease,Giant cell arteritis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Giant cell arteritis,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,27214746[PMID],30.4,30.4
Disease,Chronic inflammatory demyelinating polyneuropathy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,3.7,3.7
Disease,Chronic inflammatory demyelinating polyneuropathy,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,17494979[PMID],0.36,0.36
Disease,Chronic inflammatory demyelinating polyneuropathy,1-9 / 100 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,23679015[PMID]_10209187[PMID]_19260065[PMID],2.6,2.6
Disease,Chronic inflammatory demyelinating polyneuropathy,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,17494979[PMID],3.86,3.86
Disease,Chronic inflammatory demyelinating polyneuropathy,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,11284994[PMID],7.7,7.7
Disease,Chronic inflammatory demyelinating polyneuropathy,1-5 / 10 000,Egypt,409966,409966,25958,25958,en,Validated,410293,410293,23146298[PMID],12,12
Disease,Chronic inflammatory demyelinating polyneuropathy,1-9 / 1 000 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,18223015[PMID],0.48,0.48
Disease,Chronic inflammatory demyelinating polyneuropathy,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,18223015[PMID],1.61,1.61
Disease,Chronic inflammatory demyelinating polyneuropathy,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,10589544[PMID],0.15,0.15
Disease,Chronic inflammatory demyelinating polyneuropathy,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,10589544[PMID],1.9,1.9
Disease,Multiple symmetric lipomatosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Multiple symmetric lipomatosis,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],2,2
Disease,Dermatitis herpetiformis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],27,27
Disease,Dermatitis herpetiformis,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.9,0.9
Disease,Dermatitis herpetiformis,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,5023901[PMID]_6641006[PMID]_[EXPERT]_ORPHANET,1.5,1.5
Disease,Dermatitis herpetiformis,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,5023901[PMID]_6641006[PMID]_[EXPERT]_ORPHANET,17.6,17.6
Disease,Dermatitis herpetiformis,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,6208718[PMID],1.1,1.1
Disease,Dermatitis herpetiformis,1-5 / 10 000,Sweden,409966,409966,25965,25965,en,Not yet validated,410294,410294,6208718[PMID],21,21
Disease,Dermatitis herpetiformis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,1456754[PMID],0.98,0.98
Disease,Dermatitis herpetiformis,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,1456754[PMID],11.2,11.2
Disease,Dermatitis herpetiformis,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,21517799[PMID],3.5,3.5
Disease,Dermatitis herpetiformis,6-9 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,21517799[PMID],75.3,75.3
Disease,Dermatitis herpetiformis,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,6693042[PMID],11.5,11.5
Category,Rare genetic syndromic intellectual disability,,,,,,,,,,,,,
Category,Rare genetic immune disease,,,,,,,,,,,,,
Disease,Stiff person syndrome and related disorders,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21921002[PMID],0,0
Disease,Stiff person syndrome and related disorders,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21921002[PMID],0.15,0.15
Disease,Stiff person syndrome and related disorders,<1 / 1 000 000,"Tanzania, United Republic of",409966,409966,25958,25958,en,Validated,410293,410293,26316197[PMID],0.09,0.09
Category,Rare genetic intellectual disability,,,,,,,,,,,,,
Disease,Juvenile polyposis syndrome,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,20301642[PMID]_[EXPERT],3.85,3.85
Disease,Juvenile polyposis syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Non-rare gastroenterologic disease,,,,,,,,,,,,,
Category,Non-rare gynecologic and obstetric disease,,,,,,,,,,,,,
Disease,Budd-Chiari syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.5,1.5
Disease,Budd-Chiari syndrome,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,18694401[PMID],0.08,0.08
Disease,Budd-Chiari syndrome,1-9 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,18694401[PMID],0.14,0.14
Disease,Budd-Chiari syndrome,<1 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,2010159[PMID],0.05,0.05
Disease,Budd-Chiari syndrome,<1 / 1 000 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,7751574[PMID],0.02,0.02
Disease,Budd-Chiari syndrome,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,7751574[PMID],0.24,0.24
Disease,Budd-Chiari syndrome,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,19433611[PMID],0.04,0.04
Disease,Budd-Chiari syndrome,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,28180235[PMID],0.21,0.21
Disease,Budd-Chiari syndrome,<1 / 1 000 000,"Korea, Republic of",409967,409967,25958,25958,en,Validated,410293,410293,26558363[PMID],0.087,0.087
Disease,Budd-Chiari syndrome,1-9 / 1 000 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,26558363[PMID],0.529,0.529
Disease,Budd-Chiari syndrome,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,30528513[PMID],0.1,0.1
Disease,Budd-Chiari syndrome,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,30528513[PMID],1.1,1.1
Category,Non-rare cardiac disease,,,,,,,,,,,,,
Disease,Niemann-Pick disease type C,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20525256[PMID]_European Medicines Agency 2011[INST],1,1
Disease,Niemann-Pick disease type C,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,20525256[PMID]_12974729[PMID]_[EXPERT],0.77,0.77
Disease,Niemann-Pick disease type C,1-9 / 1 000 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,12974729[PMID],0.75,0.75
Disease,Niemann-Pick disease type C,1-9 / 1 000 000,Germany,409968,409968,25965,25965,en,Not yet validated,410294,410294,12974729[PMID],0.75,0.75
Disease,Niemann-Pick disease type C,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.35,0.35
Disease,Niemann-Pick disease type C,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],2.2,2.2
Disease,Niemann-Pick disease type C,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.47,0.47
Disease,Niemann-Pick disease type C,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.91,0.91
Disease,Niemann-Pick disease type C,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.48,0.48
Category,Non-rare circulatory system disease,,,,,,,,,,,,,
Disease,Nephroblastoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22357215[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.14,0.14
Disease,Nephroblastoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Nephroblastoma,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],3.65,3.65
Disease,Nephroblastoma,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.144,0.144
Disease,Nephroblastoma,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Nephroblastoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.072,0.072
Disease,Nephroblastoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Nephroblastoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.089,0.089
Disease,Nephroblastoma,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Nephroblastoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.065,0.065
Disease,Nephroblastoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.066,0.066
Disease,Nephroblastoma,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.121,0.121
Disease,Nephroblastoma,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.195,0.195
Disease,Nephroblastoma,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.155,0.155
Disease,Nephroblastoma,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.139,0.139
Disease,Nephroblastoma,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.158,0.158
Disease,Nephroblastoma,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.17,0.17
Disease,Nephroblastoma,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.111,0.111
Disease,Nephroblastoma,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.12,0.12
Disease,Nephroblastoma,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.157,0.157
Disease,Nephroblastoma,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.131,0.131
Disease,Nephroblastoma,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.111,0.111
Disease,Nephroblastoma,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.162,0.162
Disease,Nephroblastoma,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.144,0.144
Disease,Nephroblastoma,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.113,0.113
Disease,Nephroblastoma,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.135,0.135
Disease,Nephroblastoma,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.176,0.176
Disease,Whooping cough,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],8.9,8.9
Disease,Whooping cough,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],9.76,9.76
Disease,Whooping cough,1-5 / 10 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],10.08,10.08
Disease,Whooping cough,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.08,1.08
Disease,Whooping cough,1-9 / 1 000 000,Cyprus,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.88,0.88
Disease,Whooping cough,1-5 / 10 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],10.7,10.7
Disease,Whooping cough,1-5 / 10 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],19.16,19.16
Disease,Whooping cough,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],4.66,4.66
Disease,Whooping cough,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],5.1,5.1
Disease,Whooping cough,1-5 / 10 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],15.4,15.4
Disease,Whooping cough,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.38,0.38
Disease,Whooping cough,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.16,0.16
Disease,Whooping cough,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.34,2.34
Disease,Whooping cough,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],5.3,5.3
Disease,Whooping cough,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],3.58,3.58
Disease,Whooping cough,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.2,1.2
Disease,Whooping cough,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],8.48,8.48
Disease,Whooping cough,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.22,2.22
Disease,Whooping cough,1-9 / 100 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.14,2.14
Disease,Whooping cough,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.52,0.52
Disease,Whooping cough,1-5 / 10 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],31.72,31.72
Disease,Whooping cough,1-5 / 10 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],47.24,47.24
Disease,Whooping cough,1-5 / 10 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],10.6,10.6
Disease,Whooping cough,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.1,2.1
Disease,Whooping cough,1-9 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.42,0.42
Disease,Whooping cough,1-5 / 10 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],10.5,10.5
Disease,Whooping cough,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],9.5,9.5
Disease,Whooping cough,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],8.3,8.3
Disease,Whooping cough,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],6.2,6.2
Disease,Whooping cough,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],8.5,8.5
Category,Non-rare immune disease,,,,,,,,,,,,,
Disease,Osteochondritis dissecans,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,16958015[PMID],35,35
Category,Non-rare infertility disease,,,,,,,,,,,,,
Category,Non-rare bone disease,,,,,,,,,,,,,
Disease,Myeloperoxidase deficiency,,,,,,,,,,,,,
Category,Non-rare maxillo-facial surgical disease,,,,,,,,,,,,,
Disease,Tuberculosis,1-9 / 100 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],4,4
Disease,Tuberculosis,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],5,5
Disease,Tuberculosis,1-9 / 100 000,Israel,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],6,6
Disease,Tuberculosis,1-5 / 10 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],15,15
Disease,Tuberculosis,1-5 / 10 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],24,24
Disease,Tuberculosis,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],8,8
Disease,Tuberculosis,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],4,4
Disease,Tuberculosis,6-9 / 10 000,Algeria,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],90,90
Disease,Tuberculosis,1-5 / 10 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],23,23
Disease,Tuberculosis,1-5 / 10 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],42,42
Disease,Tuberculosis,1-5 / 10 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],59,59
Disease,Tuberculosis,1-5 / 10 000,Bosnia and Herzegovina,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],49,49
Disease,Tuberculosis,1-5 / 10 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],17,17
Disease,Tuberculosis,>1 / 1000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],101,101
Disease,Tuberculosis,6-9 / 10 000,Russian Federation,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],97,97
Disease,Tuberculosis,>1 / 1000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,21420560[PMID],139,139
Disease,Tuberculosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],16,16
Disease,Tuberculosis,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Centers for Disease Control and Prevention 2011[INST],3.4,3.4
Disease,Tuberculosis,1-5 / 10 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],20,20
Disease,Tuberculosis,1-9 / 100 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],6,6
Disease,Tuberculosis,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],4,4
Disease,Tuberculosis,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],8,8
Disease,Tuberculosis,1-5 / 10 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],18,18
Disease,Tuberculosis,>1 / 1000,India,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],181,181
Disease,Tuberculosis,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],7,7
Disease,Tuberculosis,1-5 / 10 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],14,14
Disease,Tuberculosis,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],6,6
Disease,Tuberculosis,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],7,7
Disease,Tuberculosis,6-9 / 10 000,China,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],75,75
Disease,Tuberculosis,1-5 / 10 000,Latin America,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],47,47
Disease,Tuberculosis,>1 / 1000,South Africa,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],993,993
Disease,Tuberculosis,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],7.1,7.1
Disease,Tuberculosis,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],6,6
Disease,Tuberculosis,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],5,5
Disease,Tuberculosis,1-5 / 10 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],10.7,10.7
Disease,Tuberculosis,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],3,3
Disease,Tuberculosis,1-5 / 10 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],25,25
Disease,Tuberculosis,1-5 / 10 000,Turkey,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],24,24
Disease,Tuberculosis,6-9 / 10 000,Ukraine,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],89,89
Disease,Tuberculosis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2011[INST],9,9
Category,Non-rare odontologic disease,,,,,,,,,,,,,
Category,Non-rare otorhinolaryngologic disease,,,,,,,,,,,,,
Disease,Diphtheria,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011[INST],0,0
Category,Non-rare cardiac malformation,,,,,,,,,,,,,
Disease,Botulism,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.022,0.022
Disease,Botulism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Botulism,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut de Veille Sanitaire 2016[INST],0.255,0.255
Disease,Botulism,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention 2006[INST]_ORPHANET,0.35,0.35
Disease,Botulism,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.026,0.026
Disease,Botulism,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.006,0.006
Disease,Botulism,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.028,0.028
Disease,Botulism,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2015[INST],0.04,0.04
Disease,Botulism,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.01,0.01
Disease,Botulism,<1 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.024,0.024
Disease,Botulism,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.012,0.012
Disease,Botulism,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.006,0.006
Disease,Botulism,<1 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.052,0.052
Disease,Botulism,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.012,0.012
Disease,Botulism,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.052,0.052
Disease,Botulism,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.086,0.086
Disease,Botulism,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.002,0.002
Disease,Botulism,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.038,0.038
Disease,Botulism,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.018,0.018
Disease,Botulism,1-9 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.104,0.104
Disease,Botulism,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.02,0.02
Disease,Botulism,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.004,0.004
Disease,Botulism,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.01,0.01
Disease,Botulism,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.008,0.008
Disease,Botulism,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.098,0.098
Disease,Pityriasis rubra pilaris,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,48,48
Disease,Pityriasis rubra pilaris,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Non-rare neurologic disease,,,,,,,,,,,,,
Clinical group,Guillain-Barré syndrome,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,19088488[PMID]_[EXPERT]_ ORPHANET,1.45,1.45
Clinical group,Guillain-Barré syndrome,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,22846726[PMID],1.72,1.72
Clinical group,Guillain-Barré syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_European Medicines Agency 2007[INST]_ ORPHANET,3.5,3.5
Clinical group,Guillain-Barré syndrome,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,20066507[PMID],25,25
Clinical group,Guillain-Barré syndrome,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,22694000[PMID]_ORPHANET,1.4,1.4
Clinical group,Guillain-Barré syndrome,1-5 / 10 000,Egypt,409966,409966,25958,25958,en,Validated,410293,410293,23146298[PMID],12,12
Clinical group,Guillain-Barré syndrome,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,27991707[PMID],2.42,2.42
Category,Agammaglobulinemia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.13,0.13
Category,Agammaglobulinemia,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.287,0.287
Category,Agammaglobulinemia,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.134,0.134
Category,Agammaglobulinemia,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.192,0.192
Category,Agammaglobulinemia,<1 / 1 000 000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.045,0.045
Category,Agammaglobulinemia,<1 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.094,0.094
Category,Agammaglobulinemia,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.205,0.205
Category,Agammaglobulinemia,<1 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.077,0.077
Category,Agammaglobulinemia,<1 / 1 000 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.071,0.071
Disease,Hyper-IgM syndrome without susceptibility to opportunistic infections,,,,,,,,,,,,,
Disease,Eosinophilic gastroenteritis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11345185[PMID]_23904840[PMID],280,280
Disease,Eosinophilic gastroenteritis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Eosinophilic gastroenteritis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11345185[PMID]_23904840[PMID],0,0
Disease,Hyper-IgM syndrome with susceptibility to opportunistic infections,,,,,,,,,,,,,
Disease,Transient familial neonatal hyperbilirubinemia,,,,,,,,,,,,,
Disease,Neutrophil immunodeficiency syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10758162[PMID],2,2
Disease,Neutrophil immunodeficiency syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10758162[PMID],0,0
Disease,Autosomal dominant hyper-IgE syndrome,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Autosomal dominant hyper-IgE syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0,0
Category,Functional neutrophil defect,,,,,,,,,,,,,
Clinical subtype,Hermansky-Pudlak syndrome with neutropenia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29580292[PMID],40,40
Clinical subtype,Hermansky-Pudlak syndrome with neutropenia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29580292[PMID],0,0
Disease,Hepatoblastoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Hepatoblastoma,1-9 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.54,0.54
Disease,Hepatoblastoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hepatoblastoma,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0,0
Disease,Hepatoblastoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Hepatoblastoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Hepatoblastoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Hepatoblastoma,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.042,0.042
Disease,Hepatoblastoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Hepatoblastoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.046,0.046
Disease,Hepatoblastoma,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Hepatoblastoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.021,0.021
Disease,Hepatoblastoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Hepatoblastoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Hepatoblastoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.022,0.022
Disease,Hepatoblastoma,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Hepatoblastoma,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Hepatoblastoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.033,0.033
Disease,Hepatoblastoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.023,0.023
Disease,Hepatoblastoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Hepatoblastoma,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.032,0.032
Disease,Hepatoblastoma,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.025,0.025
Disease,Hepatoblastoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Hepatoblastoma,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Hepatoblastoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.032,0.032
Disease,Hepatoblastoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.028,0.028
Disease,Recurrent infections associated with rare immunoglobulin isotypes deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Hydranencephaly,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,10207424[PMID],0,0
Malformation syndrome,Hydranencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Hydranencephaly,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,26545857[PMID],2.1,2.1
Malformation syndrome,Hydranencephaly,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,18383510[PMID],2.8,2.8
Category,Rare genetic gynecological and obstetrical diseases,,,,,,,,,,,,,
Disease,Listeriosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Listeriosis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.43,0.43
Disease,Listeriosis,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,25241232[PMID],0.337,0.337
Disease,Listeriosis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,17243053[PMID]_CDC Centers for disease Control and prevention 1996-2003[INST],0.31,0.31
Disease,Listeriosis,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.48,0.48
Disease,Listeriosis,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],1.07,1.07
Disease,Listeriosis,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.09,0.09
Disease,Listeriosis,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.05,0.05
Disease,Listeriosis,<1 / 1 000 000,Cyprus,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.05,0.05
Disease,Listeriosis,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.36,0.36
Disease,Listeriosis,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.98,0.98
Disease,Listeriosis,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.4,0.4
Disease,Listeriosis,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],1.1,1.1
Disease,Listeriosis,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.57,0.57
Disease,Listeriosis,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.68,0.68
Disease,Listeriosis,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.15,0.15
Disease,Listeriosis,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.28,0.28
Disease,Listeriosis,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.29,0.29
Disease,Listeriosis,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.24,0.24
Disease,Listeriosis,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.28,0.28
Disease,Listeriosis,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.25,0.25
Disease,Listeriosis,1-9 / 1 000 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.4,0.4
Disease,Listeriosis,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.38,0.38
Disease,Listeriosis,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.47,0.47
Disease,Listeriosis,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.23,0.23
Disease,Listeriosis,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2015-2016[INST],0.29,0.29
Disease,Listeriosis,<1 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.05,0.05
Disease,Listeriosis,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.31,0.31
Disease,Listeriosis,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.67,0.67
Disease,Listeriosis,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.9,0.9
Disease,Listeriosis,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.92,0.92
Disease,Listeriosis,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.3,0.3
Disease,Listeriosis,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.56,0.56
Disease,Listeriosis,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.46,0.46
Disease,Bacterial susceptibility due to TLR signaling pathway deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],24,24
Disease,Bacterial susceptibility due to TLR signaling pathway deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Laryngocele,,,,,,,,,,,,,
Category,Genetic susceptibility to infections due to particular pathogens,,,,,,,,,,,,,
Disease,Legg-Calvé-Perthes disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Progressive supranuclear palsy,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,11487180[PMID]_9371909[PMID]_4792160[PMID]_3405368[PMID]_6333204[PMID]_3386818[PMID]_[EXPERT],0.65,0.65
Disease,Progressive supranuclear palsy,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,15054950[PMID]_10817953[PMID]_[EXPERT],6,6
Disease,Progressive supranuclear palsy,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],14,14
Disease,Progressive supranuclear palsy,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,3386818[PMID],1.39,1.39
Disease,Progressive supranuclear palsy,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,9613728[PMID],3.2,3.2
Disease,Progressive supranuclear palsy,1-5 / 10 000,Guadeloupe,409966,409966,25958,25958,en,Validated,410293,410293,11912113[PMID],14,14
Disease,Progressive supranuclear palsy,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21088431[PMID]_10577638[PMID]_11408338[PMID]_ORPHANET,3.75,3.75
Disease,Progressive supranuclear palsy,1-9 / 1 000 000,Libyan Arab Jamahiriya,409967,409967,25958,25958,en,Validated,410293,410293,3405368[PMID],0.3,0.3
Disease,Progressive supranuclear palsy,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,6333204[PMID]_9371909[PMID]_3386818[PMID],0.63,0.63
Disease,Progressive supranuclear palsy,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,4792160[PMID],0.4,0.4
Category,Non-rare psychiatric disease,,,,,,,,,,,,,
Category,Non-rare hepatic disease,,,,,,,,,,,,,
Disease,Pancreatoblastoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16080945[PMID],60,60
Disease,Pancreatoblastoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Pancreatoblastoma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pancreatoblastoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Pancreatoblastoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,Pancreatoblastoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Pancreatoblastoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Pancreatoblastoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Pancreatoblastoma,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Pancreatoblastoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Pancreatoblastoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Pancreatoblastoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Pancreatoblastoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Category,Non-rare metabolic disease,,,,,,,,,,,,,
Category,Genetic gynecological tumor,,,,,,,,,,,,,
Category,Rare constitutional anemia,,,,,,,,,,,,,
Clinical group,Severe combined immunodeficiency,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,1.65,1.65
Clinical group,Severe combined immunodeficiency,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22288591[PMID],1.6,1.6
Clinical group,Severe combined immunodeficiency,1-9 / 100 000,Greece,409968,409968,25958,25958,en,Validated,410293,410293,21732012[PMID],1.7,1.7
Clinical group,Severe combined immunodeficiency,1-9 / 100 000,Australia,409968,409968,25965,25965,en,Not yet validated,410294,410294,18221464[PMID]_9314356[PMID]_ ORPHANET,1.75,1.75
Clinical group,Severe combined immunodeficiency,1-9 / 100 000,Chile,409968,409968,25958,25958,en,Validated,410293,410293,17191150[PMID],1.28,1.28
Clinical group,Severe combined immunodeficiency,1-9 / 100 000,Costa rica,409968,409968,25958,25958,en,Validated,410293,410293,17191150[PMID],3.79,3.79
Clinical group,Severe combined immunodeficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Severe combined immunodeficiency,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,25138334[PMID],1.72,1.72
Clinical group,Severe combined immunodeficiency,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Waardenburg-Shah syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Dr Véronique PINGAULT[EXPERT],100,100
Disease,Waardenburg-Shah syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare genetic coagulation disorder,,,,,,,,,,,,,
Category,Rare genetic adrenal disease,,,,,,,,,,,,,
Malformation syndrome,Seckel syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301772[PMID],50,50
Malformation syndrome,Seckel syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25284118[PMID],0,0
Malformation syndrome,Seckel syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.2,0.2
Category,Genetic polyendocrinopathy,,,,,,,,,,,,,
Category,Rare genetic hypothalamic or pituitary disease,,,,,,,,,,,,,
Category,Rare genetic diabetes mellitus,,,,,,,,,,,,,
Category,Rare genetic parathyroid disease and phosphocalcic metabolism disorder,,,,,,,,,,,,,
Disease,Lown-Ganong-Levine syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,836114[PMID],12,12
Disease,Lown-Ganong-Levine syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_836114[PMID],0,0
Category,Rare genetic thyroid disease,,,,,,,,,,,,,
Category,Genetic neuro-ophthalmological disease,,,,,,,,,,,,,
Malformation syndrome,Caudal regression sequence,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic respiratory malformation,,,,,,,,,,,,,
Category,Genetic eye tumor,,,,,,,,,,,,,
Category,Genetic lens and zonula anomaly,,,,,,,,,,,,,
Disease,Hereditary chronic pancreatitis,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,18755888[PMID],0.3,0.3
Disease,Hereditary chronic pancreatitis,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,20502448[PMID],0.57,0.57
Disease,Hereditary chronic pancreatitis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,18755888[PMID]_20502448[PMID],0.43,0.43
Category,Genetic thrombotic microangiopathy,,,,,,,,,,,,,
Category,Genetic renal tubular disease,,,,,,,,,,,,,
Disease,Giant axonal neuropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301315[PMID],50,50
Disease,Giant axonal neuropathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301315[PMID],0,0
Category,Genetic renal tumor,,,,,,,,,,,,,
Disease,Netherton syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Netherton syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Malformation syndrome,Campomelic dysplasia,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.33,0.33
Malformation syndrome,Campomelic dysplasia,1-5 / 10 000,Norway,409968,409968,25965,25965,en,Not yet validated,410294,410294,8482284[PMID]_ORPHANET,19,19
Malformation syndrome,Campomelic dysplasia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic branchial arch or oral-acral syndrome,,,,,,,,,,,,,
Disease,Young-onset Parkinson disease,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10875828[PMID]_15172778[PMID],15,15
Disease,Young-onset Parkinson disease,1-5 / 10 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,15172778[PMID],0,0
Category,Genetic malformation syndrome with odontal and/or periodontal component,,,,,,,,,,,,,
Disease,Hereditary sensory and autonomic neuropathy type 4,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,23495212[PMID],0.14,0.14
Disease,Hereditary sensory and autonomic neuropathy type 4,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic head and neck malformation,,,,,,,,,,,,,
Category,Genetic glomerular disease,,,,,,,,,,,,,
Category,Genetic developmental defect of the eye,,,,,,,,,,,,,
Malformation syndrome,Nance-Horan syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27616609[PMID],196,196
Malformation syndrome,Nance-Horan syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27616609[PMID],0,0
Category,Genetic malformation syndrome with short stature,,,,,,,,,,,,,
Malformation syndrome,Neurofibromatosis-Noonan syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic overgrowth/obesity syndrome,,,,,,,,,,,,,
Disease,Congenital factor V deficiency,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19598066[PMID],0.1,0.1
Category,Genetic respiratory or mediastinal malformation,,,,,,,,,,,,,
Disease,Liddle syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29534496[PMID]_[EXPERT],72,72
Disease,Liddle syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,"Genetic visceral malformation of the liver, biliary tract, pancreas or spleen",,,,,,,,,,,,,
Disease,LCAT deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,125,125
Disease,LCAT deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial hypoaldosteronism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic digestive tract malformation,,,,,,,,,,,,,
Category,Genetic cranial malformation,,,,,,,,,,,,,
Disease,Congenital stationary night blindness,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic renal or urinary tract malformation,,,,,,,,,,,,,
Disease,Familial Mediterranean fever,>1 / 1000,Turkey,409966,409966,25965,25965,en,Not yet validated,410294,410294,9858443[PMID]_15515780[PMID]_15643295[PMID],175,175
Disease,Familial Mediterranean fever,>1 / 1000,Armenia,409966,409966,25958,25958,en,Validated,410293,410293,18403822[PMID],200,200
Disease,Familial Mediterranean fever,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,23194659[PMID],2.5,2.5
Disease,Familial Mediterranean fever,1-9 / 1 000 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,23111802[PMID]_ORPHANET,0.23,0.23
Disease,Familial Mediterranean fever,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial Mediterranean fever,1-5 / 10 000,Specific population,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,14,14
Category,Genetic congenital limb malformation,,,,,,,,,,,,,
Disease,Choroideremia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],2,2
Category,Genetic multiple congenital anomalies/dysmorphic syndrome,,,,,,,,,,,,,
Category,Rare genetic developmental defect during embryogenesis,,,,,,,,,,,,,
Clinical group,Androgen insensitivity syndrome,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,11549642[PMID],1.01,1.01
Clinical group,Androgen insensitivity syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Androgen insensitivity syndrome,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,27603905[PMID],4.1,4.1
Clinical group,Androgen insensitivity syndrome,<1 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,27603905[PMID],0.04,0.04
Clinical group,Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic bone tumor,,,,,,,,,,,,,
Category,Rare genetic bone disease,,,,,,,,,,,,,
Disease,Congenital factor VII deficiency,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.33,0.33
Category,Rare genetic movement disorder,,,,,,,,,,,,,
Category,Rare hereditary ataxia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,22689585[PMID],0,0
Category,Rare genetic medullar disease,,,,,,,,,,,,,
Malformation syndrome,Simpson-Golabi-Behmel syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Simpson-Golabi-Behmel syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25238977[PMID]_[EXPERT],250,250
Category,Rare genetic epilepsy,,,,,,,,,,,,,
Category,Rare genetic headache,,,,,,,,,,,,,
Disease,Familial hyperaldosteronism type I,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23610123[PMID],0,0
Disease,Familial hyperaldosteronism type I,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic central nervous system and retinal vascular disease,,,,,,,,,,,,,
Category,Genetic central nervous system malformation,,,,,,,,,,,,,
Malformation syndrome,Monosomy 21,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Malformation syndrome,Monosomy 21,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic neuromuscular disease,,,,,,,,,,,,,
Category,Genetic neurodegenerative disease,,,,,,,,,,,,,
Category,Genetic photodermatosis,,,,,,,,,,,,,
Category,Genetic immune deficiency with skin involvement,,,,,,,,,,,,,
Disease,Multiple endocrine neoplasia type 2,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:9283224167[OTHER]_[EXPERT],2.9,2.9
Disease,Multiple endocrine neoplasia type 2,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,23211574[PMID],1.25,1.25
Disease,Differentiated thyroid carcinoma,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,5.25,5.25
Disease,Differentiated thyroid carcinoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2,2
Disease,Differentiated thyroid carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic subcutaneous tissue disorder,,,,,,,,,,,,,
Category,Genetic skin tumor,,,,,,,,,,,,,
Disease,Familial prostate cancer,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_National Cancer Institute 2006-2010[INST]_ ORPHANET,9.4,9.4
Category,Genetic skin vascular disorder,,,,,,,,,,,,,
Category,Genetic mixed dermis disorder,,,,,,,,,,,,,
Disease,Carnitine palmitoyltransferase II deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,300,300
Disease,Carnitine palmitoyltransferase II deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Carnitine palmitoyltransferase II deficiency,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22766612[PMID],0.2,0.2
Disease,Carnitine palmitoyltransferase II deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],1,1
Category,Genetic dermis disorder,,,,,,,,,,,,,
Disease,Alpha-thalassemia-X-linked intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301622[PMID]_16722615[PMID],200,200
Disease,Alpha-thalassemia-X-linked intellectual disability syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic hyperpigmentation of the skin,,,,,,,,,,,,,
Category,Genetic hypopigmentation of the skin,,,,,,,,,,,,,
Category,Genetic sebaceous gland anomaly,,,,,,,,,,,,,
Malformation syndrome,Ring chromosome 22 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:978-3-8055-9280-2[OTHER],100,100
Malformation syndrome,Ring chromosome 22 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:978-3-8055-9280-2[OTHER],0,0
Category,Genetic pigmentation anomaly of the skin,,,,,,,,,,,,,
Category,Genetic erythrokeratoderma,,,,,,,,,,,,,
Category,Inherited ichthyosis,1-9 / 100 000,France,409966,409966,25965,25965,en,Not yet validated,410294,410294,24393603[PMID],1.33,1.33
Malformation syndrome,ICF syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23486536[PMID],66,66
Malformation syndrome,ICF syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic porokeratosis,,,,,,,,,,,,,
Category,Genetic acrokeratoderma,,,,,,,,,,,,,
Category,Genetic hair anomaly,,,,,,,,,,,,,
Category,Genetic epidermal appendage anomaly,,,,,,,,,,,,,
Malformation syndrome,Joubert syndrome,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20301500[PMID],1.125,1.125
Malformation syndrome,Joubert syndrome,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,Kroes_Fransen van de Putte_Ravesloot 2007[AUTHOR],1,1
Malformation syndrome,Joubert syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Holt-Oram syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,25344219[PMID]_EUROCAT European surveillance of congenital anomalies 1990-2011[REG],0.7,0.7
Malformation syndrome,Holt-Oram syndrome,1-9 / 1 000 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,1996196[PMID]_[EXPERT],0.95,0.95
Malformation syndrome,Holt-Oram syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic nail anomaly,,,,,,,,,,,,,
Category,Systemic autoimmune disease,,,,,,,,,,,,,
Category,Rare systemic disease,,,,,,,,,,,,,
Disease,Bazex-Dupré-Christol syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,143,143
Disease,Bazex-Dupré-Christol syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial abdominal aortic aneurysm,,,,,,,,,,,,,
Category,Rare rheumatologic disease,,,,,,,,,,,,,
Malformation syndrome,"46,XX gonadal dysgenesis",1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical group,Genetic urticaria,,,,,,,,,,,,,
Category,Genetic epidermal disorder,,,,,,,,,,,,,
Category,Polymalformative genetic syndrome with increased risk of developing cancer,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Category,Respiratory malformation,,,,,,,,,,,,,
Disease,CADASIL,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,12146805[PMID]_15834040[PMID]_22422895[PMID]_[EXPERT]_ORPHANET,3,3
Disease,CADASIL,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,22422895[PMID]_15834040[PMID]_ [EXPERT],2,2
Disease,CADASIL,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,12146805[PMID]_[EXPERT]_ ORPHANET,3,3
Category,Rare urogenital tumor,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,22425262[PMID],0.13,0.13
Category,Rare urogenital tumor,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,22425262[PMID],0.21,0.21
Morphological anomaly,Congenital bilateral absence of vas deferens,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,50,50
Category,Non-syndromic urogenital tract malformation of female,,,,,,,,,,,,,
Category,Non-syndromic urogenital tract malformation of male,,,,,,,,,,,,,
Category,Non-syndromic urogenital tract malformation of male and female,,,,,,,,,,,,,
Disease,Extragonadal germinoma,,,,,,,,,,,,,
Category,Tumor of endocrine glands,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,22361014[PMID],3.75,3.75
Category,Tumor of endocrine glands,6-9 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,22361014[PMID],64,64
Disease,Berardinelli-Seip congenital lipodystrophy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],0.5,0.5
Disease,Berardinelli-Seip congenital lipodystrophy,<1 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,16722806[PMID],0.01,0.01
Disease,Berardinelli-Seip congenital lipodystrophy,<1 / 1 000 000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,27144933[PMID],0.05,0.05
Disease,Severe combined immunodeficiency due to DCLRE1C deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Category,Channelopathy with epilepsy,,,,,,,,,,,,,
Category,Acquired peripheral neuropathy,,,,,,,,,,,,,
Category,Pulmonary arterial hypertension,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST]_16456139[PMID]_17360728[PMID],2,2
Category,Pulmonary arterial hypertension,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22362843[PMID],1.6,1.6
Category,Pulmonary arterial hypertension,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,22362843[PMID],0.37,0.37
Category,Pulmonary arterial hypertension,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID],1.5,1.5
Category,Pulmonary arterial hypertension,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,16456139[PMID],0.24,0.24
Category,Pulmonary arterial hypertension,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,21793646[PMID],1.09,1.09
Category,Pulmonary arterial hypertension,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,24629043[PMID],1.07,1.07
Category,Pulmonary arterial hypertension,1-9 / 100 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,24629043[PMID],2.24,2.24
Category,Pulmonary arterial hypertension,1-9 / 100 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,18587690[PMID],1.55,1.55
Category,Pulmonary arterial hypertension,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,18587690[PMID],0.35,0.35
Category,Pulmonary arterial hypertension,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,21885399[PMID]_17360728[PMID],0.72,0.72
Category,Pulmonary arterial hypertension,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,17360728[PMID],5.2,5.2
Category,Interstitial lung disease,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,24636811[PMID],4.1,4.1
Category,Interstitial lung disease,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,24636811[PMID],5.4,5.4
Category,Interstitial lung disease,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,15127977[PMID],7.6,7.6
Category,Interstitial lung disease,1-9 / 100 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,19345567[PMID],4.63,4.63
Category,Interstitial lung disease,1-5 / 10 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,19345567[PMID],17.3,17.3
Clinical group,Pneumoconiosis,,,,,,,,,,,,,
Malformation syndrome,Cherubism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Cherubism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],300,300
Clinical group,Idiopathic eosinophilic pneumonia,,,,,,,,,,,,,
Category,Secondary interstitial lung disease in childhood and adulthood associated with a connective tissue disease,,,,,,,,,,,,,
Category,Sideroblastic anemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Thoracic malformation,,,,,,,,,,,,,
Disease,Chylomicron retention disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,55,55
Disease,Chylomicron retention disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Glial tumor,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2004[REG]_24193082[PMID],5.26,5.26
Clinical group,Glial tumor,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],26,26
Clinical group,Glial tumor,1-9 / 100 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,19494549[PMID],5.7,5.7
Clinical group,Glial tumor,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,15103760[PMID],6.2,6.2
Clinical group,Glial tumor,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.35,5.35
Category,Rare neuroinflammatory or neuroimmunological disease,,,,,,,,,,,,,
Category,Cerebellar malformation,,,,,,,,,,,,,
Clinical group,Primary orthostatic hypotension,,,,,,,,,,,,,
Clinical group,ARX-related epileptic encephalopathy,,,,,,,,,,,,,
Disease,Benign familial neonatal epilepsy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_20437616[PMID]_24375629[PMID],100,100
Disease,Benign familial neonatal epilepsy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Syndromic neurometabolic disease with X-linked intellectual disability,,,,,,,,,,,,,
Disease,Hidrotic ectodermal dysplasia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1,1
Malformation syndrome,Uveal coloboma-cleft lip and palate-intellectual disability,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24462371[PMID],12,12
Malformation syndrome,Uveal coloboma-cleft lip and palate-intellectual disability,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Syndromic neurometabolic disease with non-X-linked intellectual disability,,,,,,,,,,,,,
Category,Rare neurodegenerative disease,,,,,,,,,,,,,
Category,Aplastic anemia,,,,,,,,,,,,,
Category,Rare thrombotic disease of hematologic origin,,,,,,,,,,,,,
Disease,Atrial standstill,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,MYH9-related disease,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,20301740[PMID],0.29,0.29
Disease,MYH9-related disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20301740[PMID]_[EXPERT],0.3,0.3
Category,Rare acquired hemolytic anemia,,,,,,,,,,,,,
Category,Rare constitutional hemolytic anemia,,,,,,,,,,,,,
Malformation syndrome,Roberts syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301332[PMID],150,150
Malformation syndrome,Roberts syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301332[PMID],0,0
Clinical group,Hyperalphalipoproteinemia,,,,,,,,,,,,,
Category,Rare hypoaldosteronism,,,,,,,,,,,,,
Category,Rare hyperlipidemia,,,,,,,,,,,,,
Malformation syndrome,Peters plus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301637[PMID],100,100
Malformation syndrome,Peters plus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301637[PMID],0,0
Category,Rare syndromic dyslipidemia,,,,,,,,,,,,,
Category,Rare disorder with hypergonadotropic hypogonadism,,,,,,,,,,,,,
Category,Rare hypolipidemia,,,,,,,,,,,,,
Malformation syndrome,X-linked intellectual disability with marfanoid habitus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare hyperthyroidism,,,,,,,,,,,,,
Category,Syndrome with hypoparathyroidism,,,,,,,,,,,,,
Category,Growth hormone insensitivity syndrome,,,,,,,,,,,,,
Disease,Werner syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Werner syndrome,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,10484259[PMID],0.5,0.5
Disease,Werner syndrome,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,10347997[PMID]_[EXPERT],2,2
Disease,Werner syndrome,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,17478382[PMID]_[EXPERT],2,2
Category,Rare hypothyroidism,,,,,,,,,,,,,
Malformation syndrome,Van der Woude syndrome,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,7459520[PMID],1.7,1.7
Malformation syndrome,Van der Woude syndrome,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22925539[PMID],1.3,1.3
Malformation syndrome,Van der Woude syndrome,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22925539[PMID],0,0
Malformation syndrome,Van der Woude syndrome,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,20415912[PMID],1.4,1.4
Malformation syndrome,Van der Woude syndrome,1-9 / 1 000 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,18177185[PMID]_ORPHANET,0.85,0.85
Malformation syndrome,Van der Woude syndrome,1-9 / 1 000 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,18177185[PMID]_ORPHANET,0,0
Malformation syndrome,Van der Woude syndrome,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,9450872[PMID],0.9,0.9
Malformation syndrome,Van der Woude syndrome,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,9450872[PMID],0,0
Malformation syndrome,Van der Woude syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Adrenogenital syndrome,,,,,,,,,,,,,
Category,Rare primary hyperaldosteronism,,,,,,,,,,,,,
Category,Rare hypoparathyroidism,,,,,,,,,,,,,
Disease,Familial progressive cardiac conduction defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Disease,Familial progressive cardiac conduction defect,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare hyperparathyroidism,,,,,,,,,,,,,
Malformation syndrome,Distal monosomy 17q,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Distal monosomy 13q,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24433316[PMID],150,150
Malformation syndrome,Distal monosomy 13q,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24433316[PMID],0,0
Malformation syndrome,Monosomy 13q14,,,,,,,,,,,,,
Malformation syndrome,3q13 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24650298[PMID],42,42
Malformation syndrome,3q13 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24650298[PMID],0,0
Malformation syndrome,Distal monosomy 3p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN-10:0781730635[OTHER],34,34
Malformation syndrome,Distal monosomy 3p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN-10:0781730635[OTHER],0,0
Malformation syndrome,Xp22.3 microdeletion syndrome,,,,,,,,,,,,,
Malformation syndrome,Deletion 5q35,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11562936[PMID]_[EXPERT],10,10
Malformation syndrome,Deletion 5q35,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Trisomy 12p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16502429[PMID],40,40
Malformation syndrome,Trisomy 12p,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,8723118[PMID],2,2
Malformation syndrome,Trisomy 12p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,8723118[PMID]_ORPHANET,0,0
Malformation syndrome,Non-distal trisomy 10q,,,,,,,,,,,,,
Malformation syndrome,Noonan syndrome with multiple lentigines,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21500339[PMID],296,296
Malformation syndrome,Noonan syndrome with multiple lentigines,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21500339[PMID],0,0
Disease,Leishmaniasis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],0.1,0.1
Disease,Leishmaniasis,1-5 / 10 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization[INST]_ORPHANET,25,25
Disease,Leprosy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Leprosy,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],3.7,3.7
Malformation syndrome,Duane retraction syndrome,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ISBN:3642022014[OTHER],10,10
Clinical group,Congenital isolated hyperinsulinism,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,14518075[PMID],2,2
Clinical group,Congenital isolated hyperinsulinism,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,9130925[PMID]_14518075[PMID],2,2
Clinical group,Congenital isolated hyperinsulinism,1-5 / 10 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,21967988[PMID],40,40
Clinical group,Congenital isolated hyperinsulinism,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Congenital isolated hyperinsulinism,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,2,2
Category,Conotruncal heart malformations,,,,,,,,,,,,,
Disease,Meningioma,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2005[REG],2,2
Disease,Meningioma,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],8.14,8.14
Disease,Meningioma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.15,0.15
Disease,Meningioma,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.75,1.75
Disease,Meningioma,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial or sporadic hemiplegic migraine,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Familial or sporadic hemiplegic migraine,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,12023326[PMID],10,10
Clinical group,Cleft palate,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],53.6,53.6
Clinical group,Cleft palate,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],19.6,19.6
Clinical group,Cleft palate,1-5 / 10 000,Austria,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],40.8,40.8
Clinical group,Cleft palate,1-5 / 10 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],56.8,56.8
Clinical group,Cleft palate,1-5 / 10 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Clinical group,Cleft palate,>1 / 1000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],127.6,127.6
Clinical group,Cleft palate,>1 / 1000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],25.5,25.5
Clinical group,Cleft palate,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],47.5,47.5
Clinical group,Cleft palate,1-5 / 10 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,6-9 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],67.5,67.5
Clinical group,Cleft palate,6-9 / 10 000,Hungary,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],54.2,54.2
Clinical group,Cleft palate,1-5 / 10 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],39.6,39.6
Clinical group,Cleft palate,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,6-9 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],74.7,74.7
Clinical group,Cleft palate,6-9 / 10 000,Malta,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.7,11.7
Clinical group,Cleft palate,1-5 / 10 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Clinical group,Cleft palate,6-9 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],65.4,65.4
Clinical group,Cleft palate,6-9 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],36.5,36.5
Clinical group,Cleft palate,1-5 / 10 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],14.2,14.2
Clinical group,Cleft palate,1-5 / 10 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],30.7,30.7
Clinical group,Cleft palate,1-5 / 10 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],25.1,25.1
Clinical group,Cleft palate,1-5 / 10 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,6-9 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],60.2,60.2
Clinical group,Cleft palate,6-9 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],57.2,57.2
Clinical group,Cleft palate,1-5 / 10 000,Ukraine,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],0,0
Clinical group,Cleft palate,>1 / 1000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,23371924[PMID],101.2,101.2
Clinical group,Cleft palate,>1 / 1000,Australia,409966,409966,25965,25965,en,Not yet validated,410294,410294,23371924[PMID],0,0
Clinical group,Cleft palate,1-5 / 10 000,Chile,409968,409968,25958,25958,en,Validated,410293,410293,11372296[PMID],52,52
Clinical group,Cleft palate,1-5 / 10 000,Chile,409966,409966,25965,25965,en,Not yet validated,410294,410294,11372296[PMID],0,0
Clinical group,Cleft palate,1-5 / 10 000,Sudan,409968,409968,25958,25958,en,Validated,410293,410293,15854114[PMID],27,27
Clinical group,Cleft palate,1-5 / 10 000,Sudan,409966,409966,25965,25965,en,Not yet validated,410294,410294,15854114[PMID],0,0
Clinical group,Cleft palate,1-5 / 10 000,"Iran, Islamic Republic of",409968,409968,25958,25958,en,Validated,410293,410293,20648890[PMID],26,26
Clinical group,Cleft palate,1-5 / 10 000,"Iran, Islamic Republic of",409966,409966,25965,25965,en,Not yet validated,410294,410294,20648890[PMID],0,0
Clinical group,Cleft palate,1-5 / 10 000,Mexico,409968,409968,25958,25958,en,Validated,410293,410293,8442867[PMID],27,27
Clinical group,Cleft palate,1-5 / 10 000,Mexico,409966,409966,25965,25965,en,Not yet validated,410294,410294,8442867[PMID],0,0
Clinical group,Cleft palate,1-9 / 100 000,Bolivia,409968,409968,25958,25958,en,Validated,410293,410293,14989684[PMID],4,4
Clinical group,Cleft palate,1-9 / 100 000,Bolivia,409966,409966,25965,25965,en,Not yet validated,410294,410294,14989684[PMID],0,0
Clinical group,Cleft palate,6-9 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,15516165[PMID],68,68
Clinical group,Cleft palate,6-9 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,15516165[PMID],0,0
Clinical group,Cleft palate,1-5 / 10 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,23555592[PMID],40,40
Clinical group,Cleft palate,1-5 / 10 000,"Taiwan, Province of China",409966,409966,25965,25965,en,Not yet validated,410294,410294,23555592[PMID],0,0
Malformation syndrome,Léri-Weill dyschondrosteosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,Autosomal recessive spondylocostal dysostosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Gitelman syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2.5,2.5
Malformation syndrome,"46,XY complete gonadal dysgenesis",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"46,XY complete gonadal dysgenesis",<1 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,27603905[PMID],0.02,0.02
Malformation syndrome,"46,XY complete gonadal dysgenesis",1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,27603905[PMID],1.5,1.5
Malformation syndrome,Fraser syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,23532946[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0.2,0.2
Malformation syndrome,Fraser syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Fraser syndrome,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,9662850[PMID],0.43,0.43
Malformation syndrome,Heart defects-limb shortening syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2074559[PMID],2,2
Malformation syndrome,Heart defects-limb shortening syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2074559[PMID],0,0
Malformation syndrome,Carey-Fineman-Ziter syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27232676[PMID],20,20
Malformation syndrome,Carey-Fineman-Ziter syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27232676[PMID],0,0
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,17651510[PMID]_[EXPERT],20,20
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2009[REG],24,24
Clinical group,Isolated anorectal malformation,6-9 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2006[REG],78,78
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],26.2,26.2
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.4,11.4
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.3,21.3
Clinical group,Isolated anorectal malformation,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],23.6,23.6
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],53.5,53.5
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],43.2,43.2
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],28.9,28.9
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],11.3,11.3
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],29.2,29.2
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],29.5,29.5
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.6,11.6
Clinical group,Isolated anorectal malformation,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],4.7,4.7
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],13.8,13.8
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],49,49
Clinical group,Isolated anorectal malformation,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.6,21.6
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],28.6,28.6
Clinical group,Isolated anorectal malformation,6-9 / 10 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,23232683[PMID],60.8,60.8
Clinical group,Isolated anorectal malformation,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Barth syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.22,0.22
Disease,Barth syndrome,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.29,0.29
Disease,Barth syndrome,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,23656970[PMID],0.15,0.15
Disease,Barth syndrome,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,23398819[PMID]_[EXPERT],0.71,0.71
Malformation syndrome,"48,XXYY syndrome",1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_568179[PMID]_14477077[PMID]_2090319[PMID],1.9,1.9
Malformation syndrome,"48,XXYY syndrome",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,C syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_17162528[PMID],0.11,0.11
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,China,409967,409967,25958,25958,en,Validated,410293,410293,8061578[PMID],0.2,0.2
Disease,Nasopharyngeal carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Nasopharyngeal carcinoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],2,2
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID],0.36,0.36
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.337,0.337
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.317,0.317
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.766,0.766
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.423,0.423
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.437,0.437
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.24,0.24
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.177,0.177
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.35,0.35
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.383,0.383
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.207,0.207
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.618,0.618
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.254,0.254
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.228,0.228
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.264,0.264
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.426,0.426
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.62,0.62
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.491,0.491
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.394,0.394
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.779,0.779
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.462,0.462
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.288,0.288
Disease,Nasopharyngeal carcinoma,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.211,0.211
Disease,Nasopharyngeal carcinoma,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.256,1.256
Disease,Chronic beryllium disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Currarino syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1,1
Malformation syndrome,Ring chromosome 8 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15337475[PMID]_ISBN 10:3110116073[OTHER],8,8
Malformation syndrome,Ring chromosome 8 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN 10:3110116073[OTHER]_15337475[PMID],0,0
Malformation syndrome,Ring chromosome 6 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23398904[PMID],25,25
Malformation syndrome,Ring chromosome 6 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23398904[PMID],0,0
Malformation syndrome,Non-distal monosomy 10q,,,,,,,,,,,,,
Malformation syndrome,Distal monosomy 10p,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Ring chromosome 1 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17710876[PMID],35,35
Malformation syndrome,Ring chromosome 1 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17710876[PMID],0,0
Disease,Progressive familial intrahepatic cholestasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Ring chromosome 4 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27610251[PMID],20,20
Malformation syndrome,Ring chromosome 4 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27610251[PMID],0,0
Malformation syndrome,Ring chromosome 20 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Malformation syndrome,Ring chromosome 20 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Ring chromosome 12 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17880954[PMID]_20933620[PMID],10,10
Malformation syndrome,Ring chromosome 12 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17880954[PMID]_20933620[PMID],0,0
Malformation syndrome,Ring chromosome 10 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23247912[PMID],16,16
Malformation syndrome,Ring chromosome 10 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Nakajo-Nishimura syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4126345[PMID]_8495043[PMID]_21852578[PMID]_22441638[PMID]_23942189[PMID],30,30
Clinical subtype,Nakajo-Nishimura syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Familial multiple nevi flammei,,,,,,,,,,,,,
Malformation syndrome,Myopathy-growth delay-intellectual disability-hypospadias syndrome,,,,,,,,,,,,,
Malformation syndrome,Duplication/inversion 15q11,,,,,,,,,,,,,
Malformation syndrome,Trisomy X,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,42.5,42.5
Malformation syndrome,Tetrasomy 9p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_25847481[PMID]_25944096[PMID]_25951732[PMID]_26216333[PMID],70,70
Malformation syndrome,Tetrasomy 9p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25847481[PMID],0,0
Disease,Familial male-limited precocious puberty,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Tetraploidy,,,,,,,,,,,,,
Malformation syndrome,Spina bifida-hypospadias syndrome,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,7977461[PMID],6.1,6.1
Malformation syndrome,Mosaic trisomy 16,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16557642[PMID],0,0
Malformation syndrome,Mosaic trisomy 16,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16557642[PMID],226,226
Malformation syndrome,Mosaic trisomy 17,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27751421[PMID],31,31
Malformation syndrome,Mosaic trisomy 17,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27751421[PMID],0,0
Malformation syndrome,Triploidy,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,22234154[PMID]_EUROCAT European surveillance of congenital anomalies[REG],12.6,12.6
Malformation syndrome,Triploidy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Mosaic trisomy 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8835327[PMID],1,1
Malformation syndrome,Mosaic trisomy 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8835327[PMID],0,0
Malformation syndrome,Mosaic trisomy 12,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28345774[PMID],0,0
Malformation syndrome,Mosaic trisomy 15,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25736076[PMID],0,0
Malformation syndrome,Aase-Smith syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,Aase-Smith syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Ablepharon macrostomia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27196381[PMID],16,16
Malformation syndrome,Ablepharon macrostomia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27196381[PMID],0,0
Malformation syndrome,Ring chromosome 21 syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,3C syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18957854[PMID],25,25
Malformation syndrome,3C syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18957854[PMID],0,0
Morphological anomaly,Acheiropodia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Acheiropodia,1-9 / 1 000 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,1155460[PMID],0.4,0.4
Morphological anomaly,Acheiropodia,<1 / 1 000 000,Brazil,409966,409966,25958,25958,en,Validated,410293,410293,1155460[PMID],0.03,0.03
Malformation syndrome,Achalasia-microcephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3048841[PMID]_2591072[PMID],7,7
Malformation syndrome,Achalasia-microcephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3048841[PMID]_2591072[PMID],0,0
Disease,Triple A syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14723589[PMID]_[EXPERT],100,100
Disease,Triple A syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Insulin-resistance syndrome type A,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial nasal acilia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4002006[PMID]_8813877[PMID],8,8
Disease,Familial nasal acilia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4002006[PMID]_8813877[PMID],0,0
Malformation syndrome,Abruzzo-Erickson syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,839509[PMID]_[EXPERT],4,4
Malformation syndrome,Abruzzo-Erickson syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Vitamin B12-unresponsive methylmalonic acidemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,3-hydroxyisobutyric aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16466957[PMID]_19650361[PMID],13,13
Disease,3-hydroxyisobutyric aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16466957[PMID]_19650361[PMID],0,0
Disease,Oxoglutaric aciduria,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Short-limb skeletal dysplasia with severe combined immunodeficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1999827[PMID],19,19
Disease,Short-limb skeletal dysplasia with severe combined immunodeficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1999827[PMID],0,0
Disease,Achondrogenesis,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,2785882[PMID],2.8,2.8
Disease,Achondrogenesis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Peripheral dysostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7205902[PMID]_6018472[PMID],6,6
Malformation syndrome,Peripheral dysostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7205902[PMID]_6018472[PMID],0,0
Disease,Acrodermatitis enteropathica,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,17190629[PMID]_8562288[PMID],0.2,0.2
Disease,Acrodermatitis enteropathica,1-9 / 1 000 000,Denmark,409966,409966,25965,25965,en,Not yet validated,410294,410294,17190629[PMID],0,0
Disease,Acrodermatitis enteropathica,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,Acrodysostosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Acrodysostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],80,80
Malformation syndrome,Acrocraniofacial dysostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3344780[PMID],2,2
Malformation syndrome,Acrocraniofacial dysostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3344780[PMID],0,0
Malformation syndrome,Acalvaria,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,Acalvaria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Acrocephalosyndactyly,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,Acropectorovertebral dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Acropectorovertebral dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Acro-renal-mandibular syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25075450[PMID],10,10
Malformation syndrome,Acro-renal-mandibular syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25075450[PMID],0,0
Malformation syndrome,Acroosteolysis dominant type,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25491639[PMID],100,100
Malformation syndrome,Acroosteolysis dominant type,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25491639[PMID],0,0
Malformation syndrome,"Acrofacial dysostosis, Weyers type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Non-distal trisomy 13q,,,,,,,,,,,,,
Malformation syndrome,Mosaic trisomy 14,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 14q,,,,,,,,,,,,,
Malformation syndrome,17p11.2 microduplication syndrome,,,,,,,,,,,,,
Malformation syndrome,Trisomy 4p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12239731[PMID],85,85
Malformation syndrome,Trisomy 4p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12239731[PMID],0,0
Malformation syndrome,Trisomy 5p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Malformation syndrome,Trisomy 5p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal trisomy 6p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Malformation syndrome,Distal trisomy 6p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Trisomy 8q,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15581839[PMID],30,30
Malformation syndrome,Trisomy 8q,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Trisomy Xq28,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,TRIM32-related  limb-girdle muscular dystrophy R8,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Oculogastrointestinal muscular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3366929[PMID],1,1
Disease,Oculogastrointestinal muscular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Epilepsy-microcephaly-skeletal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8867658[PMID],2,2
Malformation syndrome,Epilepsy-microcephaly-skeletal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8867658[PMID],0,0
Malformation syndrome,Amelocerebrohypohidrotic syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Epilepsy-telangiectasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,627106[PMID],6,6
Disease,Epilepsy-telangiectasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_627106[PMID],0,0
Disease,Griscelli syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30207398[PMID],150,150
Disease,Griscelli syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30207398[PMID],0,0
Disease,Familial visceral myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Carnitine palmitoyl transferase 1A deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301700[PMID],60,60
Disease,Carnitine palmitoyl transferase 1A deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301700[PMID],0,0
Disease,Mitochondrial myopathy-lactic acidosis-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4725145[PMID],2,2
Disease,Mitochondrial myopathy-lactic acidosis-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4725145[PMID],0,0
Disease,Mitochondrial myopathy and sideroblastic anemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15971356[PMID],7,7
Disease,Mitochondrial myopathy and sideroblastic anemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Thumb stiffness-brachydactyly-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6631421[PMID]_2363441[PMID],7,7
Malformation syndrome,Thumb stiffness-brachydactyly-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6631421[PMID]_2363441[PMID],0,0
Malformation syndrome,Dental ankylosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Ankyloblepharon filiforme adnatum-imperforate anus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8135297[PMID],3,3
Clinical subtype,Ankyloblepharon filiforme adnatum-imperforate anus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8135297[PMID],0,0
Clinical subtype,Ankyloblepharon filiforme adnatum-cleft palate syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Aniridia-absent patella syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1218204[PMID],3,3
Malformation syndrome,Aniridia-absent patella syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1218204[PMID],0,0
Malformation syndrome,Aniridia-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4422267[PMID],2,2
Malformation syndrome,Aniridia-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4422267[PMID],0,0
Malformation syndrome,Aniridia-ptosis-intellectual disability-familial obesity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3091805[PMID],3,3
Malformation syndrome,Aniridia-ptosis-intellectual disability-familial obesity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3091805[PMID],0,0
Malformation syndrome,Aniridia-renal agenesis-psychomotor retardation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4419812[PMID],2,2
Malformation syndrome,Aniridia-renal agenesis-psychomotor retardation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4419812[PMID],0,0
Disease,Hereditary neurocutaneous malformation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,537017[PMID]_3342546[PMID]_7189031[PMID]_998575[PMID]_14186663[PMID]_8929507[PMID],9,9
Disease,Hereditary neurocutaneous malformation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3342546[PMID],0,0
Category,Rare sucking/swallowing disorder,,,,,,,,,,,,,
Clinical group,Acquired alimentary behavior disorder of infancy,,,,,,,,,,,,,
Morphological anomaly,Vein of Galen aneurysmal malformation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_1997895[PMID],0,0
Category,Sucking/swallowing disorder associated with a neuromuscular disease,,,,,,,,,,,,,
Category,Sucking/swallowing disorder associated with cerebellar anomalies,,,,,,,,,,,,,
Malformation syndrome,Congenital left ventricular aneurysm,,,,,,,,,,,,,
Category,Sucking/swallowing disorder associated with posterior fossa anomalies,,,,,,,,,,,,,
Category,Sucking/swallowing disorder associated with basal ganglia anomalies,,,,,,,,,,,,,
Malformation syndrome,Mosaic variegated aneuploidy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16059936[PMID]_[EXPERT],41,41
Malformation syndrome,Mosaic variegated aneuploidy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Sucking/swallowing disorder associated with suprabulbar anomalies,,,,,,,,,,,,,
Category,Sucking/swallowing disorder associated with neurologic anomalies,,,,,,,,,,,,,
Category,Sucking/swallowing disorder associated to cervicofacial or esophageal malformation,,,,,,,,,,,,,
Disease,Metaphyseal anadysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,27,27
Disease,Metaphyseal anadysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Syndromic sucking/swallowing disorder with unidentifyed syndrome,,,,,,,,,,,,,
Malformation syndrome,Hydrops fetalis,>1 / 1000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,16964808[PMID],134,134
Malformation syndrome,Hydrops fetalis,>1 / 1000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,24094760[PMID],380,380
Malformation syndrome,Hydrops fetalis,>1 / 1000,Thailand,409968,409968,25958,25958,en,Validated,410293,410293,19459517[PMID],180,180
Malformation syndrome,Hydrops fetalis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Sucking/swallowing disorder associated to a chromosomal anomaly,,,,,,,,,,,,,
Clinical group,Arthrogryposis multiplex congenita,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,22005589[PMID]_EUROCAT European surveillance of congenital anomalies[REG],5.7,5.7
Clinical group,Arthrogryposis multiplex congenita,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9928642[PMID],8.3,8.3
Clinical group,Arthrogryposis multiplex congenita,1-5 / 10 000,Canada,409968,409968,25965,25965,en,Not yet validated,410294,410294,21157886[PMID],0,0
Clinical group,Arthrogryposis multiplex congenita,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Sucking/swallowing disorder associated with an identified syndrome,,,,,,,,,,,,,
Malformation syndrome,Aprosencephaly cerebellar dysgenesis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8826432[PMID],2,2
Malformation syndrome,Aprosencephaly cerebellar dysgenesis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8826432[PMID],0,0
Disease,"Ocular motor apraxia, Cogan type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,"Ocular motor apraxia, Cogan type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Radial deficiency-tibial hypoplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8723109[PMID],0,0
Malformation syndrome,Lung agenesis-heart defect-thumb anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25487726[PMID]_26513515[PMID],0,0
Malformation syndrome,Lung agenesis-heart defect-thumb anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25487726[PMID]_26513515[PMID],9,9
Malformation syndrome,Ulnar hypoplasia-split foot syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_565745[PMID],0,0
Malformation syndrome,Ulnar hypoplasia-split foot syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,565745[PMID],1,1
Disease,Aplasia cutis congenita-intestinal lymphangiectasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3984978[PMID],3,3
Disease,Aplasia cutis congenita-intestinal lymphangiectasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3984978[PMID],0,0
Malformation syndrome,Fibular aplasia-ectrodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Malformation syndrome,Fibular aplasia-ectrodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Aplasia cutis-myopia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3395567[PMID]_8741916[PMID],4,4
Disease,Aplasia cutis-myopia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3395567[PMID]_8741916[PMID],0,0
Malformation syndrome,Aortic arch anomaly-facial dysmorphism-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5696314[PMID],4,4
Malformation syndrome,Aortic arch anomaly-facial dysmorphism-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5696314[PMID],0,0
Malformation syndrome,Aphalangy-syndactyly-microcephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19449409[PMID],5,5
Malformation syndrome,Aphalangy-syndactyly-microcephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19449409[PMID],0,0
Malformation syndrome,Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2282714[PMID],3,3
Malformation syndrome,Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2282714[PMID],0,0
Malformation syndrome,Microphthalmia with limb anomalies,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21750680[PMID]_21194680[PMID],35,35
Malformation syndrome,Microphthalmia with limb anomalies,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Antley-Bixler syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,34,34
Malformation syndrome,Antley-Bixler syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Anophthalmia plus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24341146[PMID]_25804017[PMID],17,17
Malformation syndrome,Anophthalmia plus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24341146[PMID]_25804017[PMID],0,0
Malformation syndrome,Anonychia-microcephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8985482[PMID],4,4
Malformation syndrome,Anonychia-microcephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8985482[PMID],0,0
Malformation syndrome,PAGOD syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8291549[PMID],6,6
Malformation syndrome,PAGOD syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8291549[PMID],0,0
Category,Orofacial clefting syndrome,,,,,,,,,,,,,
Malformation syndrome,Agnathia-holoprosencephaly-situs inversus syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,20849990[PMID]_ORPHANET,0,0
Malformation syndrome,Hypoglossia-hypodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23431477[PMID],47,47
Malformation syndrome,Hypoglossia-hypodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23431477[PMID],0,0
Category,Malformation syndrome with odontal and/or periodontal component,,,,,,,,,,,,,
Malformation syndrome,Fetal akinesia deformation sequence,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.6,0.6
Malformation syndrome,Fetal akinesia deformation sequence,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Disease,Aicardi-Goutières syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],10,10
Disease,Aicardi-Goutières syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301648[PMID],0,0
Category,Malformation syndrome with short stature,,,,,,,,,,,,,
Morphological anomaly,Internal carotid agenesis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_22851490[PMID],100,100
Morphological anomaly,Internal carotid agenesis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Overgrowth/obesity syndrome,,,,,,,,,,,,,
Malformation syndrome,ADULT syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Pr MANOUVRIER-HANU Sylvie[EXPERT],50,50
Malformation syndrome,ADULT syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27469932[PMID]_22607287[PMID]_21078104[PMID]_16114047[PMID]_16724007[PMID],0,0
Disease,Adrenomyodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7153060[PMID],2,2
Disease,Adrenomyodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7153060[PMID],0,0
Malformation syndrome,Tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome,,,,,,,,,,,,,
Category,Progeroid syndrome,,,,,,,,,,,,,
Category,Branchial arch or oral-acral syndrome,,,,,,,,,,,,,
Category,Rare developmental defect with skin/mucosae involvement,,,,,,,,,,,,,
Morphological anomaly,Testicular regression syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare developmental defect with connective tissue involvement,,,,,,,,,,,,,
Disease,Hereditary sensory and autonomic neuropathy type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,35,35
Disease,Hereditary sensory and autonomic neuropathy type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Acrorenal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Acrorenal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Acromesomelic dysplasia, Maroteaux type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Malformation syndrome,"Acromesomelic dysplasia, Maroteaux type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Acromicric dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],60,60
Malformation syndrome,Acromicric dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare bone development disorder,,,,,,,,,,,,,
Malformation syndrome,Adams-Oliver syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28160419[PMID],0,0
Malformation syndrome,Adams-Oliver syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28160419[PMID],398,398
Category,Developmental anomaly of metabolic origin,,,,,,,,,,,,,
Disease,Hereditary continuous muscle fiber activity,,,,,,,,,,,,,
Morphological anomaly,"Congenital absence/hypoplasia of fingers excluding thumb, unilateral",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3725479[PMID],2,2
Morphological anomaly,"Congenital absence/hypoplasia of fingers excluding thumb, unilateral",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3725479[PMID],0,0
Malformation syndrome,Acro-renal-ocular syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Acro-renal-ocular syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Acromesomelic dysplasia, Hunter-Thompson type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,"Acromesomelic dysplasia, Hunter-Thompson type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Acromegaloid facial appearance syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23533839[PMID]_23307537[PMID],23,23
Malformation syndrome,Acromegaloid facial appearance syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23533839[PMID]_23307537[PMID],0,0
Malformation syndrome,Hypertrichosis-acromegaloid facial appearance syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23307537[PMID],27,27
Malformation syndrome,Hypertrichosis-acromegaloid facial appearance syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23307537[PMID],0,0
Disease,Carney triad,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Carney triad,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23652673[PMID],150,150
Disease,Congenital panfollicular nevus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26822169[PMID],3,3
Disease,Congenital panfollicular nevus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26822169[PMID],0,0
Malformation syndrome,Amelo-onycho-hypohidrotic syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,122795[PMID],2,2
Malformation syndrome,Amelo-onycho-hypohidrotic syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_122795[PMID],0,0
Disease,Acute transverse myelitis,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,7196523[PMID]_19812117[PMID],1.6,1.6
Disease,Acute transverse myelitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Enamel-renal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21212699[PMID],11,11
Malformation syndrome,Enamel-renal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Secondary acute transverse myelitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Idiopathic acute transverse myelitis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.25,0.25
Clinical subtype,Idiopathic acute transverse myelitis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Perioral myoclonia with absences,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Perioral myoclonia with absences,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Jeavons syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Biological anomaly,Beta-mercaptolactate cysteine disulfiduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4973015[PMID],1,1
Biological anomaly,Beta-mercaptolactate cysteine disulfiduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4973015[PMID],0,0
Disease,Multicentric reticulohistiocytosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Multicentric reticulohistiocytosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Amaurosis-hypertrichosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2769722[PMID],2,2
Disease,Amaurosis-hypertrichosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2769722[PMID],0,0
Disease,Alström syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_22043170[PMID],0,0
Disease,Alström syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],950,950
Clinical subtype,"Congenital generalized hypertrichosis, Ambras type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Clinical subtype,"Congenital generalized hypertrichosis, Ambras type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Isolated craniosynostosis,,,,,,,,,,,,,
Category,Syndromic craniosynostosis,,,,,,,,,,,,,
Clinical subtype,X-linked cerebral adrenoleukodystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Adrenomyeloneuropathy,,,,,,,,,,,,,
Disease,Drug rash with eosinophilia and systemic symptoms,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Autosomal recessive amelia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7625439[PMID],3,3
Malformation syndrome,Autosomal recessive amelia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7625439[PMID],0,0
Disease,Encephalopathy due to prosaposin deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Encephalopathy due to prosaposin deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Alopecia-epilepsy-pyorrhea-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,830443[PMID],12,12
Disease,Alopecia-epilepsy-pyorrhea-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_830443[PMID],0,0
Disease,Alopecia universalis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2006[INST],25,25
Disease,Autosomal dominant palmoplantar keratoderma and congenital alopecia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Autosomal dominant palmoplantar keratoderma and congenital alopecia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8721564[PMID],2,2
Disease,Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8721564[PMID],0,0
Malformation syndrome,2q37 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23073310[PMID],115,115
Malformation syndrome,2q37 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23073310[PMID],0,0
Disease,Allan-Herndon-Dudley syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25905294[PMID],320,320
Disease,Allan-Herndon-Dudley syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25905294[PMID],0,0
Disease,Allan-Herndon-Dudley syndrome,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medecines Agency 2017[INST],0,0
Malformation syndrome,Scalp defects-postaxial polydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4029956[PMID]_468253[PMID],2,2
Malformation syndrome,Scalp defects-postaxial polydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4029956[PMID]_468253[PMID],0,0
Malformation syndrome,Alopecia-contractures-dwarfism-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6250998[PMID]_7158638[PMID]_10861681[PMID],5,5
Malformation syndrome,Alopecia-contractures-dwarfism-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6250998[PMID]_7158638[PMID]_10861681[PMID],0,0
Malformation syndrome,Ascher syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8994475[PMID],50,50
Malformation syndrome,Ascher syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Blepharonasofacial malformation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10631920[PMID],3,3
Malformation syndrome,Blepharonasofacial malformation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10631920[PMID],0,0
Malformation syndrome,Maxillonasal dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Borjeson-Forssman-Lehmann syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22190899[PMID]_15994862[PMID]_14756673[PMID]_[EXPERT],50,50
Malformation syndrome,Borjeson-Forssman-Lehmann syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Tricho-retino-dento-digital syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8279493[PMID],9,9
Malformation syndrome,Tricho-retino-dento-digital syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8279493[PMID],0,0
Malformation syndrome,Böök syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],26,26
Malformation syndrome,Böök syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Boomerang dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15994868[PMID]_22354125[PMID],10,10
Disease,Boomerang dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15994868[PMID]_22354125[PMID],0,0
Disease,Blepharoptosis-myopia-ectopia lentis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6978128[PMID],3,3
Disease,Blepharoptosis-myopia-ectopia lentis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6978128[PMID],0,0
Malformation syndrome,Bonnemann-Meinecke-Reich syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2654691[PMID]_1941968[PMID],4,4
Malformation syndrome,Bonnemann-Meinecke-Reich syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2654691[PMID]_1941968[PMID],0,0
Malformation syndrome,Bartsocas-Papas syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,24,24
Malformation syndrome,Bartsocas-Papas syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Bartsocas-Papas syndrome,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,1867261[PMID],0.15,0.15
Malformation syndrome,Barber-Say syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27196381[PMID],16,16
Malformation syndrome,Barber-Say syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27196381[PMID],0,0
Malformation syndrome,Congenital intrauterine infection-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Congenital intrauterine infection-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Bannayan-Riley-Ruvalcaba syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Banki syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI: 10.1055/s-0029-1227792[OTHER],1,1
Malformation syndrome,Banki syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI: 10.1055/s-0029-1227792[OTHER],0,0
Malformation syndrome,Bencze syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,519901[PMID],2,2
Malformation syndrome,Bencze syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_519901[PMID],0,0
Disease,Metaphyseal acroscyphodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6543849[PMID]_1860252[PMID],4,4
Disease,Metaphyseal acroscyphodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6543849[PMID]_1860252[PMID],0,0
Malformation syndrome,Beemer-Ertbruggen syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6507485[PMID],2,2
Malformation syndrome,Beemer-Ertbruggen syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6507485[PMID],0,0
Malformation syndrome,Auriculoosteodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6065451[PMID],2,2
Malformation syndrome,Auriculoosteodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6065451[PMID],0,0
Malformation syndrome,Congenital contractural arachnodactyly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1609828[PMID],2,2
Malformation syndrome,Severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1609828[PMID],0,0
Malformation syndrome,Intractable diarrhea-choanal atresia-eye anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17786112[PMID],3,3
Malformation syndrome,Intractable diarrhea-choanal atresia-eye anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17786112[PMID],0,0
Disease,Nephrogenic systemic fibrosis,,,,,,,,,,,,,
Malformation syndrome,Brachymorphism-onychodysplasia-dysphalangism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5567413[PMID]_8445623[PMID],9,9
Malformation syndrome,Brachymorphism-onychodysplasia-dysphalangism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5567413[PMID]_8445623[PMID],0,0
Malformation syndrome,Cardiac anomalies-heterotaxy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17938964[PMID],9,9
Malformation syndrome,Cardiac anomalies-heterotaxy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17938964[PMID],0,0
Clinical group,Brachyolmia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Brachyolmia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Disease,Glycogen storage disease due to muscle and heart glycogen synthase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17928598[PMID]_19699667[PMID],4,4
Disease,Glycogen storage disease due to muscle and heart glycogen synthase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17928598[PMID]_19699667[PMID],0,0
Malformation syndrome,Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome,,,,,,,,,,,,,
Malformation syndrome,Branchioskeletogenital syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5141271[PMID]_9843000[PMID]_20949527[PMID],7,7
Malformation syndrome,Branchioskeletogenital syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5141271[PMID]_9843000[PMID]_20949527[PMID],0,0
Disease,Pellucid marginal degeneration,,,,,,,,,,,,,
Malformation syndrome,Autosomal dominant popliteal pterygium syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Autosomal dominant popliteal pterygium syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],200,200
Malformation syndrome,Capillary malformation-arteriovenous malformation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24038909[PMID],261,261
Malformation syndrome,Capillary malformation-arteriovenous malformation,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Overgrowth-macrocephaly-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17632510[PMID],6,6
Malformation syndrome,Overgrowth-macrocephaly-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17632510[PMID],0,0
Malformation syndrome,Brachytelephalangy-dysmorphism-Kallmann syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3728571[PMID],2,2
Malformation syndrome,Brachytelephalangy-dysmorphism-Kallmann syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3728571[PMID],0,0
Disease,"Lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17937424[PMID],2,2
Disease,"Lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17937424[PMID],0,0
Malformation syndrome,Lambert syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2352262[PMID],4,4
Malformation syndrome,Lambert syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2352262[PMID],0,0
Malformation syndrome,Branchio-oculo-facial syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21634087[PMID],150,150
Malformation syndrome,Branchio-oculo-facial syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21634087[PMID],0,0
Clinical subtype,Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15851747[PMID]_17712733[PMID],8,8
Clinical subtype,Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15851747[PMID]_17712733[PMID],0,0
Particular clinical situation in a disease or syndrome,Neonatal hypoxic and ischemic brain injury,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0,0
Disease,Vulvar intraepithelial neoplasia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2008[INST],20,20
Malformation syndrome,Brachydactyly-arterial hypertension syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,Brachydactyly-arterial hypertension syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Brachydactyly-elbow wrist dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23587911[PMID],4,4
Malformation syndrome,Brachydactyly-elbow wrist dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23587911[PMID],0,0
Category,Herpes simplex virus keratitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Herpes simplex virus keratitis,1-5 / 10 000,France,409967,409967,25958,25958,en,Validated,410293,410293,22944008[PMID],31.5,31.5
Malformation syndrome,Bowen-Conradi syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],60,60
Malformation syndrome,Bowen-Conradi syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Legius syndrome,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2.2,2.2
Malformation syndrome,Legius syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Infectious epithelial keratitis,,,,,,,,,,,,,
Disease,Neurotrophic keratopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24672223[PMID],0,0
Disease,Neurotrophic keratopathy,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],4.2,4.2
Malformation syndrome,Brachydactyly-preaxial hallux varus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5082920[PMID],8,8
Malformation syndrome,Brachydactyly-preaxial hallux varus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5082920[PMID],0,0
Disease,Herpes simplex virus stromal keratitis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],16,16
Disease,Herpes simplex virus stromal keratitis,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,22944008[PMID],5.4,5.4
Disease,Endotheliitis,,,,,,,,,,,,,
Morphological anomaly,Congenital unilateral hypoplasia of depressor anguli oris,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ataxia-oculomotor apraxia type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Extrapelvic endometriosis,,,,,,,,,,,,,
Disease,Chylous ascites,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22319743[PMID],0,0
Disease,Arachnoiditis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Macular amyloidosis,,,,,,,,,,,,,
Malformation syndrome,Cerebellar ataxia-ectodermal dysplasia syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lemierre syndrome,1-5 / 10 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,20181152[PMID],10,10
Disease,Lemierre syndrome,1-5 / 10 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,22633566[PMID],36,36
Disease,Lemierre syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Frank-Ter Haar syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22037860[PMID]_23140272[PMID],30,30
Disease,Frank-Ter Haar syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22037860[PMID]_23140272[PMID],0,0
Disease,X-linked intellectual disability-cerebellar hypoplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20528889[PMID],14,14
Disease,X-linked intellectual disability-cerebellar hypoplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20528889[PMID],0,0
Disease,Autosomal recessive cerebelloparenchymal disorder type 3,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ataxia-tapetoretinal degeneration syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,X-linked progressive cerebellar ataxia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ataxia-hypogonadism-choroidal dystrophy syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Benign paroxysmal tonic upgaze of childhood with ataxia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8495825[PMID],12,12
Disease,Benign paroxysmal tonic upgaze of childhood with ataxia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8495825[PMID],0,0
Disease,Cerebellar ataxia-hypogonadism syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Madras motor neuron disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Madras motor neuron disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21119709[PMID],2,2
Disease,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21119709[PMID],0,0
Malformation syndrome,AREDYLD syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6638067[PMID]_1488989[PMID],3,3
Malformation syndrome,AREDYLD syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6638067[PMID]_1488989[PMID],0,0
Disease,Histiocytoid cardiomyopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,X-linked mandibulofacial dysostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4039890[PMID]_8465866[PMID]_12002155[PMID],7,7
Malformation syndrome,X-linked mandibulofacial dysostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4039890[PMID]_8465866[PMID]_12002155[PMID],0,0
Disease,"Czech dysplasia, metatarsal type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30363003[PMID]_19764028[PMID]_[EXPERT],13,13
Disease,"Czech dysplasia, metatarsal type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30363003[PMID],0,0
Particular clinical situation in a disease or syndrome,Cytomegalovirus disease in patients with impaired cell mediated immunity deemed at risk,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST]_ORPHANET,25.5,25.5
Disease,Neurological conditions associated with aminoacylase 1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29653693[PMID],0,0
Disease,Neurological conditions associated with aminoacylase 1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29653693[PMID],15,15
Disease,Infantile-onset X-linked spinal muscular atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301739[PMID],14,14
Disease,Infantile-onset X-linked spinal muscular atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301739[PMID],0,0
Disease,Asherman syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2017[INST],44,44
Malformation syndrome,Arthrogryposis-like hand anomaly-sensorineural deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5539065[PMID],1,1
Malformation syndrome,Arthrogryposis-like hand anomaly-sensorineural deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5539065[PMID],0,0
Malformation syndrome,Lethal congenital contracture syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12548738[PMID],1,1
Malformation syndrome,Lethal congenital contracture syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12548738[PMID],0,0
Malformation syndrome,Arthrogryposis multiplex congenita-whistling face syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,Arthrogryposis multiplex congenita-whistling face syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Kuskokwim syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23712425[PMID],0,0
Malformation syndrome,Kuskokwim syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23712425[PMID],8,8
Clinical group,Primary cutaneous amyloidosis,1-9 / 100 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,21070198[PMID],9.8,9.8
Clinical group,Primary cutaneous amyloidosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Progressive pseudorheumatoid arthropathy of childhood,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Nodular cutaneous amyloidosis,,,,,,,,,,,,,
Malformation syndrome,Lethal congenital contracture syndrome type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17701898[PMID]_22610851[PMID],14,14
Malformation syndrome,Lethal congenital contracture syndrome type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17701898[PMID]_22610851[PMID],0,0
Disease,Progressive hemifacial atrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Progressive hemifacial atrophy,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,12963760[PMID]_[EXPERT],0.143,0.143
Disease,Autosomal dominant optic atrophy plus syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22776096[PMID]_ORPHANET,0.4,0.4
Disease,Autosomal dominant optic atrophy plus syndrome,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,22776096[PMID],0.4,0.4
Category,Pierre Robin syndrome associated with collagen disease,,,,,,,,,,,,,
Disease,Autosomal dominant congenital benign spinal muscular atrophy,,,,,,,,,,,,,
Category,Pierre Robin syndrome associated with a chromosomal anomaly,,,,,,,,,,,,,
Category,Rare disease with Pierre Robin syndrome,Unknown,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,24433508[PMID],0,0
Category,Rare disease with Pierre Robin syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Pierre Robin syndrome associated with bone disease,,,,,,,,,,,,,
Disease,Cheilitis glandularis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cheilitis glandularis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Category,Pierre Robin syndrome associated with branchial archs anomalies,,,,,,,,,,,,,
Category,Teratogenic Pierre Robin syndrome,,,,,,,,,,,,,
Malformation syndrome,Baller-Gerold syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29080750[PMID],40,40
Malformation syndrome,Baller-Gerold syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29080750[PMID],0,0
Category,Sucking/swallowing disorder not related with Pierre Robin syndrome,,,,,,,,,,,,,
Malformation syndrome,Bamforth-Lazarus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],8,8
Malformation syndrome,Bamforth-Lazarus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Bangstad syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2662702[PMID],2,2
Malformation syndrome,Bangstad syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2662702[PMID],0,0
Malformation syndrome,Ataxia-photosensitivity-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6620277[PMID],2,2
Malformation syndrome,Ataxia-photosensitivity-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6620277[PMID],0,0
Disease,Spastic ataxia with congenital miosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6821680[PMID]_17584505[PMID],3,3
Disease,Spastic ataxia with congenital miosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17584505[PMID],0,0
Malformation syndrome,Auriculocondylar syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Auriculocondylar syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22560091[PMID]_23315542[PMID],50,50
Clinical subtype,Male infertility due to large-headed multiflagellar polyploid spermatozoa,,,,,,,,,,,,,
Disease,Infantile onset spinocerebellar ataxia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27551684[PMID],29,29
Disease,Infantile onset spinocerebellar ataxia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301746[PMID]_27551684[PMID],0,0
Disease,Spinocerebellar ataxia-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3980016[PMID],3,3
Disease,Spinocerebellar ataxia-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3980016[PMID],0,0
Disease,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24566671[PMID],127,127
Disease,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Ataxia-deafness-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4728186[PMID]_3470627[PMID]_8411058[PMID],8,8
Malformation syndrome,Ataxia-deafness-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4728186[PMID]_3470627[PMID]_8411058[PMID],0,0
Morphological anomaly,Isolated optic nerve hypoplasia/aplasia,,,,,,,,,,,,,
Category,Syndromic optic nerve hypoplasia,,,,,,,,,,,,,
Disease,Lethal ataxia with deafness and optic atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27256512[PMID],4,4
Disease,Lethal ataxia with deafness and optic atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27256512[PMID],0,0
Malformation syndrome,Atelosteogenesis type I,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Hypotonia with lactic acidemia and hyperammonemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17873122[PMID]_21189481[PMID],4,4
Disease,Hypotonia with lactic acidemia and hyperammonemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17873122[PMID]_21189481[PMID],0,0
Malformation syndrome,Autism-facial port-wine stain syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17765807[PMID],4,4
Malformation syndrome,Autism-facial port-wine stain syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17765807[PMID],0,0
Morphological anomaly,Choanal atresia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2012[REG],8.6,8.6
Morphological anomaly,Choanal atresia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Choanal atresia,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],9.8,9.8
Morphological anomaly,Choanal atresia,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],14.6,14.6
Morphological anomaly,Choanal atresia,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.3,21.3
Morphological anomaly,Choanal atresia,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],15.7,15.7
Morphological anomaly,Choanal atresia,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.9,5.9
Morphological anomaly,Choanal atresia,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],10,10
Morphological anomaly,Choanal atresia,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],7.2,7.2
Morphological anomaly,Choanal atresia,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.7,5.7
Morphological anomaly,Choanal atresia,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],11.7,11.7
Morphological anomaly,Choanal atresia,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],4.9,4.9
Morphological anomaly,Choanal atresia,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],2.2,2.2
Morphological anomaly,Choanal atresia,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],6.3,6.3
Morphological anomaly,Choanal atresia,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],12.6,12.6
Morphological anomaly,Choanal atresia,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],8.9,8.9
Morphological anomaly,Choanal atresia,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],3.2,3.2
Malformation syndrome,Atkin-Flaitz syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4025397[PMID],14,14
Malformation syndrome,Atkin-Flaitz syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4025397[PMID],0,0
Clinical subtype,"Choanal atresia, unilateral",1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_EUROCAT European surveillance of congenital anomalies[REG],0,0
Clinical subtype,"Choanal atresia, unilateral",1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_EUROCAT European surveillance of congenital anomalies[REG],0,0
Malformation syndrome,Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25434003[PMID],11,11
Malformation syndrome,Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25434003[PMID],0,0
Clinical subtype,"Choanal atresia, bilateral",Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Colonic atresia,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,31891361[PMID],5,5
Morphological anomaly,Colonic atresia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Colonic atresia,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,2342005[PMID],1.5,1.5
Morphological anomaly,Colonic atresia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_2342005[PMID]_16080929[PMID],0,0
Malformation syndrome,Primary laryngeal lymphangioma,,,,,,,,,,,,,
Disease,Neonatal brainstem dysfunction,,,,,,,,,,,,,
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],9,9
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],9,9
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],9,9
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],4,4
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],6,6
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],7,7
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],11,11
Morphological anomaly,Duodenal atresia,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],5,5
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Malta,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],9,9
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],11,11
Morphological anomaly,Duodenal atresia,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Reunion,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],7,7
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Reunion,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],3,3
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],9,9
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],5,5
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Austria,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],3,3
Morphological anomaly,Duodenal atresia,1-9 / 100 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG],0,0
Morphological anomaly,Pulmonary atresia-intact ventricular septum syndrome,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,9714114[PMID],4.5,4.5
Morphological anomaly,Pulmonary atresia-intact ventricular septum syndrome,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,11515692[PMID],4.2,4.2
Malformation syndrome,Congenital laryngeal palsy,,,,,,,,,,,,,
Disease,Laryngotracheal angioma,,,,,,,,,,,,,
Malformation syndrome,Ring chromosome 7 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23509645[PMID],18,18
Malformation syndrome,Ring chromosome 7 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23509645[PMID],0,0
Morphological anomaly,Paramedian nasal cleft,,,,,,,,,,,,,
Malformation syndrome,Cleidorhizomelic syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3239579[PMID],2,2
Malformation syndrome,Cleidorhizomelic syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3239579[PMID],0,0
Morphological anomaly,Median cleft of the upper lip and maxilla,,,,,,,,,,,,,
Malformation syndrome,Ring chromosome 14 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28399932[PMID],80,80
Malformation syndrome,Ring chromosome 14 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28399932[PMID],0,0
Clinical group,Median facial cleft,,,,,,,,,,,,,
Malformation syndrome,Ring chromosome 19 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15270770[PMID],10,10
Malformation syndrome,Ring chromosome 19 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15270770[PMID],0,0
Category,Facial cleft,,,,,,,,,,,,,
Morphological anomaly,Tessier number 5 facial cleft,,,,,,,,,,,,,
Morphological anomaly,Tessier number 4 facial cleft,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3398011[PMID]_21703590[PMID],2,2
Morphological anomaly,Tessier number 4 facial cleft,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3398011[PMID]_21703590[PMID],0,0
Malformation syndrome,CODAS syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25574826[PMID]_20503327[PMID],12,12
Malformation syndrome,CODAS syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Oblique facial cleft,1-9 / 1 000 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,21703590[PMID]_ORPHANET,0.31,0.31
Clinical group,Oblique facial cleft,1-9 / 1 000 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,21703590[PMID]_ORPHANET,0,0
Clinical group,Oblique facial cleft,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Joubert syndrome with hepatic defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,8,8
Disease,Joubert syndrome with hepatic defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Coats disease,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,20865031[PMID]_[EXPERT],0.09,0.09
Disease,Coats disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Cerebrofacial arteriovenous metameric syndrome type 3,,,,,,,,,,,,,
Disease,Benign hereditary chorea,,,,,,,,,,,,,
Malformation syndrome,Cerebrofacial arteriovenous metameric syndrome type 1,,,,,,,,,,,,,
Clinical group,Cerebrofacial arteriovenous metameric syndrome,,,,,,,,,,,,,
Disease,Greenberg dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14684697[PMID],10,10
Disease,Greenberg dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Rapidly involuting congenital hemangioma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Otospondylomegaepiphyseal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Otospondylomegaepiphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Xq21 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7258279[PMID]_2624260[PMID]_17935254[PMID],13,13
Malformation syndrome,Xq21 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7258279[PMID]_2624260[PMID]_17935254[PMID],0,0
Morphological anomaly,Nasal dorsum fistula,,,,,,,,,,,,,
Malformation syndrome,X-linked skeletal dysplasia-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,837562[PMID],4,4
Malformation syndrome,X-linked skeletal dysplasia-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_837562[PMID],0,0
Malformation syndrome,Isolated congenital syngnathia,,,,,,,,,,,,,
Malformation syndrome,Diffuse lymphatic malformation,,,,,,,,,,,,,
Malformation syndrome,Choroidal atrophy-alopecia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10994447[PMID],2,2
Malformation syndrome,Choroidal atrophy-alopecia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10994447[PMID],0,0
Category,Rare head and neck malformation,,,,,,,,,,,,,
Malformation syndrome,Contractures-ectodermal dysplasia-cleft lip/palate syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7504881[PMID],2,2
Malformation syndrome,Contractures-ectodermal dysplasia-cleft lip/palate syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7504881[PMID],0,0
Category,Cysts and fistulae of the face and oral cavity,,,,,,,,,,,,,
Disease,Biemond syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9098485[PMID],0,0
Category,Particular clinical situation or non rare disorder with an orphan designation,,,,,,,,,,,,,
Morphological anomaly,Submucosal cleft palate,,,,,,,,,,,,,
Malformation syndrome,Corneal dystrophy-perceptive deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18922146[PMID],24,24
Malformation syndrome,Corneal dystrophy-perceptive deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18922146[PMID],0,0
Malformation syndrome,Cooks syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22329539[PMID],12,12
Malformation syndrome,Cooks syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22329539[PMID],0,0
Morphological anomaly,Pinnae fistula or cyst,,,,,,,,,,,,,
Clinical group,Paramedian facial cleft,,,,,,,,,,,,,
Malformation syndrome,Lethal congenital contracture syndrome type 1,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,16892327[PMID],3.96,3.96
Morphological anomaly,Tessier number 7 facial cleft,,,,,,,,,,,,,
Morphological anomaly,Tessier number 6 facial cleft,,,,,,,,,,,,,
Clinical subtype,COFS syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Clinical subtype,COFS syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Lateral facial cleft,,,,,,,,,,,,,
Malformation syndrome,Orofaciodigital syndrome type 12,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9546832[PMID]_17963220[PMID],1,1
Malformation syndrome,Orofaciodigital syndrome type 12,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9546832[PMID],0,0
Malformation syndrome,Orofaciodigital syndrome type 13,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10683749[PMID]_17963220[PMID],1,1
Malformation syndrome,Orofaciodigital syndrome type 13,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10683749[PMID],0,0
Malformation syndrome,Coloboma of macula-brachydactyly type B syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3385739[PMID]_12919145[PMID],10,10
Malformation syndrome,Coloboma of macula-brachydactyly type B syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3385739[PMID]_12919145[PMID],0,0
Morphological anomaly,Midline cervical cleft,,,,,,,,,,,,,
Morphological anomaly,Cleft lip and alveolus,6-9 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Polyrrhinia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Hair defect-photosensitivity-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,501478[PMID],3,3
Malformation syndrome,Hair defect-photosensitivity-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_501478[PMID],0,0
Morphological anomaly,Nasolacrimal duct cyst,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,21035068[PMID],25.7,25.7
Morphological anomaly,Nasolacrimal duct cyst,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Uncombable hair syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Proboscis lateralis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Supernumerary nostril,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23348320[PMID],32,32
Malformation syndrome,Supernumerary nostril,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23348320[PMID],0,0
Malformation syndrome,Tarsal-carpal coalition syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Malformation syndrome,Tarsal-carpal coalition syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Nasopharyngeal teratoma,,,,,,,,,,,,,
Morphological anomaly,Nasal dermoid cyst,,,,,,,,,,,,,
Clinical subtype,Nasal ganglioglioma,,,,,,,,,,,,,
Disease,Familial calcium pyrophosphate deposition,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Disease,Familial calcium pyrophosphate deposition,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Nasal glial heterotopia,,,,,,,,,,,,,
Malformation syndrome,Cerebrofaciothoracic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24194475[PMID],20,20
Malformation syndrome,Cerebrofaciothoracic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24194475[PMID],0,0
Morphological anomaly,Facial dermoid cyst,,,,,,,,,,,,,
Morphological anomaly,Lower lip fistula,,,,,,,,,,,,,
Morphological anomaly,Commissural lip fistula,,,,,,,,,,,,,
Morphological anomaly,Digestive duplication cyst of the tongue,,,,,,,,,,,,,
Malformation syndrome,Hydrocephaly-cerebellar agenesis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_657584[PMID],0,0
Malformation syndrome,Hydrocephaly-cerebellar agenesis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,657584[PMID],2,2
Morphological anomaly,Cervicofacial fibrochondroma,,,,,,,,,,,,,
Morphological anomaly,Isolated cerebellar agenesis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Richards-Rundle syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Epignathus,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_21701667[PMID],1.68,1.68
Malformation syndrome,CHAND syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28940926[PMID],0,0
Morphological anomaly,External auditory canal aplasia/hypoplasia,,,,,,,,,,,,,
Morphological anomaly,Isolated congenital hypoglossia/aglossia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Metaphyseal chondrodysplasia, Schmid type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Glossopalatine ankylosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Glossopalatine ankylosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Frontonasal arteriovenous malformation,,,,,,,,,,,,,
Malformation syndrome,Maxillary arteriovenous malformation,,,,,,,,,,,,,
Malformation syndrome,Desbuquois syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16642505[PMID]_[EXPERT],50,50
Malformation syndrome,Desbuquois syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Mandibular arteriovenous malformation,,,,,,,,,,,,,
Disease,Non-involuting congenital hemangioma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Nasal encephalocele,,,,,,,,,,,,,
Malformation syndrome,Congenital subglottic stenosis,,,,,,,,,,,,,
Morphological anomaly,Congenital laryngeal cyst,,,,,,,,,,,,,
Morphological anomaly,Congenital tracheal stenosis,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,17712567[PMID],1.6,1.6
Clinical group,Oculo-auriculo-vertebral spectrum,,,,,,,,,,,,,
Malformation syndrome,Otomandibular syndrome,,,,,,,,,,,,,
Malformation syndrome,Hemifacial hyperplasia,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,ISBN-10:0867153903[OTHER]_28163490[PMID],1.16,1.16
Malformation syndrome,Hemifacial myohyperplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20583183[PMID],12,12
Malformation syndrome,Hemifacial myohyperplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20583183[PMID],0,0
Disease,"Spondyloepimetaphyseal dysplasia, matrilin-3 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15121775[PMID],5,5
Disease,"Spondyloepimetaphyseal dysplasia, matrilin-3 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15121775[PMID],0,0
Malformation syndrome,Cataract-hypertrichosis-intellectual disability syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary hyperferritinemia-cataract syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,64,64
Disease,Hereditary hyperferritinemia-cataract syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic endocrine growth disease,,,,,,,,,,,,,
Category,Rare genetic endocrine disease,,,,,,,,,,,,,
Category,Rare genetic cause of hypertension,,,,,,,,,,,,,
Malformation syndrome,Cataract-aberrant oral frenula-growth delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1951441[PMID],3,3
Malformation syndrome,Cataract-aberrant oral frenula-growth delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1951441[PMID],0,0
Category,Genetic urogenital tract malformation,,,,,,,,,,,,,
Category,Rare genetic urogenital disease,,,,,,,,,,,,,
Disease,Cataract-ataxia-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1661780[PMID],2,2
Disease,Cataract-ataxia-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1661780[PMID],0,0
Category,Rare genetic respiratory disease,,,,,,,,,,,,,
Disease,Autosomal recessive palmoplantar keratoderma and congenital alopecia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,8,8
Disease,Autosomal recessive palmoplantar keratoderma and congenital alopecia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic biliary tract disease,,,,,,,,,,,,,
Category,Genetic parenchymatous liver disease,,,,,,,,,,,,,
Category,Rare genetic hepatic disease,,,,,,,,,,,,,
Category,Rare syndrome with cardiac malformations,,,,,,,,,,,,,
Category,Tracheal anomaly,,,,,,,,,,,,,
Biological anomaly,Carnosinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:0-7817-3063-5[OTHER],24,24
Biological anomaly,Carnosinase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Biological anomaly,Carnosinase deficiency,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,16722645[PMID],0.2,0.2
Malformation syndrome,Cerebrocostomandibular syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20507350[PMID],75,75
Malformation syndrome,Cerebrocostomandibular syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical syndrome,Klüver-Bucy syndrome,,,,,,,,,,,,,
Disease,Congenital epulis,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Congenital pseudoarthrosis of the limbs,,,,,,,,,,,,,
Malformation syndrome,Night blindness-skeletal anomalies-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,314984 [PMID],2,2
Malformation syndrome,Night blindness-skeletal anomalies-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_314984 [PMID],0,0
Disease,Cold-induced sweating syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,6,6
Disease,Cold-induced sweating syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Cortical blindness-intellectual disability-polydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4064363[PMID],3,3
Malformation syndrome,Cortical blindness-intellectual disability-polydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4064363[PMID],0,0
Disease,Hyperplastic polyposis syndrome,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,22851664[PMID]_21636642[PMID],1,1
Disease,Hyperplastic polyposis syndrome,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Catel-Manzke syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,33,33
Malformation syndrome,Catel-Manzke syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Mesoaxial synostotic syndactyly with phalangeal reduction,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25466284[PMID],6,6
Morphological anomaly,Mesoaxial synostotic syndactyly with phalangeal reduction,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Cataract-intellectual disability-hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23420520[PMID],20,20
Malformation syndrome,Cataract-intellectual disability-hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Epithelioid hemangioendothelioma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_25992243[PMID],0,0
Disease,Hereditary mixed polyposis syndrome,,,,,,,,,,,,,
Morphological anomaly,Situs ambiguus,,,,,,,,,,,,,
Clinical subtype,Late infantile CACH syndrome,,,,,,,,,,,,,
Malformation syndrome,Cataract-intellectual disability-anal atresia-urinary defects syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,541035[PMID],3,3
Malformation syndrome,Cataract-intellectual disability-anal atresia-urinary defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_541035[PMID],0,0
Clinical subtype,Juvenile or adult CACH syndrome,,,,,,,,,,,,,
Malformation syndrome,Cataract-nephropathy-encephalopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14065995[PMID],2,2
Malformation syndrome,Cataract-nephropathy-encephalopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14065995[PMID],0,0
Clinical subtype,Congenital or early infantile CACH syndrome,,,,,,,,,,,,,
Disease,"Dyssegmental dysplasia, Rolland-Desbuquois type",,,,,,,,,,,,,
Malformation syndrome,Cataract-microcornea syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,8,8
Malformation syndrome,Cataract-microcornea syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25406294[PMID],0,0
Disease,Hereditary hypophosphatemic rickets with hypercalciuria,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Camptodactyly-taurinuria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16178082[PMID],17,17
Malformation syndrome,Camptodactyly-taurinuria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16178082[PMID],0,0
Category,Isolated dystonia,,,,,,,,,,,,,
Malformation syndrome,"Camptodactyly syndrome, Guadalajara type 2",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4040823[PMID],2,2
Malformation syndrome,"Camptodactyly syndrome, Guadalajara type 2",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4040823[PMID],0,0
Category,Retinal ciliopathy,,,,,,,,,,,,,
Malformation syndrome,"Camptodactyly syndrome, Guadalajara type 1",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7192193[PMID]_7681735[PMID]_8116673[PMID]_12002144[PMID],8,8
Malformation syndrome,"Camptodactyly syndrome, Guadalajara type 1",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7192193[PMID]_7681735[PMID]_8116673[PMID]_12002144[PMID],0,0
Category,Nephropathy-associated ciliopathy,,,,,,,,,,,,,
Malformation syndrome,Camurati-Engelmann disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301335[PMID],300,300
Malformation syndrome,Camurati-Engelmann disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Predominantly small-vessel vasculitis,,,,,,,,,,,,,
Malformation syndrome,Camptodactyly-fibrous tissue hyperplasia-skeletal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5046631[PMID],3,3
Malformation syndrome,Camptodactyly-fibrous tissue hyperplasia-skeletal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5046631[PMID],0,0
Clinical group,Predominantly medium-vessel vasculitis,,,,,,,,,,,,,
Malformation syndrome,Camptodactyly-joint contractures-facial skeletal defects syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16688750[PMID],4,4
Malformation syndrome,Camptodactyly-joint contractures-facial skeletal defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16688750[PMID],0,0
Clinical group,Anti-neutrophil cytoplasmic antibody-associated vasculitis,1-5 / 10 000,Germany,409966,409966,25965,25965,en,Not yet validated,410294,410294,24425780[PMID],14.9,14.9
Clinical group,Anti-neutrophil cytoplasmic antibody-associated vasculitis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Anti-neutrophil cytoplasmic antibody-associated vasculitis,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,28881446[PMID],3.3,3.3
Clinical group,Anti-neutrophil cytoplasmic antibody-associated vasculitis,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,28881446[PMID],42.1,42.1
Category,Immune complex mediated vasculitis,,,,,,,,,,,,,
Disease,Symmetrical thalamic calcifications,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28063749[PMID],30,30
Disease,Symmetrical thalamic calcifications,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28063749[PMID],0,0
Clinical group,Primary early-onset glaucoma,,,,,,,,,,,,,
Clinical group,Predominantly large-vessel vasculitis,,,,,,,,,,,,,
Malformation syndrome,"Campomelia, Cumming type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15754354[PMID],8,8
Malformation syndrome,"Campomelia, Cumming type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15754354[PMID],0,0
Malformation syndrome,Camptobrachydactyly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5031984[PMID],1,1
Malformation syndrome,Camptobrachydactyly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5031984[PMID],0,0
Morphological anomaly,Coloboma of inferior eyelid,,,,,,,,,,,,,
Malformation syndrome,Feingold syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,123,123
Malformation syndrome,Feingold syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal limb deficiencies-micrognathia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19584065[PMID],6,6
Malformation syndrome,Distal limb deficiencies-micrognathia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19584065[PMID],0,0
Morphological anomaly,Coloboma of superior eyelid,,,,,,,,,,,,,
Clinical group,Mandibulofacial dysostosis,,,,,,,,,,,,,
Category,Otomandibular dysplasia,,,,,,,,,,,,,
Disease,Infantile choroidocerebral calcification syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,315525[PMID]_8232964[PMID],10,10
Disease,Infantile choroidocerebral calcification syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_315525[PMID]_8232964[PMID],0,0
Category,Syndrome or malformation associated with head and neck malformations,,,,,,,,,,,,,
Malformation syndrome,Heart-hand syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1976459[PMID],2,2
Malformation syndrome,Heart-hand syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Pinnae and external auditory canal anomaly,,,,,,,,,,,,,
Category,Nose and cavum anomaly,,,,,,,,,,,,,
Malformation syndrome,Congenital heart defect-round face-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3225826[PMID],3,3
Malformation syndrome,Congenital heart defect-round face-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3225826[PMID],0,0
Malformation syndrome,Atrioventricular defect-blepharophimosis-radial and anal defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8031543[PMID],2,2
Malformation syndrome,Atrioventricular defect-blepharophimosis-radial and anal defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8031543[PMID],0,0
Category,Larynx anomaly,,,,,,,,,,,,,
Category,Hypoglossia/aglossia,,,,,,,,,,,,,
Malformation syndrome,Heart-hand syndrome type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7450756[PMID],3,3
Malformation syndrome,Heart-hand syndrome type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7450756[PMID],0,0
Category,Oromandibular-limb anomalies syndrome,,,,,,,,,,,,,
Category,Paralytic facial malformation,,,,,,,,,,,,,
Disease,Cardiomyopathy-cataract-hip spine disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3965265[PMID],9,9
Disease,Cardiomyopathy-cataract-hip spine disease syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3965265[PMID],0,0
Clinical group,Facial arteriovenous malformation,,,,,,,,,,,,,
Category,Retinal ciliopathy due to mutation in nephronophthisis gene,,,,,,,,,,,,,
Malformation syndrome,Heart defect-tongue hamartoma-polysyndactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25427950[PMID]_1516223[PMID]_8733055[PMID],4,4
Malformation syndrome,Heart defect-tongue hamartoma-polysyndactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25427950[PMID]_1516223[PMID]_8733055[PMID],0,0
Category,Retinal ciliopathy due to mutation in Bardet-Biedl gene,,,,,,,,,,,,,
Category,Otomandibular dysplasia associated with monogenic syndromes,,,,,,,,,,,,,
Malformation syndrome,Cardiofaciocutaneous syndrome,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,22495831[PMID],0.12,0.12
Malformation syndrome,Cardiofaciocutaneous syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22495831[PMID]_[EXPERT],300,300
Malformation syndrome,Cardiofaciocutaneous syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Macroglossia,,,,,,,,,,,,,
Category,Retinal ciliopathy due to mutation in the retinitis pigmentosa-1 gene,,,,,,,,,,,,,
Malformation syndrome,Persistent Müllerian duct syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Retinal ciliopathy due to mutation in the RPGR gene,,,,,,,,,,,,,
Category,Retinal ciliopathy due to mutation in the RPGRIP gene,,,,,,,,,,,,,
Disease,Hyperkeratosis-hyperpigmentation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,151611[PMID]_8448904[PMID],10,10
Disease,Hyperkeratosis-hyperpigmentation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_151611[PMID]_8448904[PMID],0,0
Category,Retinal ciliopathy due to mutation in Usher gene,,,,,,,,,,,,,
Malformation syndrome,Pentalogy of Cantrell,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.55,0.55
Malformation syndrome,Pentalogy of Cantrell,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pentalogy of Cantrell,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,25092102[PMID]_[EXPERT],0.67,0.67
Malformation syndrome,Arterial dissection-lentiginosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7838191[PMID],4,4
Malformation syndrome,Arterial dissection-lentiginosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7838191[PMID],0,0
Malformation syndrome,Fibular dimelia-diplopodia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,11,11
Malformation syndrome,Fibular dimelia-diplopodia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Caudal duplication,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Dyschondrosteosis-nephritis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,788812[PMID],1,1
Malformation syndrome,Dyschondrosteosis-nephritis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_788812[PMID],0,0
Category,Inherited cancer-predisposing syndrome,,,,,,,,,,,,,
Disease,Dysequilibrium syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22973972[PMID]_21885617[PMID]_19461874[PMID]_22892528[PMID],0,0
Disease,Dysequilibrium syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Dr Kym Boycott[EXPERT]_22973972[PMID]_21885617[PMID]_19461874[PMID]_22892528[PMID],51,51
Malformation syndrome,Temtamy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24798461[PMID],7,7
Malformation syndrome,Temtamy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24798461[PMID],0,0
Malformation syndrome,Thakker-Donnai syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1956065[PMID],2,2
Malformation syndrome,Thakker-Donnai syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1956065[PMID],0,0
Malformation syndrome,"45,X/46,XY mixed gonadal dysgenesis",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Acrofrontofacionasal dysostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22052670[PMID]_18553510[PMID]_2830788[PMID]_2986457[PMID],12,12
Malformation syndrome,Acrofrontofacionasal dysostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22052670[PMID]_18553510[PMID]_2830788[PMID]_2986457[PMID],0,0
Malformation syndrome,Dysosteosclerosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Hypomandibular faciocranial dysostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8135280[PMID],3,3
Malformation syndrome,Hypomandibular faciocranial dysostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8135280[PMID],0,0
Malformation syndrome,"Acrofacial dysostosis, Catania type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8826434[PMID],2,2
Malformation syndrome,"Acrofacial dysostosis, Catania type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8826434[PMID],0,0
Malformation syndrome,"Acrofacial dysostosis, Rodríguez type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18000904[PMID],13,13
Malformation syndrome,"Acrofacial dysostosis, Rodríguez type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18000904[PMID],0,0
Disease,Transcobalamin deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21312325[PMID],40,40
Disease,Transcobalamin deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hypomyelination with atrophy of basal ganglia and cerebellum,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,19,19
Disease,Hypomyelination with atrophy of basal ganglia and cerebellum,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Steroid dehydrogenase deficiency-dental anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8832133[PMID],1,1
Disease,Steroid dehydrogenase deficiency-dental anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8832133[PMID],0,0
Disease,Leukoencephalopathy with bilateral anterior temporal lobe cysts,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,29,29
Disease,Leukoencephalopathy with bilateral anterior temporal lobe cysts,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Progressive cavitating leukoencephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,19,19
Disease,Progressive cavitating leukoencephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Hypotrichosis with juvenile macular degeneration,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Malformation syndrome,Hypotrichosis with juvenile macular degeneration,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Alpers-Huttenlocher syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,19766516_Pr Robert NAVIAUX[EXPERT],0.7,0.7
Disease,Alpers-Huttenlocher syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.07,0.07
Malformation syndrome,Microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18179897[PMID],1,1
Malformation syndrome,Microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18179897[PMID],0,0
Disease,Autosomal recessive bestrophinopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21825197[PMID]_24337562[PMID],20,20
Disease,Autosomal recessive bestrophinopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Retinal degeneration-nanophthalmos-glaucoma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3827713[PMID],7,7
Malformation syndrome,Retinal degeneration-nanophthalmos-glaucoma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3827713[PMID],0,0
Malformation syndrome,SERKAL syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18179883[PMID],3,3
Malformation syndrome,SERKAL syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18179883[PMID],0,0
Malformation syndrome,Distal monosomy 15q,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22065603[PMID],30,30
Malformation syndrome,Distal monosomy 15q,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22065603[PMID],0,0
Malformation syndrome,Microphthalmia with brain and digit anomalies,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18252212[PMID],2,2
Malformation syndrome,Microphthalmia with brain and digit anomalies,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18252212[PMID],0,0
Malformation syndrome,17q11.2 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18183042[PMID],7,7
Malformation syndrome,17q11.2 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18183042[PMID],0,0
Malformation syndrome,2q24 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],23,23
Malformation syndrome,2q24 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,1p36 deletion syndrome,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,9326330[PMID],15,15
Malformation syndrome,1p36 deletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal recessive spastic paraplegia type 39,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24355708[PMID],2,2
Disease,Autosomal recessive spastic paraplegia type 39,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24355708[PMID],0,0
Malformation syndrome,Oculocerebrocutaneous syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,38,38
Malformation syndrome,Oculocerebrocutaneous syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive ataxia due to ubiquinone deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24164873[PMID],31,31
Disease,Autosomal recessive ataxia due to ubiquinone deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hemochromatosis type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Hemochromatosis type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dentin dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,African iron overload,,,,,,,,,,,,,
Disease,Charcot-Marie-Tooth disease type 4J,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21705420[PMID]_23489662[PMID]_24878229[PMID],18,18
Disease,Charcot-Marie-Tooth disease type 4J,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21705420[PMID]_23489662[PMID]_24878229[PMID],0,0
Disease,Neuropathy with hearing impairment,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11309368[PMID],1,1
Disease,Neuropathy with hearing impairment,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11309368[PMID],0,0
Malformation syndrome,"Dermatoosteolysis, Kirghizian type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6224420[PMID],5,5
Malformation syndrome,"Dermatoosteolysis, Kirghizian type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6224420[PMID],0,0
Disease,Distal hereditary motor neuropathy type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3789668[PMID]_7125978[PMID]_3789668[PMID]_1517763[PMID],0,0
Disease,Distal hereditary motor neuropathy type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3789668[PMID]_7125978[PMID]_3789668[PMID]_1517763[PMID],4,4
Disease,Absence of fingerprints-congenital milia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26932190[PMID],10,10
Disease,Absence of fingerprints-congenital milia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26932190[PMID],0,0
Disease,Distal hereditary motor neuropathy type 1,,,,,,,,,,,,,
Disease,Dermatoleukodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,655904[PMID],2,2
Disease,Dermatoleukodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_655904[PMID],0,0
Disease,Distal spinal muscular atrophy type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,512678[PMID]_12112104[PMID]_15054395[PMID],28,28
Disease,Distal spinal muscular atrophy type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_512678[PMID]_12112104[PMID]_15054395[PMID],0,0
Disease,Distal hereditary motor neuropathy type 5,,,,,,,,,,,,,
Malformation syndrome,Dermoodontodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6616948[PMID],11,11
Malformation syndrome,Dermoodontodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6616948[PMID],0,0
Disease,X-linked distal spinal muscular atrophy type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14985388[PMID]_19153371[PMID]_20170900[PMID],2,2
Disease,X-linked distal spinal muscular atrophy type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14985388[PMID]_19153371[PMID]_20170900[PMID],0,0
Disease,X-linked corneal dermoid,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11594343[PMID],6,6
Disease,X-linked corneal dermoid,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11594343[PMID],0,0
Disease,Restrictive dermopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Restrictive dermopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Distal hereditary motor neuropathy, Jerash type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11117544[PMID]_26078401[PMID],30,30
Disease,"Distal hereditary motor neuropathy, Jerash type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11117544[PMID]_26078401[PMID],0,0
Disease,Hereditary sensory and autonomic neuropathy with deafness and global delay,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12160974[PMID],4,4
Disease,Hereditary sensory and autonomic neuropathy with deafness and global delay,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12160974[PMID],0,0
Malformation syndrome,Sporadic fetal brain disruption sequence,,,,,,,,,,,,,
Disease,Hereditary sensory and autonomic neuropathy type 1B,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12870133[PMID],2,2
Disease,Hereditary sensory and autonomic neuropathy type 1B,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12870133[PMID],0,0
Disease,X-linked hereditary sensory and autonomic neuropathy with deafness,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25986071[PMID],5,5
Disease,X-linked hereditary sensory and autonomic neuropathy with deafness,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25986071,0,0
Disease,Wolcott-Rallison syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21050479[PMID],60,60
Disease,Wolcott-Rallison syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mutilating hereditary sensory neuropathy with spastic paraplegia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,218673[PMID]_7922454[PMID]_16333315[PMID],14,14
Disease,Mutilating hereditary sensory neuropathy with spastic paraplegia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16333315[PMID],0,0
Disease,Distal hereditary motor neuropathy type 7,,,,,,,,,,,,,
Morphological anomaly,Diastematomyelia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22371545[PMID],0,0
Malformation syndrome,Stapes ankylosis with broad thumbs and toes,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,6,6
Malformation syndrome,Stapes ankylosis with broad thumbs and toes,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Cryptorchidism-arachnodactyly-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4394203[PMID],3,3
Malformation syndrome,Cryptorchidism-arachnodactyly-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4394203[PMID],0,0
Malformation syndrome,Cryptomicrotia-brachydactyly-excess fingertip arch syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3400730[PMID],2,2
Malformation syndrome,Cryptomicrotia-brachydactyly-excess fingertip arch syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3400730[PMID],0,0
Disease,Titin-related  limb-girdle muscular dystrophy R10,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1745277[PMID]_1487757[PMID],1,1
Disease,Titin-related  limb-girdle muscular dystrophy R10,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1745277[PMID]_1487757[PMID],0,0
Malformation syndrome,Crisponi syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Crisponi syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hyperlipidemia due to hepatic triacylglycerol lipase deficiency,,,,,,,,,,,,,
Malformation syndrome,Jackson-Weiss syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Jackson-Weiss syndrome,,Worldwide,409970,409970,25965,25965,en,Not yet validated,410294,410294,ORPHANET,200,200
Clinical subtype,Brachydactyly type B2,,,,,,,,,,,,,
Malformation syndrome,Craniosynostosis-fibular aplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4403018[PMID],2,2
Malformation syndrome,Craniosynostosis-fibular aplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4403018[PMID],0,0
Category,Joubert syndrome and related disorders,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,18054307[PMID]_17377524[PMID]_20301500[PMID]_20615230[PMID]_[EXPERT],1.1,1.1
Category,Joubert syndrome and related disorders,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20615230[PMID],1,1
Category,Joubert syndrome and related disorders,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,18054307[PMID],1,1
Category,Joubert syndrome and related disorders,>1 / 1000,North America,409966,409966,25958,25958,en,Validated,410293,410293,22152675[PMID],666.67,666.67
Category,Joubert syndrome and related disorders,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute respiratory coronavirus infection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute respiratory coronavirus infection,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011[INST],0,0
Malformation syndrome,Gómez-López-Hernández syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28357184[PMID],36,36
Malformation syndrome,Gómez-López-Hernández syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28357184[PMID],0,0
Malformation syndrome,Syndactyly-telecanthus-anogenital and renal malformations syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18297069[PMID],6,6
Malformation syndrome,Syndactyly-telecanthus-anogenital and renal malformations syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18297069[PMID],0,0
Disease,Autosomal dominant macrothrombocytopenia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18065693[PMID]_18849486[PMID]_24069336[PMID],100,100
Disease,Autosomal dominant macrothrombocytopenia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,CLOVES syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,31334068[PMID],150,150
Malformation syndrome,CLOVES syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_31334068[PMID],0,0
Particular clinical situation in a disease or syndrome,Low-flow priapism,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2010[INST],0,0
Malformation syndrome,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19610084[PMID],12,12
Malformation syndrome,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19610084[PMID],0,0
Malformation syndrome,Lelis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1628512[PMID]_12457412[PMID]_18627052[PMID],9,9
Malformation syndrome,Lelis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1628512[PMID]_12457412[PMID]_18627052[PMID],0,0
Disease,Short stature due to primary acid-labile subunit deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Curry-Jones syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18798318[PMID],9,9
Malformation syndrome,Curry-Jones syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Benign familial neonatal-infantile seizures,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15048894[PMID],10,10
Disease,Benign familial neonatal-infantile seizures,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15048894[PMID],0,0
Disease,Linear atrophoderma of Moulin,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Linear atrophoderma of Moulin,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary angiitis of the central nervous system,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,21601163[PMID]_21180634[PMID]_22575778[PMID],0.24,0.24
Disease,Primary angiitis of the central nervous system,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Dandy-Walker malformation-postaxial polydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23324646[PMID],5,5
Malformation syndrome,Dandy-Walker malformation-postaxial polydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23324646[PMID],0,0
Disease,RHYNS syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9375913[PMID],4,4
Disease,RHYNS syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9375913[PMID],0,0
Malformation syndrome,Dahlberg-Borer-Newcomer syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6638075[PMID],2,2
Malformation syndrome,Dahlberg-Borer-Newcomer syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6638075[PMID,0,0
Disease,Saldino-Mainzer syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22503633[PMID]_23418020[PMID]_28724397[PMID],13,13
Disease,Saldino-Mainzer syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22503633[PMID]_23418020[PMID]_28724397[PMID],0,0
Disease,"Palmoplantar keratoderma, Nagashima type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27666198[PMID],40,40
Disease,"Palmoplantar keratoderma, Nagashima type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27666198[PMID],0,0
Malformation syndrome,Dacryocystitis-osteopoikilosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8261652[PMID],5,5
Malformation syndrome,Dacryocystitis-osteopoikilosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8261652[PMID],0,0
Malformation syndrome,Bilateral microtia-deafness-cleft palate syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23775976[PMID]_27503514[PMID],3,3
Malformation syndrome,Bilateral microtia-deafness-cleft palate syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23775976[PMID]_27503514[PMID],0,0
Morphological anomaly,Cervical dermoid cyst,,,,,,,,,,,,,
Disease,Guanidinoacetate methyltransferase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301745[PMID],80,80
Disease,Guanidinoacetate methyltransferase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Prolidase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26110198[PMID],90,90
Disease,Prolidase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,Dr Heng Wang[EXPERT]_ORPHANET,0,0
Disease,Prolidase deficiency,<1 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:978-2-550-55181-2[OTHER],0.08,0.08
Morphological anomaly,Fourth branchial cleft anomaly,,,,,,,,,,,,,
Morphological anomaly,Third branchial cleft anomaly,,,,,,,,,,,,,
Morphological anomaly,Second branchial cleft anomaly,,,,,,,,,,,,,
Disease,Lipodystrophy due to peptidic growth factors deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2477323[PMID],1,1
Disease,Lipodystrophy due to peptidic growth factors deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2477323[PMID],0,0
Morphological anomaly,First branchial cleft anomaly,,,,,,,,,,,,,
Malformation syndrome,Knobloch syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Orofaciodigital syndrome type 9,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Malformation syndrome,Orofaciodigital syndrome type 9,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial benign copper deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2978614[PMID],1,1
Disease,Familial benign copper deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2978614[PMID],0,0
Malformation syndrome,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23756445[PMID]_23756445[PMID],10,10
Malformation syndrome,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Orofaciodigital syndrome type 11,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Orofaciodigital syndrome,,,,,,,,,,,,,
Clinical subtype,X-linked complicated corpus callosum dysgenesis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,11,11
Clinical subtype,X-linked complicated corpus callosum dysgenesis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary intraosseous venous malformation,,,,,,,,,,,,,
Category,Autosomal dominant hereditary demyelinating motor and sensory neuropathy,,,,,,,,,,,,,
Malformation syndrome,Vici syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26917586[PMID],50,50
Malformation syndrome,Vici syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26917586[PMID],0,0
Disease,Secondary hypoparathyroidism due to impaired parathormon secretion,,,,,,,,,,,,,
Malformation syndrome,Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3400727[PMID],3,3
Malformation syndrome,Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3400727[PMID],0,0
Category,Autosomal recessive distal hereditary motor neuropathy,,,,,,,,,,,,,
Disease,Coxopodopatellar syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11303519[PMID],47,47
Disease,Coxopodopatellar syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11303519[PMID],0,0
Clinical group,Hereditary sensory and autonomic neuropathy,,,,,,,,,,,,,
Malformation syndrome,Crane-Heise syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21094705[PMID],9,9
Malformation syndrome,Crane-Heise syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21094705[PMID],0,0
Category,Autosomal dominant hereditary sensory and autonomic neuropathy,,,,,,,,,,,,,
Category,Autosomal recessive hereditary sensory and autonomic neuropathy,,,,,,,,,,,,,
Malformation syndrome,Thin ribs-tubular bones-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2400886[PMID],2,2
Malformation syndrome,Thin ribs-tubular bones-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2400886[PMID],0,0
Category,Autosomal dominant hereditary axonal motor and sensory neuropathy,,,,,,,,,,,,,
Category,Autosomal recessive hereditary demyelinating motor and sensory neuropathy,,,,,,,,,,,,,
Malformation syndrome,Coxoauricular syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7282772[PMID],4,4
Malformation syndrome,Coxoauricular syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7282772[PMID],0,0
Category,Autosomal dominant distal hereditary motor neuropathy,,,,,,,,,,,,,
Clinical subtype,Autosomal recessive Robinow syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Clinical subtype,Autosomal recessive Robinow syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Hypertrichotic osteochondrodysplasia, Cantu type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28690487[PMID],50,50
Malformation syndrome,"Hypertrichotic osteochondrodysplasia, Cantu type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28690487[PMID],0,0
Malformation syndrome,"Hypertelorism, Teebi type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26111080[PMID],25,25
Malformation syndrome,"Hypertelorism, Teebi type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26111080[PMID],0,0
Malformation syndrome,Craniofrontonasal dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Craniodiaphyseal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21221996[PMID],20,20
Malformation syndrome,Craniodiaphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Craniodigital-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17715284[PMID],5,5
Malformation syndrome,Craniodigital-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17715284[PMID],0,0
Disease,Autosomal dominant slowed nerve conduction velocity,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9678704[PMID],1,1
Disease,Autosomal dominant slowed nerve conduction velocity,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9678704[PMID],0,0
Malformation syndrome,Cranioectodermal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24027799[PMID],60,60
Malformation syndrome,Cranioectodermal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24027799[PMID],0,0
Malformation syndrome,Craniofacial dyssynostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15723305[PMID],14,14
Malformation syndrome,Craniofacial dyssynostosis,<1 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Craniofacial dyssynostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Craniofacial dyssynostosis,<1 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,15551327[PMID]_[EXPERT],0.05,0.05
Malformation syndrome,"Craniosynostosis, Philadelphia type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8882401[PMID],1,1
Malformation syndrome,"Craniosynostosis, Philadelphia type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8882401[PMID],0,0
Category,Neuro-ophthalmological disease,,,,,,,,,,,,,
Malformation syndrome,Craniotelencephalic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6859106[PMID],4,4
Malformation syndrome,Craniotelencephalic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6859106[PMID],0,0
Malformation syndrome,Craniofacial-deafness-hand syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14556253[PMID],3,3
Malformation syndrome,Craniofacial-deafness-hand syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14556253[PMID],0,0
Malformation syndrome,Craniofrontonasal dysplasia-Poland anomaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2225532[PMID],2,2
Malformation syndrome,Craniofrontonasal dysplasia-Poland anomaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2225532[PMID],0,0
Malformation syndrome,Craniometaphyseal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:781730635[OTHER],160,160
Malformation syndrome,Craniometaphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:0781730635[OTHER],0,0
Malformation syndrome,Cranio-osteoarthropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Cranio-osteoarthropathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Facial dysmorphism-anorexia-cachexia-eye and skin anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6438152[PMID],3,3
Malformation syndrome,Facial dysmorphism-anorexia-cachexia-eye and skin anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6438152[PMID],0,0
Malformation syndrome,Flat face-microstomia-ear anomaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2929657[PMID],2,2
Malformation syndrome,Flat face-microstomia-ear anomaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2929657[PMID],0,0
Malformation syndrome,Facial dysmorphism-macrocephaly-myopia-Dandy-Walker malformation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2591071[PMID],3,3
Malformation syndrome,Facial dysmorphism-macrocephaly-myopia-Dandy-Walker malformation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2591071[PMID],0,0
Malformation syndrome,Faciocardiorenal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,880742[PMID]_1887846[PMID],4,4
Malformation syndrome,Faciocardiorenal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_880742[PMID]_1887846[PMID],0,0
Malformation syndrome,Lethal faciocardiomelic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1218241[PMID],3,3
Malformation syndrome,Lethal faciocardiomelic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1218241[PMID],0,0
Malformation syndrome,Autosomal recessive faciodigitogenital syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3398008[PMID]_1770541[PMID]_20607856[PMID],26,26
Malformation syndrome,Autosomal recessive faciodigitogenital syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3398008[PMID]_1770541[PMID]_20607856[PMID],0,0
Malformation syndrome,Exostoses-anetodermia-brachydactyly type E syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6334993[PMID],1,1
Malformation syndrome,Exostoses-anetodermia-brachydactyly type E syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6334993[PMID],0,0
Malformation syndrome,Extrasystoles-short stature-hyperpigmentation-microcephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1218236[PMID],2,2
Malformation syndrome,Extrasystoles-short stature-hyperpigmentation-microcephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1218236[PMID],0,0
Malformation syndrome,Dysplasia epiphysealis hemimelica,1-9 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,13295331[PMID]_29252895[PMID],0.1,0.1
Disease,Lowry-Wood syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12605445[PMID]_19288552[PMID],8,8
Disease,Lowry-Wood syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12605445[PMID]_19288552[PMID],0,0
Malformation syndrome,Pacman dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12709756[PMID],4,4
Malformation syndrome,Pacman dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12709756[PMID],0,0
Disease,Congenital lethal erythroderma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1535034[PMID],17,17
Disease,Congenital lethal erythroderma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1535034[PMID],0,0
Disease,Spinocerebellar ataxia type 34,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_31105016[PMID]_31750392[PMID]_[EXPERT],0,0
Disease,Spinocerebellar ataxia type 34,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,31105016[PMID]_31750392[PMID]_[EXPERT],45,45
Malformation syndrome,Diabetic embryopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Maternal phenylketonuria,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Maternal phenylketonuria,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Malformation syndrome,Emery-Nelson syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5501704[PMID],2,2
Malformation syndrome,Emery-Nelson syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5501704[PMID],0,0
Malformation syndrome,Eng-Strom syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3812565[PMID],0,0
Malformation syndrome,Eng-Strom syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3812565[PMID],2,2
Malformation syndrome,Toluene embryopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Phenobarbital embryopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Fetal methylmercury syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,800,800
Malformation syndrome,Fetal methylmercury syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Methimazole embryofetopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Malformation syndrome,Methimazole embryofetopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Fetal hydantoin syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Fetal minoxidil syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Cocaine embryofetopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Fetal iodine syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Diethylstilbestrol syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fetal cytomegalovirus syndrome,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,40,40
Malformation syndrome,Vitamin K antagonist embryofetopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Fetal trimethadione syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,EEC syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:978-0-387-21753-6[OTHER],1.11,1.11
Malformation syndrome,EEC syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:978-0-387-21753-6[OTHER],0,0
Malformation syndrome,EEM syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15805154[PMID],7,7
Malformation syndrome,EEM syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Aminopterin/methotrexate embryofetopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,17,17
Malformation syndrome,Aminopterin/methotrexate embryofetopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Indomethacin embryofetopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Fetal valproate syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Asher Ornoy[PMID],0,0
Malformation syndrome,Fetal valproate syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,29753923[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2014[REG],1.02,1.02
Malformation syndrome,Fetal valproate syndrome,1-5 / 10 000,Reunion,409968,409968,25958,25958,en,Validated,410293,410293,29753923[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2014[REG],11.7,11.7
Malformation syndrome,Fetal valproate syndrome,1-9 / 1 000 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,29753923[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2014[REG],0.5,0.5
Malformation syndrome,Fetal valproate syndrome,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,29753923[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2014[REG],1.7,1.7
Malformation syndrome,Fetal valproate syndrome,1-9 / 100 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,29753923[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2014[REG],1.3,1.3
Malformation syndrome,Fetal valproate syndrome,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,29753923[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2014[REG],1.2,1.2
Malformation syndrome,Fetal valproate syndrome,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,29753923[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2014[REG],1.3,1.3
Malformation syndrome,Edinburgh malformation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2057251[PMID],2,2
Malformation syndrome,Edinburgh malformation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2057251[PMID],0,0
Malformation syndrome,Intellectual disability-spasticity-ectrodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8368260[PMID],3,3
Malformation syndrome,Intellectual disability-spasticity-ectrodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8368260[PMID],0,0
Malformation syndrome,Ectrodactyly-polydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7151304[PMID],1,1
Malformation syndrome,Ectrodactyly-polydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7151304[PMID],0,0
Malformation syndrome,Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,13867923[PMID],4,4
Malformation syndrome,Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_13867923[PMID],0,0
Clinical subtype,Focal facial dermal dysplasia type III,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Focal facial dermal dysplasia type III,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21931173[PMID],20,20
Malformation syndrome,"Ectodermal dysplasia, trichoodontoonychial type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3740884[PMID],7,7
Malformation syndrome,"Ectodermal dysplasia, trichoodontoonychial type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3740884[PMID],0,0
Malformation syndrome,Ectodermal dysplasia-sensorineural deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5422345[PMID],0,0
Malformation syndrome,Ectodermal dysplasia-sensorineural deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5422345[PMID],2,2
Malformation syndrome,Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7463217[PMID]_3944674[PMID],3,3
Malformation syndrome,Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7463217[PMID]_3944674[PMID],0,0
Disease,Congenital muscular dystrophy-infantile cataract-hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_13385309[PMID],0,0
Disease,Congenital muscular dystrophy-infantile cataract-hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,13385309[PMID],7,7
Malformation syndrome,Jalili syndrome,1-9 / 100 000,"Palestinian Territory, occupied",409966,409966,25958,25958,en,Validated,410293,410293,20706282[PMID],8.3,8.3
Malformation syndrome,Jalili syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23362848[PMID]_20706282[PMID]_21728811[PMID]_[EXPERT],49,49
Malformation syndrome,Jalili syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Melorheostosis with osteopoikilosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Malformation syndrome,Melorheostosis with osteopoikilosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Hereditary bullous dystrophy, macular type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7943046[PMID],2,2
Disease,"Hereditary bullous dystrophy, macular type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7943046[PMID],0,0
Disease,Cone rod dystrophy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2.5,2.5
Disease,Progressive cone dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Thanatophoric dysplasia type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Thoracic dysplasia-hydrocephalus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3295244[PMID],2,2
Malformation syndrome,Thoracic dysplasia-hydrocephalus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3295244[PMID],0,0
Disease,"Dyssegmental dysplasia, Silverman-Handmaker type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20542149[PMID],0,0
Malformation syndrome,Skeletal dysplasia-epilepsy-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9916849[PMID]_1488978[PMID]_8882779[PMID],7,7
Malformation syndrome,Skeletal dysplasia-epilepsy-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9916849[PMID]_1488978[PMID]_8882779[PMID],0,0
Clinical group,Spondylometaphyseal dysplasia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,1,1
Clinical group,Spondylometaphyseal dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,X-linked retinal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7333018[PMID],8,8
Disease,X-linked retinal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7333018[PMID],0,0
Malformation syndrome,"Bone dysplasia, lethal Holmgren type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3396596[PMID],7,7
Malformation syndrome,"Bone dysplasia, lethal Holmgren type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3396596[PMID],0,0
Malformation syndrome,Hereditary mucoepithelial dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ulna metaphyseal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3732330[PMID],3,3
Disease,Ulna metaphyseal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3732330[PMID],0,0
Malformation syndrome,"Mesomelic dysplasia, Kantaputra type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15211647[PMID]_15264287[PMID]_1481840[PMID]_20577005[PMID]_21654727[PMID],5,5
Malformation syndrome,"Mesomelic dysplasia, Kantaputra type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15211647[PMID]_15264287[PMID]_1481840[PMID]_20577005[PMID]_21654727[PMID],0,0
Malformation syndrome,Axial mesodermal dysplasia spectrum,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7243441[PMID]_26949683[PMID],0,0
Disease,Schimke immuno-osseous dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22888040[PMID]_22998683[PMID],71,71
Disease,Schimke immuno-osseous dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Epiphyseal dysplasia-hearing loss-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1642273[PMID],2,2
Malformation syndrome,Epiphyseal dysplasia-hearing loss-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1642273[PMID],0,0
Clinical group,Multiple epiphyseal dysplasia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Malformation syndrome,Odontomicronychial dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8728698[PMID],5,5
Malformation syndrome,Odontomicronychial dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8728698[PMID],0,0
Malformation syndrome,Ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"Hidrotic ectodermal dysplasia, Christianson-Fourie type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8826433[PMID],6,6
Malformation syndrome,"Hidrotic ectodermal dysplasia, Christianson-Fourie type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8826433[PMID],0,0
Malformation syndrome,"Hidrotic ectodermal dysplasia, Halal type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2063897[PMID],4,4
Malformation syndrome,"Hidrotic ectodermal dysplasia, Halal type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Ectodermal dysplasia-blindness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1583659[PMID],2,2
Malformation syndrome,Ectodermal dysplasia-blindness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1583659[PMID],0,0
Malformation syndrome,Ghosal hematodiaphyseal dysplasia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Thoracomelic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3184141[PMID],2,2
Disease,Thoracomelic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3184141[PMID],0,0
Malformation syndrome,Kyphomelic dysplasia,,,,,,,,,,,,,
Malformation syndrome,"Dysostosis, Stanescu type",<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical syndrome,Familial developmental dysphasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8031532[PMID],6,6
Clinical syndrome,Familial developmental dysphasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8031532[PMID],0,0
Malformation syndrome,Oculomaxillofacial dysostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7856656[PMID],4,4
Malformation syndrome,Oculomaxillofacial dysostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7856656[PMID],0,0
Morphological anomaly,Isolated hemihyperplasia,,,,,,,,,,,,,
Clinical group,Hemimelia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,4.15,4.15
Malformation syndrome,Hennekam syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Malformation syndrome,Hennekam syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"46,XX ovotesticular disorder of sex development",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_23926413[PMID],500,500
Malformation syndrome,"46,XX ovotesticular disorder of sex development",1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2.5,2.5
Malformation syndrome,"46,XX ovotesticular disorder of sex development",1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,Hernández-Aguirre Negrete syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Diaphragmatic defect-limb deficiency-skull defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8779324[PMID]_19318925[PMID]_23448910[PMID],7,7
Malformation syndrome,Diaphragmatic defect-limb deficiency-skull defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8779324[PMID]_19318925[PMID]_23448910[PMID],0,0
Malformation syndrome,Donnai-Barrow syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Malformation syndrome,Donnai-Barrow syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Craniosynostosis, Herrmann-Opitz type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3300335[PMID]_5783388[PMID],2,2
Malformation syndrome,"Craniosynostosis, Herrmann-Opitz type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3300335[PMID]_5783388[PMID],0,0
Morphological anomaly,Nodular neuronal heterotopia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lissencephaly type 1 due to doublecortin gene mutation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Hemophagocytic syndrome associated with an infection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Acquired hemophagocytic lymphohistiocytosis associated with malignant disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Hallermann-Streiff syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10388418[PMID],150,150
Malformation syndrome,Hallermann-Streiff syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10388418[PMID],0,0
Malformation syndrome,Hallermann-Streiff syndrome,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,2092586[PMID],3.6,3.6
Clinical syndrome,Macrophage activation syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Hall-Riggs syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11185076[PMID],8,8
Malformation syndrome,Hall-Riggs syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11185076[PMID],0,0
Malformation syndrome,Hallux varus-preaxial polysyndactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6255798[PMID],2,2
Malformation syndrome,Hallux varus-preaxial polysyndactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6255798[PMID],0,0
Malformation syndrome,Hallermann-Streiff-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8585575[PMID],2,2
Malformation syndrome,Hallermann-Streiff-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8585575[PMID],0,0
Disease,Cystic hamartoma of lung and kidney,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3605206[PMID],3,3
Disease,Cystic hamartoma of lung and kidney,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3605206[PMID],0,0
Category,Genetic dementia,,,,,,,,,,,,,
Clinical group,Huntington disease-like syndrome,,,,,,,,,,,,,
Malformation syndrome,Harrod syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8669446[PMID],3,3
Malformation syndrome,Harrod syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8669446[PMID],0,0
Category,Rare genetic hematologic disease,,,,,,,,,,,,,
Disease,"Hip dysplasia, Beukes type",<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Short stature-craniofacial anomalies-genital hypoplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10733241[PMID],3,3
Malformation syndrome,Short stature-craniofacial anomalies-genital hypoplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10733241[PMID],0,0
Malformation syndrome,Hartsfield syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23812909[PMID],17,17
Malformation syndrome,Hartsfield syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23812909[PMID],0,0
Malformation syndrome,HEC syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7747788[PMID],2,2
Malformation syndrome,HEC syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7747788[PMID],0,0
Malformation syndrome,Cavernous hemangiomas of face-supraumbilical midline raphe syndrome,,,,,,,,,,,,,
Malformation syndrome,Diffuse neonatal hemangiomatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,70,70
Malformation syndrome,Diffuse neonatal hemangiomatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Benign cephalic histiocytosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,GMS syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1308345[PMID],1,1
Malformation syndrome,GMS syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1308345[PMID],0,0
Disease,Generalized eruptive histiocytosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Multinodular goiter-cystic kidney-polydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4020555[PMID],3,3
Malformation syndrome,Multinodular goiter-cystic kidney-polydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4020555[PMID],0,0
Clinical group,Non-Langerhans cell histiocytosis,,,,,,,,,,,,,
Disease,Necrobiotic xanthogranuloma,,,,,,,,,,,,,
Disease,Papular xanthoma,,,,,,,,,,,,,
Malformation syndrome,Gordon syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Xanthoma disseminatum,,,,,,,,,,,,,
Malformation syndrome,Focal dermal hypoplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,300,300
Malformation syndrome,Focal dermal hypoplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Juvenile xanthogranuloma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,22969141[PMID],0.005,0.005
Malformation syndrome,"Acromesomelic dysplasia, Grebe type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary progressive mucinous histiocytosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28556021[PMID],18,18
Disease,Hereditary progressive mucinous histiocytosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28556021[PMID],0,0
Disease,Progressive nodular histiocytosis,,,,,,,,,,,,,
Malformation syndrome,Greig cephalopolysyndactyly syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_ 25297527[PMID]_[EXPERT],0,0
Malformation syndrome,Greig cephalopolysyndactyly syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,Gorlin-Chaudhry-Moss syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23686885[PMID],7,7
Malformation syndrome,Gorlin-Chaudhry-Moss syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Indeterminate cell histiocytosis,,,,,,,,,,,,,
Disease,Rosaï-Dorfman disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21816647[PMID],1000,1000
Disease,Rosaï-Dorfman disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Grant syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3742858[PMID],1,1
Malformation syndrome,Grant syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3742858[PMID],0,0
Category,Secondary hemophagocytic lymphohistiocytosis,,,,,,,,,,,,,
Malformation syndrome,Grubben-de Cock-Borghgraef syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1378778[PMID],3,3
Malformation syndrome,Grubben-de Cock-Borghgraef syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1378778[PMID],0,0
Clinical group,Primary hemophagocytic lymphohistiocytosis,,,,,,,,,,,,,
Malformation syndrome,Dysmorphism-pectus carinatum-joint laxity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7438507[PMID],2,2
Malformation syndrome,Dysmorphism-pectus carinatum-joint laxity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7438507[PMID],0,0
Category,Hemophagocytic syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sea-blue histiocytosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,60,60
Disease,Sea-blue histiocytosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Trigeminal autonomic cephalalgia,,,,,,,,,,,,,
Disease,Gastrocutaneous syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7065007[PMID],24,24
Disease,Gastrocutaneous syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7065007[PMID],0,0
Disease,Neuroferritinopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27022507[PMID],90,90
Disease,Neuroferritinopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27022507[PMID],0,0
Malformation syndrome,Craniorhiny,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1896543[PMID]_1897582[PMID],4,4
Malformation syndrome,Craniorhiny,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1896543[PMID]_1897582[PMID],0,0
Malformation syndrome,GAPO syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23602711[PMID]_16272061[PMID],38,38
Malformation syndrome,GAPO syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Paroxysmal hemicrania,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_29720814[PMID],0,0
Malformation syndrome,Galloway-Mowat syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28805828[PMID]_30079490[PMID]_30053862[PMID],97,97
Malformation syndrome,Galloway-Mowat syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30053862[PMID],0,0
Malformation syndrome,Genitopalatocardiac syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19283856[PMID],15,15
Malformation syndrome,Genitopalatocardiac syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19283856[PMID],0,0
Disease,Huntington disease-like 1,,,,,,,,,,,,,
Malformation syndrome,Gemignani syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3958822[PMID],2,2
Malformation syndrome,Gemignani syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3958822[PMID],0,0
Disease,Pantothenate kinase-associated neurodegeneration,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22027213[PMID]_[EXPERT]_ ORPHANET,0.15,0.15
Clinical subtype,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Clinical subtype,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,ANE syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18439547[PMID],5,5
Disease,ANE syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18439547[PMID],0,0
Malformation syndrome,"Oculoauricular syndrome, Schorderet type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18423520[PMID]_25574057[PMID],5,5
Malformation syndrome,"Oculoauricular syndrome, Schorderet type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18423520[PMID]_25574057[PMID],0,0
Disease,Huntington disease-like 3,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Geroderma osteodysplastica,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18304158[PMID],50,50
Malformation syndrome,Geroderma osteodysplastica,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Combined immunodeficiency with granulomatosis,,,,,,,,,,,,,
Malformation syndrome,German syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3812590[PMID],5,5
Malformation syndrome,German syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3812590[PMID],0,0
Disease,Congenital muscular dystrophy due to LMNA mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28125586[PMID],23,23
Disease,Congenital muscular dystrophy due to LMNA mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28125586[PMID],0,0
Disease,Glaucoma-sleep apnea syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7164003[PMID],5,5
Disease,Glaucoma-sleep apnea syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7164003[PMID],0,0
Malformation syndrome,Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1519650[PMID],3,3
Malformation syndrome,Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1519650[PMID],0,0
Clinical subtype,SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18513683[PMID]_18985159[PMID],8,8
Clinical subtype,SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18513683[PMID]_18985159[PMID],0,0
Malformation syndrome,Prominent glabella-microcephaly-hypogenitalism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2705483[PMID],2,2
Malformation syndrome,Prominent glabella-microcephaly-hypogenitalism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2705483[PMID],0,0
Malformation syndrome,Frontofacionasal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26495166[PMID],14,14
Malformation syndrome,Frontofacionasal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26495166[PMID],0,0
Disease,Frontometaphyseal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Frontometaphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Flynn-Aird syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5878601[PMID],10,10
Disease,Flynn-Aird syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5878601[PMID],0,0
Malformation syndrome,Foix-Chavany-Marie syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,150,150
Malformation syndrome,Foix-Chavany-Marie syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Cole-Carpenter syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25683117[PMID],3,3
Malformation syndrome,Cole-Carpenter syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25683117[PMID],0,0
Malformation syndrome,Splenogonadal fusion-limb defects-micrognathia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10494091[PMID]_12884431[PMID],30,30
Malformation syndrome,Splenogonadal fusion-limb defects-micrognathia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10494091[PMID]_12884431[PMID],0,0
Malformation syndrome,Posterior fusion of lumbosacral vertebrae-blepharoptosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5443339[PMID],3,3
Malformation syndrome,Posterior fusion of lumbosacral vertebrae-blepharoptosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5443339[PMID],0,0
Clinical group,Frontonasal dysplasia,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Frontonasal dysplasia,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.7,0.7
Malformation syndrome,Blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1311991[PMID],6,6
Malformation syndrome,Blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1311991[PMID],0,0
Malformation syndrome,Fryns syndrome,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,2650934[PMID],7,7
Malformation syndrome,Fryns syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Fryns syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,2650934[PMID],7,7
Malformation syndrome,Gingival fibromatosis-hypertrichosis syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Gingival fibromatosis-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1493643[PMID],2,2
Malformation syndrome,Gingival fibromatosis-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1493643[PMID],0,0
Clinical subtype,Juvenile hyaline fibromatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI: 10.1016/j.jdds.2014.06.003[OTHER],70,70
Clinical subtype,Juvenile hyaline fibromatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI: 10.1016/j.jdds.2014.06.003[OTHER],0,0
Malformation syndrome,Gingival fibromatosis-progressive deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4061496[PMID],2,2
Malformation syndrome,Gingival fibromatosis-progressive deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4061496[PMID],0,0
Disease,Fibrochondrogenesis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24127948[PMID],20,20
Disease,Fibrochondrogenesis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24127948[PMID],0,0
Malformation syndrome,Femur-fibula-ulna complex,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1.5,1.5
Malformation syndrome,Femur-fibula-ulna complex,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,Hereditary gingival fibromatosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,26818898[PMID],0,0
Disease,Endocardial fibroelastosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Paraplegia-intellectual disability-hyperkeratosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23613454[PMID],6,6
Malformation syndrome,Paraplegia-intellectual disability-hyperkeratosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,FLOTCH syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24816854[PMID],6,6
Disease,FLOTCH syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24816854[PMID],0,0
Malformation syndrome,Floating-Harbor syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30425916[PMID],0,0
Malformation syndrome,Hepatic fibrosis-renal cysts-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3085498[PMID]_4430157[PMID],4,4
Malformation syndrome,Hepatic fibrosis-renal cysts-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3085498[PMID]_4430157[PMID],0,0
Malformation syndrome,Scalp-ear-nipple syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Scalp-ear-nipple syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Plaque-form urticaria pigmentosa,,,,,,,,,,,,,
Morphological anomaly,Median cleft lip/mandibule,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,70,70
Morphological anomaly,Median cleft lip/mandibule,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Typical urticaria pigmentosa,,,,,,,,,,,,,
Malformation syndrome,Alar cartilages hypoplasia-coloboma-telecanthus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1273139[PMID],2,2
Malformation syndrome,Alar cartilages hypoplasia-coloboma-telecanthus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1273139[PMID],0,0
Malformation syndrome,Cleft lip/palate-deafness-sacral lipoma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2002486[PMID],2,2
Malformation syndrome,Cleft lip/palate-deafness-sacral lipoma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2002486[PMID],0,0
Disease,Lethal acantholytic epidermolysis bullosa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20613772[PMID]_20302578[PMID],4,4
Disease,Lethal acantholytic epidermolysis bullosa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20613772[PMID]_20302578[PMID],0,0
Disease,Epidermolysis bullosa simplex with pyloric atresia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Laryngotracheoesophageal cleft,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],7.5,7.5
Morphological anomaly,Laryngotracheoesophageal cleft,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Cleft lip/palate-intestinal malrotation-cardiopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8779326[PMID]_9415467[PMID],5,5
Malformation syndrome,Cleft lip/palate-intestinal malrotation-cardiopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8779326[PMID]_9415467[PMID],0,0
Disease,Epidermolysis bullosa simplex with circinate migratory erythema,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Dominant dystrophic epidermolysis bullosa, nails only",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Dominant dystrophic epidermolysis bullosa, nails only",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Acral dystrophic epidermolysis bullosa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Acral dystrophic epidermolysis bullosa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Epidermolysis bullosa simplex due to plakophilin deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Cleft palate-lateral synechia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19368978[PMID]_24163560[PMID],11,11
Malformation syndrome,Cleft palate-lateral synechia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Sternal cleft,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2,2
Morphological anomaly,Sternal cleft,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,Cleft palate-large ears-small head syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10449654[PMID],8,8
Malformation syndrome,Cleft palate-large ears-small head syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10449654[PMID],0,0
Malformation syndrome,Cleft palate-stapes fixation-oligodontia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5173249[PMID],2,2
Malformation syndrome,Cleft palate-stapes fixation-oligodontia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5173249[PMID],0,0
Disease,Isolated bone marrow mastocytosis,,,,,,,,,,,,,
Disease,Smoldering systemic mastocytosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Nodular urticaria pigmentosa,,,,,,,,,,,,,
Malformation syndrome,Acrocardiofacial syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20920258[PMID]_1746602[PMID]_15937946[PMID],10,10
Malformation syndrome,Acrocardiofacial syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20920258[PMID],0,0
Malformation syndrome,Femoral agenesis/hypoplasia,,,,,,,,,,,,,
Malformation syndrome,Gollop-Wolfgang complex,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],200,200
Malformation syndrome,Gollop-Wolfgang complex,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Bilateral striopallidodentate calcinosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9065541[PMID],200,200
Disease,Bilateral striopallidodentate calcinosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Suprabasal epidermolysis bullosa simplex,,,,,,,,,,,,,
Clinical group,Basal epidermolysis bullosa simplex,,,,,,,,,,,,,
Malformation syndrome,Blepharo-cheilo-odontic syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Malformation syndrome,Blepharo-cheilo-odontic syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Cleft lip-retinopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8905195[PMID],2,2
Malformation syndrome,Cleft lip-retinopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Pai syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30195458[PMID],67,67
Malformation syndrome,Pai syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30195458[PMID],0,0
Malformation syndrome,Femoral-facial syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25210574[PMID],62,62
Malformation syndrome,Femoral-facial syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25210574[PMID],0,0
Disease,"Familial partial lipodystrophy, Dunnigan type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Mayer-Rokitansky-Küster-Hauser syndrome type 1,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Kousseff syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22380655[PMID],8,8
Malformation syndrome,Kousseff syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22380655[PMID],0,0
Malformation syndrome,Müllerian aplasia and hyperandrogenism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Schilbach-Rott syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19921646[PMID],18,18
Malformation syndrome,Schilbach-Rott syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19921646[PMID],0,0
Disease,FTH1-related iron overload,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11389486[PMID],4,4
Disease,FTH1-related iron overload,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11389486[PMID],0,0
Clinical subtype,MUTYH-related attenuated familial adenomatous polyposis,,,,,,,,,,,,,
Disease,Juvenile cataract-microcornea-renal glucosuria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18304496[PMID],12,12
Disease,Juvenile cataract-microcornea-renal glucosuria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18304496[PMID],0,0
Disease,Autosomal recessive ataxia due to PEX10 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27230853[PMID],6,6
Disease,Autosomal recessive ataxia due to PEX10 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27230853[PMID],0,0
Clinical subtype,APC-related attenuated familial adenomatous polyposis,,,,,,,,,,,,,
Malformation syndrome,Lacrimoauriculodentodigital syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23010692[PMID]_Pr MANOUVRIER-HANU Sylvie[EXPERT],100,100
Malformation syndrome,Lacrimoauriculodentodigital syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23010692[PMID],0,0
Disease,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Keratosis follicularis spinulosa decalvans,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Odontohypophosphatasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Haim-Munk syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Haim-Munk syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Multiple endocrine neoplasia type 2B,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Multiple endocrine neoplasia type 2A,,,,,,,,,,,,,
Disease,Idiopathic eosinophilic myositis,,,,,,,,,,,,,
Disease,Inflammatory myopathy with abundant macrophages,,,,,,,,,,,,,
Category,X-linked cerebellar ataxia,,,,,,,,,,,,,
Disease,Kniest dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lipoblastoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Lethal Kniest-like dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6358440[PMID],2,2
Malformation syndrome,Lethal Kniest-like dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6358440[PMID],0,0
Disease,Citrullinemia type II,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Kenny-Caffey syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22522175[PMID],65,65
Malformation syndrome,Kenny-Caffey syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Neonatal intrahepatic cholestasis due to citrin deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,KBG syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21782149[PMID]_29565525[PMID],100,100
Malformation syndrome,KBG syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29565525[PMID],0,0
Disease,Juvenile primary lateral sclerosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,4,4
Disease,Juvenile primary lateral sclerosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Perinatal lethal hypophosphatasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Prenatal benign hypophosphatasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Isolated punctate palmoplantar keratoderma,,,,,,,,,,,,,
Disease,Non-epidermolytic palmoplantar keratoderma,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2.5,2.5
Clinical subtype,Infantile hypophosphatasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Childhood-onset hypophosphatasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Keratosis follicularis-dwarfism-cerebral atrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4834251[PMID],6,6
Malformation syndrome,Keratosis follicularis-dwarfism-cerebral atrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4834251[PMID],0,0
Clinical subtype,Adult hypophosphatasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Keratoderma hereditarium mutilans,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19282408[PMID],50,50
Disease,Keratoderma hereditarium mutilans,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19282408[PMID],0,0
Malformation syndrome,Kabuki syndrome,1-9 / 100 000,New Zealand,409968,409968,25958,25958,en,Validated,410293,410293,15108197[PMID],1.16,1.16
Malformation syndrome,Kabuki syndrome,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,15108197[PMID],1.16,1.16
Malformation syndrome,Kabuki syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_21882399[PMID],3.1,3.1
Malformation syndrome,Kabuki syndrome,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,3067577[PMID],3.1,3.1
Disease,Autosomal recessive secondary polycythemia not associated with VHL gene,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Jung syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7537583[PMID],2,2
Malformation syndrome,Jung syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7537583[PMID],0,0
Malformation syndrome,Osteopenia-intellectual disability-sparse hair syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1415349[PMID],2,2
Malformation syndrome,Osteopenia-intellectual disability-sparse hair syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1415349[PMID],0,0
Disease,Autosomal dominant secondary polycythemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Sanjad-Sakati syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary ciliary dyskinesia-retinitis pigmentosa syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Primary ciliary dyskinesia-retinitis pigmentosa syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Citrullinemia type I,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],2.4,2.4
Disease,Citrullinemia type I,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,20938748[PMID],1.28,1.28
Disease,Citrullinemia type I,1-9 / 100 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,15906713[PMID],4.5,4.5
Disease,Citrullinemia type I,1-9 / 1 000 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,20567911[PMID],0.84,0.84
Disease,Citrullinemia type I,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,ISBN:79130356[OTHER]_15906712[PMID]_ ORPHANET,1.13,1.13
Clinical subtype,Acute neonatal citrullinemia type I,,,,,,,,,,,,,
Malformation syndrome,Epidermolysis bullosa simplex with anodontia/hypodontia,,,,,,,,,,,,,
Clinical subtype,Adult-onset citrullinemia type I,,,,,,,,,,,,,
Malformation syndrome,Karsch-Neugebauer syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9450888[PMID]_23066244[PMID],11,11
Malformation syndrome,Karsch-Neugebauer syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9450888[PMID]_23066244[PMID],0,0
Category,Citrin deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Kapur-Toriello syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1776630[PMID]_10319207[PMID]_18831061[PMID]_20358618[PMID]_26049588[PMID],6,6
Malformation syndrome,Kapur-Toriello syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1776630[PMID]_10319207[PMID]_18831061[PMID]_20358618[PMID]_26049588[PMID],0,0
Category,Rare thrombotic disorder due to an acquired platelet anomaly,,,,,,,,,,,,,
Malformation syndrome,Lowe-Kohn-Cohen syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6627722[PMID],1,1
Malformation syndrome,Lowe-Kohn-Cohen syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6627722[PMID],0,0
Category,Rare thrombotic disorder due to a constitutional platelet anomaly,,,,,,,,,,,,,
Malformation syndrome,Lowry-MacLean syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9415481[PMID],3,3
Malformation syndrome,Lowry-MacLean syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9415481[PMID],0,0
Malformation syndrome,Thickened earlobes-conductive deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5657116[PMID]_5428055[PMID],2,2
Malformation syndrome,Thickened earlobes-conductive deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5657116[PMID]_5428055[PMID],0,0
Category,Rare thrombotic disorder due to a platelet anomaly,,,,,,,,,,,,,
Category,Rare thrombotic disorder due to an acquired coagulation factors defect,,,,,,,,,,,,,
Disease,LOC syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Disease,LOC syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic polycythemia,,,,,,,,,,,,,
Malformation syndrome,Dislocation of the hip-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8574416[PMID],4,4
Malformation syndrome,Dislocation of the hip-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8574416[PMID],0,0
Disease,Cystic fibrosis-gastritis-megaloblastic anemia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2029916[PMID],2,2
Disease,Cystic fibrosis-gastritis-megaloblastic anemia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2029916[PMID],0,0
Clinical subtype,Familial hypodysfibrinogenemia,,,,,,,,,,,,,
Malformation syndrome,Hypergonadotropic hypogonadism-cataract syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6418006[PMID],3,3
Malformation syndrome,Hypergonadotropic hypogonadism-cataract syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6418006[PMID],0,0
Category,Rare hemorrhagic disorder due to a platelet anomaly,,,,,,,,,,,,,
Malformation syndrome,Nasopalpebral lipoma-coloboma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Nasopalpebral lipoma-coloboma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare hemorrhagic disorder due to a coagulation factors defect,,,,,,,,,,,,,
Disease,Peripheral motor neuropathy-dysautonomia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7282784[PMID],2,2
Disease,Peripheral motor neuropathy-dysautonomia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7282784[PMID],0,0
Category,Rare hemorrhagic disorder,,,,,,,,,,,,,
Disease,Encephalocraniocutaneous lipomatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24881613[PMID],77,77
Disease,Encephalocraniocutaneous lipomatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare thrombotic disorder due to a constitutional coagulation factors defect,,,,,,,,,,,,,
Category,Rare thrombotic disorder due to a coagulation factors defect,,,,,,,,,,,,,
Category,Rare hemorrhagic disorder due to an acquired platelet anomaly,,,,,,,,,,,,,
Disease,Isolated delta-storage pool disease,,,,,,,,,,,,,
Disease,Choreoacanthocytosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Juvenile Huntington disease,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.04,0.04
Disease,Juvenile Huntington disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.6,0.6
Disease,Leukonychia totalis,,,,,,,,,,,,,
Disease,Leukoencephalopathy-palmoplantar keratoderma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7854535[PMID],4,4
Disease,Leukoencephalopathy-palmoplantar keratoderma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7854535[PMID],0,0
Clinical group,Primary hypertrophic osteoarthropathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Early-onset parkinsonism-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4025396[PMID]_25434005[PMID],2,2
Disease,Early-onset parkinsonism-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4025396[PMID]_25434005[PMID],0,0
Category,Rare acquired deficiency anemia,,,,,,,,,,,,,
Malformation syndrome,Congenitally short costocoracoid ligament,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2596500[PMID],1,1
Malformation syndrome,Congenitally short costocoracoid ligament,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2596500[PMID],0,0
Category,Rare deficiency anemia,,,,,,,,,,,,,
Disease,Lichtenstein syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Lichtenstein 1972[AUTHOR],2,2
Disease,Lichtenstein syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Constitutional deficiency anemia,,,,,,,,,,,,,
Disease,Occult macular dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Lethal Larsen-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19014058[PMID],8,8
Malformation syndrome,Lethal Larsen-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19014058[PMID],0,0
Etiological subtype,Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies,,,,,,,,,,,,,
Malformation syndrome,Limb body wall complex,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,12420845[PMID],3,3
Malformation syndrome,Limb body wall complex,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Limb body wall complex,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,8092190[PMID],2.5,2.5
Malformation syndrome,Ectodermal dysplasia-syndactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25529316[PMID],22,22
Malformation syndrome,Ectodermal dysplasia-syndactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25529316[PMID],0,0
Malformation syndrome,Ectodermal dysplasia-cutaneous syndactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19221800[PMID],4,4
Malformation syndrome,Ectodermal dysplasia-cutaneous syndactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19221800[PMID],0,0
Etiological subtype,Rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies,,,,,,,,,,,,,
Malformation syndrome,Laurin-Sandrow syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18792985[PMID],14,14
Malformation syndrome,Laurin-Sandrow syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18792985[PMID],0,0
Disease,NLRP12-associated hereditary periodic fever syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24131530[PMID],19,19
Disease,NLRP12-associated hereditary periodic fever syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24131530[PMID],0,0
Etiological subtype,Oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies,,,,,,,,,,,,,
Malformation syndrome,Laryngeal abductor paralysis-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Laryngeal abductor paralysis-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies,,,,,,,,,,,,,
Morphological anomaly,Familial supernumerary nipples,,,,,,,,,,,,,
Malformation syndrome,Mandibuloacral dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24123119[PMID],40,40
Malformation syndrome,Mandibuloacral dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24123119[PMID],0,0
Malformation syndrome,Mucocutaneous venous malformations,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Patterson-Stevenson-Fontaine syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9098499[PMID],7,7
Malformation syndrome,Patterson-Stevenson-Fontaine syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9098499[PMID],0,0
Disease,Dominant hypophosphatemia with nephrolithiasis or osteoporosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12324554[PMID]_18784102[PMID]_26787776[PMID]_29924459[PMID],12,12
Disease,Dominant hypophosphatemia with nephrolithiasis or osteoporosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29924459[PMID],0,0
Malformation syndrome,Biliary atresia with splenic malformation syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Isolated split hand-split foot malformation,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,8766141[PMID]_EUROCAT European surveillance of congenital anomalies[REG],5.4,5.4
Malformation syndrome,Isolated split hand-split foot malformation,1-5 / 10 000,China,409968,409968,25958,25958,en,Validated,410293,410293,20506663[PMID],16.4,16.4
Malformation syndrome,Isolated split hand-split foot malformation,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,20506663[PMID],5.1,5.1
Malformation syndrome,Isolated split hand-split foot malformation,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:9630566311[OTHER],6,6
Malformation syndrome,Isolated split hand-split foot malformation,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,11581472[PMID],6,6
Malformation syndrome,Isolated split hand-split foot malformation,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,RFT1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23111317[PMID],8,8
Disease,RFT1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23111317[PMID],0,0
Disease,HELLP syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Ollier disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,16995932[PMID],1,1
Malformation syndrome,Czeizel-Losonci syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3308683[PMID],3,3
Malformation syndrome,Czeizel-Losonci syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3308683[PMID],0,0
Particular clinical situation in a disease or syndrome,De novo thrombotic microangiopathy after kidney transplantation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Hand-foot-genital syndrome,,,,,,,,,,,,,
Disease,Dimethylglycine dehydrogenase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10102904[PMID],1,1
Disease,Dimethylglycine dehydrogenase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10102904[PMID],0,0
Disease,Acute fatty liver of pregnancy,,,,,,,,,,,,,
Disease,Hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,666331[PMID],14,14
Disease,Hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_666331[PMID],0,0
Malformation syndrome,Macrocephaly-spastic paraplegia-dysmorphism syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Macrosomia-microphthalmia-cleft palate syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2791331[PMID],5,5
Malformation syndrome,Macrosomia-microphthalmia-cleft palate syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2791331[PMID],0,0
Malformation syndrome,Upper limb defect-eye and ear abnormalities syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1518028[PMID],2,2
Malformation syndrome,Upper limb defect-eye and ear abnormalities syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1518028[PMID],0,0
Disease,Generalized pustular psoriasis,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,17229609[PMID],0.18,0.18
Disease,Generalized pustular psoriasis,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hyperphosphatasia-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,24,24
Disease,Hyperphosphatasia-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Lower limb malformation-hypospadias syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,592351[PMID],2,2
Malformation syndrome,Lower limb malformation-hypospadias syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_592351[PMID],0,0
Disease,Inhalational anthrax,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],0,0
Disease,Superficial siderosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20083040[PMID],300,300
Disease,Superficial siderosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Acquired ataxia,,,,,,,,,,,,,
Malformation syndrome,Melorheostosis,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,9040882[PMID],0.09,0.09
Category,Non-hereditary degenerative ataxia,,,,,,,,,,,,,
Disease,Sporadic adult-onset ataxia of unknown etiology,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,20083040[PMID],7.6,7.6
Disease,Sporadic adult-onset ataxia of unknown etiology,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,7793232[PMID],6.9,6.9
Disease,Sporadic adult-onset ataxia of unknown etiology,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,15258214[PMID],8.4,8.4
Malformation syndrome,Melkersson-Rosenthal syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Collecting duct carcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Malformation syndrome,Melnick-Needles syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,70,70
Malformation syndrome,Melnick-Needles syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Progressive cerebello-cerebral atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12920088[PMID]_25044680[PMID],7,7
Disease,Progressive cerebello-cerebral atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12920088[PMID]_25044680[PMID],0,0
Disease,Neurocutaneous melanocytosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.25,1.25
Malformation syndrome,Melhem-Fahl syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3969298[PMID],2,2
Malformation syndrome,Melhem-Fahl syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3969298[PMID],0,0
Disease,Infantile mercury poisoning,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Megalencephaly,,,,,,,,,,,,,
Malformation syndrome,Megalocornea-intellectual disability syndrome,,,,,,,,,,,,,
Malformation syndrome,White forelock with malformations,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7398117[PMID],0,0
Malformation syndrome,White forelock with malformations,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7398117[PMID],2,2
Malformation syndrome,Dysraphism-cleft lip/palate-limb reduction defects syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7981865[PMID],3,3
Malformation syndrome,Dysraphism-cleft lip/palate-limb reduction defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7981865[PMID],0,0
Malformation syndrome,McKusick-Kaufman syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301675[PMID],0,0
Malformation syndrome,McKusick-Kaufman syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301675[PMID],90,90
Malformation syndrome,McKusick-Kaufman syndrome,1-5 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,20301675[PMID],10,10
Malformation syndrome,McDonough syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6147215[PMID]_1189520[PMID],2,2
Malformation syndrome,McDonough syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6147215[PMID]_1189520[PMID],0,0
Malformation syndrome,Matthew-Wood syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26373900[PMID],43,43
Malformation syndrome,Matthew-Wood syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26373900[PMID],0,0
Malformation syndrome,Marshall-Smith syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,33,33
Malformation syndrome,Marshall-Smith syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Marfanoid syndrome, De Silva type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,13880014[PMID]_8976669[PMID],6,6
Malformation syndrome,"Marfanoid syndrome, De Silva type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_13880014[PMID]_8976669[PMID],0,0
Disease,Marinesco-Sjögren syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Marinesco-Sjögren syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Marfanoid habitus-autosomal recessive intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6705253[PMID],4,4
Malformation syndrome,Marfanoid habitus-autosomal recessive intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6705253[PMID],0,0
Malformation syndrome,Shprintzen-Goldberg syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301454[PMID],60,60
Malformation syndrome,Shprintzen-Goldberg syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301454[PMID],0,0
Malformation syndrome,Marden-Walker syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Malformation syndrome,Marden-Walker syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Marden-Walker syndrome,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2.5,2.5
Disease,Anaplastic oligodendroglioma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.09,0.09
Disease,Anaplastic oligodendroglioma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.11,0.11
Malformation syndrome,Microcephaly-glomerulonephritis-marfanoid habitus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1345513[PMID],2,2
Malformation syndrome,Microcephaly-glomerulonephritis-marfanoid habitus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1345513[PMID],0,0
Disease,Ependymoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.16,0.16
Disease,Ependymoma,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Subependymoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Clinical subtype,Infantile systemic hyalinosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25754064[PMID],0,0
Disease,Myxopapillary ependymoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Myxopapillary ependymoma,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Anaplastic ependymoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,23660944[PMID],0.04,0.04
Clinical group,Oligoastrocytic tumor,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.11,0.11
Clinical group,Oligoastrocytic tumor,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.19,0.19
Malformation syndrome,Hydrocephaly-tall stature-joint laxity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2918526[PMID],2,2
Malformation syndrome,Hydrocephaly-tall stature-joint laxity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2918526[PMID],0,0
Disease,Oligoastrocytoma,,,,,,,,,,,,,
Malformation syndrome,Hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8585573[PMID]_6893487[PMID],8,8
Malformation syndrome,Hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8585573[PMID]_6893487[PMID],0,0
Disease,Anaplastic oligoastrocytoma,,,,,,,,,,,,,
Malformation syndrome,Hydrocephalus-blue sclerae-nephropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,728573[PMID],1,1
Malformation syndrome,Hydrocephalus-blue sclerae-nephropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_728573[PMID],0,0
Clinical group,Glial tumor of neuroepithelial tissue with unknown origin,,,,,,,,,,,,,
Disease,Angiocentric glioma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24348765[PMID],52,52
Disease,Angiocentric glioma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24348765[PMID],0,0
Malformation syndrome,Hydrolethalus,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,11152149[PMID],5,5
Malformation syndrome,Hydrolethalus,<1 / 1 000 000,Finland,409966,409966,25965,25965,en,Not yet validated,410294,410294,11152149[PMID],0,0
Malformation syndrome,Hydrolethalus,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chordoid glioma,,,,,,,,,,,,,
Disease,Astroblastoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Autosomal dominant epidermolytic ichthyosis,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,22930352[PMID],0.29,0.29
Disease,Autosomal dominant epidermolytic ichthyosis,1-9 / 1 000 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,8053700[PMID]_7692917[PMID]_ ORPHANET,0.65,0.65
Disease,Autosomal dominant epidermolytic ichthyosis,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],72,72
Disease,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Embryonal tumor of neuroepithelial tissue,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.22,0.22
Histopathological subtype,Gliosarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.03,0.03
Clinical group,High-grade astrocytoma,,,,,,,,,,,,,
Malformation syndrome,Hirschsprung disease-type D brachydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6823428[PMID],4,4
Malformation syndrome,Hirschsprung disease-type D brachydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6823428[PMID],0,0
Disease,Gliomatosis cerebri,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Histopathological subtype,Giant cell glioblastoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Malformation syndrome,Mowat-Wilson syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Mowat-Wilson syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,21343952[PMID]_20301585[PMID]_ ISBN:470191414[OTHER],1.7,1.7
Malformation syndrome,Hirschsprung disease-nail hypoplasia-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3236354[PMID],3,3
Malformation syndrome,Hirschsprung disease-nail hypoplasia-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Low-grade astrocytoma,,,,,,,,,,,,,
Disease,Anaplastic astrocytoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.4,0.4
Histopathological subtype,Protoplasmic astrocytoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Malformation syndrome,Hirschsprung disease-deafness-polydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3351909[PMID],2,2
Malformation syndrome,Hirschsprung disease-deafness-polydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3351909[PMID],0,0
Disease,Diffuse astrocytoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.48,0.48
Histopathological subtype,Gemistocytic astrocytoma,,,,,,,,,,,,,
Histopathological subtype,Fibrillary astrocytoma,,,,,,,,,,,,,
Disease,Histidinuria-renal tubular defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1481808[PMID],5,5
Disease,Histidinuria-renal tubular defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1481808[PMID],0,0
Disease,Pilocytic astrocytoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.36,0.36
Malformation syndrome,Holoprosencephaly-craniosynostosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20104614[PMID],11,11
Malformation syndrome,Holoprosencephaly-craniosynostosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20104614[PMID],0,0
Disease,Pleomorphic xanthoastrocytoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Subependymal giant cell astrocytoma,,,,,,,,,,,,,
Malformation syndrome,Holoprosencephaly-caudal dysgenesis syndrome,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,7802035[PMID],0.9,0.9
Histopathological subtype,Pilomyxoid astrocytoma,,,,,,,,,,,,,
Malformation syndrome,Holoprosencephaly-postaxial polydactyly syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Oligodendroglioma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.25,0.25
Malformation syndrome,Holzgreve syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6741992[PMID]_3309184[PMID]_3232694[PMID],3,3
Malformation syndrome,Holzgreve syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6741992[PMID]_3309184[PMID]_3232694[PMID],0,0
Disease,Pituicytoma,,,,,,,,,,,,,
Clinical subtype,Methylcobalamin deficiency type cblE,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,27,27
Clinical subtype,Methylcobalamin deficiency type cblE,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Extraventricular neurocytoma,,,,,,,,,,,,,
Disease,Cerebellar liponeurocytoma,,,,,,,,,,,,,
Disease,Hypertrichosis lanuginosa congenita,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Hypertrichosis lanuginosa congenita,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pineal parenchymal tumor of intermediate differenciation,,,,,,,,,,,,,
Malformation syndrome,Hypertrichosis cubiti,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16355816[PMID],28,28
Malformation syndrome,Hypertrichosis cubiti,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Neuronal tumor,,,,,,,,,,,,,
Malformation syndrome,Ramos-Arroyo syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21910235[PMID],6,6
Malformation syndrome,Ramos-Arroyo syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Desmoplastic infantile astrocytoma/ganglioglioma,,,,,,,,,,,,,
Disease,Dysembryoplastic neuroepithelial tumor,,,,,,,,,,,,,
Malformation syndrome,Hypodontia-dysplasia of nails syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Mixed neuronal-glial tumor,,,,,,,,,,,,,
Disease,Hypertryptophanemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],12,12
Disease,Hypertryptophanemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Gangliocytoma,,,,,,,,,,,,,
Disease,Primary hypergonadotropic hypogonadism-partial alopecia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19213036[PMID],7,7
Disease,Primary hypergonadotropic hypogonadism-partial alopecia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19213036[PMID],0,0
Disease,Papillary glioneuronal tumor,,,,,,,,,,,,,
Disease,Rosette-forming glioneuronal tumor,,,,,,,,,,,,,
Disease,Hypogonadotropic hypogonadism-frontoparietal alopecia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,466617[PMID],6,6
Disease,Hypogonadotropic hypogonadism-frontoparietal alopecia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_466617[PMID],0,0
Disease,Ganglioglioma,,,,,,,,,,,,,
Malformation syndrome,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Anaplastic ganglioglioma,,,,,,,,,,,,,
Clinical subtype,Yolk sac tumor of central nervous system,,,,,,,,,,,,,
Disease,Familial isolated hypoparathyroidism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Familial isolated hypoparathyroidism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Choriocarcinoma of the central nervous system,,,,,,,,,,,,,
Malformation syndrome,Hypoparathyroidism-sensorineural deafness-renal disease syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29663634[PMID],0,0
Malformation syndrome,Hypoparathyroidism-sensorineural deafness-renal disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29663634[PMID],180,180
Disease,Hypogonadotropic hypogonadism-retinitis pigmentosa syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6795223[PMID],2,2
Disease,Hypogonadotropic hypogonadism-retinitis pigmentosa syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6795223[PMID],0,0
Disease,Ganglioneuroma,,,,,,,,,,,,,
Category,Primary germ cell tumor of central nervous system,,,,,,,,,,,,,
Malformation syndrome,Male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,13030490[PMID],2,2
Malformation syndrome,Male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_13030490[PMID],0,0
Histopathological subtype,Classic medulloblastoma,,,,,,,,,,,,,
Disease,Epidermolytic palmoplantar keratoderma,,,,,,,,,,,,,
Histopathological subtype,Desmoplastic/nodular medulloblastoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Focal palmoplantar and gingival keratoderma,,,,,,,,,,,,,
Disease,Palmoplantar keratoderma-esophageal carcinoma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Palmoplantar keratoderma-esophageal carcinoma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Histopathological subtype,Medulloblastoma with extensive nodularity,,,,,,,,,,,,,
Disease,Transgrediens et progrediens palmoplantar keratoderma,,,,,,,,,,,,,
Histopathological subtype,Anaplastic/large cell medulloblastoma,,,,,,,,,,,,,
Disease,Medulloepithelioma of the central nervous system,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Malformation syndrome,Ankylosing vertebral hyperostosis with tylosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5346342[PMID],8,8
Malformation syndrome,Ankylosing vertebral hyperostosis with tylosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5346342[PMID],0,0
Disease,Ependymoblastoma,,,,,,,,,,,,,
Disease,Palmoplantar keratoderma-spastic paralysis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6227331[PMID],1,1
Disease,Palmoplantar keratoderma-spastic paralysis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6227331[PMID],0,0
Disease,Ganglioneuroblastoma,,,,,,,,,,,,,
Disease,Palmoplantar keratoderma-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Palmoplantar keratoderma-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Central nervous system embryonal tumor,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.07,0.07
Disease,Atypical papilloma of choroid plexus,,,,,,,,,,,,,
Disease,Choroid plexus carcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,2033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Choroid plexus carcinoma,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,2033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Choroid plexus carcinoma,1-9 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,2033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.35,0.35
Malformation syndrome,Hypertelorism-microtia-facial clefting syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11152141[PMID],9,9
Malformation syndrome,Hypertelorism-microtia-facial clefting syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11152141[PMID],0,0
Clinical group,Choroid plexus tumor,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.05,0.05
Malformation syndrome,Hypertelorism-hypospadias-polysyndactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18553510[PMID],3,3
Malformation syndrome,Hypertelorism-hypospadias-polysyndactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18553510[PMID],0,0
Disease,Papillary tumor of the pineal region,,,,,,,,,,,,,
Disease,Pineocytoma,,,,,,,,,,,,,
Disease,Cervical hypertrichosis-peripheral neuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1666396[PMID]_8281287[PMID],4,4
Disease,Cervical hypertrichosis-peripheral neuropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1666396[PMID]_8281287[PMID],0,0
Disease,Pineoblastoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Malformation syndrome,Multiple pterygium-malignant hyperthermia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3346884[PMID],4,4
Malformation syndrome,Multiple pterygium-malignant hyperthermia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3346884[PMID],0,0
Clinical group,Pineal tumor of neuroepithelial tissue,,,,,,,,,,,,,
Malformation syndrome,Maternal hyperthermia-induced birth defects,,,,,,,,,,,,,
Malformation syndrome,2q32q33 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],25,25
Malformation syndrome,2q32q33 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Hypotrichosis-intellectual disability, Lopes type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8652088[PMID],2,2
Disease,"Hypotrichosis-intellectual disability, Lopes type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8652088[PMID],0,0
Malformation syndrome,2q33.1 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21343628[PMID],20,20
Malformation syndrome,2q33.1 microdeletion syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3829441[PMID],4,4
Disease,Ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3829441[PMID],0,0
Malformation syndrome,3q29 microduplication syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,1q41q42 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"Hypospadias-intellectual disability, Goldblatt type syndrome",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3673966[PMID],3,3
Malformation syndrome,"Hypospadias-intellectual disability, Goldblatt type syndrome",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3673966[PMID],0,0
Malformation syndrome,Paternal uniparental disomy of chromosome 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Maternal uniparental disomy of chromosome 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pallister-Hall syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301638[PMID],100,100
Malformation syndrome,Pallister-Hall syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301638[PMID],0,0
Malformation syndrome,2q31.1 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Superficial epidermolytic ichthyosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Superficial epidermolytic ichthyosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,7q31 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27075776[PMID],20,20
Malformation syndrome,7q31 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27075776[PMID],0,0
Malformation syndrome,8p11.2 deletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15948194[PMID],3,3
Malformation syndrome,8p11.2 deletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15948194[PMID],0,0
Malformation syndrome,Ichthyosis-oral and digital anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2732996[PMID],2,2
Malformation syndrome,Ichthyosis-oral and digital anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2732996[PMID],0,0
Malformation syndrome,8p23.1 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,444432[PMID],2,2
Disease,Ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_444432[PMID],0,0
Malformation syndrome,8p23.1 duplication syndrome,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23345203[PMID],1.72,1.72
Disease,Ichthyosis follicularis-alopecia-photophobia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21600032[PMID],40,40
Disease,Ichthyosis follicularis-alopecia-photophobia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Ring chromosome 5 syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Neutral lipid storage disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Neutral lipid storage disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Malformation syndrome,6p22 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23294540[PMID],19,19
Malformation syndrome,6p22 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,CHILD syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20929975[PMID],60,60
Disease,CHILD syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Harlequin ichthyosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24920541[PMID],0,0
Disease,Harlequin ichthyosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24920541[PMID],200,200
Disease,Congenital ichthyosis-microcephalus-tetraplegia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7619196[PMID],0,0
Disease,Congenital ichthyosis-microcephalus-tetraplegia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7619196[PMID],2,2
Malformation syndrome,6q25 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19034313[PMID],4,4
Malformation syndrome,6q25 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19034313[PMID],0,0
Category,Serpinopathy with toxic serpin polymerization,,,,,,,,,,,,,
Category,Serpinopathy,,,,,,,,,,,,,
Malformation syndrome,Cerebellar hypoplasia-tapetoretinal degeneration syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1622524[PMID],3,3
Malformation syndrome,Cerebellar hypoplasia-tapetoretinal degeneration syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1622524[PMID],0,0
Disease,Logopenic progressive aphasia,,,,,,,,,,,,,
Malformation syndrome,Ulna hypoplasia-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7625433[PMID],2,2
Malformation syndrome,Ulna hypoplasia-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7625433[PMID],0,0
Category,Serpinopathy with loss of serpin function,,,,,,,,,,,,,
Clinical subtype,Familial isolated hypoparathyroidism due to agenesis of parathyroid gland,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14431322[PMID]_8981958[PMID],2,2
Clinical subtype,Familial isolated hypoparathyroidism due to agenesis of parathyroid gland,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14431322[PMID]_8981958[PMID],0,0
Malformation syndrome,Megacystis-microcolon-intestinal hypoperistalsis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],230,230
Malformation syndrome,Megacystis-microcolon-intestinal hypoperistalsis syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Autosomal recessive Stickler syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16909383[PMID]_ 21421862[PMID]_21671392[PMID],15,15
Clinical subtype,Autosomal recessive Stickler syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16909383[PMID]_ 21421862[PMID]_21671392[PMID],0,0
Malformation syndrome,Fibulo-ulnar hypoplasia-renal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2773984[PMID],2,2
Malformation syndrome,Fibulo-ulnar hypoplasia-renal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2773984[PMID],0,0
Malformation syndrome,Primary pulmonary hypoplasia,,,,,,,,,,,,,
Disease,AICA-ribosiduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15114530[PMID],1,1
Disease,AICA-ribosiduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15114530[PMID],0,0
Disease,Congenital unilateral pulmonary hypoplasia,,,,,,,,,,,,,
Malformation syndrome,1q21.1 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,46,46
Malformation syndrome,1q21.1 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,1q21.1 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6802865[PMID],2,2
Disease,Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6802865[PMID],0,0
Morphological anomaly,Isolated aniridia,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,1.31,1.31
Morphological anomaly,Isolated aniridia,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,18494745[PMID],1.38,1.38
Morphological anomaly,Isolated aniridia,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,18494745[PMID],1.38,1.38
Morphological anomaly,Isolated aniridia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Thumb deformity-alopecia-pigmentation anomaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3344769[PMID],2,2
Malformation syndrome,Thumb deformity-alopecia-pigmentation anomaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3344769[PMID],0,0
Category,Rare neoplastic disease,,,,,,,,,,,,,
Malformation syndrome,Radial hypoplasia-triphalangeal thumbs-hypospadias-maxillary diastema syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7137222[PMID],8,8
Malformation syndrome,Radial hypoplasia-triphalangeal thumbs-hypospadias-maxillary diastema syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7137222[PMID],0,0
Malformation syndrome,Polymicrogyria with optic nerve hypoplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19896110[PMID],4,4
Malformation syndrome,Polymicrogyria with optic nerve hypoplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19896110[PMID],0,0
Disease,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant optic atrophy and peripheral neuropathy,,,,,,,,,,,,,
Disease,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22766612[PMID],10.6,10.6
Disease,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Isotretinoin-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15602090[PMID],6,6
Malformation syndrome,Isotretinoin-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15602090[PMID],0,0
Malformation syndrome,CK syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21290788[PMID],24,24
Malformation syndrome,CK syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21290788[PMID],0,0
Malformation syndrome,Isotretinoin syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sickle cell-hemoglobin D disease syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sickle cell-hemoglobin E disease syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sickle cell-beta-thalassemia disease syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sickle cell-hemoglobin C disease syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial articular hypermobility syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Sickle cell disease associated with an other hemoglobin anomaly,,,,,,,,,,,,,
Malformation syndrome,Congenital bowing of long bones,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Maternal disease-related embryofetopathy,,,,,,,,,,,,,
Malformation syndrome,Juberg-Hayward syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22811276[PMID],13,13
Malformation syndrome,Juberg-Hayward syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22811276[PMID],0,0
Category,Rare tumor of neuroepithelial tissue,,,,,,,,,,,,,
Disease,Hyperzincemia and hypercalprotectinemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12480428[PMID]_DOI: 10.1007/978-3-319-96929-9_4[OTHER],18,18
Disease,Hyperzincemia and hypercalprotectinemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI: 10.1007/978-3-319-96929-9_4[OTHER],0,0
Malformation syndrome,Johnson neuroectodermal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Toxic or drug-related embryofetopathy,,,,,,,,,,,,,
Malformation syndrome,Johanson-Blizzard syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,16311597[PMID],0.4,0.4
Malformation syndrome,"46,XY partial gonadal dysgenesis",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Distal arthrogryposis type 10,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17103435[PMID],53,53
Malformation syndrome,Distal arthrogryposis type 10,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Absence deformity of leg-cataract syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5694533[PMID],2,2
Malformation syndrome,Absence deformity of leg-cataract syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5694533[PMID],0,0
Disease,Pachyonychia congenita,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],1000,1000
Disease,Pachyonychia congenita,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Localized junctional epidermolysis bullosa, non-Herlitz type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Clinical subtype,"Localized junctional epidermolysis bullosa, non-Herlitz type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,IVIC syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17256792[PMID],4,4
Malformation syndrome,IVIC syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pigmented paravenous retinochoroidal atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24926324[PMID],100,100
Disease,Pigmented paravenous retinochoroidal atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24926324[PMID],0,0
Malformation syndrome,Parietal foramina with clavicular hypoplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14571277[PMID],8,8
Malformation syndrome,Parietal foramina with clavicular hypoplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14571277[PMID],0,0
Malformation syndrome,Dysmorphism-short stature-deafness-disorder of sex development syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3757305[PMID],2,2
Malformation syndrome,Dysmorphism-short stature-deafness-disorder of sex development syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3757305[PMID],0,0
Disease,Benign concentric annular macular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,27,27
Disease,Benign concentric annular macular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant spastic ataxia type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22958904[PMID],0,0
Disease,Autosomal dominant spastic ataxia type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22958904[PMID],53,53
Disease,Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19753314[PMID],9,9
Disease,Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19753314[PMID],0,0
Disease,Familial hyperaldosteronism type III,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24037882[PMID],7,7
Disease,Familial hyperaldosteronism type III,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1149323[PMID],4,4
Malformation syndrome,Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ 1149323[PMID],0,0
Disease,Familial osteochondritis dissecans,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Congenital velopharyngeal incompetence,,,,,,,,,,,,,
Disease,Ataxia-telangiectasia-like disorder,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Unexplained long-lasting fever/inflammatory syndrome,,,,,,,,,,,,,
Disease,Unclassified vasculitis,,,,,,,,,,,,,
Disease,Neuronal intranuclear inclusion disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Drug-induced vasculitis,,,,,,,,,,,,,
Disease,Microvillus inclusion disease,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,16800870[PMID],0,0
Disease,Microvillus inclusion disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24014347[PMID],137,137
Disease,Microvillus inclusion disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24014347[PMID],0,0
Morphological anomaly,Fused mandibular incisors,,,,,,,,,,,,,
Clinical group,Overlapping connective tissue disease,,,,,,,,,,,,,
Morphological anomaly,Primary basilar invagination,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Idiopathic recurrent pericarditis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Infantile onset panniculitis with uveitis and systemic granulomatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18035159[PMID],4,4
Disease,Infantile onset panniculitis with uveitis and systemic granulomatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18035159[PMID],0,0
Clinical group,Exercise intolerance with lactic acidosis,,,,,,,,,,,,,
Malformation syndrome,Cyprus facial-neuromusculoskeletal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1481843[PMID],1,1
Malformation syndrome,Cyprus facial-neuromusculoskeletal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1481843[PMID],0,0
Category,Isolated oxidative phosphorylation complex disorder,,,,,,,,,,,,,
Clinical group,Unspecified mitochondrial disorder,,,,,,,,,,,,,
Malformation syndrome,Neurofaciodigitorenal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7081297[PMID]_9354842[PMID],3,3
Malformation syndrome,Neurofaciodigitorenal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7081297[PMID],0,0
Malformation syndrome,Neuhauser-Eichner-Opitz syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6859111[PMID],5,5
Malformation syndrome,Neuhauser-Eichner-Opitz syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6859111[PMID],0,0
Disease,Lethal infantile mitochondrial myopathy,,,,,,,,,,,,,
Malformation syndrome,Neurofibromatosis type 6,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mitochondrial myopathy with reversible cytochrome C oxidase deficiency,,,,,,,,,,,,,
Disease,Mitochondrial DNA-related dystonia,,,,,,,,,,,,,
Disease,Pure mitochondrial myopathy,,,,,,,,,,,,,
Malformation syndrome,Nephropathy-deafness-hyperparathyroidism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2732989[PMID],5,5
Malformation syndrome,Nephropathy-deafness-hyperparathyroidism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2732989[PMID],0,0
Category,Multiple mitochondrial DNA deletion syndrome,,,,,,,,,,,,,
Malformation syndrome,Nathalie syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1204231[PMID],1,1
Malformation syndrome,Nathalie syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1204231[PMID],0,0
Clinical group,Ataxia neuropathy spectrum,,,,,,,,,,,,,
Malformation syndrome,Keipert syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21567928[PMID],12,12
Malformation syndrome,Keipert syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21567928[PMID],0,0
Category,Mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA,,,,,,,,,,,,,
Clinical group,"Mitochondrial DNA depletion syndrome, encephalomyopathic form",,,,,,,,,,,,,
Malformation syndrome,Neu-Laxova syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25152457[PMID]_24371398[PMID],91,91
Malformation syndrome,Neu-Laxova syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25152457[PMID]_24371398[PMID],0,0
Category,Mitochondrial substrate carrier disorder,,,,,,,,,,,,,
Malformation syndrome,Renal coloboma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22213154[PMID],180,180
Malformation syndrome,Renal coloboma syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Mitochondrial protein import disorder,,,,,,,,,,,,,
Malformation syndrome,Pierson syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27130041[PMID],40,40
Malformation syndrome,Pierson syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27130041[PMID],0,0
Category,Mitochondrial oxidative phosphorylation disorder with no known mechanism,,,,,,,,,,,,,
Malformation syndrome,Nephrosis-deafness-urinary tract-digital malformations syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,13872585[PMID],5,5
Malformation syndrome,Nephrosis-deafness-urinary tract-digital malformations syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_13872585[PMID],0,0
Category,Mitochondrial membrane transport disorder,,,,,,,,,,,,,
Disease,Combined oxidative phosphorylation defect type 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24284555[PMID],7,7
Disease,Combined oxidative phosphorylation defect type 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24284555[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17160893[PMID],2,2
Disease,Combined oxidative phosphorylation defect type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17160893[PMID],0,0
Malformation syndrome,Arthrogryposis-renal dysfunction-cholestasis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Malformation syndrome,Arthrogryposis-renal dysfunction-cholestasis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Combined oxidative phosphorylation defect type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15505824[PMID],1,1
Disease,Combined oxidative phosphorylation defect type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15505824[PMID],0,0
Malformation syndrome,Bifid nose,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Isolated ATP synthase deficiency,,,,,,,,,,,,,
Clinical subtype,Pyruvate dehydrogenase E3-binding protein deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Noonan syndrome-like disorder with loose anagen hair,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,27,27
Malformation syndrome,Noonan syndrome-like disorder with loose anagen hair,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Pyruvate dehydrogenase E1-beta deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adult-onset autosomal recessive sideroblastic anemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17485548[PMID]_25342667[PMID],0,0
Disease,Adult-onset autosomal recessive sideroblastic anemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17485548[PMID]_25342667[PMID],2,2
Disease,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22421650[PMID],0,0
Malformation syndrome,Median nodule of the upper lip,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1068420[PMID]_8030663[PMID],4,4
Malformation syndrome,Median nodule of the upper lip,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1068420[PMID]_8030663[PMID],0,0
Disease,Autosomal recessive progressive external ophthalmoplegia,,,,,,,,,,,,,
Disease,Spinocerebellar ataxia with epilepsy,,,,,,,,,,,,,
Disease,"Mitochondrial DNA depletion syndrome, myopathic form",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23230576[PMID],45,45
Disease,"Mitochondrial DNA depletion syndrome, myopathic form",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23230576[PMID],0,0
Clinical group,"Mitochondrial DNA depletion syndrome, hepatocerebral form",,,,,,,,,,,,,
Disease,Isolated cytochrome C oxidase deficiency,,,,,,,,,,,,,
Disease,Renal tubulopathy-encephalopathy-liver failure syndrome,,,,,,,,,,,,,
Disease,Neutropenia-monocytopenia-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6604450[PMID],3,3
Disease,Neutropenia-monocytopenia-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6604450[PMID],0,0
Disease,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17332895[PMID],2,2
Disease,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17332895[PMID],0,0
Disease,Autosomal dominant progressive external ophthalmoplegia,,,,,,,,,,,,,
Malformation syndrome,Oculofaciocardiodental syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Oculo-palato-cerebral syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3995792[PMID]_11241490[PMID]_15368502[PMID],5,5
Malformation syndrome,Oculo-palato-cerebral syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3995792[PMID]_11241490[PMID]_15368502[PMID],0,0
Malformation syndrome,Oculoosteocutaneous syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4974459[PMID],3,3
Malformation syndrome,Oculoosteocutaneous syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4974459[PMID],0,0
Malformation syndrome,Severe oculo-renal-cerebellar syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7091183[PMID],5,5
Malformation syndrome,Severe oculo-renal-cerebellar syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7091183[PMID],0,0
Malformation syndrome,Oculotrichodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3398012[PMID],2,2
Malformation syndrome,Oculotrichodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3398012[PMID],0,0
Malformation syndrome,Oculotrichoanal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301721[PMID],20,20
Malformation syndrome,Oculotrichoanal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301721[PMID],0,0
Malformation syndrome,Ochoa syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Malformation syndrome,Ochoa syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Port-wine nevi-mega cisterna magna-hydrocephalus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,501430[PMID],5,5
Malformation syndrome,Port-wine nevi-mega cisterna magna-hydrocephalus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_501430[PMID],0,0
Disease,Mitochondrial DNA-associated Leigh syndrome,,,,,,,,,,,,,
Disease,Navajo neurohepatopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23714749[PMID],49,49
Disease,Navajo neurohepatopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23714749[PMID],0,0
Malformation syndrome,"Oculocerebrofacial syndrome, Kaufman type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27763745[PMID],14,14
Malformation syndrome,"Oculocerebrofacial syndrome, Kaufman type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27763745[PMID],0,0
Disease,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17486094[PMID]_19138848[PMID],5,5
Disease,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17486094[PMID]_19138848[PMID],0,0
Malformation syndrome,Oculodentodigital dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12021949[PMID],243,243
Malformation syndrome,Oculodentodigital dysplasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Leigh syndrome with leukodystrophy,,,,,,,,,,,,,
Malformation syndrome,"Oculodental syndrome, Rutherfurd type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25714557[PMID],1,1
Malformation syndrome,"Oculodental syndrome, Rutherfurd type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25714557[PMID],0,0
Disease,Leigh syndrome with nephrotic syndrome,,,,,,,,,,,,,
Malformation syndrome,"Blepharophimosis-intellectual disability syndrome, Ohdo type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,"Blepharophimosis-intellectual disability syndrome, Ohdo type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Postaxial tetramelic oligodactyly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8100684[PMID],4,4
Malformation syndrome,Postaxial tetramelic oligodactyly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8100684[PMID],0,0
Malformation syndrome,Taurodontia-absent teeth-sparse hair syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,15,15
Malformation syndrome,Taurodontia-absent teeth-sparse hair syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Olivopontocerebellar atrophy-deafness syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Omodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Omodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,"Oculocerebral hypopigmentation syndrome, Cross type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9112000[PMID],14,14
Malformation syndrome,"Oculocerebral hypopigmentation syndrome, Cross type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9112000[PMID],0,0
Malformation syndrome,"Oculocerebral hypopigmentation syndrome, Preus type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6663291[PMID],2,2
Malformation syndrome,"Oculocerebral hypopigmentation syndrome, Preus type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6663291[PMID],0,0
Disease,Odonto-onycho-dermal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26964878[PMID],30,30
Disease,Odonto-onycho-dermal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26964878[PMID],0,0
Malformation syndrome,Odonto-onycho dysplasia-alopecia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2982262[PMID],2,2
Malformation syndrome,Odonto-onycho dysplasia-alopecia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2982262[PMID],0,0
Malformation syndrome,Odontotrichomelic syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5432287[PMID],4,4
Malformation syndrome,Odontotrichomelic syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5432287[PMID],0,0
Malformation syndrome,Odontomatosis-aortae esophagus stenosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4424740[PMID]_5229432[PMID],3,3
Malformation syndrome,Odontomatosis-aortae esophagus stenosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4424740[PMID]_5229432[PMID],0,0
Disease,Autosomal recessive sideroblastic anemia,,,,,,,,,,,,,
Malformation syndrome,Eye defects-arachnodactyly-cardiopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10319196[PMID]_15602085[PMID],6,6
Malformation syndrome,Eye defects-arachnodactyly-cardiopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10319196[PMID]_15602085[PMID],0,0
Malformation syndrome,Orofaciodigital syndrome type 8,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Malformation syndrome,Orofaciodigital syndrome type 8,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Orofaciodigital syndrome type 6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20512146[PMID],2,2
Malformation syndrome,Orofaciodigital syndrome type 6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20512146[PMID],0,0
Disease,Benign schwannoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],6,6
Malformation syndrome,Orofaciodigital syndrome type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,29,29
Malformation syndrome,Orofaciodigital syndrome type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Orofaciodigital syndrome type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5004413[PMID]_8230165[PMID],5,5
Malformation syndrome,Orofaciodigital syndrome type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5004413[PMID]_8230165[PMID],0,0
Malformation syndrome,Orofaciodigital syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Pr Marie-Paule VAZQUEZ [EXPERT],20,20
Malformation syndrome,Orofaciodigital syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Histopathological subtype,Malignant peripheral nerve sheath tumor with perineurial differentiation,,,,,,,,,,,,,
Malformation syndrome,Orofaciodigital syndrome type 1,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22925539[PMID],0.65,0.65
Malformation syndrome,Orofaciodigital syndrome type 1,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,20301367[PMID],1.2,1.2
Malformation syndrome,Orofaciodigital syndrome type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Benign peripheral nerve sheath tumor,,,,,,,,,,,,,
Category,Tumor of cranial and spinal nerves,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],1.89,1.89
Disease,Primary melanoma of the central nervous system,,,,,,,,,,,,,
Malformation syndrome,Ophthalmoplegia-intellectual disability-lingua scrotalis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1167409[PMID],6,6
Malformation syndrome,Ophthalmoplegia-intellectual disability-lingua scrotalis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1167409[PMID],0,0
Disease,Hemangioblastoma,,,,,,,,,,,,,
Malformation syndrome,Ophthalmomandibulomelic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14161103[PMID],3,3
Malformation syndrome,Ophthalmomandibulomelic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14161103[PMID],0,0
Disease,Diffuse leptomeningeal melanocytosis,,,,,,,,,,,,,
Disease,Meningeal melanocytoma,,,,,,,,,,,,,
Category,Tumor of meninges,,,,,,,,,,,,,
Category,Primary melanocytic tumor of central nervous system,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.01,0.01
Clinical subtype,Teratoma of the central nervous system,,,,,,,,,,,,,
Disease,Ondine syndrome,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,15653965[PMID],0.5,0.5
Disease,Ondine syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Lethal omphalocele-cleft palate syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6873946[PMID]_26867152[PMID],5,5
Malformation syndrome,Lethal omphalocele-cleft palate syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6873946[PMID]_26867152[PMID],0,0
Clinical subtype,Mixed germ cell tumor of central nervous system,,,,,,,,,,,,,
Category,Rare lichen planus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Autosomal recessive distal osteolysis syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Osteomesopyknosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26185059[PMID],35,35
Malformation syndrome,Osteomesopyknosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26185059[PMID],0,0
Disease,Plectin-related  limb-girdle muscular dystrophy R17,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21109228[PMID],6,6
Disease,Plectin-related  limb-girdle muscular dystrophy R17,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21109228[PMID],0,0
Malformation syndrome,Multicentric carpo-tarsal osteolysis with or without nephropathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Distal 7q11.23 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23637006[PMID],41,41
Malformation syndrome,Distal 7q11.23 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Familial osteodysplasia, Anderson type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5067603[PMID],0,0
Malformation syndrome,"Familial osteodysplasia, Anderson type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5067603[PMID],4,4
Malformation syndrome,19p13.12 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22419660[PMID],6,6
Malformation syndrome,19p13.12 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22419660[PMID],0,0
Malformation syndrome,Nasu-Hakola disease,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Nasu-Hakola disease,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,9463329[PMID],0.15,0.15
Disease,Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20970105[PMID],6,6
Disease,Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20970105[PMID],0,0
Malformation syndrome,Carpotarsal osteochondromatosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal recessive intermediate Charcot-Marie-Tooth disease type B,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20920668[PMID],1,1
Disease,Autosomal recessive intermediate Charcot-Marie-Tooth disease type B,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20920668[PMID],0,0
Malformation syndrome,Blount disease,Not yet documented,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Progressive osseous heteroplasia,,,,,,,,,,,,,
Histopathological subtype,Malignant triton tumor,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24474920[PMID],170,170
Histopathological subtype,Malignant triton tumor,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24474920[PMID],0,0
Malformation syndrome,Osteocraniostenosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12210352[PMID],30,30
Malformation syndrome,Osteocraniostenosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Melanoma and neural system tumor syndrome,,,,,,,,,,,,,
Disease,Constitutional mismatch repair deficiency syndrome,,,,,,,,,,,,,
Malformation syndrome,Imperforate oropharynx-costovertebral anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2929659[PMID],2,2
Malformation syndrome,Imperforate oropharynx-costovertebral anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2929659[PMID],0,0
Malformation syndrome,OSLAM syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,201363[PMID],3,3
Malformation syndrome,OSLAM syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_201363[PMID],0,0
Category,Inherited nervous system cancer-predisposing syndrome,,,,,,,,,,,,,
Disease,Neurofibroma,,,,,,,,,,,,,
Clinical subtype,Vestibular schwannoma,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,20871439[PMID]_24655069[PMID],2,2
Clinical subtype,Vestibular schwannoma,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer Institute[INST]_23432451[PMID],1.2,1.2
Clinical subtype,Vestibular schwannoma,1-9 / 1 000 000,Specific population,409967,409967,25958,25958,en,Validated,410293,410293,21897393[PMID],0.8,0.8
Clinical subtype,Vestibular schwannoma,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Temple syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26377239[PMID],53,53
Malformation syndrome,Temple syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26377239[PMID],0,0
Malformation syndrome,Otoonychoperoneal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15216555[PMID],6,6
Malformation syndrome,Otoonychoperoneal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15216555[PMID],0,0
Malformation syndrome,Otofaciocervical syndrome,,,,,,,,,,,,,
Malformation syndrome,Kagami-Ogata syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28640239[PMID],84,84
Malformation syndrome,Kagami-Ogata syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28640239[PMID],0,0
Etiological subtype,Temple syndrome due to paternal 14q32.2 microdeletion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26377239[PMID],9,9
Etiological subtype,Temple syndrome due to paternal 14q32.2 microdeletion,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26377239[PMID],0,0
Malformation syndrome,Pachygyria-intellectual disability-epilepsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17343267[PMID]_8129645[PMID],5,5
Malformation syndrome,Pachygyria-intellectual disability-epilepsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17343267[PMID]_8129645[PMID],0,0
Malformation syndrome,Pachydermoperiostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16283874[PMID],204,204
Malformation syndrome,Pachydermoperiostosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28640239[PMID]_24891339[PMID],8,8
Etiological subtype,Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28640239[PMID]_24891339[PMID],0,0
Disease,Lichen planus pemphigoides,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23237497[PMID],100,100
Disease,Lichen planus pemphigoides,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Lateral meningocele syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23696373[PMID]_24311540[PMID],14,14
Malformation syndrome,Lateral meningocele syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Osteoporosis-pseudoglioma syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.05,0.05
Disease,Frontal fibrosing alopecia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Otodental syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16722606[PMID],10,10
Malformation syndrome,Otodental syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Inhalational botulism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Clinical subtype,Inhalational botulism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Endosteal hyperostosis, Worth type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8030669[PMID]_18031587 [PMID],6,6
Malformation syndrome,"Endosteal hyperostosis, Worth type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8030669[PMID]_18031587 [PMID],0,0
Clinical subtype,Iatrogenic botulism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],180,180
Clinical subtype,Iatrogenic botulism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Annular atrophic lichen planus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Annular atrophic lichen planus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Buschke-Ollendorff syndrome,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,7793762[PMID],5,5
Disease,Annular lichen planus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Autosomal dominant osteopetrosis type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,33,33
Malformation syndrome,Autosomal dominant osteopetrosis type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Atrophic lichen planus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Osteoporosis-oculocutaneous hypopigmentation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8721572[PMID],0,0
Malformation syndrome,Osteoporosis-oculocutaneous hypopigmentation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8721572[PMID],1,1
Disease,Lichen planus pigmentosus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare cutaneous lichen planus,,,,,,,,,,,,,
Malformation syndrome,Osteopathia striata-cranial sclerosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15266607[PMID],100,100
Malformation syndrome,Osteopathia striata-cranial sclerosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare mucosal lichen planus,,,,,,,,,,,,,
Malformation syndrome,Osteopathia striata-pigmentary dermopathy-white forelock syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7405956[PMID],3,3
Malformation syndrome,Osteopathia striata-pigmentary dermopathy-white forelock syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7405956[PMID],0,0
Disease,Linear lichen planus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Actinic lichen planus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Autosomal recessive malignant osteopetrosis,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.75,0.75
Malformation syndrome,Autosomal recessive malignant osteopetrosis,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Spastic paraparesis-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3741213[PMID],6,6
Malformation syndrome,Spastic paraparesis-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3741213[PMID],0,0
Category,Mitochondrial oxidative phosphorylation disorder due to a large-scale single deletion of mitochondrial DNA,,,,,,,,,,,,,
Category,Mitochondrial oxidative phosphorylation disorder due to mitochondrial DNA anomalies,,,,,,,,,,,,,
Clinical group,Mitochondrial DNA-related mitochondrial myopathy,,,,,,,,,,,,,
Disease,Spastic paraplegia-glaucoma-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7298353[PMID_3802560[PMID],2,2
Disease,Spastic paraplegia-glaucoma-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7298353[PMID_3802560[PMID],0,0
Category,Mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA,,,,,,,,,,,,,
Malformation syndrome,Laryngeal abductor paralysis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2277390[PMID]_7149532[PMID]_4058983[PMID],9,9
Malformation syndrome,Laryngeal abductor paralysis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2277390[PMID]_7149532[PMID]_4058983[PMID],0,0
Disease,Familial recurrent peripheral facial palsy,,,,,,,,,,,,,
Category,Tricarboxylic acid cycle disorder,,,,,,,,,,,,,
Disease,Parana hard skin syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4129896[PMID],8,8
Disease,Parana hard skin syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4129896[PMID],0,0
Category,Pyruvate metabolism disorder,,,,,,,,,,,,,
Morphological anomaly,Partial pancreatic agenesis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8988180[PMID],50,50
Morphological anomaly,Partial pancreatic agenesis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Epithelioid trophoblastic tumor,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Partial hydatidiform mole,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Annular pancreas,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG],1.8,1.8
Morphological anomaly,Annular pancreas,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],29.4,29.4
Morphological anomaly,Annular pancreas,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],2.9,2.9
Morphological anomaly,Annular pancreas,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.3,21.3
Morphological anomaly,Annular pancreas,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],7.9,7.9
Morphological anomaly,Annular pancreas,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.9,5.9
Morphological anomaly,Annular pancreas,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],1,1
Morphological anomaly,Annular pancreas,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],3.6,3.6
Morphological anomaly,Annular pancreas,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.7,5.7
Morphological anomaly,Annular pancreas,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],24.9,24.9
Morphological anomaly,Annular pancreas,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],17.1,17.1
Morphological anomaly,Annular pancreas,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.7,0.7
Morphological anomaly,Annular pancreas,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.1,3.1
Morphological anomaly,Annular pancreas,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.8,0.8
Morphological anomaly,Annular pancreas,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.2,3.2
Morphological anomaly,Annular pancreas,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Papilloma of choroid plexus,,,,,,,,,,,,,
Disease,Papillon-Lefèvre syndrome,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,14244097[PMID],0.25,0.25
Biological anomaly,Genetic hyperferritinemia without iron overload,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26377239[PMID],7,7
Etiological subtype,Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26377239[PMID],0,0
Disease,X-linked sideroblastic anemia and spinocerebellar ataxia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22398176[PMID],5,5
Disease,X-linked sideroblastic anemia and spinocerebellar ataxia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Temple syndrome due to paternal 14q32.2 hypomethylation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28640239[PMID]_24891339[PMID],12,12
Etiological subtype,Temple syndrome due to paternal 14q32.2 hypomethylation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28640239[PMID]_24891339[PMID],0,0
Clinical subtype,Complete hydatidiform mole,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,W syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10594887[PMID],6,6
Malformation syndrome,W syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Gestational trophoblastic disease,,,,,,,,,,,,,
Category,Anomaly of chromosome 8,,,,,,,,,,,,,
Category,Anomaly of chromosome 7,,,,,,,,,,,,,
Category,Anomaly of chromosome 6,,,,,,,,,,,,,
Malformation syndrome,Müllerian duct anomalies-limb anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3706400[PMID],5,5
Malformation syndrome,Müllerian duct anomalies-limb anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3706400[PMID],0,0
Category,Anomaly of chromosome 5,,,,,,,,,,,,,
Malformation syndrome,FATCO syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI:10.15520.v3i12.33[OTHER],22,22
Malformation syndrome,FATCO syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI:10.15520.v3i12.33[OTHER],0,0
Morphological anomaly,Syndactyly type 8,,,,,,,,,,,,,
Category,Anomaly of chromosome 11,,,,,,,,,,,,,
Malformation syndrome,Metachondromatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,25,25
Malformation syndrome,Metachondromatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Anomaly of chromosome 10,,,,,,,,,,,,,
Malformation syndrome,Mesomelia-synostoses syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19725128[PMID],5,5
Malformation syndrome,Mesomelia-synostoses syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19725128[PMID],0,0
Malformation syndrome,Upper limb mesomelic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3342548[PMID]_16283892[PMID],4,4
Malformation syndrome,Upper limb mesomelic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3342548[PMID]_16283892[PMID],0,0
Category,Anomaly of chromosome 9,,,,,,,,,,,,,
Category,Anomaly of chromosome 15,,,,,,,,,,,,,
Malformation syndrome,Metaphyseal dysostosis-intellectual disability-conductive deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5173335[PMID],3,3
Malformation syndrome,Metaphyseal dysostosis-intellectual disability-conductive deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5173335[PMID],0,0
Category,Anomaly of chromosome 14,,,,,,,,,,,,,
Category,Anomaly of chromosome 13,,,,,,,,,,,,,
Malformation syndrome,Acrogeria,,,,,,,,,,,,,
Category,Anomaly of chromosome 12,,,,,,,,,,,,,
Disease,"Metaphyseal chondrodysplasia, Spahr type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24648384[PMID]_2225533[PMID]_19615667[PMID]_24781753[PMID]_18553549[PMID],18,18
Disease,"Metaphyseal chondrodysplasia, Spahr type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24648384[PMID],0,0
Category,Anomaly of chromosome 19,,,,,,,,,,,,,
Category,Anomaly of chromosome 18,,,,,,,,,,,,,
Category,Anomaly of chromosome 17,,,,,,,,,,,,,
Malformation syndrome,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23290074[PMID],2,2
Malformation syndrome,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Anomaly of chromosome 16,,,,,,,,,,,,,
Disease,Multiple benign circumferential skin creases on limbs,,,,,,,,,,,,,
Category,Anomaly of chromosome 22,,,,,,,,,,,,,
Malformation syndrome,Microbrachycephaly-ptosis-cleft lip syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1605250[PMID],2,2
Malformation syndrome,Microbrachycephaly-ptosis-cleft lip syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1605250[PMID],0,0
Category,Partial deletion of chromosome 1,,,,,,,,,,,,,
Malformation syndrome,Micro syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23420520[PMID]_24239381[PMID],203,203
Malformation syndrome,Micro syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Anomaly of chromosome 20,,,,,,,,,,,,,
Malformation syndrome,Corpus callosum agenesis-abnormal genitalia syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Anomaly of chromosome 21,,,,,,,,,,,,,
Category,Partial deletion of chromosome 4,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-cardiac defect-lung malsegmentation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8723562[PMID],3,3
Malformation syndrome,Microcephaly-cardiac defect-lung malsegmentation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8723562[PMID],0,0
Category,Partial deletion of chromosome 5,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-cardiomyopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1956062[PMID]_10544231[PMID],3,3
Malformation syndrome,Microcephaly-cardiomyopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1956062[PMID]_10544231[PMID],0,0
Category,Partial deletion of chromosome 2,,,,,,,,,,,,,
Etiological subtype,Autosomal dominant primary microcephaly,,,,,,,,,,,,,
Category,Partial deletion of chromosome 3,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-albinism-digital anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6660641[PMID],2,2
Malformation syndrome,Microcephaly-albinism-digital anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6660641[PMID],0,0
Category,Partial deletion of chromosome 8,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-cleft palate-abnormal retinal pigmentation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6859112[PMID],3,3
Malformation syndrome,Microcephaly-cleft palate-abnormal retinal pigmentation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6859112[PMID],0,0
Category,Partial deletion of chromosome 9,,,,,,,,,,,,,
Category,Partial deletion of chromosome 6,,,,,,,,,,,,,
Malformation syndrome,Autosomal recessive chorioretinopathy-microcephaly syndrome,,,,,,,,,,,,,
Category,Partial deletion of chromosome 7,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 12,,,,,,,,,,,,,
Malformation syndrome,Pontocerebellar hypoplasia type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],81,81
Malformation syndrome,Pontocerebellar hypoplasia type 2,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Partial deletion of chromosome 16,,,,,,,,,,,,,
Category,Partial deletion of chromosome 10,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-brain defect-spasticity-hypernatremia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3784440[PMID],3,3
Malformation syndrome,Microcephaly-brain defect-spasticity-hypernatremia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3784440[PMID],0,0
Category,Partial deletion of chromosome 11,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-cervical spine fusion anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5033742[PMID],2,2
Malformation syndrome,Microcephaly-cervical spine fusion anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5033742[PMID],0,0
Category,Partial deletion of chromosome 18,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-lymphedema-chorioretinopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Malformation syndrome,Microcephaly-lymphedema-chorioretinopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19076985[PMID],0,0
Category,Partial deletion of chromosome 17,,,,,,,,,,,,,
Category,Partial deletion of chromosome 20,,,,,,,,,,,,,
Malformation syndrome,"Microcephaly-microcornea syndrome, Seemanova type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8958326[PMID],2,2
Malformation syndrome,"Microcephaly-microcornea syndrome, Seemanova type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8958326[PMID],0,0
Category,Partial deletion of chromosome 19,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 2,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 1,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 4,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-deafness-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3608216[PMID],2,2
Malformation syndrome,Microcephaly-deafness-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3608216[PMID],0,0
Category,Partial deletion of the short arm of chromosome 3,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 6,,,,,,,,,,,,,
Malformation syndrome,Microcornea-glaucoma-absent frontal sinuses syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5781804[PMID]_7636671[PMID],5,5
Malformation syndrome,Microcornea-glaucoma-absent frontal sinuses syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5781804[PMID]_7636671[PMID,0,0
Category,Partial deletion of the short arm of chromosome 5,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 8,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 7,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 10,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 9,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 16,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 11,,,,,,,,,,,,,
Category,Partial monosomy of the short arm of chromosome 17,,,,,,,,,,,,,
Malformation syndrome,Oculoauriculovertebral spectrum with radial defects,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 18,,,,,,,,,,,,,
Category,Partial deletion of the short arm of chromosome 19,,,,,,,,,,,,,
Malformation syndrome,Microspherophakia-metaphyseal dysplasia syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Partial monosomy of the short arm of chromosome 20,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 1,,,,,,,,,,,,,
Malformation syndrome,Ear-patella-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26381604[PMID],67,67
Malformation syndrome,Ear-patella-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26381604[PMID],0,0
Category,Partial deletion of the long arm of chromosome 2,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 3,,,,,,,,,,,,,
Malformation syndrome,Microphthalmia with linear skin defects syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23122588[PMID],55,55
Malformation syndrome,Microphthalmia with linear skin defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Partial deletion of the long arm of chromosome 4,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 5,,,,,,,,,,,,,
Malformation syndrome,Mikati-Najjar-Sahli syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2998187[PMID],5,5
Malformation syndrome,Mikati-Najjar-Sahli syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2998187[PMID],0,0
Category,Partial deletion of the long arm of chromosome 6,,,,,,,,,,,,,
Malformation syndrome,Mietens syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16760739[PMID],9,9
Malformation syndrome,Mietens syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16760739[PMID],0,0
Malformation syndrome,Pyramidal molars-abnormal upper lip syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4349385[PMID],8,8
Malformation syndrome,Pyramidal molars-abnormal upper lip syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4349385[PMID],0,0
Category,Partial deletion of the long arm of chromosome 7,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 8,,,,,,,,,,,,,
Malformation syndrome,Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17401577[PMID],7,7
Malformation syndrome,Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17401577[PMID],0,0
Malformation syndrome,Tetramelic monodactyly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1308366[PMID],0,0
Category,Partial monosomy of the long arm of chromosome 9,,,,,,,,,,,,,
Category,Partial monosomy of the long arm of chromosome 10,,,,,,,,,,,,,
Malformation syndrome,MOMO syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23034868[PMID]_22821547[PMID],8,8
Malformation syndrome,MOMO syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Partial deletion of the long arm of chromosome 11,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 13,,,,,,,,,,,,,
Malformation syndrome,Mononen-Karnes-Senac syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1632443[PMID],1,1
Malformation syndrome,Mononen-Karnes-Senac syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1632443[PMID],0,0
Malformation syndrome,Moynahan syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2319580[PMID],26,26
Malformation syndrome,Moynahan syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2319580[PMID],0,0
Disease,Muckle-Wells syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Muckle-Wells syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spastic ataxia-corneal dystrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3465874[PMID],1,1
Disease,Spastic ataxia-corneal dystrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3465874[PMID],0,0
Disease,Moyamoya disease,1-9 / 1 000 000,Japan,409967,409967,25965,25965,en,Not yet validated,410294,410294,9409395[PMID]_18048855[PMID],0.74,0.74
Disease,Moyamoya disease,1-9 / 100 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,9409395[PMID]_18048855[PMID]_23041378[PMID],6.2,6.2
Disease,Moyamoya disease,1-9 / 1 000 000,China,409967,409967,25958,25958,en,Validated,410293,410293,20004511[PMID],0.43,0.43
Disease,Moyamoya disease,1-9 / 100 000,China,409966,409966,25958,25958,en,Validated,410293,410293,20004511[PMID],3.92,3.92
Disease,Moyamoya disease,<1 / 1 000 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,9409399[PMID],0.048,0.048
Disease,Moyamoya disease,1-9 / 1 000 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,9409399[PMID],0.44,0.44
Disease,Moyamoya disease,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,16186547[PMID],0.086,0.086
Disease,Moyamoya disease,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.33,0.33
Disease,Moyamoya disease,<1 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ISBN:9783211243381[OTHER],0.035,0.035
Disease,Moyamoya disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3321025[PMID]_3211858[PMID],4,4
Malformation syndrome,Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3321025[PMID]_3211858[PMID],0,0
Disease,X-linked immunoneurologic disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7783167[PMID],5,5
Disease,X-linked immunoneurologic disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7783167[PMID],0,0
Malformation syndrome,15q11.2 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25689425[PMID],200,200
Malformation syndrome,15q11.2 microdeletion syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25689425[PMID],0,0
Malformation syndrome,Ataxia-pancytopenia syndrome,,,,,,,,,,,,,
Malformation syndrome,14q12 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19303466[PMID]_18627055[PMID],3,3
Malformation syndrome,14q12 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,14q11.2 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17545556[PMID],3,3
Malformation syndrome,14q11.2 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Mayer-Rokitansky-Küster-Hauser syndrome type 2,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,19821675[PMID],1,1
Clinical subtype,Mayer-Rokitansky-Küster-Hauser syndrome type 2,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Monosomy 9p,,,,,,,,,,,,,
Disease,Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5748751[PMID]_6302225[PMID],12,12
Disease,Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5748751[PMID]_6302225[PMID],0,0
Malformation syndrome,Distal 7q11.23 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI:10.1159/000448698[OTHER],5,5
Malformation syndrome,Distal 7q11.23 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI:10.1159/000448698[OTHER],0,0
Malformation syndrome,Mulibrey nanism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29731032[PMID],150,150
Malformation syndrome,Mulibrey nanism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29731032[PMID],0,0
Malformation syndrome,Mulibrey nanism,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,12627297[PMID],2.7,2.7
Malformation syndrome,16p13.11 microdeletion syndrome,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,24105370[PMID],7,7
Malformation syndrome,16p13.11 microdeletion syndrome,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23637818[PMID],0,0
Malformation syndrome,16p13.11 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27378146[PMID],162,162
Malformation syndrome,16p13.11 microduplication syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27378146[PMID],0,0
Malformation syndrome,N syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4216437[PMID],3,3
Malformation syndrome,N syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4216437[PMID],0,0
Malformation syndrome,Distal 16p11.2 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Carney complex,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16756677[PMID],160,160
Disease,Carney complex,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26130139[PMID],0,0
Disease,Tubular aggregate myopathy,,,,,,,,,,,,,
Malformation syndrome,14q11.2 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20736978[PMID],7,7
Malformation syndrome,14q11.2 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinal muscular atrophy-progressive myoclonic epilepsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Spinal muscular atrophy-progressive myoclonic epilepsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,16p11.2p12.2 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24259393[PMID],0,0
Malformation syndrome,16p11.2p12.2 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24259393[PMID],7,7
Malformation syndrome,16p11.2p12.2 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24259393[PMID],8,8
Malformation syndrome,16p11.2p12.2 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24259393[PMID],0,0
Malformation syndrome,Myoclonus-cerebellar ataxia-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5698045[PMID]_6537856[PMID],4,4
Malformation syndrome,Myoclonus-cerebellar ataxia-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5698045[PMID]_6537856[PMID],0,0
Malformation syndrome,15q14 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24678003[PMID],9,9
Malformation syndrome,15q14 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24678003[PMID],0,0
Malformation syndrome,Myhre syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28406602[PMID],55,55
Malformation syndrome,Myhre syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28406602[PMID],0,0
Malformation syndrome,Proximal 16p11.2 microdeletion syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,19306953[PMID]_[EXPERT],20,20
Malformation syndrome,Proximal 16p11.2 microdeletion syndrome,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,21731881[PMID],20,20
Malformation syndrome,20p12.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18812404[PMID],3,3
Malformation syndrome,20p12.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18812404[PMID],0,0
Malformation syndrome,Paternal 20q13.2q13.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15915160[PMID],2,2
Malformation syndrome,Paternal 20q13.2q13.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15915160[PMID],0,0
Malformation syndrome,17q23.1q23.2 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20206336[PMID],7,7
Malformation syndrome,17q23.1q23.2 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20206336[PMID],0,0
Malformation syndrome,Trisomy 17p,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"Microcephalic primordial dwarfism, Montreal type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5458566[PMID],3,3
Malformation syndrome,"Microcephalic primordial dwarfism, Montreal type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5458566[PMID],0,0
Malformation syndrome,17q12 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27409573[PMID],0,0
Malformation syndrome,17q12 microdeletion syndrome,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,27409573[PMID],0.16,0.16
Malformation syndrome,17q12 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27409573[PMID],103,103
Malformation syndrome,17q12 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27409573[PMID],118,118
Malformation syndrome,17q12 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27409573[PMID],0,0
Malformation syndrome,17q12 microduplication syndrome,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,27409573[PMID],0.46,0.46
Malformation syndrome,16q24.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28422132[PMID],27,27
Malformation syndrome,16q24.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28422132[PMID],0,0
Malformation syndrome,3M syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_22624670[PMID],200,200
Malformation syndrome,3M syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Nail-patella-like renal disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6507504[PMID],3,3
Disease,Nail-patella-like renal disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6507504[PMID],0,0
Malformation syndrome,Distal 17p13.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20599530[PMID],16,16
Malformation syndrome,Distal 17p13.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20599530[PMID],0,0
Malformation syndrome,Trisomy 1q,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28437579[PMID],18,18
Malformation syndrome,Trisomy 1q,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28437579[PMID],0,0
Malformation syndrome,Distal 22q11.2 microduplication syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Xp21 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25917374[PMID],0,0
Disease,Xp21 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25917374[PMID],100,100
Malformation syndrome,2p15p16.1 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24810580[PMID],11,11
Malformation syndrome,2p15p16.1 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24810580[PMID],0,0
Malformation syndrome,Trisomy 20p,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,20q13.33 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Geleophysic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15088061[PMID],27,27
Malformation syndrome,Geleophysic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal 22q11.2 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,21q22.11q22.12 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20578134[PMID]_7515754[PMID],14,14
Malformation syndrome,21q22.11q22.12 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20578134[PMID]_7515754[PMID],0,0
Malformation syndrome,Paternal uniparental disomy of chromosome X,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Fibular aplasia-complex brachydactyly syndrome,,,,,,,,,,,,,
Malformation syndrome,Maternal uniparental disomy of chromosome X,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"49,XXXYY syndrome",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3697588[PMID]_14015109[PMID],2,2
Malformation syndrome,"49,XXXYY syndrome",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Ring chromosome Y syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Mesomelic dwarfism-cleft palate-camptodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8267013[PMID],2,2
Malformation syndrome,Mesomelic dwarfism-cleft palate-camptodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8267013[PMID],0,0
Malformation syndrome,Kleefstra syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22670141[PMID]_[EXPERT],114,114
Malformation syndrome,Kleefstra syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Xq27.3q28 duplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19844254[PMID],8,8
Malformation syndrome,Xq27.3q28 duplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Langer mesomelic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23863349[PMID]_[EXPERT],100,100
Malformation syndrome,Langer mesomelic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,"Mesomelic dysplasia, Nievergelt type",,,,,,,,,,,,,
Malformation syndrome,Atypical Norrie disease due to Xp11.3 microdeletion,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"Mesomelic dwarfism, Reinhardt-Pfeiffer type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Parastremmatic dwarfism,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Blepharophimosis-epicanthus inversus-ptosis due to copy number variations,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Osteoglosphonic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3409933[PMID],7,7
Malformation syndrome,Osteoglosphonic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3409933[PMID],0,0
Etiological subtype,Familial adenomatous polyposis due to 5q22.2 microdeletion,,,,,,,,,,,,,
Etiological subtype,Alagille syndrome due to 20p12 microdeletion,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Alagille syndrome due to a JAG1 point mutation,,,,,,,,,,,,,
Etiological subtype,Mowat-Wilson syndrome due to monosomy 2q22,,,,,,,,,,,,,
Malformation syndrome,"Microcephalic primordial dwarfism, Toriello type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3799711[PMID],2,2
Malformation syndrome,"Microcephalic primordial dwarfism, Toriello type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3799711[PMID],0,0
Etiological subtype,Mowat-Wilson syndrome due to a ZEB2 point mutation,,,,,,,,,,,,,
Etiological subtype,Blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Microcephalic osteodysplastic primordial dwarfism types I and III,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Microcephalic osteodysplastic primordial dwarfism types I and III,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Anomaly of chromosome 1,,,,,,,,,,,,,
Malformation syndrome,Lenz-Majewski hyperostotic dwarfism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10756342[PMID]_24241535[PMID],10,10
Malformation syndrome,Lenz-Majewski hyperostotic dwarfism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Anomaly of chromosome 2,,,,,,,,,,,,,
Category,Anomaly of chromosome 3,,,,,,,,,,,,,
Category,Anomaly of chromosome 4,,,,,,,,,,,,,
Etiological subtype,Alagille syndrome due to a NOTCH2 point mutation,,,,,,,,,,,,,
Etiological subtype,Okihiro syndrome due to 20q13 microdeletion,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Okihiro syndrome due to a point mutation,,,,,,,,,,,,,
Etiological subtype,Kleefstra syndrome due to a point mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22670141[PMID]_[EXPERT],23,23
Etiological subtype,Kleefstra syndrome due to a point mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,14q22q23 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24311462[PMID],5,5
Malformation syndrome,14q22q23 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24311462[PMID],0,0
Category,Y chromosomal anomaly,,,,,,,,,,,,,
Category,Uniparental disomy of chromosome X,,,,,,,,,,,,,
Category,Partial duplication of the long arm of chromosome X,,,,,,,,,,,,,
Disease,"X-linked intellectual disability, Brooks type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16477654[PMID],9,9
Disease,"X-linked intellectual disability, Brooks type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16477654[PMID],0,0
Category,Partial duplication of the short arm of chromosome X,,,,,,,,,,,,,
Category,Partial duplication of chromosome X,,,,,,,,,,,,,
Disease,Monoamine oxidase A deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7175926[PMID],4,4
Malformation syndrome,X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7175926[PMID],0,0
Category,Partial deletion of the long arm of chromosome X,,,,,,,,,,,,,
Category,X and Y chromosomal anomaly,,,,,,,,,,,,,
Category,Y chromosome number anomaly,,,,,,,,,,,,,
Disease,X-linked intellectual disability-seizures-psoriasis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3177453[PMID],4,4
Disease,X-linked intellectual disability-seizures-psoriasis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3177453[PMID],0,0
Category,Partial monosomy of the short arm of chromosome X,,,,,,,,,,,,,
Category,Partial deletion of chromosome X,,,,,,,,,,,,,
Malformation syndrome,"Blepharophimosis-intellectual disability syndrome, SBBYS type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Malformation syndrome,"Blepharophimosis-intellectual disability syndrome, SBBYS type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Polysomy of X chromosome,,,,,,,,,,,,,
Category,X chromosome number anomaly with male phenotype,,,,,,,,,,,,,
Malformation syndrome,Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2107046[PMID],4,4
Malformation syndrome,Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2107046[PMID],0,0
Category,X chromosome number anomaly,,,,,,,,,,,,,
Malformation syndrome,Intellectual disability-cataracts-calcified pinnae-myopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27061120[PMID]_28462983[PMID],13,13
Malformation syndrome,Intellectual disability-cataracts-calcified pinnae-myopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28462983[PMID],0,0
Category,X chromosome number anomaly with female phenotype,,,,,,,,,,,,,
Malformation syndrome,Intellectual disability-balding-patella luxation-acromicria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2002488[PMID]_8487281[PMID],3,3
Malformation syndrome,Intellectual disability-balding-patella luxation-acromicria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2002488[PMID]_8487281[PMID],0,0
Category,Complex chromosomal rearrangement,,,,,,,,,,,,,
Category,X chromosome anomaly,,,,,,,,,,,,,
Malformation syndrome,Delayed speech-facial asymmetry-strabismus-ear lobe creases syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16055361[PMID],6,6
Malformation syndrome,Delayed speech-facial asymmetry-strabismus-ear lobe creases syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16055361[PMID],0,0
Disease,NK-cell enteropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20966166[PMID],8,8
Disease,NK-cell enteropathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Peeling skin syndrome type C,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Growth delay-hydrocephaly-lung hypoplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2764038[PMID],4,4
Malformation syndrome,Growth delay-hydrocephaly-lung hypoplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2764038[PMID],0,0
Disease,Familial multiple meningioma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Delayed membranous cranial ossification,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10861662[PMID]_1481847[PMID],2,2
Malformation syndrome,Delayed membranous cranial ossification,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10861662[PMID]_1481847[PMID],0,0
Clinical subtype,Peeling skin syndrome type A,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Clinical subtype,Peeling skin syndrome type A,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Renal tubular dysgenesis,,,,,,,,,,,,,
Clinical subtype,Peeling skin syndrome type B,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Clinical subtype,Peeling skin syndrome type B,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,NPHP3-related Meckel-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,NPHP3-related Meckel-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acral peeling skin syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22622422[PMID],40,40
Disease,Acral peeling skin syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Generalized peeling skin syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Progressive myoclonic epilepsy type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22693283[PMID]_22748208[PMID],9,9
Clinical subtype,Progressive myoclonic epilepsy type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22693283[PMID]_22748208[PMID],0,0
Disease,Acute necrotizing encephalopathy of childhood,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,COG4-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22516080[PMID],2,2
Disease,COG4-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Radial ray hypoplasia-choanal atresia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3425633[PMID],0,0
Malformation syndrome,Radial ray hypoplasia-choanal atresia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3425633[PMID],3,3
Disease,COG1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16537452[PMID]_19008299[PMID],3,3
Disease,COG1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16537452[PMID]_19008299[PMID],0,0
Disease,"Spondyloepiphyseal dysplasia, Maroteaux type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,"Spondyloepiphyseal dysplasia, Maroteaux type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,RAPADILINO syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18716613[PMID],20,20
Malformation syndrome,RAPADILINO syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18716613[PMID],0,0
Disease,Fuchs heterochromic iridocyclitis,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,9088407[PMID],0.2,0.2
Disease,Fuchs heterochromic iridocyclitis,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,9088407[PMID],0.5,0.5
Disease,Fuchs heterochromic iridocyclitis,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,DPM3-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19576565[PMID],1,1
Disease,DPM3-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19576565[PMID],0,0
Malformation syndrome,External auditory canal atresia-vertical talus-hypertelorism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22152683[PMID]_495079[PMID]_12116258[PMID],10,10
Malformation syndrome,External auditory canal atresia-vertical talus-hypertelorism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22152683[PMID]_495079[PMID]_12116258[PMID],0,0
Disease,COG5-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22516080[PMID]_23228021[PMID],9,9
Disease,COG5-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hyperinsulinism due to INSR deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15161766[PMID],10,10
Disease,Hyperinsulinism due to INSR deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15161766[PMID],0,0
Disease,Hyperinsulinism due to HNF4A deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Lethal osteosclerotic bone dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25974638[PMID],40,40
Malformation syndrome,Lethal osteosclerotic bone dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25974638[PMID],0,0
Malformation syndrome,Retinal ischemic syndrome-digestive tract small vessel hyalinosis-diffuse cerebral calcifications syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3485063[PMID],3,3
Malformation syndrome,Retinal ischemic syndrome-digestive tract small vessel hyalinosis-diffuse cerebral calcifications syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3485063[PMID],0,0
Malformation syndrome,Ramon syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11746043[PMID],8,8
Malformation syndrome,Ramon syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11746043[PMID]_6829604[PMID],0,0
Disease,CHST3-related skeletal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24458487[PMID],2,2
Disease,CHST3-related skeletal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24458487[PMID],0,0
Disease,Nevus of Ito,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1.17,1.17
Disease,Nevus of Ito,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Nevus of Ota,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Radio-renal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7363497[PMID]_6829604[PMID],4,4
Malformation syndrome,Radio-renal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7363497[PMID]_,0,0
Clinical group,Neuroacanthocytosis,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,22027213[PMID],0,0
Disease,Congenital smooth muscle hamartoma,1-5 / 10 000,Israel,409968,409968,25958,25958,en,Validated,410293,410293,2356798[PMID],38.5,38.5
Disease,Congenital smooth muscle hamartoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Absent radius-anogenital anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8456854[PMID],2,2
Malformation syndrome,Absent radius-anogenital anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8456854[PMID],0,0
Disease,Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21176162[PMID],4,4
Disease,Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Qazi-Markouizos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8064821[PMID],3,3
Disease,Qazi-Markouizos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8064821[PMID],0,0
Clinical group,ATR-X-related syndrome,,,,,,,,,,,,,
Disease,Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1271602[PMID],2,2
Disease,Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1271602[PMID],0,0
Malformation syndrome,Rabson-Mendenhall syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Angiosarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],0,0
Disease,Angiosarcoma,<1 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Angiosarcoma,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pyknoachondrogenesis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7460382[PMID]_3791681[PMID],5,5
Malformation syndrome,Pyknoachondrogenesis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7460382[PMID]_3791681[PMID],0,0
Histopathological subtype,Moderately-differentiated thymic neuroendocrine carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,Poorly differentiated thymic neuroendocrine carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pyle disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Pyle disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,MRCS syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16458719[PMID]_12543751[PMID],7,7
Disease,MRCS syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16458719[PMID]_12543751[PMID],0,0
Particular clinical situation in a disease or syndrome,Postcardiotomy right ventricular failure,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2010[INST],0,0
Malformation syndrome,Mirror polydactyly-vertebral segmentation-limbs defects syndrome,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,9409874[PMID],0.3,0.3
Malformation syndrome,Mirror polydactyly-vertebral segmentation-limbs defects syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.3,0.3
Histopathological subtype,Thymoma type A,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],0,0
Histopathological subtype,Thymoma type A,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Ptosis-vocal cord paralysis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6633110[PMID],2,2
Malformation syndrome,Ptosis-vocal cord paralysis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6633110[PMID],0,0
Histopathological subtype,Thymoma type B,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],0,0
Histopathological subtype,Thymoma type B,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,Thymoma type AB,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],0,0
Histopathological subtype,Thymoma type AB,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Ptosis-strabismus-ectopic pupils syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,949861[PMID],1,1
Malformation syndrome,Ptosis-strabismus-ectopic pupils syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_949861[PMID],0,0
Histopathological subtype,Well-differentiated thymic neuroendocrine carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Uniparental disomy of chromosome 15,,,,,,,,,,,,,
Category,Uniparental disomy of chromosome 20,,,,,,,,,,,,,
Malformation syndrome,Autosomal recessive multiple pterygium syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30868735[PMID],0,0
Malformation syndrome,Autosomal recessive multiple pterygium syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30868735[PMID],64,64
Category,Uniparental disomy of chromosome 21,,,,,,,,,,,,,
Disease,Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20357282[PMID],1,1
Disease,Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20357282[PMID],0,0
Category,Uniparental disomy of chromosome 11,,,,,,,,,,,,,
Malformation syndrome,Antecubital pterygium syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3409540[PMID],11,11
Malformation syndrome,Antecubital pterygium syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3409540[PMID],0,0
Malformation syndrome,Pseudoprogeria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4418946[PMID],2,2
Malformation syndrome,Pseudoprogeria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4418946[PMID],0,0
Category,Uniparental disomy of chromosome 13,,,,,,,,,,,,,
Morphological anomaly,Familial pterygium of the conjunctiva,,,,,,,,,,,,,
Category,Uniparental disomy of chromosome 14,,,,,,,,,,,,,
Malformation syndrome,Pterygium colli-intellectual disability-digital anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7977463[PMID],2,2
Malformation syndrome,Pterygium colli-intellectual disability-digital anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7977463[PMID],0,0
Category,Partial trisomy of the long arm of chromosome 20,,,,,,,,,,,,,
Category,Partial duplication of the long arm of chromosome 19,,,,,,,,,,,,,
Malformation syndrome,Ulnar-mammary syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24679913[PMID],117,117
Malformation syndrome,Ulnar-mammary syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24679913[PMID],0,0
Category,Partial trisomy of the long arm of chromosome 18,,,,,,,,,,,,,
Category,Partial duplication of the long arm of chromosome 17,,,,,,,,,,,,,
Category,Uniparental disomy of chromosome 7,,,,,,,,,,,,,
Disease,Nephrogenic diabetes insipidus-intracranial calcification syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2133981[PMID],2,2
Disease,Nephrogenic diabetes insipidus-intracranial calcification syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2133981[PMID],0,0
Category,Uniparental disomy of chromosome 6,,,,,,,,,,,,,
Category,Uniparental disomy of chromosome 1,,,,,,,,,,,,,
Disease,Autoimmune polyendocrinopathy type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Schneckenbecken dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25997753[PMID],0,0
Category,Partial duplication of the long arm of chromosome 22,,,,,,,,,,,,,
Category,Partial duplication of the long arm of chromosome 11,,,,,,,,,,,,,
Malformation syndrome,Say-Barber-Miller syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3746838[PMID]_8728697[PMID]_19108857[PMID],4,4
Malformation syndrome,Say-Barber-Miller syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3746838[PMID]_8728697[PMID],0,0
Category,Partial duplication of the long arm of chromosome 10,,,,,,,,,,,,,
Category,Partial trisomy of the long arm of chromosome 9,,,,,,,,,,,,,
Disease,Satoyoshi syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19839037[PMID],50,50
Disease,Satoyoshi syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19839037[PMID],0,0
Category,Partial duplication of the long arm of chromosome 8,,,,,,,,,,,,,
Category,Partial trisomy of the long arm of chromosome 16,,,,,,,,,,,,,
Malformation syndrome,Schinzel-Giedion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18398855[PMID],0,0
Malformation syndrome,Schinzel-Giedion syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,Schinzel-Giedion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18398855[PMID]_[EXPERT],46,46
Category,Partial duplication of the long arm of chromosome 15,,,,,,,,,,,,,
Malformation syndrome,Say-Field-Coldwell syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,953232[PMID],4,4
Malformation syndrome,Say-Field-Coldwell syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_953232[PMID],0,0
Category,Partial duplication of the long arm of chromosome 14,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27286879[PMID],50,50
Category,Partial duplication of the long arm of chromosome 14,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27286879[PMID],0,0
Malformation syndrome,SCARF syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2596519[PMID],2,2
Malformation syndrome,SCARF syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2596519[PMID],0,0
Category,Partial duplication of the long arm of chromosome 13,,,,,,,,,,,,,
Malformation syndrome,Ruvalcaba syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Partial duplication of the long arm of chromosome 2,,,,,,,,,,,,,
Category,Partial duplication of the long arm of chromosome 3,,,,,,,,,,,,,
Category,Partial duplication of the long arm of chromosome 1,,,,,,,,,,,,,
Category,Partial duplication of the long arm of chromosome 6,,,,,,,,,,,,,
Category,Partial duplication of the long arm of chromosome 7,,,,,,,,,,,,,
Category,Partial duplication of the long arm of chromosome 4,,,,,,,,,,,,,
Category,Partial trisomy of the long arm of chromosome 5,,,,,,,,,,,,,
Category,Partial trisomy/tetrasomy of the short arm of chromosome 9,,,,,,,,,,,,,
Category,Partial duplication of the short arm of chromosome 10,,,,,,,,,,,,,
Disease,Rothmund-Thomson syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29642415[PMID],400,400
Disease,Rothmund-Thomson syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29642415[PMID],0,0
Category,Partial duplication of the short arm of chromosome 7,,,,,,,,,,,,,
Disease,Rombo syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Partial duplication of the short arm of chromosome 8,,,,,,,,,,,,,
Category,Partial duplication of the short arm of chromosome 17,,,,,,,,,,,,,
Category,Partial trisomy/tetrasomy of the short arm of chromosome 18,,,,,,,,,,,,,
Disease,Roussy-Lévy syndrome,,,,,,,,,,,,,
Category,Partial duplication of the short arm of chromosome 11,,,,,,,,,,,,,
Category,Partial duplication of the short arm of chromosome 16,,,,,,,,,,,,,
Malformation syndrome,Richieri Costa-da Silva syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6716408[PMID],4,4
Malformation syndrome,Richieri Costa-da Silva syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6716408[PMID],0,0
Category,Partial duplication of chromosome 19,,,,,,,,,,,,,
Malformation syndrome,Richieri Costa-Pereira syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23794199[PMID],33,33
Malformation syndrome,Richieri Costa-Pereira syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Partial trisomy/tetrasomy of chromosome 18,,,,,,,,,,,,,
Malformation syndrome,Robin sequence-oligodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3777025[PMID]_3425604[PMID],3,3
Malformation syndrome,Robin sequence-oligodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3777025[PMID]_3425604[PMID],0,0
Category,Partial duplication of the short arm of chromosome 2,,,,,,,,,,,,,
Category,Partial trisomy of chromosome 20,,,,,,,,,,,,,
Category,Partial duplication of the short arm of chromosome 4,,,,,,,,,,,,,
Category,Partial duplication of the short arm of chromosome 3,,,,,,,,,,,,,
Clinical subtype,Autosomal dominant Robinow syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Clinical subtype,Autosomal dominant Robinow syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Partial duplication of the short arm of chromosome 6,,,,,,,,,,,,,
Category,Partial trisomy/tetrasomy of the short arm of chromosome 5,,,,,,,,,,,,,
Malformation syndrome,Mayer-Rokitansky-Küster-Hauser syndrome,1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_22740494[PMID]_17359527[PMID],11,11
Malformation syndrome,Mayer-Rokitansky-Küster-Hauser syndrome,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Category,Partial trisomy/tetrasomy of chromosome 9,,,,,,,,,,,,,
Category,Partial duplication of chromosome 8,,,,,,,,,,,,,
Disease,Autosomal dominant vitreoretinochoroidopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15452077[PMID],3,3
Disease,Autosomal dominant vitreoretinochoroidopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Partial duplication of chromosome 11,,,,,,,,,,,,,
Malformation syndrome,Revesz syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1404302[PMID]_18252230[PMID]_21477109[PMID],4,4
Malformation syndrome,Revesz syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_1404302[PMID]_18252230[PMID]_21477109[PMID],0,0
Category,Partial duplication of chromosome 10,,,,,,,,,,,,,
Clinical group,Congenital pulmonary venous return anomaly,,,,,,,,,,,,,
Category,Partial trisomy/tetrasomy of the short arm of chromosome 12,,,,,,,,,,,,,
Malformation syndrome,Meacham syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17853480[PMID],13,13
Malformation syndrome,Meacham syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17853480[PMID],0,0
Malformation syndrome,"Rhizomelic syndrome, Urbach type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3948431[PMID],3,3
Malformation syndrome,"Rhizomelic syndrome, Urbach type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3591839[PMID],0,0
Category,Partial duplication of chromosome 17,,,,,,,,,,,,,
Category,Partial duplication of chromosome 16,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 22,,,,,,,,,,,,,
Category,Partial duplication of chromosome 1,,,,,,,,,,,,,
Category,Partial duplication of chromosome 2,,,,,,,,,,,,,
Category,Partial duplication of chromosome 3,,,,,,,,,,,,,
Malformation syndrome,"Severe X-linked intellectual disability, Gustavson type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8456840[PMID],7,7
Malformation syndrome,"Severe X-linked intellectual disability, Gustavson type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8456840[PMID],0,0
Category,Partial duplication of chromosome 4,,,,,,,,,,,,,
Malformation syndrome,X-linked intellectual disability-psychosis-macroorchidism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8651288[PMID],6,6
Malformation syndrome,X-linked intellectual disability-psychosis-macroorchidism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8651288[PMID],0,0
Category,Partial trisomy/tetrasomy of chromosome 5,,,,,,,,,,,,,
Category,Partial duplication of chromosome 6,,,,,,,,,,,,,
Malformation syndrome,"Intellectual disability, Wolff type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8151642[PMID],2,2
Malformation syndrome,"Intellectual disability, Wolff type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8151642[PMID],0,0
Category,Partial duplication of chromosome 7,,,,,,,,,,,,,
Malformation syndrome,"Intellectual disability, Buenos-Aires type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5025484[PMID]_10190479[PMID],5,5
Malformation syndrome,"Intellectual disability, Buenos-Aires type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5025484[PMID]_10190479[PMID],0,0
Category,Partial deletion of the long arm of chromosome 14,,,,,,,,,,,,,
Disease,"X-linked intellectual disability, Snyder type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23897707[PMID]_23696453[PMID],21,21
Disease,"X-linked intellectual disability, Snyder type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23897707[PMID]_23696453[PMID],0,0
Category,Partial deletion of the long arm of chromosome 15,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 16,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 17,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 18,,,,,,,,,,,,,
Disease,Intellectual disability-myopathy-short stature-endocrine defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3970066[PMID],2,2
Disease,Intellectual disability-myopathy-short stature-endocrine defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3970066[PMID],0,0
Category,Partial deletion of the long arm of chromosome 19,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 20,,,,,,,,,,,,,
Category,Partial deletion of the long arm of chromosome 21,,,,,,,,,,,,,
Category,"Malformation of the neurenteric canal, spinal cord and column",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,TARP syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24259342[PMID],6,6
Malformation syndrome,TARP syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,"ORPHANET_24259342,[PMID]",0,0
Morphological anomaly,Primary tethered cord syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Piebald trait-neurologic defects syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5097904[PMID],8,8
Malformation syndrome,Piebald trait-neurologic defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5097904[PMID],0,0
Morphological anomaly,Leptomyelolipoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Piebaldism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cutaneous photosensitivity-lethal colitis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2002480[PMID],3,3
Disease,Cutaneous photosensitivity-lethal colitis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2002480[PMID],0,0
Clinical group,Lipoma associated with neurospinal dysraphism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"Phocomelia, Schinzel type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Lipomyelomeningocele,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,18050337[PMID],5,5
Morphological anomaly,Lipomyelomeningocele,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7077621[PMID]_4447434[PMID],4,4
Malformation syndrome,Phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7077621[PMID]_4447434[PMID],0,0
Clinical subtype,Parietal encephalocele,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Basal encephalocele,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Isolated megalencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Arnold-Chiari malformation type I,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pilodental dysplasia-refractive errors syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4018802[PMID],2,2
Malformation syndrome,Pilodental dysplasia-refractive errors syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4018802[PMID],0,0
Malformation syndrome,Pili torti-developmental delay-neurological abnormalities syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1379303[PMID],2,2
Malformation syndrome,Pili torti-developmental delay-neurological abnormalities syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1379303[PMID],0,0
Disease,Pili torti,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pili torti-onychodysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1879585[PMID],1,1
Malformation syndrome,Pili torti-onychodysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1879585[PMID],0,0
Morphological anomaly,Neurenteric cyst,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pierre Robin syndrome-faciodigital anomaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1897570[PMID],2,2
Malformation syndrome,Pierre Robin syndrome-faciodigital anomaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1897570[PMID],0,0
Morphological anomaly,Isolated amyelia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Upper thoracic spina bifida cystica,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Short stature-webbed neck-heart disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8905197[PMID],4,4
Malformation syndrome,Short stature-webbed neck-heart disease syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8905197[PMID],0,0
Malformation syndrome,Short stature-deafness-neutrophil dysfunction-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,654917[PMID],2,2
Malformation syndrome,Short stature-deafness-neutrophil dysfunction-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_654917[PMID],0,0
Clinical subtype,Cervicothoracic spina bifida cystica,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Short stature-wormian bones-dextrocardia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15211658[PMID],3,3
Malformation syndrome,Short stature-wormian bones-dextrocardia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15211658[PMID],0,0
Clinical subtype,Cervical spina bifida cystica,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Lumbosacral spina bifida cystica,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Thoracolumbosacral spina bifida cystica,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Total spina bifida cystica,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Spina bifida cystica,1-5 / 10 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,17587020[PMID],33,33
Clinical group,Spina bifida cystica,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Upper thoracic spina bifida aperta,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Phakomatosis pigmentovascularis,,,,,,,,,,,,,
Clinical subtype,Occipital encephalocele,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,PHAVER syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8279476[PMID],2,2
Malformation syndrome,PHAVER syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8279476[PMID],0,0
Morphological anomaly,Cranial meningocele,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Cephalocele,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Phakomatosis pigmentokeratotica,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Phakomatosis pigmentokeratotica,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24877171[PMID],34,34
Morphological anomaly,Myelocystocele,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Posterior meningocele,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pfeiffer-Palm-Teller syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,144791[PMID],2,2
Malformation syndrome,Pfeiffer-Palm-Teller syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_144791[PMID],0,0
Malformation syndrome,"Cardiocranial syndrome, Pfeiffer type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16531733[PMID]_9415478[PMID],7,7
Malformation syndrome,"Cardiocranial syndrome, Pfeiffer type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16531733[PMID]_9415478[PMID],0,0
Malformation syndrome,"Short stature, Brussels type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8867654[PMID],2,2
Malformation syndrome,"Short stature, Brussels type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8867654[PMID],0,0
Malformation syndrome,Short stature-valvular heart disease-characteristic facies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2302822[PMID],3,3
Malformation syndrome,Short stature-valvular heart disease-characteristic facies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2302822[PMID],0,0
Category,Congenital pericardium anomaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Penoscrotal transposition,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15702367[PMID],30,30
Disease,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Pericardial and diaphragmatic defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Pericardial and diaphragmatic defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Neural tube closure defect,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Renal caliceal diverticuli-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6785452[PMID],4,4
Malformation syndrome,Renal caliceal diverticuli-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6785452[PMID],0,0
Disease,Hereditary thrombocytopenia with normal platelets,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pelvic dysplasia-arthrogryposis of lower limbs syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9489787[PMID],5,5
Malformation syndrome,Pelvic dysplasia-arthrogryposis of lower limbs syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9489787[PMID],0,0
Malformation syndrome,Pelvis-shoulder dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,Pelvis-shoulder dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Autosomal recessive intermediate Charcot-Marie-Tooth disease,,,,,,,,,,,,,
Clinical subtype,Thoracolumbosacral spina bifida aperta,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Perrault syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23332201[PMID],61,61
Disease,Perrault syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Fuhrmann syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16826533[PMID]_12868468[PMID],11,11
Malformation syndrome,Fuhrmann syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12868468[PMID]_16826533[PMID],0,0
Clinical subtype,Lumbosacral spina bifida aperta,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Cervical spina bifida aperta,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Peters anomaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21448066[PMID],60,60
Morphological anomaly,Peters anomaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Cervicothoracic spina bifida aperta,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Open iniencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Closed iniencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Alopecia-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28054173[PMID],0,0
Disease,Alopecia-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18616779[PMID]_28054173[PMID],15,15
Morphological anomaly,Spina bifida aperta,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,2785614[PMID],51.5,51.5
Morphological anomaly,Spina bifida aperta,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Spina bifida aperta,1-5 / 10 000,France,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,50,50
Morphological anomaly,Spina bifida aperta,>1 / 1000,Ireland,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,400,400
Morphological anomaly,Spina bifida aperta,6-9 / 10 000,Latin America,409968,409968,25958,25958,en,Validated,410293,410293,3907353[PMID],62,62
Morphological anomaly,Spina bifida aperta,>1 / 1000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,400,400
Clinical subtype,Total spina bifida aperta,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,RAS-associated autoimmune leukoproliferative disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,RAS-associated autoimmune leukoproliferative disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Malformation syndrome,PARC syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2242783[PMID],2,2
Malformation syndrome,PARC syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2242783[PMID],0,0
Disease,Spastic paraplegia-precocious puberty syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6639408[PMID],2,2
Disease,Spastic paraplegia-precocious puberty syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6639408[PMID],0,0
Disease,Intraocular medulloepithelioma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spheroid body myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Spastic paraplegia-facial-cutaneous lesions syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7117711[PMID],5,5
Malformation syndrome,Spastic paraplegia-facial-cutaneous lesions syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7117711[PMID],0,0
Clinical syndrome,Spastic paraplegia-nephritis-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3351903[PMID],4,4
Clinical syndrome,Spastic paraplegia-nephritis-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3351903[PMID],0,0
Disease,Spastic paraplegia-neuropathy-poikiloderma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1623621[PMID],1,1
Disease,Spastic paraplegia-neuropathy-poikiloderma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1623621[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 11,1-9 / 1 000 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,23609960[PMID],0.26,0.26
Malformation syndrome,Pectus excavatum-macrocephaly-dysplastic nails syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Zori 1992[AUTHOR],1,1
Malformation syndrome,Pectus excavatum-macrocephaly-dysplastic nails syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26922654[PMID],19,19
Clinical subtype,DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26922654[PMID],0,0
Disease,PEHO syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Mycophenolate mofetil embryopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],25,25
Malformation syndrome,Mycophenolate mofetil embryopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Complication in hemodialysis,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],13,13
Particular clinical situation in a disease or syndrome,Complication in hemodialysis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Intermediate maple syrup urine disease,Unknown,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Intermediate maple syrup urine disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Short tarsus-absence of lower eyelashes syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7889642[PMID],11,11
Malformation syndrome,Short tarsus-absence of lower eyelashes syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7889642[PMID],0,0
Clinical subtype,Classic maple syrup urine disease,Unknown,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Classic maple syrup urine disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Thiamine-responsive maple syrup urine disease,Unknown,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Thiamine-responsive maple syrup urine disease,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Stiff skin syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27846975[PMID]_26944597[PMID],54,54
Disease,Stiff skin syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27846975[PMID]_26944597[PMID],0,0
Clinical subtype,Wrinkly skin syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Clinical subtype,Wrinkly skin syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Intermittent maple syrup urine disease,Unknown,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Intermittent maple syrup urine disease,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Proteus-like syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Autosomal dominant prognathism,,,,,,,,,,,,,
Disease,De Barsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Disease,De Barsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"46,XX disorder of sex development-anorectal anomalies syndrome",,,,,,,,,,,,,
Malformation syndrome,Non-eruption of teeth-maxillary hypoplasia-genu valgum syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,975598[PMID],4,4
Malformation syndrome,Non-eruption of teeth-maxillary hypoplasia-genu valgum syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pseudoachondroplasia,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301660[PMID],3.3,3.3
Malformation syndrome,"Pseudoleprechaunism syndrome, Patterson type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7277424 [PMID],2,2
Malformation syndrome,"Pseudoleprechaunism syndrome, Patterson type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7277424 [PMID][PMID],0,0
Malformation syndrome,"46,XX disorder of sex development-skeletal anomalies syndrome",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5042791[PMID],2,2
Malformation syndrome,"46,XX disorder of sex development-skeletal anomalies syndrome",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5042791[PMID],0,0
Malformation syndrome,Acrootoocular syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical syndrome,Chronic intestinal pseudoobstruction,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Secondary interstitial lung disease in childhood and adulthood associated with a systemic vasculitis,,,,,,,,,,,,,
Category,Secondary interstitial lung disease in childhood and adulthood associated with a metabolic disease,,,,,,,,,,,,,
Malformation syndrome,Brachydactyly-long thumb syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7246605[PMID],4,4
Malformation syndrome,Brachydactyly-long thumb syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7246605[PMID],0,0
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,16053904[PMID]_EUROCAT European surveillance of congenital anomalies 2009-2010[REG],1.7,1.7
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],4.5,4.5
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.8,5.8
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.4,1.4
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.7,5.7
Clinical subtype,"Renal agenesis, bilateral",1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],10.8,10.8
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.2,3.2
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.2,1.2
Clinical subtype,"Renal agenesis, bilateral",1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],0.6,0.6
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],2.2,2.2
Clinical subtype,"Renal agenesis, bilateral",1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],19,19
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.7,9.7
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3,3
Clinical subtype,"Renal agenesis, bilateral",1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],13.6,13.6
Clinical subtype,"Renal agenesis, bilateral",1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],24.1,24.1
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.2,1.2
Clinical subtype,"Renal agenesis, bilateral",1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.2,3.2
Clinical subtype,"Renal agenesis, bilateral",Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Secondary interstitial lung disease in childhood and adulthood associated with a systemic disease,,,,,,,,,,,,,
Malformation syndrome,Triphalangeal thumb-polysyndactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,15,15
Malformation syndrome,Triphalangeal thumb-polysyndactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Absent thumb-short stature-immunodeficiency syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,728551[PMID],3,3
Malformation syndrome,Absent thumb-short stature-immunodeficiency syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_728551[PMID],0,0
Category,Genetic interstitial lung disease,,,,,,,,,,,,,
Malformation syndrome,Triphalangeal thumbs-brachyectrodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7438506[PMID]_3568429[PMID]_8946115[PMID],4,4
Malformation syndrome,Triphalangeal thumbs-brachyectrodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7438506[PMID]_3568429[PMID]_8946115[PMID],0,0
Category,Exposure-related interstitial lung disease,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Drug or radiation exposure-related interstitial lung disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Acrodysplasia scoliosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6335370[PMID],2,2
Malformation syndrome,Acrodysplasia scoliosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6335370[PMID],0,0
Malformation syndrome,"Adducted thumbs-arthrogryposis syndrome, Christian type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6662143[PMID],9,9
Malformation syndrome,"Adducted thumbs-arthrogryposis syndrome, Christian type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6662143[PMID],0,0
Disease,Hutchinson-Gilford progeria syndrome,<1 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.025,0.025
Disease,Hutchinson-Gilford progeria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.005,0.005
Malformation syndrome,Progeria-short stature-pigmented nevi syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29718885[PMID],11,11
Malformation syndrome,Progeria-short stature-pigmented nevi syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29718885[PMID],0,0
Malformation syndrome,Guttmacher syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8484413[PMID],0,0
Malformation syndrome,Guttmacher syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8484413[PMID],3,3
Malformation syndrome,X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3121220[PMID],8,8
Malformation syndrome,X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3121220[PMID],0,0
Malformation syndrome,Isolated polycystic liver disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Category,Interstitial lung disease specific to infancy,,,,,,,,,,,,,
Category,Secondary interstitial lung disease specific to childhood associated with a systemic disease,,,,,,,,,,,,,
Category,Secondary interstitial lung disease specific to childhood associated with a connective tissue disease,,,,,,,,,,,,,
Malformation syndrome,Digital extensor muscle aplasia-polyneuropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3459358[PMID],3,3
Malformation syndrome,Digital extensor muscle aplasia-polyneuropathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3459358[PMID],0,0
Category,Secondary interstitial lung disease specific to childhood associated with a systemic vasculitis,,,,,,,,,,,,,
Category,Secondary interstitial lung disease specific to childhood associated with a granulomatous disease,,,,,,,,,,,,,
Malformation syndrome,Polyneuropathy-intellectual disability-acromicria-premature menopause syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5117105[PMID],3,3
Malformation syndrome,Polyneuropathy-intellectual disability-acromicria-premature menopause syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5117105[PMID],0,0
Category,Secondary interstitial lung disease specific to childhood associated with a metabolic disease,,,,,,,,,,,,,
Disease,Cronkhite-Canada syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25004941[PMID],500,500
Disease,Cronkhite-Canada syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25004941[PMID],0,0
Category,Interstitial lung disease specific to adulthood,,,,,,,,,,,,,
Category,Primary interstitial lung disease specific to adulthood,,,,,,,,,,,,,
Malformation syndrome,Crossed polysyndactyly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8042663[PMID]_20127219 [PMID],12,12
Malformation syndrome,Crossed polysyndactyly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8042663[PMID]_20127219 [PMID],0,0
Category,Secondary interstitial lung disease specific to adulthood associated with a systemic disease,,,,,,,,,,,,,
Malformation syndrome,Polysyndactyly-cardiac malformation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12749069[PMID]_19400539[PMID],8,8
Malformation syndrome,Polysyndactyly-cardiac malformation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12749069[PMID]_19400539[PMID],0,0
Category,Interstitial lung disease in childhood and adulthood,,,,,,,,,,,,,
Category,Primary interstitial lung disease in childhood and adulthood,,,,,,,,,,,,,
Category,Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder,,,,,,,,,,,,,
Malformation syndrome,Porencephaly-cerebellar hypoplasia-internal malformations syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8737647[PMID],2,2
Malformation syndrome,Porencephaly-cerebellar hypoplasia-internal malformations syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8737647[PMID],0,0
Category,Primary interstitial lung disease in childhood and adulthood due to alveolar vascular disorder,,,,,,,,,,,,,
Category,Secondary interstitial lung disease in childhood and adulthood,,,,,,,,,,,,,
Disease,Porencephaly,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Porencephaly,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,18383510[PMID],3.5,3.5
Disease,Porencephaly,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,26545857[PMID],5.2,5.2
Malformation syndrome,Pitt-Hopkins syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT]_30677142[PMID],0,0
Malformation syndrome,Pitt-Hopkins syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Brachyolmia-amelogenesis imperfecta syndrome,,,,,,,,,,,,,
Malformation syndrome,Leri pleonosteosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Partial duplication of the short arm of chromosome 1,,,,,,,,,,,,,
Disease,POEMS syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,POEMS syndrome,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,22338030[PMID],0.33,0.33
Malformation syndrome,Trisomy 8p,,,,,,,,,,,,,
Disease,Hereditary acrokeratotic poikiloderma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4253719[PMID]_7015974[PMID],0,0
Disease,Hereditary acrokeratotic poikiloderma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4253719[PMID]_7015974[PMID],41,41
Malformation syndrome,Poland syndrome,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,205132[PMID],3.1,3.1
Malformation syndrome,Poland syndrome,1-9 / 100 000,Canada,409966,409966,25965,25965,en,Not yet validated,410294,410294,205132[PMID],0,0
Malformation syndrome,Poland syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],1.5,1.5
Malformation syndrome,Poland syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0,0
Disease,Glycogen storage disease due to liver phosphorylase kinase deficiency,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Glycogen storage disease due to liver phosphorylase kinase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Interstitial lung disease specific to childhood,,,,,,,,,,,,,
Malformation syndrome,Postaxial polydactyly-dental and vertebral anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,187745[PMID],3,3
Malformation syndrome,Postaxial polydactyly-dental and vertebral anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_187745[PMID],0,0
Category,Primary interstitial lung disease specific to childhood due to alveolar structure disorder,,,,,,,,,,,,,
Malformation syndrome,Polydactyly-myopia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3802559[PMID],1,1
Malformation syndrome,Polydactyly-myopia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3802559[PMID],0,0
Category,Primary interstitial lung disease specific to childhood,,,,,,,,,,,,,
Category,Primary interstitial lung disease specific to childhood due to alveolar vascular disorder,,,,,,,,,,,,,
Malformation syndrome,Orofaciodigital syndrome type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7150858[PMID]_23972372[PMID],12,12
Malformation syndrome,Orofaciodigital syndrome type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7150858[PMID]_23972372[PMID],0,0
Disease,Hereditary pulmonary alveolar proteinosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20622029[PMID],0,0
Malformation syndrome,Oliver syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16278897[PMID],7,7
Malformation syndrome,Oliver syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16278897[PMID],0,0
Disease,Isolated pulmonary capillaritis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Preaxial polydactyly-colobomata-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3441111[PMID],0,0
Malformation syndrome,Preaxial polydactyly-colobomata-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3441111[PMID],2,2
Disease,Congenital chylothorax,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital chylothorax,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,25480460[PMID],4.17,4.17
Morphological anomaly,Triopia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17558850[PMID],0,0
Clinical group,Pulmonary arterial hypertension associated with congenital heart disease,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID],0.17,0.17
Clinical group,Pulmonary arterial hypertension associated with congenital heart disease,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,16456139[PMID],0.026,0.026
Clinical group,Pulmonary arterial hypertension associated with congenital heart disease,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21885399[PMID]_17360728[PMID],0.95,0.95
Clinical group,Pulmonary arterial hypertension associated with congenital heart disease,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,21885399[PMID]_17360728[PMID],0.2,0.2
Clinical group,Pulmonary arterial hypertension associated with congenital heart disease,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22362843[PMID],0.3,0.3
Clinical group,Pulmonary arterial hypertension associated with congenital heart disease,1-9 / 1 000 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,24629043[PMID],0.46,0.46
Clinical group,Pulmonary arterial hypertension associated with congenital heart disease,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,24629043[PMID],0.22,0.22
Clinical group,Pulmonary arterial hypertension associated with congenital heart disease,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,24794056[PMID],0,0
Clinical group,Pulmonary arterial hypertension associated with congenital heart disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22362843[PMID]_16456139[PMID]_24629043[PMID]_21885399[PMID]_17360728[PMID],0.57,0.57
Clinical group,Pulmonary arterial hypertension associated with HIV infection,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Pulmonary arterial hypertension associated with portal hypertension,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal trisomy 19q,,,,,,,,,,,,,
Malformation syndrome,Trismus-pseudocamptodactyly syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Pulmonary arterial hypertension associated with schistosomiasis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Trigonocephaly-bifid nose-acral anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2063891[PMID],2,2
Malformation syndrome,Trigonocephaly-bifid nose-acral anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2063891[PMID],0,0
Etiological subtype,Heritable pulmonary arterial hypertension,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID]_ORPHANET,0.08,0.08
Etiological subtype,Heritable pulmonary arterial hypertension,<1 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID]_ORPHANET,0.08,0.08
Etiological subtype,Heritable pulmonary arterial hypertension,1-9 / 1 000 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,24629043[PMID]_ORPHANET,0.8,0.8
Clinical group,Drug- or toxin-induced pulmonary arterial hypertension,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID]_ORPHANET,0,0
Category,Pulmonary arterial hypertension associated with another disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Trigonocephaly-short stature-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6168197[PMID],3,3
Malformation syndrome,Trigonocephaly-short stature-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6168197[PMID],0,0
Clinical group,Pulmonary arterial hypertension associated with connective tissue disease,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID],0.23,0.23
Clinical group,Pulmonary arterial hypertension associated with connective tissue disease,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,16456139[PMID],0.036,0.036
Clinical group,Pulmonary arterial hypertension associated with connective tissue disease,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22362843[PMID],0.25,0.25
Clinical group,Pulmonary arterial hypertension associated with connective tissue disease,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21885399[PMID]_17360728[PMID],1.25,1.25
Clinical group,Pulmonary arterial hypertension associated with connective tissue disease,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,21885399[PMID]_17360728[PMID],0.25,0.25
Clinical group,Pulmonary arterial hypertension associated with connective tissue disease,1-9 / 1 000 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,24629043[PMID],0.25,0.25
Clinical group,Pulmonary arterial hypertension associated with connective tissue disease,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,24629043[PMID],0.12,0.12
Clinical group,Pulmonary arterial hypertension associated with connective tissue disease,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,24629043[PMID]_22362843[PMID]_16456139[PMID]_21885399[PMID]_17360728[PMID],0.25,0.25
Malformation syndrome,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25480986[PMID],14,14
Malformation syndrome,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25480986[PMID],0,0
Category,Beta-thalassemia and related diseases,,,,,,,,,,,,,
Category,Sickle cell disease and related diseases,,,,,,,,,,,,,
Disease,Lysosomal acid lipase deficiency,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.27,0.27
Disease,Lysosomal acid lipase deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],2,2
Morphological anomaly,Isolated trigonocephaly,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,21931569[PMID]_19326483[PMID],6.7,6.7
Malformation syndrome,Trigonocephaly-broad thumbs syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1271432[PMID],2,2
Malformation syndrome,Trigonocephaly-broad thumbs syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1271432[PMID],0,0
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID],0.59,0.59
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,16456139[PMID],0.1,0.1
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22362843[PMID],0.56,0.56
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,22362843[PMID],0.12,0.12
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 100 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,24629043[PMID],1.4,1.4
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,24629043[PMID],0.62,0.62
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,18587690[PMID],0.86,0.86
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,18587690[PMID],0.12,0.12
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,21885399[PMID]_17360728[PMID],0.25,0.25
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21885399[PMID]_17360728[PMID],1.7,1.7
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,20558556[PMID],0.11,0.11
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,8692238[PMID],0.17,0.17
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,Israel,409967,409967,25958,25958,en,Validated,410293,410293,11399707[PMID],0.14,0.14
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 1 000 000,Israel,409966,409966,25958,25958,en,Validated,410293,410293,11399707[PMID],0.8,0.8
Etiological subtype,Idiopathic pulmonary arterial hypertension,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID]_22362843[PMID]_18587690[PMID]_21885399[PMID]_17360728[PMID]_24629043[PMID],1.1,1.1
Category,Rare hemorrhagic disorder due to a constitutional thrombocytopenia,,,,,,,,,,,,,
Category,Rare hemorrhagic disorder due to a qualitative platelet defect,,,,,,,,,,,,,
Malformation syndrome,Trichodysplasia-xeroderma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3608221[PMID],1,1
Malformation syndrome,Trichodysplasia-xeroderma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3608221[PMID],0,0
Category,Genetic infertility,,,,,,,,,,,,,
Category,Alpha-thalassemia and related diseases,,,,,,,,,,,,,
Malformation syndrome,Upington disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5316541[PMID],1,1
Malformation syndrome,Upington disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5316541[PMID],0,0
Disease,Benign epithelial tumor of salivary glands,,,,,,,,,,,,,
Malformation syndrome,Urban-Rogers-Meyer syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,758422[PMID]_3239569[PMID],3,3
Malformation syndrome,Urban-Rogers-Meyer syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_758422[PMID]_3239569[PMID],0,0
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.73,0.73
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.85,0.85
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.986,0.986
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.809,0.809
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.737,0.737
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.98,0.98
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.817,0.817
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.864,0.864
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.937,0.937
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.899,0.899
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.99,0.99
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.657,0.657
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.919,0.919
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.906,0.906
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.786,0.786
Disease,Malignant epithelial tumor of salivary glands,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.906,0.906
Disease,Malignant epithelial tumor of salivary glands,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.121,1.121
Disease,Malignant epithelial tumor of salivary glands,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.026,1.026
Disease,Malignant epithelial tumor of salivary glands,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.261,1.261
Disease,Malignant epithelial tumor of salivary glands,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.113,1.113
Disease,Malignant epithelial tumor of salivary glands,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.127,1.127
Disease,Malignant epithelial tumor of salivary glands,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.093,1.093
Disease,Malignant epithelial tumor of salivary glands,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.227,1.227
Disease,Malignant epithelial tumor of salivary glands,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.213,1.213
Clinical group,Multiple endocrine neoplasia,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,2575263[PMID],0.05,0.05
Clinical group,Multiple endocrine neoplasia,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,VACTERL with hydrocephalus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,VACTERL with hydrocephalus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Multiple endocrine neoplasia type 4,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic frontotemporal degeneration with dementia,,,,,,,,,,,,,
Morphological anomaly,Uhl anomaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,84,84
Morphological anomaly,Uhl anomaly,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1,1
Morphological anomaly,Uhl anomaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic neurodegenerative disease with dementia,,,,,,,,,,,,,
Malformation syndrome,Ulbright-Hodes syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6711618[PMID]_2240030[PMID],3,3
Malformation syndrome,Ulbright-Hodes syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6711618[PMID]_2240030[PMID],0,0
Category,Rare tumor of salivary glands,,,,,,,,,,,,,
Disease,Bile acid CoA ligase deficiency and defective amidation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Frontotemporal dementia with motor neuron disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Humerus trochlea aplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Mead 1963[AUTHOR],5,5
Malformation syndrome,Humerus trochlea aplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],4.3,4.3
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],4.8,4.8
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.8,5.8
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],9.8,9.8
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.8,5.8
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.5,5.5
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],3.6,3.6
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],2.8,2.8
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.8,5.8
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],3.3,3.3
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],2.2,2.2
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.9,1.9
Morphological anomaly,Truncus arteriosus,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],12.6,12.6
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],7.7,7.7
Morphological anomaly,Truncus arteriosus,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],6.4,6.4
Morphological anomaly,Truncus arteriosus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Behavioral variant of frontotemporal dementia,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,22950490[PMID],4,4
Disease,Hemolytic disease of the newborn with Kell alloimmunization,>1 / 1000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,2081378[PMID],116,116
Disease,Hemolytic disease of the newborn with Kell alloimmunization,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Isolated anterior cervical hypertrichosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Isolated anterior cervical hypertrichosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Neural tube defect,6-9 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention 2004[INST]_26108864[PMID],55,55
Category,Neural tube defect,6-9 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],91.05,91.05
Category,Neural tube defect,6-9 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],88.75,88.75
Category,Neural tube defect,6-9 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2009[REG],76.8,76.8
Category,Neural tube defect,6-9 / 10 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 2000-2009[REG],74.7,74.7
Category,Neural tube defect,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2010[REG],47.9,47.9
Category,Neural tube defect,>1 / 1000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],109.6,109.6
Category,Neural tube defect,6-9 / 10 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1993-2010[REG],86.7,86.7
Category,Neural tube defect,>1 / 1000,France,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],120.2,120.2
Category,Neural tube defect,>1 / 1000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],138.25,138.25
Category,Neural tube defect,6-9 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1998-2010[REG],67.2,67.2
Category,Neural tube defect,6-9 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],87.4,87.4
Category,Neural tube defect,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],54.65,54.65
Category,Neural tube defect,>1 / 1000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2010[REG],109.5,109.5
Category,Neural tube defect,6-9 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],84.2,84.2
Category,Neural tube defect,6-9 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1999-2011[REG],92.7,92.7
Category,Neural tube defect,6-9 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1999-2010[REG],92.5,92.5
Category,Neural tube defect,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2010[REG],47.3,47.3
Category,Neural tube defect,6-9 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2010[REG],98.5,98.5
Category,Neural tube defect,>1 / 1000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],101.7,101.7
Category,Neural tube defect,>1 / 1000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG],115.5,115.5
Category,Neural tube defect,>1 / 1000,China,409968,409968,25958,25958,en,Validated,410293,410293,16575897[PMID],1387,1387
Category,Neural tube defect,1-5 / 10 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,23990401[PMID],31,31
Category,Hemolytic disease due to fetomaternal alloimmunization,,,,,,,,,,,,,
Clinical group,Pulmonary hypertension owing to lung disease and/or hypoxia,,,,,,,,,,,,,
Malformation syndrome,Mosaic trisomy 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23276565[PMID],22,22
Malformation syndrome,Mosaic trisomy 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23276565[PMID],0,0
Clinical group,Pulmonary arterial hypertension associated with chronic hemolytic anemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Mosaic trisomy 20,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23548241[PMID],0,0
Category,Syndrome with pulmonary hypertension as a major feature,,,,,,,,,,,,,
Malformation syndrome,Mosaic trisomy 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28099615[PMID]_21056320[PMID],31,31
Malformation syndrome,Mosaic trisomy 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28099615[PMID]_21056320[PMID],0,0
Clinical group,Pulmonary hypertension with unclear multifactorial mechanism,,,,,,,,,,,,,
Category,Genetic cardiac tumor,,,,,,,,,,,,,
Category,Genetic soft tissue tumor,,,,,,,,,,,,,
Malformation syndrome,Hypoplastic tibiae-postaxial polydactyly syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Genetic digestive tract tumor,,,,,,,,,,,,,
Malformation syndrome,Tibial aplasia-ectrodactyly syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Malformation syndrome,Absent tibia-polydactyly-arachnoid cyst syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8592337[PMID],3,3
Malformation syndrome,Absent tibia-polydactyly-arachnoid cyst syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8592337[PMID],0,0
Malformation syndrome,Thyrocerebrorenal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,728567[PMID],2,2
Malformation syndrome,Thyrocerebrorenal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_728567[PMID],0,0
Malformation syndrome,Thymic-renal-anal-lung dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2260572[PMID],3,3
Malformation syndrome,Thymic-renal-anal-lung dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2260572[PMID],0,0
Disease,Hoyeraal-Hreidarsson syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hoyeraal-Hreidarsson syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23453664[PMID]_23453664[PMID]_23329068[PMID],33,33
Malformation syndrome,Thoracolaryngopelvic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,Thoracolaryngopelvic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Thomas syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8456859[PMID]_8882777[PMID],6,6
Malformation syndrome,Thomas syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8456859[PMID]_8882777[PMID],0,0
Disease,"Thiemann disease, familial form",,,,,,,,,,,,,
Malformation syndrome,Trichoodontoonychial dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6859125[PMID],4,4
Malformation syndrome,Trichoodontoonychial dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6859125[PMID],0,0
Disease,Preeclampsia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],45,45
Malformation syndrome,L1 syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Trichodermodysplasia-dental alterations syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3720011[PMID],3,3
Malformation syndrome,Trichodermodysplasia-dental alterations syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3720011[PMID],0,0
Disease,Myostatin-related muscle hypertrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Dianzani autoimmune lymphoproliferative disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dianzani autoimmune lymphoproliferative disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Malformation syndrome,Trichodental syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8574424[PMID],5,5
Malformation syndrome,Trichodental syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8574424[PMID],0,0
Disease,Autoimmune lymphoproliferative syndrome with recurrent viral infections,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12353035[PMID],0,0
Disease,Autoimmune lymphoproliferative syndrome with recurrent viral infections,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12353035[PMID]_Dr Koneti RAO[EXPERT],1,1
Malformation syndrome,Tricho-dento-osseous syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Tricho-dento-osseous syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Tremor-nystagmus-duodenal ulcer syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1248168[PMID],17,17
Disease,Tremor-nystagmus-duodenal ulcer syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1248168[PMID],0,0
Malformation syndrome,Weismann-Netter syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19839038[PMID],100,100
Malformation syndrome,Weismann-Netter syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19839038[PMID],0,0
Clinical syndrome,Mounier-Kühn syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_25130790[PMID],300,300
Clinical syndrome,Mounier-Kühn syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25130790[PMID],0,0
Malformation syndrome,Torticollis-keloids-cryptorchidism-renal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12725596[PMID]_4387470[PMID],7,7
Malformation syndrome,Torticollis-keloids-cryptorchidism-renal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12725596[PMID]_4387470[PMID],0,0
Category,Rare genetic systemic or rheumatologic disease,,,,,,,,,,,,,
Malformation syndrome,Arterial tortuosity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29323665[PMID],102,102
Malformation syndrome,Arterial tortuosity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29323665[PMID],0,0
Malformation syndrome,Toriello-Lacassie-Droste syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25251940[PMID],19,19
Malformation syndrome,Toriello-Lacassie-Droste syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25251940[PMID],0,0
Clinical group,Hereditary ATTR amyloidosis,,,,,,,,,,,,,
Category,Genetic cardiac anomaly,,,,,,,,,,,,,
Category,Genetic neuroendocrine tumor,,,,,,,,,,,,,
Malformation syndrome,Toriello-Carey syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27510950[PMID],59,59
Malformation syndrome,Toriello-Carey syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27510950[PMID],0,0
Category,Genetic urogenital tumor,,,,,,,,,,,,,
Malformation syndrome,XK aprosencephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,XK aprosencephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic syndrome with a cerebellar malformation as major feature,,,,,,,,,,,,,
Category,Genetic syndrome with a Dandy-Walker malformation as major feature,,,,,,,,,,,,,
Malformation syndrome,Yunis-Varon syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23623387[PMID],25,25
Malformation syndrome,Yunis-Varon syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature,,,,,,,,,,,,,
Disease,Young syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital amegakaryocytic thrombocytopenia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital amegakaryocytic thrombocytopenia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21337678[PMID]_22102270[PMID],100,100
Disease,Congenital amegakaryocytic thrombocytopenia,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.15,0.15
Malformation syndrome,Zimmermann-Laband syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23994350[PMID],52,52
Malformation syndrome,Zimmermann-Laband syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Wilson-Turner syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1746601[PMID]_22889856[PMID],28,28
Malformation syndrome,Wilson-Turner syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1746601[PMID]_22889856[PMID],0,0
Category,Other syndrome with a central nervous system malformation as major feature,,,,,,,,,,,,,
Category,Syndrome with a Dandy-Walker malformation as major feature,,,,,,,,,,,,,
Category,Genetic non-syndromic central nervous system malformation,,,,,,,,,,,,,
Disease,Woodhouse-Sakati syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18175354[PMID],25,25
Disease,Woodhouse-Sakati syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18175354[PMID],0,0
Category,Genetic cerebral malformation,,,,,,,,,,,,,
Category,Genetic posterior fossa malformation,,,,,,,,,,,,,
Disease,WT limb-blood syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,890097[PMID],3,3
Disease,WT limb-blood syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_890097[PMID],0,0
Category,Genetic cerebellar malformation,,,,,,,,,,,,,
Malformation syndrome,Worster-Drought syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,3.7,3.7
Category,Genetic syndrome with a central nervous system malformation as major feature,,,,,,,,,,,,,
Clinical group,Oromandibular-limb hypogenesis syndrome,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Baraitser-Winter cerebrofrontofacial syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27625340[PMID],60,60
Malformation syndrome,Baraitser-Winter cerebrofrontofacial syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27625340[PMID],0,0
Malformation syndrome,Arthrogryposis-ectodermal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1590979[PMID],2,2
Malformation syndrome,Arthrogryposis-ectodermal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1590979[PMID],0,0
Malformation syndrome,Symbrachydactyly of hands and feet,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9555583[PMID],2,2
Malformation syndrome,Symbrachydactyly of hands and feet,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9555583[PMID],0,0
Disease,Sweet syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Sweet syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17655751[PMID],0,0
Malformation syndrome,Acromelic frontonasal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15264282[PMID]_25105228[PMID]_26706854[PMID],22,22
Malformation syndrome,Acromelic frontonasal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15264282[PMID]_25105228[PMID]_26706854[PMID],0,0
Clinical group,X-linked intellectual disability-epilepsy syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,Isolated focal cortical dysplasia type Ib,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,Isolated focal cortical dysplasia type Ic,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Velo-facial-skeletal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7573161[PMID],2,2
Malformation syndrome,Velo-facial-skeletal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7573161[PMID],0,0
Histopathological subtype,Isolated focal cortical dysplasia type Ia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,Isolated focal cortical dysplasia type IIb,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Microcephaly-brachydactyly-kyphoscoliosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1884519[PMID],3,3
Malformation syndrome,Microcephaly-brachydactyly-kyphoscoliosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1884519[PMID],0,0
Clinical group,Encephaloclastic disorder,,,,,,,,,,,,,
Clinical subtype,Isolated focal cortical dysplasia type II,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Verloove Vanhorick-Brubakk syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7324930[PMID],2,2
Malformation syndrome,Verloove Vanhorick-Brubakk syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7324930[PMID],0,0
Histopathological subtype,Isolated focal cortical dysplasia type IIa,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Van den Ende-Gupta syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24478002[PMID],29,29
Malformation syndrome,Van den Ende-Gupta syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24478002[PMID],0,0
Morphological anomaly,Bilateral polymicrogyria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Unilateral polymicrogyria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Hyperostosis corticalis generalisata,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26968112[PMID],35,35
Malformation syndrome,Hyperostosis corticalis generalisata,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26968112[PMID],0,0
Category,Midline cerebral malformation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Isolated arhinencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Isolated focal cortical dysplasia type I,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Unilateral focal polymicrogyria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Van den Bosch syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI:10.1159/000303582[OTHER],1,1
Malformation syndrome,Van den Bosch syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI:10.1159/000303582[OTHER],0,0
Clinical group,Cerebral cortical dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Pontine tegmental cap dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21651769[PMID]_21705787[PMID],22,22
Morphological anomaly,Pontine tegmental cap dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autoimmune polyendocrinopathy type 1,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Disease,Autoimmune polyendocrinopathy type 1,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Autoimmune polyendocrinopathy type 1,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Global cerebellar malformation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Weaver-Williams syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,890101[PMID],2,2
Malformation syndrome,Weaver-Williams syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_890101[PMID],0,0
Morphological anomaly,Isolated bilateral hemispheric cerebellar hypoplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Weill-Marchesani syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301293[PMID],1,1
Morphological anomaly,Isolated unilateral hemispheric cerebellar hypoplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Wildervanck syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20534924[PMID],0,0
Category,Syndrome with microcephaly as major feature,,,,,,,,,,,,,
Category,Syndrome with a cerebellar malformation as major feature,,,,,,,,,,,,,
Clinical subtype,Congenital non-communicating hydrocephalus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Intellectual disability-developmental delay-contractures syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_23623388[PMID],5,5
Malformation syndrome,Intellectual disability-developmental delay-contractures syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Wiedemann-Rautenstrauch syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28447407[PMID],54,54
Malformation syndrome,Wiedemann-Rautenstrauch syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28447407[PMID],0,0
Clinical subtype,Congenital communicating hydrocephalus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Isolated cerebellar vermis agenesis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10488899[PMID]_7724272[PMID],0,0
Morphological anomaly,Glioependymal/ependymal cyst,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,MMEP syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Central nervous system cystic malformation,,,,,,,,,,,,,
Clinical subtype,Isolated Dandy-Walker malformation without hydrocephalus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Isolated Dandy-Walker malformation with hydrocephalus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Isolated partial cerebellar vermis agenesis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Isolated total cerebellar vermis agenesis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spondyloperipheral dysplasia-short ulna syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23545312[PMID],0,0
Disease,Spondyloperipheral dysplasia-short ulna syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23545312[PMID],10,10
Clinical subtype,Autoimmune pancreatitis type 2,,,,,,,,,,,,,
Morphological anomaly,Sprengel deformity,,,,,,,,,,,,,
Clinical subtype,Autoimmune pancreatitis type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14678799[PMID]_21388311[PMID],1,1
Disease,Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21388311[PMID],0,0
Malformation syndrome,Distal monosomy 12p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21144913[PMID],8,8
Malformation syndrome,Distal monosomy 12p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Pelizaeus-Merzbacher-like disease due to AIMP1 mutation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare disorder,,,,,,,,,,,,,
Category,Rare pediatric vasculitis,,,,,,,,,,,,,
Malformation syndrome,Corneodermatoosseous syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6234802[PMID],7,7
Malformation syndrome,Corneodermatoosseous syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6234802[PMID],0,0
Disease,Autosomal semi-dominant severe lipodystrophic laminopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21346069[PMID],7,7
Disease,Autosomal semi-dominant severe lipodystrophic laminopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Erythropoietic uroporphyria associated with myeloid malignancy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary hyperekplexia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,150,150
Disease,Hereditary hyperekplexia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Stimmler syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5477682[PMID],2,2
Malformation syndrome,Stimmler syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5477682[PMID],0,0
Category,Rare pediatric systemic disease,,,,,,,,,,,,,
Malformation syndrome,Steatocystoma multiplex-natal teeth syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare systemic or rheumatological disease of childhood,,,,,,,,,,,,,
Malformation syndrome,Holoprosencephaly-radial heart renal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20583155[PMID],4,4
Malformation syndrome,Holoprosencephaly-radial heart renal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20583155[PMID],0,0
Malformation syndrome,Subaortic stenosis-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,573203[PMID],1,1
Malformation syndrome,Subaortic stenosis-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_573203[PMID],0,0
Morphological anomaly,Supravalvular aortic stenosis,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Morphological anomaly,Supravalvular aortic stenosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],13.3,13.3
Disease,PLIN1-related familial partial lipodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21345103[PMID],3,3
Disease,PLIN1-related familial partial lipodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Deaf blind hypopigmentation syndrome, Yemenite type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2280978[PMID],2,2
Malformation syndrome,"Deaf blind hypopigmentation syndrome, Yemenite type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Inherited prion disease,,,,,,,,,,,,,
Malformation syndrome,Familial omphalocele syndrome with facial dysmorphism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21333766[PMID],5,5
Malformation syndrome,Familial omphalocele syndrome with facial dysmorphism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial steroid-resistant nephrotic syndrome with sensorineural deafness,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21540551[PMID],13,13
Disease,Familial steroid-resistant nephrotic syndrome with sensorineural deafness,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Summitt syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,474616[PMID],3,3
Malformation syndrome,Summitt syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_474616[PMID],0,0
Malformation syndrome,Ventricular extrasystoles with syncopal episodes-perodactyly-Robin sequence syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21330303[PMID],12,12
Disease,Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial Alzheimer-like prion disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21416485[PMID],2,2
Disease,Familial Alzheimer-like prion disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21416485[PMID],0,0
Malformation syndrome,Nestor-Guillermo progeria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21932319[PMID]_21549337[PMID],2,2
Malformation syndrome,Nestor-Guillermo progeria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Deafness-enamel hypoplasia-nail defects syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26387595[PMID]_27633571[PMID]_27302843[PMID],15,15
Malformation syndrome,Deafness-enamel hypoplasia-nail defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26387595[PMID]_27633571[PMID]_27302843[PMID],0,0
Malformation syndrome,Fountain syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8897038[PMID],8,8
Malformation syndrome,Fountain syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8897038[PMID],0,0
Disease,Phosphoribosylpyrophosphate synthetase superactivity,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23190330[PMID],30,30
Disease,Phosphoribosylpyrophosphate synthetase superactivity,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Chondrodysplasia with joint dislocations, gPAPP type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21549340[PMID],4,4
Malformation syndrome,"Chondrodysplasia with joint dislocations, gPAPP type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Deafness-small bowel diverticulosis-neuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4028504[PMID],5,5
Disease,Deafness-small bowel diverticulosis-neuropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4028504[PMID],0,0
Disease,Fatal infantile hypertonic myofibrillar myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21337604[PMID]_22734908[PMID],11,11
Disease,Fatal infantile hypertonic myofibrillar myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21337604[PMID]_22734908[PMID],0,0
Malformation syndrome,Warsaw breakage syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20137776[PMID]_21490908[PMID]_23033317[PMID],4,4
Malformation syndrome,Warsaw breakage syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Conductive deafness-malformed external ear syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5771216[PMID]_624552[PMID],8,8
Malformation syndrome,Conductive deafness-malformed external ear syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5771216[PMID]_624552[PMID],0,0
Malformation syndrome,Deafness-epiphyseal dysplasia-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8867655[PMID],2,2
Malformation syndrome,Deafness-epiphyseal dysplasia-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8867655[PMID],0,0
Clinical subtype,Calciphylaxis cutis,,,,,,,,,,,,,
Malformation syndrome,Nijmegen breakage syndrome,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301355[PMID],1,1
Malformation syndrome,Nijmegen breakage syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Calciphylaxis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],5,5
Clinical syndrome,Postorgasmic illness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical syndrome,Postorgasmic illness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21241453[PMID],45,45
Disease,Hereditary neutrophilia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19620628[PMID],16,16
Disease,Hereditary neutrophilia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19620628[PMID],0,0
Disease,"Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,"Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29137425[PMID]_[EXPERT],100,100
Malformation syndrome,Sclerosteosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301406[PMID],80,80
Malformation syndrome,Sclerosteosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301406[PMID],0,0
Disease,Paraneoplastic uveitis,,,,,,,,,,,,,
Disease,Infectious panuveitis,,,,,,,,,,,,,
Disease,Infectious anterior uveitis,,,,,,,,,,,,,
Disease,Severe combined immunodeficiency due to LCK deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9664084[PMID]_22985903[PMID],4,4
Disease,Severe combined immunodeficiency due to LCK deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Omphalocele syndrome, Shprintzen-Goldberg type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16411191[PMID],5,5
Malformation syndrome,"Omphalocele syndrome, Shprintzen-Goldberg type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16411191[PMID],0,0
Malformation syndrome,Sillence syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,671485[PMID],5,5
Malformation syndrome,Sillence syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Complement component 3 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21664996[PMID],27,27
Disease,Complement component 3 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21664996[PMID],0,0
Malformation syndrome,SHORT syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26497935[PMID],32,32
Malformation syndrome,SHORT syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26497935[PMID],0,0
Malformation syndrome,Atrial septal defect-atrioventricular conduction defects syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9561886[PMID],11,11
Malformation syndrome,Atrial septal defect-atrioventricular conduction defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Senior-Loken syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:1438120958[OTHER],150,150
Disease,Senior-Loken syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:1438120958[OTHER],0,0
Disease,ALG11-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28122681[PMID],8,8
Disease,ALG11-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28122681[PMID],0,0
Clinical subtype,Visceral calciphylaxis,,,,,,,,,,,,,
Malformation syndrome,Septo-optic dysplasia spectrum,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Malformation syndrome,Septo-optic dysplasia spectrum,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,Spondylocamptodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8591666[PMID],5,5
Malformation syndrome,Spondylocamptodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8591666[PMID],0,0
Clinical subtype,"Pelizaeus-Merzbacher disease, connatal form",<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.03,0.03
Clinical subtype,"Pelizaeus-Merzbacher disease, classic form",1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.17,0.17
Malformation syndrome,Microform holoprosencephaly,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Spinocerebellar degeneration-corneal dystrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3872072[PMID],2,2
Malformation syndrome,Spinocerebellar degeneration-corneal dystrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3872072[PMID],0,0
Clinical subtype,Laryngotracheoesophageal cleft type 0,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,X-linked spasticity-intellectual disability-epilepsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12177367[PMID],6,6
Disease,X-linked spasticity-intellectual disability-epilepsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12177367[PMID],0,0
Clinical subtype,Septopreoptic holoprosencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Eyebrow duplication-syndactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3359678[PMID]_2736796[PMID],3,3
Malformation syndrome,Eyebrow duplication-syndactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3359678[PMID]_2736796[PMID],0,0
Biological anomaly,Methylmalonic aciduria due to transcobalamin receptor defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20524213[PMID],5,5
Biological anomaly,Methylmalonic aciduria due to transcobalamin receptor defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare disease,,,,,,,,,,,,,
Clinical subtype,Pelizaeus-Merzbacher-like disease due to GJC2 mutation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pelizaeus-Merzbacher-like disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Null syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Spondyloenchondrodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16470600[PMID],36,36
Malformation syndrome,Spondyloenchondrodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16470600[PMID],0,0
Clinical subtype,"Pelizaeus-Merzbacher disease, transitional form",<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.03,0.03
Malformation syndrome,Autosomal dominant spondylocostal dysostosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Pelizaeus-Merzbacher disease in female carriers,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal dominant hyperinsulinism due to Kir6.2 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Cenani-Lenz syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Malformation syndrome,Cenani-Lenz syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant hyperinsulinism due to SUR1 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Dobrow syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6580396[PMID]_15365455[PMID],2,2
Malformation syndrome,Dobrow syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6580396[PMID]_15365455[PMID],0,0
Disease,Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Diazoxide-resistant hyperinsulinism,,,,,,,,,,,,,
Disease,Adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Humero-radial synostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,150,150
Morphological anomaly,Humero-radial synostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Humero-radio-ulnar synostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Morphological anomaly,Humero-radio-ulnar synostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Sporadic pheochromocytoma,,,,,,,,,,,,,
Morphological anomaly,Familial lambdoid synostosis,,,,,,,,,,,,,
Disease,Sporadic pheochromocytoma/secreting paraganglioma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Radioulnar synostosis-microcephaly-scoliosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20635354[PMID],13,13
Malformation syndrome,Radioulnar synostosis-microcephaly-scoliosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20635354[PMID],0,0
Malformation syndrome,Symptomatic form of Coffin-Lowry syndrome in female carriers,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Radioulnar synostosis-developmental delay-hypotonia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1384331[PMID]_18618994[PMID],4,4
Malformation syndrome,Radioulnar synostosis-developmental delay-hypotonia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1384331[PMID]_18618994[PMID],0,0
Clinical subtype,Sporadic secreting paraganglioma,,,,,,,,,,,,,
Malformation syndrome,Spondylocarpotarsal synostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29566257[PMID],35,35
Malformation syndrome,Spondylocarpotarsal synostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29566257[PMID],0,0
Disease,Apolipoprotein A-I deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17991756[PMID],30,30
Disease,Apolipoprotein A-I deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Apolipoprotein A-I deficiency,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],0,0
Morphological anomaly,Taurodontism,,,,,,,,,,,,,
Malformation syndrome,Teebi-Shaltout syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23918592[PMID],5,5
Malformation syndrome,Teebi-Shaltout syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23918592[PMID],0,0
Malformation syndrome,Telecanthus-hypertelorism-strabismus-pes cavus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3970067[PMID],2,2
Malformation syndrome,Telecanthus-hypertelorism-strabismus-pes cavus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3970067[PMID],0,0
Malformation syndrome,Tel Hashomer camptodactyly syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical syndrome,Spasmus nutans,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Extensor tendons of finger anomalies,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7363507[PMID],2,2
Malformation syndrome,Extensor tendons of finger anomalies,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7363507[PMID],0,0
Clinical subtype,Acute endophthalmitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Chronic endophthalmitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Toxic maculopathy due to antimalarial drugs,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Tetraamelia-multiple malformations syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301453[PMID],0,0
Malformation syndrome,Tetraamelia-multiple malformations syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301453[PMID],5,5
Disease,Primary oculocerebral lymphoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary intraocular lymphoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Primary organ-specific lymphoma,,,,,,,,,,,,,
Malformation syndrome,Fallot complex-intellectual disability-growth delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8010348[PMID]_15578610[PMID],5,5
Malformation syndrome,Fallot complex-intellectual disability-growth delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8010348[PMID]_15578610[PMID],0,0
Malformation syndrome,Thalidomide embryopathy,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.77,0.77
Disease,Intermediate uveitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Infectious posterior uveitis,,,,,,,,,,,,,
Disease,Spinocerebellar ataxia type 36,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25101480[PMID],100,100
Disease,Spinocerebellar ataxia type 36,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25101480[PMID],0,0
Malformation syndrome,Hearing loss-familial salivary gland insensitivity to aldosterone syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2280149[PMID],2,2
Malformation syndrome,Hearing loss-familial salivary gland insensitivity to aldosterone syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2280149[PMID],0,0
Disease,Spinocerebellar ataxia type 35,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30229425[PMID],28,28
Disease,Spinocerebellar ataxia type 35,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,Deafness-lymphedema-leukemia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_21892158[PMID]_20803646[PMID],20,20
Malformation syndrome,Deafness-lymphedema-leukemia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 32,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Jiang_Zhu_Gomez 2010[AUTHOR],1,1
Disease,Spinocerebellar ataxia type 32,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15887301[PMID],2,2
Malformation syndrome,Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15887301[PMID],0,0
Disease,Idiopathic recurrent stupor,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Machado-Joseph disease type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Non-syndromic male infertility due to sperm motility disorder,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Mucopolysaccharidosis type 6, slowly progressing",,,,,,,,,,,,,
Clinical subtype,"Mucopolysaccharidosis type 6, rapidly progressing",,,,,,,,,,,,,
Malformation syndrome,Deafness-oligodontia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_646726[PMID]_485932[PMID]_9720683[PMID],0,0
Malformation syndrome,Deafness-oligodontia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,646726[PMID]_485932[PMID]_9720683[PMID],5,5
Clinical group,Deafness-onychodystrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Clinical group,Deafness-onychodystrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Machado-Joseph disease type 3,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23994570[PMID],0,0
Clinical subtype,Machado-Joseph disease type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Progressive deafness with stapes fixation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Conductive deafness-ptosis-skeletal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,728561[PMID],3,3
Malformation syndrome,Conductive deafness-ptosis-skeletal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_728561[PMID],0,0
Malformation syndrome,Deafness-ear malformation-facial palsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6851230[PMID],4,4
Malformation syndrome,Deafness-ear malformation-facial palsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6851230[PMID],0,0
Malformation syndrome,Cochleosaccular degeneration-cataract syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7121157[PMID]_1623624[PMID],2,2
Malformation syndrome,Cochleosaccular degeneration-cataract syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7121157[PMID]_1623624[PMID],0,0
Malformation syndrome,Deafness-craniofacial syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3690878[PMID],2,2
Malformation syndrome,Deafness-craniofacial syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3690878[PMID],0,0
Malformation syndrome,Hemihyperplasia-multiple lipomatosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9781913[PMID]_20058713[PMID]_19438675[PMID]_20105568[PMID],10,10
Malformation syndrome,Hemihyperplasia-multiple lipomatosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial multinodular goiter,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Deafness-vitiligo-achalasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5100941[PMID],2,2
Malformation syndrome,Deafness-vitiligo-achalasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5100941[PMID],0,0
Malformation syndrome,Cardiospondylocarpofacial syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5901343[PMID]_20186786[PMID],5,5
Malformation syndrome,Cardiospondylocarpofacial syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5901343[PMID]_20186786[PMID],0,0
Malformation syndrome,Multiple synostoses syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Multiple synostoses syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Symphalangism with multiple anomalies of hands and feet,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6272576[PMID],6,6
Malformation syndrome,Symphalangism with multiple anomalies of hands and feet,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6272576[PMID],0,0
Malformation syndrome,10q22.3q23.3 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Limbic encephalitis with caspr2 antibodies,,,,,,,,,,,,,
Malformation syndrome,Renpenning syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20950397[PMID]_16493439[PMID]_17033686[PMID]_11950858[PMID]_[EXPERT],64,64
Malformation syndrome,Renpenning syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hyperbiliverdinemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19580635[PMID]_21278388[PMID],2,2
Disease,Hyperbiliverdinemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Proximal symphalangism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Distal symphalangism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3436086[PMID]_2061594[PMID],8,8
Morphological anomaly,Distal symphalangism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3436086[PMID]_2061594[PMID],0,0
Malformation syndrome,10q22.3q23.3 microduplication syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hypnic headache,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Familial hyperinsulinism,,,,,,,,,,,,,
Malformation syndrome,Filippi syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26813917[PMID],29,29
Malformation syndrome,Filippi syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26813917[PMID],0,0
Disease,Hyperinsulinism due to UCP2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19065272[PMID],2,2
Disease,Hyperinsulinism due to UCP2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Ogden syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21700266[PMID],8,8
Malformation syndrome,Ogden syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Zlotogora-Ogur syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Zlotogora-Ogur syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Disease,Lower motor neuron syndrome with late-adult onset,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25428574[PMID],55,55
Disease,Lower motor neuron syndrome with late-adult onset,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25428574[PMID],0,0
Disease,Combined immunodeficiency due to ZAP70 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Heparin-induced thrombocytopenia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mitochondrial trifunctional protein deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_22000755[PMID],100,100
Disease,Mitochondrial trifunctional protein deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22000755[PMID,0,0
Disease,Mitochondrial trifunctional protein deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],1,1
Disease,Malonic aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23177061[PMID],34,34
Disease,Malonic aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary methemoglobinemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glycogen storage disease due to hepatic glycogen synthase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12072888[PMID],16,16
Disease,Glycogen storage disease due to hepatic glycogen synthase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dysbetalipoproteinemia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,7.8,7.8
Disease,Dysbetalipoproteinemia,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,21354122[PMID]_24314366[PMID],10,10
Disease,Severe hereditary thrombophilia due to congenital protein S deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,Pr Jenny GOUDEMAND [EXPERT],0,0
Disease,Severe hereditary thrombophilia due to congenital protein S deficiency,Unknown,Europe,409968,409968,25958,25958,en,Validated,410293,410293,Pr Jenny GOUDEMAND [EXPERT],0,0
Disease,Familial hyperthyroidism due to mutations in TSH receptor,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial hyperthyroidism due to mutations in TSH receptor,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],28,28
Disease,Congenital factor II deficiency,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,10595621[PMID],0.05,0.05
Disease,Hyperimmunoglobulinemia D with periodic fever,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Hyperimmunoglobulinemia D with periodic fever,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Immunodeficiency by defective expression of MHC class II,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27510876[PMID],179,179
Disease,Immunodeficiency by defective expression of MHC class II,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27510876[PMID],0,0
Disease,Familial thrombomodulin anomalies,,,,,,,,,,,,,
Disease,Herpes simplex virus encephalitis,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,16675036[PMID],0.3,0.3
Disease,Herpes simplex virus encephalitis,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,20657024[PMID],0.3,0.3
Disease,Herpes simplex virus encephalitis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,16675036[PMID],0.3,0.3
Disease,Herpes simplex virus encephalitis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Systemic primary carnitine deficiency,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,22989098[PMID],3.2,3.2
Disease,Systemic primary carnitine deficiency,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22989098[PMID],3.2,3.2
Disease,Systemic primary carnitine deficiency,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,10545605[PMID],2.5,2.5
Disease,Systemic primary carnitine deficiency,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,12788994[PMID],0.83,0.83
Disease,Systemic primary carnitine deficiency,6-9 / 10 000,Faroe Islands,409966,409966,25958,25958,en,Validated,410293,410293,17417720[PMID],77,77
Disease,Systemic primary carnitine deficiency,>1 / 1000,Faroe Islands,409967,409967,25958,25958,en,Validated,410293,410293,17417720[PMID],138.9,138.9
Category,Syndromic microphthalmia-anophthalmia-coloboma,,,,,,,,,,,,,
Category,Anomaly of puberty or/and menstrual cycle of genetic origin,,,,,,,,,,,,,
Disease,Essential fructosuria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Infantile Krabbe disease,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,26795590[PMID],0.254,0.254
Clinical subtype,Infantile Krabbe disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29391017[PMID],0,0
Disease,Sneddon syndrome,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.4,0.4
Disease,Sneddon syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Hypoxanthine-guanine phosphoribosyltransferase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Rolandic epilepsy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Rolandic epilepsy,1-5 / 10 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,16638642[PMID],20,20
Disease,Succinyl-CoA:3-ketoacid CoA transferase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],32,32
Disease,Succinyl-CoA:3-ketoacid CoA transferase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,3-methylcrotonyl-CoA carboxylase deficiency,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2.65,2.65
Disease,3-methylcrotonyl-CoA carboxylase deficiency,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,12872837[PMID],1.9,1.9
Disease,3-methylcrotonyl-CoA carboxylase deficiency,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,11170888[PMID],3.3,3.3
Disease,3-methylcrotonyl-CoA carboxylase deficiency,1-9 / 100 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,20567911[PMID],1.36,1.36
Disease,3-methylcrotonyl-CoA carboxylase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,3-methylcrotonyl-CoA carboxylase deficiency,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,3-hydroxy-3-methylglutaric aciduria,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,19177531[PMID]_[EXPERT],0,0
Disease,3-hydroxy-3-methylglutaric aciduria,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.8,0.8
Disease,3-hydroxy-3-methylglutaric aciduria,<1 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22766612[PMID],0,0
Disease,3-hydroxy-3-methylglutaric aciduria,<1 / 1 000 000,China,409968,409968,25958,25958,en,Validated,410293,410293,19036343[PMID]_29039164[PMID],0,0
Disease,Hemolytic anemia due to diphosphoglycerate mutase deficiency,,,,,,,,,,,,,
Disease,Hemolytic anemia due to glucophosphate isomerase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Hemolytic anemia due to glucophosphate isomerase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Rhizomelic dysplasia, Patterson-Lowry type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15103724[PMID],5,5
Malformation syndrome,"Rhizomelic dysplasia, Patterson-Lowry type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15103724[PMID],0,0
Malformation syndrome,Arachnodactyly-abnormal ossification-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8533819[PMID],5,5
Malformation syndrome,Arachnodactyly-abnormal ossification-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8533819[PMID],0,0
Disease,Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Cataract-deafness-hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8574417[PMID],3,3
Malformation syndrome,Cataract-deafness-hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8574417[PMID],0,0
Disease,Malignant non-dysgerminomatous germ cell tumor of ovary,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Fukutin-related  limb-girdle muscular dystrophy R13,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17878207[PMID]_19342235[PMID]_19179078[PMID],5,5
Disease,Fukutin-related  limb-girdle muscular dystrophy R13,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17878207[PMID]_19342235[PMID]_19179078[PMID],0,0
Malformation syndrome,Craniomicromelic syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Anoctamin-5-related  limb-girdle muscular dystrophy R12,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23670307[PMID],0,0
Malformation syndrome,Caudal appendage-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7894739[PMID],2,2
Malformation syndrome,Caudal appendage-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7894739[PMID],0,0
Disease,POMGNT1-related  limb-girdle muscular dystrophy R15,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18195152[PMID]_22419172[PMID],2,2
Disease,POMGNT1-related  limb-girdle muscular dystrophy R15,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18195152[PMID]_22419172[PMID],0,0
Disease,POMT2-related  limb-girdle muscular dystrophy R14,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17923109[PMID],0,0
Disease,POMT2-related  limb-girdle muscular dystrophy R14,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17923109[PMID],1,1
Disease,Overlap myositis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Syngnathia-cleft palate syndrome,,,,,,,,,,,,,
Disease,Immune-mediated necrotizing myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],300,300
Disease,Immune-mediated necrotizing myopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Autosomal recessive lower motor neuron disease with childhood onset,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16728649[PMID],5,5
Disease,Autosomal recessive lower motor neuron disease with childhood onset,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16728649[PMID],0,0
Disease,Rippling muscle disease with myasthenia gravis,,,,,,,,,,,,,
Clinical subtype,Late-infantile/juvenile Krabbe disease,,,,,,,,,,,,,
Malformation syndrome,Von Voss-Cherstvoy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI:10.2147/IMCRJ.S108746[OTHER],10,10
Malformation syndrome,Von Voss-Cherstvoy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI:10.2147/IMCRJ.S108746[OTHER],0,0
Clinical subtype,Adult Krabbe disease,,,,,,,,,,,,,
Disease,Cystadenoma of childhood,,,,,,,,,,,,,
Disease,Spinal atrophy-ophthalmoplegia-pyramidal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8068160[PMID],2,2
Disease,Spinal atrophy-ophthalmoplegia-pyramidal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8068160[PMID],0,0
Disease,Borderline epithelial tumor of ovary,,,,,,,,,,,,,
Malformation syndrome,Hypomyelination neuropathy-arthrogryposis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24319099[PMID],9,9
Malformation syndrome,Hypomyelination neuropathy-arthrogryposis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24319099[PMID],0,0
Disease,Gonadoblastoma,,,,,,,,,,,,,
Morphological anomaly,Diprosopus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27704687[PMID],33,33
Morphological anomaly,Diprosopus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27704687[PMID],0,0
Morphological anomaly,Diprosopus,1-9 / 1 000 000,Argentina,409968,409968,25958,25958,en,Validated,410293,410293,27704687[PMID],0.2,0.2
Disease,Malignant germ cell tumor of the vagina,,,,,,,,,,,,,
Disease,Vulvovaginal rhabdomyosarcoma,,,,,,,,,,,,,
Malformation syndrome,Müllerian derivatives-lymphangiectasia-polydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8256813[PMID]_11746031[PMID]_11746030[PMID],8,8
Malformation syndrome,Müllerian derivatives-lymphangiectasia-polydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8256813[PMID]_11746031[PMID]_11746030[PMID],0,0
Category,Bulbospinal muscular atrophy,,,,,,,,,,,,,
Disease,Laron syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2003[INST],0.3,0.3
Category,Inclusion myopathy,,,,,,,,,,,,,
Disease,Kallmann syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3.75,3.75
Disease,Kallmann syndrome,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,4147392[PMID],5,5
Disease,Kallmann syndrome,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,21682876[PMID],2.1,2.1
Disease,Kallmann syndrome,1-9 / 1 000 000,Specific population,409967,409967,25958,25958,en,Validated,410293,410293,3791676[PMID],0.6,0.6
Clinical group,Generalized bulbospinal muscular atrophy,,,,,,,,,,,,,
Clinical group,Bulbospinal muscular atrophy of adult,,,,,,,,,,,,,
Disease,Hereditary spherocytosis,1-5 / 10 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,1554800[PMID],50,50
Disease,Hereditary spherocytosis,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,14476391[PMID],20,20
Disease,Hereditary spherocytosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_1554800[PMID],0,0
Disease,Xeroderma pigmentosum,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Xeroderma pigmentosum,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,16905156[PMID],4.5,4.5
Disease,Xeroderma pigmentosum,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,18329345[PMID],0.23,0.23
Disease,Xeroderma pigmentosum,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.19,0.19
Disease,Xeroderma pigmentosum,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.41,0.41
Disease,Xeroderma pigmentosum,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.16,0.16
Disease,Xeroderma pigmentosum,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.34,0.34
Disease,Xeroderma pigmentosum,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.18,0.18
Disease,Xeroderma pigmentosum,1-9 / 100 000,Libyan Arab Jamahiriya,409967,409967,25965,25965,en,Not yet validated,410294,410294,10440281[PMID],1.75,1.75
Clinical group,Bulbospinal muscular atrophy of childhood,,,,,,,,,,,,,
Disease,Familial aortic dissection,,,,,,,,,,,,,
Category,Mitochondrial myopathy,,,,,,,,,,,,,
Clinical group,Muscular glycogenosis,,,,,,,,,,,,,
Etiological subtype,X-linked non-syndromic intellectual disability,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Muscular lipidosis,,,,,,,,,,,,,
Disease,Hemolytic anemia due to red cell pyruvate kinase deficiency,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,10828047[PMID],5.1,5.1
Disease,Hemolytic anemia due to red cell pyruvate kinase deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],5,5
Disease,Hemolytic anemia due to red cell pyruvate kinase deficiency,1-9 / 1 000 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,1511997[PMID],0.96,0.96
Clinical group,Periodic paralysis,,,,,,,,,,,,,
Disease,Vitamin B12-responsive methylmalonic acidemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],192,192
Disease,Vitamin B12-responsive methylmalonic acidemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Congenital myotonia,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,1822774[PMID]_20301529[PMID],1,1
Category,Myotonic syndrome,,,,,,,,,,,,,
Disease,Subacute inflammatory demyelinating polyneuropathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Biological anomaly,Isolated asymptomatic elevation of creatine phosphokinase,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Stüve-Wiedemann syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19207241[PMID],0,0
Malformation syndrome,Stüve-Wiedemann syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19207241[PMID],56,56
Malformation syndrome,Stüve-Wiedemann syndrome,1-5 / 10 000,United Arab Emirates,409968,409968,25958,25958,en,Validated,410293,410293,21337444[PMID],20,20
Clinical subtype,Adult polyglucosan body disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Clinical subtype,Adult polyglucosan body disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Neurolymphomatosis,,,,,,,,,,,,,
Category,Infectious disease with peripheral neuropathy,,,,,,,,,,,,,
Malformation syndrome,Okamoto syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20179579[PMID],5,5
Malformation syndrome,Okamoto syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20179579[PMID],0,0
Category,Acquired skeletal muscle disease,,,,,,,,,,,,,
Disease,Leber congenital amaurosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0,0
Disease,Leber congenital amaurosis,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301475[PMID],2.5,2.5
Disease,Leber congenital amaurosis,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,17964524[PMID],1.23,1.23
Disease,Leber congenital amaurosis,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT]_20301475[PMID],2.5,2.5
Category,Progressive muscular dystrophy,,,,,,,,,,,,,
Category,Genetic skeletal muscle disease,,,,,,,,,,,,,
Category,Autosomal recessive distal myopathy,,,,,,,,,,,,,
Disease,Multiple osteochondromas,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,13754517[PMID],100,100
Disease,Multiple osteochondromas,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,6417335[PMID],0.9,0.9
Disease,Multiple osteochondromas,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,1856833[PMID],1.35,1.35
Disease,Multiple osteochondromas,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],3,3
Disease,Multiple osteochondromas,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,8027127[PMID],2,2
Category,Non-dystrophic myopathy,,,,,,,,,,,,,
Disease,Lynch syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Myotonic dystrophy,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,2330114[PMID],189,189
Clinical group,Myotonic dystrophy,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25532075[PMID],6.7,6.7
Clinical group,Myotonic dystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25532075[PMID],8.78,8.78
Clinical group,Myotonic dystrophy,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,25532075[PMID],2.1,2.1
Clinical group,Myotonic dystrophy,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,25532075[PMID],5.5,5.5
Clinical group,Myotonic dystrophy,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,8845721[PMID],8.4,8.4
Clinical group,Myotonic dystrophy,1-5 / 10 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,9088385[PMID]_25532075[PMID],13.3,13.3
Clinical group,Myotonic dystrophy,1-5 / 10 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,16964297[PMID]_25532075[PMID],11.6,11.6
Clinical group,Myotonic dystrophy,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,21364698[PMID],20,20
Clinical group,Myotonic dystrophy,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,3263224[PMID],1.22,1.22
Clinical group,Myotonic dystrophy,1-5 / 10 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,1369611[PMID]_25532075[PMID],10.9,10.9
Clinical group,Myotonic dystrophy,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,6333203[PMID]_25532075[PMID],2,2
Category,Autosomal dominant distal myopathy,,,,,,,,,,,,,
Disease,Bardet-Biedl syndrome,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,2591073[PMID],7.4,7.4
Disease,Bardet-Biedl syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,5367041[PMID]_ORPHANET_[EXPERT],0.7,0.7
Disease,Bardet-Biedl syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.5,0.5
Disease,Bardet-Biedl syndrome,1-9 / 1 000 000,Tunisia,409966,409966,25958,25958,en,Validated,410293,410293,22109794[PMID],0.64,0.64
Disease,Bardet-Biedl syndrome,1-9 / 1 000 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,5367041[PMID],0.6,0.6
Disease,Bardet-Biedl syndrome,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,9039982[PMID],0.8,0.8
Disease,Bardet-Biedl syndrome,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,15637713[PMID],5.6,5.6
Disease,Bardet-Biedl syndrome,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,20949666[PMID],1,1
Category,Qualitative or quantitative defects of dystrophin,,,,,,,,,,,,,
Malformation syndrome,Orofaciodigital syndrome type 10,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Qualitative or quantitative defects of collagen 6,,,,,,,,,,,,,
Disease,Atypical Rett syndrome,,,,,,,,,,,,,
Category,Laminin subunit alpha 2-related muscular dystrophy,,,,,,,,,,,,,
Malformation syndrome,Kallmann syndrome-heart disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8322819[PMID],8,8
Malformation syndrome,Kallmann syndrome-heart disease syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8322819[PMID],0,0
Category,Qualitative or quantitative defects of integrin alpha-7,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of gamma-sarcoglycan,,,,,,,,,,,,,
Malformation syndrome,Arachnodactyly-intellectual disability-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8357568[PMID]_7794564[PMID],3,3
Malformation syndrome,Arachnodactyly-intellectual disability-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8357568[PMID]_7794564[PMID],0,0
Category,Qualitative or quantitative defects of delta-sarcoglycan,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of dysferlin,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of caveolin-3,,,,,,,,,,,,,
Malformation syndrome,White matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8327066[PMID],4,4
Malformation syndrome,White matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8327066[PMID],0,0
Category,Qualitative or quantitative protein defects in neuromuscular diseases,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of sarcoglycan,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of alpha-sarcoglycan,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of beta-sarcoglycan,,,,,,,,,,,,,
Category,Acute and subacute inflammatory demyelinating polyneuropathy,,,,,,,,,,,,,
Malformation syndrome,Fryns-Smeets-Thiry syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8172258[PMID],2,2
Malformation syndrome,Fryns-Smeets-Thiry syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8172258[PMID],0,0
Malformation syndrome,Microgastria-limb reduction defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12072798[PMID],16,16
Malformation syndrome,Microgastria-limb reduction defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8172238[PMID],2,2
Malformation syndrome,Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8172238[PMID],0,0
Category,Malignant lymphoma with peripheral neuropathy,,,,,,,,,,,,,
Category,Rare hereditary systemic disease with peripheral neuropathy,,,,,,,,,,,,,
Malformation syndrome,Progressive non-infectious anterior vertebral fusion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25485486[PMID]_28235247[PMID],67,67
Malformation syndrome,Progressive non-infectious anterior vertebral fusion,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25485486[PMID]_28235247[PMID],0,0
Category,Rare hereditary metabolic disease with peripheral neuropathy,,,,,,,,,,,,,
Malformation syndrome,Cleft palate-short stature-vertebral anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8110419[PMID],2,2
Malformation syndrome,Cleft palate-short stature-vertebral anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8110419[PMID],0,0
Category,Cerebellar ataxia with peripheral neuropathy,,,,,,,,,,,,,
Malformation syndrome,Macrocephaly-short stature-paraplegia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8471221[PMID],2,2
Malformation syndrome,Macrocephaly-short stature-paraplegia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8471221[PMID],0,0
Category,Rare hereditary neurologic disease with peripheral neuropathy,,,,,,,,,,,,,
Malformation syndrome,X-linked intellectual disability-plagiocephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1433236[PMID],2,2
Malformation syndrome,X-linked intellectual disability-plagiocephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1433236[PMID],0,0
Category,Rare hereditary disease with peripheral neuropathy,,,,,,,,,,,,,
Clinical group,Spinal muscular atrophy associated with central nervous system anomaly,,,,,,,,,,,,,
Category,Parasitic myositis,,,,,,,,,,,,,
Disease,Bacterial myositis,,,,,,,,,,,,,
Disease,Fungal myositis,,,,,,,,,,,,,
Disease,Muscular pseudohypertrophy-hypothyroidism syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Lethal recessive chondrodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3396596[PMID],4,4
Malformation syndrome,Lethal recessive chondrodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Hydrocephalus-obesity-hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4039476[PMID],2,2
Malformation syndrome,Hydrocephalus-obesity-hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4039476[PMID],0,0
Category,Muscular tumor,,,,,,,,,,,,,
Disease,Viral myositis,,,,,,,,,,,,,
Category,"Infectious, fungal or parasitic myopathy",,,,,,,,,,,,,
Category,Systemic inflammatory disease associated with an acquired peripheral neuropathy,,,,,,,,,,,,,
Category,Peripheral neuropathy associated with monoclonal gammopathy,,,,,,,,,,,,,
Malformation syndrome,Aplasia cutis congenita,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,12596124[PMID]_[EXPERT],0,0
Malformation syndrome,Aplasia cutis congenita,1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,5910871[PMID]_12596124[PMID]_[EXPERT],10,10
Malformation syndrome,Aplasia cutis congenita,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,25430571[PMID],7.69,7.69
Category,Paraneoplastic sensory ganglionopathy,,,,,,,,,,,,,
Disease,Axonal polyneuropathy associated with IgG/IgM/IgA monoclonal gammopathy,,,,,,,,,,,,,
Category,Non-paraneoplastic sensory ganglionopathy,,,,,,,,,,,,,
Disease,Polyradiculoneuropathy associated with IgG/IgA/IgM monoclonal gammopathy without known antibodies,,,,,,,,,,,,,
Category,Acquired sensory ganglionopathy,,,,,,,,,,,,,
Clinical group,Chronic acquired demyelinating polyneuropathy,,,,,,,,,,,,,
Malformation syndrome,Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1415344[PMID],3,3
Malformation syndrome,Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1415344[PMID],0,0
Clinical group,Chronic polyradiculoneuropathy,,,,,,,,,,,,,
Malformation syndrome,Hydrocephaly-low insertion umbilicus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8305966[PMID],2,2
Malformation syndrome,Hydrocephaly-low insertion umbilicus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8305966[PMID],0,0
Malformation syndrome,Dysmorphism-cleft palate-loose skin syndrome,,,,,,,,,,,,,
Clinical group,Cryopyrin-associated periodic syndrome,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,21109514[PMID],0.28,0.28
Malformation syndrome,Aymé-Gripp syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19396831[PMID]_19251507[PMID]_25865493[PMID]_28482824[PMID],18,18
Malformation syndrome,Aymé-Gripp syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28482824[PMID],0,0
Category,Genetic hypoparathyroidism,,,,,,,,,,,,,
Category,Genetic hyperparathyroidism,,,,,,,,,,,,,
Disease,Spinocerebellar ataxia type 29,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],50,50
Disease,Spinocerebellar ataxia type 29,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Herpetiform pemphigus,,,,,,,,,,,,,
Malformation syndrome,"Arthrogryposis-hyperkeratosis syndrome, lethal form",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8213913[PMID],2,2
Malformation syndrome,"Arthrogryposis-hyperkeratosis syndrome, lethal form",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8213913[PMID],0,0
Clinical group,Autosomal dominant cerebellar ataxia type II,,,,,,,,,,,,,
Clinical subtype,Bilateral generalized polymicrogyria,,,,,,,,,,,,,
Malformation syndrome,Intellectual disability-sparse hair-brachydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25169878[PMID],61,61
Malformation syndrome,Intellectual disability-sparse hair-brachydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25169878[PMID],0,0
Clinical subtype,Bilateral frontal polymicrogyria,,,,,,,,,,,,,
Clinical subtype,Bilateral parasagittal parieto-occipital polymicrogyria,,,,,,,,,,,,,
Malformation syndrome,Isolated arrhinia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Isolated arrhinia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Familial caudal dysgenesis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2225526[PMID],0,0
Malformation syndrome,Familial caudal dysgenesis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2225526[PMID],4,4
Category,Qualitative or quantitative defects of fukutin,,,,,,,,,,,,,
Malformation syndrome,Dysplastic cortical hyperostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12401992[PMID],2,2
Malformation syndrome,Dysplastic cortical hyperostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12401992[PMID],0,0
Category,Qualitative or quantitative defects of FKRP,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan,,,,,,,,,,,,,
Malformation syndrome,"Progeroid syndrome, Petty type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2309786[PMID],1,1
Malformation syndrome,"Progeroid syndrome, Petty type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2309786[PMID],0,0
Category,Qualitative or quantitative defects of myotubularin,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of TRIM32,,,,,,,,,,,,,
Disease,"Brachydactylous dwarfism, Mseleni type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Qualitative or quantitative defects of calpain,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of perlecan,,,,,,,,,,,,,
Malformation syndrome,"Craniosynostosis, Boston type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23949913[PMID]_23918290[PMID]_8357019[PMID],3,3
Malformation syndrome,"Craniosynostosis, Boston type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23949913[PMID]_23918290[PMID]_8357019[PMID],0,0
Malformation syndrome,Cholestasis-pigmentary retinopathy-cleft palate syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22243360[PMID],5,5
Malformation syndrome,Cholestasis-pigmentary retinopathy-cleft palate syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22243360[PMID],0,0
Malformation syndrome,Hirschsprung disease-ganglioneuroblastoma syndrome,,,,,,,,,,,,,
Malformation syndrome,Osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2783003[PMID],2,2
Malformation syndrome,Osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2783003[PMID],0,0
Disease,Autosomal dominant adult-onset proximal spinal muscular atrophy,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.1,0.1
Etiological subtype,DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20697106[PMID]_22459677[PMID]_22847149[PMID],0,0
Etiological subtype,DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20697106[PMID]_22459677[PMID]_22847149[PMID],37,37
Category,Qualitative or quantitative defects of beta-myosin heavy chain (MYH7),,,,,,,,,,,,,
Category,Qualitative or quantitative defects of emerin,,,,,,,,,,,,,
Malformation syndrome,Siegler-Brewer-Carey syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1442888[PMID],2,2
Malformation syndrome,Siegler-Brewer-Carey syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1442888[PMID],0,0
Category,Qualitative or quantitative defects of selenoprotein N1,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of plectin,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of protein SERCA1,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase -,,,,,,,,,,,,,
Category,Myotilinopathy,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of alphaB-cristallin,,,,,,,,,,,,,
Malformation syndrome,Brachydactyly-mesomelia-intellectual disability-heart defects syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8484398[PMID]_8074158[PMID],2,2
Malformation syndrome,Brachydactyly-mesomelia-intellectual disability-heart defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8484398[PMID]_8074158[PMID],0,0
Category,Qualitative or quantitative defects of desmin,,,,,,,,,,,,,
Malformation syndrome,Microphthalmia-microtia-fetal akinesia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8484406[PMID],0,0
Malformation syndrome,Microphthalmia-microtia-fetal akinesia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8484406[PMID],2,2
Category,Qualitative or quantitative defects of protein ZASP,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of filamin C,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of telethonin,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of titin,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of nebulin,,,,,,,,,,,,,
Malformation syndrome,Facial dysmorphism-shawl scrotum-joint laxity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1776627[PMID],2,2
Malformation syndrome,Facial dysmorphism-shawl scrotum-joint laxity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1776627[PMID],0,0
Category,Qualitative or quantitative defects of alpha-actin,,,,,,,,,,,,,
Malformation syndrome,Intellectual disability-short stature-hypertelorism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1877628[PMID],6,6
Malformation syndrome,Intellectual disability-short stature-hypertelorism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1877628[PMID],0,0
Category,Hematological disease associated with an acquired peripheral neuropathy,,,,,,,,,,,,,
Category,Acquired amyloid peripheral neuropathy,,,,,,,,,,,,,
Category,"Qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase",,,,,,,,,,,,,
Malformation syndrome,Thoraco-abdominal enteric duplication,,,,,,,,,,,,,
Category,Solid tumor associated with an acquired peripheral neuropathy,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of protein O-mannosyltransferase 1,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of protein glycosyltransferase-like,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of myofibrillar proteins,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of protein O-mannosyltransferase 2,,,,,,,,,,,,,
Malformation syndrome,Intermediate osteopetrosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Umbilical cord ulceration-intestinal atresia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_20881370[PMID]_29516584[PMID],66,66
Malformation syndrome,Umbilical cord ulceration-intestinal atresia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Sterile multifocal osteomyelitis with periostitis and pustulosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24131530[PMID],17,17
Disease,Sterile multifocal osteomyelitis with periostitis and pustulosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24131530[PMID],0,0
Disease,Ectopia lentis-chorioretinal dystrophy-myopia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8334934[PMID]_10420198[PMID]_12049599[PMID],8,8
Disease,Ectopia lentis-chorioretinal dystrophy-myopia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8334934[PMID]_10420198[PMID]_12049599[PMID],0,0
Disease,IRIDA syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28491880[PMID],75,75
Disease,IRIDA syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28491880[PMID],0,0
Disease,Non-papillary transitional cell carcinoma of the bladder,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2009[INST],37,37
Disease,Celiac disease-epilepsy-cerebral calcification syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,170,170
Disease,Celiac disease-epilepsy-cerebral calcification syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19401242[PMID],11,11
Disease,Leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19401242[PMID],0,0
Disease,Pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19401489[PMID],4,4
Disease,Pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19401489[PMID],0,0
Malformation syndrome,Myalgia-eosinophilia syndrome associated with tryptophan,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21702023[PMID],0,0
Disease,Congenital alveolar capillary dysplasia,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10735455[PMID]_9369882[PMID],1.2,1.2
Disease,Congenital alveolar capillary dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10735455[PMID],40,40
Disease,Congenital alveolar capillary dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Urocanic aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19304569[PMID],4,4
Disease,Urocanic aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19304569[PMID],0,0
Malformation syndrome,Pontocerebellar hypoplasia type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],40,40
Malformation syndrome,Pontocerebellar hypoplasia type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Phacoanaphylactic uveitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Solitary rectal ulcer syndrome,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,18188027[PMID],1,1
Disease,Solitary rectal ulcer syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal recessive spastic paraplegia type 18,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16636240[PMID]_23109145[PMID]_21796390[PMID],9,9
Disease,Autosomal recessive spastic paraplegia type 18,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16636240[PMID]_23109145[PMID]_21796390[PMID],0,0
Disease,Idiopathic uveal effusion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Benign nocturnal alternating hemiplegia of childhood,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23820111[PMID],12,12
Disease,Benign nocturnal alternating hemiplegia of childhood,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23820111[PMID],0,0
Clinical group,Alternating hemiplegia,,,,,,,,,,,,,
Disease,Episodic ataxia type 6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_19139306[PMID]_16116111[PMID]_23107647[PMID],4,4
Disease,Episodic ataxia type 6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Episodic ataxia type 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_17502476[PMID],7,7
Disease,Episodic ataxia type 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Fowler urethral sphincter dysfunction syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3147005[PMID],33,33
Disease,Fowler urethral sphincter dysfunction syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3147005[PMID],0,0
Disease,Childhood apraxia of speech,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,22,22
Disease,Childhood apraxia of speech,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Brain-lung-thyroid syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28286255[PMID],100,100
Disease,Brain-lung-thyroid syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28286255[PMID],0,0
Disease,Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,24,24
Disease,Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Adult familial nephronophthisis-spastic quadriparesia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2354560[PMID],2,2
Disease,Adult familial nephronophthisis-spastic quadriparesia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2354560[PMID],0,0
Disease,IRVAN syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,IRVAN syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cone dystrophy with supernormal rod response,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,45,45
Disease,Cone dystrophy with supernormal rod response,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Idiopathic copper-associated cirrhosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Extraskeletal myxoid chondrosarcoma,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.2,0.2
Malformation syndrome,Microcephaly-seizures-intellectual disability-heart disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2585466[PMID],2,2
Malformation syndrome,Microcephaly-seizures-intellectual disability-heart disease syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2585466[PMID],0,0
Disease,Severe neonatal-onset encephalopathy with microcephaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Severe neonatal-onset encephalopathy with microcephaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant rhegmatogenous retinal detachment,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,38,38
Disease,Autosomal dominant rhegmatogenous retinal detachment,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dystonia 16,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18420150[PMID]_22842711[PMID]_25142429[PMID],12,12
Disease,Dystonia 16,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18420150[PMID]_22842711[PMID]_25142429[PMID],0,0
Disease,Catecholaminergic polymorphic ventricular tachycardia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23916535[PMID],10,10
Clinical syndrome,Mal de débarquement,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Macrocephaly-intellectual disability-autism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Disease,Macrocephaly-intellectual disability-autism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Adult hepatocellular carcinoma,,,,,,,,,,,,,
Disease,His bundle tachycardia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Congenital lethal myopathy, Compton-North type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19026398[PMID],4,4
Disease,"Congenital lethal myopathy, Compton-North type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19026398[PMID],0,0
Disease,Central nervous system calcification-deafness-tubular acidosis-anemia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9112970[PMID],2,2
Disease,Central nervous system calcification-deafness-tubular acidosis-anemia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9112970[PMID],0,0
Disease,Inherited congenital spastic tetraplegia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16301218[PMID]_23836506[PMID]_9084927[PMID],17,17
Disease,Inherited congenital spastic tetraplegia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16301218[PMID]_23836506[PMID]_9084927[PMID],0,0
Malformation syndrome,"Lethal polymalformative syndrome, Boissel type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26378117[PMID]_19559399[PMID],10,10
Malformation syndrome,"Lethal polymalformative syndrome, Boissel type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26378117[PMID]_19559399[PMID],0,0
Disease,Cryptococcosis,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],11,11
Disease,Cryptococcosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Amoebiasis due to Entamoeba histolytica,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spindle cell hemangioma,,,,,,,,,,,,,
Disease,Undifferentiated pleomorphic sarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.9,0.9
Disease,Undifferentiated pleomorphic sarcoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer institute[INST]_17013893[PMID],0.9,0.9
Disease,Undifferentiated pleomorphic sarcoma,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Infantile hemangioma of rare localization,,,,,,,,,,,,,
Disease,Primary hyperoxaluria,1-9 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,15961947[PMID],0.2,0.2
Disease,Primary hyperoxaluria,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15961947[PMID],0,0
Disease,Primary hyperoxaluria,<1 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,19225556[PMID],0,0
Disease,Congenital temporomandibular joint ankylosis,,,,,,,,,,,,,
Category,Temporomandibular joint anomaly,,,,,,,,,,,,,
Category,Distal myopathy,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID]_[EXPERT],0.33,0.33
Disease,Tularemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.2,0.2
Disease,Tularemia,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0,0
Disease,Tularemia,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0,0
Disease,Tularemia,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],4,4
Disease,Tularemia,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],1.27,1.27
Disease,Tularemia,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],9.1,9.1
Disease,Tularemia,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.1,0.1
Disease,Tularemia,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.005,0.005
Disease,Tularemia,<1 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.05,0.05
Disease,Tularemia,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.3,0.3
Disease,Tularemia,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.6,0.6
Disease,Tularemia,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.075,0.075
Disease,Tularemia,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.08,0.08
Disease,Tularemia,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.02,0.02
Disease,Tularemia,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.035,0.035
Disease,Tularemia,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.145,0.145
Disease,Tularemia,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.07,0.07
Disease,Tularemia,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.01,0.01
Disease,Tularemia,<1 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.01,0.01
Disease,Tularemia,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.01,0.01
Disease,Tularemia,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.25,0.25
Disease,Tularemia,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],0.75,0.75
Disease,Tularemia,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,26738841[PMID],1.83,1.83
Disease,Tularemia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],2,2
Disease,Tularemia,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.5,0.5
Disease,Tularemia,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.1,0.1
Category,Genetic vascular anomaly,,,,,,,,,,,,,
Disease,Tufted angioma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25365496[PMID],200,200
Disease,Tufted angioma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25365496[PMID],0,0
Category,Rare vascular tumor,,,,,,,,,,,,,
Disease,Onchocerciasis,>1 / 1000,Specific population,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Onchocerciasis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Episodic ataxia type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_16100538[PMID],7,7
Disease,Episodic ataxia type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Toxocariasis,1-9 / 100 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,emedicine[OTHER],3.3,3.3
Disease,Toxocariasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Hereditary episodic ataxia,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Specific language disorder,,,,,,,,,,,,,
Category,Filariasis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Filariasis,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization 2016[INST],0,0
Clinical group,Specific learning disability,,,,,,,,,,,,,
Disease,Mycetoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Distomatosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Autosomal dominant proximal spinal muscular atrophy,,,,,,,,,,,,,
Disease,Spinocerebellar ataxia type 30,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18996908[PMID],6,6
Disease,Spinocerebellar ataxia type 30,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18996908[PMID],0,0
Disease,Ehrlichiosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Ehrlichiosis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention[INST],0.25,0.25
Disease,Ehrlichiosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Genetic steroid-resistant nephrotic syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Complex vascular malformation with associated anomalies,,,,,,,,,,,,,
Category,Rare arteriovenous malformation,,,,,,,,,,,,,
Disease,Nephronophthisis,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,10196704[PMID],1.25,1.25
Disease,Nephronophthisis,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Category,Rare lymphatic system anomaly,,,,,,,,,,,,,
Category,Rare venous malformation,,,,,,,,,,,,,
Category,Rare lymphatic malformation,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,12.5,12.5
Category,Rare capillary malformation,,,,,,,,,,,,,
Disease,Kaposiform hemangioendothelioma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Simple vascular malformation,,,,,,,,,,,,,
Disease,Infantile myofibromatosis,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:443043469[OTHER]_23686518[PMID],0.67,0.67
Disease,Infantile myofibromatosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Propionic acidemia,>1 / 1000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10820128[PMID]_23509210[PMID],100,100
Disease,Propionic acidemia,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,22593918[PMID]_14586648[PMID],1.5,1.5
Disease,Propionic acidemia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23509210[PMID],0.2,0.2
Disease,Propionic acidemia,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],0.6,0.6
Disease,Propionic acidemia,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,23509210[PMID],4,4
Disease,Propionic acidemia,1-5 / 10 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,23509210[PMID],33,33
Disease,Propionic acidemia,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,12189489[PMID]_23509210[PMID],5.7,5.7
Disease,Propionic acidemia,1-9 / 100 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,24101962[PMID],1.23,1.23
Disease,Glycine encephalopathy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2002[INST],0.17,0.17
Disease,Glycine encephalopathy,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,20301531[PMID],1.8,1.8
Disease,Glycine encephalopathy,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10617747[PMID],1.59,1.59
Disease,Glycine encephalopathy,1-9 / 100 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,20622343[PMID],1,1
Disease,Glycine encephalopathy,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,22532538[PMID],2,2
Disease,Glycine encephalopathy,1-9 / 1 000 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,22532538[PMID],0.13,0.13
Disease,Leukocyte adhesion deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,350,350
Disease,Leukocyte adhesion deficiency,<1 / 1 000 000,Latin America,409966,409966,25965,25965,en,Not yet validated,410294,410294,22965369[PMID],0,0
Disease,Leukocyte adhesion deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mitochondrial DNA-related progressive external ophthalmoplegia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Congenital disorder of glycosylation,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,1.5,1.5
Category,Congenital disorder of glycosylation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Denys-Drash syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],300,300
Disease,Denys-Drash syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1,1
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,20373143[PMID],0.4,0.4
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20373143[PMID],0.4,0.4
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,15896654[PMID],0.5,0.5
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,7564259[PMID],2,2
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,20814823[PMID],0.84,0.84
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,1-9 / 100 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,23430857[PMID],1.09,1.09
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],8,8
Disease,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,1-9 / 100 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,31241292[PMID],1.24,1.24
Clinical group,Congenital dyserythropoietic anemia,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,20824457[PMID],0.16,0.16
Clinical group,Congenital dyserythropoietic anemia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,20824457[PMID],0,0
Clinical group,Congenital dyserythropoietic anemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20665989[PMID],740,740
Clinical group,Congenital dyserythropoietic anemia,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Glutaryl-CoA dehydrogenase deficiency,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],333,333
Disease,Glutaryl-CoA dehydrogenase deficiency,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],2,2
Disease,Glutaryl-CoA dehydrogenase deficiency,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,15505392[PMID],1,1
Disease,Glutaryl-CoA dehydrogenase deficiency,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,22000754[PMID],2.85,2.85
Disease,Glutaryl-CoA dehydrogenase deficiency,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,12127323[PMID],0.48,0.48
Disease,Glutaryl-CoA dehydrogenase deficiency,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,6601872[PMID],0.76,0.76
Disease,Glutaryl-CoA dehydrogenase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glutaryl-CoA dehydrogenase deficiency,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,31241292[PMID],0.56,0.56
Disease,Rhizomelic chondrodysplasia punctata,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Malformation syndrome,Brachydactyly-nystagmus-cerebellar ataxia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,PDF:1934114230001a[OTHER],1,1
Malformation syndrome,Brachydactyly-nystagmus-cerebellar ataxia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_PDF:1934114230001a[OTHER],0,0
Disease,Familial melanoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1.5,1.5
Disease,Familial melanoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Hereditary glaucoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Familial partial epilepsy,,,,,,,,,,,,,
Category,Ovarian cancer,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],49,49
Disease,Glycogen storage disease due to lactate dehydrogenase deficiency,,,,,,,,,,,,,
Malformation syndrome,Smith-Lemli-Opitz syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_10807690[PMID],3.7,3.7
Malformation syndrome,Smith-Lemli-Opitz syndrome,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,9678700[PMID],1.7,1.7
Malformation syndrome,Smith-Lemli-Opitz syndrome,1-9 / 100 000,Slovakia,409968,409968,25958,25958,en,Validated,410293,410293,10678669[PMID],5.85,5.85
Malformation syndrome,Smith-Lemli-Opitz syndrome,1-9 / 100 000,Canada,409968,409968,25965,25965,en,Not yet validated,410294,410294,7395908[PMID]_11471166[PMID]_15480380[PMID],2.6,2.6
Malformation syndrome,Smith-Lemli-Opitz syndrome,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,9024554[PMID],2.65,2.65
Malformation syndrome,Smith-Lemli-Opitz syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Smith-Lemli-Opitz syndrome,1-5 / 10 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,10439210[PMID]_23059950[PMID],0,0
Disease,Malignant mixed Müllerian tumor of the ovary,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.12,0.12
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.97,5.97
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.635,5.635
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.773,6.773
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.162,6.162
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.103,6.103
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.229,7.229
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.881,6.881
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.973,5.973
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.593,6.593
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.09,4.09
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.079,5.079
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.518,5.518
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],8.353,8.353
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.79,7.79
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.653,5.653
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.116,7.116
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.698,5.698
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.834,2.834
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.519,5.519
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.575,6.575
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.263,4.263
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.379,6.379
Disease,Adenocarcinoma of ovary,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.306,5.306
Disease,Adenocarcinoma of ovary,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.09,6.09
Disease,Cartilage-hair hypoplasia,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,22420014[PMID],150,150
Disease,Cartilage-hair hypoplasia,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,1404295[PMID],4.34,4.34
Disease,Cartilage-hair hypoplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Cutis laxa,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Clinical group,Cutis laxa,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,Haute Autorité de Santé 2011[INST],12,12
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-5 / 10 000,Germany,409968,409968,25965,25965,en,Not yet validated,410294,410294,11388605[PMID]_15832312[PMID],16.1,16.1
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,United Kingdom,409968,409968,25965,25965,en,Not yet validated,410294,410294,22166308[PMID]_9797590[PMID],7.25,7.25
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,23842438[PMID],8.5,8.5
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Spain,409968,409968,25965,25965,en,Not yet validated,410294,410294,23842438[PMID],4.8,4.8
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,22630369[PMID],11.49,11.49
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,23543005[PMID],4.3,4.3
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,19620191[PMID],5.26,5.26
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,12127323[PMID],1.96,1.96
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 1 000 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,23700290[PMID],0.38,0.38
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,22542437[PMID],11.1,11.1
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Greece,409968,409968,25958,25958,en,Validated,410293,410293,22683754[PMID],6.3,6.3
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,12142359[PMID]_16617240[PMID]_ ORPHANET,5.85,5.85
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16763904[PMID],6.85,6.85
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,20938748[PMID],4.02,4.02
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,24294134[PMID],4.35,4.35
Disease,Medium chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,31241292[PMID],4.5,4.5
Category,Rare uterine cancer,,,,,,,,,,,,,
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.05,0.05
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.038,0.038
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.095,0.095
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.024,0.024
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.014,0.014
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.068,0.068
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.024,0.024
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.077,0.077
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.075,0.075
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.06,0.06
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.044,0.044
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.054,0.054
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.09,0.09
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.064,0.064
Disease,Salivary gland type cancer of the breast,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.053,0.053
Disease,Salivary gland type cancer of the breast,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.323,0.323
Disease,Rare variants of adenocarcinoma of the corpus uteri,,,,,,,,,,,,,
Category,Rare cancer of corpus uteri,,,,,,,,,,,,,
Disease,Hereditary site-specific ovarian cancer syndrome,,,,,,,,,,,,,
Clinical group,Familial ovarian cancer,,,,,,,,,,,,,
Disease,Gamma-aminobutyric acid transaminase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25738457[PMID],3,3
Disease,Gamma-aminobutyric acid transaminase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25738457[PMID],0,0
Disease,Bifunctional enzyme deficiency,,,,,,,,,,,,,
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.06,0.06
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.081,0.081
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.059,0.059
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.074,0.074
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.065,0.065
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.096,0.096
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.084,0.084
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.06,0.06
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.082,0.082
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.074,0.074
Disease,Metaplastic carcinoma of the breast,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.07,0.07
Disease,Metaplastic carcinoma of the breast,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.226,0.226
Disease,Metaplastic carcinoma of the breast,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.11,0.11
Disease,Metaplastic carcinoma of the breast,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.136,0.136
Disease,Metaplastic carcinoma of the breast,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.108,0.108
Disease,Metaplastic carcinoma of the breast,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.104,0.104
Disease,Metaplastic carcinoma of the breast,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.163,0.163
Disease,Metaplastic carcinoma of the breast,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.128,0.128
Disease,Metaplastic carcinoma of the breast,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.135,0.135
Disease,Metaplastic carcinoma of the breast,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.238,0.238
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.55,3.55
Disease,Rare adenocarcinoma of the breast,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.898,0.898
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.325,2.325
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.221,2.221
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.397,2.397
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.175,2.175
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.717,2.717
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.371,3.371
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.615,2.615
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.812,3.812
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.428,2.428
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.305,2.305
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.103,4.103
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.191,1.191
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.199,2.199
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.017,3.017
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.812,1.812
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.697,1.697
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.171,2.171
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.315,2.315
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.142,2.142
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.187,3.187
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.264,3.264
Disease,Rare adenocarcinoma of the breast,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.638,3.638
Morphological anomaly,Congenital pulmonary veins atresia or stenosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Carcinofibroma of the corpus uteri,,,,,,,,,,,,,
Disease,Carcinosarcoma of the corpus uteri,,,,,,,,,,,,,
Malformation syndrome,Congenital pulmonary sequestration,,,,,,,,,,,,,
Clinical group,Malignant mixed epithelial and mesenchymal tumor of corpus uteri,,,,,,,,,,,,,
Disease,Adenosarcoma of the corpus uteri,,,,,,,,,,,,,
Morphological anomaly,Congenitally uncorrected transposition of the great arteries,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],24.25,24.25
Morphological anomaly,Congenitally uncorrected transposition of the great arteries,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Leiomyosarcoma of the corpus uteri,,,,,,,,,,,,,
Malformation syndrome,Scimitar syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2,2
Malformation syndrome,Scimitar syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primitive neuroectodermal tumor of the corpus uteri,,,,,,,,,,,,,
Clinical subtype,Subpulmonary stenosis,,,,,,,,,,,,,
Disease,Rhabdomyosarcoma of the corpus uteri,,,,,,,,,,,,,
Clinical group,Sarcoma of the corpus uteri,,,,,,,,,,,,,
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],39.3,39.3
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],27.2,27.2
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],19.6,19.6
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],29.1,29.1
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],14.6,14.6
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],59.5,59.5
Morphological anomaly,Congenital pulmonary valve stenosis,6-9 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],63.6,63.6
Morphological anomaly,Congenital pulmonary valve stenosis,6-9 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],63.1,63.1
Morphological anomaly,Congenital pulmonary valve stenosis,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.6,3.6
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],26.1,26.1
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],48.2,48.2
Morphological anomaly,Congenital pulmonary valve stenosis,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],6.3,6.3
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],35.3,35.3
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.4,11.4
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],23.7,23.7
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],25.7,25.7
Morphological anomaly,Congenital pulmonary valve stenosis,6-9 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],98.4,98.4
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],42.5,42.5
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],19.4,19.4
Morphological anomaly,Congenital pulmonary valve stenosis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Undifferentiated carcinoma of the corpus uteri,,,,,,,,,,,,,
Morphological anomaly,Univentricular heart,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,23705101[PMID],7.5,7.5
Disease,Papillary carcinoma of the corpus uteri,,,,,,,,,,,,,
Morphological anomaly,Aorto-ventricular tunnel,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,130,130
Morphological anomaly,Aorto-ventricular tunnel,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Endometrial stromal sarcoma,,,,,,,,,,,,,
Disease,Squamous cell carcinoma of the corpus uteri,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.12,0.12
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.014,0.014
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.044,0.044
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.083,0.083
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.034,0.034
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.056,0.056
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Squamous cell carcinoma of the corpus uteri,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.041,0.041
Disease,Squamous cell carcinoma of the corpus uteri,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.117,0.117
Disease,Squamous cell carcinoma of the corpus uteri,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.12,0.12
Disease,Squamous cell carcinoma of the corpus uteri,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.177,0.177
Disease,Squamous cell carcinoma of the corpus uteri,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.139,0.139
Disease,Squamous cell carcinoma of the corpus uteri,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.113,0.113
Disease,Squamous cell carcinoma of the corpus uteri,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.173,0.173
Disease,Squamous cell carcinoma of the corpus uteri,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.228,0.228
Disease,Squamous cell carcinoma of the corpus uteri,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.106,0.106
Disease,Transitional cell carcinoma of the corpus uteri,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Common variable immunodeficiency,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Disease,Common variable immunodeficiency,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,22288591[PMID],2.3,2.3
Disease,Common variable immunodeficiency,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.98,0.98
Disease,Common variable immunodeficiency,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.66,0.66
Disease,Common variable immunodeficiency,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.87,0.87
Disease,Common variable immunodeficiency,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.6,0.6
Disease,Common variable immunodeficiency,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.72,0.72
Disease,Common variable immunodeficiency,1-9 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.52,0.52
Disease,Common variable immunodeficiency,1-9 / 1 000 000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.1,0.1
Disease,Common variable immunodeficiency,<1 / 1 000 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],0.073,0.073
Disease,Common variable immunodeficiency,1-9 / 1 000 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,9314356[PMID],0.77,0.77
Disease,Common variable immunodeficiency,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,High-grade neuroendocrine carcinoma of the corpus uteri,,,,,,,,,,,,,
Disease,Autoimmune lymphoproliferative syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20538792[PMID],500,500
Disease,Autoimmune lymphoproliferative syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20538792[PMID],0,0
Disease,Low-grade neuroendocrine tumor of the corpus uteri,,,,,,,,,,,,,
Malformation syndrome,Perlman syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Perlman syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Adenocarcinoma of the cervix uteri,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.01,1.01
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.762,0.762
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.966,0.966
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.968,0.968
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.85,0.85
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.899,0.899
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.987,0.987
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.789,0.789
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.734,0.734
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.774,0.774
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.471,0.471
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.766,0.766
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.868,0.868
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.738,0.738
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.765,0.765
Disease,Adenocarcinoma of the cervix uteri,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.918,0.918
Disease,Adenocarcinoma of the cervix uteri,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.108,1.108
Disease,Adenocarcinoma of the cervix uteri,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.108,1.108
Disease,Adenocarcinoma of the cervix uteri,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.065,1.065
Disease,Adenocarcinoma of the cervix uteri,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.118,1.118
Disease,Adenocarcinoma of the cervix uteri,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.177,1.177
Disease,Adenocarcinoma of the cervix uteri,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.007,1.007
Disease,Adenocarcinoma of the cervix uteri,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.048,1.048
Disease,Adenocarcinoma of the cervix uteri,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.12,1.12
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.28,4.28
Disease,Squamous cell carcinoma of the cervix uteri,1-5 / 10 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],11.822,11.822
Disease,Squamous cell carcinoma of the cervix uteri,1-5 / 10 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],10.336,10.336
Disease,Squamous cell carcinoma of the cervix uteri,1-5 / 10 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],11.192,11.192
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.104,4.104
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.67,4.67
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.539,5.539
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],8.277,8.277
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.885,1.885
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.871,4.871
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.707,3.707
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.204,4.204
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.307,3.307
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.362,7.362
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.759,1.759
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.756,4.756
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.941,7.941
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.478,5.478
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],8.555,8.555
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.507,7.507
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.867,2.867
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.657,2.657
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.063,3.063
Disease,Squamous cell carcinoma of the cervix uteri,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.312,3.312
Category,Rare cancer of cervix uteri,,,,,,,,,,,,,
Disease,Malignant germ cell tumor of the corpus uteri,,,,,,,,,,,,,
Disease,Adenosarcoma of the cervix uteri,<1 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_19685064[PMID],0,0
Disease,Carcinosarcoma of the cervix uteri,<1 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_26023676[PMID],0,0
Clinical group,Malignant mixed epithelial and mesenchymal tumor of cervix uteri,,,,,,,,,,,,,
Disease,High-grade neuroendocrine carcinoma of the cervix uteri,,,,,,,,,,,,,
Disease,Primitive neuroectodermal tumor of the cervix uteri,<1 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_21962148[PMID],0,0
Disease,Autoimmune pulmonary alveolar proteinosis,<1 / 1 000 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,18202348[PMID],0.049,0.049
Disease,Autoimmune pulmonary alveolar proteinosis,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,18202348[PMID],0.62,0.62
Disease,Autoimmune pulmonary alveolar proteinosis,<1 / 1 000 000,Israel,409967,409967,25958,25958,en,Validated,410293,410293,10731299[PMID],0.036,0.036
Disease,Autoimmune pulmonary alveolar proteinosis,1-9 / 1 000 000,Israel,409966,409966,25958,25958,en,Validated,410293,410293,10731299[PMID],0.37,0.37
Disease,Autoimmune pulmonary alveolar proteinosis,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,18202348[PMID]_10731299[PMID],0.5,0.5
Disease,Autoimmune pulmonary alveolar proteinosis,1-9 / 1 000 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,ISBN:721638902[OTHER]_18202348[PMID],0.25,0.25
Disease,Autoimmune pulmonary alveolar proteinosis,<1 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,18202348[PMID]_10731299[PMID],0.04,0.04
Disease,Leiomyosarcoma of the cervix uteri,<1 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_23519508[PMID],0,0
Disease,Rhabdomyosarcoma of the cervix uteri,,,,,,,,,,,,,
Disease,Musculocontractural Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26373698[PMID],34,34
Disease,Musculocontractural Ehlers-Danlos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26373698[PMID],0,0
Clinical group,Sarcoma of cervix uteri,,,,,,,,,,,,,
Disease,Glassy cell carcinoma of the cervix uteri,,,,,,,,,,,,,
Disease,Adenoid basal carcinoma of the cervix uteri,,,,,,,,,,,,,
Disease,Adenoid cystic carcinoma of the cervix uteri,,,,,,,,,,,,,
Malformation syndrome,Intellectual disability-polydactyly-uncombable hair syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9028447[PMID],2,2
Malformation syndrome,Intellectual disability-polydactyly-uncombable hair syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9028447[PMID],0,0
Disease,Papillary carcinoma of the cervix uteri,,,,,,,,,,,,,
Malformation syndrome,Axenfeld-Rieger syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Morphological anomaly,Congenital radioulnar synostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22802806[PMID],350,350
Morphological anomaly,Congenital radioulnar synostosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22802806[PMID],0,0
Disease,Malignant germ cell tumor of the cervix uteri,,,,,,,,,,,,,
Malformation syndrome,Syndactyly-polydactyly-ear lobe syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,182299[PMID],10,10
Malformation syndrome,Syndactyly-polydactyly-ear lobe syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_182299[PMID],0,0
Malformation syndrome,Tetrasomy 5p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25424187[PMID],0,0
Category,Transposition of the great arteries,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],31.7,31.7
Category,Transposition of the great arteries,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,17051527[PMID]_Center for Diseases Control and Prevention[INST],50,50
Category,Transposition of the great arteries,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],23.3,23.3
Category,Transposition of the great arteries,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],59.5,59.5
Category,Transposition of the great arteries,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],33.4,33.4
Category,Transposition of the great arteries,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],47.5,47.5
Category,Transposition of the great arteries,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],28.8,28.8
Category,Transposition of the great arteries,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],18.1,18.1
Category,Transposition of the great arteries,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],22.6,22.6
Category,Transposition of the great arteries,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],40.9,40.9
Category,Transposition of the great arteries,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],31.1,31.1
Category,Transposition of the great arteries,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],14,14
Category,Transposition of the great arteries,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],4.7,4.7
Category,Transposition of the great arteries,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],15.7,15.7
Category,Transposition of the great arteries,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],37.7,37.7
Category,Transposition of the great arteries,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],33.9,33.9
Category,Transposition of the great arteries,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],22.3,22.3
Category,Transposition of the great arteries,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Distal trisomy 17q,,,,,,,,,,,,,
Morphological anomaly,Congenitally corrected transposition of the great arteries,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],3,3
Morphological anomaly,Congenitally corrected transposition of the great arteries,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Isolated congenitally uncorrected transposition of the great arteries,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Double uterus-hemivagina-renal agenesis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,60,60
Malformation syndrome,Double uterus-hemivagina-renal agenesis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Congenitally uncorrected transposition of the great arteries with cardiac malformation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Tyrosinemia type 1,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20301688[PMID],0.9,0.9
Disease,Tyrosinemia type 1,1-9 / 100 000,Norway,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301688[PMID]_22554029[PMID],1.5,1.5
Disease,Tyrosinemia type 1,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,20301688[PMID],1.67,1.67
Disease,Tyrosinemia type 1,1-9 / 100 000,Tunisia,409968,409968,25958,25958,en,Validated,410293,410293,22481200[PMID],6.7,6.7
Disease,Tyrosinemia type 1,1-9 / 100 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,20301688[PMID],6.25,6.25
Disease,Tyrosinemia type 1,1-5 / 10 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,2378355[PMID],54,54
Disease,Tyrosinemia type 1,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Osteogenesis imperfecta type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Osteogenesis imperfecta type 1,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25944380[PMID],5.16,5.16
Disease,Von Willebrand disease,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],12.5,12.5
Clinical subtype,Osteogenesis imperfecta type 2,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.4,0.4
Clinical subtype,Osteogenesis imperfecta type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Osteogenesis imperfecta type 3,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Osteogenesis imperfecta type 3,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25944380[PMID],0.89,0.89
Clinical subtype,Osteogenesis imperfecta type 4,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Osteogenesis imperfecta type 4,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25944380[PMID],1.35,1.35
Clinical subtype,Osteogenesis imperfecta type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,47,47
Clinical subtype,Osteogenesis imperfecta type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,CHIME syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22444671[PMID],8,8
Malformation syndrome,CHIME syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22444671[PMID],0,0
Clinical subtype,Classic pantothenate kinase-associated neurodegeneration,,,,,,,,,,,,,
Clinical subtype,Atypical pantothenate kinase-associated neurodegeneration,,,,,,,,,,,,,
Clinical subtype,"Niemann-Pick disease type C, severe perinatal form",,,,,,,,,,,,,
Malformation syndrome,Ring chromosome 17 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24393457[PMID]_25635406[PMID],18,18
Malformation syndrome,Ring chromosome 17 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24393457[PMID]_25635406[PMID],0,0
Clinical subtype,"Niemann-Pick disease type C, late infantile neurologic onset",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial glucocorticoid deficiency,1-9 / 1 000 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,18430777[PMID],0.4953,0.4953
Disease,Familial glucocorticoid deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Niemann-Pick disease type C, severe early infantile neurologic onset",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Niemann-Pick disease type C, adult neurologic onset",,,,,,,,,,,,,
Malformation syndrome,"Acrofacial dysostosis, Palagonia type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9098488[PMID],4,4
Malformation syndrome,"Acrofacial dysostosis, Palagonia type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9098488[PMID],0,0
Clinical subtype,"Niemann-Pick disease type C, juvenile neurologic onset",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Bockenheimer syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN-13: 978-0323073677[OTHER],40,40
Malformation syndrome,Bockenheimer syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN-13: 978-0323073677[OTHER],0,0
Malformation syndrome,Zechi-Ceide syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17907157[PMID],3,3
Malformation syndrome,Zechi-Ceide syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17907157[PMID],0,0
Disease,Spinocerebellar ataxia type 31,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22353852[PMID]_24344778[PMID],30,30
Disease,Spinocerebellar ataxia type 31,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Fanconi-Bickel Syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11949937[PMID],200,200
Disease,Fanconi-Bickel Syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11152145[PMID]_19373080[PMID],5,5
Malformation syndrome,"Microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11152145[PMID]_19373080[PMID],0,0
Malformation syndrome,BNAR syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24115501[PMID],9,9
Malformation syndrome,BNAR syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Birdshot chorioretinopathy,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,27175923[PMID],0.35,0.35
Disease,Birdshot chorioretinopathy,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,16263368[PMID],0.14,0.14
Disease,Progressive multifocal leukoencephalopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Progressive multifocal leukoencephalopathy,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,29321229[PMID],0.068,0.068
Disease,Congenital enterovirus infection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Limbic encephalitis with NMDA receptor antibodies,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Polyarteritis nodosa,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,17553910[PMID],3.1,3.1
Disease,Polyarteritis nodosa,1-9 / 1 000 000,United Kingdom,409967,409967,25965,25965,en,Not yet validated,410294,410294,10693883[PMID]_11156552[PMID],0.9,0.9
Disease,Polyarteritis nodosa,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,14872461[PMID],3.07,3.07
Disease,Polyarteritis nodosa,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,18771432[PMID],0.11,0.11
Disease,Polyarteritis nodosa,1-9 / 1 000 000,Germany,409966,409966,25965,25965,en,Not yet validated,410294,410294,11136884[PMID],0.5,0.5
Disease,Polyarteritis nodosa,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,11156552[PMID],0.62,0.62
Disease,Polyarteritis nodosa,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9805179[PMID],3.3,3.3
Disease,Polyarteritis nodosa,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3,3
Disease,Polyarteritis nodosa,<1 / 1 000 000,Norway,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.05,0.05
Disease,Polyarteritis nodosa,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,15696553[PMID],0.04,0.04
Disease,Classic mycosis fungoides,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Classic mycosis fungoides,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Mucopolysaccharidosis type 2, attenuated form",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sézary syndrome,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,17638728[PMID]_National Cancer Institute[INST]_ORPHANET,0.02,0.02
Disease,Sézary syndrome,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,18808419[PMID]_ ORPHANET_[EXPERT],0.012,0.012
Disease,Sézary syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Mucopolysaccharidosis type 2, severe form",1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0.4,0.4
Clinical subtype,"Mucopolysaccharidosis type 2, severe form",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Pulmonary fungal infections in patients deemed at risk,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],22,22
Category,Rare carcinoma of pancreas,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],11.79,11.79
Category,Rare carcinoma of pancreas,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],8.3,8.3
Category,Rare carcinoma of pancreas,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2013[INST]_ORPHANET,15.5,15.5
Category,Rare carcinoma of pancreas,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],3.9,3.9
Category,Rare carcinoma of pancreas,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],3.5,3.5
Disease,Kasabach-Merritt syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN-10: 0071354557[OTHER],300,300
Disease,Kasabach-Merritt syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN-10: 0071354557[OTHER],0,0
Clinical group,Renal cell carcinoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2010[INST],42,42
Clinical group,Renal cell carcinoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],8.35,8.35
Particular clinical situation in a disease or syndrome,Pouchitis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],22,22
Disease,Noma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,5-fluorouracil poisoning,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],2,2
Disease,CINCA syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT]_21109514[PMID],0,0
Morphological anomaly,Isolated congenital digital clubbing,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_24036948[PMID],0,0
Disease,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,8,8
Disease,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Malakoplakia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,RIN2 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27277385[PMID],10,10
Malformation syndrome,RIN2 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27277385[PMID],0,0
Malformation syndrome,Opitz G/BBB syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3,3
Malformation syndrome,17q21.31 microduplication syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Idiopathic hypereosinophilic syndrome,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22740191[PMID],0,0
Clinical subtype,REN-related autosomal dominant tubulointerstitial kidney disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,21,21
Clinical subtype,REN-related autosomal dominant tubulointerstitial kidney disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Optic pathway glioma,1-9 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,22796286[PMID],0.12,0.12
Disease,Optic pathway glioma,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chronic Epstein-Barr virus infection syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21348109[PMID],0,0
Disease,African trypanosomiasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23260189[PMID],0,0
Disease,Cysticercosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Congenital microcoria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Arbovirus fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Viral hemorrhagic fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hemorrhagic fever-renal syndrome,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.74,0.74
Disease,Hemorrhagic fever-renal syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2004[INST],37,37
Disease,Hemorrhagic fever-renal syndrome,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.92,0.92
Disease,Hemorrhagic fever-renal syndrome,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.78,0.78
Disease,Hemorrhagic fever-renal syndrome,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.06,0.06
Disease,Hemorrhagic fever-renal syndrome,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2015[INST],2.2,2.2
Disease,Hemorrhagic fever-renal syndrome,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.08,0.08
Disease,Hemorrhagic fever-renal syndrome,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.36,1.36
Disease,Hemorrhagic fever-renal syndrome,1-5 / 10 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],29.16,29.16
Disease,Hemorrhagic fever-renal syndrome,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.18,0.18
Disease,Hemorrhagic fever-renal syndrome,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.16,1.16
Disease,Hemorrhagic fever-renal syndrome,<1 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.08,0.08
Disease,Hemorrhagic fever-renal syndrome,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.3,0.3
Disease,Hemorrhagic fever-renal syndrome,1-9 / 100 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],1.44,1.44
Disease,Hemorrhagic fever-renal syndrome,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.02,0.02
Disease,Hemorrhagic fever-renal syndrome,<1 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.02,0.02
Disease,Hemorrhagic fever-renal syndrome,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.24,0.24
Disease,Hemorrhagic fever-renal syndrome,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],2.32,2.32
Disease,Hemorrhagic fever-renal syndrome,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],2.52,2.52
Disease,Hemorrhagic fever-renal syndrome,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.5,0.5
Disease,Microsporidiosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24468074[PMID],10,10
Disease,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24468074[PMID],0,0
Clinical group,Triatrial heart,,,,,,,,,,,,,
Disease,Neuroendocrine cell hyperplasia of infancy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pulmonary interstitial glycogenosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Cardiac diverticulum,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chronic respiratory distress with surfactant metabolism deficiency,,,,,,,,,,,,,
Disease,Neonatal acute respiratory distress due to SP-B deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Neonatal acute respiratory distress due to SP-B deficiency,<1 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,14977415[PMID],0.067,0.067
Disease,Hereditary hypotrichosis with recurrent skin vesicles,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19765682[PMID],4,4
Disease,Hereditary hypotrichosis with recurrent skin vesicles,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19765682[PMID],0,0
Clinical subtype,Atypical coarctation of aorta,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.17,0.17
Clinical subtype,Atypical coarctation of aorta,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency,,,,,,,,,,,,,
Clinical group,Rare hereditary thrombophilia,,,,,,,,,,,,,
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],35.6,35.6
Morphological anomaly,Aorta coarctation,6-9 / 10 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],78.5,78.5
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],43.7,43.7
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],22.7,22.7
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.3,21.3
Morphological anomaly,Aorta coarctation,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],27.5,27.5
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],59.4,59.4
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],31,31
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],32.5,32.5
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],39.6,39.6
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],24.9,24.9
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],11.7,11.7
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.3,21.3
Morphological anomaly,Aorta coarctation,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],8,8
Morphological anomaly,Aorta coarctation,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],9.5,9.5
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],16.9,16.9
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],25.1,25.1
Morphological anomaly,Aorta coarctation,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],40.1,40.1
Morphological anomaly,Aorta coarctation,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],38.1,38.1
Morphological anomaly,Aorta coarctation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Combined immunodeficiency due to DOCK8 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19776401[PMID],11,11
Disease,Combined immunodeficiency due to DOCK8 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19776401[PMID],0,0
Category,Aortic arch defects,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,17p13.3 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23813913[PMID],50,50
Malformation syndrome,17p13.3 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Abnormal origin of the pulmonary artery,,,,,,,,,,,,,
Morphological anomaly,Pulmonary atresia with ventricular septal defect,,,,,,,,,,,,,
Disease,Congenital insensitivity to pain with hyperhidrosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19836135[PMID],2,2
Disease,Congenital insensitivity to pain with hyperhidrosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19836135[PMID],0,0
Disease,Progressive polyneuropathy with bilateral striatal necrosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19798730[PMID],4,4
Disease,Progressive polyneuropathy with bilateral striatal necrosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19798730[PMID],0,0
Clinical group,Pulmonary valve agenesis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23625533[PMID]_25665837[PMID],19,19
Disease,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23625533[PMID]_25665837[PMID],0,0
Malformation syndrome,19q13.11 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24243649[PMID],12,12
Malformation syndrome,19q13.11 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Absence of the pulmonary artery,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Morphological anomaly,Absence of the pulmonary artery,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Neurodegenerative syndrome due to cerebral folate transport deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19732866[PMID],3,3
Disease,Neurodegenerative syndrome due to cerebral folate transport deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19732866[PMID],0,0
Morphological anomaly,Aneurysm of sinus of Valsalva,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Coronary artery congenital malformation,,,,,,,,,,,,,
Malformation syndrome,Microduplication Xp11.22p11.23 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19716111[PMID],12,12
Malformation syndrome,Microduplication Xp11.22p11.23 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19716111[PMID],0,0
Category,Congenital systemic veins anomaly,,,,,,,,,,,,,
Category,Mitochondrial disease with dilated cardiomyopathy,,,,,,,,,,,,,
Category,Fatty acid oxidation and ketogenesis disorder with dilated cardiomyopathy,,,,,,,,,,,,,
Category,Syndrome associated with dilated cardiomyopathy,,,,,,,,,,,,,
Morphological anomaly,Congenital aortic valve stenosis,,,,,,,,,,,,,
Disease,Sensorineural deafness with dilated cardiomyopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10769282[PMID],2,2
Disease,Sensorineural deafness with dilated cardiomyopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10769282[PMID],0,0
Morphological anomaly,Fixed subaortic stenosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hypertrophic cardiomyopathy due to intensive athletic training,,,,,,,,,,,,,
Category,Dilated cardiomyopathy,,,,,,,,,,,,,
Morphological anomaly,Aortic arch interruption,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,24457106[PMID],0.3,0.3
Morphological anomaly,Aortic arch interruption,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Double outlet left ventricle,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,21106011[PMID]_22644696[PMID],0.5,0.5
Morphological anomaly,Double outlet left ventricle,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Familial dilated cardiomyopathy,,,,,,,,,,,,,
Category,Neuromuscular disease with dilated cardiomyopathy,,,,,,,,,,,,,
Morphological anomaly,Double outlet right ventricle,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,22644696[PMID],10,10
Morphological anomaly,Double outlet right ventricle,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Isolated right ventricular hypoplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Mitochondrial disease with hypertrophic cardiomyopathy,,,,,,,,,,,,,
Category,Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy,,,,,,,,,,,,,
Disease,Idiopathic/heritable pulmonary arterial hypertension,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,20558556[PMID],0.11,0.11
Disease,Idiopathic/heritable pulmonary arterial hypertension,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID],0.65,0.65
Disease,Idiopathic/heritable pulmonary arterial hypertension,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,16456139[PMID],0.1,0.1
Disease,Idiopathic/heritable pulmonary arterial hypertension,1-9 / 100 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,24629043[PMID],1.4,1.4
Disease,Idiopathic/heritable pulmonary arterial hypertension,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,24629043[PMID],0.62,0.62
Disease,Idiopathic/heritable pulmonary arterial hypertension,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,16456139[PMID]_24629043[PMID],1,1
Category,Syndrome associated with hypertrophic cardiomyopathy,,,,,,,,,,,,,
Category,Congenital mitral malformation,,,,,,,,,,,,,
Category,Non-familial hypertrophic cardiomyopathy,,,,,,,,,,,,,
Morphological anomaly,Pulmonary arteriovenous malformation,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,24008954[PMID],2.5,2.5
Morphological anomaly,Pulmonary arteriovenous malformation,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Pulmonary arteriovenous malformation,1-5 / 10 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,22790125[PMID]_[EXPERT],38,38
Category,Hypertrophic cardiomyopathy,,,,,,,,,,,,,
Morphological anomaly,Congenital aortopulmonary window,,,,,,,,,,,,,
Category,Glycogen storage disease with hypertrophic cardiomyopathy,,,,,,,,,,,,,
Morphological anomaly,Coronary arterial fistula,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_24940026[PMID],0,0
Category,Lysosomal disease with hypertrophic cardiomyopathy,,,,,,,,,,,,,
Morphological anomaly,Congenital systemic arteriovenous fistula,,,,,,,,,,,,,
Clinical group,Frontotemporal dementia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,20971753[PMID],3,3
Clinical group,Frontotemporal dementia,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,30979859[PMID],3.05,3.05
Category,Non-familial restrictive cardiomyopathy,,,,,,,,,,,,,
Disease,Congenital factor XIII deficiency,<1 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.04,0.04
Disease,Congenital factor XIII deficiency,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],0.05,0.05
Disease,Carnitine-acylcarnitine translocase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24088670[PMID],60,60
Disease,Carnitine-acylcarnitine translocase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Primary cutaneous lymphoma,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,15692063[PMID]_16192622[PMID]_ ORPHANET,0.75,0.75
Category,Primary cutaneous lymphoma,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Plague,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Plague,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011[INST],2.2,2.2
Category,Lysosomal disease with restrictive cardiomyopathy,,,,,,,,,,,,,
Category,Familial restrictive cardiomyopathy,,,,,,,,,,,,,
Disease,Congenital fibrinogen deficiency,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,National haemophilia foundation[OTHER],0.15,0.15
Category,Restrictive cardiomyopathy,,,,,,,,,,,,,
Category,Non-familial dilated cardiomyopathy,,,,,,,,,,,,,
Category,Unclassified cardiomyopathy,,,,,,,,,,,,,
Disease,Congenital alpha2-antiplasmin deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23396430[PMID],40,40
Disease,Congenital alpha2-antiplasmin deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23396430[PMID],0,0
Disease,Familial isolated arrhythmogenic right ventricular dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Anisakiasis,1-9 / 100 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_17428725[PMID],1.6,1.6
Disease,Anisakiasis,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,23092000[PMID],0.32,0.32
Disease,Anisakiasis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24630706[PMID],0,0
Disease,Cogan syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18037121[PMID],300,300
Disease,Cogan syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18037121[PMID],0,0
Disease,Histidinemia,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,8463510[PMID],2.7,2.7
Disease,Histidinemia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Histidinemia,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],8.3,8.3
Disease,Histidinemia,1-5 / 10 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,6468444[PMID],11.9,11.9
Clinical subtype,Limited cutaneous systemic sclerosis,,,,,,,,,,,,,
Disease,Saccharopinuria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Limited systemic sclerosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23661427[PMID],200,200
Clinical subtype,Limited systemic sclerosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Semilobar holoprosencephaly,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hyperlysinemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Diffuse cutaneous systemic sclerosis,1-9 / 100 000,"Taiwan, Province of China",409966,409966,25965,25965,en,Not yet validated,410294,410294,22899470[PMID],3.8,3.8
Clinical subtype,Diffuse cutaneous systemic sclerosis,1-9 / 100 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,22899470[PMID],1.5,1.5
Disease,Congenital intrinsic factor deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Disease,Congenital intrinsic factor deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Macrothrombocytopenia with mitral valve insufficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9482416[PMID],2,2
Disease,Macrothrombocytopenia with mitral valve insufficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9482416[PMID],0,0
Disease,Transcobalamin I deficiency,,,,,,,,,,,,,
Category,Isolated hereditary giant platelet disorder,,,,,,,,,,,,,
Disease,Quebec platelet disorder,1-9 / 1 000 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,21495923[PMID]_22102275[PMID],0.45,0.45
Disease,Quebec platelet disorder,1-9 / 1 000 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,18988861[PMID]_21495923[PMID]_22102275[PMID],0.15,0.15
Disease,Dicarboxylic aminoaciduria,1-9 / 100 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,17570073[PMID]_21123949[PMID],2.76,2.76
Disease,Bleeding diathesis due to thromboxane synthesis deficiency,,,,,,,,,,,,,
Category,Rare cardiac rhythm disease,,,,,,,,,,,,,
Category,Non-genetic cardiac rhythm disease,,,,,,,,,,,,,
Clinical subtype,Methylcobalamin deficiency type cblG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,33,33
Clinical subtype,Methylcobalamin deficiency type cblG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Xeroderma pigmentosum-Cockayne syndrome complex,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Disease,Xeroderma pigmentosum-Cockayne syndrome complex,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Gyrate atrophy of choroid and retina,1-9 / 100 000,Finland,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2,2
Disease,Gyrate atrophy of choroid and retina,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Gyrate atrophy of choroid and retina,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Homocystinuria without methylmalonic aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],73,73
Disease,Homocystinuria without methylmalonic aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hyperammonemia due to N-acetylglutamate synthase deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Transient tyrosinemia of the newborn,,,,,,,,,,,,,
Disease,Phosphoenolpyruvate carboxykinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Phosphoenolpyruvate carboxykinase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,D-glyceric aciduria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Laron syndrome with immunodeficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Laron syndrome with immunodeficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Attenuated familial adenomatous polyposis,,,,,,,,,,,,,
Category,Rare hereditary hemochromatosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,2-hydroxyglutaric aciduria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pentosuria,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Joubert syndrome with renal defect,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cystathioninuria,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,519848[PMID],7.1,7.1
Disease,Cystathioninuria,1-9 / 100 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,519848[PMID],7.1,7.1
Disease,Cystathioninuria,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Joubert syndrome with ocular defect,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lysinuric protein intolerance,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lysinuric protein intolerance,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1.7,1.7
Disease,Lysinuric protein intolerance,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,15050971[PMID],1.7,1.7
Disease,Lysinuric protein intolerance,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,10980538[PMID],1.75,1.75
Disease,Lysinuric protein intolerance,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hyperdibasic aminoaciduria type 1,,,,,,,,,,,,,
Disease,Marchiafava-Bignami disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11328337[PMID],250,250
Disease,Marchiafava-Bignami disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11328337[PMID],0,0
Disease,Combined hyperactive dysfunction syndrome of the cranial nerves,,,,,,,,,,,,,
Disease,Hereditary breast and ovarian cancer syndrome,1-9 / 100 000,Specific population,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,7,7
Disease,Hereditary breast and ovarian cancer syndrome,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,25,25
Disease,Prolactinoma,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19650784[PMID],44.4,44.4
Disease,Prolactinoma,6-9 / 10 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,16968795[PMID],62,62
Disease,Prolactinoma,1-5 / 10 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,19968031[PMID],45.7,45.7
Disease,Prolactinoma,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,23239049[PMID],2.05,2.05
Disease,Hemifacial spasm,,,,,,,,,,,,,
Disease,Trigeminal neuralgia,,,,,,,,,,,,,
Disease,Lymphangioleiomyomatosis,<1 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,21764810[PMID],0.0135,0.0135
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,21764810[PMID]_ ORPHANET_[EXPERT],0.15,0.15
Disease,Lymphangioleiomyomatosis,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,21764810[PMID],0.015,0.015
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,21764810[PMID],0.17,0.17
Disease,Lymphangioleiomyomatosis,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,10499073[PMID],0.01,0.01
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,21764810[PMID],0.19,0.19
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,21764810[PMID],0.21,0.21
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21764810[PMID],0.25,0.25
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,21764810[PMID],0.32,0.32
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,21764810[PMID],0.39,0.39
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,21764810[PMID],0.26,0.26
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,21764810[PMID],0.25,0.25
Disease,Lymphangioleiomyomatosis,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,DOI:10.1517/21678707.2015.1022529[OTHER],0.25,0.25
Disease,Glossopharyngeal neuralgia,,,,,,,,,,,,,
Disease,Postpoliomyelitis syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Isolated facial myokymia,,,,,,,,,,,,,
Clinical subtype,Pterin-4 alpha-carbinolamine dehydratase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,21,21
Clinical subtype,Pterin-4 alpha-carbinolamine dehydratase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical group,Cranial neuralgia,,,,,,,,,,,,,
Category,Acquired peripheral movement disorder,,,,,,,,,,,,,
Disease,Isolated succinate-CoQ reductase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23322652[PMID],37,37
Disease,Isolated succinate-CoQ reductase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23322652[PMID],0,0
Clinical subtype,Rothmund-Thomson syndrome type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Clinical subtype,Rothmund-Thomson syndrome type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Fumaric aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22069215[PMID],40,40
Disease,Fumaric aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22069215[PMID],0,0
Clinical subtype,Rothmund-Thomson syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Clinical subtype,Rothmund-Thomson syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Fatal infantile cytochrome C oxidase deficiency,,,,,,,,,,,,,
Disease,"Hereditary sclerosing poikiloderma, Weary type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10233244[PMID],0,0
Disease,"Hereditary sclerosing poikiloderma, Weary type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10233244[PMID],9,9
Disease,Isolated complex III deficiency,,,,,,,,,,,,,
Disease,Paris-Trousseau thrombocytopenia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Paris-Trousseau thrombocytopenia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26471370[PMID],15,15
Disease,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26471370[PMID],0,0
Disease,Poikiloderma with neutropenia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18925663[PMID]_20004881[PMID],50,50
Disease,Poikiloderma with neutropenia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Severe hereditary thrombophilia due to congenital protein C deficiency,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,16689776[PMID],0.16,0.16
Malformation syndrome,Acrocephalopolydactyly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22413886[PMID],8,8
Malformation syndrome,Acrocephalopolydactyly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22413886[PMID],0,0
Malformation syndrome,Familial cerebral cavernous malformation,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],15,15
Disease,Glanzmann thrombasthenia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial infantile bilateral striatal necrosis,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hemochromatosis type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,33,33
Disease,Hemochromatosis type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Sporadic infantile bilateral striatal necrosis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Hereditary poikiloderma,,,,,,,,,,,,,
Category,Mitochondrial oxidative phosphorylation disorder,,,,,,,,,,,,,
Category,Lymphoma,,,,,,,,,,,,,
Clinical group,Bone sarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.8,0.8
Clinical group,Bone sarcoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],9.29,9.29
Disease,Gerstmann syndrome,,,,,,,,,,,,,
Malformation syndrome,Pseudoaminopterin syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22811276[PMID],11,11
Malformation syndrome,Pseudoaminopterin syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22811276[PMID],0,0
Malformation syndrome,Fowler vasculopaty,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25677735[PMID],44,44
Malformation syndrome,Fowler vasculopaty,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25677735[PMID],0,0
Disease,Combined immunodeficiency with faciooculoskeletal anomalies,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19863561[PMID],2,2
Disease,Combined immunodeficiency with faciooculoskeletal anomalies,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19863561[PMID],0,0
Disease,Confetti-like macular atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19878392[PMID],2,2
Disease,Confetti-like macular atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19878392[PMID],0,0
Malformation syndrome,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26866239[PMID],21,21
Malformation syndrome,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26866239[PMID],0,0
Disease,Pitt-Hopkins-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22670138[PMID],105,105
Disease,Pitt-Hopkins-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Severe combined immunodeficiency due to CORO1A deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29942301[PMID],9,9
Disease,Severe combined immunodeficiency due to CORO1A deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29942301[PMID],0,0
Category,Thymic epithelial neoplasm,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_RARECARE surveillance of rare cancers in Europe 2011[REG],0.17,0.17
Category,Thymic epithelial neoplasm,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,22406029[PMID],1.3,1.3
Category,Thymic epithelial neoplasm,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Biological anomaly,Idiopathic CD4 lymphocytopenia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Non-Hodgkin lymphoma,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,22835603[PMID],0,0
Category,Non-Hodgkin lymphoma,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],11.6,11.6
Disease,Autoimmune polyendocrinopathy type 4,,,,,,,,,,,,,
Disease,Testicular seminomatous germ cell tumor,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],1.71,1.71
Disease,Testicular seminomatous germ cell tumor,1-5 / 10 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],46.01,46.01
Disease,Testicular seminomatous germ cell tumor,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autoimmune polyendocrinopathy type 3,,,,,,,,,,,,,
Disease,"Autosomal recessive optic atrophy, OPA7 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22815638[PMID]_20405026[PMID]_19327736[PMID],0,0
Disease,"Autosomal recessive optic atrophy, OPA7 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22815638[PMID]_20405026[PMID]_19327736[PMID],17,17
Disease,Yolk sac tumor,,,,,,,,,,,,,
Disease,Toxic oil syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12192735[PMID],0,0
Disease,Toxic oil syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12192735[PMID],20000,20000
Disease,Extragonadal teratoma,,,,,,,,,,,,,
Disease,Fundus albipunctatus,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Coccidioidomycosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fusariosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hughes-Stovin syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21489283[PMID]_15696563[PMID]_ [EXPERT],30,30
Disease,Hughes-Stovin syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Anal fistula,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,DOI:10.12998/wjcc.v7.i14.1795[OTHER],18.3,18.3
Particular clinical situation in a disease or syndrome,Anal fistula,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,DOI:10.12998/wjcc.v7.i14.1795[OTHER],18,18
Category,Germ cell tumor,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Langerhans cell histiocytosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.5,1.5
Disease,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18212818[PMID],4,4
Disease,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18212818[PMID],0,0
Disease,Medulloblastoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.11,0.11
Disease,Medulloblastoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2010[INST],1,1
Disease,Medulloblastoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2004-2007[REG],0.74,0.74
Clinical group,Ependymal tumor,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22227039[PMID]_22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.2,0.2
Clinical group,Ependymal tumor,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0,0
Clinical group,Ependymal tumor,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],3.85,3.85
Clinical group,Ependymal tumor,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,22227039[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.2,0.2
Clinical group,Ependymal tumor,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.43,0.43
Clinical group,Primary cutaneous CD30+ T-cell lymphoproliferative disease,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,Institut de Veille Sanitaire 1990[INST],0.18,0.18
Clinical group,Primary cutaneous CD30+ T-cell lymphoproliferative disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Burkitt lymphoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2003[REG],0.17,0.17
Disease,Burkitt lymphoma,1-5 / 10 000,Africa,409966,409966,25958,25958,en,Validated,410293,410293,National Institutes of Health[INST],12.5,12.5
Disease,Burkitt lymphoma,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,National Cancer Institute 2001-2009[INST],0.4,0.4
Disease,Burkitt lymphoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ewing sarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.13,0.13
Disease,Ewing sarcoma,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],2.33,2.33
Disease,Ewing sarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary breast cancer,,,,,,,,,,,,,
Disease,Osteosarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.23,0.23
Disease,Osteosarcoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Osteosarcoma,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],3.17,3.17
Disease,Osteosarcoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,19197972[PMID],0.4,0.4
Clinical subtype,"Multiple system atrophy, cerebellar type",1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Astrocytoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.8,4.8
Clinical group,Astrocytoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]_ ORPHANET,2.5,2.5
Clinical group,Astrocytoma,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.909,4.909
Clinical group,Astrocytoma,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.777,5.777
Clinical group,Astrocytoma,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.768,3.768
Clinical group,Astrocytoma,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.184,4.184
Clinical group,Astrocytoma,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.251,4.251
Clinical group,Astrocytoma,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.443,4.443
Clinical group,Astrocytoma,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.263,5.263
Clinical group,Astrocytoma,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.829,5.829
Clinical group,Astrocytoma,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.538,5.538
Clinical group,Astrocytoma,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.147,5.147
Clinical group,Astrocytoma,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.786,4.786
Clinical group,Astrocytoma,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.632,3.632
Clinical group,Astrocytoma,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.801,4.801
Clinical group,Astrocytoma,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.392,3.392
Clinical group,Astrocytoma,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.78,5.78
Clinical group,Astrocytoma,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.543,3.543
Clinical group,Astrocytoma,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.931,3.931
Clinical group,Astrocytoma,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.707,3.707
Clinical group,Astrocytoma,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.523,4.523
Clinical group,Astrocytoma,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.087,5.087
Clinical group,Astrocytoma,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.574,5.574
Clinical group,Astrocytoma,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.544,4.544
Clinical group,Astrocytoma,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.591,5.591
Disease,Glioblastoma,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],3,3
Disease,Glioblastoma,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Glioblastoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2003[REG],2.52,2.52
Disease,Glioblastoma,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],3.2,3.2
Disease,Glioblastoma,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,15103760[PMID],4.2,4.2
Disease,Glioblastoma,1-9 / 100 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,19494549[PMID],3.7,3.7
Disease,Glioblastoma,1-9 / 100 000,Specific population,409967,409967,25958,25958,en,Validated,410293,410293,14648713[PMID],3,3
Category,Permanent congenital hypothyroidism,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],33.3,33.3
Category,Permanent congenital hypothyroidism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Acute lymphoblastic leukemia,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2.75,2.75
Clinical group,Acute lymphoblastic leukemia,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],1.3,1.3
Clinical group,Acute lymphoblastic leukemia,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer institute[INST]_23523389[PMID],1.6,1.6
Clinical group,Acute lymphoblastic leukemia,1-5 / 10 000,United States,409969,409969,25958,25958,en,Validated,410293,410293,National Cancer institute 2009[INST],22,22
Clinical group,Acute lymphoblastic leukemia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2005[INST],11,11
Disease,Esthesioneuroblastoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Esthesioneuroblastoma,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Central congenital hypothyroidism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fibrosarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Fibrosarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Solitary fibrous tumour/hemangiopericytoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,24625420[PMID],0,0
Clinical group,Primary congenital hypothyroidism,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],37.5,37.5
Clinical group,Primary congenital hypothyroidism,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22766612[PMID],58.62,58.62
Disease,Pseudoxanthoma elasticum,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22209248[PMID],2.5,2.5
Disease,Hyperprolinemia type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],0.75,0.75
Disease,Adrenocortical carcinoma,<1 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,22796286[PMID],0.03,0.03
Disease,Adrenocortical carcinoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.082,0.082
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.173,0.173
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.18,0.18
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.249,0.249
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.547,0.547
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.271,0.271
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.314,0.314
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.225,0.225
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.173,0.173
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.17,0.17
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.133,0.133
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.288,0.288
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.514,0.514
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.464,0.464
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.188,0.188
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.226,0.226
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.433,0.433
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.234,0.234
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.244,0.244
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.215,0.215
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.141,0.141
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.167,0.167
Disease,Adrenocortical carcinoma,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.183,0.183
Disease,Genetic transient congenital hypothyroidism,,,,,,,,,,,,,
Disease,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Malignant peripheral nerve sheath tumor,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,24470531[PMID],1,1
Disease,Malignant peripheral nerve sheath tumor,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24470531[PMID],0,0
Disease,Synovial sarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital hypothyroidism due to maternal intake of antithyroid drugs,,,,,,,,,,,,,
Clinical group,Peripheral hypothyroidism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe [REG],2.463,2.463
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],2.95,2.95
Disease,Classic Hodgkin lymphoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2010[REG],0,0
Disease,Classic Hodgkin lymphoma,1-5 / 10 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2010[REG],22.9,22.9
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer Institute 2008[INST]_emedicine[OTHER],2.8,2.8
Disease,Classic Hodgkin lymphoma,1-9 / 1 000 000,China,409967,409967,25965,25965,en,Not yet validated,410294,410294,emedicine[OTHER],0.25,0.25
Disease,Classic Hodgkin lymphoma,1-9 / 1 000 000,Japan,409967,409967,25965,25965,en,Not yet validated,410294,410294,emedicine[OTHER],0.25,0.25
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.012,2.012
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.443,2.443
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.083,2.083
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.923,2.923
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.418,2.418
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.392,2.392
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.232,2.232
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.333,2.333
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.599,2.599
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.355,2.355
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.361,3.361
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.868,1.868
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.372,2.372
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.701,2.701
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.267,2.267
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.2,2.2
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.435,2.435
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.261,2.261
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.265,2.265
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.617,2.617
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.091,3.091
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.27,2.27
Disease,Classic Hodgkin lymphoma,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.504,2.504
Morphological anomaly,Oligomeganephronia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Amino acid or protein metabolism disease with epilepsy,,,,,,,,,,,,,
Category,Metal transport or utilization disorder with epilepsy,,,,,,,,,,,,,
Malformation syndrome,Larsen syndrome,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22925539[PMID],0.65,0.65
Malformation syndrome,Larsen syndrome,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22925539[PMID],0,0
Malformation syndrome,Larsen syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG],0.4,0.4
Malformation syndrome,Larsen syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Disease,Dent disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20946626[PMID],250,250
Disease,Dent disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Energy metabolism disorder with epilepsy,,,,,,,,,,,,,
Category,Mitochondrial disease with epilepsy,,,,,,,,,,,,,
Clinical group,Isolated microphthalmia-anophthalmia-coloboma,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,8921488[PMID],2.18,2.18
Clinical group,Isolated microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,8921488[PMID],3.33,3.33
Clinical group,Isolated microphthalmia-anophthalmia-coloboma,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,8921488[PMID],3.7,3.7
Clinical group,Isolated microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2000-2016[REG]_[EXPERT],0,0
Clinical group,Isolated microphthalmia-anophthalmia-coloboma,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical group,Syringomyelia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],8.4,8.4
Clinical group,Syringomyelia,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,4224973[PMID],8.4,8.4
Clinical group,Syringomyelia,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,2054207[PMID],9,9
Clinical group,Syringomyelia,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,21943925[PMID],1.94,1.94
Clinical group,Syringomyelia,1-9 / 100 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,16549414[PMID],8.2,8.2
Disease,Megalencephalic leukoencephalopathy with subcortical cysts,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21977097[PMID]_12189496[PMID],100,100
Disease,Megalencephalic leukoencephalopathy with subcortical cysts,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Lysosomal disease with epilepsy,,,,,,,,,,,,,
Category,Peroxisomal disease with epilepsy,,,,,,,,,,,,,
Disease,Primary Fanconi syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Nephrogenic diabetes insipidus,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.15,0.15
Disease,Nephrogenic diabetes insipidus,1-9 / 1 000 000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,10820168[PMID],0.44,0.44
Category,Mitochondrial disease with peripheral neuropathy,,,,,,,,,,,,,
Category,Metabolic neurotransmission anomaly with epilepsy,,,,,,,,,,,,,
Category,Sterol metabolism disorder with epilepsy,,,,,,,,,,,,,
Disease,Pseudohypoaldosteronism type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22073419[PMID],180,180
Disease,Pseudohypoaldosteronism type 2,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22073419[PMID],0,0
Category,Other metabolic disease with epilepsy,,,,,,,,,,,,,
Disease,Monocytopenia with susceptibility to infections,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20040766[PMID]_21242295[PMID],22,22
Disease,Monocytopenia with susceptibility to infections,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Chronic myeloid leukemia,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],1.25,1.25
Disease,Chronic myeloid leukemia,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],1.25,1.25
Disease,Chronic myeloid leukemia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],6,6
Disease,Chronic myeloid leukemia,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],5.63,5.63
Disease,Chronic myeloid leukemia,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,SEER Surveillance Epidemiology and End Results Program 2008-2012[REG],1.7,1.7
Malformation syndrome,5q35 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24819041[PMID],30,30
Malformation syndrome,5q35 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24819041[PMID],0,0
Disease,Butyrylcholinesterase deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Autosomal recessive cerebellar ataxia,1-9 / 100 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,23609960[PMID],3.3,3.3
Category,Autosomal recessive cerebellar ataxia,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24603320[PMID],3.3,3.3
Category,Autosomal recessive cerebellar ataxia,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,19440741[PMID],5.3,5.3
Category,Autosomal recessive cerebellar ataxia,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,19339254[PMID],2.3,2.3
Category,Autosomal recessive cerebellar ataxia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,19440741[PMID]_19339254[PMID]_23609960[PMID],3.6,3.6
Disease,Isolated agammaglobulinemia,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0.3,0.3
Category,Syndromic agammaglobulinemia,,,,,,,,,,,,,
Disease,Syndromic multisystem autoimmune disease due to Itch deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20170897[PMID],10,10
Disease,Syndromic multisystem autoimmune disease due to Itch deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20170897[PMID],0,0
Malformation syndrome,Isolated Klippel-Feil syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],2,2
Malformation syndrome,Isolated Klippel-Feil syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.6,0.6
Disease,Familial pancreatic carcinoma,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19941420[PMID],3,3
Malformation syndrome,Ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19941420[PMID],0,0
Disease,Spondylo-megaepiphyseal-metaphyseal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22791571[PMID],19,19
Disease,Spondylo-megaepiphyseal-metaphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22791571[PMID],0,0
Malformation syndrome,Frontonasal dysplasia-alopecia-genital anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24668755[PMID],5,5
Malformation syndrome,Frontonasal dysplasia-alopecia-genital anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Polyvalvular heart disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19932204[PMID],19,19
Malformation syndrome,Polyvalvular heart disease syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19932204[PMID],0,0
Malformation syndrome,8q12 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22902603[PMID],4,4
Malformation syndrome,8q12 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Osteopetrosis and related disorders,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,16307387[PMID],1,1
Clinical group,Osteopetrosis and related disorders,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,2q23.1 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22407754[PMID],18,18
Malformation syndrome,2q23.1 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,CLN7 disease,,,,,,,,,,,,,
Etiological subtype,CLN6 disease,,,,,,,,,,,,,
Etiological subtype,CLN5 disease,,,,,,,,,,,,,
Etiological subtype,CLN9 disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15349861[PMID],2,2
Etiological subtype,CLN9 disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15349861[PMID],0,0
Malformation syndrome,5q14.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23824879[PMID],40,40
Malformation syndrome,5q14.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23824879[PMID],0,0
Disease,Virus-associated trichodysplasia spinulosa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,7,7
Disease,Virus-associated trichodysplasia spinulosa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Charcot-Marie-Tooth disease type 2B5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20039262[PMID],4,4
Disease,Charcot-Marie-Tooth disease type 2B5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20039262[PMID],0,0
Clinical subtype,Foodborne botulism,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,21495856[PMID]_[EXPERT],0.1,0.1
Clinical subtype,Foodborne botulism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Foodborne botulism,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,21495856[PMID],0.01,0.01
Clinical subtype,Foodborne botulism,1-9 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,21495856[PMID],0.18,0.18
Etiological subtype,CLN4A disease,,,,,,,,,,,,,
Etiological subtype,CLN10 disease,,,,,,,,,,,,,
Etiological subtype,CLN1 disease,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,25205113[PMID],5,5
Etiological subtype,CLN8 disease,,,,,,,,,,,,,
Etiological subtype,CLN2 disease,,,,,,,,,,,,,
Etiological subtype,CLN3 disease,,,,,,,,,,,,,
Etiological subtype,CLN4B disease,,,,,,,,,,,,,
Disease,White fibrous papulosis of the neck,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pseudoxanthoma elasticum-like papillary dermal elastolysis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mid-dermal elastolysis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Carnitine palmitoyl transferase II deficiency, myopathic form",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301431[PMID],300,300
Clinical subtype,"Carnitine palmitoyl transferase II deficiency, myopathic form",Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301431[PMID],0,0
Clinical subtype,"Carnitine palmitoyl transferase II deficiency, severe infantile form",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301431[PMID],30,30
Clinical subtype,"Carnitine palmitoyl transferase II deficiency, severe infantile form",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301431[PMID],0,0
Clinical subtype,"Carnitine palmitoyl transferase II deficiency, neonatal form",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301431[PMID],20,20
Clinical subtype,"Carnitine palmitoyl transferase II deficiency, neonatal form",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301431[PMID],0,0
Clinical group,"Autoimmune hemolytic anemia, cold type",1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Elastoderma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25072684[PMID],5,5
Disease,Elastoderma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25072684[PMID],0,0
Disease,CACH syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,148,148
Disease,CACH syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Elastofibroma dorsi,,,,,,,,,,,,,
Disease,Acquired pseudoxanthoma elasticum,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Acquired pseudoxanthoma elasticum,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Elastoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Papular elastorrhexis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary anetoderma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial anetoderma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21719400[PMID],12,12
Disease,Familial anetoderma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21719400[PMID],0,0
Disease,Acquired cutis laxa,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10533032[PMID],7,7
Malformation syndrome,Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Overhydrated hereditary stomatocytosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Overhydrated hereditary stomatocytosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dehydrated hereditary stomatocytosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9718354[PMID]_11001917[PMID]_23479567[PMID],0,0
Disease,Dehydrated hereditary stomatocytosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9718354[PMID]_11001917[PMID]_23479567[PMID]_Pr Loïc GARÇON_Dr Véronique PICARD[EXPERT],20,20
Category,Acquired dermis elastic tissue disorder,,,,,,,,,,,,,
Category,Genetic dermis elastic tissue disorder,,,,,,,,,,,,,
Category,Acquired dermis elastic tissue disorder with increased elastic tissue,,,,,,,,,,,,,
Category,Acquired dermis elastic tissue disorder with decreased elastic tissue,,,,,,,,,,,,,
Disease,Benign focal seizures of adolescence,,,,,,,,,,,,,
Disease,Linear focal elastosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Linear focal elastosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Late-onset focal dermal elastosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15670180[PMID],5,5
Disease,Late-onset focal dermal elastosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15670180[PMID],0,0
Category,Multiple sclerosis variant,,,,,,,,,,,,,
Disease,"Idiopathic ventricular fibrillation, non Brugada type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,X-linked Alport syndrome-diffuse leiomyomatosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Baló concentric sclerosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Benign familial infantile epilepsy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Marburg acute multiple sclerosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital factor X deficiency,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2008[INST],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2N,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,28,28
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2N,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant striatal neurodegeneration,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15210883[PMID]_26769607[PMID]_26475694[PMID],11,11
Disease,Autosomal dominant striatal neurodegeneration,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15210883[PMID]_26769607[PMID]_26475694[PMID],0,0
Disease,Hemoglobin C disease,>1 / 1000,United States,409966,409966,25958,25958,en,Validated,410293,410293,23591685[PMID],166.66,166.66
Disease,Hemoglobin C disease,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,19103861[PMID],3.65,3.65
Disease,Hemoglobin E disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Heart-hand syndrome,,,,,,,,,,,,,
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2M,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2M,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary elliptocytosis,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Hermansky-Pudlak syndrome type 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12923531[PMID]_23364359[PMID],2,2
Clinical subtype,Hermansky-Pudlak syndrome type 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,12923531[PMID]_23364359[PMID],0,0
Clinical subtype,Hermansky-Pudlak syndrome type 8,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16385460[PMID],6,6
Clinical subtype,Hermansky-Pudlak syndrome type 8,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,16385460[PMID],0,0
Clinical subtype,Hermansky-Pudlak syndrome without pulmonary fibrosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Idiopathic camptocormia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Early-onset generalized limb-onset dystonia,1-5 / 10 000,Specific population,409967,409967,25958,25958,en,Validated,410293,410293,7719342[PMID],20,20
Disease,Early-onset generalized limb-onset dystonia,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,3264051[PMID],0.2,0.2
Disease,Early-onset generalized limb-onset dystonia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,17129379[PMID]_23596437[PMID],0.4,0.4
Disease,Early-onset generalized limb-onset dystonia,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,3264051[PMID],3.4,3.4
Disease,Early-onset generalized limb-onset dystonia,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,17290457[PMID],8.3,8.3
Clinical subtype,Hermansky-Pudlak syndrome with pulmonary fibrosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pure autonomic failure,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2007[INST],0,0
Disease,Acute pandysautonomia,,,,,,,,,,,,,
Disease,Acute sensory ataxic neuropathy,,,,,,,,,,,,,
Clinical group,Infantile bilateral striatal necrosis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Paraparetic variant of Guillain-Barré syndrome,,,,,,,,,,,,,
Disease,Acute pure sensory neuropathy,,,,,,,,,,,,,
Disease,Narcolepsy type 1,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],25,25
Disease,Narcolepsy type 1,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,11902429[PMID],0.74,0.74
Disease,Narcolepsy type 1,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,19456307[PMID]_24849861[PMID],22,22
Disease,Narcolepsy type 1,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,8210228[PMID]_24849861[PMID],26,26
Disease,Narcolepsy type 1,1-5 / 10 000,China,409966,409966,25958,25958,en,Validated,410293,410293,11164060[PMID]_24849861[PMID],34,34
Disease,Narcolepsy type 1,1-5 / 10 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,11902429[PMID]_19013100[PMID]_24849861[PMID]_ORPHANET,28.9,28.9
Disease,Narcolepsy type 1,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,8894197[PMID]_24849861[PMID],40,40
Disease,Pharyngeal-cervical-brachial variant of Guillain-Barré syndrome,,,,,,,,,,,,,
Clinical group,Regional variant of Guillain-Barré syndrome,,,,,,,,,,,,,
Clinical group,Functional variant of Guillain-Barré syndrome,,,,,,,,,,,,,
Disease,Alpha-thalassemia-myelodysplastic syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],80,80
Disease,Alpha-thalassemia-myelodysplastic syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Variant of Guillain-Barré syndrome,,,,,,,,,,,,,
Category,"Focal, segmental or multifocal dystonia",1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2,2
Category,"Focal, segmental or multifocal dystonia",1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,11127535[PMID],11.7,11.7
Category,"Focal, segmental or multifocal dystonia",1-5 / 10 000,Serbia,409966,409966,25958,25958,en,Validated,410293,410293,14639690[PMID],11.2,11.2
Category,"Focal, segmental or multifocal dystonia",1-5 / 10 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,16211610[PMID],31.2,31.2
Category,"Focal, segmental or multifocal dystonia",1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,3264051[PMID],29.5,29.5
Category,"Focal, segmental or multifocal dystonia",1-5 / 10 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,16755586[PMID],13.7,13.7
Category,"Focal, segmental or multifocal dystonia",1-5 / 10 000,Egypt,409966,409966,25958,25958,en,Validated,410293,410293,7969703[PMID],10,10
Category,"Focal, segmental or multifocal dystonia",1-5 / 10 000,Thailand,409966,409966,25958,25958,en,Validated,410293,410293,21999890[PMID],14.3,14.3
Disease,Linear verrucous nevus syndrome,,,,,,,,,,,,,
Disease,Beta-thalassemia-X-linked thrombocytopenia syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mixed connective tissue disease,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,21398332[PMID],0.17,0.17
Disease,Mixed connective tissue disease,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,21398332[PMID],3,3
Disease,Mixed connective tissue disease,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],2.7,2.7
Disease,Mixed connective tissue disease,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mixed connective tissue disease,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,26946215[PMID],1.9,1.9
Disease,Mixed connective tissue disease,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,8810933[PMID]_26946215[PMID],0.8,0.8
Category,Beta-thalassemia with other manifestations,,,,,,,,,,,,,
Morphological anomaly,Medullary sponge kidney,,,,,,,,,,,,,
Disease,Hemoglobin E-beta-thalassemia syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hemoglobin C-beta-thalassemia syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Idiopathic hypercalciuria,,,,,,,,,,,,,
Disease,Delta-beta-thalassemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Beta-thalassemia associated with another hemoglobin anomaly,,,,,,,,,,,,,
Clinical subtype,Dominant beta-thalassemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Distal renal tubular acidosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22872862[PMID],0,0
Clinical subtype,Beta-thalassemia intermedia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Castleman disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Castleman disease,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_25120049[PMID],0,0
Clinical subtype,Beta-thalassemia major,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Beta-thalassemia major,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22766612[PMID],0.7,0.7
Clinical subtype,Beta-thalassemia major,>1 / 1000,Bahrain,409966,409966,25958,25958,en,Validated,410293,410293,24044606[PMID],160,160
Clinical subtype,Beta-thalassemia major,1-5 / 10 000,Oman,409966,409966,25958,25958,en,Validated,410293,410293,11360093[PMID]_12934793[PMID],40,40
Disease,Familial benign chronic pemphigus,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Usher syndrome type 3,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,9212179[PMID],0.1,0.1
Clinical subtype,Usher syndrome type 3,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Usher syndrome type 3,1-9 / 100 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,14569126[PMID],1.2,1.2
Disease,Frasier syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_25623218[PMID],150,150
Disease,Frasier syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT]_25623218[PMID],0,0
Clinical subtype,Usher syndrome type 2,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,9212179[PMID],2.2,2.2
Clinical subtype,Usher syndrome type 2,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chronic diarrhea with villous atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8283377[PMID],2,2
Disease,Chronic diarrhea with villous atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8283377[PMID],0,0
Disease,Combined immunodeficiency due to partial RAG1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16276422[PMID],9,9
Disease,Combined immunodeficiency due to partial RAG1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16276422[PMID],0,0
Disease,Myopathy and diabetes mellitus,,,,,,,,,,,,,
Disease,Properdin deficiency,,,,,,,,,,,,,
Disease,Familial cerebral saccular aneurysm,,,,,,,,,,,,,
Clinical subtype,Usher syndrome type 1,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,9212179[PMID],1.5,1.5
Clinical subtype,Usher syndrome type 1,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Silver-Russell syndrome due to 7p11.2p13 microduplication,,,,,,,,,,,,,
Etiological subtype,Silver-Russell syndrome due to an imprinting defect of 11p15,,,,,,,,,,,,,
Etiological subtype,Silver-Russell syndrome due to 11p15 microduplication,,,,,,,,,,,,,
Disease,Anti-HLA hyperimmunization,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Silver-Russell syndrome due to maternal uniparental disomy of chromosome 11,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Beckwith-Wiedemann syndrome due to CDKN1C mutation,,,,,,,,,,,,,
Etiological subtype,Beckwith-Wiedemann syndrome due to 11p15 microdeletion,,,,,,,,,,,,,
Etiological subtype,Beckwith-Wiedemann syndrome due to 11p15 translocation/inversion,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,High-grade dysplasia in patients with Barrett esophagus,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2002[INST],36,36
Clinical subtype,Familial rhabdoid tumor,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,5,5
Clinical subtype,Familial rhabdoid tumor,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial hypocalciuric hypercalcemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Drug-induced lupus erythematosus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,,,,,,,,,,,,,
Disease,Balantidiasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial generalized lentiginosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Essential thrombocythemia,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,18181200[PMID],24,24
Disease,Essential thrombocythemia,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,16673273[PMID],1.55,1.55
Disease,Essential thrombocythemia,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,16673273[PMID],30,30
Disease,Essential thrombocythemia,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Essential thrombocythemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.48,0.48
Disease,Ehlers-Danlos/osteogenesis imperfecta syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_23692737[PMID],0,0
Disease,Cardiac-valvular Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16816023[PMID]_1507720[PMID]_2952379[PMID],6,6
Disease,Cardiac-valvular Ehlers-Danlos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Erythema palmare hereditarium,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Zollinger-Ellison syndrome,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.15,0.15
Disease,Zollinger-Ellison syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Zollinger-Ellison syndrome,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,ISBN:0849359937[OTHER],0.15,0.15
Disease,Zollinger-Ellison syndrome,1-9 / 1 000 000,Switzerland,409967,409967,25965,25965,en,Not yet validated,410294,410294,ISBN:0849359937[OTHER],0.3,0.3
Disease,Zollinger-Ellison syndrome,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,2575263[PMID],0.05,0.05
Disease,Zollinger-Ellison syndrome,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,22261919[PMID],0.125,0.125
Disease,Congenital trigeminal anesthesia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Toxin-mediated infectious botulism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary thrombophilia due to congenital antithrombin deficiency,,,,,,,,,,,,,
Disease,Classical-like Ehlers-Danlos syndrome type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27582382[PMID],17,17
Disease,Classical-like Ehlers-Danlos syndrome type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27582382[PMID],0,0
Clinical group,Acute myeloid leukemia,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,17019734[PMID],2.5,2.5
Clinical group,Acute myeloid leukemia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],10,10
Clinical group,Acute myeloid leukemia,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],3.39,3.39
Clinical group,Acute myeloid leukemia,1-5 / 10 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],10.98,10.98
Clinical group,Acute myeloid leukemia,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],4.4,4.4
Clinical group,Acute myeloid leukemia,1-9 / 100 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,24039451[PMID],2.8,2.8
Clinical group,Acute myeloid leukemia,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer institute 2010[INST],3.7,3.7
Category,Rare genetic vascular disease,,,,,,,,,,,,,
Clinical group,Congenital vascular bone syndrome,,,,,,,,,,,,,
Clinical group,Familial hyperaldosteronism,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Infundibulo-neurohypophysitis,,,,,,,,,,,,,
Clinical subtype,AApoAII amyloidosis,,,,,,,,,,,,,
Malformation syndrome,15q11q13 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,15q11q13 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Severe X-linked mitochondrial encephalomyopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20362274[PMID],0,0
Disease,Severe X-linked mitochondrial encephalomyopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20362274[PMID],2,2
Disease,Congenital erosive and vesicular dermatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28247410[PMID],31,31
Disease,Congenital erosive and vesicular dermatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28247410[PMID],0,0
Disease,Primary unilateral adrenal hyperplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1642260[PMID],2,2
Disease,Late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1642260[PMID],0,0
Disease,Generalized dominant dystrophic epidermolysis bullosa,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ectopic aldosterone-producing tumor,,,,,,,,,,,,,
Category,Rare surgically correctable form of primary aldosteronism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adrenocortical carcinoma with pure aldosterone hypersecretion,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,21699693[PMID]_15666309[PMID],1,1
Clinical subtype,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Isolated growth hormone deficiency type IB,,,,,,,,,,,,,
Disease,Vascular Ehlers-Danlos syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1,1
Clinical subtype,Isolated growth hormone deficiency type II,,,,,,,,,,,,,
Category,Rare non surgically correctable form of primary aldosteronism,,,,,,,,,,,,,
Disease,Hypermobile Ehlers-Danlos syndrome,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,12.5,12.5
Clinical subtype,Isolated growth hormone deficiency type IA,,,,,,,,,,,,,
Malformation syndrome,Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20417569[PMID],8,8
Malformation syndrome,Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20417569[PMID],0,0
Malformation syndrome,Epibulbar lipodermoid-preauricular appendage-polythelia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20450310[PMID],1,1
Malformation syndrome,Epibulbar lipodermoid-preauricular appendage-polythelia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20450310[PMID],0,0
Disease,Epidermolysis bullosa simplex with muscular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],40,40
Disease,Epidermolysis bullosa simplex with muscular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dermatosparaxis Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26765342[PMID],15,15
Disease,Dermatosparaxis Ehlers-Danlos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26765342[PMID],0,0
Clinical subtype,Isolated growth hormone deficiency type III,,,,,,,,,,,,,
Malformation syndrome,Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_19762173[PMID],13,13
Malformation syndrome,Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Arthrochalasia Ehlers-Danlos syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,"Congenital nephrotic syndrome, Finnish type",Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Congenital nephrotic syndrome, Finnish type",1-5 / 10 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,4127143[PMID],12.2,12.2
Category,Infectious embryofetopathy,,,,,,,,,,,,,
Category,Disease associated with a genetic susceptibility or tested for a biomarker,,,,,,,,,,,,,
Malformation syndrome,Miller-Dieker syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Malformation syndrome,Miller-Dieker syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Soft tissue sarcoma,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,21826194[PMID],3.6,3.6
Clinical group,Soft tissue sarcoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],30,30
Clinical group,Soft tissue sarcoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.74,4.74
Disease,Isolated lissencephaly type 1 without known genetic defects,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Alpha-thalassemia-related diseases,,,,,,,,,,,,,
Morphological anomaly,Microlissencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,X-linked lissencephaly with abnormal genitalia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17480217[PMID],30,30
Malformation syndrome,X-linked lissencephaly with abnormal genitalia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17480217[PMID],0,0
Malformation syndrome,4q21 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,4q21 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20522426[PMID]_22903878[PMID]_21834054[PMID],14,14
Disease,Autosomal dominant limb-girdle muscular dystrophy type 1H,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20068593[PMID],11,11
Disease,Autosomal dominant limb-girdle muscular dystrophy type 1H,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20068593[PMID],0,0
Malformation syndrome,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22025892[PMID],12,12
Malformation syndrome,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22025892[PMID],0,0
Category,Transient congenital hypothyroidism due to maternal factor,,,,,,,,,,,,,
Category,Transient congenital hypothyroidism due to neonatal factor,,,,,,,,,,,,,
Disease,Familial congenital mirror movements,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19127048[PMID]_19720981[PMID]_21242494[PMID]_27830107[PMID]_25098561[PMID],75,75
Disease,Familial congenital mirror movements,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19127048[PMID]_19720981[PMID]_21242494[PMID]_27830107[PMID]_25098561[PMID],0,0
Malformation syndrome,Mammary-digital-nail syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20145678[PMID],11,11
Malformation syndrome,Mammary-digital-nail syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20145678[PMID],0,0
Malformation syndrome,1q44 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21800092[PMID],100,100
Malformation syndrome,1q44 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Lymphoproliferative syndrome,,,,,,,,,,,,,
Clinical group,Hypotonia-cystinuria type 1 syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Combined immunodeficiency due to CD27 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29942301[PMID],18,18
Disease,Combined immunodeficiency due to CD27 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29942301[PMID],0,0
Disease,Hypohidrotic ectodermal dysplasia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],6.7,6.7
Disease,Familial hypercholanemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,23,23
Disease,Familial hypercholanemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Infantile dystonia-parkinsonism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24613933[PMID]_19478460[PMID]_22279524[PMID],16,16
Disease,Infantile dystonia-parkinsonism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24613933[PMID]_19478460[PMID]_22279524[PMID],0,0
Disease,SLC35A1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11157507[PMID]_23873973[PMID]_28856833[PMID],3,3
Disease,SLC35A1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11157507[PMID]_23873973[PMID]_28856833[PMID],0,0
Etiological subtype,Familial clubfoot due to 17q23.1q23.2 microduplication,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20598276[PMID]_22678995[PMID],4,4
Etiological subtype,Familial clubfoot due to 17q23.1q23.2 microduplication,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20598276[PMID]_22678995[PMID],0,0
Disease,Hyperphenylalaninemia due to tetrahydrobiopterin deficiency,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,6468444[PMID],0.22,0.22
Disease,Hyperphenylalaninemia due to tetrahydrobiopterin deficiency,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.2,0.2
Disease,Chuvash erythrocytosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24089328[PMID],80,80
Disease,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Acquired secondary polycythemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Atypical hypotonia-cystinuria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18234729[PMID],2,2
Disease,Atypical hypotonia-cystinuria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18234729[PMID],0,0
Category,Congenital secondary polycythemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Megacystis-megaureter syndrome,,,,,,,,,,,,,
Disease,Idiopathic intracranial hypertension,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2016[INST],14,14
Particular clinical situation in a disease or syndrome,Ileal pouch anal anastomosis related faecal incontinence,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2009[INST],3,3
Etiological subtype,Beckwith-Wiedemann syndrome due to NSD1 mutation,,,,,,,,,,,,,
Disease,Primary orthostatic tremor,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],390,390
Disease,Primary orthostatic tremor,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,IgG4-related mesenteritis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Neonatal iodine exposure,,,,,,,,,,,,,
Disease,Isolated thyrotropin-releasing hormone deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Isolated congenital hypogonadotropic hypogonadism,,,,,,,,,,,,,
Clinical subtype,"Congenital primary megaureter, nonrefluxing and unobstructed form",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Congenital primary megaureter, refluxing form",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Congenital primary megaureter, obstructed form",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Primary megaureter, adult-onset form",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Irinotecan toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Isoniazid toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Efavirenz toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Codeine toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Flucloxacilline toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Voriconazole toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Raltegravir toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Syndromic obesity,,,,,,,,,,,,,
Clinical subtype,Classic progressive supranuclear palsy syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Progressive supranuclear palsy-progressive non-fluent aphasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Clinical subtype,Progressive supranuclear palsy-progressive non-fluent aphasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Progressive supranuclear palsy-corticobasal syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.6,0.6
Clinical subtype,Progressive supranuclear palsy-pure akinesia with gait freezing syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Progressive supranuclear palsy-parkinsonism syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Particular clinical situation in a disease or syndrome,Cisplatin toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,5-fluorouracil toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Abacavir toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Nijmegen breakage syndrome-like disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1887849[PMID]_19409520[PMID],1,1
Malformation syndrome,Nijmegen breakage syndrome-like disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1887849[PMID]_19409520[PMID],0,0
Particular clinical situation in a disease or syndrome,Allopurinol toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Tacrolimus dose selection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Resistance to tamoxifene,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Resistance to clopidogrel,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Susceptibility to infection due to TYK2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26304966[PMID],8,8
Disease,Susceptibility to infection due to TYK2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26304966[PMID],0,0
Clinical group,Hyper-IgE syndrome,,,,,,,,,,,,,
Disease,Selective IgM deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23760686[PMID],0,0
Category,Immunodeficiency with isotype or light chain deficiencies with normal number of B-cells,,,,,,,,,,,,,
Category,Other immunodeficiency syndrome with predominantly antibody defects,,,,,,,,,,,,,
Category,Immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of B-cells,,,,,,,,,,,,,
Category,Immunodeficiency syndrome with hypopigmentation,,,,,,,,,,,,,
Disease,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23758768[PMID],57,57
Disease,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Constitutional neutropenia with extra-hematopoietic manifestations,,,,,,,,,,,,,
Disease,Immunodeficiency due to MASP-2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12904520[PMID],1,1
Disease,Immunodeficiency due to MASP-2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12904520[PMID],0,0
Disease,Immunodeficiency due to ficolin3 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19535802[PMID],1,1
Disease,Immunodeficiency due to ficolin3 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19535802[PMID],0,0
Category,Other immunodeficiency syndromes due to defects in innate immunity,,,,,,,,,,,,,
Disease,Severe combined immunodeficiency due to complete RAG1/2 deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],1,1
Category,Syndrome with combined immunodeficiency,,,,,,,,,,,,,
Category,Immunodeficiency due to absence of thymus,,,,,,,,,,,,,
Category,Genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability,,,,,,,,,,,,,
Category,Genetic multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome,,,,,,,,,,,,,
Disease,Chronic actinic dermatitis,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,15813653[PMID],16.7,16.7
Disease,Chronic actinic dermatitis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Wild type ATTR amyloidosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],30,30
Clinical subtype,Classic neuroendocrine tumor of appendix,1-9 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,20524865[PMID],0.25,0.25
Clinical subtype,Classic neuroendocrine tumor of appendix,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Goblet cell carcinoma,<1 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,20524865[PMID],0.025,0.025
Clinical subtype,Goblet cell carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,High altitude pulmonary edema,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2013[INST],0,0
Disease,Lead poisoning,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2013[INST],2.3,2.3
Disease,Lead poisoning,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,Institut de Veille Sanitaire 2010[INST]_ORPHANET,0.68,0.68
Disease,Hemoglobin Lepore-beta-thalassemia syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hemoglobin M disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mercury poisoning,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],0,0
Disease,Hypotrichosis-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16280295[PMID],1,1
Disease,Hypotrichosis-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hydroa vacciniforme,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,10642674[PMID],0.34,0.34
Disease,Hydroa vacciniforme,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Actinic prurigo,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17460227[PMID]_26825290[PMID]_26992161[PMID]_26604000[PMID]_27145208[PMID]_30109270[PMID]_27328748[PMID],11,11
Etiological subtype,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17460227[PMID]_26825290[PMID]_26992161[PMID]_26604000[PMID]_27145208[PMID]_30109270[PMID]_27328748[PMID],0,0
Disease,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19409522[PMID],3,3
Disease,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Mosaic genome-wide paternal uniparental disomy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23804593[PMID],13,13
Malformation syndrome,Mosaic genome-wide paternal uniparental disomy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23804593[PMID],0,0
Malformation syndrome,5p13 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20052029[PMID]_21211577[PMID]_23085304[PMID],7,7
Malformation syndrome,5p13 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Non-hypoproteinemic hypertrophic gastropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22711003[PMID],1,1
Disease,Non-hypoproteinemic hypertrophic gastropathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Idiopathic giant cell myocarditis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spastic paraplegia-Paget disease of bone syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22991237[PMID],1,1
Disease,Spastic paraplegia-Paget disease of bone syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Lipoprotein glomerulopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24149835[PMID],0,0
Disease,Lipoprotein glomerulopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24149835[PMID],150,150
Disease,Adult-onset distal myopathy due to VCP mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21684747[PMID],9,9
Disease,Adult-onset distal myopathy due to VCP mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Transient neonatal multiple acyl-CoA dehydrogenase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17689999[PMID]_21089064[PMID]_21089064[PMID],1,1
Disease,Transient neonatal multiple acyl-CoA dehydrogenase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Histopathological subtype,C3 glomerulonephritis,,,,,,,,,,,,,
Clinical subtype,Generalized juvenile polyposis/juvenile polyposis coli,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Intermittent hydrarthrosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Juvenile overlap myositis,,,,,,,,,,,,,
Category,Juvenile idiopathic inflammatory myopathy,,,,,,,,,,,,,
Clinical subtype,C3 glomerulopathy,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,27056062[PMID],0.15,0.15
Clinical subtype,C3 glomerulopathy,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],12,12
Clinical subtype,Immunoglobulin-mediated membranoproliferative glomerulonephritis,,,,,,,,,,,,,
Disease,Fatty acid hydroxylase-associated neurodegeneration,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21735565[PMID],0,0
Disease,Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Thrombocythemia with distal limb defects,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19553636[PMID],3,3
Disease,Thrombocythemia with distal limb defects,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Inverse Klippel-Trénaunay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17341861[PMID]_23000147[PMID],15,15
Disease,Inverse Klippel-Trénaunay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Beta-propeller protein-associated neurodegeneration,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29445477[PMID],68,68
Disease,Beta-propeller protein-associated neurodegeneration,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29445477[PMID],0,0
Clinical group,PLA2G6-associated neurodegeneration,,,,,,,,,,,,,
Disease,Distal arthrogryposis type 5D,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25099528[PMID]_24782201[PMID],33,33
Disease,Distal arthrogryposis type 5D,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25099528[PMID]_24782201[PMID],0,0
Disease,"Autosomal dominant focal dystonia, DYT25 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23222958[PMID],28,28
Disease,"Autosomal dominant focal dystonia, DYT25 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23222958[PMID],0,0
Clinical subtype,Acute megakaryoblastic leukemia without Down syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Autosomal recessive frontotemporal pachygyria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23022981[PMID],7,7
Malformation syndrome,Autosomal recessive frontotemporal pachygyria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22002884[PMID],4,4
Malformation syndrome,Microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Limbic encephalitis with DPP6 antibodies,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23225603[PMID],4,4
Disease,Limbic encephalitis with DPP6 antibodies,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Microcephalic primordial dwarfism due to ZNF335 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23178126[PMID]_27540107[PMID]_29652087[PMID],10,10
Malformation syndrome,Microcephalic primordial dwarfism due to ZNF335 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29652087[PMID],0,0
Malformation syndrome,Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23159249[PMID],2,2
Malformation syndrome,Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cerebral sinovenous thrombosis,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,15858188[PMID]_ORPHANET,0,0
Disease,Cerebral sinovenous thrombosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal dominant neovascular inflammatory vitreoretinopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23055945[PMID],99,99
Disease,Autosomal dominant neovascular inflammatory vitreoretinopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Developmental delay with autism spectrum disorder and gait instability,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23065719[PMID]_23243086[PMID],22,22
Disease,Developmental delay with autism spectrum disorder and gait instability,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Tall stature-scoliosis-macrodactyly of the great toes syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22870295[PMID]_23243086[PMID]_24259409[PMID],2,2
Disease,Tall stature-scoliosis-macrodactyly of the great toes syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital muscular dystrophy with intellectual disability and severe epilepsy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23109149[PMID],3,3
Disease,Congenital muscular dystrophy with intellectual disability and severe epilepsy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2Q,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23141294[PMID],8,8
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2Q,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spondylocostal dysostosis-hypospadias-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23166036[PMID],2,2
Disease,Spondylocostal dysostosis-hypospadias-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23160192[PMID],13,13
Etiological subtype,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23160192[PMID],0,0
Disease,Congenital chronic diarrhea with protein-losing enteropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23114594[PMID],2,2
Disease,Congenital chronic diarrhea with protein-losing enteropathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,X-linked central congenital hypothyroidism with late-onset testicular enlargement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23143598[PMID],27,27
Disease,X-linked central congenital hypothyroidism with late-onset testicular enlargement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30936877[PMID]_23104095[PMID]_26008899[PMID],5,5
Disease,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30936877[PMID],0,0
Category,"Genetic 46,XX disorder of sex development",,,,,,,,,,,,,
Category,Genetic disorder of sex development,,,,,,,,,,,,,
Category,"Genetic 46,XY disorder of sex development of endocrine origin",,,,,,,,,,,,,
Category,"Genetic 46,XY disorder of sex development",,,,,,,,,,,,,
Category,Syndrome with disorder of sex development of gynecological interest,,,,,,,,,,,,,
Category,Genetic disorder of sex development of gynecological interest,,,,,,,,,,,,,
Category,Disorder of sex development of gynecological interest,,,,,,,,,,,,,
Category,"46,XY disorder of sex development of gynecological interest",,,,,,,,,,,,,
Disease,Congenital factor XI deficiency,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.1,0.1
Disease,Best vitelliform macular dystrophy,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,22633354[PMID],1.5,1.5
Disease,Best vitelliform macular dystrophy,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,4448697[PMID],20,20
Disease,Best vitelliform macular dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Best vitelliform macular dystrophy,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,22633354[PMID],1.5,1.5
Disease,Best vitelliform macular dystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22633354[PMID]_4448697[PMID],0,0
Category,"46,XY disorder of sex development due to a cholesterol synthesis defect",,,,,,,,,,,,,
Clinical subtype,Classic congenital lipoid adrenal hyperplasia due to STAR deficency,,,,,,,,,,,,,
Category,"46,XY disorder of sex development due to impaired androgen production",,,,,,,,,,,,,
Clinical subtype,Leydig cell hypoplasia due to LHB deficiency,,,,,,,,,,,,,
Category,Sex chromosome disorder of sex development,,,,,,,,,,,,,
Clinical subtype,Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency,,,,,,,,,,,,,
Category,"46,XY disorder of sex development induced by maternal exposure to endocrine disruptors",,,,,,,,,,,,,
Morphological anomaly,Testicular agenesis,,,,,,,,,,,,,
Category,"46,XY disorder of gonadal development",,,,,,,,,,,,,
Category,"46,XY disorder of sex development of endocrine origin",,,,,,,,,,,,,
Disease,"46,XY ovotesticular disorder of sex development",,,,,,,,,,,,,
Category,"46,XX disorder of gonadal development",,,,,,,,,,,,,
Category,"Syndrome with 46,XX disorder of sex development",,,,,,,,,,,,,
Clinical group,"46,XX disorder of sex development induced by exogenous maternal-derived androgen",,,,,,,,,,,,,
Clinical group,"46,XX disorder of sex development induced by endogenous maternal-derived androgen",,,,,,,,,,,,,
Category,"46,XX disorder of sex development induced by fetoplacental androgens excess",,,,,,,,,,,,,
Clinical subtype,JMP syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21129723[PMID]_20534754[PMID],3,3
Clinical subtype,JMP syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,21129723[PMID]_20534754[PMID],0,0
Clinical subtype,CANDLE syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26711936[PMID],30,30
Clinical subtype,CANDLE syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26711936[PMID],0,0
Category,Unexplained periodic fever syndrome of childhood,,,,,,,,,,,,,
Disease,Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,12183714[PMID],0.3,0.3
Disease,Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,12183714[PMID],2.5,2.5
Disease,MAGIC syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27293269[PMID],21,21
Disease,MAGIC syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27293269[PMID],0,0
Disease,Proteasome disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24131530[PMID],0,0
Disease,Proteasome disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24131530[PMID],40,40
Category,Periodic fever syndrome of childhood,,,,,,,,,,,,,
Category,Pyogenic autoinflammatory syndrome of childhood,,,,,,,,,,,,,
Category,Granulomatous autoinflammatory syndrome of childhood,,,,,,,,,,,,,
Category,Unclassified autoinflammatory syndrome of childhood,,,,,,,,,,,,,
Category,Pyogenic autoinflammatory syndrome,,,,,,,,,,,,,
Category,Granulomatous autoinflammatory syndrome,,,,,,,,,,,,,
Category,Mixed autoinflammatory and autoimmune syndrome,,,,,,,,,,,,,
Category,Unclassified autoinflammatory syndrome,,,,,,,,,,,,,
Clinical group,Trichorhinophalangeal syndrome,,,,,,,,,,,,,
Clinical group,Microcephalic primordial dwarfism,,,,,,,,,,,,,
Category,Hereditary periodic fever syndrome,,,,,,,,,,,,,
Category,Non-familial rare disease with dilated cardiomyopathy,,,,,,,,,,,,,
Clinical subtype,ABetaA21G amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],2,2
Clinical subtype,ABetaA21G amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"ABeta amyloidosis, Italian type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20697050[PMID]_10821838[PMID],7,7
Clinical subtype,"ABeta amyloidosis, Italian type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20697050[PMID]_10821838[PMID],0,0
Disease,SRD5A3-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18271001[PMID]_20637498[PMID],7,7
Disease,SRD5A3-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18271001[PMID]_20637498[PMID],0,0
Clinical subtype,"ABeta amyloidosis, Arctic type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11528419[PMID],1,1
Clinical subtype,"ABeta amyloidosis, Arctic type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11528419[PMID],0,0
Disease,Invasive non-typhoidal salmonellosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autoerythrocyte sensitization syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19192020[PMID],170,170
Disease,Autoerythrocyte sensitization syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"ABeta amyloidosis, Iowa type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11409420[PMID]_12654973[PMID],2,2
Clinical subtype,"ABeta amyloidosis, Iowa type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11409420[PMID]_12654973[PMID],0,0
Clinical subtype,ABetaL34V amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16178030[PMID]_19225789[PMID],1,1
Clinical subtype,ABetaL34V amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16178030[PMID]_19225789[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Classic multiminicore myopathy,,,,,,,,,,,,,
Disease,Hendra virus infection,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22752412[PMID],7,7
Disease,Hendra virus infection,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Chikungunya,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut de Veille Sanitaire 2009[INST],0.02,0.02
Disease,Chikungunya,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chikungunya,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.12,0.12
Disease,Chikungunya,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.32,0.32
Disease,Chikungunya,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.06,0.06
Disease,Chikungunya,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.13,0.13
Disease,Chikungunya,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.3,0.3
Disease,Chikungunya,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.02,0.02
Disease,Chikungunya,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2014-2017[INST],0.35,0.35
Disease,Chikungunya,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.16,0.16
Disease,Chikungunya,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.24,0.24
Disease,Chikungunya,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.4,0.4
Disease,Chikungunya,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.02,0.02
Disease,Chikungunya,<1 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Chikungunya,<1 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Chikungunya,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Chikungunya,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2015-2017[INST],0,0
Disease,Familial dyskinesia and facial myokymia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11310626[PMID]_22782511[PMID],18,18
Disease,Familial dyskinesia and facial myokymia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,X-linked cleft palate and ankyloglossia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Benign Samaritan congenital myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22752422[PMID],4,4
Disease,Benign Samaritan congenital myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22704856[PMID],9,9
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Pontocerebellar hypoplasia type 8,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23023333[PMID],6,6
Malformation syndrome,Pontocerebellar hypoplasia type 8,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hyperinsulinism due to HNF1A deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22802087[PMID],2,2
Disease,Hyperinsulinism due to HNF1A deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Aphonia-deafness-retinal dystrophy-bifid halluces-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22991300[PMID],2,2
Malformation syndrome,Aphonia-deafness-retinal dystrophy-bifid halluces-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hypopigmentation-punctate palmoplantar keratoderma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24075184[PMID],6,6
Disease,Hypopigmentation-punctate palmoplantar keratoderma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23000145[PMID],2,2
Disease,Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23000145[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 11,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27412952[PMID],32,32
Disease,Combined oxidative phosphorylation defect type 11,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27412952[PMID],0,0
Disease,Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22781753[PMID],3,3
Disease,Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive axonal neuropathy with neuromyotonia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22961002[PMID],33,33
Disease,Autosomal recessive axonal neuropathy with neuromyotonia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Muscular hypertrophy-hepatomegaly-polyhydramnios syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22683912[PMID],2,2
Malformation syndrome,Muscular hypertrophy-hepatomegaly-polyhydramnios syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,ALG13-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22492991[PMID],1,1
Disease,ALG13-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22492991[PMID],0,0
Disease,X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22814392[PMID],2,2
Disease,X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary inclusion body myopathy type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22723986[PMID],17,17
Disease,Hereditary inclusion body myopathy type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mixed sclerosing bone dystrophy with extra-skeletal manifestations,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22821701[PMID],2,2
Disease,Mixed sclerosing bone dystrophy with extra-skeletal manifestations,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22821701[PMID],0,0
Morphological anomaly,Congenital achiasma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sinoatrial node dysfunction and deafness,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21131953[PMID],8,8
Disease,Sinoatrial node dysfunction and deafness,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,9p13 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22887577[PMID],4,4
Malformation syndrome,9p13 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Severe lateral tibial bowing with short stature,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22927185[PMID],2,2
Disease,Severe lateral tibial bowing with short stature,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Multiple paragangliomas associated with polycythemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22931260[PMID],2,2
Clinical subtype,Multiple paragangliomas associated with polycythemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,T-cell immunodeficiency with epidermodysplasia verruciformis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22850876[PMID],2,2
Disease,T-cell immunodeficiency with epidermodysplasia verruciformis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Early-onset Lafora body disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22961547[PMID],3,3
Disease,Early-onset Lafora body disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22961547[PMID],0,0
Category,Rare disorders,,,,,,,,,,,,,
Category,Genetic tumor of hematopoietic and lymphoid tissues,,,,,,,,,,,,,
Clinical subtype,Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22901947[PMID],10,10
Clinical subtype,Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Autoinflammatory syndrome of childhood,,,,,,,,,,,,,
Clinical group,Cleft lip/palate-ectodermal dysplasia syndrome,,,,,,,,,,,,,
Clinical group,X-linked pure spastic paraplegia,,,,,,,,,,,,,
Clinical group,Pure or complex hereditary spastic paraplegia,,,,,,,,,,,,,
Clinical group,Pure or complex autosomal dominant spastic paraplegia,,,,,,,,,,,,,
Clinical group,Pure or complex autosomal recessive spastic paraplegia,,,,,,,,,,,,,
Clinical group,Pure or complex X-linked spastic paraplegia,,,,,,,,,,,,,
Disease,MT-ATP6-related mitochondrial spastic paraplegia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20656066[PMID],5,5
Disease,MT-ATP6-related mitochondrial spastic paraplegia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20656066[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 41,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18364116[PMID],7,7
Disease,Autosomal dominant spastic paraplegia type 41,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18364116[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 43,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20039086[PMID],2,2
Disease,Autosomal recessive spastic paraplegia type 43,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20039086[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 36,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19357379[PMID],1,1
Disease,Autosomal dominant spastic paraplegia type 36,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19357379[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 54,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23486545[PMID]_24482476[PMID],6,6
Disease,Autosomal recessive spastic paraplegia type 54,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23486545[PMID]_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 55,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24080142[PMID]_24424123[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 55,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24080142[PMID]_24424123[PMID],14,14
Disease,Autosomal recessive spastic paraplegia type 46,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20593214[PMID],5,5
Disease,Autosomal recessive spastic paraplegia type 46,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20593214[PMID],0,0
Disease,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23176824[PMID],5,5
Disease,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23176824[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 44,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19056803[PMID],3,3
Disease,Autosomal recessive spastic paraplegia type 44,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19056803[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 45,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28884889[PMID],7,7
Disease,Autosomal recessive spastic paraplegia type 45,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28884889[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 56,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23176821[PMID],5,5
Disease,Autosomal recessive spastic paraplegia type 56,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23176821[PMID],0,0
Disease,Spastic paraplegia-optic atrophy-neuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26385635[PMID],75,75
Disease,Spastic paraplegia-optic atrophy-neuropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26385635[PMID],0,0
Category,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to a partial deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],13,13
Disease,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Category,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a complete deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a partial deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Combined oxidative phosphorylation defect type 14,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22833457[PMID]_22499341[PMID],5,5
Disease,Combined oxidative phosphorylation defect type 14,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22833457[PMID]_22499341[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 15,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24461907[PMID],16,16
Disease,Combined oxidative phosphorylation defect type 15,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24461907[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 9,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21786366[PMID],4,4
Disease,Combined oxidative phosphorylation defect type 9,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21786366[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 13,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23084291[PMID],2,2
Disease,Combined oxidative phosphorylation defect type 13,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23084291[PMID],0,0
Disease,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_23963039[PMID],2,2
Disease,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],17,17
Disease,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Disease,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],6,6
Disease,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Disease,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],68,68
Disease,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Disease,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],6,6
Disease,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Disease,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],18,18
Disease,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Disease,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],180,180
Disease,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Disease,Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],49,49
Disease,Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Constitutional megaloblastic anemia with severe neurologic disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21310276[PMID]_21310277[PMID],6,6
Disease,Constitutional megaloblastic anemia with severe neurologic disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21310276[PMID]_21310277[PMID],0,0
Disease,PGM1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27206562[PMID]_24499211[PMID],46,46
Disease,PGM1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27206562[PMID]_24499211[PMID],0,0
Disease,Retinal macular dystrophy type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20393116[PMID],5,5
Disease,Retinal macular dystrophy type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20393116[PMID],0,0
Disease,Amyloidosis cutis dyschromia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24746296[PMID],27,27
Disease,Amyloidosis cutis dyschromia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24746296[PMID],0,0
Etiological subtype,X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21278736[PMID],7,7
Etiological subtype,X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21278736[PMID],0,0
Etiological subtype,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],6,6
Etiological subtype,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Disease,X-linked mendelian susceptibility to mycobacterial diseases,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21278736[PMID]_16818673[PMID],13,13
Disease,X-linked mendelian susceptibility to mycobacterial diseases,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21278736[PMID]_16818673[PMID],0,0
Disease,Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],2,2
Disease,Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Disease,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11562630[PMID],1,1
Disease,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11562630[PMID],0,0
Malformation syndrome,"Microcephalic primordial dwarfism, Dauber type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22933543[PMID],2,2
Malformation syndrome,"Microcephalic primordial dwarfism, Dauber type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22933543[PMID],0,0
Malformation syndrome,"Microcephalic primordial dwarfism, Alazami type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22865833[PMID],10,10
Malformation syndrome,"Microcephalic primordial dwarfism, Alazami type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22865833[PMID],0,0
Disease,Primary lymphoma of the conjunctiva,,,,,,,,,,,,,
Disease,Kyasanur forest disease,,,,,,,,,,,,,
Disease,Omsk hemorrhagic fever,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Susceptibility/resistance to HIV infection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Clear cell renal carcinoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.99,1.99
Disease,Brazilian hemorrhagic fever,,,,,,,,,,,,,
Disease,Chapare hemorrhagic fever,,,,,,,,,,,,,
Disease,Hantavirus pulmonary syndrome,,,,,,,,,,,,,
Disease,Rift valley fever,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011[INST],0,0
Disease,Renal medullary carcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Mucinous tubular and spindle cell renal carcinoma,,,,,,,,,,,,,
Disease,Tubulocystic renal cell carcinoma,,,,,,,,,,,,,
Histopathological subtype,Multilocular cystic renal neoplasm of low malignant potential,,,,,,,,,,,,,
Disease,Papillary renal cell carcinoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.14,0.14
Disease,Chromophobe renal cell carcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,MiT family translocation renal cell carcinoma,,,,,,,,,,,,,
Disease,Autosomal recessive myogenic arthrogryposis multiplex congenita,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19542096[PMID],1,1
Disease,Autosomal recessive myogenic arthrogryposis multiplex congenita,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19542096[PMID],0,0
Category,Inherited renal cancer-predisposing syndrome,,,,,,,,,,,,,
Disease,Carney complex-trismus-pseudocamptodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15282353[PMID],3,3
Disease,Carney complex-trismus-pseudocamptodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15282353[PMID],0,0
Disease,Familial papillary or follicular thyroid carcinoma,,,,,,,,,,,,,
Disease,Acute myeloid leukemia with CEBPA somatic mutations,,,,,,,,,,,,,
Disease,Combined oxidative phosphorylation defect type 8,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21549344[PMID]_25058219[PMID],7,7
Disease,Combined oxidative phosphorylation defect type 8,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21549344[PMID]_25058219[PMID],0,0
Clinical group,Familial nonmedullary thyroid carcinoma,,,,,,,,,,,,,
Disease,Inherited acute myeloid leukemia,,,,,,,,,,,,,
Disease,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations,,,,,,,,,,,,,
Etiological subtype,Bilateral massive adrenal hemorrhage,,,,,,,,,,,,,
Disease,Lujo hemorrhagic fever,,,,,,,,,,,,,
Disease,Chondroectodermal dysplasia with night blindness,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22579605[PMID],4,4
Disease,Chondroectodermal dysplasia with night blindness,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22579605[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 53,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22717650[PMID],9,9
Disease,Autosomal recessive spastic paraplegia type 53,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22717650[PMID],0,0
Disease,Bolivian hemorrhagic fever,,,,,,,,,,,,,
Disease,Venezuelan hemorrhagic fever,,,,,,,,,,,,,
Disease,Ebola hemorrhagic fever,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,World health Organisation 2015[INST]_26607790[PMID],28220,28220
Disease,Ebola hemorrhagic fever,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011[INST],0,0
Disease,Ebola hemorrhagic fever,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],0,0
Disease,Argentine hemorrhagic fever,,,,,,,,,,,,,
Disease,Congenital myopathy with internal nuclei and atypical cores,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22818856[PMID],5,5
Disease,Congenital myopathy with internal nuclei and atypical cores,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22818856[PMID],0,0
Malformation syndrome,Distal 17p13.1 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24501763[PMID],16,16
Malformation syndrome,Distal 17p13.1 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24501763[PMID],0,0
Disease,Familial cortical myoclonus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2292685[PMID],11,11
Disease,Familial cortical myoclonus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2292685[PMID],0,0
Morphological anomaly,Diencephalic-mesencephalic junction dysplasia,,,,,,,,,,,,,
Malformation syndrome,Wiedemann-Steiner syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27777327[PMID],18,18
Malformation syndrome,Wiedemann-Steiner syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27777327[PMID],0,0
Clinical group,T-B- severe combined immunodeficiency,,,,,,,,,,,,,
Clinical group,T-B+ severe combined immunodeficiency,,,,,,,,,,,,,
Clinical subtype,Combined immunodeficiency due to ORAI1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20004786[PMID],6,6
Clinical subtype,Combined immunodeficiency due to ORAI1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20004786[PMID],0,0
Disease,Severe combined immunodeficiency due to DNA-PKcs deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19075392[PMID]_23722905[PMID],2,2
Disease,Severe combined immunodeficiency due to DNA-PKcs deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19075392[PMID]_23722905[PMID],0,0
Clinical subtype,Combined immunodeficiency due to STIM1 deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pancytopenia due to IKZF1 mutations,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21548011[PMID]_26981933[PMID]_27939403[PMID],39,39
Disease,Pancytopenia due to IKZF1 mutations,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21548011[PMID]_26981933[PMID]_27939403[PMID],0,0
Disease,"X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24550228[PMID],7,7
Disease,"X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24550228[PMID],0,0
Category,Autoimmune disease with skin involvement,,,,,,,,,,,,,
Clinical subtype,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form",1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],2.5,2.5
Clinical subtype,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],7.5,7.5
Clinical subtype,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],7.5,7.5
Malformation syndrome,Cataract-congenital heart disease-neural tube defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11836368[PMID],2,2
Malformation syndrome,Cataract-congenital heart disease-neural tube defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11836368[PMID],0,0
Disease,X-linked non progressive cerebellar ataxia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18241076[PMID]_22912398[PMID],3,3
Disease,X-linked non progressive cerebellar ataxia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Lymphocytic hypereosinophilic syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Secondary hypereosinophilic syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary hypereosinophilic syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mycobacterium xenopi infection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Normal pressure hydrocephalus,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,18205881[PMID],5.5,5.5
Disease,Normal pressure hydrocephalus,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,18205881[PMID],21.9,21.9
Disease,Normal pressure hydrocephalus,1-9 / 100 000,Sweden,409966,409966,25965,25965,en,Not yet validated,410294,410294,24682964[PMID]_ORPHANET,0,0
Disease,Normal pressure hydrocephalus,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Mild Canavan disease,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Severe Canavan disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Partial deletion of the short arm of chromosome 12,,,,,,,,,,,,,
Category,Autosomal dominant spastic ataxia,,,,,,,,,,,,,
Category,Autosomal recessive spastic ataxia,,,,,,,,,,,,,
Clinical group,Spastic ataxia,,,,,,,,,,,,,
Clinical subtype,Primary systemic amyloidosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2003[INST],30,30
Etiological subtype,Acquired porencephaly,,,,,,,,,,,,,
Clinical subtype,Primary localized amyloidosis,,,,,,,,,,,,,
Malformation syndrome,Cerebrofacioarticular syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22473091[PMID]_24056717[PMID],9,9
Malformation syndrome,Cerebrofacioarticular syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,TMEM165-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22683087[PMID]_26238249[PMID],6,6
Disease,TMEM165-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22683087[PMID]_26238249[PMID],0,0
Disease,Combined immunodeficiency due to STK4 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22294732[PMID]_22174160[PMID],7,7
Disease,Combined immunodeficiency due to STK4 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary bone lymphoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Variant ABeta2M amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22693999[PMID],5,5
Disease,Variant ABeta2M amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22693999[PMID],0,0
Disease,Non-progressive cerebellar ataxia with intellectual disability,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22693284[PMID],15,15
Disease,Non-progressive cerebellar ataxia with intellectual disability,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Segmental progressive overgrowth syndrome with fibroadipose hyperplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22729222[PMID],10,10
Disease,Segmental progressive overgrowth syndrome with fibroadipose hyperplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23950017[PMID],7,7
Etiological subtype,Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23950017[PMID],0,0
Etiological subtype,CLN11 disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22608501[PMID],2,2
Etiological subtype,CLN11 disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Duplication of the pituitary gland,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22439114[PMID],38,38
Morphological anomaly,Duplication of the pituitary gland,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23929671[PMID],8,8
Disease,Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,ATP13A2-related juvenile neuronal ceroid lipofuscinosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22388936[PMID],4,4
Disease,ATP13A2-related juvenile neuronal ceroid lipofuscinosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Short stature due to partial GHR deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Short stature due to GHSR deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16511605[PMID],8,8
Disease,Short stature due to GHSR deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16511605[PMID],0,0
Clinical group,Primary renal tubular acidosis,,,,,,,,,,,,,
Clinical subtype,Autosomal dominant proximal renal tubular acidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10972690[PMID],1,1
Clinical subtype,Autosomal dominant proximal renal tubular acidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10972690[PMID],0,0
Disease,Familial isolated pituitary adenoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22720333[PMID],150,150
Disease,Familial isolated pituitary adenoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Histopathological subtype,Silent pituitary adenoma,,,,,,,,,,,,,
Histopathological subtype,Null pituitary adenoma,,,,,,,,,,,,,
Disease,SHOX-related short stature,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Functioning pituitary adenoma,,,,,,,,,,,,,
Category,Mixed functioning pituitary adenoma,,,,,,,,,,,,,
Disease,Somatomammotropinoma,,,,,,,,,,,,,
Disease,Lethal arteriopathy syndrome due to fibulin-4 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22943132[PMID],22,22
Disease,Lethal arteriopathy syndrome due to fibulin-4 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Atypical dentin dysplasia due to SMOC2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15243476[PMID]_22152679[PMID],4,4
Clinical subtype,Atypical dentin dysplasia due to SMOC2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare disease with Cushing syndrome as a major feature,,,,,,,,,,,,,
Disease,Medich giant platelet syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22931192[PMID]_15370096[PMID],3,3
Disease,Medich giant platelet syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Ataxia-telangiectasia variant,,,,,,,,,,,,,
Category,Rare disorder with dystonia and other neurologic or systemic manifestation,,,,,,,,,,,,,
Disease,"Primary dystonia, DYT17 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18688663[PMID],3,3
Disease,"Primary dystonia, DYT17 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18688663[PMID],0,0
Disease,Oculocutaneous albinism type 6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23364476[PMID],1,1
Disease,Oculocutaneous albinism type 6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Oculocutaneous albinism type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23050561[PMID],1,1
Disease,Oculocutaneous albinism type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Small cell carcinoma of the ovary,,,,,,,,,,,,,
Disease,Peripheral primitive neuroectodermal tumor,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.077,0.077
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.056,0.056
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.023,0.023
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.052,0.052
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.083,0.083
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.071,0.071
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.055,0.055
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.068,0.068
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.05,0.05
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.076,0.076
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.092,0.092
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.081,0.081
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.087,0.087
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.056,0.056
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.089,0.089
Disease,Extraskeletal Ewing sarcoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.058,0.058
Disease,Extraskeletal Ewing sarcoma,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.112,0.112
Disease,Extraskeletal Ewing sarcoma,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.126,0.126
Disease,Extraskeletal Ewing sarcoma,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.106,0.106
Disease,White platelet syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15203719[PMID],1,1
Disease,White platelet syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Didymosis aplasticosebacea,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11385232[PMID],18,18
Disease,Didymosis aplasticosebacea,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Familial syringomyelia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,7482254[PMID]_18050067[PMID],0,0
Disease,Angora hair nevus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23858341[PMID],2,2
Disease,Angora hair nevus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24013853[PMID],7,7
Disease,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acute myeloid leukemia with t(8;16)(p11;p13) translocation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23974201[PMID],0,0
Disease,"Spondyloepimetaphyseal dysplasia, Isidor type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23956136[PMID],2,2
Disease,"Spondyloepimetaphyseal dysplasia, Isidor type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Spondylometaphyseal dysplasia, Czarny-Ratajczak type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19764033[PMID],2,2
Disease,"Spondylometaphyseal dysplasia, Czarny-Ratajczak type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acute infantile liver failure-multisystemic involvement syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22607940[PMID],6,6
Disease,Acute infantile liver failure-multisystemic involvement syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Fetal carbamazepine syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Proximal 16p11.2 microduplication syndrome,,,,,,,,,,,,,
Clinical group,Fetal anticonvulsant syndrome,,,,,,,,,,,,,
Disease,SCALP syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22122611[PMID],4,4
Disease,SCALP syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22122611[PMID],0,0
Disease,NEVADA syndrome,,,,,,,,,,,,,
Category,X-linked congenital disorder of glycosylation with intellectual disability as a major feature,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with neurological involvement,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with epilepsy as a major feature,,,,,,,,,,,,,
Category,Non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature,,,,,,,,,,,,,
Disease,Congenital muscular dystrophy with hyperlaxity,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16760198[PMID],14,14
Disease,Congenital muscular dystrophy with hyperlaxity,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16760198[PMID],0,0
Disease,Muscle-eye-brain disease with bilateral multicystic leucodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24052401[PMID],2,2
Disease,Muscle-eye-brain disease with bilateral multicystic leucodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24052401[PMID],0,0
Category,Primary qualitative or quantitative defects of alpha-dystroglycan,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of alpha-dystroglycan,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with cardiac malformation as a major feature,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with dilated cardiomyopathy,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation-related bone disorder,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with intestinal involvement,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with hepatic involvement,,,,,,,,,,,,,
Disease,STT3A-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23842455[PMID],2,2
Disease,STT3A-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23842455[PMID,0,0
Disease,STT3B-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23842455[PMID],1,1
Disease,STT3B-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23842455[PMID],0,0
Disease,SSR4-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26264460[PMID],9,9
Disease,SSR4-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26264460[PMID],0,0
Disease,XYLT1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23982343[PMID],2,2
Disease,XYLT1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Congenital muscular dystrophy due to dystroglycanopathy,,,,,,,,,,,,,
Disease,Congenital muscular dystrophy with cerebellar involvement,,,,,,,,,,,,,
Disease,Congenital muscular dystrophy with intellectual disability,,,,,,,,,,,,,
Disease,Congenital muscular dystrophy without intellectual disability,,,,,,,,,,,,,
Clinical group,GM3 synthase deficiency,,,,,,,,,,,,,
Disease,Salt-and-pepper syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24026681[PMID],3,3
Disease,Salt-and-pepper syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autism spectrum disorder-epilepsy-arthrogryposis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24031089[PMID],8,8
Disease,Autism spectrum disorder-epilepsy-arthrogryposis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24031089[PMID],0,0
Clinical group,Primary short bowel syndrome,,,,,,,,,,,,,
Disease,Primary hyperaldosteronism-seizures-neurological abnormalities syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23913001[PMID],2,2
Disease,Primary hyperaldosteronism-seizures-neurological abnormalities syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Pontocerebellar hypoplasia type 9,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28815207[PMID],14,14
Malformation syndrome,Pontocerebellar hypoplasia type 9,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28815207[PMID],0,0
Disease,CADDS,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11992258[PMID]_22994209[PMID],4,4
Disease,CADDS,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24011989[PMID],7,7
Malformation syndrome,Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Methylmalonic acidemia with homocystinuria, type cblJ",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24011988[PMID]_22922874[PMID],2,2
Clinical subtype,"Methylmalonic acidemia with homocystinuria, type cblJ",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Intellectual disability-seizures-macrocephaly-obesity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23980137[PMID],7,7
Disease,Intellectual disability-seizures-macrocephaly-obesity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Microcornea-myopic chorioretinal atrophy-telecanthus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23818446[PMID],14,14
Disease,Microcornea-myopic chorioretinal atrophy-telecanthus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Methylmalonic acidemia with homocystinuria, type cblX",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24011988[PMID]_22922874[PMID],18,18
Clinical subtype,"Methylmalonic acidemia with homocystinuria, type cblX",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Finger hyperphalangy-toe anomalies-severe pectus excavatum syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23824731[PMID],2,2
Malformation syndrome,Finger hyperphalangy-toe anomalies-severe pectus excavatum syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Severe dermatitis-multiple allergies-metabolic wasting syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23974871[PMID],3,3
Disease,Severe dermatitis-multiple allergies-metabolic wasting syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Focal palmoplantar keratoderma with joint keratoses,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,16484817[PMID],0,0
Disease,Diffuse palmoplantar keratoderma with painful fissures,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,15897387[PMID],0,0
Malformation syndrome,Intellectual disability-facial dysmorphism-hand anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23949889[PMID],3,3
Malformation syndrome,Intellectual disability-facial dysmorphism-hand anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23636107[PMID],4,4
Malformation syndrome,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,TRAPPC11-related  limb-girdle muscular dystrophy R18,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23830518[PMID],3,3
Disease,TRAPPC11-related  limb-girdle muscular dystrophy R18,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Intellectual disability-hyperkinetic movement-truncal ataxia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23830518[PMID],5,5
Disease,Intellectual disability-hyperkinetic movement-truncal ataxia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital neutropenia-myelofibrosis-nephromegaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26358756[PMID]_28453180[PMID],16,16
Disease,Congenital neutropenia-myelofibrosis-nephromegaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26358756[PMID]_28453180[PMID]],0,0
Disease,Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25193871[PMID],16,16
Disease,Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25193871[PMID],0,0
Disease,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23844677[PMID],3,3
Disease,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Obesity due to SIM1 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23778136[PMID]_23778139[PMID],0,0
Malformation syndrome,2p21 microdeletion syndrome without cystinuria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23794250[PMID],2,2
Malformation syndrome,2p21 microdeletion syndrome without cystinuria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Homozygous 2p21 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23794250[PMID],0,0
Malformation syndrome,Developmental delay-facial dysmorphism syndrome due to MED13L deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28645799[PMID],26,26
Malformation syndrome,Developmental delay-facial dysmorphism syndrome due to MED13L deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28645799[PMID],0,0
Disease,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23993193[PMID]_23993194[PMID],20,20
Disease,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Combined oxidative phosphorylation defect type 17,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23849775[PMID]_27769300[PMID]_28441660[PMID],20,20
Disease,Combined oxidative phosphorylation defect type 17,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27769300[PMID]_28441660[PMID],0,0
Disease,Infantile epileptic-dyskinetic encephalopathy,,,,,,,,,,,,,
Disease,Severe early-childhood-onset retinal dystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,Pr Birgit LORENZ_Dr Markus PREISING[EXPERT],0,0
Disease,Hydroa vacciniforme-like lymphoma,,,,,,,,,,,,,
Disease,ALK-positive large B-cell lymphoma,,,,,,,,,,,,,
Disease,X-linked intellectual disability due to GRIA3 mutations,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24721225[PMID],14,14
Disease,X-linked intellectual disability due to GRIA3 mutations,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24721225[PMID],0,0
Disease,Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Infantile Refsum disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,TMEM70-related mitochondrial encephalo-cardio-myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Non-immune hydrops fetalis,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,42,42
Clinical subtype,Non-immune hydrops fetalis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Non-immune hydrops fetalis,>1 / 1000,Thailand,409966,409966,25958,25958,en,Validated,410293,410293,9280003[PMID],300,300
Morphological anomaly,Isolated anencephaly/exencephaly,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],35,35
Morphological anomaly,Isolated anencephaly/exencephaly,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Morphological anomaly,Isolated anencephaly/exencephaly,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20878909[PMID]_Center for Diseases Control and Prevention 2004-2006[INST],20.6,20.6
Morphological anomaly,Isolated anencephaly/exencephaly,>1 / 1000,India,409968,409968,25958,25958,en,Validated,410293,410293,23873811[PMID],210,210
Morphological anomaly,Isolated anencephaly/exencephaly,>1 / 1000,"Iran, Islamic Republic of",409968,409968,25958,25958,en,Validated,410293,410293,20039767[PMID],120,120
Morphological anomaly,Isolated anencephaly/exencephaly,1-5 / 10 000,Thailand,409968,409968,25958,25958,en,Validated,410293,410293,16858850[PMID],26,26
Morphological anomaly,Isolated anencephaly/exencephaly,1-5 / 10 000,Singapore,409968,409968,25958,25958,en,Validated,410293,410293,17245510[PMID],58,58
Clinical subtype,Immune hydrops fetalis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Immune hydrops fetalis,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,19334091[PMID]_[EXPERT],33.3,33.3
Disease,Familial benign flecked retina,,,,,,,,,,,,,
Clinical group,Isolated spina bifida,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2007-2011[REG],18.6,18.6
Clinical group,Isolated spina bifida,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2007-2011[REG],0,0
Clinical group,Isolated spina bifida,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Clinical group,Isolated spina bifida,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22140002[PMID]_Center for Diseases Control and Prevention 19129744[INST]_ ORPHANET,24.8,24.8
Clinical group,Isolated spina bifida,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],9.8,9.8
Clinical group,Isolated spina bifida,1-5 / 10 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],17.5,17.5
Clinical group,Isolated spina bifida,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11.4,11.4
Clinical group,Isolated spina bifida,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],21.3,21.3
Clinical group,Isolated spina bifida,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],19.6,19.6
Clinical group,Isolated spina bifida,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],17.8,17.8
Clinical group,Isolated spina bifida,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],14.4,14.4
Clinical group,Isolated spina bifida,1-5 / 10 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],50.6,50.6
Clinical group,Isolated spina bifida,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],12.7,12.7
Clinical group,Isolated spina bifida,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],24.9,24.9
Clinical group,Isolated spina bifida,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],17.5,17.5
Clinical group,Isolated spina bifida,1-5 / 10 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],14.7,14.7
Clinical group,Isolated spina bifida,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],24.4,24.4
Clinical group,Isolated spina bifida,1-5 / 10 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],18.9,18.9
Clinical group,Isolated spina bifida,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5,5
Clinical group,Isolated spina bifida,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],12.6,12.6
Clinical group,Isolated spina bifida,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],13.1,13.1
Clinical group,Isolated spina bifida,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],41.3,41.3
Disease,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23754960[PMID]_24940034[PMID],7,7
Disease,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24940034[PMID],0,0
Disease,Giant cell tumor of bone,,,,,,,,,,,,,
Disease,Charcot-Marie-Tooth disease type 4B3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23749797[PMID],3,3
Disease,Charcot-Marie-Tooth disease type 4B3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive cerebral atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23957953[PMID],4,4
Disease,Autosomal recessive cerebral atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Noonan syndrome-like disorder with juvenile myelomonocytic leukemia,,,,,,,,,,,,,
Etiological subtype,Koolen-De Vries syndrome due to a point mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22544363[PMID]_22544367[PMID],4,4
Etiological subtype,Koolen-De Vries syndrome due to a point mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,17q21.31 microdeletion syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,26306646[PMID]_[EXPERT],1.82,1.82
Disease,Balint syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,22999103[PMID],0,0
Disease,Colobomatous microphthalmia-obesity-hypogenitalism-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,9098485[PMID],0,0
Disease,X-linked dyserythropoietic anemia with abnormal platelets and neutropenia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16783379[PMID],1,1
Disease,X-linked dyserythropoietic anemia with abnormal platelets and neutropenia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Alexander disease type II,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23700170[PMID],0,0
Clinical subtype,Alexander disease type I,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23700170[PMID],0,0
Disease,Spinocerebellar ataxia type 37,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23700170[PMID],9,9
Disease,Spinocerebellar ataxia type 37,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Craniofaciofrontodigital syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7151302[PMID],4,4
Disease,Craniofaciofrontodigital syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7151302[PMID],0,0
Etiological subtype,Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion,,,,,,,,,,,,,
Disease,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21255763[PMID],4,4
Disease,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23644463[PMID],4,4
Disease,Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,2p13.2 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23837398[PMID],2,2
Malformation syndrome,2p13.2 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Childhood-onset autosomal recessive myopathy with external ophthalmoplegia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15548556[PMID]_23388406[PMID],22,22
Disease,Childhood-onset autosomal recessive myopathy with external ophthalmoplegia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare bone disease related to a common gene or pathway defect,,,,,,,,,,,,,
Category,Aggrecan-related bone disorder,,,,,,,,,,,,,
Category,TRPV4-related bone disorder,,,,,,,,,,,,,
Clinical group,Acrofacial dysostosis,,,,,,,,,,,,,
Category,Dysostosis with limb and face anomalies as a major feature,,,,,,,,,,,,,
Malformation syndrome,Intellectual disability-brachydactyly-Pierre Robin syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15057987[PMID],4,4
Malformation syndrome,Intellectual disability-brachydactyly-Pierre Robin syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15057987[PMID],0,0
Category,Dysostosis,,,,,,,,,,,,,
Clinical group,Otopalatodigital syndrome spectrum disorder,,,,,,,,,,,,,
Category,Dysostosis with limb anomaly as a major feature,,,,,,,,,,,,,
Category,Primary bone dysplasia,,,,,,,,,,,,,
Category,Primary bone dysplasia with micromelia,,,,,,,,,,,,,
Category,"Primary bone dysplasia with progressive ossification of skin, skeletal muscle, fascia, tendons and ligaments",,,,,,,,,,,,,
Morphological anomaly,Bipartite talus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24095243[PMID],23,23
Morphological anomaly,Bipartite talus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24095243[PMID],0,0
Particular clinical situation in a disease or syndrome,Resistance to bleomycine in the treatment of testicular cancer,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Temtamy preaxial brachydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21129727[PMID]_2129728[PMID]_19952732[PMID]_15365460[PMID]_9823490[PMID],18,18
Malformation syndrome,Temtamy preaxial brachydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Fetal akinesia-cerebral and retinal hemorrhage syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23092955[PMID],3,3
Disease,Fetal akinesia-cerebral and retinal hemorrhage syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hypomyelination with brain stem and spinal cord involvement and leg spasticity,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25527264[PMID],13,13
Disease,Hypomyelination with brain stem and spinal cord involvement and leg spasticity,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25527264[PMID],0,0
Disease,Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22901947[PMID]_24078737[PMID]_23611888[PMID],17,17
Disease,Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22901947[PMID]_24078737[PMID]_23611888[PMID],0,0
Clinical subtype,Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23611888[PMID]_24078737[PMID],7,7
Clinical subtype,Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Multiple mitochondrial dysfunctions syndrome type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23462291[PMID],2,2
Disease,Multiple mitochondrial dysfunctions syndrome type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic intestinal polyposis,,,,,,,,,,,,,
Category,Genetic intractable diarrhea of infancy,,,,,,,,,,,,,
Category,Genetic intestinal disease due to fat malabsorption,,,,,,,,,,,,,
Disease,High myopia-sensorineural deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23543054[PMID],7,7
Disease,High myopia-sensorineural deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Severe neurodegenerative syndrome with lipodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27632409[PMID],10,10
Disease,Severe neurodegenerative syndrome with lipodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27632409[PMID],0,0
Category,Ciliopathy,,,,,,,,,,,,,
Category,Genetic syndromic Pierre Robin syndrome,,,,,,,,,,,,,
Category,Genetic progeroid syndrome,,,,,,,,,,,,,
Category,Ring chromosome,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,1175321[PMID],2,2
Category,Congenital anomaly of the great veins,,,,,,,,,,,,,
Disease,LMNA-related cardiocutaneous progeria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23666920[PMID],5,5
Disease,LMNA-related cardiocutaneous progeria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23666920[PMID],0,0
Disease,GMPPB-related  limb-girdle muscular dystrophy R19,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23768512[PMID],2,2
Disease,GMPPB-related  limb-girdle muscular dystrophy R19,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28521875[PMID],21,21
Disease,Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28521875[PMID],0,0
Disease,X-linked parkinsonism-spasticity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20629132[PMID]_23595882[PMID],5,5
Disease,X-linked parkinsonism-spasticity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,20q11.2 microduplication syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23704076[PMID],0,0
Disease,Acroosteolysis-keloid-like lesions-premature aging syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26279204[PMID],5,5
Disease,Acroosteolysis-keloid-like lesions-premature aging syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26279204[PMID],0,0
Disease,Leukoencephalopathy with mild cerebellar ataxia and white matter edema,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23707145[PMID],6,6
Disease,Leukoencephalopathy with mild cerebellar ataxia and white matter edema,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acute encephalopathy with biphasic seizures and late reduced diffusion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21924570[PMID]_23772250[PMID],283,283
Disease,Acute encephalopathy with biphasic seizures and late reduced diffusion,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,New-onset refractory status epilepticus,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28396650[PMID],0,0
Clinical group,Acute encephalopathy with inflammation-mediated status epilepticus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Extragonadal germ cell tumor,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.13,0.13
Category,Gonadal germ cell tumor,,,,,,,,,,,,,
Disease,Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28619046[PMID],5,5
Disease,Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28619046[PMID],0,0
Category,Germ cell tumor of testis,,,,,,,,,,,,,
Disease,Non-seminomatous germ cell tumor of testis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],1.21,1.21
Disease,Non-seminomatous germ cell tumor of testis,1-5 / 10 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],33.53,33.53
Disease,Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23606727[PMID],12,12
Disease,Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Mitochondrial DNA depletion syndrome, hepatocerebrorenal form",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23375728[PMID],3,3
Disease,"Mitochondrial DNA depletion syndrome, hepatocerebrorenal form",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Intellectual disability-strabismus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23620220[PMID],34,34
Disease,Intellectual disability-strabismus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23621916[PMID],4,4
Malformation syndrome,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26594138[PMID]_26998597[PMID]_27784775[PMID],60,60
Etiological subtype,BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26594138[PMID]_27784775[PMID],0,0
Disease,Autosomal dominant childhood-onset proximal spinal muscular atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20697106[PMID]_22459677[PMID]_22847149[PMID]_26594138[PMID]_26998597[PMID]_27784775[PMID],0,0
Disease,Autosomal dominant childhood-onset proximal spinal muscular atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20697106[PMID]_22459677[PMID]_22847149[PMID]_26594138[PMID]_26998597[PMID]_27784775[PMID],97,97
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Paratesticular adenocarcinoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Category,Tumor of testis and paratestis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],3.15,3.15
Category,Tumor of testis and paratestis,6-9 / 10 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],87.77,87.77
Category,Tumor of testis and paratestis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Sex cord-stromal tumor of testis,1-9 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.44,0.44
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.049,0.049
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.048,0.048
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.034,0.034
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.022,0.022
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.021,0.021
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.023,0.023
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Disease,Sex cord-stromal tumor of testis,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.023,0.023
Disease,Testicular teratoma,<1 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.04,0.04
Disease,Testicular teratoma,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Short ulna-dysmorphism-hypotonia-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20950399[PMID],4,4
Malformation syndrome,Short ulna-dysmorphism-hypotonia-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Selection of therapeutic option in non-small cell lung carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Selection of therapeutic option in colorectal cancer,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Combined immunodeficiency due to IL21R deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23440042[PMID]_25769540[PMID]_25398835[PMID],6,6
Disease,Combined immunodeficiency due to IL21R deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23440042[PMID]_25769540[PMID]_25398835[PMID],0,0
Malformation syndrome,Syndactyly-camptodactyly and clinodactyly of fifth fingers-bifid toes syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20683984[PMID],26,26
Malformation syndrome,Syndactyly-camptodactyly and clinodactyly of fifth fingers-bifid toes syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary essential cutis verticis gyrata,,,,,,,,,,,,,
Disease,Primary non-essential cutis verticis gyrata,,,,,,,,,,,,,
Disease,Severe combined immunodeficiency due to CARD11 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25087226[PMID],3,3
Disease,Severe combined immunodeficiency due to CARD11 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25087226[PMID],0,0
Category,Genetic non-syndromic renal or urinary tract malformation,,,,,,,,,,,,,
Clinical group,Idiopathic nephrotic syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"D,L-2-hydroxyglutaric aciduria",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23561848[PMID],13,13
Disease,"D,L-2-hydroxyglutaric aciduria",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,3q26q27 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23357683[PMID]_24055528[PMID],4,4
Malformation syndrome,3q26q27 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,SLC35A2-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25778940[PMID],4,4
Disease,SLC35A2-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hemolytic uremic syndrome with DGKE deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23542698[PMID]_28526779 [PMID]_ 28242109[PMID],47,47
Disease,Hemolytic uremic syndrome with DGKE deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28526779 [PMID],0,0
Malformation syndrome,19p13.13 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23495138[PMID],7,7
Malformation syndrome,19p13.13 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,ANK3-related intellectual disability-sleep disturbance syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23390136[PMID]_28687526[PMID],5,5
Disease,ANK3-related intellectual disability-sleep disturbance syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23390136[PMID]_28687526[PMID],0,0
Disease,Amyotrophic lateral sclerosis type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9497266[PMID]_12023320[PMID],70,70
Disease,Amyotrophic lateral sclerosis type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9497266[PMID]_12023320[PMID],0,0
Clinical subtype,Non-hereditary retinoblastoma,<1 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.038,0.038
Clinical subtype,Non-hereditary retinoblastoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Hereditary retinoblastoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Autosomal recessive cutis laxa type 2, classic type",,,,,,,,,,,,,
Disease,Autosomal recessive cutis laxa type 2B,,,,,,,,,,,,,
Disease,Autosomal recessive cutis laxa type 2A,,,,,,,,,,,,,
Disease,Mandibulofacial dysostosis-macroblepharon-macrostomia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9018413[PMID]_23448909[PMID],2,2
Disease,Mandibulofacial dysostosis-macroblepharon-macrostomia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9018413[PMID]_23448909[PMID,0,0
Disease,Oral submucous fibrosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Venous thoracic outlet syndrome,,,,,,,,,,,,,
Clinical subtype,Arterial thoracic outlet syndrome,,,,,,,,,,,,,
Disease,Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23359680[PMID]_28007905[PMID],6,6
Disease,Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28007905[PMID],0,0
Disease,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23349227[PMID]_27662089[PMID],19,19
Disease,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET__27662089[PMID],0,0
Disease,Hereditary benign intraepithelial dyskeratosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal recessive cerebellar ataxia with late-onset spasticity,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23332917[PMID],10,10
Disease,Autosomal recessive cerebellar ataxia with late-onset spasticity,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Phalangeal microgeodic syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Phalangeal microgeodic syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Brain dopamine-serotonin vesicular transport disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23363473[PMID],8,8
Disease,Brain dopamine-serotonin vesicular transport disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Progressive myoclonic epilepsy with dystonia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21087195[PMID],5,5
Disease,Progressive myoclonic epilepsy with dystonia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,16q24.1 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27071622[PMID],42,42
Disease,16q24.1 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27071622[PMID],0,0
Disease,Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28955728[PMID],28,28
Disease,Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28955728[PMID],0,0
Disease,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23517570[PMID],7,7
Disease,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial infantile myoclonic epilepsy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20727515[PMID],7,7
Disease,Familial infantile myoclonic epilepsy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Disorder of melanin metabolism,,,,,,,,,,,,,
Disease,Oculocutaneous albinism type 1,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2.5,2.5
Clinical subtype,Minimal pigment oculocutaneous albinism type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Clinical subtype,Minimal pigment oculocutaneous albinism type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Temperature-sensitive oculocutaneous albinism type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Clinical subtype,Temperature-sensitive oculocutaneous albinism type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,CLN13 disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23297359[PMID],4,4
Etiological subtype,CLN13 disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Facial dysmorphism-immunodeficiency-livedo-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23230001[PMID],11,11
Disease,Facial dysmorphism-immunodeficiency-livedo-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Progressive retinal dystrophy due to retinol transport defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9888420[PMID]_23189188[PMID]_27892788[PMID],5,5
Disease,Progressive retinal dystrophy due to retinol transport defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23189188[PMID]_27892788[PMID],0,0
Disease,Attenuated Chédiak-Higashi syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Attenuated Chédiak-Higashi syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies,,,,,,,,,,,,,
Etiological subtype,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24501764[PMID]_25348648[PMID],2,2
Etiological subtype,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24501764[PMID]_25348648[PMID],0,0
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23434117[PMID],8,8
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,X-linked Charcot-Marie-Tooth disease type 6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23297365[PMID],8,8
Disease,X-linked Charcot-Marie-Tooth disease type 6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23297365[PMID],0,0
Disease,Cobblestone lissencephaly without muscular or ocular involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23472759[PMID]_25925986[PMID],6,6
Disease,Cobblestone lissencephaly without muscular or ocular involvement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23472759[PMID]_25925986[PMID],0,0
Clinical subtype,Rubinstein-Taybi syndrome due to CREBBP mutations,,,,,,,,,,,,,
Disease,Burning mouth syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10478959[PMID],0,0
Disease,Burning mouth syndrome,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10478959[PMID],0,0
Disease,Familial primary localized cutaneous amyloidosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Epileptic encephalopathy with global cerebral demyelination,,,,,,,,,,,,,
Disease,Scleredema,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Oculocutaneous albinism type 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23395477[PMID],9,9
Disease,Oculocutaneous albinism type 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Ocular albinism with congenital sensorineural deafness,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9158138[PMID]_19938076[PMID],3,3
Disease,Ocular albinism with congenital sensorineural deafness,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9158138[PMID]_19938076[PMID],0,0
Disease,Vasoproliferative tumor of the retina,,,,,,,,,,,,,
Disease,Idiopathic macular telangiectasia type 1,,,,,,,,,,,,,
Disease,Idiopathic macular telangiectasia type 3,,,,,,,,,,,,,
Morphological anomaly,Congenital retinal arteriovenous communication,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Pyruvate carboxylase deficiency, benign type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301764[PMID],5,5
Clinical subtype,"Pyruvate carboxylase deficiency, benign type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301764[PMID],0,0
Etiological subtype,Congenital myasthenic syndromes with glycosylation defect,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Pyruvate carboxylase deficiency, infantile type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Pyruvate carboxylase deficiency, severe neonatal type",Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Roifman syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16901296[PMID]_21977988[PMID],7,7
Disease,Roifman syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Rubinstein-Taybi syndrome due to 16p13.3 microdeletion,,,,,,,,,,,,,
Clinical subtype,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27465822[PMID],34,34
Clinical subtype,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27465822[PMID],0,0
Category,"Disorder of phospholipids, sphingolipids and fatty acids biosynthesis",,,,,,,,,,,,,
Disease,Spectrin-associated autosomal recessive cerebellar ataxia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23236289[PMID]_23838597[PMID],2,2
Disease,Spectrin-associated autosomal recessive cerebellar ataxia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22100072[PMID],2,2
Disease,Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,MEGDEL syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29205472[PMID],67,67
Disease,MEGDEL syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29205472[PMID],0,0
Disease,Progressive external ophthalmoplegia-myopathy-emaciation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23313956[PMID],6,6
Disease,Progressive external ophthalmoplegia-myopathy-emaciation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,"Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement",,,,,,,,,,,,,
Category,"Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with peripheral nerves predominant involvement",,,,,,,,,,,,,
Category,"Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with central nervous system predominant involvement",,,,,,,,,,,,,
Disease,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22549410[PMID],2,2
Disease,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23315540[PMID],2,2
Disease,Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Oncogenic osteomalacia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23220596[PMID],400,400
Disease,Oncogenic osteomalacia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,ISPD-related  limb-girdle muscular dystrophy R20,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23288328[PMID],8,8
Disease,ISPD-related  limb-girdle muscular dystrophy R20,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Mitochondrial DNA maintenance syndrome,,,,,,,,,,,,,
Disease,DNA2-related mitochondrial DNA deletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23352259[PMID],4,4
Disease,DNA2-related mitochondrial DNA deletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autism spectrum disorder due to AUTS2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23332918[PMID]_27075013[PMID],60,60
Disease,Autism spectrum disorder due to AUTS2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23332918[PMID]_27075013[PMID],0,0
Category,Congenital joint dislocations,,,,,,,,,,,,,
Category,Joint formation defects,,,,,,,,,,,,,
Category,Syndrome with limb reduction defects,,,,,,,,,,,,,
Category,Non syndromic limb overgrowth,,,,,,,,,,,,,
Category,Congenital deformities of fingers,,,,,,,,,,,,,
Category,Congenital deformities of limbs,,,,,,,,,,,,,
Clinical group,Amelia,,,,,,,,,,,,,
Clinical group,Intercalary limb defects,,,,,,,,,,,,,
Malformation syndrome,Renal-hepatic-pancreatic dysplasia,,,,,,,,,,,,,
Clinical syndrome,Chronic intestinal failure,6-9 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,18589446[PMID],86,86
Disease,Reunion Island Larsen-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21882400[PMID],30,30
Disease,Reunion Island Larsen-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare nevus,,,,,,,,,,,,,
Clinical group,Multiple pterygium syndrome,,,,,,,,,,,,,
Disease,Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_30584530[PMID],96,96
Disease,Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,Microcephaly-capillary malformation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23542699[PMID],10,10
Malformation syndrome,Microcephaly-capillary malformation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Neonatal inflammatory skin and bowel disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22010916[PMID]_24691054[PMID],3,3
Disease,Neonatal inflammatory skin and bowel disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22010916[PMID]_24691054[PMID],0,0
Malformation syndrome,Syndactyly-nystagmus syndrome due to 2q31.1 microduplication,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21654727[PMID],2,2
Malformation syndrome,Syndactyly-nystagmus syndrome due to 2q31.1 microduplication,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21654727[PMID],0,0
Disease,Hypoinsulinemic hypoglycemia and body hemihypertrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14764948[PMID]_21979934[PMID],5,5
Disease,Hypoinsulinemic hypoglycemia and body hemihypertrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22002932[PMID],4,4
Malformation syndrome,Hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Deficiency in anterior pituitary function-variable immunodeficiency syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22013103[PMID],7,7
Disease,Deficiency in anterior pituitary function-variable immunodeficiency syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Hypertelorism-preauricular sinus-punctual pits-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21480481[PMID],13,13
Malformation syndrome,Hypertelorism-preauricular sinus-punctual pits-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Childhood encephalopathy due to thiamine pyrophosphokinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22152682[PMID],5,5
Disease,Childhood encephalopathy due to thiamine pyrophosphokinase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,1p21.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22003227[PMID]_21114665[PMID],9,9
Malformation syndrome,1p21.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal Xq28 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21984752[PMID],9,9
Malformation syndrome,Distal Xq28 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,EDICT syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22131394[PMID]_24138095[PMID],4,4
Disease,EDICT syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22131394[PMID]_24138095[PMID],0,0
Malformation syndrome,Lethal occipital encephalocele-skeletal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27410456[PMID],5,5
Malformation syndrome,Lethal occipital encephalocele-skeletal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27410456,0,0
Clinical subtype,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form",,,,,,,,,,,,,
Clinical subtype,"Familial isolated arrhythmogenic ventricular dysplasia, biventricular form",,,,,,,,,,,,,
Clinical subtype,"Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",,,,,,,,,,,,,
Malformation syndrome,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21965172[PMID],16,16
Malformation syndrome,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Frontotemporal dementia, right temporal atrophy variant",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,"Frontotemporal dementia, right temporal atrophy variant",Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,3MC syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21258343[PMID],32,32
Malformation syndrome,3MC syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21258343[PMID],0,0
Category,Constitutional dyserythropoietic anemia,,,,,,,,,,,,,
Disease,MITF-related melanoma and renal cell carcinoma predisposition syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,MITF-related melanoma and renal cell carcinoma predisposition syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital dyserythropoietic anemia type IV,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23522491[PMID],4,4
Disease,Congenital dyserythropoietic anemia type IV,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23522491[PMID],0,0
Disease,Fixed drug eruption,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26548517[PMID],0,0
Category,Toxic dermatosis,,,,,,,,,,,,,
Disease,Ketamine-induced biliary dilatation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22124288[PMID],2,2
Disease,Ketamine-induced biliary dilatation,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22124288[PMID],0,0
Malformation syndrome,"Blepharophimosis-intellectual disability syndrome, Verloes type",<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Blepharophimosis-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22077973[PMID]_21567902[PMID]_18798845[PMID]_16700052[PMID]_15176598[PMID]_15127758[PMID]_12868473[PMID]_10955481[PMID]_10631927[PMID]_9605288[PMID]_9546834[PMID],58,58
Clinical group,Blepharophimosis-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Blepharophimosis-intellectual disability syndrome, MKB type",<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,PYCR1-related De Barsy syndrome,,,,,,,,,,,,,
Morphological anomaly,Macrodactyly of fingers,,,,,,,,,,,,,
Morphological anomaly,Macrodactyly of toes,,,,,,,,,,,,,
Morphological anomaly,Upper limb hypertrophy,,,,,,,,,,,,,
Morphological anomaly,Lower limb hypertrophy,,,,,,,,,,,,,
Clinical subtype,Congenital pseudoarthrosis of the fibula,,,,,,,,,,,,,
Clinical subtype,Congenital pseudoarthrosis of the radius,,,,,,,,,,,,,
Clinical subtype,Congenital pseudoarthrosis of the ulna,,,,,,,,,,,,,
Morphological anomaly,Tibio-fibular synostosis,,,,,,,,,,,,,
Morphological anomaly,True congenital shoulder dislocation,,,,,,,,,,,,,
Morphological anomaly,Isolated congenital radial head dislocation,,,,,,,,,,,,,
Morphological anomaly,Congenital knee dislocation,,,,,,,,,,,,,
Morphological anomaly,Congenital patella dislocation,,,,,,,,,,,,,
Morphological anomaly,Syndactyly type 6,,,,,,,,,,,,,
Clinical subtype,Congenital pseudoarthrosis of the femur,,,,,,,,,,,,,
Clinical subtype,Congenital pseudoarthrosis of the tibia,,,,,,,,,,,,,
Morphological anomaly,Camptodactyly of fingers,,,,,,,,,,,,,
Morphological anomaly,Familial isolated clinodactyly of fingers,,,,,,,,,,,,,
Morphological anomaly,Central polydactyly,,,,,,,,,,,,,
Morphological anomaly,Hyperphalangy,,,,,,,,,,,,,
Malformation syndrome,Constriction rings syndrome,,,,,,,,,,,,,
Morphological anomaly,Congenital absence of thigh and lower leg with foot present,,,,,,,,,,,,,
Morphological anomaly,Congenital absence of both forearm and hand,,,,,,,,,,,,,
Morphological anomaly,Humeral agenesis/hypoplasia,,,,,,,,,,,,,
Morphological anomaly,Congenital absence of upper arm and forearm with hand present,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,22002800[PMID],0.62,0.62
Morphological anomaly,Congenital absence of upper arm and forearm with hand present,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22002800[PMID],0,0
Morphological anomaly,Apodia,,,,,,,,,,,,,
Morphological anomaly,Congenital hypoplasia of thumb,,,,,,,,,,,,,
Morphological anomaly,Congenital absence of both lower leg and foot,,,,,,,,,,,,,
Morphological anomaly,Acheiria,,,,,,,,,,,,,
Clinical group,Popliteal pterygium syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,2352260[PMID],0.3,0.3
Category,Dysostosis with combined reduction defects of upper and lower limbs,,,,,,,,,,,,,
Category,"Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy",,,,,,,,,,,,,
Morphological anomaly,Amelia of lower limb,,,,,,,,,,,,,
Morphological anomaly,Tetra-amelia,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Lethal congenital contracture syndrome,,,,,,,,,,,,,
Morphological anomaly,Amelia of upper limb,,,,,,,,,,,,,
Category,Autoinflammatory syndrome with skin involvement,,,,,,,,,,,,,
Category,Rare head and neck tumor,,,,,,,,,,,,,
Disease,Hypermethioninemia due to glycine N-methyltransferase deficiency,,,,,,,,,,,,,
Clinical group,3-methylglutaconic aciduria,,,,,,,,,,,,,
Category,Organic aciduria,,,,,,,,,,,,,
Category,Disorder of proline metabolism,,,,,,,,,,,,,
Clinical subtype,Atypical glycine encephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Clinical subtype,Atypical glycine encephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Transient hyperammonemia of the newborn,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Disorder of ornithine metabolism,,,,,,,,,,,,,
Category,Autoinflammatory syndrome with immune deficiency,,,,,,,,,,,,,
Category,Systemic disease with skin involvement,,,,,,,,,,,,,
Clinical subtype,Vitamin B12-unresponsive methylmalonic acidemia type mut0,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lymphoepithelial-like carcinoma,,,,,,,,,,,,,
Disease,Myopericytoma,,,,,,,,,,,,,
Disease,Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly,,,,,,,,,,,,,
Disease,Plasmablastic lymphoma,,,,,,,,,,,,,
Category,Epstein-Barr Virus-associated carcinoma,,,,,,,,,,,,,
Category,Epstein-Barr Virus-associated mesenchymal tumor,,,,,,,,,,,,,
Category,Epstein-Barr Virus-related tumor,,,,,,,,,,,,,
Category,Epstein-Barr virus-associated malignant lymphoproliferative disorder,,,,,,,,,,,,,
Clinical subtype,Neonatal glycine encephalopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Infantile glycine encephalopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Glutathione synthetase deficiency with 5-oxoprolinuria,,,,,,,,,,,,,
Clinical subtype,Glutathione synthetase deficiency without 5-oxoprolinuria,,,,,,,,,,,,,
Category,Disorder of lysine and hydroxylysine metabolism,,,,,,,,,,,,,
Category,Disorder of glutamine metabolism,,,,,,,,,,,,,
Clinical group,Late-onset primary lymphedema without systemic or visceral involvement,,,,,,,,,,,,,
Category,Disorder of tryptophan metabolism,,,,,,,,,,,,,
Clinical group,Multiple mitochondrial dysfunctions syndrome,,,,,,,,,,,,,
Disease,Mitochondrial membrane protein-associated neurodegeneration,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_24575447[PMID],0.1,0.1
Malformation syndrome,Dysmorphism-conductive hearing loss-heart defect syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,BAP1-related tumor predisposition syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare virus associated tumor,,,,,,,,,,,,,
Disease,Hereditary arterial and articular multiple calcification syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21288095[PMID],0,0
Disease,Hereditary arterial and articular multiple calcification syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21288095[PMID],16,16
Disease,Juvenile nasopharyngeal angiofibroma,,,,,,,,,,,,,
Disease,Exfoliative ichthyosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Methylmalonic acidemia without homocystinuria,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Grayson-Wilbrandt corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8230838[PMID]_[EXPERT],1,1
Disease,Grayson-Wilbrandt corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8230838[PMID],0,0
Disease,Epithelial recurrent erosion dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18700883[PMID]_6887751[PMID]_12035594[PMID]_18700883[PMID]_187789[PMID]_19710953[PMID]_20597871[PMID],186,186
Disease,Epithelial recurrent erosion dystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pre-Descemet corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,5,5
Disease,Pre-Descemet corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital hereditary endothelial dystrophy type II,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,X-linked endothelial corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16490493[PMID],35,35
Disease,X-linked endothelial corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Shwachman-Diamond syndrome,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,22887728[PMID],0.59,0.59
Disease,Shwachman-Diamond syndrome,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:407002049[OTHER],0.5,0.5
Disease,Shwachman-Diamond syndrome,1-9 / 1 000 000,Puerto rico,409968,409968,25958,25958,en,Validated,410293,410293,8637967[PMID],0.67,0.67
Disease,Shwachman-Diamond syndrome,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,11254457[PMID],1.3,1.3
Disease,Shwachman-Diamond syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Shwachman-Diamond syndrome,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Shwachman-Diamond syndrome,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,22491737[PMID],0.28,0.28
Etiological subtype,Familial clubfoot due to PITX1 point mutation,,,,,,,,,,,,,
Morphological anomaly,Familial mitral valve prolapse,,,,,,,,,,,,,
Etiological subtype,Familial clubfoot due to 5q31 microdeletion,,,,,,,,,,,,,
Disease,Infantile-onset ascending hereditary spastic paralysis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12145748[PMID]_12919135[PMID]_12601111[PMID]_12509863[PMID]_18394004[PMID]_16718699[PMID]_18810511[PMID]_18523452[PMID],17,17
Disease,Infantile-onset ascending hereditary spastic paralysis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Skin fragility-woolly hair-palmoplantar keratoderma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20738328[PMID],7,7
Disease,Skin fragility-woolly hair-palmoplantar keratoderma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Autosomal dominant hypocalcemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Malignant migrating focal seizures of infancy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19469847[PMID]_23086397[PMID]_23599387[PMID],114,114
Disease,Malignant migrating focal seizures of infancy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_235999387[PMID],0,0
Disease,Malignant migrating focal seizures of infancy,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23599387[PMID],0.11,0.11
Disease,Malignant migrating focal seizures of infancy,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,235999387[PMID],0.4,0.4
Disease,Insulin-resistance syndrome type B,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,24548843[PMID]_21854373[PMID],0,0
Clinical group,Familial primary hyperparathyroidism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute generalized exanthematous pustulosis,1-9 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,11168761[PMID]_ORPHANET,0.3,0.3
Disease,Acute generalized exanthematous pustulosis,<1 / 1 000 000,Israel,409967,409967,25958,25958,en,Validated,410293,410293,18669133[PMID],0.035,0.035
Disease,Acute generalized exanthematous pustulosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Pleomorphic rhabdomyosarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],0,0
Clinical subtype,Pleomorphic rhabdomyosarcoma,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"46,XX testicular disorder of sex development",1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,16200839[PMID]_6945286[PMID]_[EXPERT],2.5,2.5
Disease,Epithelioid sarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],0,0
Disease,Epithelioid sarcoma,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Epithelioid sarcoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,1922430[PMID],0.04,0.04
Clinical subtype,Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Celiac artery compression syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mansonelliasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mansonelliasis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Loiasis,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22784545[PMID],0,0
Disease,Loiasis,>1 / 1000,Specific population,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Pyruvate dehydrogenase E3 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Clinical subtype,Pyruvate dehydrogenase E3 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Arachnoid cyst,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adult-onset Still disease,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,7668903[PMID],0.16,0.16
Disease,Adult-onset Still disease,1-9 / 1 000 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,9465547[PMID],0.13,0.13
Disease,Adult-onset Still disease,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,25382730[PMID],3.9,3.9
Disease,Adult-onset Still disease,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,16467042[PMID],0.4,0.4
Disease,Adult-onset Still disease,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,16467042[PMID],6.9,6.9
Disease,Adult-onset Still disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16467042[PMID],0,0
Disease,Adult-onset Still disease,1-9 / 1 000 000,Turkey,409967,409967,25958,25958,en,Validated,410293,410293,26320744[PMID],0.62,0.62
Disease,Adult-onset Still disease,1-9 / 100 000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,26320744[PMID],6.77,6.77
Disease,Reye syndrome,,,,,,,,,,,,,
Disease,Rasmussen subacute encephalitis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Rasmussen subacute encephalitis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Opsoclonus-myoclonus syndrome,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_19423368[PMID],0.02,0.02
Disease,Opsoclonus-myoclonus syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Opsoclonus-myoclonus syndrome,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,19423368[PMID],0.018,0.018
Disease,Adult idiopathic neutropenia,,,,,,,,,,,,,
Disease,Cyclic neutropenia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.1,0.1
Disease,Hepatic veno-occlusive disease,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_European Medicines Agency[INST],11,11
Clinical group,Non-rhizomelic chondrodysplasia punctata,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Dracunculiasis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dracunculiasis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lymphatic filariasis,>1 / 1000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization[INST],0,0
Disease,Lymphatic filariasis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Disorder of folate metabolism and transport,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of troponin,,,,,,,,,,,,,
Category,Qualitative or quantitative defects of tropomyosin,,,,,,,,,,,,,
Clinical group,Ocular albinism,,,,,,,,,,,,,
Disease,CLIPPERS,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24028073[PMID],50,50
Disease,CLIPPERS,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acute zonal occult outer retinopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21056448[PMID],150,150
Disease,Acute zonal occult outer retinopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acute annular outer retinopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16181293[PMID],12,12
Disease,Acute annular outer retinopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Glycerol kinase deficiency, adult form",,,,,,,,,,,,,
Disease,Phosphoserine aminotransferase deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare disease with thoracic aortic aneurysm and aortic dissection,,,,,,,,,,,,,
Category,Marfan and Marfan-related disorders,,,,,,,,,,,,,
Clinical subtype,Marfan syndrome type 2,,,,,,,,,,,,,
Clinical subtype,Marfan syndrome type 1,,,,,,,,,,,,,
Disease,Aneurysm-osteoarthritis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22167769[PMID],45,45
Disease,Aneurysm-osteoarthritis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Neonatal Marfan syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Disorder of phenylalanine metabolism,,,,,,,,,,,,,
Category,Syndromic oculocutaneous albinism,,,,,,,,,,,,,
Category,Disorder of tyrosine metabolism,,,,,,,,,,,,,
Clinical subtype,Non-central nervous system-localized embryonal carcinoma,,,,,,,,,,,,,
Malformation syndrome,Familial vesicoureteral reflux,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Infective dermatitis associated with HTLV-1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary non-gestational choriocarcinoma of ovary,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Early-onset myopathy with fatal cardiomyopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Myosclerosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hypermethioninemia encephalopathy due to adenosine kinase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Tropical spastic paraparesis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Combined malonic and methylmalonic acidemia,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,21841779[PMID],3.3,3.3
Disease,Combined malonic and methylmalonic acidemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Congenital cataract microcornea with corneal opacity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,4H leukodystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,4H leukodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_22855961[PMID]_25339210[PMID],200,200
Malformation syndrome,Microtriplication 11q24.1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21617255[PMID],2,2
Malformation syndrome,Microtriplication 11q24.1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21617255[PMID],0,0
Malformation syndrome,12q15q21.1 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28159701[PMID],6,6
Malformation syndrome,12q15q21.1 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28159701[PMID],0,0
Disease,Isolated congenital adermatoglyphia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary Sjögren syndrome,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,23983119[PMID]_25387476[PMID],11.343,11.343
Disease,Primary Sjögren syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,25387476[PMID],48.99,48.99
Disease,Primary Sjögren syndrome,6-9 / 10 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,16332955[PMID]_25387476[PMID],86.398,86.398
Disease,Primary Sjögren syndrome,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,21231797[PMID]_25387476[PMID],49.745,49.745
Disease,Primary Sjögren syndrome,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,17582741[PMID]_25387476[PMID],45.47,45.47
Disease,Primary Sjögren syndrome,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,11393497[PMID],3.95,3.95
Disease,Primary Sjögren syndrome,1-5 / 10 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,22899470[PMID]_23916348[PMID]_24938285[PMID],37.15,37.15
Disease,Primary Sjögren syndrome,>1 / 1000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,18422594[PMID]_24938285[PMID],207.83,207.83
Disease,Primary Sjögren syndrome,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,22396771[PMID]_24938285[PMID],30.91,30.91
Disease,Primary Sjögren syndrome,>1 / 1000,Brazil,409966,409966,25958,25958,en,Validated,410293,410293,23588513[PMID]_24938285[PMID],165.98,165.98
Disease,Primary Sjögren syndrome,1-9 / 100 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,21239759[PMID]_23916348[PMID]_22899470[PMID]_24938285[PMID],9.5,9.5
Disease,Primary Sjögren syndrome,1-9 / 100 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,16332955[PMID]_24938285[PMID],5.3,5.3
Disease,Primary Sjögren syndrome,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,15194588[PMID]_24938285[PMID],3.9,3.9
Disease,Primary Sjögren syndrome,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,24938285[PMID],6.92,6.92
Particular clinical situation in a disease or syndrome,Malignancy diagnosed during pregnancy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Intellectual disability-alacrima-achalasia syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pyoderma gangrenosum-acne-suppurative hidradenitis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28696038[PMID],0,0
Disease,Pyoderma gangrenosum-acne-suppurative hidradenitis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28696038[PMID],36,36
Clinical group,Hypocalcemic rickets,,,,,,,,,,,,,
Category,Disorders of vitamin D metabolism,,,,,,,,,,,,,
Disease,Autosomal recessive hypophosphatemic rickets,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hypocalcemic vitamin D-dependent rickets,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Systemic diseases with anterior uveitis,,,,,,,,,,,,,
Disease,Idiopathic panuveitis,,,,,,,,,,,,,
Disease,Idiopathic posterior uveitis,,,,,,,,,,,,,
Disease,Idiopathic anterior uveitis,,,,,,,,,,,,,
Category,Panuveitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Posterior uveitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Anterior uveitis,>1 / 1000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,20066507[PMID],185,185
Category,Anterior uveitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare disorder without orphan designation,,,,,,,,,,,,,
Clinical group,Keratinopathic ichthyosis,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.11,0.11
Clinical group,Autosomal recessive congenital ichthyosis,1-9 / 1 000 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,20301593[PMID]_ORPHANET,0.5,0.5
Clinical group,Autosomal recessive congenital ichthyosis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,8006437[PMID]_European Medicines Agency 2012[INST],0.5,0.5
Clinical group,Autosomal recessive congenital ichthyosis,1-9 / 1 000 000,Spain,409966,409966,25965,25965,en,Not yet validated,410294,410294,22000705[PMID]_21668430[PMID],0.77,0.77
Clinical group,Autosomal recessive congenital ichthyosis,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,9887377[PMID],1.1,1.1
Disease,Syndromic recessive X-linked ichthyosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.3,1.3
Category,Inherited ichthyosis syndromic form,1-9 / 1 000 000,France,409966,409966,25965,25965,en,Not yet validated,410294,410294,24393603[PMID],0.19,0.19
Category,Inherited non-syndromic ichthyosis,1-9 / 100 000,France,409966,409966,25965,25965,en,Not yet validated,410294,410294,24393603[PMID],1.13,1.13
Category,Systemic diseases with panuveitis,,,,,,,,,,,,,
Category,Systemic diseases with posterior uveitis,,,,,,,,,,,,,
Clinical group,X-linked ichthyosis syndrome,,,,,,,,,,,,,
Category,Autosomal ichthyosis syndrome,,,,,,,,,,,,,
Disease,Congenital reticular ichthyosiform erythroderma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26381864[PMID],40,40
Disease,Congenital reticular ichthyosiform erythroderma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26381864[PMID],0,0
Disease,Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Annular epidermolytic ichthyosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17596149[PMID]_14594577[PMID],7,7
Disease,Annular epidermolytic ichthyosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Self-improving collodion baby,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],25,25
Disease,Self-improving collodion baby,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acral self-healing collodion baby,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19500103[PMID]_[EXPERT],2,2
Disease,Acral self-healing collodion baby,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Autosomal ichthyosis syndrome with other associated signs,,,,,,,,,,,,,
Category,Autosomal ichthyosis syndrome with prominent neurologic signs,,,,,,,,,,,,,
Category,Autosomal ichthyosis syndrome with fatal disease course,,,,,,,,,,,,,
Category,Autosomal ichthyosis syndrome with prominent hair abnormalities,,,,,,,,,,,,,
Disease,Familial progressive hyper- and hypopigmentation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21368769[PMID],3,3
Disease,Familial progressive hyper- and hypopigmentation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Multiple congenital anomalies-hypotonia-seizures syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26394714[PMID]_26364997[PMID],15,15
Malformation syndrome,Multiple congenital anomalies-hypotonia-seizures syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26394714[PMID]_26364997[PMID],0,0
Disease,Hemoglobinopathy Toms River,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21561349[PMID],10,10
Disease,Hemoglobinopathy Toms River,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary sensorimotor neuropathy with hyperelastic skin,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21576112[PMID],4,4
Disease,Hereditary sensorimotor neuropathy with hyperelastic skin,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Progressive myoclonic epilepsy type 6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21549339[PMID]_23449775[PMID],12,12
Disease,Progressive myoclonic epilepsy type 6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21549339[PMID]_23449775[PMID],0,0
Clinical subtype,Hermansky-Pudlak syndrome type 9,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21665000[PMID]_22461475[PMID],2,2
Clinical subtype,Hermansky-Pudlak syndrome type 9,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Megaconial congenital muscular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23945283[PMID],19,19
Disease,Megaconial congenital muscular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Occipital pachygyria and polymicrogyria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21572413[PMID],3,3
Malformation syndrome,Occipital pachygyria and polymicrogyria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive nail dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21665003[PMID],4,4
Disease,Autosomal recessive nail dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acrodysostosis with multiple hormone resistance,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21651393[PMID],40,40
Disease,Acrodysostosis with multiple hormone resistance,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cutaneous collagenous vasculopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21916964[PMID]_21571177[PMID]_20525488[PMID]_20451292[PMID]_20000878[PMID]_18537865[PMID]_10660131[PMID]_[EXPERT],20,20
Disease,Cutaneous collagenous vasculopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Bullous diffuse cutaneous mastocytosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Clinical subtype,Bullous diffuse cutaneous mastocytosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Pseudoxanthomatous diffuse cutaneous mastocytosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Clinical subtype,Pseudoxanthomatous diffuse cutaneous mastocytosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Intralobar congenital pulmonary sequestration,,,,,,,,,,,,,
Disease,Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21596366[PMID],9,9
Disease,Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Severe intellectual disability and progressive spastic paraplegia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21620353[PMID],15,15
Disease,Severe intellectual disability and progressive spastic paraplegia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Generalized essential telangiectasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Congenital pulmonary airway malformation type 2,,,,,,,,,,,,,
Clinical subtype,Congenital pulmonary airway malformation type 3,,,,,,,,,,,,,
Clinical subtype,Congenital pulmonary airway malformation type 4,,,,,,,,,,,,,
Category,Rare disorder with RCH resources uncovered otherwise,,,,,,,,,,,,,
Clinical subtype,Extralobar congenital pulmonary sequestration,,,,,,,,,,,,,
Clinical subtype,Communicating congenital bronchopulmonary-foregut malformation,,,,,,,,,,,,,
Clinical subtype,Congenital pulmonary airway malformation type 0,,,,,,,,,,,,,
Clinical subtype,Congenital pulmonary airway malformation type 1,,,,,,,,,,,,,
Malformation syndrome,Craniosynostosis-dental anomalies,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"Larsen-like syndrome, B3GAT3 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25893793[PMID],14,14
Malformation syndrome,"Larsen-like syndrome, B3GAT3 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25893793[PMID],0,0
Malformation syndrome,Xp22.13p22.2 duplication syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29663678[PMID],0,0
Clinical subtype,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29663678[PMID],19,19
Malformation syndrome,8q21.11 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21802062[PMID]_[EXPERT],13,13
Malformation syndrome,8q21.11 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Familial retinal arterial macroaneurysm,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2O,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical syndrome,TEMPI syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Clinical syndrome,TEMPI syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive cerebellar ataxia-psychomotor delay syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,IgG4-related disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adult-onset autosomal recessive cerebellar ataxia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25182700[PMID],0,0
Disease,Adult-onset autosomal recessive cerebellar ataxia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25182700[PMID],14,14
Clinical subtype,Pleuropulmonary blastoma familial tumor susceptibility syndrome,<1 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,22796286[PMID],0.007,0.007
Disease,Infantile-onset autosomal recessive nonprogressive cerebellar ataxia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Pontocerebellar hypoplasia type 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21594990[PMID]_[EXPERT],4,4
Malformation syndrome,Pontocerebellar hypoplasia type 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Familial intrahepatic cholestasis,,,,,,,,,,,,,
Clinical syndrome,Reversible cerebral vasoconstriction syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Fetal lung interstitial tumor,,,,,,,,,,,,,
Clinical subtype,"Glycerol kinase deficiency, infantile form",,,,,,,,,,,,,
Clinical subtype,"Glycerol kinase deficiency, juvenile form",,,,,,,,,,,,,
Disease,Well-differentiated fetal adenocarcinoma of the lung,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Small cell carcinoma of the bladder,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,21567387[PMID],0.14,0.14
Disease,Small cell carcinoma of the bladder,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Small cell carcinoma of the bladder,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Category,Partial deletion of chromosome 12,,,,,,,,,,,,,
Clinical group,Autoimmune polyendocrinopathy,,,,,,,,,,,,,
Disease,Inherited Creutzfeldt-Jakob disease,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Response to antiviral treatment in hepatitis C,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Susceptibility to adverse reaction due to mercaptopurine,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Toxicity or absent response to clozapine,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Disorder of magnesium transport,,,,,,,,,,,,,
Category,Disorder of zinc metabolism and transport,,,,,,,,,,,,,
Category,Disorder of iron metabolism and transport,,,,,,,,,,,,,
Category,Disorder of copper metabolism,,,,,,,,,,,,,
Category,Acquired immunodeficiency,,,,,,,,,,,,,
Disease,Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22934317[PMID],20,20
Disease,Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22934317[PMID],0,0
Category,Disorder of manganese transport,,,,,,,,,,,,,
Category,Disorder of metabolite absorption and transport,,,,,,,,,,,,,
Category,Disorder of pterin metabolism,,,,,,,,,,,,,
Category,Disorder of bilirubin metabolism and excretion,,,,,,,,,,,,,
Category,Disorder of porphyrin and heme metabolism,,,,,,,,,,,,,
Category,Disorder of mineral absorption and transport,,,,,,,,,,,,,
Category,Disorder of other vitamins and cofactors metabolism and transport,,,,,,,,,,,,,
Category,Disorder of catecholamine synthesis,,,,,,,,,,,,,
Category,Disorder of vitamin and non-protein cofactor absorption and transport,,,,,,,,,,,,,
Category,Defect in conserved oligomeric Golgi complex,,,,,,,,,,,,,
Category,Defect in V-ATPase,,,,,,,,,,,,,
Category,Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation,,,,,,,,,,,,,
Category,Disorder of multiple glycosylation,,,,,,,,,,,,,
Etiological subtype,Rhizomelic chondrodysplasia punctata type 3,,,,,,,,,,,,,
Category,"Disorder of peroxisomal alpha-, beta- and omega-oxidation",,,,,,,,,,,,,
Etiological subtype,Rhizomelic chondrodysplasia punctata type 1,,,,,,,,,,,,,
Etiological subtype,Rhizomelic chondrodysplasia punctata type 2,,,,,,,,,,,,,
Category,Disorder of protein O-glycosylation,,,,,,,,,,,,,
Category,Disorder of O-xylosylglycan synthesis,,,,,,,,,,,,,
Category,Disorder of lysosomal-related organelles,,,,,,,,,,,,,
Category,Disorder of protein N-glycosylation,,,,,,,,,,,,,
Category,Disorder of O-mannosylglycan synthesis,,,,,,,,,,,,,
Category,Disorder of fucoglycosan synthesis,,,,,,,,,,,,,
Category,Disorder of O-N-acetylgalactosaminylglycan synthesis,,,,,,,,,,,,,
Category,Disorder of O-xylosyl/N-acetylgalactosaminylglycan synthesis,,,,,,,,,,,,,
Disease,High bone mass osteogenesis imperfecta,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21344539[PMID],2,2
Disease,High bone mass osteogenesis imperfecta,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Gastric adenocarcinoma and proximal polyposis of the stomach,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21813476[PMID],28,28
Disease,Gastric adenocarcinoma and proximal polyposis of the stomach,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Idiopathic linear interstitial keratitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Contractures-webbed neck-micrognathia-hypoplastic nipples syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22383252[PMID],2,2
Malformation syndrome,Contractures-webbed neck-micrognathia-hypoplastic nipples syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,2q23.1 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22085900[PMID],2,2
Malformation syndrome,2q23.1 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,PENS syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22414678[PMID]_21315481[PMID],13,13
Disease,PENS syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Epstein-Barr virus-associated gastric carcinoma,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,22392024[PMID]_ORPHANET,1.2,1.2
Disease,Epstein-Barr virus-associated gastric carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Congenital pancreatic cyst,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19231513[PMID]_2202976[PMID],10,10
Morphological anomaly,Congenital pancreatic cyst,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Developmental and speech delay due to SOX5 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26111154[PMID]_29477873[PMID],14,14
Disease,Developmental and speech delay due to SOX5 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29477873[PMID],0,0
Malformation syndrome,12p12.1 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22290657[PMID]_29477873[PMID],11,11
Malformation syndrome,12p12.1 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29477873[PMID],0,0
Disease,FGFR2-related bent bone dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27240702[PMID],11,11
Disease,FGFR2-related bent bone dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27240702[PMID],0,0
Disease,Infantile cerebellar-retinal degeneration,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22405087[PMID]_25351951[PMID],11,11
Disease,Infantile cerebellar-retinal degeneration,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22405087[PMID]_25351951[PMID],0,0
Disease,Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22341969[PMID],24,24
Disease,Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Coats plus syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Optic nerve edema-splenomegaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22307799[PMID],3,3
Disease,Optic nerve edema-splenomegaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22197934[PMID]_10668715[PMID],27,27
Disease,Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,20p13 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22274139[PMID]_23165892[PMID],4,4
Malformation syndrome,20p13 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Jawad syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21998596[PMID]_8434622[PMID],4,4
Malformation syndrome,Jawad syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21998596[PMID]_8434622[PMID],0,0
Disease,Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22022284[PMID],2,2
Disease,Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22022284[PMID],0,0
Disease,Autosomal recessive spastic ataxia with leukoencephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22448145[PMID],54,54
Disease,Autosomal recessive spastic ataxia with leukoencephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22448145[PMID],0,0
Malformation syndrome,Chudley-McCullough syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,25,25
Malformation syndrome,Chudley-McCullough syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Growing teratoma syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22611637[PMID],2,2
Malformation syndrome,Intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22436252[PMID],3,3
Disease,Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Distal tetrasomy 15q,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24793337[PMID],23,23
Etiological subtype,Distal tetrasomy 15q,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24793337[PMID],0,0
Malformation syndrome,15q overgrowth syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19133692[PMID],12,12
Malformation syndrome,15q overgrowth syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Young adult-onset distal hereditary motor neuropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22522442[PMID],3,3
Disease,Young adult-onset distal hereditary motor neuropathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary progressive apraxia of speech,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22382356[PMID]_23078273[PMID],16,16
Disease,Primary progressive apraxia of speech,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Craniofacial dysplasia-osteopenia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22581230[PMID],5,5
Malformation syndrome,Craniofacial dysplasia-osteopenia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical syndrome,Atypical Meigs syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7112481[PMID]_9336761[PMID]_12632574[PMID]_12087934[PMID]_15739106[PMID],9,9
Clinical syndrome,Atypical Meigs syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical syndrome,Pseudo-Meigs syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ovarian fibrothecoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ovarian fibroma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ameloblastic carcinoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22493395[PMID]_19674470[PMID]_23251064[PMID]_23099227[PMID],40,40
Disease,Ameloblastic carcinoma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare odontogenic tumor,,,,,,,,,,,,,
Malformation syndrome,Spigelian hernia-cryptorchidism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20680633[PMID],15,15
Malformation syndrome,Spigelian hernia-cryptorchidism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical syndrome,Meigs syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22440536[PMID]_22840364[PMID]_22840363[PMID],14,14
Disease,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant aplasia and myelodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22541560[PMID],6,6
Disease,Autosomal dominant aplasia and myelodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22541560[PMID],0,0
Disease,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22328086[PMID]_23904686[PMID],24,24
Disease,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22328086[PMID]_23904686[PMID],0,0
Disease,Ameloblastoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chronic infantile diarrhea due to guanylate cyclase 2C overactivity,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22436048[PMID],32,32
Disease,Chronic infantile diarrhea due to guanylate cyclase 2C overactivity,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22521417[PMID]_25370039[PMID],16,16
Disease,Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22521417[PMID]_25370039[PMID],0,0
Disease,Hereditary sensory and autonomic neuropathy type 6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22522446[PMID],4,4
Disease,Hereditary sensory and autonomic neuropathy type 6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Xq12-q13.3 duplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22213401[PMID],3,3
Malformation syndrome,Xq12-q13.3 duplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,7p22.1 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26297194[PMID],0,0
Malformation syndrome,7p22.1 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26297194[PMID],5,5
Malformation syndrome,Marfanoid habitus-inguinal hernia-advanced bone age syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22489068[PMID],2,2
Malformation syndrome,Marfanoid habitus-inguinal hernia-advanced bone age syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22492562[PMID]_23008233[PMID]_25854774[PMID],14,14
Disease,Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22492562[PMID]_23008233[PMID]_25854774[PMID],0,0
Category,Epilepsy and/or ataxia with myoclonus as major feature,,,,,,,,,,,,,
Category,Non progressive epilepsy and/or ataxia with myoclonus as a major feature,,,,,,,,,,,,,
Category,Primary myoclonus,,,,,,,,,,,,,
Category,Rare disease with myoclonus as a major feature,,,,,,,,,,,,,
Category,Rare paroxysmal movement disorder,,,,,,,,,,,,,
Clinical group,Hyperekplexia,,,,,,,,,,,,,
Category,Motor stereotypies,,,,,,,,,,,,,
Category,Rare parkinsonian syndrome due to genetic neurodegenerative disease,,,,,,,,,,,,,
Category,Miscellaneous movement disorder due to genetic neurodegenerative disease,,,,,,,,,,,,,
Disease,Sporadic hyperekplexia,,,,,,,,,,,,,
Category,Rare genetic parkinsonian disorder,,,,,,,,,,,,,
Category,Rare genetic disease with myoclonus as a major feature,,,,,,,,,,,,,
Category,Diffuse palmoplantar keratoderma,,,,,,,,,,,,,
Category,Rare genetic tremor disorder,,,,,,,,,,,,,
Category,Rare genetic myoclonus,,,,,,,,,,,,,
Disease,Manganese poisoning,,,,,,,,,,,,,
Category,Rare parkinsonian syndrome due to intoxication,,,,,,,,,,,,,
Disease,Kufor-Rakeb syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20853184[PMID]_21094623[PMID]_DOI: 10.1002/mdc3.12175[OTHER],16,16
Disease,Kufor-Rakeb syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20853184[PMID]_21094623[PMID],0,0
Disease,Hemiparkinsonism-hemiatrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23986429[PMID],0,0
Disease,Hemiparkinsonism-hemiatrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23986429[PMID],68,68
Category,Frontotemporal neurodegeneration with movement disorder,,,,,,,,,,,,,
Category,Miscellaneous movement disorder due to neurodegenerative disease,,,,,,,,,,,,,
Disease,Cyanide-induced parkinsonism-dystonia,,,,,,,,,,,,,
Disease,Delayed encephalopathy due to carbon monoxide poisoning,,,,,,,,,,,,,
Category,Postinfectious autoimmune disease with chorea,,,,,,,,,,,,,
Category,Neurodegenerative disease with chorea,,,,,,,,,,,,,
Category,Rare choreic movement disorder,,,,,,,,,,,,,
Category,Rare tremor disorder,,,,,,,,,,,,,
Category,Rare myoclonus,,,,,,,,,,,,,
Disease,Hemidystonia-hemiatrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,100,100
Disease,Hemidystonia-hemiatrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0,0
Disease,"Primary dystonia, DYT21 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21301909[PMID],16,16
Disease,"Primary dystonia, DYT21 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21301909[PMID],0,0
Particular clinical situation in a disease or syndrome,Sydenham chorea,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Erythrokeratoderma variabilis progressiva,<1 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,24393603[PMID]_[EXPERT],0.046,0.046
Clinical subtype,Methylcobalamin deficiency type cblDv1,,,,,,,,,,,,,
Etiological subtype,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_European Medicines Agency 2010[INST],0,0
Etiological subtype,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,,,,,,,,,,,,,
Etiological subtype,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,,,,,,,,,,,,,
Category,Disorder of beta and omega amino acid metabolism,,,,,,,,,,,,,
Disease,Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24449431[PMID],5,5
Disease,Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24449431[PMID],0,0
Disease,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27699154[PMID],7,7
Disease,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27699154[PMID],0,0
Category,Disease with diffuse palmoplantar keratoderma as a major feature,,,,,,,,,,,,,
Clinical group,Isolated diffuse palmoplantar keratoderma,,,,,,,,,,,,,
Disease,Curly hair-acral keratoderma-caries syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11453928[PMID],14,14
Disease,Curly hair-acral keratoderma-caries syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11453928[PMID],0,0
Category,Autosomal recessive disease with diffuse palmoplantar keratoderma as a major feature,,,,,,,,,,,,,
Clinical group,Autosomal dominant diffuse mutilating palmoplantar keratoderma,,,,,,,,,,,,,
Clinical group,Isolated focal palmoplantar keratoderma,,,,,,,,,,,,,
Category,Focal palmoplantar keratoderma,,,,,,,,,,,,,
Disease,Hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12207605[PMID],0,0
Disease,Hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12207605[PMID],2,2
Category,Disease with focal palmoplantar keratoderma as a major feature,,,,,,,,,,,,,
Clinical group,Marginal papular palmoplantar keratoderma,,,,,,,,,,,,,
Category,Punctate palmoplantar keratoderma,,,,,,,,,,,,,
Category,Disease with punctate palmoplantar keratoderma as a major feature,,,,,,,,,,,,,
Disease,Focal acral hyperkeratosis,,,,,,,,,,,,,
Category,Autosomal recessive disease associated with punctate palmoplantar keratoderma as a major feature,,,,,,,,,,,,,
Category,Autosomal dominant disease associated with punctate palmoplantar keratoderma as a major feature,,,,,,,,,,,,,
Category,Disorder of carbohydrate absorption and transport,,,,,,,,,,,,,
Category,Disorder of lipid metabolism,,,,,,,,,,,,,
Clinical group,Glycerol kinase deficiency,,,,,,,,,,,,,
Category,Disorder of glyoxylate metabolism,,,,,,,,,,,,,
Clinical subtype,"Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form",,,,,,,,,,,,,
Clinical subtype,"Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form",,,,,,,,,,,,,
Clinical subtype,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form",,,,,,,,,,,,,
Clinical subtype,"Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form",,,,,,,,,,,,,
Disease,Combined pancreatic lipase-colipase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2265786[PMID],3,3
Disease,Combined pancreatic lipase-colipase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2265786[PMID],0,0
Category,Disorder of fatty acid oxidation and ketogenesis,,,,,,,,,,,,,
Disease,Pancreatic triacylglycerol lipase deficiency,,,,,,,,,,,,,
Disease,Pancreatic colipase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7068048[PMID],2,2
Disease,Pancreatic colipase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7068048[PMID],0,0
Clinical group,Mevalonate kinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27142780[PMID],300,300
Clinical group,Mevalonate kinase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27142780[PMID],0,0
Category,Disorder of lipid absorption and transport,,,,,,,,,,,,,
Etiological subtype,Familial lipoprotein lipase deficiency,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,20301485[PMID],0.1,0.1
Etiological subtype,Familial lipoprotein lipase deficiency,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Familial apolipoprotein C-II deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25732519[PMID],10,10
Etiological subtype,Familial apolipoprotein C-II deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25732519[PMID],0,0
Clinical subtype,Generalized galactose epimerase deficiency,,,,,,,,,,,,,
Disease,Chordoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,22300861[PMID]_ ORPHANET_[EXPERT],0.06,0.06
Clinical subtype,Erythrocyte galactose epimerase deficiency,,,,,,,,,,,,,
Category,Disorder of galactose metabolism,,,,,,,,,,,,,
Malformation syndrome,Microcephalic osteodysplastic primordial dwarfism type II,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23498563[PMID],150,150
Malformation syndrome,Microcephalic osteodysplastic primordial dwarfism type II,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Disorder of fructose metabolism,,,,,,,,,,,,,
Disease,Macrophagic myofasciitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Disorder of glycolysis,,,,,,,,,,,,,
Category,Disorder of neutral amino acid transport,,,,,,,,,,,,,
Clinical group,Aminoacylase deficiency,,,,,,,,,,,,,
Clinical subtype,"Vitamin B12-responsive methylmalonic acidemia, type cblDv2",,,,,,,,,,,,,
Clinical subtype,"Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form",,,,,,,,,,,,,
Clinical subtype,"Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form",,,,,,,,,,,,,
Clinical subtype,"Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form",,,,,,,,,,,,,
Clinical subtype,"Glycogen storage disease due to acid maltase deficiency, infantile onset",1-9 / 100 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,18519449[PMID]_24243590[PMID],3,3
Clinical subtype,"Glycogen storage disease due to acid maltase deficiency, infantile onset",1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10482961[PMID],0.72,0.72
Clinical subtype,"Glycogen storage disease due to acid maltase deficiency, infantile onset",Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Glycogen storage disease due to glycogen synthase deficiency,,,,,,,,,,,,,
Clinical subtype,"Metachromatic leukodystrophy, adult form",1-9 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Metachromatic leukodystrophy, adult form",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Glycoproteinosis,,,,,,,,,,,,,
Clinical subtype,"Alpha-mannosidosis, infantile form",,,,,,,,,,,,,
Clinical subtype,"Alpha-mannosidosis, adult form",,,,,,,,,,,,,
Disease,"GM2 gangliosidosis, AB variant",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26082327[PMID],10,10
Disease,"GM2 gangliosidosis, AB variant",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26082327[PMID],0,0
Clinical subtype,Atypical Gaucher disease due to saposin C deficiency,,,,,,,,,,,,,
Clinical subtype,"Metachromatic leukodystrophy, late infantile form",1-9 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET_24001781[PMID],0,0
Clinical subtype,"Metachromatic leukodystrophy, late infantile form",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Metachromatic leukodystrophy, juvenile form",1-9 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Metachromatic leukodystrophy, juvenile form",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Free sialic acid storage disease, infantile form",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Free sialic acid storage disease, infantile form",1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.14,0.14
Clinical subtype,Intermediate severe Salla disease,,,,,,,,,,,,,
Clinical subtype,Salla disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,16584062[PMID]_ORPHANET,0,0
Clinical subtype,Salla disease,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],1.59,1.59
Category,Lysosomal glycogen storage disease,,,,,,,,,,,,,
Clinical group,Sialidosis,<1 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.05,0.05
Clinical group,Sialidosis,<1 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.02,0.02
Clinical group,Sialidosis,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Sialidosis,<1 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.05,0.05
Clinical group,Sialidosis,<1 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.07,0.07
Clinical group,Sialidosis,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.1,0.1
Clinical subtype,Mucopolysaccharidosis type 4A,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2009[INST],15,15
Clinical subtype,Mucopolysaccharidosis type 4A,1-9 / 1 000 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,25404155[PMID],0.15,0.15
Clinical subtype,Mucopolysaccharidosis type 4A,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,16435194[PMID]_25404155[PMID],0.38,0.38
Clinical subtype,Mucopolysaccharidosis type 4A,1-9 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,25404155[PMID],0.12,0.12
Clinical subtype,Mucopolysaccharidosis type 4A,1-9 / 100 000,United Arab Emirates,409968,409968,25958,25958,en,Validated,410293,410293,23430803[PMID]_25404155[PMID],1.4,1.4
Clinical subtype,Mucopolysaccharidosis type 4A,1-9 / 1 000 000,United Arab Emirates,409966,409966,25958,25958,en,Validated,410293,410293,25404155[PMID],0.46,0.46
Clinical subtype,Mucopolysaccharidosis type 4A,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID]_25404155[PMID],0.497,0.497
Clinical subtype,Mucopolysaccharidosis type 4A,1-9 / 1 000 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,25404155[PMID],0.153,0.153
Clinical subtype,Mucopolysaccharidosis type 4A,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,10617747[PMID]_25404155[PMID],0.48,0.48
Clinical subtype,Mucopolysaccharidosis type 4A,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.29,0.29
Clinical subtype,Mucopolysaccharidosis type 4B,,,,,,,,,,,,,
Category,Disorder of sialic acid metabolism,,,,,,,,,,,,,
Category,Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes,,,,,,,,,,,,,
Disease,Hyper-beta-alaninemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17926374[PMID]_7936305[PMID],2,2
Disease,Hyper-beta-alaninemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17926374[PMID]_7936305[PMID],0,0
Category,Gangliosidosis,,,,,,,,,,,,,
Clinical group,3-hydroxyacyl-CoA dehydrogenase deficiency,,,,,,,,,,,,,
Clinical group,Acyl-CoA dehydrogenase deficiency,,,,,,,,,,,,,
Category,Metabolic disease due to other fatty acid oxidation disorder,,,,,,,,,,,,,
Category,Disorder of carnitine cycle and carnitine transport,,,,,,,,,,,,,
Clinical subtype,"Tay-Sachs disease, B variant, juvenile form",,,,,,,,,,,,,
Clinical subtype,"Tay-Sachs disease, B variant, infantile form",,,,,,,,,,,,,
Clinical subtype,"Tay-Sachs disease, B1 variant",,,,,,,,,,,,,
Clinical subtype,"Tay-Sachs disease, B variant, adult form",,,,,,,,,,,,,
Clinical subtype,"Sandhoff disease, infantile form",,,,,,,,,,,,,
Clinical group,GM2 gangliosidosis,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.87,0.87
Clinical group,GM2 gangliosidosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medecines Agency 2017[INST],5,5
Clinical subtype,"Sandhoff disease, adult form",,,,,,,,,,,,,
Clinical subtype,"Sandhoff disease, juvenile form",,,,,,,,,,,,,
Disease,Autosomal recessive infantile hypercalcemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,12,12
Disease,Autosomal recessive infantile hypercalcemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Follicular cholangitis and pancreatitis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22211284[PMID],5,5
Disease,Follicular cholangitis and pancreatitis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Carcinoma of the ampulla of Vater,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,10656214[PMID],0.59,0.59
Disease,Carcinoma of the ampulla of Vater,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Carcinoma of the ampulla of Vater,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,3664230[PMID],0.57,0.57
Disease,Combined pulmonary fibrosis-emphysema syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20829227[PMID],12,12
Disease,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Polymicrogyria due to TUBB2B mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19465910[PMID]_17036343[PMID],36,36
Malformation syndrome,Polymicrogyria due to TUBB2B mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Oligodontia-cancer predisposition syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15042511[PMID]_21416598[PMID],2,2
Disease,Oligodontia-cancer predisposition syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Staphylococcal toxemia,,,,,,,,,,,,,
Malformation syndrome,Multiple congenital anomalies-hypotonia-seizures syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16783569[PMID]_22305531[PMID]_24357517[PMID]_24259288[PMID]_24259184[PMID]_24706016[PMID]_26545172[PMID],24,24
Malformation syndrome,Multiple congenital anomalies-hypotonia-seizures syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26545172[PMID],0,0
Disease,Painful orbital and systemic neurofibromas-marfanoid habitus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22258529[PMID],4,4
Disease,Painful orbital and systemic neurofibromas-marfanoid habitus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Onychocytic matricoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22197859[PMID],5,5
Disease,Onychocytic matricoma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Onychomatricoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21965578[PMID],50,50
Disease,Onychomatricoma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare nail tumor,,,,,,,,,,,,,
Etiological subtype,Pseudohypoaldosteronism type 2D,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22266938[PMID],24,24
Etiological subtype,Pseudohypoaldosteronism type 2D,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Pseudohypoaldosteronism type 2E,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22266938[PMID],17,17
Etiological subtype,Pseudohypoaldosteronism type 2E,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,DDOST-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22305527[PMID],1,1
Disease,DDOST-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22305527[PMID],0,0
Disease,Diffuse large B-cell lymphoma of the central nervous system,,,,,,,,,,,,,
Category,Aggressive B-cell non-Hodgkin lymphoma,,,,,,,,,,,,,
Disease,Primary cutaneous anaplastic large cell lymphoma,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,T-cell/histiocyte rich large B cell lymphoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,29845599[PMID],0.023,0.023
Disease,Hairy cell leukemia variant,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0.22,0.22
Disease,Hairy cell leukemia variant,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Splenic diffuse red pulp small B-cell lymphoma,,,,,,,,,,,,,
Histopathological subtype,ALK-positive anaplastic large cell lymphoma,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Diffuse large B-cell lymphoma with chronic inflammation,,,,,,,,,,,,,
Disease,Juvenile amyotrophic lateral sclerosis,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Laminopathy with striated muscle involvement,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Laminopathy with lipodystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Laminopathy with peripheral neuropathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Indolent B-cell non-Hodgkin lymphoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Laminopathy with premature aging,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,ALK-negative anaplastic large cell lymphoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Marginal zone lymphoma,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],2.8,2.8
Clinical group,Marginal zone lymphoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],7,7
Clinical group,Marginal zone lymphoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.3,0.3
Category,Pituitary tumor,,,,,,,,,,,,,
Clinical subtype,Congenital sucrase-isomaltase deficiency with starch intolerance,,,,,,,,,,,,,
Disease,Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Congenital sucrase-isomaltase deficiency without starch intolerance,,,,,,,,,,,,,
Clinical subtype,Congenital sucrase-isomaltase deficiency with minimal starch tolerance,,,,,,,,,,,,,
Disease,FADD-related immunodeficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21109225[PMID],4,4
Disease,FADD-related immunodeficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21109225[PMID],0,0
Disease,Myospherulosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20451171[PMID],3,3
Malformation syndrome,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Porencephaly-microcephaly-bilateral congenital cataract syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21109224[PMID],8,8
Malformation syndrome,Porencephaly-microcephaly-bilateral congenital cataract syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Congenital hereditary facial paralysis-variable hearing loss syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3775291[PMID]_22770981[PMID],13,13
Morphological anomaly,Congenital hereditary facial paralysis-variable hearing loss syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3775291[PMID]_22770981[PMID],0,0
Clinical group,Genetic primary hypomagnesemia with normocalciuria,,,,,,,,,,,,,
Morphological anomaly,Isolated hereditary congenital facial paralysis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,8,8
Morphological anomaly,Isolated hereditary congenital facial paralysis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23334384[PMID],200,200
Clinical group,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Genetic primary hypomagnesemia with hypocalciuria,,,,,,,,,,,,,
Disease,Autosomal recessive spastic paraplegia type 48,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20613862[PMID],2,2
Disease,Autosomal recessive spastic paraplegia type 48,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,PTEN hamartoma tumor syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Junctional epidermolysis bullosa with respiratory and renal involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22512483[PMID],3,3
Disease,Junctional epidermolysis bullosa with respiratory and renal involvement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22512483[PMID],0,0
Clinical subtype,Congenital sucrase-isomaltase deficiency with starch and lactose intolerance,,,,,,,,,,,,,
Clinical subtype,Congenital sucrase-isomaltase deficiency without sucrose intolerance,,,,,,,,,,,,,
Category,Rare parkinsonian syndrome due to neurodegenerative disease,,,,,,,,,,,,,
Clinical subtype,Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome,,,,,,,,,,,,,
Clinical subtype,Familial normophosphatemic tumoral calcinosis,,,,,,,,,,,,,
Category,Non-infectious anterior uveitis,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Complication after organ transplantation,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2013[INST],9,9
Category,Rare intoxication due to medical products,,,,,,,,,,,,,
Category,Rare tumor of liver and intrahepatic biliary tract,,,,,,,,,,,,,
Category,Rare tumor of gallbladder and extrahepatic biliary tract,,,,,,,,,,,,,
Clinical subtype,X-linked complicated spastic paraplegia type 1,,,,,,,,,,,,,
Etiological subtype,X-linked Opitz G/BBB syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Autosomal dominant Opitz G/BBB syndrome,,,,,,,,,,,,,
Disease,Sodium channelopathy-related small fiber neuropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21698661[PMID],8,8
Disease,Sodium channelopathy-related small fiber neuropathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28711742[PMID],8,8
Disease,Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28711742[PMID],0,0
Clinical subtype,Zygodactyly type 1,,,,,,,,,,,,,
Clinical subtype,Zygodactyly type 4,,,,,,,,,,,,,
Clinical subtype,Synpolydactyly type 1,,,,,,,,,,,,,
Clinical subtype,Zygodactyly type 2,,,,,,,,,,,,,
Clinical subtype,Zygodactyly type 3,,,,,,,,,,,,,
Clinical subtype,"Congenital vertical talus, unilateral",,,,,,,,,,,,,
Clinical subtype,"Congenital vertical talus, bilateral",,,,,,,,,,,,,
Clinical subtype,Synpolydactyly type 2,,,,,,,,,,,,,
Clinical subtype,Synpolydactyly type 3,,,,,,,,,,,,,
Clinical subtype,"Radio-ulnar synostosis, unilateral",,,,,,,,,,,,,
Clinical subtype,"Radio-ulnar synostosis, bilateral",,,,,,,,,,,,,
Clinical subtype,"Humero-ulnar synostosis, unilateral",,,,,,,,,,,,,
Clinical subtype,"Humero-ulnar synostosis, bilateral",,,,,,,,,,,,,
Clinical subtype,Congenital genu flexum,,,,,,,,,,,,,
Clinical subtype,Congenital genu recurvatum,,,,,,,,,,,,,
Clinical subtype,"Madelung deformity, bilateral",,,,,,,,,,,,,
Clinical subtype,"Madelung deformity, unilateral",,,,,,,,,,,,,
Clinical subtype,"Congenital elbow dislocation, bilateral",,,,,,,,,,,,,
Clinical subtype,"Congenital elbow dislocation, unilateral",,,,,,,,,,,,,
Clinical subtype,"Macrodactyly of fingers, bilateral",,,,,,,,,,,,,
Clinical subtype,"Macrodactyly of fingers, unilateral",,,,,,,,,,,,,
Clinical subtype,"Macrodactyly of toes, bilateral",,,,,,,,,,,,,
Clinical subtype,"Macrodactyly of toes, unilateral",,,,,,,,,,,,,
Category,Disorder of thiamine metabolism and transport,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27149304[PMID],9,9
Clinical subtype,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27149304[PMID],0,0
Disease,Charcot-Marie-Tooth disease type 2P,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22781092[PMID],18,18
Disease,Charcot-Marie-Tooth disease type 2P,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Persistent polyclonal B-cell lymphocytosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18668130[PMID]_21396665[PMID]_2785931[PMID]_7934138[PMID]_11552996[PMID],154,154
Disease,Persistent polyclonal B-cell lymphocytosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital cataract-hearing loss-severe developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15902551[PMID]_22243965[PMID],5,5
Disease,Congenital cataract-hearing loss-severe developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15902551[PMID]_22243965[PMID],0,0
Disease,Severe congenital hypochromic anemia with ringed sideroblasts,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22031863[PMID],3,3
Disease,Severe congenital hypochromic anemia with ringed sideroblasts,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,11p15.4 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22052655[PMID],1,1
Malformation syndrome,11p15.4 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Connective tissue disorder due to lysyl hydroxylase-3 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18834968[PMID],0,0
Disease,Connective tissue disorder due to lysyl hydroxylase-3 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18834968[PMID],2,2
Disease,Transient infantile hypertriglyceridemia and hepatosteatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22226083[PMID]_24549054[PMID],11,11
Disease,Transient infantile hypertriglyceridemia and hepatosteatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22226083[PMID]_24549054[PMID],0,0
Disease,Pituitary carcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22361014[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.04,0.04
Disease,Pituitary carcinoma,1-9 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.87,0.87
Disease,Pituitary carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pituitary carcinoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.026,0.026
Disease,Pituitary carcinoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.041,0.041
Disease,Pituitary carcinoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.014,0.014
Disease,Pituitary carcinoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Pituitary carcinoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Pituitary carcinoma,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Pituitary carcinoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.033,0.033
Disease,Pituitary carcinoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.099,0.099
Disease,Pituitary carcinoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.052,0.052
Disease,Pituitary carcinoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Pituitary carcinoma,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.025,0.025
Disease,Pituitary carcinoma,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.063,0.063
Disease,Pituitary carcinoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.025,0.025
Disease,Pituitary carcinoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Pituitary carcinoma,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.021,0.021
Disease,Pituitary carcinoma,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Pituitary carcinoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.021,0.021
Disease,Pituitary carcinoma,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Pituitary carcinoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.015,0.015
Disease,Pituitary carcinoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.036,0.036
Disease,Pituitary carcinoma,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.135,0.135
Disease,Pituitary carcinoma,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.213,0.213
Disease,Pituitary carcinoma,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.171,0.171
Particular clinical situation in a disease or syndrome,Sagliker syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22200434[PMID],60,60
Particular clinical situation in a disease or syndrome,Sagliker syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,X-linked acrogigantism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29389097[PMID],33,33
Disease,X-linked acrogigantism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Progeroid and marfanoid aspect-lipodystrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24613577[PMID]_24665001[PMID],7,7
Disease,Progeroid and marfanoid aspect-lipodystrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal systemic lupus erythematosus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22019780[PMID],7,7
Disease,Autosomal systemic lupus erythematosus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,PLCG2-associated antibody deficiency and immune dysregulation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22236196[PMID],3,3
Disease,PLCG2-associated antibody deficiency and immune dysregulation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Nephrotic syndrome-deafness-pretibial epidermolysis bullosa syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15265795[PMID],3,3
Disease,Nephrotic syndrome-deafness-pretibial epidermolysis bullosa syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15265795[PMID],0,0
Disease,Fever-associated acute infantile liver failure syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26073778[PMID],11,11
Disease,Fever-associated acute infantile liver failure syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26073778[PMID],0,0
Malformation syndrome,Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25792360[PMID],7,7
Malformation syndrome,Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25792360[PMID],0,0
Morphological anomaly,Familial cavitary optic disc anomaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25581579[PMID],0,0
Morphological anomaly,Familial cavitary optic disc anomaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25581579[PMID],17,17
Disease,Familial gastric type 1 neuroendocrine tumor,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25678551[PMID],5,5
Disease,Familial gastric type 1 neuroendocrine tumor,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25678551[PMID],0,0
Clinical group,Immune-mediated acquired neuromuscular junction disease,,,,,,,,,,,,,
Disease,Symptomatic form of hemochromatosis type 1,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Particular clinical situation with a FDA orphan designation,,,,,,,,,,,,,
Disease,Spastic paraplegia-severe developmental delay-epilepsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26424145[PMID]_26437029[PMID],16,16
Disease,Spastic paraplegia-severe developmental delay-epilepsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26424145[PMID]_26437029[PMID],0,0
Malformation syndrome,Short stature-brachydactyly-obesity-global developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26437029[PMID],6,6
Malformation syndrome,Short stature-brachydactyly-obesity-global developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26437029[PMID],0,0
Malformation syndrome,DYRK1A-related intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26922654[PMID],54,54
Malformation syndrome,DYRK1A-related intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26922654[PMID],0,0
Disease,Kaposiform lymphangiomatosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27053281[PMID],0,0
Disease,Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26148948[PMID],0,0
Disease,Verrucous hemangioma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25263605[PMID],0,0
Clinical subtype,Intellectual disability syndrome due to a DYRK1A point mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26922654[PMID],35,35
Clinical subtype,Intellectual disability syndrome due to a DYRK1A point mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26922654[PMID],0,0
Malformation syndrome,NEK9-related lethal skeletal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26908619[PMID],5,5
Malformation syndrome,NEK9-related lethal skeletal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26908619[PMID],0,0
Disease,Benign metanephric tumour,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26870216[PMID]_27227914[PMID],0,0
Disease,Catastrophic antiphospholipid syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27375916[PMID],0,0
Disease,BENTA disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25930198[PMID],8,8
Disease,BENTA disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25930198[PMID],0,0
Disease,Acquired methemoglobinemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15342970[PMID]_19224791[PMID],242,242
Disease,Acquired methemoglobinemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15342970[PMID]_19224791[PMID],0,0
Disease,COG6-CGD,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26260076[PMID]_23430903[PMID],10,10
Disease,COG6-CGD,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26260076[PMID]_23430903[PMID],0,0
Disease,"Primary dystonia, DYT27 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26260724[PMID]_26004199[PMID],5,5
Disease,"Primary dystonia, DYT27 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26260724[PMID]_26004199[PMID],0,0
Disease,Neonatal alloimmune neutropenia,1-5 / 10 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,11696231[PMID],16.6,16.6
Disease,Neonatal alloimmune neutropenia,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Paracetamol poisoning,1-5 / 10 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,22827594[PMID]_15543083[PMID],16,16
Particular clinical situation in a disease or syndrome,Paracetamol poisoning,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Yellow nail syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28241848[PMID],400,400
Disease,Yellow nail syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28241848[PMID],0,0
Clinical subtype,Toxic epidermal necrolysis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,SAPHO syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,1p35.2 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25900906[PMID],2,2
Malformation syndrome,1p35.2 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25900906[PMID],0,0
Disease,X-linked myotubular myopathy-abnormal genitalia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10449925[PMID],4,4
Disease,X-linked myotubular myopathy-abnormal genitalia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10449925[PMID],0,0
Disease,Hereditary neuroendocrine tumor of small intestine,,,,,,,,,,,,,
Disease,Infantile multisystem neurologic-endocrine-pancreatic disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25574476[PMID],2,2
Disease,Infantile multisystem neurologic-endocrine-pancreatic disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25574476[PMID],0,0
Disease,Hereditary sensory neuropathy-deafness-dementia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23365052[PMID],6,6
Disease,Hereditary sensory neuropathy-deafness-dementia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23365052[PMID],0,0
Clinical subtype,NTHL1-related attenuated familial adenomatous polyposis,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Acute radiation syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],0,0
Disease,Avian influenza,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,World Health Organization 2015[INST],826,826
Disease,Avian influenza,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Avian influenza,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_World Health Organization 2015[INST],0,0
Disease,Corticobasal syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Variably protease-sensitive prionopathy,,,,,,,,,,,,,
Disease,Endometrioid carcinoma of ovary,1-9 / 1 000 000,"Korea, Republic of",409967,409967,25958,25958,en,Validated,410293,410293,26463436[PMID],0.51,0.51
Disease,Endometrioid carcinoma of ovary,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.81,0.81
Disease,Holmes-Adie syndrome,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,613531[PMID],4.7,4.7
Disease,Holmes-Adie syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Plasma cell leukemia,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,20664057[PMID],0.04,0.04
Histopathological subtype,Pleomorphic salivary gland adenoma,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2005[INST],2.725,2.725
Morphological anomaly,Isolated tracheoesophageal fistula,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,25976171[PMID],4.2,4.2
Morphological anomaly,Isolated tracheoesophageal fistula,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,22945024[PMID],2.2,2.2
Disease,Kuru,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16798390[PMID],2700,2700
Disease,Kuru,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16798390[PMID],0,0
Disease,Polyendocrine-polyneuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25248098[PMID],3,3
Disease,Polyendocrine-polyneuropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25248098[PMID],0,0
Disease,Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15981765[PMID],2,2
Disease,Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15981765[PMID],0,0
Disease,Anti-p200 pemphigoid,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24767733[PMID],50,50
Disease,Anti-p200 pemphigoid,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24767733[PMID],0,0
Disease,Progressive muscular atrophy,,,,,,,,,,,,,
Disease,Acquired Creutzfeldt-Jakob disease,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary cutaneous plasmacytosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cutaneous pseudolymphoma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27057027[PMID],0,0
Disease,Cutaneous pseudolymphoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27057027[PMID],60,60
Morphological anomaly,Familial congenital nasolacrimal duct obstruction,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24372406[PMID],4,4
Morphological anomaly,Familial congenital nasolacrimal duct obstruction,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24372406[PMID],0,0
Malformation syndrome,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29904177[PMID]_30998304[PMID],25,25
Malformation syndrome,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30998304[PMID],0,0
Etiological subtype,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29904177[PMID],10,10
Etiological subtype,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29904177[PMID],0,0
Disease,Congenital insensitivity to pain with severe intellectual disability,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26068709[PMID],3,3
Disease,Congenital insensitivity to pain with severe intellectual disability,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26068709[PMID],0,0
Clinical syndrome,Polyclonal hyperviscosity syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Eosinophilic angiocentric fibrosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26674883[PMID],52,52
Disease,Eosinophilic angiocentric fibrosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26674883[PMID],0,0
Disease,IgG4-related ophthalmic disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24513111[PMID],0,0
Particular clinical situation in a disease or syndrome,Susceptibility to infection in immunocompromised patient,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Symptomatic form of fragile X syndrome in female carrier,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19642710[PMID],0,0
Disease,IgG4-related aortitis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21124083[PMID],0,0
Disease,IgG4-related kidney disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26666884[PMID],0,0
Disease,IgG4-related submandibular gland disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24844187[PMID],0,0
Disease,IgG4-related pachymeningitis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24733677[PMID],0,0
Disease,Scedosporiosis,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,19549223[PMID],0.1,0.1
Disease,Scedosporiosis,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],0,0
Disease,Snakebite envenomation,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0,0
Particular clinical situation in a disease or syndrome,Pleural empyema,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],13,13
Category,Genetic primary orthostatic hypotension,,,,,,,,,,,,,
Disease,Isolated focal non-epidermolytic palmoplantar keratoderma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25285920[PMID],2,2
Disease,Isolated focal non-epidermolytic palmoplantar keratoderma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25285920[PMID],0,0
Disease,Progressive autosomal recessive ataxia-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3739762[PMID]_25205112[PMID]_3465984[PMID]_2603781[PMID],0,0
Disease,Progressive autosomal recessive ataxia-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3739762[PMID]_25205112[PMID]_3465984[PMID]_2603781[PMID],13,13
Morphological anomaly,Ectopia cordis,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20965559[PMID],0.67,0.67
Morphological anomaly,Ectopia cordis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Regressive spondylometaphyseal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25348816[PMID]_23824842[PMID],2,2
Malformation syndrome,Regressive spondylometaphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25348816[PMID]_23824842[PMID],0,0
Disease,CAD-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25678555[PMID],1,1
Disease,CAD-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25678555[PMID],0,0
Disease,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25930971[PMID]_26041762[PMID]_26138499[PMID],15,15
Disease,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25930971[PMID]_26041762[PMID]_26138499[PMID],0,0
Malformation syndrome,Autosomal recessive brachyolmia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Autosomal recessive brachyolmia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Dr Gen NISHIMURA[EXPERT],20,20
Disease,Zika virus disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Zika virus disease,1-5 / 10 000,Brazil,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2016[INST],58.8,58.8
Disease,Progressive scapulohumeroperoneal distal myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25938801[PMID],33,33
Disease,Progressive scapulohumeroperoneal distal myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25938801[PMID],0,0
Malformation syndrome,Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25748484[PMID],2,2
Malformation syndrome,Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25748484[PMID],0,0
Category,Partial duplication of the short arm of chromosome 19,,,,,,,,,,,,,
Malformation syndrome,19p13.3 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25858326[PMID],6,6
Malformation syndrome,19p13.3 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25858326[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 25,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25754315[PMID],2,2
Disease,Combined oxidative phosphorylation defect type 25,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25754315[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2V,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25818867[PMID],21,21
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2V,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25818867[PMID],0,0
Disease,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25315659[PMID],2,2
Disease,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25315659[PMID],0,0
Disease,C1 inhibitor deficiency,,,,,,,,,,,,,
Category,Rare genetic capillary malformation,,,,,,,,,,,,,
Category,Immunodeficiency due to a complement cascade component deficiency,,,,,,,,,,,,,
Category,Immunodeficiency due to a complement regulatory deficiency,,,,,,,,,,,,,
Category,Rare genetic vascular tumor,,,,,,,,,,,,,
Category,Rare genetic venous malformation,,,,,,,,,,,,,
Category,Genetic primary lymphedema,,,,,,,,,,,,,
Category,Genetic complex vascular malformation with associated anomalies,,,,,,,,,,,,,
Category,Lethal multiple congenital anomalies/dysmorphic syndrome,,,,,,,,,,,,,
Clinical group,Rare combined vascular malformation,,,,,,,,,,,,,
Clinical group,Common cystic lymphatic malformation,,,,,,,,,,,,,
Category,Rare vascular malformation of major vessels,,,,,,,,,,,,,
Disease,Ataxia-oculomotor apraxia type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25728773[PMID]_27066586[PMID],12,12
Disease,Ataxia-oculomotor apraxia type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25728773[PMID]_27066586[PMID],0,0
Disease,"Spondyloepiphyseal dysplasia, Stanescu type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6430256[PMID]_26183434[PMID]_9592900[PMID],7,7
Disease,"Spondyloepiphyseal dysplasia, Stanescu type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6430256[PMID]_26183434[PMID]_9592900[PMID],0,0
Malformation syndrome,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26220823[PMID],8,8
Malformation syndrome,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26220823[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 75,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID]_26179919[PMID],5,5
Disease,Autosomal recessive spastic paraplegia type 75,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID]_26179919[PMID],0,0
Malformation syndrome,Corpus callosum agenesis-macrocephaly-hypertelorism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25944787[PMID],4,4
Malformation syndrome,Corpus callosum agenesis-macrocephaly-hypertelorism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25944787[PMID],0,0
Malformation syndrome,X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26290468[PMID],2,2
Malformation syndrome,X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26290468[PMID],0,0
Disease,Idiopathic spontaneous coronary artery dissection,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Composite hemangioendothelioma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25666464[PMID],39,39
Disease,Composite hemangioendothelioma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25666464[PMID],0,0
Disease,Retiform hemangioendothelioma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25812740[PMID],32,32
Disease,Retiform hemangioendothelioma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25812740[PMID],0,0
Disease,Primary intralymphatic angioendothelioma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21238627[PMID],30,30
Disease,Primary intralymphatic angioendothelioma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21238627[PMID],0,0
Clinical group,Congenital hemangioma,,,,,,,,,,,,,
Disease,Partially involuting congenital hemangioma,,,,,,,,,,,,,
Malformation syndrome,Mixed cystic lymphatic malformation,,,,,,,,,,,,,
Disease,Spinocerebellar ataxia type 41,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25477146[PMID],1,1
Disease,Spinocerebellar ataxia type 41,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25477146[PMID],0,0
Disease,Spinocerebellar ataxia type 42,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26456284[PMID]_26715324[PMID],25,25
Disease,Spinocerebellar ataxia type 42,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26456284[PMID]_26715324[PMID],0,0
Category,Vascular tumor with associated anomalies,,,,,,,,,,,,,
Category,Rare capillary malformation with associated anomalies,,,,,,,,,,,,,
Malformation syndrome,Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27753196[PMID]_DOI:10.4137/JGE.S12583[OTHER]_25851998[PMID]_26542245[PMID],8,8
Malformation syndrome,Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27753196[PMID]_DOI:10.4137/JGE.S12583[OTHER]_25851998[PMID]_26542245[PMID],0,0
Disease,Progressive myoclonic epilepsy type 9,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25954030[PMID],2,2
Disease,Progressive myoclonic epilepsy type 9,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25954030[PMID],0,0
Malformation syndrome,Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26168268[PMID],16,16
Malformation syndrome,Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26168268[PMID],0,0
Disease,X-linked intellectual disability-hypotonia-movement disorder syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26235985[PMID],38,38
Disease,X-linked intellectual disability-hypotonia-movement disorder syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26235985[PMID],0,0
Malformation syndrome,X-linked intellectual disability-short stature-overweight syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26166480[PMID],20,20
Malformation syndrome,X-linked intellectual disability-short stature-overweight syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26166480[PMID],0,0
Disease,Clear cell sarcoma of kidney,,,,,,,,,,,,,
Malformation syndrome,Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26365341[PMID],4,4
Malformation syndrome,Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26365341[PMID],0,0
Disease,Multiple mitochondrial dysfunctions syndrome type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25539947[PMID],8,8
Disease,Multiple mitochondrial dysfunctions syndrome type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25539947[PMID],0,0
Disease,ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26224535[PMID],7,7
Disease,ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26224535[PMID],0,0
Malformation syndrome,Complex lethal osteochondrodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26365339[PMID],6,6
Malformation syndrome,Complex lethal osteochondrodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26365339[PMID],0,0
Malformation syndrome,Megalencephaly-severe kyphoscoliosis-overgrowth syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26138117[PMID],2,2
Malformation syndrome,Megalencephaly-severe kyphoscoliosis-overgrowth syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26138117[PMID],0,0
Malformation syndrome,Intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26192890[PMID],3,3
Malformation syndrome,Intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26192890[PMID],0,0
Malformation syndrome,Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25533962[PMID]_26168268[PMID],5,5
Malformation syndrome,Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25533962[PMID]_26168268[PMID],0,0
Malformation syndrome,Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26299366[PMID],14,14
Malformation syndrome,Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26299366[PMID],0,0
Disease,Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26185144[PMID],11,11
Disease,Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26185144[PMID],0,0
Morphological anomaly,Isolated splenogonadal fusion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15349548[PMID],145,145
Morphological anomaly,Isolated splenogonadal fusion,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15349548[PMID],0,0
Disease,TAFRO syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27084250[PMID],28,28
Disease,TAFRO syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27084250[PMID],0,0
Disease,Actinomycosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18078685[PMID],0,0
Disease,Predisposition to invasive fungal disease due to CARD9 deficiency,,,,,,,,,,,,,
Disease,Syndromic sensorineural deafness due to combined oxidative phosphorylation defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25556185[PMID],2,2
Disease,Syndromic sensorineural deafness due to combined oxidative phosphorylation defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25556185[PMID],0,0
Disease,Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25704603[PMID],5,5
Disease,Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25704603[PMID],0,0
Malformation syndrome,Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25728775[PMID]_25728777[PMID]_27133397[PMID],16,16
Malformation syndrome,Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25728775[PMID]_25728777[PMID]_27133397[PMID],0,0
Disease,Infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25504045[PMID],2,2
Disease,Infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25504045[PMID],0,0
Disease,Polyglucosan body myopathy type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25272951[PMID]_26203156[PMID]_26255073[PMID]_26652229[PMID],15,15
Disease,Polyglucosan body myopathy type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25272951[PMID]_26203156[PMID]_26255073[PMID]_26652229[PMID],0,0
Clinical group,Pseudohypoparathyroidism with Albright hereditary osteodystrophy,,,,,,,,,,,,,
Clinical group,Pseudohypoparathyroidism without Albright hereditary osteodystrophy,,,,,,,,,,,,,
Clinical group,Congenital nemaline myopathy,,,,,,,,,,,,,
Disease,Autosomal dominant mitochondrial myopathy with exercise intolerance,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9324076[PMID],15,15
Disease,Autosomal dominant mitochondrial myopathy with exercise intolerance,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9324076[PMID],0,0
Disease,Erythrokeratodermia variabilis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Erythrokeratodermia variabilis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Short stature due to growth hormone qualitative anomaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,263308[PMID]_3965948[PMID],3,3
Clinical subtype,Short stature due to growth hormone qualitative anomaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_263308[PMID]_3965948[PMID],0,0
Clinical subtype,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,,,,,,,,,,,,,
Etiological subtype,Autosomal recessive hypohidrotic ectodermal dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Autosomal dominant hypohidrotic ectodermal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9375732[PMID],40,40
Etiological subtype,Autosomal dominant hypohidrotic ectodermal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Vogt-Koyanagi-Harada disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Vogt-Koyanagi-Harada disease,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,27008848[PMID],3.75,3.75
Disease,Idiopathic pulmonary fibrosis,1-9 / 100 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,7921471[PMID]_23204124[PMID],8.3,8.3
Disease,Idiopathic pulmonary fibrosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23204124[PMID]_European Medicines Agency 2018[INST],11.5,11.5
Disease,Idiopathic pulmonary fibrosis,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,3.81,3.81
Disease,Idiopathic pulmonary fibrosis,1-9 / 100 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,11484513[PMID],1.25,1.25
Disease,Idiopathic pulmonary fibrosis,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,23204124[PMID],0.22,0.22
Disease,Idiopathic pulmonary fibrosis,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,12693805[PMID],23.9,23.9
Disease,Idiopathic pulmonary fibrosis,1-9 / 100 000,United Kingdom,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET_16844727[PMID]_21525528[PMID],6.02,6.02
Disease,Idiopathic pulmonary fibrosis,1-5 / 10 000,Finland,409966,409966,25965,25965,en,Not yet validated,410294,410294,11923553[PMID],17,17
Disease,Idiopathic pulmonary fibrosis,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,12693805[PMID],4.3,4.3
Disease,Idiopathic pulmonary fibrosis,1-5 / 10 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,23204124[PMID],12.1,12.1
Disease,Idiopathic pulmonary fibrosis,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,23204124[PMID],0.94,0.94
Disease,Idiopathic pulmonary fibrosis,1-9 / 100 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,19345567[PMID],3.38,3.38
Disease,Idiopathic pulmonary fibrosis,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,19345567[PMID],0.93,0.93
Disease,Idiopathic pulmonary fibrosis,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,18657060[PMID],2.95,2.95
Disease,Idiopathic pulmonary fibrosis,1-9 / 100 000,"Taiwan, Province of China",409967,409967,25965,25965,en,Not yet validated,410294,410294,22954482[PMID],1.25,1.25
Disease,Idiopathic pulmonary fibrosis,1-9 / 100 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,22954482[PMID],6.4,6.4
Disease,Idiopathic pulmonary fibrosis,1-5 / 10 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_23204124[PMID]_7921471[PMID],38.5,38.5
Disease,Bronchiolitis obliterans with obstructive pulmonary disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Tracheobronchopathia osteochondroplastica,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Tracheobronchopathia osteochondroplastica,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24865333[PMID],400,400
Disease,Idiopathic chronic eosinophilic pneumonia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Idiopathic chronic eosinophilic pneumonia,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,17277407[PMID],0.23,0.23
Disease,Cryptogenic organizing pneumonia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cryptogenic organizing pneumonia,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,15127977[PMID],0.81,0.81
Disease,Cryptogenic organizing pneumonia,1-9 / 1 000 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,19345567[PMID],0.92,0.92
Disease,Cryptogenic organizing pneumonia,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,18204109[PMID],1.1,1.1
Disease,Occipital horn syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Occipital horn syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial exudative vitreoretinopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Maternally-inherited diabetes and deafness,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.1,0.1
Disease,Scorpion envenomation,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27912864[PMID],0,0
Disease,Euthyroid Graves orbitopathy,,,,,,,,,,,,,
Malformation syndrome,Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25388005[PMID],6,6
Malformation syndrome,Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25388005[PMID],0,0
Morphological anomaly,Supratip dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26947355[PMID],5,5
Morphological anomaly,Supratip dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26947355[PMID],0,0
Category,Rare disease with malignant hyperthermia,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Cyanide poisoning,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7662055[PMID],0,0
Disease,Exercise-induced malignant hyperthermia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22538307[PMID]_23476141[PMID],0,0
Disease,SMARCA4-deficient sarcoma of thorax,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26343384[PMID],19,19
Disease,SMARCA4-deficient sarcoma of thorax,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26343384[PMID],0,0
Clinical subtype,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27119754[PMID],10,10
Clinical subtype,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27119754[PMID],0,0
Malformation syndrome,WAC-related facial dysmorphism-developmental delay-behavioral abnormalities syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27119754[PMID],22,22
Malformation syndrome,WAC-related facial dysmorphism-developmental delay-behavioral abnormalities syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27119754[PMID],0,0
Disease,Seizures-scoliosis-macrocephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30997052[PMID],10,10
Disease,Seizures-scoliosis-macrocephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30997052[PMID],0,0
Disease,VPS11-related autosomal recessive hypomyelinating leukodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26307567[PMID]_27119754[PMID],13,13
Disease,VPS11-related autosomal recessive hypomyelinating leukodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26307567[PMID]_27119754[PMID],0,0
Disease,Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26581302[PMID],3,3
Disease,Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26581302[PMID],0,0
Disease,Autosomal dominant thrombocytopenia with platelet secretion defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26280575[PMID]_26769223[PMID],4,4
Disease,Autosomal dominant thrombocytopenia with platelet secretion defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26280575[PMID]_26769223[PMID],0,0
Disease,LIMS2-related limb-girdle muscular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25589244[PMID],2,2
Disease,LIMS2-related limb-girdle muscular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25589244[PMID],0,0
Disease,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26581903[PMID],3,3
Disease,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26581903[PMID],0,0
Malformation syndrome,Macrocephaly-intellectual disability-left ventricular non compaction syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26571461[PMID]_27329731[PMID]_27550220[PMID],6,6
Malformation syndrome,Macrocephaly-intellectual disability-left ventricular non compaction syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26571461[PMID]_27329731[PMID]_27550220[PMID],0,0
Disease,Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26522469[PMID],3,3
Disease,Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26522469[PMID],0,0
Disease,Autosomal recessive Charcot-Marie-Tooth disease type 2X,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26556829[PMID],29,29
Disease,Autosomal recessive Charcot-Marie-Tooth disease type 2X,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26556829[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2Z,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26497905[PMID]_26659848[PMID]_26912637[PMID]_27105897[PMID]_27329773[PMID],21,21
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2Z,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26497905[PMID]_26659848[PMID]_26912637[PMID]_27105897[PMID]_27329773[PMID],0,0
Morphological anomaly,Familial patent arterial duct,,,,,,,,,,,,,
Disease,Autosomal recessive spastic paraplegia type 77,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26553276[PMID]_29126765[PMID]_25851414[PMID],8,8
Disease,Autosomal recessive spastic paraplegia type 77,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29126765[PMID],0,0
Disease,Martinique crinkled retinal pigment epitheliopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23370609[PMID]_26744326[PMID],14,14
Disease,Martinique crinkled retinal pigment epitheliopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23370609[PMID]_26744326[PMID],0,0
Disease,TMEM199-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19067230[PMID]_26833330[PMID]_29321044[PMID],7,7
Disease,TMEM199-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19067230[PMID]_26833330[PMID]_29321044[PMID],0,0
Malformation syndrome,Fetal encasement syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20961246[PMID],2,2
Malformation syndrome,Fetal encasement syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20961246[PMID],0,0
Category,Genetic otorhinolaryngologic disease,,,,,,,,,,,,,
Category,Genetic hemoglobinopathy,,,,,,,,,,,,,
Disease,Class I glucose-6-phosphate dehydrogenase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20200584[PMID],0,0
Disease,Intellectual disability-epilepsy-extrapyramidal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26048982[PMID],3,3
Disease,Intellectual disability-epilepsy-extrapyramidal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26048982[PMID],0,0
Malformation syndrome,Microcephalic primordial dwarfism due to RTTN deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22939636[PMID]_26608784[PMID]_26940245[PMID],12,12
Malformation syndrome,Microcephalic primordial dwarfism due to RTTN deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22939636[PMID]_26608784[PMID]_26940245[PMID],0,0
Disease,Tubulinopathy-associated dysgyria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26130693[PMID],7,7
Disease,Tubulinopathy-associated dysgyria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26130693[PMID],0,0
Disease,Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26358778[PMID],6,6
Disease,Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26358778[PMID],0,0
Disease,Cryptogenic multifocal ulcerous stenosing enteritis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24369459[PMID]_25708899[PMID],60,60
Disease,Cryptogenic multifocal ulcerous stenosing enteritis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24369459[PMID]_25708899[PMID],0,0
Disease,Chronic enteropathy associated with SLCO2A1 gene,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26539716[PMID]_17709045[PMID],18,18
Disease,Chronic enteropathy associated with SLCO2A1 gene,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24035666[PMID]_23268370[PMID]_25708899[PMID]_26539716[PMID]_17709045[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 74,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25609768[PMID],11,11
Disease,Autosomal recessive spastic paraplegia type 74,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25609768[PMID],0,0
Disease,Isolated generalized anhidrosis with normal sweat glands,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25329695[PMID]_2401610[PMID],7,7
Disease,Isolated generalized anhidrosis with normal sweat glands,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25329695[PMID]_2401610[PMID],0,0
Disease,Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26739615[PMID]_27148570[PMID],0,0
Disease,CCDC115-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26833332[PMID]_26833330[PMID],8,8
Disease,CCDC115-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26833332[PMID]_26833330[PMID],0,0
Disease,Colobomatous macrophthalmia-microcornea syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12900897[PMID],21,21
Disease,Colobomatous macrophthalmia-microcornea syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12900897[PMID],0,0
Disease,Severe primary trimethylaminuria,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25335494[PMID],0,0
Disease,SLC39A8-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26637978[PMID]_26637979[PMID],10,10
Disease,SLC39A8-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26637978[PMID]_26637979[PMID],0,0
Etiological subtype,Rhizomelic chondrodysplasia punctata type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26220973[PMID],4,4
Etiological subtype,Rhizomelic chondrodysplasia punctata type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26220973[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 62,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],7,7
Disease,Autosomal recessive spastic paraplegia type 62,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 61,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],4,4
Disease,Autosomal recessive spastic paraplegia type 61,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 60,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],1,1
Disease,Autosomal recessive spastic paraplegia type 60,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 59,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],3,3
Disease,Autosomal recessive spastic paraplegia type 59,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Proximal myopathy with extrapyramidal signs,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24336167[PMID],15,15
Disease,Proximal myopathy with extrapyramidal signs,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24336167[PMID],0,0
Disease,Pancytopenia-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24507776[PMID]_27185855[PMID],3,3
Disease,Pancytopenia-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24507776[PMID]_27185855[PMID],0,0
Disease,Optic atrophy-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24462372[PMID],6,6
Disease,Optic atrophy-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24462372[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 69,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],2,2
Disease,Autosomal recessive spastic paraplegia type 69,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 70,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],4,4
Disease,Autosomal recessive spastic paraplegia type 70,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 71,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],1,1
Disease,Autosomal recessive spastic paraplegia type 71,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 63,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],2,2
Disease,Autosomal recessive spastic paraplegia type 63,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 64,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],4,4
Disease,Autosomal recessive spastic paraplegia type 64,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 66,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],2,2
Disease,Autosomal recessive spastic paraplegia type 66,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 67,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID],2,2
Disease,Autosomal recessive spastic paraplegia type 67,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,Childhood-onset spasticity with hyperglycinemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24777537[PMID]_17485548[PMID]_24334290[PMID],3,3
Disease,Childhood-onset spasticity with hyperglycinemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17485548[PMID]_24334290[PMID],0,0
Disease,Multiple mitochondrial dysfunctions syndrome type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24777537[PMID]_22077971[PMID],21,21
Disease,Multiple mitochondrial dysfunctions syndrome type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24777537[PMID]_22077971[PMID],0,0
Disease,Multiple mitochondrial dysfunctions syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24777537[PMID]_21944046[PMID]_24334290[PMID]_22562699[PMID],6,6
Disease,Multiple mitochondrial dysfunctions syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24777537[PMID]_21944046[PMID]_24334290[PMID]_22562699[PMID],0,0
Disease,Autosomal spastic paraplegia type 72,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24388663[PMID],14,14
Disease,Autosomal spastic paraplegia type 72,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24388663[PMID],0,0
Category,Lipoic acid biosynthesis defect,,,,,,,,,,,,,
Disease,Lipoic acid synthetase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24777537[PMID]_22152680[PMID]_24334290[PMID],3,3
Disease,Lipoic acid synthetase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24777537[PMID]_22152680[PMID]_24334290[PMID],0,0
Disease,Lipoyl transferase 1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27247813[PMID],4,4
Disease,Lipoyl transferase 1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27247813[PMID],0,0
Category,Rare genetic female infertility,,,,,,,,,,,,,
Category,Rare genetic disorder with obstructive azoospermia,,,,,,,,,,,,,
Category,Male infertility due to obstructive azoospermia of genetic origin,,,,,,,,,,,,,
Category,Rare male infertility due to adrenal disorder of genetic origin,,,,,,,,,,,,,
Category,Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin,,,,,,,,,,,,,
Category,Rare genetic male infertility,,,,,,,,,,,,,
Category,Rare female infertility due to an implantation defect,,,,,,,,,,,,,
Category,Rare female infertility due to gonadal dysgenesis,,,,,,,,,,,,,
Category,Female infertility due to an implantation defect of genetic origin,,,,,,,,,,,,,
Category,Rare female infertility due to an anomaly of ovarian function of genetic origin,,,,,,,,,,,,,
Category,Rare female infertility due to adrenal disorder of genetic origin,,,,,,,,,,,,,
Category,Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin,,,,,,,,,,,,,
Disease,Hepatitis delta,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],40,40
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,SEER Surveillance Epidemiology and end results [REG]_14999699[PMID],0.02,0.02
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.029,0.029
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.029,0.029
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.022,0.022
Disease,Fibrolamellar hepatocellular carcinoma,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.13,0.13
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.022,0.022
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.022,0.022
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Fibrolamellar hepatocellular carcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.025,0.025
Clinical subtype,AXIN2-related attenuated familial adenomatous polyposis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23838596[PMID],4,4
Clinical subtype,AXIN2-related attenuated familial adenomatous polyposis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23838596[PMID],0,0
Disease,Huntington disease-like syndrome due to C9ORF72 expansions,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24363131[PMID],10,10
Disease,Huntington disease-like syndrome due to C9ORF72 expansions,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24363131[PMID],0,0
Malformation syndrome,Familial median cleft of the upper and lower lips,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23860042[PMID],8,8
Malformation syndrome,Familial median cleft of the upper and lower lips,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23860042[PMID],0,0
Malformation syndrome,14q24.1q24.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24357125[PMID],3,3
Malformation syndrome,14q24.1q24.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24357125[PMID],0,0
Malformation syndrome,9q31.1q31.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24376033[PMID],2,2
Malformation syndrome,9q31.1q31.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24376033[PMID],0,0
Malformation syndrome,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24045845[PMID],2,2
Malformation syndrome,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24045845[PMID],0,0
Disease,Episodic ataxia with slurred speech,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23982692[PMID],13,13
Disease,Episodic ataxia with slurred speech,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23982692[PMID],0,0
Disease,Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25834911[PMID],4,4
Disease,Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25834911[PMID],0,0
Disease,Moyamoya disease with early-onset achalasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24581742[PMID],9,9
Disease,Moyamoya disease with early-onset achalasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24581742[PMID],0,0
Malformation syndrome,1p31p32 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24462883[PMID],5,5
Malformation syndrome,1p31p32 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24462883[PMID],0,0
Malformation syndrome,"Autosomal recessive spondylometaphyseal dysplasia, Mégarbané type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18925669[PMID]_2445848[PMID],4,4
Malformation syndrome,"Autosomal recessive spondylometaphyseal dysplasia, Mégarbané type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18925669[PMID]_2445848[PMID],0,0
Malformation syndrome,MEND syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22229330[PMID]_24459067[PMID]_24700572[PMID]_27276700[PMID],24,24
Malformation syndrome,MEND syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22229330[PMID]_24459067[PMID]_24700572[PMID]_27276700[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24500646[PMID]_15111691[PMID]_14557576[PMID],2,2
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24500646[PMID]_15111691[PMID]_14557576[PMID],0,0
Disease,Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21801157[PMID]_19609311[PMID],21,21
Disease,Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21801157[PMID]_19609311[PMID],0,0
Clinical group,Lichen myxedematosus,,,,,,,,,,,,,
Clinical group,Cold-induced sweating syndrome-hyperthermia spectrum,,,,,,,,,,,,,
Disease,Karyomegalic interstitial nephritis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22772369[PMID],12,12
Disease,Karyomegalic interstitial nephritis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22772369[PMID],0,0
Disease,Acute myeloid leukemia with t(9;11)(p22;q23),,,,,,,,,,,,,
Disease,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2),,,,,,,,,,,,,
Disease,Acute myeloid leukemia with t(6;9)(p23;q34),,,,,,,,,,,,,
Clinical group,Primary eosinophilic gastrointestinal disease,,,,,,,,,,,,,
Disease,Eosinophilic colitis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22012125[PMID],196,196
Disease,Eosinophilic colitis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22012125[PMID],0,0
Disease,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),,,,,,,,,,,,,
Disease,Acute myeloid leukemia with NPM1 somatic mutations,,,,,,,,,,,,,
Disease,Progressive myoclonic epilepsy type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21276947[PMID],3,3
Disease,Progressive myoclonic epilepsy type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21276947[PMID],0,0
Malformation syndrome,Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20950787[PMID],5,5
Malformation syndrome,Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20950787[PMID],0,0
Clinical subtype,Autosomal recessive distal renal tubular acidosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Morphological anomaly,Familial bicuspid aortic valve,,,,,,,,,,,,,
Disease,Scott syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8608230[PMID]_15790791[PMID]_19814742[PMID],4,4
Disease,Scott syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Polyarticular juvenile idiopathic arthritis,,,,,,,,,,,,,
Category,Rare genetic bone development disorder,,,,,,,,,,,,,
Category,Rare female infertility due to oocyte maturation defect,,,,,,,,,,,,,
Malformation syndrome,Severe intellectual disability-progressive spastic diplegia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24668549[PMID]_23033978[PMID]_24614104[PMID],4,4
Malformation syndrome,Severe intellectual disability-progressive spastic diplegia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24668549[PMID]_23033978[PMID]_24614104[PMID],0,0
Disease,Multisystemic smooth muscle dysfunction syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20734336[PMID],7,7
Disease,Multisystemic smooth muscle dysfunction syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20734336[PMID],0,0
Disease,Female infertility due to zona pellucida defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24670168[PMID],4,4
Disease,Female infertility due to zona pellucida defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24670168[PMID],0,0
Malformation syndrome,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24084572[PMID],3,3
Malformation syndrome,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24084572[PMID],0,0
Disease,Alacrimia-choreoathetosis-liver dysfunction syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24651605[PMID]_22581936[PMID],8,8
Disease,Alacrimia-choreoathetosis-liver dysfunction syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24651605[PMID]_22581936[PMID],0,0
Malformation syndrome,Tall stature-intellectual disability-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24614070[PMID]_27991732[PMID]_28941052[PMID],17,17
Malformation syndrome,Tall stature-intellectual disability-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24614070[PMID]_27991732[PMID]_28941052[PMID],0,0
Malformation syndrome,ADNP syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24531329[PMID],10,10
Malformation syndrome,ADNP syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24531329[PMID],0,0
Malformation syndrome,Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24656866[PMID],4,4
Malformation syndrome,Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24656866[PMID],0,0
Malformation syndrome,Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24680889[PMID],7,7
Malformation syndrome,Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24680889[PMID],0,0
Category,Genetic syndrome with limb malformations as a major feature,,,,,,,,,,,,,
Category,Genetic syndrome with limb reduction defects,,,,,,,,,,,,,
Category,Dysostosis of genetic origin with limb anomaly as a major feature,,,,,,,,,,,,,
Category,Dysostosis of genetic origin,,,,,,,,,,,,,
Disease,Familial atypical multiple mole melanoma syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Vasculitis due to ADA2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28516235[PMID],0,0
Disease,Vasculitis due to ADA2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28516235[PMID],48,48
Disease,DITRA,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25848350[PMID],70,70
Disease,DITRA,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25848350[PMID],0,0
Category,X-linked distal hereditary motor neuropathy,,,,,,,,,,,,,
Disease,Spinal muscular atrophy with respiratory distress type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24647030[PMID],1,1
Disease,Spinal muscular atrophy with respiratory distress type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24647030[PMID],0,0
Disease,Acquired cystic disease-associated renal cell carcinoma,,,,,,,,,,,,,
Histopathological subtype,Clear cell papillary renal cell carcinoma,,,,,,,,,,,,,
Disease,Chondromyxoid fibroma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24658000[PMID],50,50
Disease,Chondromyxoid fibroma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24658000[PMID],0,0
Disease,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23728897[PMID],2,2
Disease,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23728897[PMID],0,0
Disease,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24658003[PMID],3,3
Disease,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24658003[PMID],0,0
Clinical group,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome,,,,,,,,,,,,,
Malformation syndrome,Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24676357[PMID],2,2
Malformation syndrome,Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24676357[PMID],0,0
Particular clinical situation in a disease or syndrome,Central retinal vein occlusion,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medecines Agency 2014[INST],28,28
Clinical subtype,Mild phosphoribosylpyrophosphate synthetase superactivity,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Severe phosphoribosylpyrophosphate synthetase superactivity,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Wolfram-like syndrome,,,,,,,,,,,,,
Disease,Insulin autoimmune syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24111525[PMID],404,404
Disease,Insulin autoimmune syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24111525[PMID],0,0
Disease,Hereditary late-onset Parkinson disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Nephropathic infantile cystinosis,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_12110740[PMID],0,0
Clinical subtype,Nephropathic infantile cystinosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Pontocerebellar hypoplasia type 10,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24766809[PMID]_24766810[PMID],23,23
Malformation syndrome,Pontocerebellar hypoplasia type 10,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24766809[PMID]_24766810[PMID],0,0
Morphological anomaly,Williams-Campbell syndrome,,,,,,,,,,,,,
Etiological subtype,Angelman syndrome due to a point mutation,,,,,,,,,,,,,
Etiological subtype,Angelman syndrome due to imprinting defect in 15q11-q13,,,,,,,,,,,,,
Disease,Generalized eruptive keratoacanthoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25070745[PMID],40,40
Disease,Generalized eruptive keratoacanthoma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25070745[PMID],0,0
Disease,Maternal riboflavin deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21089064[PMID]_29122468[PMID],2,2
Disease,Maternal riboflavin deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21089064[PMID]_29122468[PMID],0,0
Disease,Familial isolated trichomegaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24989505[PMID],2,2
Disease,Familial isolated trichomegaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ 24989505[PMID],0,0
Malformation syndrome,Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24814191[PMID],3,3
Malformation syndrome,Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24814191[PMID],0,0
Malformation syndrome,13q12.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24664804[PMID],3,3
Malformation syndrome,13q12.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24664804[PMID],0,0
Malformation syndrome,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24768550[PMID],4,4
Malformation syndrome,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24768550[PMID],0,0
Clinical subtype,Ocular cystinosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Juvenile nephropathic cystinosis,<1 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Juvenile nephropathic cystinosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Proton-pump inhibitor-responsive esophageal eosinophilia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23567357[PMID]_25132757[PMID],0,0
Morphological anomaly,Renal agenesis,1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,24370773[PMID],0,0
Morphological anomaly,Renal agenesis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24370773[PMID],0,0
Disease,Pulmonary non-tuberculous mycobacterial infection,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],6,6
Category,Generalized isolated dystonia,,,,,,,,,,,,,
Category,Genetic syndromic esophageal malformation,,,,,,,,,,,,,
Category,Genetic hyperaldosteronism,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with developmental anomaly,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with nephropathy as a major feature,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with skin involvement,,,,,,,,,,,,,
Category,Congenital disorder of glycosylation with deafness as a major feature,,,,,,,,,,,,,
Category,Genetic neurovascular malformation,,,,,,,,,,,,,
Category,Genetic periodic paralysis,,,,,,,,,,,,,
Category,Sphingolipidosis with epilepsy,,,,,,,,,,,,,
Disease,Multicentric osteolysis-nodulosis-arthropathy spectrum,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Disease,Multicentric osteolysis-nodulosis-arthropathy spectrum,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Hypotonia-speech impairment-severe cognitive delay syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23749988[PMID]_24075186[PMID],0,0
Clinical group,Persistent combined dystonia,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Necrotizing enterocolitis,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],45,45
Malformation syndrome,Short stature-optic atrophy-Pelger-Huët anomaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20577004[PMID]_26286438[PMID]_29955634[PMID]_27789416[PMID],39,39
Malformation syndrome,Short stature-optic atrophy-Pelger-Huët anomaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20577004[PMID]_29955634[PMID]_27789416[PMID],0,0
Disease,Mucinous adenocarcinoma of the appendix,,,,,,,,,,,,,
Category,Rare genetic dystonia,,,,,,,,,,,,,
Malformation syndrome,Frontorhiny,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Transient neonatal myasthenia gravis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Juvenile myasthenia gravis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Adult-onset myasthenia gravis,1-5 / 10 000,Serbia,409966,409966,25958,25958,en,Validated,410293,410293,23363926[PMID],31.8,31.8
Clinical subtype,Adult-onset myasthenia gravis,1-9 / 100 000,Serbia,409967,409967,25958,25958,en,Validated,410293,410293,23363926[PMID],1.33,1.33
Clinical subtype,Adult-onset myasthenia gravis,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,17,17
Clinical subtype,Adult-onset myasthenia gravis,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,28,28
Clinical subtype,Adult-onset myasthenia gravis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23534974[PMID],5,5
Disease,Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23534974[PMID],0,0
Clinical subtype,Feingold syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28159702[PMID],7,7
Clinical subtype,Feingold syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28159702[PMID],0,0
Clinical subtype,Feingold syndrome type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],120,120
Clinical subtype,Feingold syndrome type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Homozygous familial hypercholesterolemia,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23956253[PMID],0.1,0.1
Disease,Homozygous familial hypercholesterolemia,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,27784735[PMID],0.22,0.22
Disease,Homozygous familial hypercholesterolemia,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,23956253[PMID],0.625,0.625
Disease,Homozygous familial hypercholesterolemia,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,24585268[PMID],0.33,0.33
Disease,Homozygous familial hypercholesterolemia,1-9 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,23662069[PMID],0.125,0.125
Particular clinical situation in a disease or syndrome,Off-periods in Parkinson disease not responding to oral treatment,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2004[INST],4.15,4.15
Disease,Glomus tumor,,,,,,,,,,,,,
Disease,Fatal post-viral neurodegenerative disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23443029[PMID],2,2
Disease,Fatal post-viral neurodegenerative disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24119684[PMID],2,2
Disease,Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,SURF1-related Charcot-Marie-Tooth disease type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24027061[PMID],3,3
Disease,SURF1-related Charcot-Marie-Tooth disease type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Growth retardation-mild developmental delay-chronic hepatitis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23908464[PMID],2,2
Disease,Growth retardation-mild developmental delay-chronic hepatitis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Intellectual disability-severe speech delay-mild dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28735298[PMID],48,48
Malformation syndrome,Intellectual disability-severe speech delay-mild dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28735298[PMID],0,0
Disease,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28776279[PMID],20,20
Disease,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28776279[PMID],0,0
Category,Disorder of asparagine metabolism,,,,,,,,,,,,,
Disease,Familial episodic pain syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Familial episodic pain syndrome with predominantly upper body involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24207120[PMID]_23115331[PMID]_20547126[PMID],21,21
Clinical subtype,Familial episodic pain syndrome with predominantly upper body involvement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Familial episodic pain syndrome with predominantly lower limb involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21698661[PMID],28,28
Clinical subtype,Familial episodic pain syndrome with predominantly lower limb involvement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary sensory and autonomic neuropathy type 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24036948[PMID]_24813307[PMID],3,3
Disease,Hereditary sensory and autonomic neuropathy type 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25053765[PMID]_26159176[PMID],8,8
Disease,Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25053765[PMID]_26159176[PMID],0,0
Disease,Atypical juvenile parkinsonism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25085748[PMID],6,6
Disease,Atypical juvenile parkinsonism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,HSD10 disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27306202[PMID]_27295195[PMID],37,37
Disease,HSD10 disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27306202[PMID]_27295195[PMID],0,0
Clinical subtype,"HSD10 disease, infantile type",,,,,,,,,,,,,
Clinical subtype,"HSD10 disease, neonatal type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22127393[PMID],3,3
Clinical subtype,"HSD10 disease, neonatal type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23956177[PMID],3,3
Malformation syndrome,Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23686771[PMID],3,3
Disease,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Susceptibility to viral and mycobacterial infections,,,,,,,,,,,,,
Disease,X-linked calvarial hyperostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24145306[PMID],1,1
Disease,X-linked calvarial hyperostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,East Texas bleeding disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23979162[PMID]_25634741[PMID],19,19
Disease,East Texas bleeding disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25634741[PMID],0,0
Disease,X-linked osteoporosis with fractures,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24088043[PMID]_24616189[PMID]_25209159[PMID],8,8
Disease,X-linked osteoporosis with fractures,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24088043[PMID]_24616189[PMID]_25209159[PMID],0,0
Disease,Refractory celiac disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23609613[PMID],0,0
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22119351[PMID]_RARECARE Surveillance of Rare Cancers in Europe 2003[REG],0.57,0.57
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.612,0.612
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.491,0.491
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.605,0.605
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.516,0.516
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.423,0.423
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.684,0.684
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.6,0.6
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.426,0.426
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.638,0.638
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.682,0.682
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.475,0.475
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.606,0.606
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.552,0.552
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.517,0.517
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.628,0.628
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.744,0.744
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.396,0.396
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.745,0.745
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.499,0.499
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.45,0.45
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.791,0.791
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.597,0.597
Disease,Squamous cell carcinoma of the penis,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.691,0.691
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22119351[PMID]_RARECARE Surveillance of Rare Cancers in Europe 2003[REG],0,0
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.025,0.025
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Adenocarcinoma of the penis,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Category,Malignant tumor of penis,1-9 / 100 000,Brazil,409967,409967,25958,25958,en,Validated,410293,410293,26076979[PMID]_18986562[PMID],4.85,4.85
Category,Malignant tumor of penis,1-9 / 100 000,Uganda,409967,409967,25958,25958,en,Validated,410293,410293,26076979[PMID]_10789729[PMID],3.5,3.5
Category,Malignant tumor of penis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,26076979[PMID]_IARC International Agency for research on cancer 2002[INST],1.075,1.075
Category,Malignant tumor of penis,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,26076979[PMID]_24101363[PMID],1.21,1.21
Category,Malignant tumor of penis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,26076979[PMID]_17826651[PMID],0.58,0.58
Disease,Intellectual disability-obesity-prognathism-eye and skin anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11746007[PMID],2,2
Disease,Intellectual disability-obesity-prognathism-eye and skin anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11746007[PMID],0,0
Disease,Charcot-Marie-Tooth disease type 2R,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23562820[PMID],1,1
Disease,Charcot-Marie-Tooth disease type 2R,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23562820[PMID],0,0
Disease,Combined immunodeficiency due to MALT1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23727036[PMID]_24332264[PMID],3,3
Disease,Combined immunodeficiency due to MALT1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23727036[PMID]_24332264[PMID],0,0
Disease,TCR-alpha-beta-positive T-cell deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21206088[PMID],2,2
Disease,TCR-alpha-beta-positive T-cell deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21206088[PMID],0,0
Disease,Microcephaly-thin corpus callosum-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24084144[PMID],4,4
Disease,Microcephaly-thin corpus callosum-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24084144[PMID],0,0
Disease,Autosomal spastic paraplegia type 58,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24482476[PMID]_24319291[PMID]_24482476[PMID]_24808017[PMID],19,19
Disease,Autosomal spastic paraplegia type 58,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24482476[PMID],0,0
Disease,MAN1B1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21763484[PMID]_24348268[PMID]_26307094[PMID],25,25
Disease,MAN1B1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21763484[PMID]_24348268[PMID]_26307094[PMID],0,0
Disease,Polyglucosan body myopathy type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23798481[PMID],11,11
Disease,Polyglucosan body myopathy type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23798481[PMID],0,0
Disease,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23674175[PMID],3,3
Disease,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23674175[PMID],0,0
Malformation syndrome,Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24369075[PMID],4,4
Malformation syndrome,Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24369075[PMID],0,0
Disease,Ferro-cerebro-cutaneous syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24259288[PMID],3,3
Disease,Ferro-cerebro-cutaneous syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24259288[PMID],0,0
Disease,Severe combined immunodeficiency due to IKK2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25139357[PMID],9,9
Disease,Severe combined immunodeficiency due to IKK2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25139357[PMID],0,0
Clinical group,T+ B+ severe combined immunodeficiency,,,,,,,,,,,,,
Disease,Periodic paralysis with transient compartment-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24240197[PMID],4,4
Disease,Periodic paralysis with transient compartment-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24240197[PMID],0,0
Disease,Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24026677[PMID],14,14
Disease,Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24026677[PMID],0,0
Disease,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21480433[PMID],15,15
Disease,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21480433[PMID],0,0
Disease,Periodic paralysis with later-onset distal motor neuropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24153443[PMID],9,9
Disease,Periodic paralysis with later-onset distal motor neuropathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24153443[PMID],0,0
Disease,COASY protein-associated neurodegeneration,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24360804[PMID],2,2
Disease,COASY protein-associated neurodegeneration,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24360804[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2U,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23729695[PMID],2,2
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2U,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23729695[PMID],0,0
Malformation syndrome,Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27913285[PMID],0,0
Malformation syndrome,Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27913285[PMID],30,30
Malformation syndrome,Joubert syndrome with Jeune asphyxiating thoracic dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24360808[PMID]_20503315[PMID],8,8
Malformation syndrome,Joubert syndrome with Jeune asphyxiating thoracic dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24360808[PMID]_20503315[PMID],0,0
Disease,Hereditary isolated aplastic anemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,3q27.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24133203[PMID],7,7
Disease,3q27.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24133203[PMID],0,0
Malformation syndrome,Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24290375[PMID],4,4
Malformation syndrome,Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24290375[PMID],0,0
Disease,Familial hyperprolactinemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Obesity due to CEP19 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24268657[PMID],15,15
Etiological subtype,Obesity due to CEP19 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24268657[PMID],0,0
Disease,Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24290379[PMID],7,7
Disease,Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24290379[PMID],0,0
Disease,Activated PI3K-delta syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24136356[PMID],18,18
Disease,Activated PI3K-delta syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24136356[PMID],0,0
Disease,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23814038[PMID]_24498631[PMID],5,5
Disease,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23814038[PMID]_24498631[PMID],0,0
Malformation syndrome,Macrocephaly-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24239382[PMID],9,9
Malformation syndrome,Macrocephaly-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24239382[PMID],0,0
Disease,PrP systemic amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25623792[PMID],0,0
Disease,PrP systemic amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25623792[PMID],16,16
Etiological subtype,Silver-Russell syndrome due to a point mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24065356[PMID],8,8
Etiological subtype,Silver-Russell syndrome due to a point mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24065356[PMID],0,0
Disease,Deep dermatophytosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Multiple acyl-CoA dehydrogenase deficiency, mild type",,,,,,,,,,,,,
Clinical subtype,"Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",,,,,,,,,,,,,
Category,Rare female infertility due to a congenital hypogonadotropic hypogonadism,,,,,,,,,,,,,
Category,Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder,,,,,,,,,,,,,
Category,Rare disorder with obstructive azoospermia,,,,,,,,,,,,,
Category,Male infertility due to sperm motility disorder,,,,,,,,,,,,,
Category,Rare female infertility due to an anomaly of ovarian function,,,,,,,,,,,,,
Category,Rare female infertility due to an adrenal disorder,,,,,,,,,,,,,
Category,Rare disorder with female infertility due to a congenital hypogonadotropic hypogonadism,,,,,,,,,,,,,
Category,Male infertility due to sperm disorder,,,,,,,,,,,,,
Category,Male infertility due to gonadal dysgenesis or sperm disorder,,,,,,,,,,,,,
Category,Rare male infertility due to testicular endocrine disorder,,,,,,,,,,,,,
Category,Rare male infertility due to adrenal disorder,,,,,,,,,,,,,
Disease,Male infertility with teratozoospermia due to single gene mutation,,,,,,,,,,,,,
Disease,Male infertility with azoospermia or oligozoospermia due to single gene mutation,,,,,,,,,,,,,
Category,Male infertility with spermatogenesis disorder due to single gene mutation,,,,,,,,,,,,,
Category,Male infertility with spermatogenesis disorder,,,,,,,,,,,,,
Disease,Epiphysiolysis of the hip,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Osteochondrosis of genetic origin,,,,,,,,,,,,,
Category,Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder,,,,,,,,,,,,,
Category,Osteonecrosis of genetic origin,,,,,,,,,,,,,
Category,Avascular necrosis of genetic origin,,,,,,,,,,,,,
Disease,Secondary non-traumatic avascular necrosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare hereditary disease with avascular necrosis,,,,,,,,,,,,,
Category,Secondary avascular necrosis,,,,,,,,,,,,,
Disease,Traumatic avascular necrosis,,,,,,,,,,,,,
Disease,Idiopathic avascular necrosis,,,,,,,,,,,,,
Category,Osteochondrosis,,,,,,,,,,,,,
Disease,Osteonecrosis of the jaw,,,,,,,,,,,,,
Clinical group,Primary avascular necrosis,,,,,,,,,,,,,
Disease,Alpha-B crystallin-related late-onset myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21920752[PMID]_9731540[PMID]_14681890[PMID]_20171888[PMID],17,17
Disease,Alpha-B crystallin-related late-onset myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21920752[PMID]_9731540[PMID]_14681890[PMID]_20171888[PMID],0,0
Disease,Malignant teratoma of ovary,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.07,0.07
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.051,0.051
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.052,0.052
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.056,0.056
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.034,0.034
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.074,0.074
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.053,0.053
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.042,0.042
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.052,0.052
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.084,0.084
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.048,0.048
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.075,0.075
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.063,0.063
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.084,0.084
Disease,Malignant teratoma of ovary,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.082,0.082
Disease,Malignant teratoma of ovary,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.056,0.056
Disease,Finnish upper limb-onset distal myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12847162[PMID],0,0
Disease,Finnish upper limb-onset distal myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12847162[PMID],7,7
Disease,KLHL9-related early-onset distal myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20554658[PMID],10,10
Disease,KLHL9-related early-onset distal myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20554658[PMID],0,0
Disease,Distal nebulin myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29070751[PMID]_25205138[PMID],13,13
Disease,Distal nebulin myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29070751[PMID]_25205138[PMID],0,0
Disease,Distal anoctaminopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9673985[PMID]_17132147[PMID]_22402862[PMID]_25864073[PMID]_23663589[PMID]_23606453[PMID],24,24
Disease,Distal anoctaminopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9673985[PMID]_25864073[PMID],0,0
Category,Avascular necrosis,,,,,,,,,,,,,
Category,Osteonecrosis,,,,,,,,,,,,,
Category,Malignant epithelial tumor of ovary,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],9.39,9.39
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.85,0.85
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.497,0.497
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.883,0.883
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.815,0.815
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.995,0.995
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.666,0.666
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.469,0.469
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.706,0.706
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.666,0.666
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.503,0.503
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.567,0.567
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.717,0.717
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.665,0.665
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.49,0.49
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.945,0.945
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.601,0.601
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.695,0.695
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.563,0.563
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.76,0.76
Disease,Mucinous adenocarcinoma of ovary,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.815,0.815
Disease,Mucinous adenocarcinoma of ovary,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.154,1.154
Disease,Mucinous adenocarcinoma of ovary,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.108,1.108
Disease,Mucinous adenocarcinoma of ovary,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.062,1.062
Disease,Mucinous adenocarcinoma of ovary,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.162,1.162
Category,Malignant non-epithelial tumor of ovary,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.43,0.43
Disease,Primary peritoneal serous/papillary carcinoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,19124490[PMID],0.678,0.678
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.32,0.32
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.112,0.112
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.361,0.361
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.201,0.201
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.147,0.147
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.165,0.165
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.24,0.24
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.359,0.359
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.182,0.182
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.383,0.383
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.395,0.395
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.227,0.227
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.162,0.162
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.166,0.166
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.534,0.534
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.425,0.425
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.118,0.118
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.119,0.119
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.273,0.273
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.388,0.388
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.343,0.343
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.282,0.282
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.342,0.342
Disease,Clear cell adenocarcinoma of the ovary,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.451,0.451
Disease,Neonatal lupus erythematosus,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,9061661[PMID],5,5
Disease,Neonatal scleroderma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16887444[PMID],6,6
Disease,Neonatal scleroderma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16887444[PMID],0,0
Disease,Persistent idiopathic facial pain,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Persistent idiopathic facial pain,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,19783099[PMID],4.4,4.4
Disease,Persistent idiopathic facial pain,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,12911872[PMID],1,1
Disease,Persistent idiopathic facial pain,1-5 / 10 000,Germany,409969,409969,25958,25958,en,Validated,410293,410293,21960648[PMID],30,30
Malformation syndrome,Oculoauriculofrontonasal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23637006[PMID],41,41
Malformation syndrome,Oculoauriculofrontonasal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23637006[PMID],0,0
Malformation syndrome,Focal facial dermal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21931173[PMID],0,0
Malformation syndrome,Focal facial dermal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21931173[PMID],147,147
Clinical subtype,Focal facial dermal dysplasia type II,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21931173[PMID],22,22
Clinical subtype,Focal facial dermal dysplasia type II,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21931173[PMID],0,0
Clinical subtype,Focal facial dermal dysplasia type IV,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23161670[PMID],21,21
Clinical subtype,Focal facial dermal dysplasia type IV,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23161670[PMID],0,0
Disease,MAGEL2-related Prader-Willi-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27195816[PMID],28,28
Disease,MAGEL2-related Prader-Willi-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27195816[PMID],0,0
Clinical group,Prader-Willi-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24737477[PMID],117,117
Clinical group,Prader-Willi-like syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24737477[PMID],0,0
Disease,SIM1-related Prader-Willi-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23778136[PMID],4,4
Disease,SIM1-related Prader-Willi-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23778136[PMID],0,0
Disease,Hereditary cryohydrocytosis with normal stomatin,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16227998[PMID],53,53
Disease,Hereditary cryohydrocytosis with normal stomatin,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16227998[PMID],0,0
Category,Secondary neonatal autoimmune disease,,,,,,,,,,,,,
Disease,Neonatal antiphospholipid syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24830792[PMID],34,34
Disease,Neonatal antiphospholipid syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24830792[PMID],0,0
Disease,Neonatal autoimmune hemolytic anemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12819171[PMID],2,2
Disease,Neonatal autoimmune hemolytic anemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12819171[PMID],0,0
Disease,Neonatal dermatomyositis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3508696[PMID]_8888050[PMID]_3508696[PMID],3,3
Disease,Neonatal dermatomyositis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3508696[PMID]_8888050[PMID]_3508696[PMID],0,0
Category,Genetic precocious puberty in female,,,,,,,,,,,,,
Category,Precocious puberty in female,,,,,,,,,,,,,
Category,Genetic precocious puberty,,,,,,,,,,,,,
Category,Genetic larynx anomaly,,,,,,,,,,,,,
Category,Genetic nose and cavum anomaly,,,,,,,,,,,,,
Category,Genetic otorhinolaryngological malformation,,,,,,,,,,,,,
Malformation syndrome,Keppen-Lubinsky syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25620207[PMID],3,3
Malformation syndrome,Keppen-Lubinsky syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25620207[PMID],0,0
Category,Genetic tracheal anomaly,,,,,,,,,,,,,
Category,Congenital urachal anomaly,,,,,,,,,,,,,
Disease,LIPE-related familial partial lipodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24848981[PMID]_27862896[PMID],4,4
Disease,LIPE-related familial partial lipodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24848981[PMID]_27862896[PMID],0,0
Disease,CIDEC-related familial partial lipodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20049731[PMID],0,0
Disease,CIDEC-related familial partial lipodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20049731[PMID],1,1
Malformation syndrome,3p25.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25256099[PMID],8,8
Malformation syndrome,3p25.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25256099[PMID],0,0
Disease,Short stature-advanced bone age-early-onset osteoarthritis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24762113[PMID],3,3
Disease,Short stature-advanced bone age-early-onset osteoarthritis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24762113[PMID],0,0
Malformation syndrome,Lethal neonatal spasticity-epileptic encephalopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25500575[PMID],8,8
Malformation syndrome,Lethal neonatal spasticity-epileptic encephalopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25500575[PMID],0,0
Disease,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24702266[PMID],3,3
Disease,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24702266[PMID],0,0
Category,Rare disease with disability,,,,,,,,,,,,,
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25098539[PMID],2,2
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25098539[PMID],0,0
Disease,Progeroid features-hepatocellular carcinoma predisposition syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25261934[PMID],3,3
Disease,Progeroid features-hepatocellular carcinoma predisposition syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25261934[PMID],0,0
Disease,Chronic atrial and intestinal dysrhythmia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25282101[PMID],17,17
Disease,Chronic atrial and intestinal dysrhythmia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25282101[PMID],0,0
Disease,COG2-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24784932[PMID],1,1
Disease,COG2-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24784932[PMID],0,0
Malformation syndrome,X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25316788[PMID],3,3
Malformation syndrome,X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25316788[PMID],0,0
Malformation syndrome,Severe intellectual disability-hypotonia-strabismus-coarse face-planovalgus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25078763[PMID],6,6
Malformation syndrome,Severe intellectual disability-hypotonia-strabismus-coarse face-planovalgus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25078763[PMID],0,0
Disease,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25057881[PMID],15,15
Disease,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25057881[PMID],0,0
Disease,Autosomal recessive intermediate Charcot-Marie-Tooth disease type D,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25152455[PMID]_26302975[PMID],4,4
Disease,Autosomal recessive intermediate Charcot-Marie-Tooth disease type D,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25152455[PMID]_26302975[PMID],0,0
Malformation syndrome,Contractures-developmental delay-Pierre Robin syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25195018[PMID],6,6
Malformation syndrome,Contractures-developmental delay-Pierre Robin syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25195018[PMID],0,0
Disease,Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25213377[PMID]_25329329[PMID],17,17
Disease,Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25213377[PMID]_25329329[PMID],0,0
Disease,Intellectual disability-expressive aphasia-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25217958[PMID],13,13
Disease,Intellectual disability-expressive aphasia-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25217958[PMID],0,0
Disease,Thrombomodulin-related bleeding disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25049278[PMID]_25564403[PMID],15,15
Disease,Thrombomodulin-related bleeding disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25049278[PMID]_25564403[PMID],0,0
Disease,Periodic fever-infantile enterocolitis-autoinflammatory syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25217959[PMID]_25217960[PMID],4,4
Disease,Periodic fever-infantile enterocolitis-autoinflammatory syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25217959[PMID]_25217960[PMID],0,0
Malformation syndrome,Microcephalic primordial dwarfism-insulin resistance syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25105364 [PMID],2,2
Malformation syndrome,Microcephalic primordial dwarfism-insulin resistance syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25105364[PMID],0,0
Disease,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25130867[PMID],3,3
Disease,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25130867[PMID],0,0
Disease,Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24916380[PMID],3,3
Disease,Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24916380[PMID],0,0
Disease,Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24925317[PMID],7,7
Disease,Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24925317[PMID],0,0
Disease,Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy,,,,,,,,,,,,,
Disease,Combined immunodeficiency-enteropathy spectrum,,,,,,,,,,,,,
Disease,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24739904[PMID],13,13
Disease,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24739904[PMID],0,0
Disease,Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23006327[PMID],3,3
Disease,Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23006327[PMID],0,0
Disease,MYH7-related late-onset scapuloperoneal muscular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7487558[PMID]_1202162[PMID]_17336526[PMID],12,12
Disease,MYH7-related late-onset scapuloperoneal muscular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7487558[PMID]_1202162[PMID]_17336526[PMID],0,0
Disease,Fatty acyl-CoA reductase 1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25439727[PMID],3,3
Disease,Fatty acyl-CoA reductase 1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25439727[PMID],0,0
Disease,STAT3-related early-onset multisystem autoimmune disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26574998[PMID],19,19
Disease,STAT3-related early-onset multisystem autoimmune disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26574998[PMID],0,0
Disease,PCNA-related progressive neurodegenerative photosensitivity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24911150[PMID],4,4
Disease,PCNA-related progressive neurodegenerative photosensitivity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24911150[PMID],0,0
Disease,Steel syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8423186[PMID]_20357596[PMID]_24986830[PMID],40,40
Disease,Steel syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8423186[PMID]_20357596[PMID]_24986830[PMID],0,0
Disease,RARS-related autosomal recessive hypomyelinating leukodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24777941[PMID],4,4
Disease,RARS-related autosomal recessive hypomyelinating leukodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24777941[PMID],0,0
Disease,Ketoacidosis due to monocarboxylate transporter-1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25390740[PMID],9,9
Disease,Ketoacidosis due to monocarboxylate transporter-1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25390740[PMID],0,0
Category,Disorder of keton body transport,,,,,,,,,,,,,
Disease,Human infection by orthopoxvirus,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2010[INST],0,0
Disease,GCGR-related hyperglucagonemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25914784[PMID],8,8
Disease,GCGR-related hyperglucagonemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25914784[PMID],0,0
Clinical subtype,Progressive encephalomyelitis with rigidity and myoclonus,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25533962[PMID]_DOI: 10.1101/mcs.a000356[OTHER],24,24
Etiological subtype,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25533962[PMID]_DOI: 10.1101/mcs.a000356[OTHER],0,0
Disease,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27148565[PMID]_25533962[PMID],24,24
Disease,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27148565[PMID]_25533962[PMID],0,0
Disease,Severe autosomal recessive macrothrombocytopenia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25061177[PMID],2,2
Disease,Severe autosomal recessive macrothrombocytopenia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25061177[PMID],0,0
Disease,ALECT2 amyloidosis,,,,,,,,,,,,,
Disease,AApoAIV amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11467836[PMID]_21900878[PMID],2,2
Disease,AApoAIV amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11467836[PMID]_21900878[PMID],0,0
Disease,Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29128256[PMID],13,13
Disease,Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29128256[PMID],0,0
Disease,KCNQ2-related epileptic encephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20437616[PMID],11,11
Disease,KCNQ2-related epileptic encephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20437616[PMID],0,0
Particular clinical situation in a disease or syndrome,Zinc-responsive necrolytic acral erythema,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Non-recovering obstetric brachial plexus lesion,,,,,,,,,,,,,
Clinical syndrome,Placental insufficiency,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],33,33
Clinical syndrome,Pediatric arterial ischemic stroke,,,,,,,,,,,,,
Clinical subtype,Systemic polyarteritis nodosa,,,,,,,,,,,,,
Malformation syndrome,PDE4D haploinsufficiency syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24203977[PMID]_21594994[PMID],7,7
Malformation syndrome,PDE4D haploinsufficiency syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24203977[PMID]_21594994[PMID],0,0
Clinical subtype,Secondary polyarteritis nodosa,,,,,,,,,,,,,
Clinical subtype,Single-organ polyarteritis nodosa,,,,,,,,,,,,,
Clinical subtype,Cutaneous polyarteritis nodosa,,,,,,,,,,,,,
Clinical subtype,Primary polyarteritis nodosa,,,,,,,,,,,,,
Clinical group,ABeta2M amyloidosis,,,,,,,,,,,,,
Disease,ITM2B amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24473189[PMID],2,2
Disease,ITM2B amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24473189[PMID],0,0
Disease,Congenital oculomotor nerve palsy,,,,,,,,,,,,,
Disease,Congenital abducens nerve palsy,,,,,,,,,,,,,
Disease,Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10368461[PMID]_15877279[PMID],10,10
Disease,Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10368461[PMID]_15877279[PMID],0,0
Category,Autosomal recessive severe congenital neutropenia,,,,,,,,,,,,,
Malformation syndrome,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24128419[PMID],2,2
Malformation syndrome,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24128419[PMID],0,0
Particular clinical situation in a disease or syndrome,Plastic bronchitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Interstitial lung disease due to ABCA3 deficiency,,,,,,,,,,,,,
Malformation syndrome,Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25091507[PMID],0,0
Malformation syndrome,Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25091507[PMID],1,1
Disease,Interstitial lung disease due to SP-C deficiency,,,,,,,,,,,,,
Disease,Necrotizing soft tissue infection,,,,,,,,,,,,,
Disease,Isolated sedoheptulokinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25647543[PMID],2,2
Disease,Isolated sedoheptulokinase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25647543[PMID],0,0
Disease,Extensive peripapillary myelinated nerve fibers,,,,,,,,,,,,,
Disease,Combined hamartoma of the retina and retinal pigment epithelium,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23960997[PMID],120,120
Disease,Combined hamartoma of the retina and retinal pigment epithelium,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23960997[PMID],0,0
Biological anomaly,L-ferritin deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23940258[PMID]_15173247[PMID],2,2
Biological anomaly,L-ferritin deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23940258[PMID]_15173247[PMID],0,0
Disease,Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency,,,,,,,,,,,,,
Disease,Familial colorectal cancer Type X,,,,,,,,,,,,,
Category,Disorders of pentose/polyol metabolism,,,,,,,,,,,,,
Disease,Ribose-5-P isomerase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14988808[PMID],1,1
Disease,Ribose-5-P isomerase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14988808[PMID],0,0
Category,Syndromic hereditary optic neuropathy,,,,,,,,,,,,,
Clinical subtype,Early-onset posterior subcapsular cataract,,,,,,,,,,,,,
Clinical subtype,Early-onset lamellar cataract,,,,,,,,,,,,,
Morphological anomaly,Isolated agenesis of gallbladder,,,,,,,,,,,,,
Clinical subtype,Sporadic porphyria cutanea tarda,,,,,,,,,,,,,
Clinical subtype,Familial porphyria cutanea tarda,,,,,,,,,,,,,
Disease,Central serous chorioretinopathy,,,,,,,,,,,,,
Clinical syndrome,Baroreflex failure,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hemicrania continua,,,,,,,,,,,,,
Disease,Charcot-Marie-Tooth disease type 2S,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28065684[PMID]_28202949[PMID],35,35
Disease,Charcot-Marie-Tooth disease type 2S,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28065684[PMID]_28202949[PMID],0,0
Disease,Undetermined early-onset epileptic encephalopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,AH amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20876678[PMID]_23302715[PMID]_23446254[PMID],12,12
Disease,AH amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20876678[PMID]_23302715[PMID]_23446254[PMID],0,0
Category,Disorder of plasmalogens biosynthesis,,,,,,,,,,,,,
Disease,X-linked erythropoietic protoporphyria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24131146[PMID],50,50
Disease,X-linked erythropoietic protoporphyria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24131146[PMID],0,0
Disease,Pyruvate carboxylase deficiency,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:79130356[OTHER],0.4,0.4
Disease,Pyruvate carboxylase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Classic stiff person syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Centronuclear myopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Spontaneous intracranial hypotension,,,,,,,,,,,,,
Disease,Postpartum psychosis,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,HIV-associated cancer,,,,,,,,,,,,,
Disease,Mitochondrial neurogastrointestinal encephalomyopathy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],0.1,0.1
Disease,Chronic hiccup,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Category,ACTH-independent Cushing syndrome due to rare cortisol-producing adrenal tumor,,,,,,,,,,,,,
Disease,Postural orthostatic tachycardia syndrome due to NET deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10684912[PMID],2,2
Disease,Postural orthostatic tachycardia syndrome due to NET deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10684912[PMID],0,0
Disease,MODY,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,MODY,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,20499044[PMID],10,10
Clinical syndrome,Primitive portal vein thrombosis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Paratyphoid fever,,,,,,,,,,,,,
Disease,Hyperostosis cranialis interna,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20140965[PMID],13,13
Disease,Hyperostosis cranialis interna,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20140965[PMID],0,0
Category,Hyperinsulinemic hypoglycaemia,,,,,,,,,,,,,
Category,"46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect",,,,,,,,,,,,,
Disease,"46,XY disorder of sex development due to testicular 17,20-desmolase deficiency",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21802064[PMID],2,2
Disease,"46,XY disorder of sex development due to testicular 17,20-desmolase deficiency",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21802064[PMID],0,0
Disease,NUT midline carcinoma,,,,,,,,,,,,,
Disease,Brugada syndrome,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,20,20
Disease,Brugada syndrome,6-9 / 10 000,South East Asia,409966,409966,25965,25965,en,Not yet validated,410294,410294,15898165[PMID]_23916535[PMID],75,75
Disease,Severe combined immunodeficiency due to adenosine deaminase deficiency,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,20301656[PMID]_ ORPHANET_[EXPERT],0.3,0.3
Disease,Severe combined immunodeficiency due to adenosine deaminase deficiency,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],0.2,0.2
Malformation syndrome,NDE1-related microhydranencephaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22526350[PMID],1,1
Malformation syndrome,NDE1-related microhydranencephaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22526350[PMID],0,0
Disease,Lymphoplasmacytic lymphoma without IgM production,,,,,,,,,,,,,
Disease,Hypothalamic adipsic hypernatraemia syndrome,,,,,,,,,,,,,
Clinical subtype,Focal stiff limb syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Focal stiff limb syndrome,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,PGM3-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24698316[PMID]_24589341[PMID]_24931394[PMID],20,20
Disease,PGM3-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24698316[PMID]_24589341[PMID]_24931394[PMID],0,0
Clinical group,Hereditary nonpolyposis colon cancer,,,,,,,,,,,,,
Disease,DNAJB2-related Charcot-Marie-Tooth disease type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25274842[PMID],2,2
Disease,DNAJB2-related Charcot-Marie-Tooth disease type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25274842[PMID],0,0
Disease,Ventriculomegaly-cystic kidney disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25557780[PMID]_2478019[PMID],11,11
Disease,Ventriculomegaly-cystic kidney disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25557780[PMID]_2478019[PMID],0,0
Disease,Autoimmune interstitial lung disease-arthritis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25894502[PMID],5,5
Disease,Autoimmune interstitial lung disease-arthritis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25894502[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 73,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25751282[PMID],1,1
Disease,Autosomal dominant spastic paraplegia type 73,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25751282[PMID],0,0
Category,Hereditary amyloidosis,,,,,,,,,,,,,
Disease,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25683118[PMID],4,4
Disease,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25683118[PMID],0,0
Malformation syndrome,11q22.2q22.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25735893[PMID],5,5
Malformation syndrome,11q22.2q22.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25735893[PMID],0,0
Malformation syndrome,Mandibulofacial dysostosis with alopecia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25772936[PMID],4,4
Malformation syndrome,Mandibulofacial dysostosis with alopecia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25772936[PMID],0,0
Disease,"46,XX ovarian dysgenesis-short stature syndrome",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25480036[PMID],3,3
Disease,"46,XX ovarian dysgenesis-short stature syndrome",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25480036[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 23,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25434004[PMID],11,11
Disease,Combined oxidative phosphorylation defect type 23,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25434004[PMID],0,0
Malformation syndrome,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25564561[PMID],4,4
Malformation syndrome,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25564561[PMID],0,0
Malformation syndrome,20q11.2 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25572454[PMID],11,11
Malformation syndrome,20q11.2 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25572454[PMID],0,0
Malformation syndrome,Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,31058441[PMID],11,11
Malformation syndrome,Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_31058441[PMID],0,0
Malformation syndrome,Cerebellar-facial-dental syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25561519[PMID],3,3
Malformation syndrome,Cerebellar-facial-dental syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25561519[PMID],0,0
Disease,Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25414442[PMID]_25525876[PMID],6,6
Disease,Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25414442[PMID]_25525876[PMID],0,0
Disease,Familial chylomicronemia syndrome,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,15758547[PMID],0.1,0.1
Disease,Familial chylomicronemia syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],0.97,0.97
Disease,Idiopathic phalangeal acro-osteolysis,,,,,,,,,,,,,
Disease,Combined oxidative phosphorylation defect type 24,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25629079[PMID]_25385316[PMID],3,3
Disease,Combined oxidative phosphorylation defect type 24,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25629079[PMID]_25385316[PMID],0,0
Disease,Limb-girdle muscular dystrophy due to POMK deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24925318[PMID],2,2
Disease,Limb-girdle muscular dystrophy due to POMK deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24925318[PMID],0,0
Disease,Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25466870[PMID],5,5
Disease,Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25466870[PMID],0,0
Disease,3-methylglutaconic aciduria type 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25650066[PMID]_25597511[PMID]_25597510[PMID],22,22
Disease,3-methylglutaconic aciduria type 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25650066[PMID]_25597511[PMID]_25597510[PMID],0,0
Disease,Combined immunodeficiency due to LRBA deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22721650[PMID]_22981790[PMID]_25468195[PMID]_26206937[PMID]_22608502[PMID],23,23
Disease,Combined immunodeficiency due to LRBA deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22721650[PMID]_22981790[PMID]_25468195[PMID]_26206937[PMID]_22608502[PMID],0,0
Clinical group,Caudal regression-sirenomelia spectrum,,,,,,,,,,,,,
Clinical group,Pseudohypoaldosteronism,,,,,,,,,,,,,
Disease,NIK deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25406581[PMID],2,2
Disease,NIK deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25406581[PMID],0,0
Disease,DOCK2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26083206[PMID],5,5
Disease,DOCK2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26083206[PMID],0,0
Disease,Susceptibility to localized juvenile periodontitis,,,,,,,,,,,,,
Category,Secondary vasculitis,,,,,,,,,,,,,
Clinical syndrome,Idiopathic dropped head syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Polymerase proofreading-related adenomatous polyposis,,,,,,,,,,,,,
Clinical subtype,Tremor-ataxia-central hypomyelination syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20640464[PMID]_22384513[PMID],7,7
Clinical subtype,Tremor-ataxia-central hypomyelination syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20640464[PMID],0,0
Clinical subtype,Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18851904[PMID]_22036171[PMID],4,4
Clinical subtype,Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18851904[PMID]_22036171[PMID],0,0
Disease,Hemochromatosis type 5,,,,,,,,,,,,,
Clinical syndrome,Cerebral visual impairment,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Biological anomaly without phenotypic characterization,,,,,,,,,,,,,
Biological anomaly,Lipoyl transferase 2 deficiency,Not yet documented,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Secondary sclerosing cholangitis,,,,,,,,,,,,,
Clinical group,Sclerosing cholangitis,,,,,,,,,,,,,
Disease,Mitochondrial pyruvate carrier deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22628558[PMID]_12649063[PMID],4,4
Disease,Mitochondrial pyruvate carrier deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22628558[PMID]_12649063[PMID],0,0
Disease,Keratocystic odontogenic tumor,,,,,,,,,,,,,
Disease,Autosomal dominant spastic paraplegia type 9B,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26026163[PMID],3,3
Disease,Autosomal dominant spastic paraplegia type 9B,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26026163[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 9A,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8779323[PMID]_9973297[PMID],2,2
Disease,Autosomal dominant spastic paraplegia type 9A,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8779323[PMID]_9973297[PMID],0,0
Disease,IgG4-related sclerosing cholangitis,,,,,,,,,,,,,
Disease,Autosomal recessive spastic paraplegia type 9B,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26026163[PMID],2,2
Disease,Autosomal recessive spastic paraplegia type 9B,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26026163[PMID],0,0
Particular clinical situation in a disease or syndrome,Antidepressant or antipsychotic toxicity or dose selection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Vitamin K antagonists toxicity or dose selection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Oral antidiabetic drugs toxicity or dose selection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Resistance to vitamin K antagonists,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Azathioprine or 6-mercatopurine toxicity or dose selection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Curariform drugs toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Statin toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,PRKAR1B-related neurodegenerative dementia with intermediate filaments,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24722252[PMID]_25108559[PMID],12,12
Disease,PRKAR1B-related neurodegenerative dementia with intermediate filaments,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24722252[PMID]_25108559[PMID],0,0
Disease,Autosomal recessive cerebellar ataxia due to STUB1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24312598[PMID]_24742043[PMID]_25258038[PMID]_25592071[PMID]_24719489[PMID],10,10
Disease,Autosomal recessive cerebellar ataxia due to STUB1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24312598[PMID]_24742043[PMID]_25258038[PMID]_25592071[PMID]_24719489[PMID],0,0
Disease,Epidermolysis bullosa simplex due to BP230 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20164846[PMID]_22113475[PMID]_24690439[PMID],2,2
Disease,Epidermolysis bullosa simplex due to BP230 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20164846[PMID]_22113475[PMID]_24690439[PMID],0,0
Malformation syndrome,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24791903[PMID],4,4
Malformation syndrome,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24791903[PMID],0,0
Disease,Epidermolysis bullosa simplex due to exophilin 5 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24690439[PMID]_23176819[PMID],3,3
Disease,Epidermolysis bullosa simplex due to exophilin 5 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24690439[PMID]_23176819[PMID],0,0
Disease,Dystonia-aphonia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24359844[PMID]_26924602[PMID],32,32
Disease,Dystonia-aphonia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26924602[PMID],0,0
Disease,Primary failure of tooth eruption,,,,,,,,,,,,,
Disease,Squamous cell carcinoma of the stomach,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.115,0.115
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.063,0.063
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.025,0.025
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.08,0.08
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.034,0.034
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.092,0.092
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.176,0.176
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.065,0.065
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.08,0.08
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.079,0.079
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.207,0.207
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.1,0.1
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.401,0.401
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.137,0.137
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.046,0.046
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.04,0.04
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.115,0.115
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.111,0.111
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.1,0.1
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.128,0.128
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.051,0.051
Disease,Squamous cell carcinoma of the stomach,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.053,0.053
Disease,Squamous cell carcinoma of the stomach,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.18,0.18
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.007,0.007
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,"Carcinoma of esophagus, salivary gland type",<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.044,0.044
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.029,0.029
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.077,0.077
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Undifferentiated carcinoma of esophagus,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.115,0.115
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Undifferentiated carcinoma of esophagus,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.118,0.118
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.042,0.042
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.085,0.085
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.041,0.041
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.087,0.087
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.021,0.021
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.038,0.038
Disease,Undifferentiated carcinoma of esophagus,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.101,0.101
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.021,0.021
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.082,0.082
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.051,0.051
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.023,0.023
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.025,0.025
Disease,Undifferentiated carcinoma of esophagus,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Secondary pulmonary alveolar proteinosis,,,,,,,,,,,,,
Malformation syndrome,Malan overgrowth syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25118028[PMID],20,20
Malformation syndrome,Malan overgrowth syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25118028[PMID],0,0
Category,Genetic facial cleft,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Phenytoin or carbamazepine toxicity,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Bilirubin encephalopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,15254556[PMID],0,0
Category,Rare genetic odontal or periodontal disorder,,,,,,,,,,,,,
Disease,Autoimmune encephalopathy with parasomnia and obstructive sleep apnea,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2623676[PMID],10,10
Disease,Autoimmune encephalopathy with parasomnia and obstructive sleep apnea,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2623676[PMID],0,0
Malformation syndrome,Cono-spondylar dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24975242[PMID],3,3
Malformation syndrome,Cono-spondylar dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24975242[PMID],0,0
Disease,Autosomal recessive severe congenital neutropenia due to CSF3R deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24753537[PMID],4,4
Disease,Autosomal recessive severe congenital neutropenia due to CSF3R deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24753537[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 20,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24958846[PMID]_25058219[PMID],2,2
Disease,Combined oxidative phosphorylation defect type 20,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24958846[PMID]_25058219[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 21,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24827421[PMID],2,2
Disease,Combined oxidative phosphorylation defect type 21,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24827421[PMID],0,0
Malformation syndrome,RIDDLE syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17940005[PMID]_21394101[PMID],2,2
Malformation syndrome,RIDDLE syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17940005[PMID]_21394101[PMID],0,0
Disease,"Adult-onset cervical dystonia, DYT23 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8232359[PMID]_21370267[PMID],2,2
Disease,"Adult-onset cervical dystonia, DYT23 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8232359[PMID]_21370267[PMID],0,0
Disease,Cranio-cervical dystonia with laryngeal and upper-limb involvement,,,,,,,,,,,,,
Disease,Visual snow syndrome,,,,,,,,,,,,,
Clinical syndrome,Semicircular canal dehiscence syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Glycogen storage disease due to acid maltase deficiency, late-onset",1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,6789760[PMID],1.75,1.75
Disease,Transient myeloproliferative syndrome,,,,,,,,,,,,,
Malformation syndrome,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24744436[PMID],112,112
Malformation syndrome,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24744436[PMID],0,0
Disease,Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24777453[PMID],2,2
Disease,Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24777453[PMID],0,0
Disease,Woolly hair-palmoplantar keratoderma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24671081[PMID],8,8
Disease,Woolly hair-palmoplantar keratoderma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_24671081[PMID],0,0
Disease,Temple-Baraitser syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27282200[PMID],8,8
Disease,Temple-Baraitser syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27282200[PMID],0,0
Disease,Severe combined immunodeficiency due to CTPS1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29942301[PMID],12,12
Disease,Severe combined immunodeficiency due to CTPS1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29942301[PMID],0,0
Disease,Bleeding disorder due to CalDAG-GEFI deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24958846[PMID],3,3
Disease,Bleeding disorder due to CalDAG-GEFI deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24958846[PMID],0,0
Clinical subtype,Mucolipidosis type III alpha/beta,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20301730[PMID],13,13
Clinical subtype,Mucolipidosis type III gamma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301784[PMID],0,0
Disease,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25152456[PMID],6,6
Disease,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25152456[PMID],0,0
Disease,Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25129144[PMID],14,14
Disease,Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25129144[PMID],0,0
Disease,Spinocerebellar ataxia type 38,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25065913[PMID],4,4
Disease,Spinocerebellar ataxia type 38,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25065913[PMID],0,0
Malformation syndrome,Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24709618[PMID],2,2
Malformation syndrome,Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24709618[PMID],0,0
Disease,Cutaneous larva migrans,,,,,,,,,,,,,
Category,Rare carcinoma of stomach,,,,,,,,,,,,,
Clinical subtype,Double outlet right ventricle with subaortic or doubly committed ventricular septal defect,,,,,,,,,,,,,
Clinical subtype,"Double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxy",,,,,,,,,,,,,
Category,Rare autonomic nervous system disorder,,,,,,,,,,,,,
Disease,X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24961627[PMID],2,2
Disease,X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24961627[PMID],0,0
Clinical group,ARX-related encephalopathy-brain malformation spectrum,,,,,,,,,,,,,
Disease,Hereditary clear cell renal cell carcinoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,3-Phosphoglycerate dehydrogenase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24836451[PMID],0,0
Disease,Spinocerebellar ataxia type 40,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25062847[PMID],5,5
Disease,Spinocerebellar ataxia type 40,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25062847[PMID],0,0
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Solid pseudopapillary carcinoma of pancreas,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.028,0.028
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.048,0.048
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.041,0.041
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.028,0.028
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Intraductal papillary mucinous carcinoma of pancreas,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Osteoclastic giant cell tumor of pancreas,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Osteoclastic giant cell tumor of pancreas,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Osteoclastic giant cell tumor of pancreas,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Osteoclastic giant cell tumor of pancreas,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Osteoclastic giant cell tumor of pancreas,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Osteoclastic giant cell tumor of pancreas,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Osteoclastic giant cell tumor of pancreas,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Osteoclastic giant cell tumor of pancreas,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Osteoclastic giant cell tumor of pancreas,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Serous cystadenocarcinoma of pancreas,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Serous cystadenocarcinoma of pancreas,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Serous cystadenocarcinoma of pancreas,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Serous cystadenocarcinoma of pancreas,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Congenital myopathy with myasthenic-like onset,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24951453[PMID],2,2
Disease,Congenital myopathy with myasthenic-like onset,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24951453[PMID],0,0
Malformation syndrome,Colobomatous microphthalmia-rhizomelic dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24906020[PMID],5,5
Malformation syndrome,Colobomatous microphthalmia-rhizomelic dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24906020[PMID],0,0
Category,Qualitative or quantitative defects of Torsin-1A-interacting protein 1,,,,,,,,,,,,,
Disease,TOR1AIP1-related limb-girdle muscular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24856141[PMID],3,3
Disease,TOR1AIP1-related limb-girdle muscular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24856141[PMID],0,0
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.253,0.253
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.238,0.238
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.226,0.226
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.485,0.485
Disease,Adenocarcinoma of the anal canal,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.076,0.076
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.269,0.269
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.24,0.24
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.105,0.105
Disease,Adenocarcinoma of the anal canal,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.09,0.09
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.12,0.12
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.256,0.256
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.299,0.299
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.499,0.499
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.287,0.287
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.215,0.215
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.144,0.144
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.217,0.217
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.406,0.406
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.382,0.382
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.343,0.343
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.135,0.135
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.12,0.12
Disease,Adenocarcinoma of the anal canal,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.26,0.26
Clinical group,Carcinoma of the anal canal,,,,,,,,,,,,,
Disease,Progressive myoclonic epilepsy type 8,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24782409[PMID],4,4
Disease,Progressive myoclonic epilepsy type 8,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24782409[PMID],0,0
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.81,0.81
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.923,0.923
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.707,0.707
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.268,0.268
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.251,0.251
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.568,0.568
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.6,0.6
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.464,0.464
Disease,Squamous cell carcinoma of the anal canal,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.096,1.096
Disease,Squamous cell carcinoma of the anal canal,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.307,1.307
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.809,0.809
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.416,0.416
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.872,0.872
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.238,0.238
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.153,0.153
Disease,Squamous cell carcinoma of the anal canal,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.071,1.071
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.411,0.411
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.603,0.603
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.194,0.194
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.331,0.331
Disease,Squamous cell carcinoma of the anal canal,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.712,1.712
Disease,Squamous cell carcinoma of the anal canal,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.621,0.621
Disease,Squamous cell carcinoma of the anal canal,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.038,1.038
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.023,0.023
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.044,0.044
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.028,0.028
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.028,0.028
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.015,0.015
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.032,0.032
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.034,0.034
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.06,0.06
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.058,0.058
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Squamous cell carcinoma of pancreas,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.023,0.023
Category,Rare epithelial tumor of pancreas,,,,,,,,,,,,,
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.007,0.007
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.024,0.024
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Mucinous cystadenocarcinoma of the pancreas,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.029,0.029
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.049,0.049
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.034,0.034
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.044,0.044
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.083,0.083
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.024,0.024
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.058,0.058
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.028,0.028
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.07,0.07
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.05,0.05
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.024,0.024
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Acinar cell carcinoma of pancreas,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.007,0.007
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.022,0.022
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Squamous cell carcinoma of the small intestine,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.012,0.012
Category,Neuroendocrine tumor of the small intestine,,,,,,,,,,,,,
Category,Epithelial tumor of the appendix,,,,,,,,,,,,,
Category,Rare epithelial tumor of colon,,,,,,,,,,,,,
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.026,0.026
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.072,0.072
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.014,0.014
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.035,0.035
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.022,0.022
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.014,0.014
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.026,0.026
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.028,0.028
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.025,0.025
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.041,0.041
Disease,Squamous cell carcinoma of the colon,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.13,0.13
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.035,0.035
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.024,0.024
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Squamous cell carcinoma of the colon,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.021,0.021
Category,Rare epithelial tumor of rectum,,,,,,,,,,,,,
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.113,0.113
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.126,0.126
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.052,0.052
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.088,0.088
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.26,0.26
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.157,0.157
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.074,0.074
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.083,0.083
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.128,0.128
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.096,0.096
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.149,0.149
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.346,0.346
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.116,0.116
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.071,0.071
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.111,0.111
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.119,0.119
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.05,0.05
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.042,0.042
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.084,0.084
Disease,Squamous cell carcinoma of the rectum,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.028,0.028
Disease,Squamous cell carcinoma of the rectum,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.143,0.143
Category,Epithelial tumor of anal canal,,,,,,,,,,,,,
Category,Hereditary gastric cancer,,,,,,,,,,,,,
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.211,0.211
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.086,0.086
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.077,0.077
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.764,0.764
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.068,0.068
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.328,0.328
Disease,Undifferentiated carcinoma of stomach,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.743,2.743
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.1,0.1
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.221,0.221
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.085,0.085
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.399,0.399
Disease,Undifferentiated carcinoma of stomach,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.571,2.571
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.877,0.877
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.251,0.251
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.087,0.087
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.386,0.386
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.072,0.072
Disease,Undifferentiated carcinoma of stomach,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.456,0.456
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.098,0.098
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Undifferentiated carcinoma of stomach,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.032,0.032
Category,Rare tumor of small intestine,,,,,,,,,,,,,
Category,Mesenchymal tumor of small intestine,,,,,,,,,,,,,
Disease,Microcephaly-complex motor and sensory axonal neuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24126608[PMID],3,3
Disease,Microcephaly-complex motor and sensory axonal neuropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24126608[PMID],0,0
Category,Rare carcinoma of small intestine,,,,,,,,,,,,,
Malformation syndrome,X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4998085[PMID]_24993872[PMID],1,1
Malformation syndrome,X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4998085[PMID]_24993872[PMID],0,0
Category,Rare epithelial tumor of small intestine,,,,,,,,,,,,,
Category,Inherited digestive cancer-predisposing syndrome,,,,,,,,,,,,,
Disease,STING-associated vasculopathy with onset in infancy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25401470[PMID]_25029335[PMID],0,0
Disease,STING-associated vasculopathy with onset in infancy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25401470[PMID]_25029335[PMID],9,9
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.412,0.412
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.715,0.715
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.201,0.201
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.219,0.219
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.659,0.659
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.471,0.471
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.309,0.309
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.262,0.262
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.582,0.582
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.256,0.256
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.642,0.642
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.426,0.426
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.267,0.267
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.481,0.481
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.365,0.365
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.154,0.154
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.471,0.471
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.377,0.377
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.753,0.753
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.157,0.157
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.206,0.206
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.467,0.467
Disease,Adenocarcinoma of the liver and intrahepatic biliary tract,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.118,0.118
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.015,0.015
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.056,0.056
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.046,0.046
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.03,0.03
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.049,0.049
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.033,0.033
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.098,0.098
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.015,0.015
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.028,0.028
Disease,Undifferentiated carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Category,Rare malignant epithelial tumor of liver and intrahepatic biliary tract,,,,,,,,,,,,,
Category,Carcinoma of liver and intrahepatic biliary tract,,,,,,,,,,,,,
Disease,Adenocarcinoma of the gallbladder and extrahepatic biliary tract,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.62,2.62
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.032,0.032
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.026,0.026
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.025,0.025
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.124,0.124
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.026,0.026
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.055,0.055
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.033,0.033
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.015,0.015
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.077,0.077
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.042,0.042
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.051,0.051
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.014,0.014
Disease,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.021,0.021
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.007,0.007
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.019,0.019
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.004,0.004
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Squamous cell carcinoma of liver and intrahepatic biliary tract,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.014,0.014
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.003,0.003
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Biliary cystadenocarcinoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Progressive encephalopathy with leukodystrophy due to DECR deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24847004[PMID]_2332510[PMID],2,2
Disease,Progressive encephalopathy with leukodystrophy due to DECR deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24847004[PMID]_2332510[PMID],0,0
Category,Pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,20456932[PMID],0.015,0.015
Morphological anomaly,Patent urachus,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,3404578[PMID],1.75,1.75
Morphological anomaly,Patent urachus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Urachal sinus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Urachal diverticulum,,,,,,,,,,,,,
Disease,X-linked scapuloperoneal muscular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18179901[PMID]_20633900[PMID],22,22
Disease,X-linked scapuloperoneal muscular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18179901[PMID]_20633900[PMID],0,0
Clinical group,Spastic paraplegia-optic atrophy-neuropathy and spastic paraplegia-optic atrophy-neuropathy-related disorder,,,,,,,,,,,,,
Disease,Autosomal recessive spastic paraplegia type 57,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23479643[PMID],2,2
Disease,Autosomal recessive spastic paraplegia type 57,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23479643[PMID],0,0
Disease,Scapuloperoneal spinal muscular atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26948711[PMID],31,31
Disease,Scapuloperoneal spinal muscular atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26948711[PMID],0,0
Clinical group,Late-onset scapuloperoneal muscular dystrophy with hyaline bodies,,,,,,,,,,,,,
Disease,Combined immunodeficiency due to OX40 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23897980[PMID],1,1
Disease,Combined immunodeficiency due to OX40 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23897980[PMID],0,0
Category,Primary immunodeficiency with predisposition to severe viral infection,,,,,,,,,,,,,
Disease,Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26424569[PMID],1,1
Disease,Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26424569[PMID],0,0
Disease,Progressive myoclonic epilepsy type 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25401298[PMID],13,13
Disease,Progressive myoclonic epilepsy type 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25401298[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2Y,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25125609[PMID]_25125609[PMID],7,7
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2Y,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25125609[PMID]_25125609[PMID],0,0
Morphological anomaly,Anterior urethral valve,,,,,,,,,,,,,
Clinical group,Fetal lower urinary tract obstruction,,,,,,,,,,,,,
Disease,Familial ossifying fibroma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Syndrome with woolly hair,,,,,,,,,,,,,
Category,Rare genetic autonomic nervous system disorder,,,,,,,,,,,,,
Malformation syndrome,Orofaciodigital syndrome type 14,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24997988[PMID],2,2
Malformation syndrome,Orofaciodigital syndrome type 14,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24997988[PMID],0,0
Disease,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25564090[PMID]_30926972[PMID],0,0
Disease,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25564090[PMID]_30926972[PMID],100,100
Disease,Severe combined immunodeficiency due to LAT deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27522155[PMID],3,3
Disease,Severe combined immunodeficiency due to LAT deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27522155[PMID],0,0
Disease,Combined immunodeficiency due to Moesin deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27405666[PMID],7,7
Disease,Combined immunodeficiency due to Moesin deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27405666[PMID],0,0
Disease,Very long chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Very long chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,16488171[PMID],3.2,3.2
Disease,Very long chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22766612[PMID],1.8,1.8
Disease,Very long chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,20547398[PMID],2,2
Disease,Very long chain acyl-CoA dehydrogenase deficiency,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,31241292[PMID],0.45,0.45
Disease,Hereditary pheochromocytoma-paraganglioma,1-9 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,20301715[PMID]_23162105[PMID],0.3,0.3
Disease,Hereditary pheochromocytoma-paraganglioma,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Tyrosinemia type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8912606[PMID],150,150
Disease,Tyrosinemia type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Reactive arthritis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Multiple myeloma,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,National Cancer Institute 2005[INST],3.8,3.8
Disease,Multiple myeloma,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],6,6
Disease,Multiple myeloma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],11.9,11.9
Disease,Multiple myeloma,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],7.7,7.7
Disease,Multiple myeloma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],2.4,2.4
Disease,Multiple myeloma,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer Institute 2005[INST],5.6,5.6
Disease,Multiple myeloma,1-9 / 100 000,"Iran, Islamic Republic of",409967,409967,25958,25958,en,Validated,410293,410293,23725136[PMID],2,2
Disease,Multiple myeloma,1-9 / 100 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,Cancer Institute New South Wales 2008[INST],5.1,5.1
Disease,Spontaneous periodic hypothermia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21166673[PMID]_15990200[PMID],50,50
Disease,Spontaneous periodic hypothermia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Isolated biliary atresia,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,4824812[PMID],10.6,10.6
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],2.9,2.9
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],2.9,2.9
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.9,5.9
Morphological anomaly,Isolated biliary atresia,1-5 / 10 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],11.9,11.9
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],4.2,4.2
Morphological anomaly,Isolated biliary atresia,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],16.6,16.6
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],1.6,1.6
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.9,1.9
Morphological anomaly,Isolated biliary atresia,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],12.6,12.6
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],2.3,2.3
Morphological anomaly,Isolated biliary atresia,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],12.7,12.7
Morphological anomaly,Isolated biliary atresia,1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],18.5,18.5
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,Japanese biliary atresia registry[REG],7.4,7.4
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,9041292[PMID]_7069535[PMID],7,7
Morphological anomaly,Isolated biliary atresia,1-5 / 10 000,French Polynesia,409968,409968,25958,25958,en,Validated,410293,410293,7987462[PMID],32,32
Morphological anomaly,Isolated biliary atresia,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,559475[PMID],7,7
Disease,Apparent mineralocorticoid excess,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Idiopathic acute eosinophilic pneumonia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12403693[PMID],100,100
Disease,Idiopathic acute eosinophilic pneumonia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dopamine beta-hydroxylase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301647[PMID],21,21
Disease,Dopamine beta-hydroxylase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301647[PMID],0,0
Disease,Continuous spikes and waves during sleep,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital myasthenic syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.3,0.3
Disease,Congenital myasthenic syndrome,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,24500997[PMID],0.92,0.92
Disease,Familial hyperaldosteronism type II,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pseudohypoaldosteronism type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28233358[PMID],107,107
Disease,Pseudohypoaldosteronism type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28233358[PMID],0,0
Malformation syndrome,Cataract-glaucoma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15665340[PMID],3,3
Malformation syndrome,Cataract-glaucoma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15665340[PMID],0,0
Clinical group,Diffuse large B-cell lymphoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],43,43
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],6.5,6.5
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.79,2.79
Clinical group,Diffuse large B-cell lymphoma,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.765,0.765
Clinical group,Diffuse large B-cell lymphoma,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.298,0.298
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.227,2.227
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.51,5.51
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.229,1.229
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.304,3.304
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.815,3.815
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.244,1.244
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.586,4.586
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.559,4.559
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.458,3.458
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.47,6.47
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.984,2.984
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.827,2.827
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.115,5.115
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.673,1.673
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.635,2.635
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.259,3.259
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.773,4.773
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.78,4.78
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.328,6.328
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.478,6.478
Clinical group,Diffuse large B-cell lymphoma,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.931,4.931
Disease,Follicular lymphoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],37,37
Disease,Follicular lymphoma,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],3.95,3.95
Disease,Follicular lymphoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.192,2.192
Disease,Follicular lymphoma,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.348,0.348
Disease,Follicular lymphoma,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.72,0.72
Disease,Follicular lymphoma,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.579,0.579
Disease,Follicular lymphoma,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.363,0.363
Disease,Follicular lymphoma,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.277,0.277
Disease,Follicular lymphoma,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.368,0.368
Disease,Follicular lymphoma,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.52,1.52
Disease,Follicular lymphoma,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.04,3.04
Disease,Follicular lymphoma,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.665,1.665
Disease,Follicular lymphoma,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.687,1.687
Disease,Follicular lymphoma,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.456,2.456
Disease,Follicular lymphoma,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.769,2.769
Disease,Follicular lymphoma,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.08,2.08
Disease,Follicular lymphoma,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.541,2.541
Disease,Follicular lymphoma,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.759,1.759
Disease,Follicular lymphoma,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.298,3.298
Disease,Follicular lymphoma,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.364,1.364
Disease,Follicular lymphoma,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.046,1.046
Disease,Follicular lymphoma,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.389,1.389
Disease,Follicular lymphoma,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.375,2.375
Disease,Follicular lymphoma,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.916,2.916
Disease,Follicular lymphoma,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.977,2.977
Disease,Follicular lymphoma,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.766,2.766
Disease,Idiopathic aplastic anemia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.4,0.4
Disease,Multiple system atrophy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,3.7,3.7
Disease,Multiple system atrophy,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3.5,3.5
Disease,Multiple system atrophy,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1.8,1.8
Disease,Multiple system atrophy,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,23192520[PMID],0.7,0.7
Disease,Multiple system atrophy,1-9 / 100 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,23192520[PMID],3.4,3.4
Disease,Multiple system atrophy,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,20108376[PMID],2.1,2.1
Disease,Multiple system atrophy,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,10577638[PMID],4.4,4.4
Disease,Multiple system atrophy,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,9371909[PMID],0.6,0.6
Disease,Multiple system atrophy,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,10841152[PMID]_15272223[PMID],1.9,1.9
Disease,Multiple system atrophy,1-9 / 1 000 000,Russian Federation,409967,409967,25958,25958,en,Validated,410293,410293,20108378[PMID],0.11,0.11
Disease,Multiple system atrophy,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,9613728[PMID],4.9,4.9
Disease,Multiple system atrophy,1-5 / 10 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,20880268[PMID]_19169038[PMID],10.3,10.3
Disease,Multiple system atrophy,1-9 / 100 000,Faroe Islands,409966,409966,25958,25958,en,Validated,410293,410293,9270572[PMID],2.3,2.3
Disease,Primary myelofibrosis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Primary myelofibrosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],3,3
Clinical group,Mendelian susceptibility to mycobacterial diseases,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Polycythemia vera,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1.9,1.9
Disease,Polycythemia vera,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_European Medicines Agency 2014[INST],30,30
Disease,Polycythemia vera,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,13679323[PMID],30,30
Disease,X-linked myopathy with excessive autophagy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25809233[PMID],18,18
Disease,X-linked myopathy with excessive autophagy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25809233[PMID],0,0
Disease,Juvenile temporal arteritis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Juvenile temporal arteritis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary diffuse gastric cancer,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1.5,1.5
Disease,Hereditary diffuse gastric cancer,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Ventilator-induced diaphragmatic dysfunction,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28887062[PMID],0,0
Disease,Benign occipital epilepsy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pseudomyxoma peritonei,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,19838447[PMID]_17524597[PMID]_16678994[PMID]_[EXPERT],0.1,0.1
Disease,Pseudomyxoma peritonei,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,17524597[PMID],0.2,0.2
Disease,Pseudomyxoma peritonei,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pseudomyxoma peritonei,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],2,2
Disease,Short chain acyl-CoA dehydrogenase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Short chain acyl-CoA dehydrogenase deficiency,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,21500142[PMID]_22608595[PMID]_22241096[PMID],2,2
Disease,Multiple acyl-CoA dehydrogenase deficiency,1-9 / 1 000 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET_24190796[PMID],0.47,0.47
Disease,Multiple acyl-CoA dehydrogenase deficiency,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acquired prothrombin deficiency,,,,,,,,,,,,,
Disease,Protein S acquired deficiency,,,,,,,,,,,,,
Morphological anomaly,Common mesentery,,,,,,,,,,,,,
Disease,Congenital cervical spinal stenosis,,,,,,,,,,,,,
Morphological anomaly,Penile agenesis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25786436[PMID],80,80
Morphological anomaly,Penile agenesis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25786436[PMID],0,0
Morphological anomaly,Diphallia,<1 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,23056729[PMID],0.02,0.02
Morphological anomaly,Diphallia,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23056729[PMID],0,0
Morphological anomaly,Accessory pancreas,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hepatic cystic hamartoma,,,,,,,,,,,,,
Disease,Autosomal dominant limb-girdle muscular dystrophy type 1A,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21336781[PMID],4,4
Disease,Autosomal dominant limb-girdle muscular dystrophy type 1A,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21336781[PMID],0,0
Disease,Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],0.2,0.2
Disease,Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.13,0.13
Disease,Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5,1-9 / 1 000 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,20350330[PMID],0.18,0.18
Disease,Delta-sarcoglycan-related  limb-girdle muscular dystrophy R6,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],0.3,0.3
Disease,Multifocal motor neuropathy,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,17075524[PMID]_11282149[PMID]_23623583[PMID],1.5,1.5
Disease,Multifocal motor neuropathy,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,23196468[PMID],0.16,0.16
Disease,Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4,<1 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.07,0.07
Disease,Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],0.1,0.1
Disease,"Distal myopathy, Welander type",>1 / 1000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,DOI:https://doi.org/10.1016/S0960-8966(02)00116-5[OTHER]_ [EXPERT],100,100
Disease,"Distal myopathy, Welander type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Combined immunodeficiency due to GINS1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28414293[PMID],5,5
Disease,Combined immunodeficiency due to GINS1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28414293[PMID],0,0
Malformation syndrome,Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28343629[PMID],12,12
Malformation syndrome,Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28343629[PMID],0,0
Malformation syndrome,Muscle-eye-brain disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Walker-Warburg syndrome,<1 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.03,0.03
Disease,Walker-Warburg syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1.65,1.65
Disease,Walker-Warburg syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Walker-Warburg syndrome,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,8786062[PMID],1.2,1.2
Disease,3-methylglutaconic aciduria type 9,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27573165[PMID],4,4
Disease,3-methylglutaconic aciduria type 9,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27573165[PMID],0,0
Malformation syndrome,"Congenital muscular dystrophy, Fukuyama type",1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,20301385[PMID],2.8,2.8
Malformation syndrome,"Congenital muscular dystrophy, Fukuyama type",1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,3-methylglutaconic aciduria type 8,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27208207[PMID]_27696117[PMID],9,9
Disease,3-methylglutaconic aciduria type 8,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27208207[PMID]_27696117[PMID],0,0
Disease,Dysferlin-related  limb-girdle muscular dystrophy R2,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.13,0.13
Disease,Dysferlin-related  limb-girdle muscular dystrophy R2,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Limb-girdle muscular dystrophy,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,8931572[PMID],0.81,0.81
Clinical group,Limb-girdle muscular dystrophy,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],2.27,2.27
Clinical group,Limb-girdle muscular dystrophy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Limb-girdle muscular dystrophy,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,1745328[PMID],1.55,1.55
Clinical group,Limb-girdle muscular dystrophy,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,25532075[PMID],2.32,2.32
Clinical group,Limb-girdle muscular dystrophy,1-9 / 100 000,Egypt,409969,409969,25958,25958,en,Validated,410293,410293,16210862[PMID],5.7,5.7
Clinical group,Limb-girdle muscular dystrophy,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,9762961[PMID],6.9,6.9
Clinical group,Limb-girdle muscular dystrophy,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,8845721[PMID],1.1,1.1
Disease,Vocal cord and pharyngeal distal myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25952333[PMID]_29628183[PMID],0,0
Malformation syndrome,Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28013294[PMID],19,19
Malformation syndrome,Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28013294[PMID],0,0
Disease,Tibial muscular dystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,24395473[PMID],6,6
Disease,Tibial muscular dystrophy,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,24395473[PMID],20,20
Disease,GNE myopathy,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,25002140[PMID],1,1
Disease,GNE myopathy,6-9 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,12743242[PMID],66.7,66.7
Disease,Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28334855[PMID],6,6
Disease,Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28334855[PMID],0,0
Malformation syndrome,MEPAN syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27817865[PMID],7,7
Malformation syndrome,MEPAN syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27817865[PMID],0,0
Disease,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28132690[PMID]_28148688[PMID],12,12
Disease,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28132690[PMID]_28148688[PMID],0,0
Disease,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28115216[PMID],5,5
Disease,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28115216[PMID],0,0
Morphological anomaly,Familial intestinal malrotation,,,,,,,,,,,,,
Disease,Congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27977684[PMID],2,2
Disease,Congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27977684[PMID],0,0
Disease,"Generalized basal epidermolysis bullosa simplex with skin atrophy, scarring and hair loss",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27889062[PMID],14,14
Disease,"Generalized basal epidermolysis bullosa simplex with skin atrophy, scarring and hair loss",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27889062[PMID],0,0
Disease,Hyperphenylalaninemia due to DNAJC12 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28132689[PMID],6,6
Disease,Hyperphenylalaninemia due to DNAJC12 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28132689[PMID],0,0
Malformation syndrome,8q24.3 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27804958[PMID],2,2
Malformation syndrome,8q24.3 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27804958[PMID],0,0
Malformation syndrome,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28081210[PMID],7,7
Malformation syndrome,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28081210[PMID],0,0
Malformation syndrome,Oral-facial-digital syndrome with short stature and brachymesophalangy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27060890[PMID],3,3
Malformation syndrome,Oral-facial-digital syndrome with short stature and brachymesophalangy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27060890[PMID],0,0
Malformation syndrome,Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28327570[PMID],18,18
Malformation syndrome,Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28327570[PMID],0,0
Disease,CDKL5-related epileptic encephalopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22872100[PMID]_24564546[PMID],0,0
Disease,CDKL5-related epileptic encephalopathy,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,29264392[PMID],0.21,0.21
Disease,CDKL5-related epileptic encephalopathy,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,31302675[PMID],2.36,2.36
Disease,CDKL5-related epileptic encephalopathy,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EpiCARE[EXPERT]_31302675[PMID],0,0
Clinical subtype,Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome,,,,,,,,,,,,,
Disease,Familial steroid-resistant nephrotic syndrome with adrenal insufficiency,,,,,,,,,,,,,
Malformation syndrome,Stromme syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18203155[PMID]_26820108[PMID]_28407396[PMID],11,11
Malformation syndrome,Stromme syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28407396[PMID],0,0
Malformation syndrome,Gabriele-de Vries syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28575647[PMID],10,10
Malformation syndrome,Gabriele-de Vries syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28575647[PMID],0,0
Disease,Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28052917[PMID],4,4
Disease,Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28052917[PMID],0,0
Category,Rare disorder potentially indicated for bowel transplant,,,,,,,,,,,,,
Category,Rare disorder potentially indicated for hematopoietic stem cell transplant,,,,,,,,,,,,,
Category,Rare disorder potentially indicated for lung transplant,,,,,,,,,,,,,
Category,Rare disorder potentially indicated for heart transplant,,,,,,,,,,,,,
Disease,Neuroendocrine neoplasm of esophagus,,,,,,,,,,,,,
Category,Rare disorder potentially indicated for transplant,,,,,,,,,,,,,
Category,Rare disorder potentially indicated for liver transplant,,,,,,,,,,,,,
Category,Rare disorder potentially indicated for kidney transplant,,,,,,,,,,,,,
Disease,Serotonin-producing neuroendocrine tumor of pancreas,,,,,,,,,,,,,
Disease,Neuroendocrine carcinoma of pancreas,,,,,,,,,,,,,
Disease,Mixed neuroendocrine-nonneuroendocrine neoplasm of pancreas,,,,,,,,,,,,,
Category,Neuroendocrine neoplasm of pancreas,,,,,,,,,,,,,
Category,Functioning neuroendocrine tumor of pancreas,,,,,,,,,,,,,
Disease,Non-functioning neuroendocrine tumor of pancreas,,,,,,,,,,,,,
Disease,Charcot-Marie-Tooth disease type 2T,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26991897[PMID],10,10
Disease,Charcot-Marie-Tooth disease type 2T,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26991897[PMID],0,0
Disease,C11ORF73-related autosomal recessive hypomyelinating leukodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26545878[PMID],6,6
Disease,C11ORF73-related autosomal recessive hypomyelinating leukodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26545878[PMID],0,0
Malformation syndrome,9q33.3q34.11 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26395556[PMID],4,4
Malformation syndrome,9q33.3q34.11 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26395556[PMID],0,0
Morphological anomaly,Congenital agenesis of the scrotum,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23374822[PMID],6,6
Morphological anomaly,Congenital agenesis of the scrotum,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23374822[PMID],0,0
Malformation syndrome,Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27075597[PMID]_27103078[PMID],3,3
Malformation syndrome,Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27075597[PMID]_27103078[PMID],0,0
Disease,Familial monosomy 7 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20614583[PMID],14,14
Disease,Familial monosomy 7 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20614583[PMID],0,0
Malformation syndrome,Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27807845[PMID]_27666374[PMID]_27666370[PMID]_27928163[PMID],22,22
Malformation syndrome,Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27807845[PMID]_27666374[PMID]_27666370[PMID]_27928163[PMID],0,0
Disease,Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27484770[PMID]_27485408[PMID],0,0
Disease,Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27484770[PMID]_27485408[PMID],3,3
Disease,Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28488683[PMID],0,0
Disease,Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28488683[PMID],12,12
Malformation syndrome,Omphalocele-diaphragmatic hernia-cardiovascular anomalies-radial ray defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26639892[PMID],7,7
Malformation syndrome,Omphalocele-diaphragmatic hernia-cardiovascular anomalies-radial ray defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26639892[PMID],0,0
Malformation syndrome,EVEN-plus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26598328[PMID],3,3
Malformation syndrome,EVEN-plus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26598328[PMID],0,0
Disease,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27666369[PMID],6,6
Disease,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27666369[PMID],0,0
Disease,Ocular anomalies-axonal neuropathy-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27640307[PMID],8,8
Disease,Ocular anomalies-axonal neuropathy-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27640307[PMID],0,0
Disease,MIRAGE syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27182967[PMID]_28346228[PMID],19,19
Disease,MIRAGE syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27182967[PMID]_28346228[PMID],0,0
Malformation syndrome,Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26843489[PMID],3,3
Malformation syndrome,Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26843489[PMID],0,0
Morphological anomaly,Extracranial carotid artery aneurysm,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26116488[PMID],0,0
Disease,Idiopathic pleuroparenchymal fibroelastosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27141432[PMID]_28344924[PMID],0,0
Disease,Idiopathic pleuroparenchymal fibroelastosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27141432[PMID],37,37
Histopathological subtype,Vulvar basal cell carcinoma,,,,,,,,,,,,,
Histopathological subtype,Vulvar adenocarcinoma,,,,,,,,,,,,,
Disease,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27808407[PMID],8,8
Disease,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27808407[PMID],0,0
Histopathological subtype,Vulvar squamous cell carcinoma,,,,,,,,,,,,,
Malformation syndrome,RERE-related neurodevelopmental syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27087320[PMID],10,10
Malformation syndrome,RERE-related neurodevelopmental syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27087320[PMID],0,0
Disease,Vulvar carcinoma,,,,,,,,,,,,,
Clinical subtype,Sacrococcygeal teratoma,,,,,,,,,,,,,
Disease,Early-onset familial noncirrhotic portal hypertension,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26874653[PMID],3,3
Disease,Early-onset familial noncirrhotic portal hypertension,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26874653[PMID],0,0
Disease,Squamous cell carcinoma of the hypopharynx,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID],1.27,1.27
Disease,Childhood-onset benign chorea with striatal involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27058447[PMID],3,3
Disease,Childhood-onset benign chorea with striatal involvement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27058447[PMID],0,0
Disease,Infantile-onset generalized dyskinesia with orofacial involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27058446[PMID],8,8
Disease,Infantile-onset generalized dyskinesia with orofacial involvement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27058446[PMID],0,0
Category,Rare hyperkinetic movement disorder,,,,,,,,,,,,,
Disease,Squamous cell carcinoma of the larynx,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID],4.61,4.61
Disease,Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28777933[PMID],7,7
Disease,Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28777933[PMID],0,0
Malformation syndrome,X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28096187[PMID],4,4
Malformation syndrome,X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28096187[PMID],0,0
Disease,Amoebiasis due to free-living amoebae,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Q fever,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,23535757[PMID]_Center for Diseases Control and Prevention[INST],0.03,0.03
Disease,Q fever,1-9 / 100 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,16503466[PMID],3,3
Disease,Q fever,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Q fever,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.16,0.16
Disease,Q fever,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.08,0.08
Disease,Q fever,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.26,0.26
Disease,Q fever,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.4,0.4
Disease,Q fever,1-9 / 1 000 000,Cyprus,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.32,0.32
Disease,Q fever,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.04,0.04
Disease,Q fever,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.26,0.26
Disease,Q fever,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.26,0.26
Disease,Q fever,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.1,0.1
Disease,Q fever,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.64,0.64
Disease,Q fever,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.06,0.06
Disease,Q fever,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.07,0.07
Disease,Q fever,<1 / 1 000 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.04,0.04
Disease,Q fever,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.1,0.1
Disease,Q fever,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.18,0.18
Disease,Q fever,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.2,0.2
Disease,Q fever,1-9 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.1,0.1
Disease,Q fever,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.1,0.1
Disease,Q fever,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0,0
Disease,Q fever,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.1,0.1
Disease,Q fever,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2016[INST],0.05,0.05
Malformation syndrome,Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27545680[PMID]_27545676[PMID]_27256762[PMID],29,29
Malformation syndrome,Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27545680[PMID]_27545676[PMID]_27256762[PMID],0,0
Malformation syndrome,Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28886345[PMID],4,4
Malformation syndrome,Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28886345[PMID],0,0
Malformation syndrome,SIN3A-related intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27399968[PMID],15,15
Malformation syndrome,SIN3A-related intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27399968[PMID],0,0
Disease,Epidermodysplasia verruciformis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Epidermodysplasia verruciformis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Tick-borne encephalitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,SIN3A-related intellectual disability syndrome due to a point mutation,,,,,,,,,,,,,
Disease,Chromomycosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Diphyllobothriasis,1-9 / 1 000 000,France,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.88,0.88
Disease,Diphyllobothriasis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Demodicidosis,,,,,,,,,,,,,
Disease,Cyclosporosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Strongyloidiasis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Strongyloidiasis,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,29284005[PMID],0.06,0.06
Disease,Angiostrongyliasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Babesiosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,emedicine[OTHER],0,0
Disease,Ankylostomiasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28264986[PMID],3,3
Malformation syndrome,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28264986[PMID],0,0
Malformation syndrome,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28777934[PMID],3,3
Malformation syndrome,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28777934[PMID],0,0
Malformation syndrome,16p13.2 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26365382[PMID],6,6
Malformation syndrome,16p13.2 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26365382[PMID],0,0
Malformation syndrome,Tall stature-intellectual disability-renal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26660953[PMID]_27183861[PMID],4,4
Malformation syndrome,Tall stature-intellectual disability-renal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26660953[PMID]_27183861[PMID],0,0
Disease,Infantile-onset periodic fever-panniculitis-dermatosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27523608[PMID]_27559085[PMID],5,5
Disease,Infantile-onset periodic fever-panniculitis-dermatosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27523608[PMID]_27559085[PMID],0,0
Disease,Pseudopelade of Brocq,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Björnstad syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11807445[PMID],33,33
Disease,Björnstad syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Wagner disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Wagner disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Squamous cell carcinoma of the oropharynx,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID],3.12,3.12
Disease,Acute megakaryoblastic leukemia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute megakaryoblastic leukemia,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Histopathological subtype,Squamous cell carcinoma of salivary glands,,,,,,,,,,,,,
Disease,Acute erythroid leukemia,,,,,,,,,,,,,
Disease,Acute monoblastic leukemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.13,0.13
Disease,Acute monoblastic leukemia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute myelomonocytic leukemia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute myelomonocytic leukemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.17,0.17
Disease,Graham Little-Piccardi-Lassueur syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Quinquaud folliculitis decalvans,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Erosive pustular dermatosis of the scalp,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Crandall syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Woolly hair,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,Osteosclerotic metaphyseal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27829680[PMID],7,7
Malformation syndrome,Osteosclerotic metaphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27829680[PMID],0,0
Disease,Ringed hair disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27170158[PMID],17,17
Disease,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27170158[PMID],0,0
Disease,Loose anagen syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28132692[PMID],6,6
Disease,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28132692[PMID],0,0
Disease,Dissecting cellulitis of the scalp,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Furuncular myiasis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pneumocystosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Isosporiasis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Creeping myiasis,,,,,,,,,,,,,
Disease,Hymenolepiasis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Histoplasmosis,,,,,,,,,,,,,
Disease,Cystic echinococcosis,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Cystic echinococcosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Squamous cell carcinoma of the nasal cavity and paranasal sinuses,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID],0.35,0.35
Disease,Acute promyelocytic leukemia,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,22707337[PMID]_21653939[PMID]_ ORPHANET,0.28,0.28
Disease,Acute promyelocytic leukemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.11,0.11
Disease,Acute promyelocytic leukemia,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],0.3,0.3
Disease,Acute promyelocytic leukemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Heterotaxia,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,11256661[PMID],10,10
Category,Heterotaxia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Roch-Leri mesosomatous lipomatosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Neonatal diabetes mellitus,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,21953423[PMID]_19499210[PMID]_20546293[PMID],1.1,1.1
Category,Neonatal diabetes mellitus,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,21953423[PMID],1.1,1.1
Category,Neonatal diabetes mellitus,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,20546293[PMID],1.12,1.12
Category,Neonatal diabetes mellitus,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,19496964[PMID],0.62,0.62
Category,Neonatal diabetes mellitus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sporotrichosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25526781[PMID],0,0
Disease,Sporotrichosis,>1 / 1000,Mexico,409966,409966,25958,25958,en,Validated,410293,410293,25526781[PMID],2500,2500
Disease,Sporotrichosis,1-5 / 10 000,Peru,409967,409967,25958,25958,en,Validated,410293,410293,10619735[PMID],54,54
Disease,Tungiasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,22941398[PMID],0,0
Morphological anomaly,Cochleovestibular dysplasia,,,,,,,,,,,,,
Morphological anomaly,Cochlear nerve deficiency,,,,,,,,,,,,,
Disease,Squamous cell carcinoma of the oral cavity,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID],3.51,3.51
Disease,Squamous cell carcinoma of the lip,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID],1.02,1.02
Category,Squamous cell carcinoma of oral cavity and lip,,,,,,,,,,,,,
Disease,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28544275[PMID]_28554942[PMID]_29339779[PMID],9,9
Disease,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28544275[PMID]_28554942[PMID]_29339779[PMID],0,0
Malformation syndrome,Metopic ridging-ptosis-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28513610[PMID],8,8
Malformation syndrome,Metopic ridging-ptosis-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28513610[PMID],0,0
Malformation syndrome,STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28119487[PMID],17,17
Malformation syndrome,STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28119487[PMID],0,0
Malformation syndrome,4q25 proximal deletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27587989[PMID],3,3
Malformation syndrome,4q25 proximal deletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27587989[PMID],0,0
Disease,Erythema multiforme major,,,,,,,,,,,,,
Disease,Alkaline ceramidase 3 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26792856[PMID],2,2
Disease,Alkaline ceramidase 3 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26792856[PMID],0,0
Disease,Normosmic congenital hypogonadotropic hypogonadism,,,,,,,,,,,,,
Disease,Aromatase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27256151[PMID]_27693882[PMID]_29324451[PMID]_29553041[PMID],38,38
Disease,Aromatase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27256151[PMID]_27693882[PMID]_29324451[PMID]_29553041[PMID],0,0
Disease,Estrogen resistance syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8090165[PMID]_23841731[PMID],2,2
Disease,Estrogen resistance syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8090165[PMID]_23841731[PMID],0,0
Disease,Desmoid tumor,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.3,0.3
Disease,Desmoid tumor,1-9 / 1 000 000,Finland,409967,409967,25965,25965,en,Not yet validated,410294,410294,3946757[PMID],0.33,0.33
Disease,Desmoid tumor,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Cushing syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2013[INST],6.5,6.5
Clinical group,Cushing syndrome,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_11231987[PMID]_8187313[PMID]_ISBN-13:978-0444813879[OTHER],0.15,0.15
Clinical group,Cushing syndrome,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,8187313[PMID],3.91,3.91
Clinical group,Cushing syndrome,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,11231987[PMID],0.15,0.15
Clinical group,Cushing syndrome,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,8187313[PMID],0.24,0.24
Clinical group,Cushing syndrome,1-9 / 1 000 000,New Zealand,409967,409967,25958,25958,en,Validated,410293,410293,21609352[PMID],0.18,0.18
Clinical group,Cushing syndrome,1-9 / 100 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,21609352[PMID],7.9,7.9
Clinical group,Cushing syndrome,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,ISBN-13:978-0444813879[OTHER]_16698415[PMID],0.07,0.07
Clinical group,Cushing syndrome,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,26004339[PMID]_8187313[PMID]_21609352[PMID],5.9,5.9
Disease,Malignant atrophic papulosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],200,200
Disease,Malignant atrophic papulosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Wells syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23730155[PMID],200,200
Disease,Wells syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23730155[PMID],0,0
Disease,Bullous pemphigoid,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,22418872[PMID]_23237497[PMID],2.17,2.17
Disease,Bullous pemphigoid,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,19170813[PMID],1.34,1.34
Disease,Bullous pemphigoid,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,18614511[PMID],4.3,4.3
Disease,Bullous pemphigoid,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,19566661[PMID],1.21,1.21
Disease,Bullous pemphigoid,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],25,25
Disease,Bullous pemphigoid,1-5 / 10 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,27456755[PMID],25.93,25.93
Disease,Sebocystomatosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Peeling skin syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Familial multiple trichoepithelioma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Porokeratosis of Mibelli,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Pr KANITAKIS Jean[EXPERT],0,0
Disease,Childhood-onset basal ganglia degeneration syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27292112[PMID],4,4
Disease,Childhood-onset basal ganglia degeneration syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27292112[PMID,0,0
Disease,Mutilating palmoplantar keratoderma with periorificial keratotic plaques,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25886873[PMID],73,73
Disease,Mutilating palmoplantar keratoderma with periorificial keratotic plaques,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Porokeratosis plantaris palmaris et disseminata,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Pr KANITAKIS Jean[EXPERT],0,0
Clinical group,C12ORF65-related combined oxidative phosphorylation defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27858754[PMID],0,0
Clinical group,C12ORF65-related combined oxidative phosphorylation defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27858754[PMID]_28091420[PMID]_28804760[PMID],30,30
Disease,Hereditary leiomyomatosis and renal cell cancer,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Hereditary leiomyomatosis and renal cell cancer,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Epidermolytic nevus,,,,,,,,,,,,,
Disease,Erythroderma desquamativum,,,,,,,,,,,,,
Disease,MME-related autosomal dominant Charcot Marie Tooth disease type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27588448[PMID],19,19
Disease,MME-related autosomal dominant Charcot Marie Tooth disease type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27588448[PMID],0,0
Disease,Spinocerebellar ataxia type 43,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27583304[PMID],7,7
Disease,Spinocerebellar ataxia type 43,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27583304[PMID],0,0
Malformation syndrome,Lipoid proteinosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26803878[PMID],500,500
Malformation syndrome,Lipoid proteinosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26803878[PMID],0,0
Disease,Familial keratoacanthoma,,,,,,,,,,,,,
Disease,Diffuse intrinsic pontine glioma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,25435089[PMID],0.056,0.056
Clinical group,Keratosis pilaris atrophicans,,,,,,,,,,,,,
Category,Rare genetic hyperkinetic movement disorder,,,,,,,,,,,,,
Category,Non-inflammatory vasculopathy,,,,,,,,,,,,,
Disease,Acquired ichthyosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Omphalomesenteric cyst,,,,,,,,,,,,,
Category,Non-syndromic postaxial polydactyly,,,,,,,,,,,,,
Category,Non-syndromic preaxial polydactyly,,,,,,,,,,,,,
Morphological anomaly,Digestive duplication,,,,,,,,,,,,,
Category,Terminal transverse limb defect,,,,,,,,,,,,,
Morphological anomaly,Congenital primary megaureter,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Urachal cyst,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Longitudinal limb defect,,,,,,,,,,,,,
Category,Dysostosis with brachydactyly with extraskeletal manifestations,,,,,,,,,,,,,
Morphological anomaly,Atresia of urethra,Unknown,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Category,Dysostosis with brachydactyly without extraskeletal manifestations,,,,,,,,,,,,,
Morphological anomaly,Duplication of urethra,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19231292[PMID],300,300
Morphological anomaly,Duplication of urethra,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19231292[PMID],0,0
Category,Overgrowth or tall stature syndrome with skeletal involvement,,,,,,,,,,,,,
Disease,Alpha delta granule deficiency,,,,,,,,,,,,,
Disease,Gray platelet syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],60,60
Disease,Gray platelet syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Genetic inflammatory or rheumatoid-like osteoarthropathy,,,,,,,,,,,,,
Disease,Hypoplasminogenemia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0.2,0.2
Disease,Congenital prekallikrein deficiency,,,,,,,,,,,,,
Disease,Fetal and neonatal alloimmune thrombocytopenia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],0,0
Disease,Fetal and neonatal alloimmune thrombocytopenia,>1 / 1000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,8960612[PMID]_9746765[PMID]_2317456[PMID]_ORPHANET,0,0
Disease,Congenital high-molecular-weight kininogen deficiency,,,,,,,,,,,,,
Disease,Aquagenic palmoplantar keratoderma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24283504[PMID],0,0
Etiological subtype,X-linked thrombocytopenia with normal platelets,,,,,,,,,,,,,
Clinical group,Syndromic biliary atresia,,,,,,,,,,,,,
Disease,Congenital plasminogen activator inhibitor type 1 deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Biliary atresia and associated disorders,,,,,,,,,,,,,
Clinical group,Reflex epilepsy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Menstrual cycle-dependent periodic fever,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7684743[PMID]_16006734[PMID]_21990073[PMID]_21501330[PMID],5,5
Disease,Menstrual cycle-dependent periodic fever,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7684743[PMID]_16006734[PMID]_21990073[PMID]_21501330[PMID],0,0
Disease,Medullary thyroid carcinoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],5,5
Disease,Medullary thyroid carcinoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,21186939[PMID]_National Cancer Institute 1992-2006[INST],0.17,0.17
Disease,Medullary thyroid carcinoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],0.22,0.22
Category,Neuroendocrine neoplasm,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,18853416[PMID],3.2,3.2
Category,Neuroendocrine neoplasm,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,18565894[PMID]_National Cancer Institute[INST],5.25,5.25
Category,Neuroendocrine neoplasm,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.53,2.53
Category,Neuroendocrine neoplasm,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,18565894[PMID],35,35
Category,Neuroendocrine neoplasm,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Gorham-Stout disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_20972870[PMID]_23897792[PMID]_25227772[PMID],300,300
Malformation syndrome,Gorham-Stout disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20972870[PMID]_23897792[PMID]_25227772[PMID],0,0
Disease,Phyllodes tumor of the prostate,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25210561[PMID],90,90
Disease,Relapsing polychondritis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,21962557[PMID]_14673390[PMID],0.35,0.35
Disease,Relapsing polychondritis,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,21962557[PMID]_14673390[PMID],0.35,0.35
Disease,Relapsing polychondritis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Relapsing polychondritis,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,26187053[PMID],0.071,0.071
Disease,Relapsing polychondritis,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,26187053[PMID],0.52,0.52
Category,Non-acquired combined pituitary hormone deficiency,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],29,29
Category,Non-acquired combined pituitary hormone deficiency,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Anaplastic thyroid carcinoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],0.17,0.17
Disease,Anaplastic thyroid carcinoma,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2004[INST],0.1,0.1
Disease,Parathyroid carcinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe 2011[REG],0.02,0.02
Disease,Parathyroid carcinoma,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Parathyroid carcinoma,1-9 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.28,0.28
Disease,Parathyroid carcinoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,26708847[PMID]_17372919[PMID]_SEER Surveillance Epidemiology and End Results Program 2003[REG],0,0
Disease,Parathyroid carcinoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.015,0.015
Disease,Parathyroid carcinoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Parathyroid carcinoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,Parathyroid carcinoma,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Parathyroid carcinoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.015,0.015
Disease,Parathyroid carcinoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Disease,Parathyroid carcinoma,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Parathyroid carcinoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Disease,Parathyroid carcinoma,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Parathyroid carcinoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Parathyroid carcinoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.052,0.052
Disease,Parathyroid carcinoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Parathyroid carcinoma,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Parathyroid carcinoma,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.031,0.031
Disease,Parathyroid carcinoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.016,0.016
Disease,Parathyroid carcinoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Parathyroid carcinoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Parathyroid carcinoma,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Parathyroid carcinoma,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Parathyroid carcinoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Disease,Parathyroid carcinoma,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Disease,Parathyroid carcinoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.015,0.015
Disease,Parathyroid carcinoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Central precocious puberty,1-5 / 10 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,20,20
Disease,Central precocious puberty,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Generalized glucocorticoid resistance syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23392096[PMID],0,0
Disease,Idiopathic pulmonary artery dilatation,,,,,,,,,,,,,
Morphological anomaly,Dextrocardia,,,,,,,,,,,,,
Morphological anomaly,Criss-cross heart,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:9781416023906[OTHER]_22555779[PMID],0.8,0.8
Morphological anomaly,Criss-cross heart,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Mitral atresia,,,,,,,,,,,,,
Clinical subtype,Supravalvular pulmonary stenosis,,,,,,,,,,,,,
Disease,Primary pediatric heart tumor,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chronic relapsing inflammatory optic neuropathy,,,,,,,,,,,,,
Disease,Familial atrial fibrillation,,,,,,,,,,,,,
Disease,Familial atrial myxoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1540058[PMID],17,17
Disease,Familial atrial myxoma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1540058[PMID],0,0
Disease,Limbic encephalitis with neurexin-3 antibodies,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27170573[PMID],5,5
Disease,Limbic encephalitis with neurexin-3 antibodies,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27170573[PMID],0,0
Disease,Primary adult heart tumor,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital syphilis,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,CDC Centers for disease Control and prevention 2016[INST],15.7,15.7
Disease,Congenital syphilis,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.3,1.3
Disease,Congenital syphilis,1-5 / 10 000,Bulgaria,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],26.6,26.6
Disease,Congenital syphilis,1-9 / 100 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.3,1.3
Disease,Congenital syphilis,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.04,1.04
Disease,Congenital syphilis,1-9 / 100 000,Greece,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2015[INST],1.1,1.1
Disease,Congenital syphilis,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.7,1.7
Disease,Congenital syphilis,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2015[INST],1.1,1.1
Disease,Congenital syphilis,1-9 / 100 000,Lithuania,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],4.6,4.6
Disease,Congenital syphilis,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.9,1.9
Disease,Congenital syphilis,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],5.4,5.4
Disease,Congenital syphilis,1-9 / 100 000,Romania,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],2.5,2.5
Disease,Congenital syphilis,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.3,0.3
Disease,Congenital syphilis,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.3,0.3
Disease,Congenital syphilis,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.8,0.8
Disease,Tuberculous meningitis,,,,,,,,,,,,,
Morphological anomaly,Partial atrioventricular canal,1-5 / 10 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,23040494[PMID],20,20
Morphological anomaly,Partial atrioventricular canal,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_17341403[PMID]_12084585[PMID],30,30
Clinical group,Autoimmune/inflammatory optic neuropathy,,,,,,,,,,,,,
Morphological anomaly,Familial idiopathic dilatation of the right atrium,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Short rib-polydactyly syndrome type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17935248[PMID],2,2
Malformation syndrome,Short rib-polydactyly syndrome type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17935248[PMID],0,0
Disease,Pili bifurcati,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Primary cutis verticis gyrata,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Trichofolliculoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Sugarman brachydactyly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4469972[PMID]_7083610[PMID],1,1
Morphological anomaly,Sugarman brachydactyly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4469972[PMID]_7083610[PMID],0,0
Clinical group,Arrhythmogenic right ventricular cardiomyopathy,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,16585401[PMID]_Pr Cristina BASSO_Dr Kalliopi PILICHOU_Pr Domenico CORRADO_Pr Gaetano THIENE[EXPERT],43.5,43.5
Clinical group,Arrhythmogenic right ventricular cardiomyopathy,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23736219[PMID],20,20
Disease,MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26661508[PMID],4,4
Disease,MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26661508[PMID],0,0
Category,Non-syndromic complex polydactyly,,,,,,,,,,,,,
Disease,Marie Unna hereditary hypotrichosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acquired hypertrichosis lanuginosa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,60,60
Disease,Acquired hypertrichosis lanuginosa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hyaline fibromatosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25186005[PMID],150,150
Disease,Hyaline fibromatosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25186005[PMID],0,0
Disease,Proliferating trichilemmal cyst,,,,,,,,,,,,,
Category,Ectrodactyly with and without other manifestations,,,,,,,,,,,,,
Malformation syndrome,LRP5-related primary osteoporosis,,,,,,,,,,,,,
Disease,Kerion celsi,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Overgrowth-metaphyseal undermodeling-spondylar dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15214018[PMID]_17618504[PMID],4,4
Malformation syndrome,Overgrowth-metaphyseal undermodeling-spondylar dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15214018[PMID]_17618504[PMID],0,0
Disease,Monilethrix,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Overgrowth syndrome with 2q37 translocation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25728306[PMID],4,4
Malformation syndrome,Overgrowth syndrome with 2q37 translocation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25728306[PMID],0,0
Disease,Lichen planopilaris,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,300,300
Disease,Lichen planopilaris,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Complete hemimelia,,,,,,,,,,,,,
Disease,Alopecia totalis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,10.5,10.5
Disease,Syringocystadenoma papilliferum,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16418676[PMID],300,300
Disease,Syringocystadenoma papilliferum,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Mirror-image polydactyly,,,,,,,,,,,,,
Disease,Huriez syndrome,,,,,,,,,,,,,
Disease,Erythrokeratoderma ''en cocardes'',<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hyperkeratosis lenticularis perstans,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Dyschromatosis symmetrica hereditaria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,300,300
Disease,Dyschromatosis symmetrica hereditaria,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dyschromatosis symmetrica hereditaria,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,12916015[PMID],1.5,1.5
Malformation syndrome,Birt-Hogg-Dubé syndrome,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.5,0.5
Disease,Acrokeratoelastoidosis of Costa,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acromelanosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Acromelanosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dyschromatosis universalis hereditaria,,,,,,,,,,,,,
Disease,Progressive symmetric erythrokeratodermia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Familial cylindromatosis,,,,,,,,,,,,,
Clinical group,Non-histaminic angioedema,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Multifocal atrial tachycardia,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.67,0.67
Disease,Systemic capillary leak syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],150,150
Disease,Systemic capillary leak syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20566927[PMID],0.7,0.7
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1.1,1.1
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,23809583[PMID],0.6,0.6
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,1419751[PMID],0.3,0.3
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:801812658[OTHER],0.93,0.93
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,6203284[PMID],0.88,0.88
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 100 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,2359725[PMID],1.9,1.9
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,2601109[PMID],0.35,0.35
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,20566927[PMID],0.1,0.1
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,20566927[PMID],0.39,0.39
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:951563203[OTHER],0.12,0.12
Clinical group,Dystrophic epidermolysis bullosa,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:801860245[OTHER],0.24,0.24
Clinical group,Junctional epidermolysis bullosa,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Junctional epidermolysis bullosa,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Junctional epidermolysis bullosa,<1 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:443048517[OTHER],0.08,0.08
Clinical group,Junctional epidermolysis bullosa,<1 / 1 000 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,1419751[PMID],0.07,0.07
Clinical group,Junctional epidermolysis bullosa,<1 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,6203284[PMID],0.02,0.02
Clinical group,Junctional epidermolysis bullosa,1-9 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.38,0.38
Clinical group,Junctional epidermolysis bullosa,<1 / 1 000 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,20566927[PMID],0.07,0.07
Clinical group,Junctional epidermolysis bullosa,<1 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,2601109[PMID],0.02,0.02
Clinical group,Junctional epidermolysis bullosa,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,ISBN:801860245[OTHER],0.22,0.22
Clinical group,Junctional epidermolysis bullosa,<1 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:801860245[OTHER],0.04,0.04
Clinical group,Junctional epidermolysis bullosa,<1 / 1 000 000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:951563203[OTHER],0.07,0.07
Disease,Ulerythema ophryogenesis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pilomatrix carcinoma,,,,,,,,,,,,,
Disease,Kindler syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26937547[PMID],250,250
Disease,Kindler syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26937547[PMID],0,0
Disease,Antisynthetase syndrome,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3.5,3.5
Disease,Antisynthetase syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Idiopathic optic perineuritis,,,,,,,,,,,,,
Disease,Peripartum cardiomyopathy,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,10703781[PMID],30,30
Disease,Peripartum cardiomyopathy,1-5 / 10 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,23090517[PMID]_10703781[PMID]_16765131[PMID],36,36
Disease,Peripartum cardiomyopathy,6-9 / 10 000,Singapore,409968,409968,25958,25958,en,Validated,410293,410293,23338912[PMID],89,89
Disease,Peripartum cardiomyopathy,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,21617320[PMID],5,5
Disease,Peripartum cardiomyopathy,>1 / 1000,Haiti,409968,409968,25958,25958,en,Validated,410293,410293,16342653[PMID],334,334
Disease,Peripartum cardiomyopathy,>1 / 1000,South Africa,409968,409968,25958,25958,en,Validated,410293,410293,16920474[PMID],100,100
Disease,Peripartum cardiomyopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pyomyositis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Isolated optic neuritis,,,,,,,,,,,,,
Disease,Reynolds syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Recurrent idiopathic neuroretinitis,,,,,,,,,,,,,
Disease,Susac syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23628737[PMID],304,304
Disease,Susac syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cutaneous small vessel vasculitis,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9805179[PMID],2.7,2.7
Disease,Cutaneous small vessel vasculitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Kimura disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18808562[PMID],300,300
Disease,Kimura disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Congenital bile acid synthesis defect,,,,,,,,,,,,,
Disease,Isolated congenital hepatic fibrosis,,,,,,,,,,,,,
Disease,Prenatal-onset spinal muscular atrophy with congenital bone fractures,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26924529[PMID]_28218388[PMID],0,0
Disease,Prenatal-onset spinal muscular atrophy with congenital bone fractures,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26924529[PMID]_28218388[PMID],7,7
Disease,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27008887[PMID],4,4
Disease,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27008887[PMID],0,0
Disease,EMILIN-1-related connective tissue disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26462740[PMID],3,3
Disease,EMILIN-1-related connective tissue disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26462740[PMID],0,0
Etiological subtype,MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26783368[PMID],4,4
Etiological subtype,MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26783368[PMID],0,0
Category,Genetic non-acquired premature ovarian failure,,,,,,,,,,,,,
Malformation syndrome,16p12.1p12.3 triplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26647099[PMID],3,3
Malformation syndrome,16p12.1p12.3 triplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26647099[PMID],0,0
Malformation syndrome,CLCN4-related X-linked intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27550844[PMID],0,0
Malformation syndrome,CLCN4-related X-linked intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27550844[PMID],38,38
Malformation syndrome,Propylthiouracil embryofetopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_25974033[PMID],0,0
Etiological subtype,Acquired schizencephaly,,,,,,,,,,,,,
Malformation syndrome,X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26804200[PMID]_26686323[PMID],15,15
Malformation syndrome,X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26804200[PMID]_26686323[PMID],0,0
Category,Rare idiopathic macular telangiectasia,,,,,,,,,,,,,
Disease,Adenylosuccinate synthetase-like 1-related distal myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26506222[PMID]_27868399[PMID]_28268051[PMID],19,19
Disease,Adenylosuccinate synthetase-like 1-related distal myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26506222[PMID]_27868399[PMID]_28268051[PMID],0,0
Particular clinical situation in a disease or syndrome,Digitalis poisoning,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26805781[PMID]_26805782[PMID],24,24
Disease,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26805781[PMID]_26805782[PMID],0,0
Disease,Pulmonary venoocclusive disease,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,21510732[PMID]_16456139[PMID],0.015,0.015
Disease,Pulmonary venoocclusive disease,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,16456139[PMID]_21510732[PMID]_ [EXPERT],0.015,0.015
Malformation syndrome,X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26637982[PMID],14,14
Malformation syndrome,X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26637982[PMID],0,0
Disease,Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26942288[PMID],6,6
Disease,Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26942288[PMID],0,0
Malformation syndrome,X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26833328[PMID],17,17
Malformation syndrome,X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26833328[PMID],0,0
Clinical group,Hypersensitivity pneumonitis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Isolated neonatal sclerosing cholangitis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27319779[PMID]_27469900[PMID],4,4
Disease,Isolated neonatal sclerosing cholangitis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27319779[PMID]_27469900[PMID],0,0
Disease,Aneurysmal bone cyst,,,,,,,,,,,,,
Category,Non-severe combined immunodeficiency,,,,,,,,,,,,,
Disease,High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement,,,,,,,,,,,,,
Disease,Infantile convulsions and choreoathetosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Ethylene glycol poisoning,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary thrombocytopenia with early-onset myelofibrosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26936507[PMID],9,9
Disease,Hereditary thrombocytopenia with early-onset myelofibrosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26936507[PMID],0,0
Disease,Paraquat poisoning,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Colchicine poisoning,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],0.1,0.1
Disease,Facial diplegia with paresthesias,,,,,,,,,,,,,
Disease,POGLUT1-related  limb-girdle muscular dystrophy R21,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27807076[PMID],4,4
Disease,POGLUT1-related  limb-girdle muscular dystrophy R21,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27807076[PMID],0,0
Disease,Methanol poisoning,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,USP18 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27821552[PMID]_2732588[PMID],5,5
Disease,USP18 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27821552[PMID]_2732588[PMID],0,0
Category,Type 1 interferonopathy of childhood,,,,,,,,,,,,,
Clinical group,HTRA1-related cerebral small vessel disease,,,,,,,,,,,,,
Disease,HTRA1-related autosomal dominant cerebral small vessel disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26063658[PMID],21,21
Disease,HTRA1-related autosomal dominant cerebral small vessel disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26063658[PMID],0,0
Category,Genetic alopecia,,,,,,,,,,,,,
Etiological subtype,Familial schizencephaly,,,,,,,,,,,,,
Malformation syndrome,PYCR2-related microcephaly-progressive leukoencephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25865492[PMID]_27130255[PMID],18,18
Malformation syndrome,PYCR2-related microcephaly-progressive leukoencephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25865492[PMID]_27130255[PMID],0,0
Disease,Familial Chilblain lupus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27566796[PMID],10,10
Disease,Familial Chilblain lupus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27566796[PMID],0,0
Category,Gastroenteric neuroendocrine neoplasm,,,,,,,,,,,,,
Clinical subtype,Progressive familial intrahepatic cholestasis type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26888176[PMID],4,4
Clinical subtype,Progressive familial intrahepatic cholestasis type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26888176[PMID],0,0
Clinical subtype,MYO5B-related progressive familial intrahepatic cholestasis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27532546[PMID],5,5
Clinical subtype,MYO5B-related progressive familial intrahepatic cholestasis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27532546[PMID],0,0
Clinical subtype,Progressive familial intrahepatic cholestasis type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26983395[PMID]_24614073[PMID],14,14
Clinical subtype,Progressive familial intrahepatic cholestasis type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26983395[PMID]_24614073[PMID],0,0
Malformation syndrome,Lethal hydranencephaly-diaphragmatic hernia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27417437[PMID],0,0
Malformation syndrome,Lethal hydranencephaly-diaphragmatic hernia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27417437[PMID],2,2
Disease,Idiopathic peliosis hepatis,,,,,,,,,,,,,
Clinical subtype,MSH3-related attenuated familial adenomatous polyposis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27476653[PMID],4,4
Clinical subtype,MSH3-related attenuated familial adenomatous polyposis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27476653[PMID],0,0
Morphological anomaly,Congenital portosystemic shunt,,,,,,,,,,,,,
Disease,Primary intrahepatic lithiasis,,,,,,,,,,,,,
Morphological anomaly,Choledochal cyst,,,,,,,,,,,,,
Malformation syndrome,Caroli syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17461493[PMID],0,0
Disease,Idiopathic ductopenia,,,,,,,,,,,,,
Category,Rare hypercholesterolemia,,,,,,,,,,,,,
Malformation syndrome,Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24781755[PMID]_26463574[PMID],9,9
Malformation syndrome,Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24781755[PMID]_26463574[PMID],0,0
Category,Genetic cardiac malformation,,,,,,,,,,,,,
Category,Other genetic dermis disorder,,,,,,,,,,,,,
Category,Syndromic constitutional thrombocytopenia,,,,,,,,,,,,,
Category,Isolated constitutional thrombocytopenia,,,,,,,,,,,,,
Disease,Primary condylar hyperplasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26629479[PMID],0,0
Disease,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25102815[PMID]_18451993[PMID],2,2
Disease,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25102815[PMID]_18451993[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 29,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26626369[PMID],1,1
Disease,Combined oxidative phosphorylation defect type 29,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26626369[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 30,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27132592[PMID],2,2
Disease,Combined oxidative phosphorylation defect type 30,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27132592[PMID],0,0
Malformation syndrome,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24838796[PMID]_26656649[PMID],3,3
Malformation syndrome,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24838796[PMID]_26656649[PMID],0,0
Disease,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26160376[PMID],7,7
Disease,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26160376[PMID],0,0
Malformation syndrome,PMP22-RAI1 contiguous gene duplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26544804[PMID],23,23
Malformation syndrome,PMP22-RAI1 contiguous gene duplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26544804[PMID],0,0
Malformation syndrome,Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25454926[PMID]_26455322[PMID],2,2
Malformation syndrome,Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25454926[PMID]_26455322,0,0
Disease,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27799064[PMID]_25778941[PMID],4,4
Disease,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27799064[PMID]_25778941[PMID],0,0
Disease,Hereditary sensory and autonomic neuropathy type 8,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26005867[PMID]_26975306[PMID]_28050684[PMID],11,11
Disease,Hereditary sensory and autonomic neuropathy type 8,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26005867[PMID]_26975306[PMID]_28050684[PMID],0,0
Category,Type 1 interferonopathy,,,,,,,,,,,,,
Disease,Fibroblastic rheumatism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25545215[PMID],30,30
Disease,Fibroblastic rheumatism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25545215[PMID],0,0
Disease,IL21-related infantile inflammatory bowel disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19890111[PMID]_24746753[PMID],3,3
Disease,IL21-related infantile inflammatory bowel disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19890111[PMID]_24746753[PMID],0,0
Disease,Combined oxidative phosphorylation defect type 26,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26189817[PMID]_2544623[PMID],2,2
Disease,Combined oxidative phosphorylation defect type 26,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26189817[PMID]_2544623[PMID],0,0
Disease,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25758935[PMID]_27601654[PMID],17,17
Disease,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25758935[PMID]_27601654[PMID],0,0
Disease,Pediatric multiple sclerosis,,,,,,,,,,,,,
Disease,Pontine autosomal dominant microangiopathy with leukoencephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19187480[PMID]_27666438[PMID],11,11
Disease,Pontine autosomal dominant microangiopathy with leukoencephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19187480[PMID]_27666438[PMID],0,0
Disease,Nodular fasciitis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,COL4A1 or COL4A2-related cerebral small vessel disease,,,,,,,,,,,,,
Category,Genetic cerebral small vessel disease,,,,,,,,,,,,,
Clinical group,COL4A1 or COL4A2-related cerebral small vessel disease with hemorrhagic tendancy,,,,,,,,,,,,,
Clinical group,COL4A1 or COL4A2-related cerebral small vessel disease with ischemic tendancy,,,,,,,,,,,,,
Category,Rare disorder with a moyamoya angiopathy,,,,,,,,,,,,,
Clinical group,Moyamoya angiopathy,,,,,,,,,,,,,
Disease,Combined oxidative phosphorylation defect type 27,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25361775[PMID]_25787132[PMID],3,3
Disease,Combined oxidative phosphorylation defect type 27,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25361775[PMID]_25787132[PMID],0,0
Clinical group,Demyelinating hereditary motor and sensory neuropathy,,,,,,,,,,,,,
Malformation syndrome,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25782671[PMID],1,1
Malformation syndrome,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25782671[PMID],0,0
Clinical group,Axonal hereditary motor and sensory neuropathy,,,,,,,,,,,,,
Disease,Combined immunodeficiency due to TFRC deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26642240[PMID],2,2
Disease,Combined immunodeficiency due to TFRC deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26642240[PMID],0,0
Clinical group,Intermediate Charcot-Marie-Tooth disease,,,,,,,,,,,,,
Malformation syndrome,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26721934[PMID],4,4
Malformation syndrome,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26721934[PMID],0,0
Disease,Congenital generalized hypercontractile muscle stiffness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26418456[PMID],2,2
Disease,Congenital generalized hypercontractile muscle stiffness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26418456[PMID],0,0
Disease,PMP2-related Charcot-Marie-Tooth disease type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26828946[PMID],13,13
Disease,PMP2-related Charcot-Marie-Tooth disease type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26828946[PMID],0,0
Clinical group,Hypercontractile muscle stiffness syndrome,,,,,,,,,,,,,
Disease,Vibratory urticaria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26841242[PMID],37,37
Disease,Vibratory urticaria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26841242[PMID],0,0
Disease,Vibratory angioedema,,,,,,,,,,,,,
Malformation syndrome,TELO2-related intellectual disability-neurodevelopmental disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27132593[PMID],6,6
Malformation syndrome,TELO2-related intellectual disability-neurodevelopmental disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27132593[PMID],0,0
Disease,DDX41-related hematologic malignancy predisposition syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26712909[PMID],3,3
Disease,DDX41-related hematologic malignancy predisposition syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26712909[PMID],0,0
Disease,"Distal myopathy, Tateyama type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11805270[PMID]_15580566[PMID]_18930476[PMID],0,0
Disease,"Distal myopathy, Tateyama type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11805270[PMID]_15580566[PMID]_18930476[PMID],7,7
Malformation syndrome,Transketolase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27259054[PMID],5,5
Malformation syndrome,Transketolase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27259054[PMID],0,0
Malformation syndrome,Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27055666[PMID],3,3
Malformation syndrome,Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27055666[PMID],0,0
Malformation syndrome,TBCK-related intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27748029[PMID],25,25
Malformation syndrome,TBCK-related intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27748029[PMID],0,0
Disease,Early-onset epilepsy-intellectual disability-brain anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26996948[PMID],5,5
Disease,Early-onset epilepsy-intellectual disability-brain anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26996948[PMID],0,0
Disease,Osteofibrous dysplasia,,,,,,,,,,,,,
Disease,Acute macular neuroretinopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26973287[PMID],101,101
Disease,Acute macular neuroretinopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26973287[PMID],0,0
Malformation syndrome,Split-foot malformation-mesoaxial polydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26755636[PMID],5,5
Malformation syndrome,Split-foot malformation-mesoaxial polydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26755636[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2W,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26072516[PMID],24,24
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2W,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26072516[PMID],0,0
Disease,14q32 duplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26280900[PMID],33,33
Disease,14q32 duplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26280900[PMID],0,0
Malformation syndrome,Congenital amyoplasia,,,,,,,,,,,,,
Malformation syndrome,SIX2-related frontonasal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26581443[PMID],1,1
Malformation syndrome,SIX2-related frontonasal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26581443[PMID],0,0
Malformation syndrome,"Camptodactyly syndrome, Guadalajara type 3",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12401988[PMID],5,5
Malformation syndrome,"Camptodactyly syndrome, Guadalajara type 3",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12401988[PMID],0,0
Malformation syndrome,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28087732[PMID],26,26
Malformation syndrome,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28087732[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 76,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27153400[PMID]_27320912[PMID],7,7
Disease,Autosomal recessive spastic paraplegia type 76,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27153400[PMID]_27320912[PMID],0,0
Disease,Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26056285[PMID],9,9
Disease,Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26056285[PMID],0,0
Malformation syndrome,Microcephaly-congenital cataract-psoriasiform dermatitis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28673550[PMID],5,5
Malformation syndrome,Microcephaly-congenital cataract-psoriasiform dermatitis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28673550[PMID],0,0
Disease,Female infertility due to oocyte meiotic arrest,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27273344[PMID],16,16
Disease,Female infertility due to oocyte meiotic arrest,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27273344[PMID],0,0
Malformation syndrome,Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26708094[PMID],2,2
Malformation syndrome,Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26708094[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26786738[PMID],2,2
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26786738[PMID],0,0
Disease,Pediatric collagenous gastritis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23538318[PMID]_25789098[PMID],24,24
Disease,Pediatric collagenous gastritis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25789098[PMID],0,0
Malformation syndrome,Pierpont syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28562391[PMID],7,7
Malformation syndrome,Pierpont syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28562391[PMID],0,0
Category,Rare pediatric rheumatologic disease,,,,,,,,,,,,,
Disease,Rat-bite fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Nocardiosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Hypobetalipoproteinemia,,,,,,,,,,,,,
Disease,Melioidosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Melioidosis,1-5 / 10 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,22970946[PMID],50,50
Disease,Melioidosis,1-5 / 10 000,Thailand,409967,409967,25958,25958,en,Validated,410293,410293,22970946[PMID],50,50
Disease,Tangier disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22913675[PMID],100,100
Disease,Tangier disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22913675[PMID],0,0
Disease,Tangier disease,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],0,0
Clinical group,Hypoalphalipoproteinemia,,,,,,,,,,,,,
Disease,Oral erosive lichen,,,,,,,,,,,,,
Disease,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,110,110
Disease,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Dermatofibrosarcoma protuberans,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_European Medicines Agency[INST],10,10
Disease,Primary hypomagnesemia with secondary hypocalcemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Primary hypomagnesemia with secondary hypocalcemia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Hereditary central diabetes insipidus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,BVES-related limb-girdle muscular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26642364[PMID],3,3
Disease,BVES-related limb-girdle muscular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26642364[PMID],0,0
Disease,Erythrokeratodermia-cardiomyopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26604139[PMID]_27408699[PMID],3,3
Disease,Erythrokeratodermia-cardiomyopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26604139[PMID]_27408699[PMID],0,0
Disease,Hereditary pediatric Behçet-like disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26642243[PMID],13,13
Disease,Hereditary pediatric Behçet-like disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26642243[PMID],0,0
Disease,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26718575[PMID],8,8
Disease,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26718575[PMID],0,0
Category,Genetic lethal multiple congenital anomalies/dysmorphic syndrome,,,,,,,,,,,,,
Clinical group,Rare congenital anomaly of ventricular septum,,,,,,,,,,,,,
Disease,Congenital brain dysgenesis due to glutamine synthetase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21353613[PMID],3,3
Disease,Congenital brain dysgenesis due to glutamine synthetase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21353613[PMID],0,0
Disease,CANOMAD syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,CANOMAD syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Category,Rare central nervous system and retinal vascular disease,,,,,,,,,,,,,
Malformation syndrome,Split hand-split foot-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,22,22
Malformation syndrome,Split hand-split foot-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Sandifer syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Renal nutcracker syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Disseminated peritoneal leiomyomatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],150,150
Disease,Disseminated peritoneal leiomyomatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Rh deficiency syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Silent sinus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,98,98
Disease,Silent sinus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Classic glucose transporter type 1 deficiency syndrome,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,16712556[PMID],1.11,1.11
Disease,Classic glucose transporter type 1 deficiency syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Classic glucose transporter type 1 deficiency syndrome,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,26537434[PMID],1.2,1.2
Category,Rare soft tissue tumor,,,,,,,,,,,,,
Disease,Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Neuromyelitis optica,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23545439[PMID],1.5,1.5
Disease,Neuromyelitis optica,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,28986408[PMID],2.1,2.1
Malformation syndrome,Dentinogenesis imperfecta-short stature-hearing loss-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16011615[PMID],2,2
Malformation syndrome,Dentinogenesis imperfecta-short stature-hearing loss-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16011615[PMID],0,0
Disease,Retinal capillary malformation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare pulmonary hypertension,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25385937[PMID],0,0
Clinical group,Autoimmune thrombocytopenia,,,,,,,,,,,,,
Category,Rare hemorrhagic disorder due to a constitutional platelet anomaly,,,,,,,,,,,,,
Disease,Idiopathic gastroparesis,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30396519[PMID],11.4,11.4
Disease,Chronic thromboembolic pulmonary hypertension,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2013[INST],3,3
Disease,Chronic thromboembolic pulmonary hypertension,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,21793646[PMID],55,55
Disease,Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21734245[PMID],49,49
Disease,Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21734245[PMID],0,0
Malformation syndrome,Bronchopulmonary dysplasia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],13,13
Disease,Infantile apnea,,,,,,,,,,,,,
Disease,Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital Epstein-Barr virus infection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Immunodeficiency due to selective anti-polysaccharide antibody deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28588580[PMID],0,0
Disease,Dopa-responsive dystonia due to sepiapterin reductase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22522443[PMID],43,43
Disease,Dopa-responsive dystonia due to sepiapterin reductase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Adult acute respiratory distress syndrome,6-9 / 10 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,16236739[PMID],64,64
Disease,Adult acute respiratory distress syndrome,1-5 / 10 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,51,51
Disease,Adult acute respiratory distress syndrome,1-5 / 10 000,Iceland,409967,409967,25965,25965,en,Not yet validated,410294,410294,23216361[PMID]_10351930[PMID]_ ORPHANET,11.5,11.5
Disease,Adult acute respiratory distress syndrome,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,21997128[PMID],7.2,7.2
Disease,Adult acute respiratory distress syndrome,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,10579250[PMID],4.9,4.9
Disease,Adult acute respiratory distress syndrome,1-5 / 10 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,10351930[PMID],13.5,13.5
Disease,Adult acute respiratory distress syndrome,1-5 / 10 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,10351930[PMID],13.5,13.5
Disease,Adult acute respiratory distress syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2008[INST],0,0
Disease,Small cell lung cancer,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],12,12
Disease,Post-transplant lymphoproliferative disease,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],26.2,26.2
Disease,Meconium aspiration syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],2.44,2.44
Disease,Infant acute respiratory distress syndrome,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,3.5,3.5
Disease,Infant acute respiratory distress syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],20,20
Disease,Leigh syndrome with cardiomyopathy,,,,,,,,,,,,,
Disease,"Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cholangiocarcinoma,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_emedicine 2011[OTHER],4.2,4.2
Disease,Cholangiocarcinoma,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],2.1,2.1
Disease,Cholangiocarcinoma,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,15765398[PMID]_19245868[PMID]_24140396[PMID],1,1
Disease,Cholangiocarcinoma,>1 / 1000,Thailand,409967,409967,25958,25958,en,Validated,410293,410293,18408464[PMID],113,113
Disease,Cholangiocarcinoma,1-9 / 100 000,Japan,409967,409967,25965,25965,en,Not yet validated,410294,410294,emedicine 2011[OTHER],5.5,5.5
Disease,Cholangiocarcinoma,1-9 / 1 000 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,15192785[PMID],0.1,0.1
Disease,Cholangiocarcinoma,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,emedicine 2011[OTHER]_22895392[PMID],4,4
Disease,Cholangiocarcinoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2004[INST]_22173164[PMID],0,0
Category,Rare disorder with Hirschsprung disease as a major feature,,,,,,,,,,,,,
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],7,7
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],7.1,7.1
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.67,6.67
Clinical group,Carcinoma of esophagus,1-5 / 10 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]_[EXPERT],12.2,12.2
Clinical group,Carcinoma of esophagus,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer Institute 2012[INST],5.5,5.5
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],9.8,9.8
Clinical group,Carcinoma of esophagus,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.873,6.873
Clinical group,Carcinoma of esophagus,1-5 / 10 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],10.82,10.82
Clinical group,Carcinoma of esophagus,1-9 / 100 000,India,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],3.9,3.9
Clinical group,Carcinoma of esophagus,1-5 / 10 000,China,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],20,20
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Africa,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],2.3,2.3
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,ISBN:443075956[OTHER]_14530066[PMID],9,9
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Canada,409967,409967,25965,25965,en,Not yet validated,410294,410294,23061066[PMID],3.9,3.9
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Russian Federation,409967,409967,25958,25958,en,Validated,410293,410293,ISBN:443075956[OTHER]_14530066[PMID],8,8
Clinical group,Carcinoma of esophagus,1-5 / 10 000,Latin America,409967,409967,25958,25958,en,Validated,410293,410293,ISBN:443075956[OTHER]_14530066[PMID],13,13
Clinical group,Carcinoma of esophagus,1-9 / 1 000 000,"Iran, Islamic Republic of",409966,409966,25958,25958,en,Validated,410293,410293,23120941[PMID],0.34,0.34
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.293,3.293
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.892,7.892
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.194,1.194
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.281,3.281
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.718,3.718
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.473,3.473
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.83,3.83
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.854,5.854
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.772,4.772
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.2,7.2
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.612,3.612
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.372,3.372
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.468,3.468
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.575,2.575
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.592,3.592
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.414,2.414
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.592,4.592
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.54,4.54
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.904,3.904
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.777,4.777
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.413,6.413
Clinical group,Carcinoma of esophagus,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],8.362,8.362
Disease,Vernal keratoconjunctivitis,>1 / 1000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,18356259[PMID],151,151
Disease,Vernal keratoconjunctivitis,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,18356259[PMID],45.5,45.5
Disease,Vernal keratoconjunctivitis,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,18356259[PMID],49.5,49.5
Disease,Vernal keratoconjunctivitis,1-5 / 10 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,18356259[PMID],26,26
Disease,Vernal keratoconjunctivitis,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,18356259[PMID],20,20
Disease,Vernal keratoconjunctivitis,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,18356259[PMID],11,11
Disease,Vernal keratoconjunctivitis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,18356259[PMID],32,32
Disease,Radiation proctitis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],35,35
Disease,Circumscribed palmoplantar hypokeratosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16700830[PMID],17,17
Disease,Circumscribed palmoplantar hypokeratosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Warty dyskeratoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_12740761[PMID],4,4
Disease,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Bilateral acute depigmentation of the iris,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23812527[PMID],62,62
Disease,Bilateral acute depigmentation of the iris,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23812527[PMID],0,0
Malformation syndrome,Bosley-Salih-Alorainy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16155570[PMID]_17875913[PMID]_18412118[PMID],16,16
Malformation syndrome,Bosley-Salih-Alorainy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16155570[PMID]_17875913[PMID]_18412118[PMID],0,0
Disease,Athabaskan brainstem dysgenesis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12833395[PMID]_18412118[PMID],13,13
Disease,Athabaskan brainstem dysgenesis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12833395[PMID]_18412118[PMID],0,0
Disease,Low phospholipid-associated cholelithiasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Intrahepatic cholestasis of pregnancy,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22892336[PMID],0,0
Disease,Tyrosinemia type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Tyrosinemia type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI:10.1007/978-3-319-96929-9_4[OTHER],53,53
Disease,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI:10.1007/978-3-319-96929-9_4[OTHER],0,0
Disease,Naegeli-Franceschetti-Jadassohn syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.035,0.035
Malformation syndrome,Anonychia with flexural pigmentation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1156563[PMID],3,3
Malformation syndrome,Anonychia with flexural pigmentation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1156563[PMID],0,0
Disease,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11242109[PMID],2,2
Disease,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11242109[PMID],0,0
Malformation syndrome,"Ectodermal dysplasia with natal teeth, Turnpenny type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8574423[PMID],0,0
Malformation syndrome,"Ectodermal dysplasia with natal teeth, Turnpenny type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8574423[PMID],1,1
Malformation syndrome,Odonto-tricho-ungual-digito-palmar syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9217212[PMID],21,21
Malformation syndrome,Odonto-tricho-ungual-digito-palmar syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9217212[PMID],0,0
Malformation syndrome,Limb-mammary syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Pr MANOUVRIER-HANU Sylvie[EXPERT]_26075610[PMID]_9973291[PMID]_20410354[PMID],38,38
Malformation syndrome,Limb-mammary syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26075610[PMID]_9973291[PMID]_20410354[PMID],0,0
Malformation syndrome,Pure hair and nail ectodermal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Pure hair and nail ectodermal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Rhabdoid tumor,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,500,500
Disease,Rhabdoid tumor,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Rhabdoid tumor,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial renal glucosuria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Liposarcoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22517534[PMID]_[EXPERT],1,1
Disease,Liposarcoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,17013893[PMID],0.59,0.59
Disease,Liposarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical syndrome,Idiopathic steroid-sensitive nephrotic syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19154696[PMID]_15464186[PMID],15,15
Disease,Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,3-methylglutaconic aciduria type 4,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Dysostosis with brachydactyly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,3-methylglutaconic aciduria type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,3-methylglutaconic aciduria type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,3-methylglutaconic aciduria type 3,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Thrombocytopenia with congenital dyserythropoietic anemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301538[PMID],3,3
Disease,Thrombocytopenia with congenital dyserythropoietic anemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,X-linked intellectual disability with isolated growth hormone deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9508246[PMID]_8826446[PMID],2,2
Clinical subtype,X-linked intellectual disability with isolated growth hormone deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9508246[PMID]_8826446[PMID],0,0
Disease,Late-onset retinal degeneration,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Amoebic keratitis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],1,1
Disease,Segmental odontomaxillary dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,32,32
Disease,Segmental odontomaxillary dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hyaluronidase deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,B-cell chronic lymphocytic leukemia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],48,48
Disease,B-cell chronic lymphocytic leukemia,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],7.05,7.05
Disease,Extracutaneous mastocytoma,,,,,,,,,,,,,
Disease,Autosomal dominant optic atrophy and cataract,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22797356[PMID],3,3
Disease,Autosomal dominant optic atrophy and cataract,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22797356[PMID],0,0
Disease,Mast cell sarcoma,,,,,,,,,,,,,
Clinical group,Cutaneous mastocytosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Diaphanospondylodysostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26467725[PMID]_21990102[PMID]_22581610[PMID],18,18
Malformation syndrome,Diaphanospondylodysostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26467725[PMID]_21990102[PMID]_22581610[PMID],0,0
Disease,Dilated cardiomyopathy with ataxia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Sensorineural hearing loss-early graying-essential tremor syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16025060[PMID],3,3
Malformation syndrome,Sensorineural hearing loss-early graying-essential tremor syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16025060[PMID],0,0
Disease,CEDNIK syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25958742[PMID],13,13
Disease,CEDNIK syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital pseudoarthrosis of the clavicle,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Congenital pseudoarthrosis of the clavicle,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Goldberg-Shprintzen megacolon syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_28277559[PMID]_23427148[PMID],24,24
Malformation syndrome,Goldberg-Shprintzen megacolon syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Etiological subtype,Obesity due to congenital leptin deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Etiological subtype,Obesity due to congenital leptin deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pigmented villonodular synovitis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],20,20
Malformation syndrome,Cerebrooculonasal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19206156[PMID],21,21
Malformation syndrome,Cerebrooculonasal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19206156[PMID],0,0
Disease,PANDAS,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Tako-Tsubo cardiomyopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Tako-Tsubo cardiomyopathy,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,23623669[PMID],2.98,2.98
Disease,Short fifth metacarpals-insulin resistance syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16132981[PMID]_12786688[PMID],6,6
Disease,Short fifth metacarpals-insulin resistance syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Goodman syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,421359[PMID],3,3
Malformation syndrome,Goodman syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_421359[PMID],0,0
Malformation syndrome,Timothy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Timothy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Carvajal syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22795705[PMID]_20940358[PMID]_16628197[PMID],7,7
Disease,Carvajal syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22795705[PMID]_20940358[PMID]_16628197[PMID],0,0
Disease,Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Lhermitte-Duclos disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16459996[PMID],220,220
Disease,Lhermitte-Duclos disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Biotin-thiamine-responsive basal ganglia disease,,,,,,,,,,,,,
Disease,Beta-ureidopropionase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17964839[PMID],5,5
Disease,Beta-ureidopropionase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17964839[PMID],0,0
Malformation syndrome,3q29 microdeletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Vaginal atresia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24212882[PMID],4,4
Malformation syndrome,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Isolated focal cortical dysplasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24649472[PMID],0,0
Disease,Benign recurrent intrahepatic cholestasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Arthrogryposis-severe scoliosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3565478[PMID]_7039311[PMID],2,2
Malformation syndrome,Arthrogryposis-severe scoliosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3565478[PMID]_7039311[PMID],0,0
Disease,Monomelic amyotrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Multiple self-healing squamous epithelioma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24747516[PMID],0,0
Disease,Multiple self-healing squamous epithelioma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24747516[PMID],100,100
Malformation syndrome,Autosomal dominant multiple pterygium syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2831369[PMID],4,4
Malformation syndrome,Autosomal dominant multiple pterygium syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Carpenter syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23063620[PMID],70,70
Malformation syndrome,Carpenter syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Charcot-Marie-Tooth disease type 1,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20301384[PMID],17.5,17.5
Disease,IgG4-related thyroid disease,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,3906289[PMID]_21832114[PMID],1.06,1.06
Disease,IgG4-related thyroid disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pruritic urticarial papules and plaques of pregnancy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27960565[PMID],0,0
Clinical group,Autosomal dominant Charcot-Marie-Tooth disease type 2,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,X-linked Charcot-Marie-Tooth disease,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1.6,1.6
Disease,Dejerine-Sottas syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12090401[PMID],0,0
Clinical group,Charcot-Marie-Tooth disease type 4,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary motor and sensory neuropathy type 5,,,,,,,,,,,,,
Disease,Heme oxygenase-1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9884342[PMID]_21088618[PMID]_22023467[PMID],3,3
Disease,Heme oxygenase-1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22023467[PMID],0,0
Disease,Hereditary sensory and autonomic neuropathy type 5,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary sensory and autonomic neuropathy type 5,<1 / 1 000 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,23495212[PMID],0.035,0.035
Disease,Spinocerebellar ataxia with axonal neuropathy type 2,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,19440741[PMID],0.11,0.11
Disease,Nevus comedonicus syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23888253[PMID],0,0
Malformation syndrome,Congenital limbs-face contractures-hypotonia-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25683120[PMID],14,14
Malformation syndrome,Congenital limbs-face contractures-hypotonia-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25683120[PMID]_28133733[PMID],0,0
Disease,Becker nevus syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26265883[PMID],0,0
Particular clinical situation in a disease or syndrome,Response to monoclonal antibody treatment,,,,,,,,,,,,,
Malformation syndrome,Anterior maxillary protrusion-strabismus-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17618476[PMID]_21035105[PMID],7,7
Malformation syndrome,Anterior maxillary protrusion-strabismus-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17618476[PMID]_21035105[PMID],0,0
Disease,Autosomal recessive extra-oral halitosis,,,,,,,,,,,,,
Disease,Perineural cyst,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Disease,Perineural cyst,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30526868[PMID],10,10
Malformation syndrome,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30526868[PMID],0,0
Disease,Tolosa-Hunt syndrome,,,,,,,,,,,,,
Disease,Benign idiopathic neonatal seizures,,,,,,,,,,,,,
Malformation syndrome,"Acrofacial dysostosis, Kennedy-Teebi type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15266620[PMID],2,2
Malformation syndrome,"Acrofacial dysostosis, Kennedy-Teebi type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15266620[PMID],0,0
Disease,Childhood absence epilepsy,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,24668022[PMID],5,5
Disease,Childhood absence epilepsy,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Granulomatous mastitis,,,,,,,,,,,,,
Disease,Leiomyosarcoma,,,,,,,,,,,,,
Disease,Trench fever,,,,,,,,,,,,,
Disease,Oroya fever,,,,,,,,,,,,,
Disease,Ovarian hyperstimulation syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Iridocorneal endothelial syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hepatoportal sclerosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pleuropulmonary blastoma,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Pleuropulmonary blastoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pulmonary blastoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],350,350
Disease,Pulmonary blastoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pulmonary blastoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Pulmonary blastoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Pulmonary blastoma,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Disease,Pulmonary blastoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.001,0.001
Disease,Pulmonary blastoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,Pulmonary blastoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Disease,FOXG1 syndrome,,,,,,,,,,,,,
Disease,Recurrent acute pancreatitis,,,,,,,,,,,,,
Morphological anomaly,Iniencephaly,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Morphological anomaly,Iniencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Craniorachischisis,,,,,,,,,,,,,
Morphological anomaly,Isolated oxycephaly,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Angel-shaped phalango-epiphyseal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15173244[PMID],20,20
Malformation syndrome,Angel-shaped phalango-epiphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Distal myopathy with posterior leg and anterior hand involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15824355[PMID]_21620354[PMID],16,16
Disease,Distal myopathy with posterior leg and anterior hand involvement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15824355[PMID]_21620354[PMID],0,0
Disease,Pemphigoid gestationis,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,19170813[PMID],0.2,0.2
Disease,Pemphigoid gestationis,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,7826096[PMID]_23237497[PMID],0.05,0.05
Disease,Pemphigoid gestationis,1-9 / 1 000 000,Kuwait,409967,409967,25958,25958,en,Validated,410293,410293,15569006[PMID],0.18,0.18
Disease,Pemphigoid gestationis,1-9 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,27456755[PMID],0.693,0.693
Category,Pattern dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Paraneoplastic pemphigus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,60,60
Disease,Paraneoplastic pemphigus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare epithelial tumor of stomach,1-5 / 10 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],18.6,18.6
Category,Rare epithelial tumor of stomach,1-5 / 10 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],49.17,49.17
Category,Rare epithelial tumor of stomach,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer Institute 2010[INST],7.5,7.5
Category,Rare epithelial tumor of stomach,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,National Cancer Institute 2010[INST],24,24
Category,Rare epithelial tumor of stomach,1-5 / 10 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer Intelligence Network 2006[OTHER],11.2,11.2
Category,Rare epithelial tumor of stomach,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,National Cancer Intelligence Network 2006[OTHER],3.9,3.9
Category,Rare epithelial tumor of stomach,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Acrocapitofemoral dysplasia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,IgG4-related mediastinitis,,,,,,,,,,,,,
Malformation syndrome,Schisis association,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Megalencephaly-capillary malformation-polymicrogyria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15712320[PMID],170,170
Malformation syndrome,Megalencephaly-capillary malformation-polymicrogyria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pudendal neuralgia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20071246[PMID],0,0
Disease,Pudendal neuralgia,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],16.67,16.67
Disease,Congenital heart block,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,4273004[PMID],4.54,4.54
Disease,Recurrent respiratory papillomatosis,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,7488368[PMID]_20553527[PMID],2.34,2.34
Disease,Recurrent respiratory papillomatosis,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,2350888[PMID]_20553527[PMID],0.76,0.76
Disease,Recurrent respiratory papillomatosis,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,27208548[PMID],1.42,1.42
Disease,Recurrent respiratory papillomatosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27208548[PMID],0,0
Disease,Idiopathic bronchiectasis,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,9787927[PMID],1.8,1.8
Disease,Idiopathic bronchiectasis,1-5 / 10 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,9787927[PMID],29,29
Disease,Neonatal ichthyosis-sclerosing cholangitis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22030598[PMID],12,12
Disease,Neonatal ichthyosis-sclerosing cholangitis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22030598[PMID],0,0
Clinical subtype,Isolated congenital hypoglossia,,,,,,,,,,,,,
Clinical group,Gestational trophoblastic neoplasm,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Isolated congenital aglossia,,,,,,,,,,,,,
Disease,McLeod neuroacanthocytosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22027213[PMID],100,100
Disease,McLeod neuroacanthocytosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Schilder disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Enlarged parietal foramina,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23543411[PMID],4.3,4.3
Malformation syndrome,Enlarged parietal foramina,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23543411[PMID],3.7,3.7
Disease,Osteochondrosis of the metatarsal bone,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pulmonary alveolar microlithiasis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Osteochondrosis of the tarsal bone,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pulmonary nodular lymphoid hyperplasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary hypomagnesemia with refractory seizures and intellectual disability,,,,,,,,,,,,,
Clinical group,Genetic nephrotic syndrome,,,,,,,,,,,,,
Malformation syndrome,Loeys-Dietz syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16928994[PMID],52,52
Malformation syndrome,Loeys-Dietz syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16928994[PMID,0,0
Malformation syndrome,Rhombencephalosynapsis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25816977[PMID],100,100
Malformation syndrome,Rhombencephalosynapsis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25816977[PMID],0,0
Disease,Argyria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cirrhotic cardiomyopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Medial condensing osteitis of the clavicle,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27622150[PMID],58,58
Disease,Medial condensing osteitis of the clavicle,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27622150[PMID],0,0
Clinical subtype,Furuncular myiasis due to Cordylobia rodhaini,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29090455[PMID],0,0
Category,Rare hepatic disease,,,,,,,,,,,,,
Disease,Syndromic congenital sodium diarrhea,,,,,,,,,,,,,
Disease,SUNCT syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],6.7,6.7
Disease,SUNCT syndrome,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,18325769[PMID],6.7,6.7
Clinical subtype,Furuncular myiasis due to Dermatobia hominis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29090455[PMID],0,0
Clinical subtype,Furuncular myiasis due to Cordylobia anthropophaga,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29090455[PMID],0,0
Category,Human prion disease,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.15,0.15
Category,Human prion disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.3,0.3
Histopathological subtype,Mucinous cystadenoma of childhood,,,,,,,,,,,,,
Disease,Cold agglutinin disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,Seromucinous cystadenoma of childhood,,,,,,,,,,,,,
Disease,Sorsby pseudoinflammatory fundus dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Laing early-onset distal myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Osteoblastoma,,,,,,,,,,,,,
Disease,Classic hairy cell leukemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.29,0.29
Disease,Classic hairy cell leukemia,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],3.12,3.12
Disease,Classic hairy cell leukemia,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,16150940[PMID]_National Cancer Institute[INST],0.33,0.33
Disease,Classic hairy cell leukemia,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,7918034[PMID],0.29,0.29
Disease,Classic hairy cell leukemia,1-9 / 1 000 000,Israel,409967,409967,25965,25965,en,Not yet validated,410294,410294,17044834[PMID],0.24,0.24
Disease,Classic hairy cell leukemia,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,12111650[PMID],0.47,0.47
Disease,Classic hairy cell leukemia,<1 / 1 000 000,Hong Kong,409967,409967,25958,25958,en,Validated,410293,410293,11135356[PMID],0.035,0.035
Disease,Classic hairy cell leukemia,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,21122460[PMID],0.37,0.37
Disease,Classic hairy cell leukemia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Mazabraud syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,54,54
Malformation syndrome,Mazabraud syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,TNP03-related  limb-girdle muscular dystrophy D2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23667635[PMID],64,64
Disease,TNP03-related  limb-girdle muscular dystrophy D2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23667635[PMID],0,0
Disease,HNRNPDL-related  limb-girdle muscular dystrophy D3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24647604[PMID],2,2
Disease,HNRNPDL-related  limb-girdle muscular dystrophy D3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24647604[PMID],0,0
Disease,Craniopharyngioma,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,17825241[PMID]_22969141[PMID],1,1
Disease,Craniopharyngioma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,17425791[PMID]_European Medicines Agency 2015[INST],2,2
Disease,Craniopharyngioma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.19,0.19
Disease,Craniopharyngioma,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,25375987[PMID]_Swedish national Health registries 1987-2011[REG],0.17,0.17
Disease,Sarcocystosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary membranoproliferative glomerulonephritis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],16,16
Disease,Hepatocellular adenoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21175790[PMID],0,0
Malformation syndrome,Atelosteogenesis type II,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,25,25
Malformation syndrome,Atelosteogenesis type II,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Histopathological subtype,Serous cystadenoma of childhood,,,,,,,,,,,,,
Malformation syndrome,Atelosteogenesis type III,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,25,25
Malformation syndrome,Atelosteogenesis type III,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Isolated exencephaly,,,,,,,,,,,,,
Clinical subtype,Isolated anencephaly,,,,,,,,,,,,,
Clinical group,Carcinoma of gallbladder and extrahepatic biliary tract,1-5 / 10 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET,12,12
Clinical group,Carcinoma of gallbladder and extrahepatic biliary tract,1-9 / 100 000,Japan,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,5.3,5.3
Clinical group,Carcinoma of gallbladder and extrahepatic biliary tract,1-9 / 100 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,13835134[PMID]_17857545[PMID]_13425293[PMID]_22570746[PMID],1.5,1.5
Clinical group,Carcinoma of gallbladder and extrahepatic biliary tract,1-5 / 10 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,16397865[PMID],14,14
Clinical group,Carcinoma of gallbladder and extrahepatic biliary tract,1-9 / 100 000,France,409967,409967,25965,25965,en,Not yet validated,410294,410294,10951337[PMID],1.27,1.27
Clinical group,Carcinoma of gallbladder and extrahepatic biliary tract,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Carcinoma of gallbladder and extrahepatic biliary tract,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.37,4.37
Clinical subtype,Seronegative autoimmune hepatitis,,,,,,,,,,,,,
Disease,Chondrosarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.24,0.24
Disease,Chondrosarcoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Chondrosarcoma,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],3.55,3.55
Clinical subtype,Autoimmune hepatitis type 2,,,,,,,,,,,,,
Disease,Adamantinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Adamantinoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Adamantinoma,1-9 / 1 000 000,Worldwide,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.11,0.11
Clinical subtype,Autoimmune hepatitis type 1,,,,,,,,,,,,,
Disease,Hypotrichosis simplex,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,38,38
Disease,Hypotrichosis simplex,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pneumococcal meningitis,,,,,,,,,,,,,
Category,Other metabolic disease with skin involvement,,,,,,,,,,,,,
Category,Oligosaccharidosis,,,,,,,,,,,,,
Category,Disorder of biogenic amine metabolism and transport,,,,,,,,,,,,,
Category,Metabolic disease involving other neurotransmitter deficiency,,,,,,,,,,,,,
Disease,Laminin subunit alpha 2-related limb-girdle muscular dystrophy R23,,,,,,,,,,,,,
Malformation syndrome,Craniosynostosis-microretrognathia-several intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29432562[PMID]_30254215[PMID],3,3
Malformation syndrome,Craniosynostosis-microretrognathia-several intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29432562[PMID]_30254215[PMID],0,0
Category,Disorder of lysosomal amino acid transport,,,,,,,,,,,,,
Disease,Infantile inflammatory bowel disease with neurological involvement,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29483653[PMID],3,3
Disease,Infantile inflammatory bowel disease with neurological involvement,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29483653[PMID],0,0
Category,Mucopolysaccharidosis,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID]_26586959[PMID],4.5,4.5
Category,Mucopolysaccharidosis,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_9918480[PMID]_14608657[PMID]_26586959[PMID],3.9,3.9
Category,Mucopolysaccharidosis,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID]_26586959[PMID],4.8,4.8
Category,Mucopolysaccharidosis,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,16435194[PMID]_26586959[PMID],3.53,3.53
Category,Mucopolysaccharidosis,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID]_25274184[PMID],2.22,2.22
Category,Mucopolysaccharidosis,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID]_26586959[PMID],3.08,3.08
Category,Mucopolysaccharidosis,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID]_26586959[PMID],1.77,1.77
Category,Mucopolysaccharidosis,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,25472774[PMID]_26586959[PMID],1.81,1.81
Category,Mucopolysaccharidosis,1-9 / 100 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID]_26586959[PMID],3.72,3.72
Category,Mucopolysaccharidosis,1-9 / 100 000,Tunisia,409968,409968,25958,25958,en,Validated,410293,410293,20209839[PMID]_26586959[PMID],2.29,2.29
Category,Mucopolysaccharidosis,1-9 / 100 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,19396827[PMID]_26586959[PMID],2.04,2.04
Category,Mucopolysaccharidosis,1-9 / 100 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,22480138[PMID]_26586959[PMID],4.05,4.05
Category,Mucopolysaccharidosis,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_28595941[PMID],0,0
Category,Mucopolysaccharidosis,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_28595941[PMID],0,0
Category,Mucopolysaccharidosis,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],1.53,1.53
Category,Mucopolysaccharidosis,1-9 / 100 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,28595941[PMID],1.56,1.56
Category,Mucopolysaccharidosis,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2016.11.285[OTHER]_28595941[PMID],1.2,1.2
Category,Mucopolysaccharidosis,1-9 / 100 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1016/j.ymgme.2014.12.082[OTHER]_28595941[PMID],1.04,1.04
Category,Mucopolysaccharidosis,1-5 / 10 000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,20626343[PMID]_28595941[PMID],16.9,16.9
Category,Mucopolysaccharidosis,1-9 / 100 000,"Korea, Republic of",409968,409968,25958,25958,en,Validated,410293,410293,25364648[PMID]_28595941[PMID],1.35,1.35
Category,Mucolipidosis,,,,,,,,,,,,,
Disease,POMGNT2-related limb-girdle muscular dystrophy R24,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27066570[PMID],3,3
Disease,POMGNT2-related limb-girdle muscular dystrophy R24,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27066570[PMID],0,0
Disease,Calpain-3-related limb-girdle muscular dystrophy D4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27259757[PMID]_28881388[PMID]_30055862[PMID],0,0
Disease,Calpain-3-related limb-girdle muscular dystrophy D4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27259757[PMID]_28881388[PMID],47,47
Disease,Hypoxanthine guanine phosphoribosyltransferase partial deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hemochromatosis type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,74,74
Disease,Hemochromatosis type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Particular clinical situation with a withdrawn orphan designation,,,,,,,,,,,,,
Disease,Galactokinase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,31201888[PMID],4,4
Disease,CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_31201888[PMID],0,0
Clinical subtype,Crigler-Najjar syndrome type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Crigler-Najjar syndrome type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Disorder of purine or pyrimidine metabolism,,,,,,,,,,,,,
Category,Sphingolipidosis,,,,,,,,,,,,,
Category,Sterol metabolism disorder,,,,,,,,,,,,,
Category,Disorder of ketolysis,,,,,,,,,,,,,
Category,Disorder of ornithine or proline metabolism,,,,,,,,,,,,,
Category,Disorder of peptide metabolism,,,,,,,,,,,,,
Category,Disorder of pentose phosphate metabolism,,,,,,,,,,,,,
Clinical group,Peroxisome biogenesis disorder,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20301621[PMID],2,2
Clinical group,Peroxisome biogenesis disorder,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301621[PMID],0,0
Clinical group,Peroxisome biogenesis disorder,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,12794690[PMID],0.2,0.2
Clinical group,Peroxisome biogenesis disorder,1-9 / 1 000 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,12794690[PMID],0,0
Clinical group,Peroxisome biogenesis disorder,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Peroxisomal beta-oxidation disorder,,,,,,,,,,,,,
Category,Disorder of gamma-aminobutyric acid metabolism,,,,,,,,,,,,,
Category,Disorder of fatty acid oxidation and ketone body metabolism,,,,,,,,,,,,,
Category,Gluconeogenesis disorder,,,,,,,,,,,,,
Category,Disorder of glycerol metabolism,,,,,,,,,,,,,
Category,Glucose transport disorder,,,,,,,,,,,,,
Category,Disorder of histidine metabolism,,,,,,,,,,,,,
Category,Disorder of energy metabolism,,,,,,,,,,,,,
Disease,Combined oxidative phosphorylation defect type 39,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22700954[PMID]_26016410[PMID]_29075935[PMID],6,6
Disease,Combined oxidative phosphorylation defect type 39,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22700954[PMID]_26016410[PMID]_29075935[PMID],0,0
Disease,Triglyceride deposit cardiomyovasculopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],200,200
Disease,Triglyceride deposit cardiomyovasculopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_31186072[PMID],0,0
Category,Glycogen storage disease,,,,,,,,,,,,,
Category,Rare disorder potentially indicated for transplant or complication after transplantation,,,,,,,,,,,,,
Disease,Primary desmosis coli,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Methotrexate dose selection,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Lipid storage disease,,,,,,,,,,,,,
Disease,Methotrexate toxicity,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],3,3
Category,Disorder of phenylalanin or tyrosine metabolism,,,,,,,,,,,,,
Category,Disorder of purine metabolism,,,,,,,,,,,,,
Category,Disorder of pyridoxine metabolism,,,,,,,,,,,,,
Category,Disorder of pyrimidine metabolism,,,,,,,,,,,,,
Category,Disorder of serine or glycine metabolism,,,,,,,,,,,,,
Category,Sterol biosynthesis disorder,,,,,,,,,,,,,
Category,Disorder of the gamma-glutamyl cycle,,,,,,,,,,,,,
Category,Disorder of branched-chain amino acid metabolism,,,,,,,,,,,,,
Disease,2-methylbutyryl-CoA dehydrogenase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,2-methylbutyryl-CoA dehydrogenase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Seizures-intellectual disability due to hydroxylysinuria syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI:10.1007/978-3-642-55878-8_18[OTHER],6,6
Disease,Seizures-intellectual disability due to hydroxylysinuria syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI:10.1007/978-3-642-55878-8_18[OTHER],0,0
Disease,Hydroxykynureninuria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Hydroxykynureninuria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,2-aminoadipic 2-oxoadipic aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23141293[PMID],20,20
Disease,2-aminoadipic 2-oxoadipic aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Idiopathic trachyonychia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Disseminated superficial actinic porokeratosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Pr KANITAKIS Jean[EXPERT],0,0
Disease,Acrokeratosis verruciformis of Hopf,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Linear and whorled nevoid hypermelanosis,,,,,,,,,,,,,
Disease,Dermochondrocorneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26440764[PMID],0,0
Disease,Dermochondrocorneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26440764[PMID],15,15
Disease,Elastosis perforans serpiginosa,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27881947[PMID],0,0
Disease,Familial reactive perforating collagenosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17567305[PMID]_20101333[PMID],0,0
Disease,Familial reactive perforating collagenosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17567305[PMID]_20101333[PMID],50,50
Disease,Familial progressive hyperpigmentation,,,,,,,,,,,,,
Disease,Dowling-Degos disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Isolated congenital onychodysplasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26509026[PMID],0,0
Disease,Isolated congenital anonychia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Isolated congenital anonychia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Creatine deficiency syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Disorder of methionine cycle and sulfur amino acid metabolism,,,,,,,,,,,,,
Category,Disorder of cobalamin metabolism and transport,,,,,,,,,,,,,
Category,Disorder of bile acid synthesis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],0.6,0.6
Category,Disorder of neurotransmitter metabolism and transport,,,,,,,,,,,,,
Category,Disorder of amino acid absorption and transport,,,,,,,,,,,,,
Category,Disorder of urea cycle metabolism and ammonia detoxification,,,,,,,,,,,,,
Category,Classic organic aciduria,,,,,,,,,,,,,
Category,Disorder of carbohydrate metabolism,,,,,,,,,,,,,
Category,Cerebral organic aciduria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Isobutyryl-CoA dehydrogenase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Developmental malformations-deafness-dystonia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12325076[PMID],2,2
Malformation syndrome,Developmental malformations-deafness-dystonia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12325076[PMID],0,0
Disease,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30842990[PMID],35,35
Disease,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30842990[PMID],0,0
Malformation syndrome,Eiken syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15525660[PMID],6,6
Malformation syndrome,Eiken syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15525660[PMID],0,0
Disease,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,14517508[PMID]_31149222[PMID],2.47,2.47
Disease,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta,1-9 / 100 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_19542904[PMID]_31149222[PMID],2.4,2.4
Disease,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12966531[PMID]_16715098[PMID],3,3
Disease,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12966531[PMID]_16715098[PMID],0,0
Clinical subtype,Acute mast cell leukemia,,,,,,,,,,,,,
Malformation syndrome,Mandibulofacial dysostosis-microcephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26507355[PMID],107,107
Malformation syndrome,Mandibulofacial dysostosis-microcephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26507355[PMID],0,0
Disease,Thyrotoxic periodic paralysis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Myxofibrosarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Interstitial granulomatous dermatitis with arthritis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22059717[PMID],53,53
Disease,Interstitial granulomatous dermatitis with arthritis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Sympathetic ophthalmia,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,10684834[PMID],0.03,0.03
Disease,Sympathetic ophthalmia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.6,0.6
Disease,Hyperprolinemia type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital autosomal recessive small-platelet thrombocytopenia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25876182[PMID],5,5
Disease,Congenital autosomal recessive small-platelet thrombocytopenia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25876182[PMID],0,0
Disease,Atrophoderma vermiculata,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital bile acid synthesis defect type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10655068[PMID]_12512044[PMID]_ [EXPERT],5,5
Disease,Congenital bile acid synthesis defect type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Grange syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22987684[PMID],7,7
Malformation syndrome,Grange syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30565236[PMID]_28657829[PMID]_28657861[PMID],0,0
Disease,Folinic acid-responsive seizures,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pyridoxal phosphate-responsive seizures,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pyridoxal phosphate-responsive seizures,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],0,0
Disease,Bickerstaff brainstem encephalitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Japanese encephalitis,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.65,0.65
Disease,Japanese encephalitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Cutaneous neuroendocrine carcinoma,1-9 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.27,0.27
Disease,Cutaneous neuroendocrine carcinoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],4,4
Disease,Cutaneous neuroendocrine carcinoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.13,0.13
Disease,Cutaneous neuroendocrine carcinoma,1-9 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.86,0.86
Disease,Cutaneous neuroendocrine carcinoma,<1 / 1 000 000,Finland,409967,409967,25965,25965,en,Not yet validated,410294,410294,21729823[PMID],0.06,0.06
Disease,Cutaneous neuroendocrine carcinoma,1-9 / 1 000 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,20870633[PMID],0.13,0.13
Disease,Cutaneous neuroendocrine carcinoma,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,20424236[PMID],0.22,0.22
Disease,Cutaneous neuroendocrine carcinoma,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,12951176[PMID],0.378,0.378
Disease,Cutaneous neuroendocrine carcinoma,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,16764197[PMID],0.13,0.13
Disease,Cutaneous neuroendocrine carcinoma,1-9 / 100 000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,24943712[PMID],1.6,1.6
Disease,Hereditary painful callosities,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,646376[PMID]_3812560[PMID],2,2
Disease,Hereditary painful callosities,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_646376[PMID]_3812560[PMID],0,0
Disease,DEND syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16670688[PMID],40,40
Disease,DEND syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Episodic ataxia type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11673600[PMID],1,1
Disease,Episodic ataxia type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11673600[PMID],0,0
Disease,Episodic ataxia type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8929156[PMID],2,2
Disease,Episodic ataxia type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8929156[PMID],0,0
Disease,Generalized epilepsy-paroxysmal dyskinesia syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Trichodysplasia-amelogenesis imperfecta syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8419879[PMID],1,1
Malformation syndrome,Trichodysplasia-amelogenesis imperfecta syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8419879[PMID],0,0
Malformation syndrome,Sparse hair-short stature-skin anomalies syndrome,,,,,,,,,,,,,
Clinical subtype,Focal facial dermal dysplasia type I,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21931173[PMID],81,81
Clinical subtype,Focal facial dermal dysplasia type I,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hepatic veno-occlusive disease-immunodeficiency syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301448[PMID]_22621957[PMID]_16648851[PMID],28,28
Disease,Hepatic veno-occlusive disease-immunodeficiency syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301448[PMID],0,0
Clinical subtype,Chronic mast cell leukemia,,,,,,,,,,,,,
Disease,Acute interstitial pneumonia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,3.8,3.8
Disease,Respiratory bronchiolitis-interstitial lung disease syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lymphoid interstitial pneumonia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Niemann-Pick disease type B,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,23412609[PMID],0.4,0.4
Clinical subtype,Odontoleukodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12605447[PMID],4,4
Clinical subtype,Odontoleukodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12605447[PMID],0,0
Clinical subtype,Gaucher disease type 3,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.05,0.05
Disease,Niemann-Pick disease type A,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.25,0.25
Disease,Niemann-Pick disease type A,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Anophthalmia/microphthalmia-esophageal atresia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15578584[PMID]_16543359[PMID],30,30
Malformation syndrome,Anophthalmia/microphthalmia-esophageal atresia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Microphthalmia-brain atrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16566018[PMID],3,3
Malformation syndrome,Microphthalmia-brain atrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16566018[PMID],0,0
Malformation syndrome,Morgagni-Stewart-Morel syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Majeed syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301735[PMID],4,4
Disease,Majeed syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301735[PMID],0,0
Disease,B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome,,,,,,,,,,,,,
Malformation syndrome,Auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16317305[PMID],2,2
Malformation syndrome,Auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16317305[PMID],0,0
Malformation syndrome,Monosomy 9q22.3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21850767[PMID],42,42
Malformation syndrome,Monosomy 9q22.3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21850767[PMID],0,0
Clinical subtype,Idiopathic multidrug-resistant nephrotic syndrome,,,,,,,,,,,,,
Category,Genetic obesity,,,,,,,,,,,,,
Clinical syndrome,Idiopathic steroid-resistant nephrotic syndrome,,,,,,,,,,,,,
Clinical syndrome,Idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistance,,,,,,,,,,,,,
Clinical syndrome,Idiopathic non-lupus full-house nephropathy,,,,,,,,,,,,,
Category,Genetic systemic disease with glomerulopathy as a major feature,,,,,,,,,,,,,
Category,Non-genetic systemic disease with glomerulopathy as a major feature,,,,,,,,,,,,,
Clinical subtype,Idiopathic steroid-resistant nephrotic syndrome with sensitivity to second-line immunosuppressive therapy,,,,,,,,,,,,,
Category,Systemic disease with glomerulopathy as a major feature,,,,,,,,,,,,,
Category,Rare genetic odontologic disease,,,,,,,,,,,,,
Category,Nephrotic syndrome without extrarenal manifestations,,,,,,,,,,,,,
Disease,PPARG-related familial partial lipodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16409151[PMID],10,10
Disease,PPARG-related familial partial lipodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,IgG4-related dacryoadenitis and sialadenitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Systemic vasculitis associated with glomerulopathy,,,,,,,,,,,,,
Clinical subtype,Juvenile polyposis of infancy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,11,11
Clinical subtype,Juvenile polyposis of infancy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Disorder with multisystemic involvement and glomerulopathy,,,,,,,,,,,,,
Category,Disorder of amino acid and other organic acid metabolism,,,,,,,,,,,,,
Disease,Acquired partial lipodystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acquired partial lipodystrophy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0,0
Disease,Acquired generalized lipodystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acquired generalized lipodystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],1,1
Disease,AKT2-related familial partial lipodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16409151[PMID],1,1
Disease,AKT2-related familial partial lipodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Familial partial lipodystrophy, Köbberling type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16409151[PMID],20,20
Disease,"Familial partial lipodystrophy, Köbberling type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Parenteral nutrition-associated cholestasis,,,,,,,,,,,,,
Malformation syndrome,Foix-Alajouanine syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Primary lymphedema without systemic or visceral involvement,,,,,,,,,,,,,
Disease,Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9708547[PMID]_23489661[PMID]_25529940[PMID],21,21
Disease,Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9708547[PMID]_23489661[PMID]_25529940[PMID],0,0
Clinical group,Localized lipodystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,North Carolina macular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21310494[PMID]_5100467[PMID],2,2
Disease,North Carolina macular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21310494[PMID]_5100467[PMID],0,0
Disease,Progressive bifocal chorioretinal atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5686965[PMID]_8541856[PMID],2,2
Disease,Progressive bifocal chorioretinal atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5686965[PMID]_8541856[PMID],0,0
Disease,Bradyopsia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14702087[PMID],5,5
Disease,Bradyopsia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14702087[PMID],0,0
Disease,Familial drusen,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Central areolar choroidal dystrophy,1-9 / 100 000,France,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,3.33,3.33
Disease,Central areolar choroidal dystrophy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Oligocone trichromacy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14736794[PMID]_17090894[PMID]_ [EXPERT],14,14
Disease,Oligocone trichromacy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cystoid macular dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25267528[PMID],97,97
Disease,Cystoid macular dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25267528[PMID],0,0
Malformation syndrome,Oguchi disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Malformation syndrome,Oguchi disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Aprosencephaly/atelencephaly spectrum,,,,,,,,,,,,,
Malformation syndrome,Brain malformation-congenital heart disease-postaxial polydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16531731[PMID],2,2
Malformation syndrome,Brain malformation-congenital heart disease-postaxial polydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Liver adenomatosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26011213[PMID],0,0
Disease,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22354167[PMID],4,4
Disease,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22354167[PMID],0,0
Clinical subtype,Aprosencephaly,,,,,,,,,,,,,
Disease,Periodontal Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22739343[PMID],62,62
Disease,Periodontal Ehlers-Danlos syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Atelencephaly,,,,,,,,,,,,,
Clinical subtype,B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26940150[PMID],0,0
Clinical subtype,B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26940150[PMID],6,6
Disease,X-linked Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4006272[PMID],2,2
Disease,X-linked Ehlers-Danlos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4006272[PMID],0,0
Malformation syndrome,Left sided atrial isomerism,,,,,,,,,,,,,
Malformation syndrome,Angioosteohypotrophic syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,X-linked sideroblastic anemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,X-linked sideroblastic anemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mueller-Weiss syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27145453[PMID],277,277
Disease,Mueller-Weiss syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27145453[PMID],0,0
Disease,Tropical endomyocardial fibrosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Acquired idiopathic sideroblastic anemia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acquired idiopathic sideroblastic anemia,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.09,0.09
Clinical syndrome,Primary progressive freezing gait,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Loeffler endocarditis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,6q terminal deletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16329114[PMID],19,19
Malformation syndrome,6q terminal deletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Congenital muscular dystrophy, Ullrich type",1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.13,0.13
Disease,"Congenital muscular dystrophy, Ullrich type",1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Primary lymphedema,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_24212289[PMID],16.7,16.7
Disease,MORM syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Trichorhinophalangeal syndrome type 1 and 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Malformation syndrome,Trichorhinophalangeal syndrome type 1 and 3,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Lipedema,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,20358611[PMID],1.39,1.39
Disease,Lipedema,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20358611[PMID],0,0
Clinical subtype,Gaucher disease type 2,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.01,0.01
Clinical subtype,Gaucher disease type 1,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Clinical subtype,Gaucher disease type 1,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],2.48,2.48
Disease,Bleeding diathesis due to a collagen receptor defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7687896[PMID],20,20
Disease,Bleeding diathesis due to a collagen receptor defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Zygomycosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Non-24-hour sleep-wake syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Central neurocytoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23810386[PMID],500,500
Disease,Central neurocytoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Paracoccidioidomycosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Visceral neuropathy-brain anomalies-facial dysmorphism-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16378921[PMID],2,2
Malformation syndrome,Visceral neuropathy-brain anomalies-facial dysmorphism-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16378921[PMID],0,0
Disease,Eosinophilic esophagitis,1-5 / 10 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,22994460[PMID],11,11
Disease,Eosinophilic esophagitis,1-5 / 10 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,21750884[PMID],17.1,17.1
Disease,Eosinophilic esophagitis,1-5 / 10 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,23075697[PMID],44.6,44.6
Disease,Eosinophilic esophagitis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2016[INST],38,38
Disease,Eosinophilic esophagitis,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,15696105[PMID],9.45,9.45
Disease,Eosinophilic esophagitis,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,19577011[PMID]_24035773[PMID]_ORPHANET,55.85,55.85
Disease,Eosinophilic esophagitis,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,22963642[PMID],1.31,1.31
Disease,Eosinophilic esophagitis,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,22019091[PMID],7.4,7.4
Disease,Eosinophilic esophagitis,1-5 / 10 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,22019091[PMID],42.8,42.8
Disease,Eosinophilic esophagitis,1-5 / 10 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_26488694[PMID],40.08,40.08
Disease,Congenital primary lymphedema of Gordon,,,,,,,,,,,,,
Disease,Acute ackee fruit intoxication,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,CELSR1-related late-onset primary lymphedema,,,,,,,,,,,,,
Disease,Acquired hemophilia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.1,0.1
Disease,Acquired hemophilia,<1 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,14754611[PMID],0.08,0.08
Disease,Acquired hemophilia,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,17047148[PMID],0.15,0.15
Disease,Growth delay due to insulin-like growth factor type 1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24389050[PMID],5,5
Disease,Growth delay due to insulin-like growth factor type 1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24389050[PMID],0,0
Disease,Growth delay due to insulin-like growth factor I resistance,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Retinal arterial tortuosity,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12745002[PMID],100,100
Disease,Retinal arterial tortuosity,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Osteosclerosis-ichthyosis-premature ovarian failure syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15995452[PMID],3,3
Disease,Osteosclerosis-ichthyosis-premature ovarian failure syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial isolated restrictive cardiomyopathy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2.5,2.5
Clinical subtype,Cholesteryl ester storage disease,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,17634524[PMID],2.5,2.5
Clinical subtype,Cholesteryl ester storage disease,1-9 / 1 000 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,23424026[PMID],0.8,0.8
Clinical subtype,Cholesteryl ester storage disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Wolman disease,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.19,0.19
Clinical subtype,Wolman disease,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,17634524[PMID],0.28,0.28
Clinical subtype,Wolman disease,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Myiasis,,,,,,,,,,,,,
Disease,EPHB4-related lymphatic-related hydrops fetalis,,,,,,,,,,,,,
Disease,Familial platelet disorder with associated myeloid malignancy,,,,,,,,,,,,,
Disease,PIEZO1-related generalized lymphatic dysplasia with non-immune hydrops fetalis,,,,,,,,,,,,,
Disease,Familial thrombocytosis,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,23736217[PMID],0,0
Disease,Cancer-associated retinopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Disorder with multisystemic involvement and primary lymphedema,,,,,,,,,,,,,
Category,Primary lymphedema with systemic or visceral involvement,,,,,,,,,,,,,
Disease,Warts-immunodeficiency-lymphedema-anogenital dysplasia syndrome,,,,,,,,,,,,,
Disease,GJC2-related late-onset primary lymphedema,,,,,,,,,,,,,
Malformation syndrome,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Obesity due to pro-opiomelanocortin deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16150380[PMID],7,7
Etiological subtype,Obesity due to pro-opiomelanocortin deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Obesity due to prohormone convertase I deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23562752[PMID],16,16
Etiological subtype,Obesity due to prohormone convertase I deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Obesity due to melanocortin 4 receptor deficiency,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Etiological subtype,Obesity due to melanocortin 4 receptor deficiency,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Angiomatoid fibrous histiocytoma,,,,,,,,,,,,,
Disease,Rapid-onset dystonia-parkinsonism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17282997[PMID]_15260953[PMID],100,100
Disease,Rapid-onset dystonia-parkinsonism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Benign paroxysmal torticollis of infancy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_19182151[PMID]_29956301[PMID]_29656928[PMID],150,150
Disease,Benign paroxysmal torticollis of infancy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Clinical syndrome,Psychogenic movement disorders,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Multiple mitochondrial dysfunctions syndrome type 5,,,,,,,,,,,,,
Category,Inherited retinal disorder,,,,,,,,,,,,,
Disease,Multiple mitochondrial dysfunctions syndrome type 6,,,,,,,,,,,,,
Category,Muscular channelopathy,,,,,,,,,,,,,
Category,Rare genetic neurological disorder,,,,,,,,,,,,,
Disease,Microcystic stromal tumor,,,,,,,,,,,,,
Disease,HANAC syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20818663[PMID],6,6
Disease,HANAC syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20818663[PMID],0,0
Disease,Tubular renal disease-cardiomyopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15769815[PMID],2,2
Disease,Tubular renal disease-cardiomyopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15769815[PMID],0,0
Malformation syndrome,Spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16024908[PMID],2,2
Malformation syndrome,Spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16024908[PMID],0,0
Disease,Ossification anomalies-psychomotor developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16086393[PMID],2,2
Disease,Ossification anomalies-psychomotor developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16086393[PMID],0,0
Clinical group,Müllerian aplasia,1-5 / 10 000,Finland,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_11570363[PMID],0,0
Clinical group,Müllerian aplasia,1-5 / 10 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,11570363[PMID],10,10
Clinical group,Müllerian aplasia,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Intractable diarrhea of infancy,,,,,,,,,,,,,
Malformation syndrome,Global developmental delay-osteopenia-ectodermal defect syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16368207[PMID],3,3
Malformation syndrome,Global developmental delay-osteopenia-ectodermal defect syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16368207[PMID],0,0
Clinical group,X-linked intellectual disability-hypotonic face syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Acitretin/etretinate embryopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18410980[PMID],26,26
Malformation syndrome,Acitretin/etretinate embryopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Eales disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Graft versus host disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],5,5
Etiological subtype,Familial apolipoprotein A5 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25732519[PMID],0,0
Etiological subtype,Familial apolipoprotein A5 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25732519[PMID],3,3
Disease,Omenn syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,25,25
Disease,Omenn syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,KRT1-related diffuse nonepidermolytic keratoderma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30452289[PMID],0,0
Disease,Uveal melanoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,17498805[PMID]_22119735[PMID]_EUROCARE Survival of cancer patients in Europe[REG],0.5,0.5
Disease,Uveal melanoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Uveal melanoma,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG],6,6
Disease,Uveal melanoma,<1 / 1 000 000,Africa,409967,409967,25965,25965,en,Not yet validated,410294,410294,19704035[PMID],0.03,0.03
Disease,RELA fusion-positive ependymoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Dihydropyrimidinuria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26771602[PMID],0,0
Malformation syndrome,Schnitzler syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,150,150
Malformation syndrome,Schnitzler syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,PIK3CA-related overgrowth syndrome,,,,,,,,,,,,,
Clinical subtype,Progressive dementia with neuroserpin inclusion bodies,,,,,,,,,,,,,
Disease,Episodic ataxia type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acquired kinky hair syndrome,,,,,,,,,,,,,
Clinical subtype,Progressive myoclonic epilepsy with neuroserpin inclusion bodies,,,,,,,,,,,,,
Disease,Andersen-Tawil syndrome,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.1,0.1
Disease,Andersen-Tawil syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Andersen-Tawil syndrome,<1 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23516313[PMID],0.08,0.08
Disease,Andersen-Tawil syndrome,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,29606556[PMID],0.1,0.1
Disease,Interstitial cystitis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_1137336[PMID],0,0
Disease,Interstitial cystitis,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,1137336[PMID],10.6,10.6
Disease,Interstitial cystitis,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:978-4471-3295-0[OTHER],30,30
Disease,Interstitial cystitis,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,1137336[PMID],0.66,0.66
Disease,Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28317311[PMID],150,150
Disease,Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28317311[PMID],0,0
Disease,Autoimmune hypoparathyroidism,,,,,,,,,,,,,
Disease,Myoclonus-dystonia syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare sleep disorder,,,,,,,,,,,,,
Category,Leukodystrophy,,,,,,,,,,,,,
Category,Rare genetic skin disease,,,,,,,,,,,,,
Category,Tumor of hematopoietic and lymphoid tissues,,,,,,,,,,,,,
Category,Scalp disease,,,,,,,,,,,,,
Category,Multiple congenital anomalies/dysmorphic syndrome,,,,,,,,,,,,,
Category,Rare hemorrhagic disorder due to a constitutional coagulation factors defect,,,,,,,,,,,,,
Category,Rare genetic tumor,,,,,,,,,,,,,
Malformation syndrome,9q21.13 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23279911[PMID]_24355400[PMID],10,10
Malformation syndrome,9q21.13 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23279911[PMID]_24355400[PMID],0,0
Category,Rare chromosomal anomaly,,,,,,,,,,,,,
Category,Rare maxillo-facial surgical disease,,,,,,,,,,,,,
Disease,Lamb-Shaffer syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29477873[PMID],25,25
Disease,Lamb-Shaffer syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29477873[PMID],0,0
Disease,Mixed phenotype acute leukemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Bietti crystalline dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Iminoglycinuria,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,6.67,6.67
Disease,Iminoglycinuria,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,6.68,6.68
Category,Neurometabolic disorder due to serine deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Category,Neurometabolic disorder due to serine deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Glutaric acidemia type 3,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,L-Arginine:glycine amidinotransferase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301745[PMID]_20625172[PMID],9,9
Disease,L-Arginine:glycine amidinotransferase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Glucose-galactose malabsorption,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22843301[PMID],0,0
Disease,Glucose-galactose malabsorption,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,23107089[PMID],0.22,0.22
Morphological anomaly,Morning glory disc anomaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Aromatic L-amino acid decarboxylase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30689738[PMID],140,140
Disease,Aromatic L-amino acid decarboxylase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30689738[PMID],0,0
Category,Mitochondrial disorder due to a defect in mitochondrial protein synthesis,,,,,,,,,,,,,
Morphological anomaly,Madelung deformity,,,,,,,,,,,,,
Disease,Primary lateral sclerosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,1.5,1.5
Disease,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23751782[PMID],9,9
Disease,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Mitochondrial DNA depletion syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Nanophthalmos,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,X-linked dominant chondrodysplasia punctata,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,21634086[PMID],0.25,0.25
Disease,X-linked dominant chondrodysplasia punctata,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Erdheim-Chester disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20724540[PMID],500,500
Disease,Erdheim-Chester disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Serpiginous choroiditis,,,,,,,,,,,,,
Etiological subtype,ALDH18A1-related De Barsy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,32,32
Etiological subtype,ALDH18A1-related De Barsy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Coenzyme Q10 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,,,,,,,,,,,,,
Disease,Desmosterolosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29175559[PMID],10,10
Disease,Desmosterolosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29175559[PMID],0,0
Morphological anomaly,Isolated brachycephaly,,,,,,,,,,,,,
Morphological anomaly,Isolated plagiocephaly,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,17629800[PMID],3,3
Disease,Epidermal nevus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,400,400
Disease,Epidermal nevus syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital sucrase-isomaltase deficiency,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,20,20
Disease,Lysosomal acid phosphatase deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Generalized epilepsy with febrile seizures-plus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Paraneoplastic neurologic syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adiposis dolorosa,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hypocomplementemic urticarial vasculitis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19922730[PMID],200,200
Disease,Hypocomplementemic urticarial vasculitis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Stevens-Johnson syndrome,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,23866878[PMID],0.36,0.36
Clinical subtype,Stevens-Johnson syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Bleeding disorder due to P2Y12 defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15852220[PMID]_19229056[PMID],14,14
Disease,Bleeding disorder due to P2Y12 defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal monosomy 1q,,,,,,,,,,,,,
Disease,Familial cervical artery dissection,,,,,,,,,,,,,
Disease,COL4A1-related familial vascular leukoencephalopathy,,,,,,,,,,,,,
Disease,Hereditary sensory and autonomic neuropathy type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,18348718[PMID],0,0
Disease,Bacterial toxic-shock syndrome,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,15264985[PMID],3,3
Disease,Staphylococcal scalded skin syndrome,<1 / 1 000 000,Germany,409967,409967,25965,25965,en,Not yet validated,410294,410294,15816826[PMID],0.01,0.01
Disease,Staphylococcal scalded skin syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Staphylococcal scarlet fever,,,,,,,,,,,,,
Disease,Staphylococcal necrotizing pneumonia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Bullous impetigo,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Gastric linitis plastica,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Buerger disease,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],16,16
Disease,Buerger disease,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],10,10
Category,Malignant sex cord stromal tumor of ovary,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.85,1.85
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.13,0.13
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,15863154[PMID],0.1,0.1
Category,Malignant sex cord stromal tumor of ovary,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.05,0.05
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.074,0.074
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.069,0.069
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.094,0.094
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.063,0.063
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.073,0.073
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.093,0.093
Category,Malignant sex cord stromal tumor of ovary,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.089,0.089
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.133,0.133
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.102,0.102
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.367,0.367
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.152,0.152
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.314,0.314
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.296,0.296
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.135,0.135
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.401,0.401
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.236,0.236
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.12,0.12
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.232,0.232
Category,Malignant sex cord stromal tumor of ovary,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.212,0.212
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.08,0.08
Category,Malignant germ cell tumor of ovary,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.3,2.3
Category,Malignant germ cell tumor of ovary,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,15863154[PMID],0.2,0.2
Category,Malignant germ cell tumor of ovary,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.072,0.072
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.07,0.07
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.089,0.089
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.093,0.093
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.087,0.087
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.062,0.062
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.065,0.065
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.085,0.085
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.065,0.065
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.065,0.065
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.081,0.081
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.095,0.095
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.09,0.09
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.098,0.098
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.064,0.064
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.075,0.075
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.072,0.072
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.051,0.051
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.061,0.061
Category,Malignant germ cell tumor of ovary,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.064,0.064
Category,Malignant germ cell tumor of ovary,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.157,0.157
Category,Malignant germ cell tumor of ovary,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.126,0.126
Category,Malignant germ cell tumor of ovary,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.141,0.141
Disease,Hyperinsulinism-hyperammonemia syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Imerslund-Gräsbeck syndrome,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,Pr Ralph GRÄSBECK[EXPERT],0.5,0.5
Disease,Imerslund-Gräsbeck syndrome,1-9 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,Pr Ralph GRÄSBECK[EXPERT],0.5,0.5
Disease,Imerslund-Gräsbeck syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Combined deficiency of factor V and factor VIII,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Combined deficiency of factor V and factor VIII,1-9 / 100 000,"Iran, Islamic Republic of",409966,409966,25958,25958,en,Validated,410293,410293,9531348[PMID],1,1
Disease,Acute opioid poisoning,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Intestinal lymphangiectasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Polymicrogyria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,5-oxoprolinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,8,8
Disease,5-oxoprolinase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Kleine-Levin syndrome,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Kleine-Levin syndrome,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,25559212[PMID],0.18,0.18
Disease,Meningococcal meningitis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2006[INST],0,0
Disease,Meningococcal meningitis,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut de Veille Sanitaire 2010[INST],2.3,2.3
Disease,Meningococcal meningitis,1-9 / 100 000,New Zealand,409967,409967,25958,25958,en,Validated,410293,410293,Institute of Environmental Science and Research 2011[INST],2.7,2.7
Disease,Meningococcal meningitis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention[INST],0.8,0.8
Malformation syndrome,Neuroectodermal melanolysosomal disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,474620[PMID]_10052404[PMID]_11170073[PMID]_17710870[PMID],20,20
Malformation syndrome,Neuroectodermal melanolysosomal disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Bullous lichen planus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Familial GPIHBP1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25732519[PMID],10,10
Etiological subtype,Familial GPIHBP1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25732519[PMID],0,0
Disease,Pediatric hepatocellular carcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,24439603[PMID],0,0
Disease,Pediatric hepatocellular carcinoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.15,0.15
Disease,Pediatric hepatocellular carcinoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,24439603[PMID],0,0
Disease,Naxos disease,,,,,,,,,,,,,
Disease,Autosomal dominant tubulointerstitial kidney disease,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal dominant tubulointerstitial kidney disease,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,30376835[PMID],1.6,1.6
Disease,Nodular non-suppurative panniculitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glutamate-cysteine ligase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18024385[PMID],10,10
Disease,Glutamate-cysteine ligase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18024385[PMID],0,0
Disease,Gamma-glutamyl transpeptidase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15702405[PMID],7,7
Disease,Gamma-glutamyl transpeptidase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15702405[PMID],0,0
Clinical subtype,Autosomal agammaglobulinemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Clinical subtype,Autosomal agammaglobulinemia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Granulomatous slack skin,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14726855[PMID],50,50
Disease,Granulomatous slack skin,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Lethal multiple pterygium syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,28,28
Malformation syndrome,Lethal multiple pterygium syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Metaphyseal chondrodysplasia, Jansen type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,16,16
Disease,"Metaphyseal chondrodysplasia, Jansen type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dravet syndrome,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,22719002[PMID],3.5,3.5
Disease,Dravet syndrome,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,2.5,2.5
Disease,Dravet syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Lymphedema-distichiasis syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_24215208[PMID],0,0
Disease,Reticular dysgenesis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.03,0.03
Disease,Reticular dysgenesis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Familial lipase maturation factor 1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25732519[PMID],2,2
Etiological subtype,Familial lipase maturation factor 1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25732519[PMID],0,0
Disease,Trichothiodystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Trichothiodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18603627[PMID]_18329345[PMID]_19681155[PMID],201,201
Disease,Trichothiodystrophy,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,18329345[PMID],0.12,0.12
Disease,Kaposi sarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.34,0.34
Disease,Kaposi sarcoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Kaposi sarcoma,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],2.11,2.11
Disease,Kaposi sarcoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.051,0.051
Disease,Kaposi sarcoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.075,0.075
Disease,Kaposi sarcoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.099,0.099
Disease,Kaposi sarcoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.092,0.092
Disease,Kaposi sarcoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.065,0.065
Disease,Kaposi sarcoma,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.014,0.014
Disease,Kaposi sarcoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.076,0.076
Disease,Kaposi sarcoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Disease,Kaposi sarcoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.043,0.043
Disease,Kaposi sarcoma,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.05,0.05
Disease,Kaposi sarcoma,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.056,0.056
Disease,Kaposi sarcoma,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.133,0.133
Disease,Kaposi sarcoma,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.111,0.111
Disease,Kaposi sarcoma,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.108,0.108
Disease,Kaposi sarcoma,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.112,0.112
Disease,Kaposi sarcoma,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.597,0.597
Disease,Kaposi sarcoma,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.915,0.915
Disease,Kaposi sarcoma,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.546,0.546
Disease,Kaposi sarcoma,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.163,0.163
Disease,Kaposi sarcoma,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.278,0.278
Disease,Kaposi sarcoma,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.192,0.192
Disease,Kaposi sarcoma,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.363,1.363
Disease,Kaposi sarcoma,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.142,1.142
Disease,Jessner lymphocytic infiltration of the skin,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Idiopathic hypersomnia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Idiopathic hypersomnia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],30,30
Disease,Waldenström macroglobulinemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.81,0.81
Disease,Waldenström macroglobulinemia,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],2.05,2.05
Disease,Waldenström macroglobulinemia,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,22139816[PMID],0.38,0.38
Disease,Waldenström macroglobulinemia,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,17416416[PMID],0.55,0.55
Disease,Waldenström macroglobulinemia,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,11736938[PMID],0.31,0.31
Disease,Waldenström macroglobulinemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Waldenström macroglobulinemia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],0,0
Disease,Idiopathic recurrent and disabling cutaneous herpes,,,,,,,,,,,,,
Disease,Infantile neuroaxonal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,150,150
Disease,Infantile neuroaxonal dystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Isolated scaphocephaly,,,,,,,,,,,,,
Disease,T-B+ severe combined immunodeficiency due to JAK3 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fulminant viral hepatitis,,,,,,,,,,,,,
Disease,Idiopathic disseminated cytomegalovirus infection,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital muscular dystrophy with integrin alpha-7 deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.03,0.03
Disease,Telethonin-related  limb-girdle muscular dystrophy R7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12921790[PMID]_18948002[PMID]_25298746[PMID],16,16
Disease,Telethonin-related  limb-girdle muscular dystrophy R7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12921790[PMID]_18948002[PMID]_25298746[PMID],0,0
Disease,FKRP-related  limb-girdle muscular dystrophy R9,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1,1
Disease,FKRP-related  limb-girdle muscular dystrophy R9,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.43,0.43
Disease,FKRP-related  limb-girdle muscular dystrophy R9,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,20961759[PMID],1.85,1.85
Disease,FKRP-related  limb-girdle muscular dystrophy R9,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,16634037[PMID],0.71,0.71
Disease,DNAJB6-related  limb-girdle muscular dystrophy D1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26847086[PMID],6,6
Disease,DNAJB6-related  limb-girdle muscular dystrophy D1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26847086[PMID],0,0
Disease,Glycogen storage disease due to LAMP-2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,84,84
Disease,Glycogen storage disease due to LAMP-2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Glycogen storage disease due to LAMP-2 deficiency,<1 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.05,0.05
Disease,Immunodeficiency by defective expression of MHC class I,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25001848[PMID],30,30
Disease,Immunodeficiency by defective expression of MHC class I,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25001848[PMID],0,0
Category,Genetic primary hypomagnesemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],500,500
Category,Genetic primary hypomagnesemia,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial primary hypomagnesemia with normocalciuria and normocalcemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24699222[PMID],5,5
Disease,Familial primary hypomagnesemia with normocalciuria and normocalcemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant primary hypomagnesemia with hypocalciuria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25765846[PMID],28,28
Disease,Autosomal dominant primary hypomagnesemia with hypocalciuria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25765846[PMID],0,0
Category,Corneal dystrophy,>1 / 1000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,21791583[PMID],110,110
Category,Corneal dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,RASopathy,,,,,,,,,,,,,
Disease,Myopathic Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28306225[PMID],8,8
Disease,Myopathic Ehlers-Danlos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28306225[PMID],0,0
Disease,Spondylodysplastic Ehlers-Danlos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29931299[PMID]_26940150[PMID]_18513683[PMID]_18985159[PMID],0,0
Disease,Spondylodysplastic Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29931299[PMID]_26940150[PMID]_18513683[PMID]_18985159[PMID],24,24
Clinical subtype,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23664117[PMID]_29931299[PMID]_23664118[PMID],15,15
Clinical subtype,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29931299[PMID],0,0
Disease,Kyphoscoliotic Ehlers-Danlos syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28306225[PMID],0,0
Disease,Classical-like Ehlers-Danlos syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30759870[PMID],7,7
Disease,Classical-like Ehlers-Danlos syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30759870[PMID],0,0
Etiological subtype,PLG-related hereditary angioedema with normal C1Inh,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30809376[PMID],105,105
Etiological subtype,PLG-related hereditary angioedema with normal C1Inh,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30809376[PMID],0,0
Disease,Tumor necrosis factor receptor 1 associated periodic syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Tumor necrosis factor receptor 1 associated periodic syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],0.1,0.1
Category,Rare teratologic disease,,,,,,,,,,,,,
Disease,Pseudo-von Willebrand disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23327637[PMID]_21301777[PMID]_23934752[PMID],60,60
Disease,Pseudo-von Willebrand disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.5,1.5
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],5.02,5.02
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,21708407[PMID],4.15,4.15
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,21708407[PMID],7,7
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],6.4,6.4
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,7718765[PMID],1.35,1.35
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,18443215[PMID]_17345612[PMID]_National Cancer Institute[INST]_ORPHANET,3.35,3.35
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Greece,409967,409967,25965,25965,en,Not yet validated,410294,410294,23572136[PMID],5.4,5.4
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,United Kingdom,409967,409967,25965,25965,en,Not yet validated,410294,410294,7986716[PMID]_7819118[PMID]_ ORPHANET,8.5,8.5
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Sweden,409967,409967,25965,25965,en,Not yet validated,410294,410294,7720834[PMID],3.5,3.5
Clinical group,Myelodysplastic syndrome,1-9 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,19411107[PMID],0.5,0.5
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,14555322[PMID],8.1,8.1
Clinical group,Myelodysplastic syndrome,1-5 / 10 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,emedicine 2009[OTHER],15,15
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,27699872[PMID],1.95,1.95
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,27699872[PMID],6.2,6.2
Clinical group,Myelodysplastic syndrome,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,28056392[PMID],3.8,3.8
Etiological subtype,ANGPT1-related hereditary angioedema with normal C1Inh,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,28601681[PMID],0,0
Etiological subtype,ANGPT1-related hereditary angioedema with normal C1Inh,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_28601681[PMID],4,4
Malformation syndrome,Branchiootic syndrome,,,,,,,,,,,,,
Disease,Autosomal recessive lethal neonatal axonal sensorimotor polyneuropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22971091[PMID]_9771672[PMID],13,13
Disease,X-linked creatine transporter deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23644449[PMID],150,150
Disease,X-linked creatine transporter deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23644449[PMID],0,0
Disease,Congenital axonal neuropathy with encephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18358405[PMID],0,0
Disease,Congenital axonal neuropathy with encephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18358405[PMID],7,7
Category,Neurological channelopathy of the central nervous system due to a genetic chloride channel defect,,,,,,,,,,,,,
Disease,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301649[PMID],26,26
Disease,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301649[PMID],0,0
Disease,Mantle cell lymphoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,28444739[PMID]_SEER Surveillance Epidemiology and End Results 2007-2013[INST],0.8,0.8
Disease,Mantle cell lymphoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_European Medicines Agency 2015[INST],3.5,3.5
Disease,Mantle cell lymphoma,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],1.05,1.05
Disease,Retinitis punctata albescens,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23929416[PMID],0.125,0.125
Disease,Retinitis punctata albescens,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_European Medecines Agency 2016[INST],0.175,0.175
Disease,MALT lymphoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG],0.3,0.3
Disease,MALT lymphoma,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,22893605[PMID]_National Cancer Institute[INST],1.59,1.59
Disease,MALT lymphoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2013[INST],4,4
Malformation syndrome,Ulnar/fibula ray defect-brachydactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14564152[PMID],1,1
Malformation syndrome,Ulnar/fibula ray defect-brachydactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14564152[PMID],0,0
Malformation syndrome,Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14556245[PMID],2,2
Malformation syndrome,Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14556245[PMID],0,0
Disease,Mohr-Tranebjaerg syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301395[PMID],91,91
Disease,Mohr-Tranebjaerg syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301395[PMID],0,0
Malformation syndrome,Muenke syndrome,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,15241680[PMID],3.33,3.33
Malformation syndrome,Muenke syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial cutaneous collagenoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5657391[PMID]_486326[PMID]_22028557[PMID],16,16
Disease,Familial cutaneous collagenoma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5657391[PMID]_486326[PMID]_22028557[PMID],0,0
Disease,Brody myopathy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Orbital leiomyoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23562416[PMID],26,26
Disease,Orbital leiomyoma,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23562416[PMID],0,0
Malformation syndrome,Caroli disease,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,14696493[PMID],0.1,0.1
Malformation syndrome,Caroli disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15559623[PMID],0,0
Category,Vasculitis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,6.3,6.3
Disease,Isolated follicle stimulating hormone deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital lactase deficiency,,,,,,,,,,,,,
Disease,Congenital chloride diarrhea,,,,,,,,,,,,,
Clinical subtype,Classic pyoderma gangrenosum,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25213386[PMID],0,0
Clinical subtype,Classic pyoderma gangrenosum,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_29877043[PMID],0,0
Disease,Familial multiple discoid fibromas,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29067220[PMID],44,44
Disease,Familial multiple discoid fibromas,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29067220[PMID],0,0
Disease,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6446889[PMID]_2976839[PMID]_27639257[PMID],23,23
Disease,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6446889[PMID]_2976839[PMID]_27639257[PMID],0,0
Disease,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21832227[PMID],20,20
Disease,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21832227[PMID],0,0
Disease,Goldmann-Favre syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Goldmann-Favre syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary geniospasm,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,X-linked dystonia-parkinsonism,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,15390042[PMID],0,0
Disease,X-linked dystonia-parkinsonism,1-9 / 1 000 000,Philippines,409966,409966,25958,25958,en,Validated,410293,410293,21047175[PMID]_20301662[PMID]_ [EXPERT],0.31,0.31
Disease,Left ventricular noncompaction,,,,,,,,,,,,,
Disease,Posterior cortical atrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,X-linked lymphoproliferative disease due to XIAP deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29942301[PMID],100,100
Disease,X-linked lymphoproliferative disease due to XIAP deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29942301[PMID],0,0
Disease,Corticosteroid-sensitive aseptic abscess syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,49,49
Disease,Corticosteroid-sensitive aseptic abscess syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,X-linked lymphoproliferative disease due to SH2D1A deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29942301[PMID],100,100
Disease,X-linked lymphoproliferative disease due to SH2D1A deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29942301[PMID],0,0
Disease,Thrombotic thrombocytopenic purpura,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,15978100[PMID]_15127914[PMID],0.3,0.3
Disease,Thrombotic thrombocytopenic purpura,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2009[INST],25.5,25.5
Disease,Thrombotic thrombocytopenic purpura,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,15127914[PMID],0.12,0.12
Disease,Thrombotic thrombocytopenic purpura,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Distal hereditary motor neuropathy,,,,,,,,,,,,,
Disease,Plummer-Vinson syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,25,25
Disease,Plummer-Vinson syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Wyburn-Mason syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:3211695001[OTHER],0,0
Malformation syndrome,Wyburn-Mason syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:3211695001[OTHER],90,90
Malformation syndrome,Spinal arteriovenous metameric syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26130930[PMID],45,45
Malformation syndrome,Spinal arteriovenous metameric syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26130930[PMID],0,0
Disease,Hyaline body myopathy,,,,,,,,,,,,,
Disease,Familial tumoral calcinosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Lethal arthrogryposis-anterior horn cell disease syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7821908[PMID],15,15
Malformation syndrome,Lethal arthrogryposis-anterior horn cell disease syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7821908[PMID],0,0
Clinical subtype,Vegetative pyoderma gangrenosum,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25213386[PMID],0,0
Clinical subtype,Vegetative pyoderma gangrenosum,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_29877043[PMID],0,0
Malformation syndrome,Gnathodiaphyseal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27068316[PMID],0,0
Morphological anomaly,Congenital cornea plana,,,,,,,,,,,,,
Clinical subtype,Bullous pyoderma gangrenosum,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25213386[PMID],0,0
Clinical subtype,Bullous pyoderma gangrenosum,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_29877043[PMID],0,0
Clinical subtype,Pustular pyoderma gangrenosum,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25213386[PMID],0,0
Clinical subtype,Pustular pyoderma gangrenosum,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_29877043[PMID],0,0
Disease,GRACILE syndrome,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,22970607[PMID],2,2
Disease,GRACILE syndrome,<1 / 1 000 000,Finland,409966,409966,25965,25965,en,Not yet validated,410294,410294,22970607[PMID],0,0
Disease,GRACILE syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Aceruloplasminemia,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,10449129[PMID],0.1,0.1
Disease,Aceruloplasminemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0.09,0.09
Clinical subtype,Embryonal carcinoma of the central nervous system,,,,,,,,,,,,,
Disease,IgG4-related retroperitoneal fibrosis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.35,0.35
Disease,IgG4-related retroperitoneal fibrosis,1-9 / 100 000,Finland,409966,409966,25965,25965,en,Not yet validated,410294,410294,16427494[PMID],0,0
Disease,IgG4-related retroperitoneal fibrosis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Focal myositis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15546587[PMID],115,115
Disease,Focal myositis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Achromatopsia,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:521590531[OTHER],2.7,2.7
Disease,Dentinogenesis imperfecta,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],14.5,14.5
Disease,Severe combined immunodeficiency due to CD70 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29942301[PMID],6,6
Disease,Severe combined immunodeficiency due to CD70 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29942301[PMID],0,0
Malformation syndrome,Congenital cataracts-facial dysmorphism-neuropathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301787[PMID],170,170
Malformation syndrome,Congenital cataracts-facial dysmorphism-neuropathy syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301787[PMID],0,0
Disease,Combined immunodeficiency due to ITK deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29942301[PMID],13,13
Disease,Combined immunodeficiency due to ITK deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29942301[PMID],0,0
Category,Lissencephaly,,,,,,,,,,,,,
Disease,Postinfectious vasculitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary effusion lymphoma,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],200,200
Disease,Primary effusion lymphoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Monosomy 22q13.3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Malformation syndrome,Monosomy 22q13.3,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Talo-patello-scaphoid osteolysis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12910489[PMID],2,2
Malformation syndrome,Talo-patello-scaphoid osteolysis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12910489[PMID],0,0
Malformation syndrome,Microlissencephaly-micromelia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12749064[PMID],2,2
Malformation syndrome,Microlissencephaly-micromelia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12749064[PMID],0,0
Disease,Lipodystrophy-intellectual disability-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12923870[PMID],3,3
Disease,Lipodystrophy-intellectual disability-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12923870[PMID],0,0
Disease,Zellweger-like syndrome without peroxisomal anomalies,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12784304[PMID],2,2
Disease,Zellweger-like syndrome without peroxisomal anomalies,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12784304[PMID],0,0
Malformation syndrome,Craniolenticulosutural dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,28,28
Malformation syndrome,Craniolenticulosutural dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Branchiogenic deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12833414[PMID],5,5
Malformation syndrome,Branchiogenic deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12833414[PMID],0,0
Disease,Acquired purpura fulminans,,,,,,,,,,,,,
Disease,Lichen amyloidosis,,,,,,,,,,,,,
Disease,Thiamine-responsive megaloblastic anemia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],80,80
Disease,Thiamine-responsive megaloblastic anemia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pleural mesothelioma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],3.1,3.1
Disease,Pleural mesothelioma,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,22406029[PMID],1.9,1.9
Disease,Pleural mesothelioma,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,19569174[PMID],0.8,0.8
Malformation syndrome,Blomstrand lethal chondrodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27353973[PMID],13,13
Malformation syndrome,Blomstrand lethal chondrodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27353973[PMID],0,0
Disease,Schöpf-Schulz-Passarge syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,25,25
Disease,Schöpf-Schulz-Passarge syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Torsade-de-pointes syndrome with short coupling interval,,,,,,,,,,,,,
Disease,Familial short QT syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23916535[PMID]_[EXPERT],0,0
Disease,Familial short QT syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],80,80
Disease,Cat-scratch disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],6.6,6.6
Disease,Duane anomaly-myopathy-scoliosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14659780[PMID],2,2
Disease,Duane anomaly-myopathy-scoliosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14659780[PMID],0,0
Disease,Keratolytic winter erythema,,,,,,,,,,,,,
Disease,Striate palmoplantar keratoderma,,,,,,,,,,,,,
Disease,Kikuchi-Fujimoto disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25500707[PMID],0,0
Disease,Kikuchi-Fujimoto disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25500707[PMID],1052,1052
Disease,Kikuchi-Fujimoto disease,1-9 / 1 000 000,Martinique,409967,409967,25958,25958,en,Validated,410293,410293,27015112[PMID],0.278,0.278
Malformation syndrome,Craniosynostosis-intracranial calcifications syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14564206[PMID],3,3
Malformation syndrome,Craniosynostosis-intracranial calcifications syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14564206[PMID],0,0
Malformation syndrome,Potocki-Shaffer syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23239541[PMID]_15852040[PMID],40,40
Malformation syndrome,Potocki-Shaffer syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23239541[PMID],0,0
Malformation syndrome,Braddock syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14556254[PMID],2,2
Malformation syndrome,Braddock syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14556254[PMID],0,0
Clinical group,Cobblestone lissencephaly,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,1,1
Clinical group,Cobblestone lissencephaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Generalized arterial calcification of infancy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25392903[PMID],0,0
Disease,Generalized arterial calcification of infancy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_25392903[PMID],300,300
Disease,Ethylmalonic encephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28933811[PMID],80,80
Disease,Ethylmalonic encephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28933811[PMID],0,0
Disease,Growth delay-intellectual disability-hepatopathy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29052218[PMID]_30431579[PMID],6,6
Disease,Growth delay-intellectual disability-hepatopathy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29052218[PMID]_30431579[PMID],0,0
Disease,Formiminoglutamic aciduria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Anomalous origin of coronary artery from the pulmonary artery,,,,,,,,,,,,,
Clinical group,Anomalous aortic origin of coronary artery,,,,,,,,,,,,,
Disease,WHIM syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23009155[PMID]_24492099[PMID],65,65
Disease,WHIM syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,WHIM syndrome,<1 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,23009155[PMID]_[EXPERT],0.023,0.023
Morphological anomaly,Anomalous aortic origin of the right coronary artery,,,,,,,,,,,,,
Disease,Anterior cutaneous nerve entrapment syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Anterior cutaneous nerve entrapment syndrome,6-9 / 10 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_25887961[PMID]_72957[PMID],55.6,55.6
Morphological anomaly,Anomalous aortic origin of the left coronary artery,,,,,,,,,,,,,
Disease,GNB5-related intellectual disability-cardiac arrhythmia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,GNB5-related intellectual disability-cardiac arrhythmia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27523599[PMID]_27677260[PMID]_28697420[PMID]_29368331[PMID]_30631341[PMID],22,22
Disease,Severe combined immunodeficiency due to CARMIL2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27896283[PMID]_27647349[PMID]_28112205[PMID]_29479355[PMID],21,21
Disease,Severe combined immunodeficiency due to CARMIL2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27896283[PMID]_27647349[PMID]_28112205[PMID]_29479355[PMID],0,0
Disease,Leukoencephalopathy with calcifications and cysts,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27571260[PMID],50,50
Disease,Leukoencephalopathy with calcifications and cysts,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27571260[PMID],0,0
Category,Vascular anomaly or angioma,,,,,,,,,,,,,
Disease,PFAPA syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24505122[PMID]_24677969[PMID],500,500
Disease,PFAPA syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Tietz syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23020089[PMID],2,2
Malformation syndrome,Tietz syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23020089[PMID],0,0
Particular clinical situation in a disease or syndrome,CAR T cell therapy-associated cytokine release syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Acute tricyclic antidepressant poisoning,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Auditory neuropathy-optic atrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28965846[PMID],8,8
Disease,Auditory neuropathy-optic atrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28965846[PMID],0,0
Disease,Serotonin syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Necrobiosis lipoidica,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29184811[PMID],0,0
Disease,Lambert-Eaton myasthenic syndrome,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,22094130[PMID]_23690300[PMID],0.06,0.06
Disease,Lambert-Eaton myasthenic syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],1,1
Disease,Lambert-Eaton myasthenic syndrome,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,22094130[PMID],0.35,0.35
Particular clinical situation in a disease or syndrome,Acute poisoning by drugs with membrane-stabilizing effect,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical syndrome,Livedoid vasculopathy,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,4830097[PMID]_21184847[PMID],1,1
Clinical syndrome,Livedoid vasculopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,PHACE syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26564079[PMID],300,300
Malformation syndrome,PHACE syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26564079[PMID],0,0
Clinical group,Severe congenital neutropenia,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.4,0.4
Clinical group,Severe congenital neutropenia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.4,0.4
Clinical group,Severe congenital neutropenia,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,12555210[PMID],0.07,0.07
Clinical group,Severe congenital neutropenia,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,22624626[PMID],1,1
Clinical group,Severe congenital neutropenia,1-9 / 1 000 000,Sweden,409966,409966,25965,25965,en,Not yet validated,410294,410294,22624626[PMID],0,0
Clinical group,Severe congenital neutropenia,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,20399414[PMID],0.6,0.6
Clinical group,Severe congenital neutropenia,<1 / 1 000 000,"Iran, Islamic Republic of",409966,409966,25958,25958,en,Validated,410293,410293,17024564[PMID],0.077,0.077
Disease,Hereditary myopathy with lactic acidosis due to ISCU deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301757[PMID],19,19
Disease,Hereditary myopathy with lactic acidosis due to ISCU deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301757[PMID],0,0
Morphological anomaly,Quadricuspid aortic valve,,,,,,,,,,,,,
Disease,Miyoshi myopathy,1-9 / 1 000 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.22,0.22
Disease,Miyoshi myopathy,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.26,0.26
Disease,Miyoshi myopathy,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29040572[PMID],17,17
Disease,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29040572[PMID],0,0
Disease,Incessant infant ventricular tachycardia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1.5,1.5
Disease,Incessant infant ventricular tachycardia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Incessant infant ventricular tachycardia,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,23551862[PMID],0.3,0.3
Disease,Incessant infant ventricular tachycardia,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23551862[PMID],0,0
Disease,Idiopathic neonatal atrial flutter,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_23551862[PMID],1.5,1.5
Disease,Idiopathic neonatal atrial flutter,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,23551862[PMID],2.1,2.1
Disease,Idiopathic neonatal atrial flutter,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Isolated hyperchlorhidrosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21035102[PMID]_26911677[PMID]_21184099[PMID],13,13
Disease,Isolated hyperchlorhidrosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21035102[PMID]_26911677[PMID]_21184099[PMID],0,0
Clinical group,Anomaly of the coronary ostia,,,,,,,,,,,,,
Disease,Gastrointestinal stromal tumor,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST]_23623056[PMID],13,13
Disease,Gastrointestinal stromal tumor,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,21420965[PMID]_23623056[PMID],1,1
Disease,Gastrointestinal stromal tumor,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,23177515[PMID],1,1
Disease,Gastrointestinal stromal tumor,1-9 / 100 000,"Korea, Republic of",409967,409967,25965,25965,en,Not yet validated,410294,410294,20514305[PMID],1.9,1.9
Disease,Gastrointestinal stromal tumor,1-5 / 10 000,Hong Kong,409966,409966,25965,25965,en,Not yet validated,410294,410294,16610025[PMID],14.5,14.5
Disease,Gastrointestinal stromal tumor,1-9 / 100 000,Hong Kong,409967,409967,25965,25965,en,Not yet validated,410294,410294,16610025[PMID],1.82,1.82
Disease,Gastrointestinal stromal tumor,1-9 / 100 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,11213830[PMID]_23079473[PMID],1.5,1.5
Disease,Gastrointestinal stromal tumor,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,15648083[PMID],12.9,12.9
Disease,Congenital fibrosis of extraocular muscles,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9797671[PMID],0,0
Disease,Congenital fibrosis of extraocular muscles,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,9797671[PMID],0.43,0.43
Particular clinical situation in a disease or syndrome,Selection of therapeutic option in melanoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Epidermolysis bullosa acquisita,<1 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,7826096[PMID]_19170813[PMID]_7669112[PMID],0.03,0.03
Disease,Epidermolysis bullosa acquisita,<1 / 1 000 000,France,409967,409967,25965,25965,en,Not yet validated,410294,410294,7826096[PMID]_23237497[PMID],0.02,0.02
Disease,Epidermolysis bullosa acquisita,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,19170813[PMID]_7669112[PMID],0.05,0.05
Disease,Epidermolysis bullosa acquisita,<1 / 1 000 000,Singapore,409967,409967,25958,25958,en,Validated,410293,410293,12207586[PMID]_23237497[PMID],0.05,0.05
Disease,Epidermolysis bullosa acquisita,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Epidermolysis bullosa acquisita,<1 / 1 000 000,Serbia,409967,409967,25958,25958,en,Validated,410293,410293,27767273[PMID],0.008,0.008
Disease,Epidermolysis bullosa acquisita,1-9 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,27456755[PMID],0.284,0.284
Disease,SYNGAP1-related developmental and epileptic encephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30541864[PMID],57,57
Disease,SYNGAP1-related developmental and epileptic encephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30541864[PMID],0,0
Disease,Linear IgA dermatosis,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,19170813[PMID],0.1,0.1
Disease,Linear IgA dermatosis,<1 / 1 000 000,Kuwait,409967,409967,25958,25958,en,Validated,410293,410293,15569006[PMID],0.069,0.069
Disease,Linear IgA dermatosis,<1 / 1 000 000,Singapore,409967,409967,25958,25958,en,Validated,410293,410293,12207586[PMID]_23237497[PMID],0.026,0.026
Clinical group,Superficial pemphigus,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.2,1.2
Disease,Mucous membrane pemphigoid,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,7826096[PMID]_23237497[PMID],0.13,0.13
Disease,Mucous membrane pemphigoid,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,19170813[PMID]_23237497[PMID],0.2,0.2
Disease,Mucous membrane pemphigoid,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mucous membrane pemphigoid,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,27456755[PMID],2.456,2.456
Disease,Paroxysmal extreme pain disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8778439[PMID],4,4
Disease,Paroxysmal extreme pain disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Oligodendroglial tumor,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.35,0.35
Clinical group,Oligodendroglial tumor,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Oligodendroglial tumor,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.24,0.24
Disease,Lathosterolosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24142275[PMID],4,4
Disease,Lathosterolosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary central nervous system lymphoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID],0.44,0.44
Disease,Primary central nervous system lymphoma,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,28983970[PMID],0.26,0.26
Clinical group,Hemolytic uremic syndrome,,,,,,,,,,,,,
Disease,Hereditary papillary renal cell carcinoma,,,,,,,,,,,,,
Morphological anomaly,Cerebral arteriovenous malformation,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,6,6
Malformation syndrome,Char syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_31012281[PMID],109,109
Malformation syndrome,Char syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Nodular regenerative hyperplasia of the liver,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,2586240[PMID],0.34,0.34
Disease,Nodular regenerative hyperplasia of the liver,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,2586240[PMID],3.1,3.1
Disease,Nodular regenerative hyperplasia of the liver,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Lewis-Sumner syndrome,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,19260065[PMID],0.9,0.9
Clinical subtype,Streptococcus pneumoniae-associated hemolytic uremic syndrome,,,,,,,,,,,,,
Disease,Pyoderma gangrenosum,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,ISBN:978-1-60831-581-9[OTHER],1,1
Disease,Pyoderma gangrenosum,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,22534879[PMID],0.91,0.91
Disease,Pyoderma gangrenosum,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25213386[PMID],0,0
Disease,Pyoderma gangrenosum,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,21782147[PMID],0.33,0.33
Disease,Pyoderma gangrenosum,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_21782147[PMID]_22534879[PMID]_ISBN:978-1-60831-581-9[OTHER],0.74,0.74
Disease,Pyoderma gangrenosum,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,29877043[PMID],0.517,0.517
Disease,RNF13-related severe early-onset epileptic encephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30595371[PMID],3,3
Disease,RNF13-related severe early-onset epileptic encephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30595371[PMID],0,0
Disease,Felty syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Infection-related hemolytic uremic syndrome,,,,,,,,,,,,,
Disease,Proximal renal tubular acidosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30239107[PMID]_30475435[PMID],5,5
Disease,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30239107[PMID]_30475435[PMID],0,0
Malformation syndrome,PRUNE1-related neurological syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30556349[PMID],48,48
Malformation syndrome,PRUNE1-related neurological syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30556349[PMID],0,0
Etiological subtype,Atypical hemolytic uremic syndrome with complement gene abnormality,,,,,,,,,,,,,
Disease,Familial cold urticaria,Unknown,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,24262697[PMID],0,0
Disease,Familial cold urticaria,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome,,,,,,,,,,,,,
Category,Collagen-related glomerular basement membrane disease,,,,,,,,,,,,,
Disease,Congenital myopathy with reduced type 2 muscle fibers,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30215711[PMID],2,2
Disease,Congenital myopathy with reduced type 2 muscle fibers,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30215711[PMID],0,0
Disease,Subcorneal pustular dermatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Subcorneal pustular dermatosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Congenital primary megaureter, refluxing and obstructed form",,,,,,,,,,,,,
Category,Rare deafness,,,,,,,,,,,,,
Category,Rare vascular disease,,,,,,,,,,,,,
Category,Rare dystonia,,,,,,,,,,,,,
Disease,NAD(P)HX dehydratase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30576410[PMID],6,6
Disease,NAD(P)HX dehydratase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30576410[PMID],0,0
Category,Hemoglobinopathy,,,,,,,,,,,,,
Clinical subtype,Fibrohistiocytic inflammatory pseudotumor of the liver,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17571078[PMID],0,0
Disease,NAD(P)HX epimerase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27616477[PMID]_27122014[PMID],11,11
Disease,NAD(P)HX epimerase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27616477[PMID]_27122014[PMID],0,0
Category,Lysosomal disease,,,,,,,,,,,,,
Category,Rare inborn errors of metabolism,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,21689452[PMID],3.3,3.3
Clinical subtype,Lymphoplasmacytic inflammatory pseudotumor of the liver,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17571078[PMID],0,0
Category,Peroxisomal disease,,,,,,,,,,,,,
Morphological anomaly,Congenital tricuspid valve dysplasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Congenital limb malformation,,,,,,,,,,,,,
Morphological anomaly,FLNA-related X-linked myxomatous valvular dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29146485[PMID],0,0
Category,Neuromuscular disease,,,,,,,,,,,,,
Disease,IgA pemphigus,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30085605[PMID],0,0
Category,Mitochondrial disease,,,,,,,,,,,,,
Category,Rare constitutional aplastic anemia,,,,,,,,,,,,,
Clinical subtype,Early-onset familial hypoaldosteronism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Neurometabolic disease,,,,,,,,,,,,,
Clinical subtype,Late-onset familial hypoaldosteronism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Early-onset calcifying leukoencephalopathy-skeletal dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30982608[PMID]_30982609[PMID]_28383543[PMID],0,0
Disease,Early-onset calcifying leukoencephalopathy-skeletal dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30982608[PMID]_30982609[PMID]_28383543[PMID],13,13
Disease,Pancreatic agenesis-holoprosencephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,31006513[PMID]_28525974[PMID],4,4
Disease,Pancreatic agenesis-holoprosencephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_31006513[PMID]_28525974[PMID],0,0
Category,Rare disorder due to poisoning,,,,,,,,,,,,,
Category,Rare parkinsonian disorder,,,,,,,,,,,,,
Disease,Neonatal epileptic encephalopathy due to glutaminase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30575854[PMID],4,4
Disease,Neonatal epileptic encephalopathy due to glutaminase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30575854[PMID],0,0
Disease,Spastic ataxia-dysarthria due to glutaminase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29468182[PMID]_30987386[PMID],5,5
Disease,Spastic ataxia-dysarthria due to glutaminase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29468182[PMID]_30987386[PMID],0,0
Disease,Oculocerebrodental syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,31034465[PMID],5,5
Disease,Oculocerebrodental syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_31034465[PMID],0,0
Category,Rare bone tumor,,,,,,,,,,,,,
Category,Rare infectious disease,,,,,,,,,,,,,
Category,Rare parathyroid disease and phosphocalcic metabolism anomaly,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Acquired aneurysmal subarachnoid hemorrhage,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],10,10
Disease,Isolated iridoschisis,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Pneumonia caused by Pseudomonas aeruginosa infection,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],50,50
Disease,Isolated blepharochalasis,,,,,,,,,,,,,
Morphological anomaly,Isolated microspherophakia,,,,,,,,,,,,,
Disease,Cocaine intoxication,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],1,1
Morphological anomaly,Isolated microphakia,,,,,,,,,,,,,
Category,Non-infectious posterior uveitis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],18,18
Morphological anomaly,Congenital cystic eye,,,,,,,,,,,,,
Clinical syndrome,Acute liver failure,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],20,20
Malformation syndrome,Autosomal recessive anterior segment dysgenesis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27839872[PMID]_29556725[PMID],8,8
Malformation syndrome,Autosomal recessive anterior segment dysgenesis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27839872[PMID]_29556725[PMID],0,0
Particular clinical situation in a disease or syndrome,Acute peripheral arterial occlusion,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],16,16
Morphological anomaly,Isolated congenital entropion,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Hepatitis B reinfection following liver transplantation,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2004[INST],2,2
Disease,Mooren ulcer,,,,,,,,,,,,,
Disease,Thygeson superficial punctate keratopathy,,,,,,,,,,,,,
Disease,Terrien marginal degeneration,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Partial deep dermal and full thickness burns,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],10,10
Disease,Systemic monochloroacetate poisoning,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2004[INST],0,0
Morphological anomaly,Peripapillary staphyloma,,,,,,,,,,,,,
Morphological anomaly,Isolated foveal hypoplasia,,,,,,,,,,,,,
Morphological anomaly,Optic disc pit,,,,,,,,,,,,,
Morphological anomaly,Isolated megalopapilla,,,,,,,,,,,,,
Disease,Retinopathy of prematurity,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Congenital optic disc excavation,,,,,,,,,,,,,
Disease,Hereditary folate malabsorption,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Hereditary folate malabsorption,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Recurrent hepatitis C virus induced liver disease in liver transplant recipients,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],7,7
Category,Disorder with optic nerve compression,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Sepsis in premature infants,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],32,32
Category,Pseudopapilledema,,,,,,,,,,,,,
Category,Syndromic inherited retinal disorder,,,,,,,,,,,,,
Disease,Gaisböck syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Syndromic vitreoretinopathy,,,,,,,,,,,,,
Disease,Hemoglobin D disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare disorder involving multiple structures of the eye,,,,,,,,,,,,,
Disease,Familial pseudohyperkalemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Category,Secondary early-onset glaucoma,,,,,,,,,,,,,
Disease,Primary familial polycythemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Spinal cord injury,1-9 / 100 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,22337075[PMID],3.57,3.57
Particular clinical situation in a disease or syndrome,Spinal cord injury,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],32,32
Category,Rare ophthalmic disorder with cranial nerve involvement,,,,,,,,,,,,,
Category,Rare optic nerve disorder,,,,,,,,,,,,,
Category,Rare trochlear nerve disorder,,,,,,,,,,,,,
Clinical syndrome,Diffuse alveolar hemorrhage,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],1,1
Category,Rare ocular motility/alignment disorder,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Acute sensorineural hearing loss by acute acoustic trauma or sudden deafness or surgery induced acoustic trauma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],40,40
Category,Rare brainstem or cerebellar disorder with ophthalmic involvement as a major feature,,,,,,,,,,,,,
Category,Rare ophthalmic disorder with cortical involvement,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Complications after hematopoietic stem cell transplantation,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],0.65,0.65
Category,Rare disorder with optic disc malformation,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Moderate and severe traumatic brain injury,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],37.8,37.8
Category,Rare neuromuscular disorder with ocular motility/alignment anomaly,,,,,,,,,,,,,
Malformation syndrome,"Deafness with labyrinthine aplasia, microtia, and microdontia",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22993869[PMID],56,56
Malformation syndrome,"Deafness with labyrinthine aplasia, microtia, and microdontia",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22993869[PMID],0,0
Category,Isolated progressive inherited retinal disorder,,,,,,,,,,,,,
Category,Non-syndromic syndactyly,,,,,,,,,,,,,
Category,Isolated vitreoretinopathy,,,,,,,,,,,,,
Category,Isolated macular dystrophy,,,,,,,,,,,,,
Disease,Primary immunodeficiency syndrome due to LAMTOR2 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17195838[PMID],4,4
Disease,Primary immunodeficiency syndrome due to LAMTOR2 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17195838[PMID],0,0
Category,Isolated chorioretinal dystrophy,,,,,,,,,,,,,
Category,Rare scleral disorder,,,,,,,,,,,,,
Disease,Amyotrophic lateral sclerosis-parkinsonism-dementia complex,,,,,,,,,,,,,
Category,Rare disorder with pigmented sclera,,,,,,,,,,,,,
Disease,Radiation myelitis,,,,,,,,,,,,,
Disease,Undifferentiated connective tissue syndrome,,,,,,,,,,,,,
Category,Syndromic microspherophakia,,,,,,,,,,,,,
Category,Syndromic ectopia lentis,,,,,,,,,,,,,
Disease,Inflammatory pseudotumor of the liver,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,140,140
Disease,Inflammatory pseudotumor of the liver,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Syndromic macular dystrophy,,,,,,,,,,,,,
Disease,Drug-induced autoimmune hemolytic anemia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Syndromic chorioretinal dystrophy,,,,,,,,,,,,,
Clinical subtype,Shiga toxin-associated hemolytic uremic syndrome,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,ISBN:0123864577[OTHER],2.1,2.1
Clinical subtype,Shiga toxin-associated hemolytic uremic syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Paroxysmal cold hemoglobinuria,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Isolated stationary inherited retinal disorder,,,,,,,,,,,,,
Category,Rare retinal vasculopathy,,,,,,,,,,,,,
Disease,Mixed-type autoimmune hemolytic anemia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare retinal disorder,,,,,,,,,,,,,
Disease,Non-spherocytic hemolytic anemia due to hexokinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,17,17
Disease,Non-spherocytic hemolytic anemia due to hexokinase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare macular disorder,,,,,,,,,,,,,
Disease,"Autoimmune hemolytic anemia, warm type",1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare disorder of the posterior segment of the eye,,,,,,,,,,,,,
Disease,Primary erythromelalgia,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,18713229[PMID],1.1,1.1
Disease,Primary erythromelalgia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare choroidal disorder,,,,,,,,,,,,,
Disease,Hemolytic anemia due to glutathione reductase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,947404[PMID],3,3
Disease,Hemolytic anemia due to glutathione reductase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_947404[PMID],0,0
Disease,X-linked hypophosphatemia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],0.21,0.21
Disease,X-linked hypophosphatemia,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,19095780[PMID],1.95,1.95
Disease,X-linked hypophosphatemia,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,19095780[PMID],2.4,2.4
Category,Structural developmental eye defect,,,,,,,,,,,,,
Category,Syndromic lacrimal system disorder,,,,,,,,,,,,,
Category,Rare disorder with ectropion,,,,,,,,,,,,,
Clinical subtype,"Lissencephaly syndrome, Norman-Roberts type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare disorder with entropion,,,,,,,,,,,,,
Disease,Dystrophic epidermolysis bullosa pruriginosa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Dystrophic epidermolysis bullosa pruriginosa,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Recessive dystrophic epidermolysis bullosa, generalized intermediate",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Inflammatory/autoimmune disorder involving the lacrimal system,,,,,,,,,,,,,
Category,Rare disorder of the ocular adnexa,,,,,,,,,,,,,
Disease,Centripetalis recessive dystrophic epidermolysis bullosa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Dr Giovanna ZAMBRUNO[EXPERT]_4026337[PMID],10,10
Disease,Centripetalis recessive dystrophic epidermolysis bullosa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4026337[PMID],0,0
Disease,"Junctional epidermolysis bullosa, non-Herlitz type",<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Epidermolysis bullosa simplex superficialis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,X-linked cone dysfunction syndrome with myopia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,X-linked cone dysfunction syndrome with myopia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare disorder with corneal involvement as a major feature,,,,,,,,,,,,,
Category,Rare inflammatory/autoimmune corneal disorder,,,,,,,,,,,,,
Disease,Erythema elevatum diutinum,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare disorder of the anterior segment of the eye,,,,,,,,,,,,,
Category,Rare disorder of the pupil,,,,,,,,,,,,,
Category,Rare conjunctivitis,,,,,,,,,,,,,
Category,Rare corneal disorder,,,,,,,,,,,,,
Category,Anterior segment developmental abnormality with extraocular manifestations,,,,,,,,,,,,,
Clinical subtype,Infantile Bartter syndrome with sensorineural deafness,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Autosomal dominant hypophosphatemic rickets,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Autosomal dominant hypophosphatemic rickets,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Infective keratitis,,,,,,,,,,,,,
Disease,Blau syndrome,<1 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.06,0.06
Disease,Blau syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Xeroderma pigmentosum variant,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Disease,Xeroderma pigmentosum variant,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant cutis laxa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Autosomal dominant cutis laxa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive cutis laxa type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,60,60
Disease,Autosomal recessive cutis laxa type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Autosomal recessive cutis laxa type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Clinical group,Autosomal recessive cutis laxa type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Brittle cornea syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14679583[PMID]_17122114[PMID],65,65
Disease,Brittle cornea syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Primary intestinal lymphangiectasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Secondary intestinal lymphangiectasia,,,,,,,,,,,,,
Clinical subtype,CREST syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,8,8
Disease,Localized scleroderma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6997748[PMID]_6587221[PMID],5,5
Disease,Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Systemic sclerosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],15.4,15.4
Disease,Systemic sclerosis,>1 / 1000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,18794710[PMID],230,230
Disease,Systemic sclerosis,1-5 / 10 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,18794710[PMID],27.7,27.7
Disease,Systemic sclerosis,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,14872101[PMID],8.8,8.8
Disease,Systemic sclerosis,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15213329[PMID]_23290691[PMID]_26816302[PMID],17.3,17.3
Disease,Systemic sclerosis,>1 / 1000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,15846586[PMID],110,110
Disease,Systemic sclerosis,1-5 / 10 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,15846586[PMID],15.4,15.4
Disease,Systemic sclerosis,6-9 / 10 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,1796818[PMID],72,72
Disease,Systemic sclerosis,1-9 / 100 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,1796818[PMID],4.6,4.6
Disease,Systemic sclerosis,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,18430269[PMID],30,30
Disease,Systemic sclerosis,1-5 / 10 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,19248123[PMID],44.3,44.3
Disease,Systemic sclerosis,>1 / 1000,Australia,409967,409967,25958,25958,en,Validated,410293,410293,11456035[PMID],204,204
Disease,Systemic sclerosis,1-5 / 10 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,11456035[PMID],23.3,23.3
Disease,Systemic sclerosis,1-9 / 100 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,21388247[PMID],1.09,1.09
Disease,Systemic sclerosis,1-9 / 100 000,"Taiwan, Province of China",409966,409966,25958,25958,en,Validated,410293,410293,21388247[PMID],5.63,5.63
Clinical subtype,Klippel-Trénaunay syndrome,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,20301304[PMID],0.007,0.007
Clinical subtype,Klippel-Trénaunay syndrome,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.007,0.007
Clinical subtype,Parkes Weber syndrome,,,,,,,,,,,,,
Clinical subtype,Cockayne syndrome type 2,,,,,,,,,,,,,
Clinical subtype,Cockayne syndrome type 1,,,,,,,,,,,,,
Clinical subtype,Cockayne syndrome type 3,,,,,,,,,,,,,
Disease,Centrifugal lipodystrophy,,,,,,,,,,,,,
Disease,Drug-induced localized lipodystrophy,,,,,,,,,,,,,
Clinical subtype,Mandibuloacral dysplasia with type A lipodystrophy,,,,,,,,,,,,,
Clinical subtype,Mandibuloacral dysplasia with type B lipodystrophy,,,,,,,,,,,,,
Disease,Pressure-induced localized lipoatrophy,,,,,,,,,,,,,
Disease,Idiopathic localized lipodystrophy,,,,,,,,,,,,,
Disease,Panniculitis-induced localized lipodystrophy,,,,,,,,,,,,,
Disease,Chilblain lupus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18543054[PMID],70,70
Disease,Chilblain lupus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18543054[PMID],0,0
Disease,Discoid lupus erythematosus,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,19289752[PMID],3.56,3.56
Disease,Discoid lupus erythematosus,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,21574972[PMID],3.2,3.2
Disease,Meige disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Lupus erythematosus panniculitis,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,19289752[PMID],0.07,0.07
Disease,Hypertrophic or verrucous lupus erythematosus,,,,,,,,,,,,,
Disease,Lupus erythematosus tumidus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21798482[PMID],250,250
Disease,Lupus erythematosus tumidus,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21798482[PMID],0,0
Particular clinical situation in a disease or syndrome,Scarring in glaucoma filtration surgical procedures,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],22,22
Particular clinical situation in a disease or syndrome,Invasive infections due to vancomycin-resistant enterococci,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Other acquired skin disease,,,,,,,,,,,,,
Malformation syndrome,Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9475604[PMID],7,7
Malformation syndrome,Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9475604[PMID],0,0
Clinical group,ATP13A2-related parkinsonism,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22388936[PMID]_29112700[PMID],0,0
Particular clinical situation in a disease or syndrome,AIDS wasting syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],20,20
Disease,Severe early-onset axonal neuropathy due to MFN2 deficiency,,,,,,,,,,,,,
Disease,"Hereditary motor and sensory neuropathy, Okinawa type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22883144[PMID],120,120
Disease,"Hereditary motor and sensory neuropathy, Okinawa type",Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Autosomal dominant intermediate Charcot-Marie-Tooth disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary motor and sensory neuropathy type 6,,,,,,,,,,,,,
Disease,Hereditary motor and sensory neuropathy with acrodystrophy,,,,,,,,,,,,,
Category,Genetic congenital malformation of the eye with glaucoma as a major feature,,,,,,,,,,,,,
Disease,Pediatric-onset Graves disease,,,,,,,,,,,,,
Disease,Prepubertal anorexia nervosa,,,,,,,,,,,,,
Category,Rare genetic choroidal disorder,,,,,,,,,,,,,
Category,Pediatric-onset glaucoma,,,,,,,,,,,,,
Category,Rare genetic macular disorder,,,,,,,,,,,,,
Category,Rare genetic retinal vasculopathy,,,,,,,,,,,,,
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,25142309[PMID]_SEER Surveillance Epidemiology and End Results 1973-2011[INST],6.2,6.2
Clinical group,Hepatocellular carcinoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2017[INST],15,15
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.264,6.264
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.106,2.106
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.129,5.129
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.212,5.212
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],9.266,9.266
Clinical group,Hepatocellular carcinoma,1-5 / 10 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,22537432[PMID],15,15
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,22537432[PMID],5,5
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Oceania,409967,409967,25958,25958,en,Validated,410293,410293,22537432[PMID],5,5
Clinical group,Hepatocellular carcinoma,1-5 / 10 000,Latin America,409967,409967,25958,25958,en,Validated,410293,410293,22537432[PMID]_18666317[PMID]_ ORPHANET,12.5,12.5
Clinical group,Hepatocellular carcinoma,1-5 / 10 000,China,409967,409967,25958,25958,en,Validated,410293,410293,12095924[PMID],35,35
Clinical group,Hepatocellular carcinoma,1-5 / 10 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,12095924[PMID],29,29
Clinical group,Hepatocellular carcinoma,1-5 / 10 000,"Korea, Republic of",409967,409967,25958,25958,en,Validated,410293,410293,12095924[PMID],49,49
Clinical group,Hepatocellular carcinoma,6-9 / 10 000,Mongolia,409967,409967,25958,25958,en,Validated,410293,410293,12095924[PMID],99,99
Clinical group,Hepatocellular carcinoma,1-5 / 10 000,Africa,409967,409967,25958,25958,en,Validated,410293,410293,18666317[PMID]_20616577[PMID]_22537432[PMID],16,16
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.221,3.221
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.296,5.296
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.275,2.275
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.697,1.697
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.762,2.762
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.979,2.979
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.487,1.487
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.382,3.382
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.278,1.278
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.045,1.045
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.933,1.933
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.146,1.146
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.627,1.627
Clinical group,Hepatocellular carcinoma,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.925,0.925
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.345,2.345
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.762,2.762
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.649,6.649
Clinical group,Hepatocellular carcinoma,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.127,1.127
Category,Rare genetic disorder involving multiple structures of the eye,,,,,,,,,,,,,
Category,Secondary early-onset glaucoma of genetic origin,,,,,,,,,,,,,
Category,Rare genetic disorder of the pupil,,,,,,,,,,,,,
Disease,"Autosomal recessive ataxia, Beauce type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,57,57
Disease,"Autosomal recessive ataxia, Beauce type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare genetic inflammatory/autoimmune corneal disorder,,,,,,,,,,,,,
Disease,Autosomal dominant progressive nephropathy with hypertension,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10930359 [PMID],14,14
Disease,Autosomal dominant progressive nephropathy with hypertension,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10930359 [PMID],0,0
Category,Rare genetic retinal disorder,,,,,,,,,,,,,
Disease,Hypertension due to gain-of-function mutations in the mineralocorticoid receptor,,,,,,,,,,,,,
Category,Rare genetic disorder of the posterior segment of the eye,,,,,,,,,,,,,
Disease,Amelogenesis imperfecta,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,13469154[PMID],7.1,7.1
Disease,Amelogenesis imperfecta,6-9 / 10 000,India,409966,409966,25958,25958,en,Validated,410293,410293,21712629[PMID],90,90
Disease,Amelogenesis imperfecta,>1 / 1000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,3169793[PMID],142,142
Disease,Amelogenesis imperfecta,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29618326[PMID],0,0
Category,Genetic corneal dystrophy,,,,,,,,,,,,,
Category,Rare genetic disorder with corneal involvement as a major feature,,,,,,,,,,,,,
Disease,Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29703962[PMID],20,20
Disease,Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29703962[PMID],0,0
Category,Syndromic genetic keratoconus,,,,,,,,,,,,,
Disease,Channelopathy-associated congenital insensitivity to pain,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Channelopathy-associated congenital insensitivity to pain,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17163533[PMID],2,2
Disease,Obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17163533[PMID],0,0
Category,Genetic superficial corneal dystrophy,,,,,,,,,,,,,
Category,Anterior segment developmental anomaly,,,,,,,,,,,,,
Category,Lens position anomaly of genetic origin,,,,,,,,,,,,,
Disease,Superior limbic keratoconjunctivitis,,,,,,,,,,,,,
Category,Lens size anomaly of genetic origin,,,,,,,,,,,,,
Disease,Vacuolar myopathy with sarcoplasmic reticulum protein aggregates,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16714317[PMID],4,4
Disease,Vacuolar myopathy with sarcoplasmic reticulum protein aggregates,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16714317[PMID],0,0
Category,Rare genetic corneal disorder,,,,,,,,,,,,,
Category,Syndromic genetic ectopia lentis,,,,,,,,,,,,,
Category,Rare genetic conjunctivitis,,,,,,,,,,,,,
Disease,Ichthyosis-prematurity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,16,16
Disease,Ichthyosis-prematurity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare genetic disorder with conjunctival involvement as a major feature,,,,,,,,,,,,,
Disease,Posterior column ataxia-retinitis pigmentosa syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Posterior column ataxia-retinitis pigmentosa syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Tritanopia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,4.8,4.8
Category,Syndromic genetic cataract,,,,,,,,,,,,,
Malformation syndrome,Terminal osseous dysplasia-pigmentary defects syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26059211[PMID],0,0
Category,Rare genetic disorder with lens opacification,,,,,,,,,,,,,
Category,Rare genetic disorder of the anterior segment of the eye,,,,,,,,,,,,,
Disease,Isolated congenital anosmia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,15,15
Disease,Isolated congenital anosmia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Anterior segment developmental anomaly of genetic origin,,,,,,,,,,,,,
Disease,Familial acute necrotizing encephalopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12874403[PMID]_19118815[PMID]_21205700[PMID],14,14
Disease,Familial acute necrotizing encephalopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12874403[PMID]_19118815[PMID]_21205700[PMID],0,0
Disease,Psychomotor delay due to S-adenosylhomocysteine hydrolase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2380820[PMID]_15024124[PMID],4,4
Disease,Psychomotor delay due to S-adenosylhomocysteine hydrolase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2380820[PMID]_15024124[PMID],0,0
Category,Lacrimal drainage system anomaly of genetic origin,,,,,,,,,,,,,
Category,Structural developmental eye defect of genetic origin,,,,,,,,,,,,,
Etiological subtype,Autosomal recessive non-syndromic intellectual disability,,,,,,,,,,,,,
Category,Rare genetic disorder with entropion,,,,,,,,,,,,,
Category,Rare genetic disorder of the lacrimal apparatus,,,,,,,,,,,,,
Disease,Non-syndromic genetic deafness,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Sialidosis type 2,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sialidosis type 2,<1 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare genetic palpebral disorder,,,,,,,,,,,,,
Category,Rare genetic eyelid malposition disorder,,,,,,,,,,,,,
Disease,Mal de Meleda,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,9887370[PMID],1,1
Category,Rare genetic neuromuscular disorder with ocular motility/alignment anomaly,,,,,,,,,,,,,
Category,Rare intellectual disability,,,,,,,,,,,,,
Category,Rare genetic disorder of the ocular adnexa,,,,,,,,,,,,,
Category,Rare genetic disorder with strabismus,,,,,,,,,,,,,
Category,Syndromic genetic disorder with strabismus,,,,,,,,,,,,,
Disease,"Hereditary palmoplantar keratoderma, Gamborg-Nielsen type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Congenital optic disc excavation of genetic origin,,,,,,,,,,,,,
Category,Rare genetic ocular motility/alignment disorder,,,,,,,,,,,,,
Category,Rare genetic ophthalmic disorder with cranial nerve involvement,,,,,,,,,,,,,
Disease,Dermatopathia pigmentosa reticularis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27512211[PMID],20,20
Disease,Dermatopathia pigmentosa reticularis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27512211[PMID],0,0
Category,Rare genetic optic nerve disorder,,,,,,,,,,,,,
Disease,Keratosis palmaris et plantaris-clinodactyly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Keratosis palmaris et plantaris-clinodactyly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare genetic ophthalmic disorder with cortical involvement,,,,,,,,,,,,,
Category,Rare genetic brainstem or cerebellar disorder with ophthalmic involvement as a major feature,,,,,,,,,,,,,
Disease,Diffuse palmoplantar keratoderma-acrocyanosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2564235[PMID]_8578969[PMID],10,10
Disease,Diffuse palmoplantar keratoderma-acrocyanosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2564235[PMID]_8578969[PMID],0,0
Category,Rare genetic disorder of the visual organs,,,,,,,,,,,,,
Malformation syndrome,Lymphedema-atrial septal defects-facial changes syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19533797[PMID],5,5
Malformation syndrome,Lymphedema-atrial septal defects-facial changes syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19533797[PMID],0,0
Disease,Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30107533[PMID],11,11
Disease,Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30107533[PMID],0,0
Clinical group,Syndromic autoimmune enteropathy,,,,,,,,,,,,,
Malformation syndrome,Myoclonic epilepsy in non-progressive encephalopathies,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25266964[PMID],0,0
Disease,Primary autoimmune enteropathy,,,,,,,,,,,,,
Malformation syndrome,Lymphedema-cerebral arteriovenous anomaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5718986[PMID],5,5
Malformation syndrome,Lymphedema-cerebral arteriovenous anomaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5718986[PMID],0,0
Disease,Myoclonic epilepsy of infancy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,106,106
Disease,Myoclonic epilepsy of infancy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Epilepsy with myoclonic absences,,,,,,,,,,,,,
Disease,Hypothalamic hamartomas with gelastic seizures,,,,,,,,,,,,,
Disease,Idiopathic hemiconvulsion-hemiplegia syndrome,,,,,,,,,,,,,
Disease,Dendritic cell sarcoma not otherwise specified,,,,,,,,,,,,,
Disease,LAMA5-related multisystemic syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28735299[PMID],11,11
Disease,LAMA5-related multisystemic syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28735299[PMID],0,0
Disease,Methotrexate-associated lymphoproliferative disorders,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28722276[PMID],10,10
Malformation syndrome,Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28722276[PMID],0,0
Malformation syndrome,Congenital vertebral-cardiac-renal anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28792876[PMID],0,0
Malformation syndrome,Congenital vertebral-cardiac-renal anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28792876[PMID],4,4
Disease,Interdigitating dendritic cell sarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27878435[PMID],0,0
Disease,Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27878435[PMID],2,2
Disease,Follicular dendritic cell sarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Malformation syndrome,PLAA-associated neurodevelopmental disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28007986[PMID]_28413018[PMID],15,15
Malformation syndrome,PLAA-associated neurodevelopmental disorder,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28007986[PMID]_28413018[PMID],0,0
Disease,Histiocytic sarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2DD,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29499166[PMID],51,51
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2DD,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29499166[PMID],0,0
Disease,Langerhans cell sarcoma,,,,,,,,,,,,,
Malformation syndrome,Xq25 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26443594[PMID],28,28
Malformation syndrome,Xq25 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26443594[PMID],0,0
Category,Rare skin disease,,,,,,,,,,,,,
Disease,Proximal myopathy with focal depletion of mitochondria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26782016[PMID]_27169979[PMID],4,4
Disease,Proximal myopathy with focal depletion of mitochondria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26782016[PMID]_27169979[PMID],0,0
Malformation syndrome,Frontonasal dysplasia-bifid nose-upper limb anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29136349[PMID],11,11
Malformation syndrome,Frontonasal dysplasia-bifid nose-upper limb anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29136349[PMID],0,0
Malformation syndrome,Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27005418[PMID],4,4
Malformation syndrome,Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27005418[PMID],0,0
Disease,Dystonia-parkinsonism-hypermanganesemia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29382362[PMID]_29685658[PMID]_27231142[PMID],11,11
Disease,Dystonia-parkinsonism-hypermanganesemia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29382362[PMID]_29685658[PMID]_27231142[PMID],0,0
Disease,"Epidermolysis bullosa simplex, autosomal recessive K14",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],19,19
Disease,"Epidermolysis bullosa simplex, autosomal recessive K14",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29351582[PMID],2,2
Disease,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29351582[PMID],0,0
Category,Progressive external ophthalmoplegia,,,,,,,,,,,,,
Disease,Radiation-induced plexopathy,,,,,,,,,,,,,
Disease,Osteoradionecrosis of the mandible,,,,,,,,,,,,,
Category,Radiation-induced disorder,,,,,,,,,,,,,
Clinical syndrome,Mirizzi syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29494098[PMID],0,0
Category,Rare dementia,,,,,,,,,,,,,
Category,Genetic primary orthostatic disorder,,,,,,,,,,,,,
Category,Primary orthostatic disorder,,,,,,,,,,,,,
Clinical subtype,MUC1-related autosomal dominant tubulointerstitial kidney disease,,,,,,,,,,,,,
Clinical subtype,UMOD-related autosomal dominant tubulointerstitial kidney disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_21868615[PMID],0,0
Category,Rare congenital non-syndromic heart malformation,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,21321151[PMID],7.8,7.8
Category,Rare congenital non-syndromic heart malformation,>1 / 1000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,23812182[PMID],223,223
Category,Esophageal malformation,,,,,,,,,,,,,
Category,Isolated inherited retinal disorder,,,,,,,,,,,,,
Category,Rare disorder of the visual organs,,,,,,,,,,,,,
Etiological subtype,Pseudohypoaldosteronism type 2C,,,,,,,,,,,,,
Etiological subtype,Pseudohypoaldosteronism type 2B,,,,,,,,,,,,,
Disease,Fungal keratitis,,,,,,,,,,,,,
Etiological subtype,Pseudohypoaldosteronism type 2A,,,,,,,,,,,,,
Disease,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Autosomal dominant Alport syndrome,,,,,,,,,,,,,
Clinical subtype,Autosomal recessive Alport syndrome,,,,,,,,,,,,,
Clinical subtype,X-linked Alport syndrome,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,16114783[PMID],1.25,1.25
Clinical subtype,X-linked Alport syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Fragile X-associated tremor/ataxia syndrome,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,15000674[PMID]_17166801[PMID]_ [EXPERT],0,0
Malformation syndrome,Fragile X-associated tremor/ataxia syndrome,1-9 / 100 000,United States,409969,409969,25958,25958,en,Validated,410293,410293,15000674[PMID]_17166801[PMID]_ [EXPERT],6.3,6.3
Malformation syndrome,Fragile X-associated tremor/ataxia syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI: https://doi.org/10.1053/j.ajkd.2018.08.015[OTHER],22,22
Disease,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI: https://doi.org/10.1053/j.ajkd.2018.08.015[OTHER],0,0
Disease,Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26537577[PMID],1,1
Disease,Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26537577[PMID],0,0
Disease,Non-specific syndromic intellectual disability,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Crouzon syndrome-acanthosis nigricans syndrome,1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,23986840[PMID]_ISBN:019511843X[OTHER],0.1,0.1
Malformation syndrome,Crouzon syndrome-acanthosis nigricans syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Pfeiffer syndrome type 3,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Pfeiffer syndrome type 2,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Clinical subtype,Pfeiffer syndrome type 1,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Malformation syndrome,"Short rib-polydactyly syndrome, Verma-Naumoff type",1-9 / 100 000,United Arab Emirates,409968,409968,25958,25958,en,Validated,410293,410293,12769508[PMID],5.2,5.2
Malformation syndrome,"Short rib-polydactyly syndrome, Majewski type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20607029[PMID],34,34
Malformation syndrome,"Short rib-polydactyly syndrome, Majewski type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20607029[PMID],0,0
Malformation syndrome,"Short rib-polydactyly syndrome, Saldino-Noonan type",,,,,,,,,,,,,
Malformation syndrome,Cloverleaf skull-multiple congenital anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12081722[PMID],3,3
Malformation syndrome,Cloverleaf skull-multiple congenital anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12081722[PMID],0,0
Malformation syndrome,"Short rib-polydactyly syndrome, Beemer-Langer type",,,,,,,,,,,,,
Disease,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,17,17
Disease,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Spondyloepiphyseal dysplasia, Kimberley type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1978986[PMID],1,1
Disease,"Spondyloepiphyseal dysplasia, Kimberley type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7757086[PMID],4,4
Disease,Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7757086[PMID],0,0
Clinical subtype,Polyostotic fibrous dysplasia,,,,,,,,,,,,,
Clinical subtype,Monostotic fibrous dysplasia,,,,,,,,,,,,,
Clinical subtype,Thanatophoric dysplasia type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Renal dysplasia,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Renal dysplasia,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies[REG]_21381187[PMID],43.5,43.5
Disease,NKX6-2-related autosomal recessive hypomyelinating leukodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29388673[PMID]_30285346[PMID],25,25
Disease,NKX6-2-related autosomal recessive hypomyelinating leukodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29388673[PMID]_30285346[PMID],0,0
Morphological anomaly,Renal hypoplasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Morphological anomaly,Posterior urethral valve,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],2,2
Morphological anomaly,Posterior urethral valve,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_19838598[PMID],4.125,4.125
Morphological anomaly,Posterior urethral valve,1-9 / 100 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,25198372[PMID],6.4,6.4
Morphological anomaly,Congenital megacalycosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23252475[PMID],25,25
Morphological anomaly,Congenital megacalycosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23252475[PMID],0,0
Malformation syndrome,Severe myopia-generalized joint laxity-short stature syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28475863[PMID],5,5
Malformation syndrome,Severe myopia-generalized joint laxity-short stature syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28475863[PMID],0,0
Disease,Relapsing fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Renal agenesis, unilateral",Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Renal agenesis, unilateral",1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,23449343[PMID],50,50
Malformation syndrome,Diaphragmatic hernia-short bowel-asplenia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28898547[PMID],2,2
Malformation syndrome,Diaphragmatic hernia-short bowel-asplenia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28898547[PMID],0,0
Disease,Congenital tufting enteropathy,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,Dr Julie Salomon_Dr Olivier Goulet[EXPERT],0.5,0.5
Disease,Congenital tufting enteropathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17448233[PMID],0,0
Disease,Hypocalcemic vitamin D-resistant rickets,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Transient pseudohypoaldosteronism,,,,,,,,,,,,,
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22187985[PMID]_24174593[PMID],21,21
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,HNF1B-related autosomal dominant tubulointerstitial kidney disease,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pauci-immune glomerulonephritis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Laure-Hélène NOEL[EXPERT],0,0
Clinical subtype,Congenital bilateral megacalycosis,,,,,,,,,,,,,
Clinical subtype,"Renal dysplasia, unilateral",1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies[REG]_ORPHANET,0,0
Clinical subtype,"Renal dysplasia, unilateral",1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies[REG]_[EXPERT],0,0
Clinical subtype,"Renal dysplasia, bilateral",Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Unilateral congenital megacalycosis,,,,,,,,,,,,,
Morphological anomaly,Tibial hemimelia,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.1,0.1
Morphological anomaly,Radial hemimelia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Ulnar hemimelia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Autosomal dominant Kenny-Caffey syndrome,,,,,,,,,,,,,
Etiological subtype,Autosomal recessive Kenny-Caffey syndrome,,,,,,,,,,,,,
Morphological anomaly,Fibular hemimelia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],2,2
Clinical subtype,Autosomal recessive omodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19481194[PMID],23,23
Clinical subtype,Autosomal recessive omodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Autosomal dominant omodysplasia,,,,,,,,,,,,,
Morphological anomaly,Polydactyly of a triphalangeal thumb,,,,,,,,,,,,,
Morphological anomaly,Postaxial polydactyly type B,1-5 / 10 000,Mexico,409968,409968,25958,25958,en,Validated,410293,410293,31091006[PMID],43.5,43.5
Morphological anomaly,Postaxial polydactyly type A,1-5 / 10 000,Mexico,409968,409968,25958,25958,en,Validated,410293,410293,31091006[PMID],15.7,15.7
Malformation syndrome,Pelviscapular dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19068278[PMID],4,4
Malformation syndrome,Pelviscapular dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19068278[PMID],0,0
Morphological anomaly,Polydactyly of a biphalangeal thumb,,,,,,,,,,,,,
Morphological anomaly,Polydactyly of an index finger,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Encephalopathy due to mitochondrial and peroxisomal fission defect,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17460227[PMID]_26825290[PMID]_26992161[PMID]_26604000[PMID]_27145208[PMID]_30109270[PMID]_27328748[PMID]_26783368[PMID],15,15
Disease,Encephalopathy due to mitochondrial and peroxisomal fission defect,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17460227[PMID]_26825290[PMID]_26992161[PMID]_26604000[PMID]_27145208[PMID]_30109270[PMID]_27328748[PMID]_26783368[PMID],0,0
Morphological anomaly,Polysyndactyly,,,,,,,,,,,,,
Disease,X-linked spondyloepimetaphyseal dysplasia,,,,,,,,,,,,,
Disease,"Spondyloepimetaphyseal dysplasia congenita, Strudwick type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Disease,"Spondyloepimetaphyseal dysplasia congenita, Strudwick type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Anauxetic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27380734[PMID],10,10
Disease,Anauxetic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27380734[PMID],0,0
Disease,"Spondyloepimetaphyseal dysplasia, Missouri type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9258750[PMID],14,14
Disease,"Spondyloepimetaphyseal dysplasia, Missouri type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Spondyloepimetaphyseal dysplasia, Irapa type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6772027[PMID],0,0
Disease,"Spondyloepimetaphyseal dysplasia, Shohat type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8357004[PMID]_8074146[PMID]_28263186[PMID],5,5
Disease,"Spondyloepimetaphyseal dysplasia, Shohat type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28263186[PMID],0,0
Disease,Spondyloepiphyseal dysplasia tarda,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adenoma of pancreas,,,,,,,,,,,,,
Malformation syndrome,Okihiro syndrome,,,,,,,,,,,,,
Clinical subtype,Achondrogenesis type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Achondrogenesis type 1B,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301689[PMID],0,0
Clinical subtype,Hypochondrogenesis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Achondrogenesis type 1A,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"Brachyolmia, Maroteaux type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2669482[PMID]_20503319[PMID],4,4
Malformation syndrome,"Brachyolmia, Maroteaux type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2669482[PMID],0,0
Malformation syndrome,Autosomal dominant brachyolmia,,,,,,,,,,,,,
Disease,Multiple epiphyseal dysplasia type 4,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18328978[PMID],0,0
Disease,Multiple epiphyseal dysplasia type 1,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18328978[PMID],0,0
Disease,Multiple epiphyseal dysplasia type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15948199[PMID],18,18
Disease,Multiple epiphyseal dysplasia type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15948199[PMID],0,0
Disease,"Spondylometaphyseal dysplasia, Kozlowski type",<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,"Spondylometaphyseal dysplasia, 'corner fracture' type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Disease,"Spondylometaphyseal dysplasia, 'corner fracture' type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29100092[PMID],0,0
Disease,"Spondylometaphyseal dysplasia, Schmidt type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23653587[PMID]_[EXPERT],7,7
Disease,"Spondylometaphyseal dysplasia, Schmidt type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Spondylometaphyseal dysplasia, Sedaghatian type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],9,9
Malformation syndrome,"Spondylometaphyseal dysplasia, Sedaghatian type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare endocrine growth disease,,,,,,,,,,,,,
Malformation syndrome,17q24.2 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28465847[PMID]_29696806[PMID],0,0
Malformation syndrome,17q24.2 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29696806[PMID],19,19
Disease,Secondary erythromelalgia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Secondary erythromelalgia,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,18713229[PMID],0.2,0.2
Disease,Combined hepatocellular carcinoma and cholangiocarcinoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23034166[PMID],0,0
Disease,Hypothyroidism due to TSH receptor mutations,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Isolated thyroid-stimulating hormone deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Letrozole toxicity,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Enzalutamide toxicity,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Particular clinical situation in a disease or syndrome,Resistance to colchicine,,,,,,,,,,,,,
Clinical syndrome,Chronic bilirubin encephalopathy,1-9 / 100 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,22966025[PMID],1.49,1.49
Clinical syndrome,Chronic bilirubin encephalopathy,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,15858962[PMID],1.4,1.4
Clinical syndrome,Chronic bilirubin encephalopathy,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,15466085[PMID],1,1
Disease,Charcot-Marie-Tooth disease type 1E,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23224996[PMID],0,0
Clinical syndrome,Acute bilirubin encephalopathy,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,17074786[PMID],0.87,0.87
Disease,Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12428206[PMID]_15671104[PMID]_17496421[PMID]_15448795[PMID]_15559435[PMID],68,68
Disease,Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital lipoid adrenal hyperplasia due to STAR deficency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,"46,XY disorder of sex development due to testicular steroidogenesis defect",,,,,,,,,,,,,
Category,"46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect",,,,,,,,,,,,,
Category,"46,XY disorder of sex development due to a testosterone synthesis defect",,,,,,,,,,,,,
Category,"46,XX disorder of sex development induced by fetal androgens excess",,,,,,,,,,,,,
Category,Disorder of sex development,,,,,,,,,,,,,
Disease,Inflammatory bowel disease-recurrent sinopulmonary infections syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25667416[PMID],1,1
Disease,Inflammatory bowel disease-recurrent sinopulmonary infections syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25667416[PMID],0,0
Morphological anomaly,Dermoid or epidermoid cyst of the central nervous system,,,,,,,,,,,,,
Clinical group,Immune dysregulation with inflammatory bowel disease,,,,,,,,,,,,,
Disease,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30026316[PMID],7,7
Disease,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30026316[PMID],0,0
Disease,Panhypopituitarism,,,,,,,,,,,,,
Malformation syndrome,Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28866611[PMID],5,5
Malformation syndrome,Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28866611[PMID],0,0
Clinical subtype,Male infertility due to acephalic spermatozoa,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27640305[PMID]_30032984[PMID],0,0
Clinical subtype,Scleromyxedema without monoclonal gammopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,15,15
Clinical subtype,Scleromyxedema without monoclonal gammopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,X-linked non-syndromic sensorineural deafness type DFN,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acral persistent papular mucinosis,,,,,,,,,,,,,
Disease,Monoclonal mast cell activation syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24745674[PMID],0,0
Disease,Self-healing papular mucinosis,,,,,,,,,,,,,
Malformation syndrome,Duane retraction syndrome with congenital deafness,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27181683[PMID],4,4
Malformation syndrome,Duane retraction syndrome with congenital deafness,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27181683[PMID,0,0
Clinical subtype,Localized lichen myxedematosus with mixed features of different subtypes,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Clinical subtype,Localized lichen myxedematosus with mixed features of different subtypes,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22235972[PMID],5,5
Clinical subtype,Localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Nodular lichen myxedematosus,,,,,,,,,,,,,
Disease,Discrete papular lichen myxedematosus,,,,,,,,,,,,,
Disease,Papular mucinosis of infancy,,,,,,,,,,,,,
Disease,Hypotrichosis simplex of the scalp,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Telangiectasia macularis eruptiva perstans,,,,,,,,,,,,,
Clinical subtype,Anonychia-onychodystrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15200512[PMID],14,14
Clinical subtype,Anonychia-onychodystrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Stickler syndrome type 1,,,,,,,,,,,,,
Malformation syndrome,Otopalatodigital syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17431908[PMID],40,40
Malformation syndrome,Otopalatodigital syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17431908[PMID],0,0
Clinical subtype,Stickler syndrome type 2,,,,,,,,,,,,,
Malformation syndrome,Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29100095[PMID],10,10
Malformation syndrome,Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29100095[PMID],0,0
Disease,Jervell and Lange-Nielsen syndrome,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.3,0.3
Malformation syndrome,Otopalatodigital syndrome type 1,,,,,,,,,,,,,
Malformation syndrome,Deafness-hypogonadism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6819099[PMID],5,5
Malformation syndrome,Deafness-hypogonadism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6819099[PMID],0,0
Category,Syndromic genetic deafness,,,,,,,,,,,,,
Etiological subtype,Mitochondrial non-syndromic sensorineural deafness,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial thoracic aortic aneurysm and aortic dissection,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,22,22
Disease,Familial thoracic aortic aneurysm and aortic dissection,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Isolated cryptophthalmia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16352480[PMID],0,0
Morphological anomaly,Isolated cryptophthalmia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16352480[PMID],30,30
Clinical group,Hereditary angioedema,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23662043[PMID]_European Medicines Agency 2018[INST],5,5
Clinical group,Hereditary angioedema,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,19709101[PMID],1.4,1.4
Clinical group,Hereditary angioedema,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,11202238[PMID],1.51,1.51
Clinical group,Hereditary angioedema,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,15875532[PMID],1.09,1.09
Clinical group,Acquired angioedema,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,23921495[PMID],0.11,0.11
Clinical group,Acquired angioedema,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23921495[PMID],200,200
Clinical group,Acquired angioedema,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Marcus-Gunn syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital Horner syndrome,,,,,,,,,,,,,
Morphological anomaly,Isolated ankyloblepharon filiforme adnatum,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital ptosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Duplication of the esophagus,,,,,,,,,,,,,
Disease,Pituitary deficiency due to empty sella turcica syndrome,,,,,,,,,,,,,
Malformation syndrome,Sheehan syndrome,Unknown,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Non-specific interstitial pneumonia,,,,,,,,,,,,,
Morphological anomaly,Congenital esophageal diverticulum,,,,,,,,,,,,,
Disease,Chronic pneumonitis of infancy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Snowflake vitreoretinal degeneration,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Snowflake vitreoretinal degeneration,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Persistent hyperplastic primary vitreous,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Macular coloboma-cleft palate-hallux valgus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4977272[PMID],2,2
Malformation syndrome,Macular coloboma-cleft palate-hallux valgus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4977272[PMID],0,0
Disease,Early-onset non-syndromic cataract,,,,,,,,,,,,,
Disease,Lyme disease,>1 / 1000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],177.5,177.5
Disease,Lyme disease,1-5 / 10 000,France,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],16.6,16.6
Disease,Lyme disease,1-5 / 10 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,emedicine[OTHER],21.9,21.9
Disease,Lyme disease,1-5 / 10 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,23428090[PMID],12.37,12.37
Disease,Lyme disease,1-5 / 10 000,Sweden,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,36,36
Disease,Lyme disease,>1 / 1000,United States,409967,409967,25958,25958,en,Validated,410293,410293,24045727[PMID],100,100
Disease,Lyme disease,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Tubulointerstitial nephritis and uveitis syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28709457[PMID],0,0
Disease,Familial congenital palsy of trochlear nerve,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3985833[PMID],6,6
Disease,Familial congenital palsy of trochlear nerve,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3985833[PMID],0,0
Disease,Ring dermoid of cornea,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Ring dermoid of cornea,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Isolated congenital alacrima,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pilomatrixoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Congenital ectropion uveae,,,,,,,,,,,,,
Morphological anomaly,Isolated congenital sclerocornea,,,,,,,,,,,,,
Morphological anomaly,Isolated congenital megalocornea,,,,,,,,,,,,,
Morphological anomaly,Rieger anomaly,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Adenovirus infection in immunocompromised patients,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2003[INST],18,18
Disease,Cardiomyopathy-hypotonia-lactic acidosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17273968[PMID],2,2
Disease,Cardiomyopathy-hypotonia-lactic acidosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17273968[PMID],0,0
Disease,DK1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23890587[PMID],17,17
Disease,DK1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23890587[PMID],0,0
Disease,Ichthyosis-hypotrichosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26596219[PMID],11,11
Disease,Ichthyosis-hypotrichosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26596219[PMID],0,0
Malformation syndrome,Osteopenia-myopia-hearing loss-intellectual disability-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17230486[PMID],2,2
Malformation syndrome,Osteopenia-myopia-hearing loss-intellectual disability-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17230486[PMID],0,0
Disease,Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],7,7
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,3259306[PMID]_15964450[PMID],7,7
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22312171[PMID],6.4,6.4
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,Italy,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,9.2,9.2
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,2321478[PMID],8.7,8.7
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,9521938[PMID]_22692165[PMID],6.2,6.2
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,New Zealand,409968,409968,25958,25958,en,Validated,410293,410293,7815200[PMID],4.2,4.2
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,19844117[PMID],6.4,6.4
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,18204270[PMID],6.2,6.2
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,Singapore,409968,409968,25958,25958,en,Validated,410293,410293,12008686[PMID],4.5,4.5
Disease,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1-9 / 100 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,6967865[PMID],6.5,6.5
Disease,Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.75,0.75
Disease,Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.47,0.47
Disease,"46,XY disorder of sex development due to isolated 17,20-lyase deficiency",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22170710[PMID],15,15
Disease,"46,XY disorder of sex development due to isolated 17,20-lyase deficiency",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22170710[PMID],0,0
Disease,Partial androgen insensitivity syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Primary lipodystrophy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical group,Autosomal recessive axonal hereditary motor and sensory neuropathy,,,,,,,,,,,,,
Category,Other metabolic disease,,,,,,,,,,,,,
Disease,TSH-secreting pituitary adenoma,1-9 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,23295463[PMID],0.28,0.28
Disease,Non-functioning pituitary adenoma,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,25946030[PMID]_20534753[PMID]_10770176[PMID],1.05,1.05
Disease,Non-functioning pituitary adenoma,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET_25946030[PMID]_20534753[PMID]_10770176[PMID],2.55,2.55
Disease,Non-functioning pituitary adenoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26072284[PMID],0,0
Disease,Non-functioning pituitary adenoma,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,20534753[PMID],4,4
Disease,Non-functioning pituitary adenoma,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,10770176[PMID],1.1,1.1
Disease,Non-functioning pituitary adenoma,6-9 / 10 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,16968795[PMID],94,94
Disease,Non-functioning pituitary adenoma,6-9 / 10 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,19968031[PMID],80.5,80.5
Disease,Non-functioning pituitary adenoma,6-9 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19650784[PMID],77.6,77.6
Disease,Non-functioning pituitary adenoma,6-9 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,20534753[PMID],68,68
Disease,Functioning gonadotropic adenoma,,,,,,,,,,,,,
Disease,Pituitary dermoid and epidermoid cysts,,,,,,,,,,,,,
Disease,Pituitary deficiency due to Rathke cleft cysts,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21951110[PMID],0,0
Clinical subtype,Germinoma of the central nervous system,,,,,,,,,,,,,
Disease,Acquired monoclonal Ig light chain-associated Fanconi syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Disease,Acquired monoclonal Ig light chain-associated Fanconi syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25151188[PMID],11,11
Disease,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25151188[PMID],0,0
Disease,Cryoglobulinemic vasculitis,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,6996482[PMID],1,1
Disease,Cryoglobulinemic vasculitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Immunotactoid or fibrillary glomerulopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Unspecified juvenile idiopathic arthritis,,,,,,,,,,,,,
Disease,Simple cryoglobulinemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary angioedema with C1Inh deficiency,,,,,,,,,,,,,
Category,"46,XX disorder of sex development induced by maternal-derived androgen",,,,,,,,,,,,,
Disease,Hereditary angioedema with normal C1Inh,,,,,,,,,,,,,
Disease,Acquired angioedema with C1Inh deficiency,,,,,,,,,,,,,
Category,Rare urticaria,,,,,,,,,,,,,
Category,Unclassified genetic skin disorder,,,,,,,,,,,,,
Category,Subcutaneous tissue disease,,,,,,,,,,,,,
Category,Lymphedema,,,,,,,,,,,,,
Category,Mucopolysaccharidosis with skin involvement,,,,,,,,,,,,,
Category,Premature aging,,,,,,,,,,,,,
Category,Rare skin tumor or hamartoma,,,,,,,,,,,,,
Category,Metabolic disease with skin involvement,,,,,,,,,,,,,
Category,Rare photodermatosis,,,,,,,,,,,,,
Category,Immune deficiency with skin involvement,,,,,,,,,,,,,
Disease,"Epidermolysis bullosa simplex, generalized severe",<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Epidermolysis bullosa simplex with mottled pigmentation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital non-bullous ichthyosiform erythroderma,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22000705[PMID],0.5,0.5
Disease,Congenital non-bullous ichthyosiform erythroderma,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.3,0.3
Disease,Keratoderma hereditarium mutilans with ichthyosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24346921[PMID],50,50
Disease,Keratoderma hereditarium mutilans with ichthyosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24346921[PMID],0,0
Category,Isolated nail anomaly,,,,,,,,,,,,,
Category,Nail anomaly,,,,,,,,,,,,,
Category,Syndromic hair shaft abnormality,,,,,,,,,,,,,
Category,Isolated hair shaft abnormality,,,,,,,,,,,,,
Category,Ectodermal dysplasia syndrome,6-9 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,15468153[PMID],0,0
Category,Sebaceous gland anomaly,,,,,,,,,,,,,
Category,Syndromic nail anomaly,,,,,,,,,,,,,
Category,Dermis disorder,,,,,,,,,,,,,
Category,Hypopigmentation of the skin,,,,,,,,,,,,,
Category,Hyperpigmentation of the skin,,,,,,,,,,,,,
Category,Pigmentation anomaly of the skin,,,,,,,,,,,,,
Category,Other dermis disorder,,,,,,,,,,,,,
Category,Mixed dermis disorder,,,,,,,,,,,,,
Category,Skin vascular disease,,,,,,,,,,,,,
Category,Dermis elastic tissue disorder,,,,,,,,,,,,,
Disease,Woolly hair nevus,,,,,,,,,,,,,
Disease,"Epidermolysis bullosa simplex, generalized intermediate",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Epidermolysis bullosa simplex, Ogna type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22854623[PMID]_23774525[PMID],6,6
Disease,"Epidermolysis bullosa simplex, Ogna type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Localized epidermolysis bullosa simplex,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Junctional epidermolysis bullosa-pyloric atresia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301336[PMID],100,100
Disease,Junctional epidermolysis bullosa-pyloric atresia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301336[PMID],0,0
Clinical subtype,"Junctional epidermolysis bullosa, generalized intermediate",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Junctional epidermolysis bullosa inversa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],9,9
Disease,Junctional epidermolysis bullosa inversa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Junctional epidermolysis bullosa, generalized severe",1-9 / 1 000 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET,0.17,0.17
Disease,"Junctional epidermolysis bullosa, generalized severe",<1 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.04,0.04
Disease,"Junctional epidermolysis bullosa, generalized severe",1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,21801158[PMID],0.4,0.4
Disease,"Junctional epidermolysis bullosa, generalized severe",<1 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.07,0.07
Disease,"Junctional epidermolysis bullosa, generalized severe",1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Late-onset junctional epidermolysis bullosa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_24005051[PMID],37,37
Disease,Late-onset junctional epidermolysis bullosa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Recessive dystrophic epidermolysis bullosa inversa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Recessive dystrophic epidermolysis bullosa inversa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Severe generalized recessive dystrophic epidermolysis bullosa,<1 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,ISBN:801860245[OTHER],0.042,0.042
Disease,Severe generalized recessive dystrophic epidermolysis bullosa,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Severe generalized recessive dystrophic epidermolysis bullosa,<1 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,9155958[PMID],0.08,0.08
Disease,Transient bullous dermolysis of the newborn,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Transient bullous dermolysis of the newborn,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pretibial dystrophic epidermolysis bullosa,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Disease,Pretibial dystrophic epidermolysis bullosa,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Milroy disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Milroy disease,1-9 / 100 000,Israel,409968,409968,25958,25958,en,Validated,410293,410293,12224079[PMID],3,3
Malformation syndrome,X-linked lethal multiple pterygium syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9916854[PMID],6,6
Malformation syndrome,X-linked lethal multiple pterygium syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9916854[PMID],0,0
Clinical subtype,Follicular atrophoderma-basal cell carcinoma,,,,,,,,,,,,,
Disease,Diffuse cutaneous mastocytosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20678092[PMID],30,30
Disease,Diffuse cutaneous mastocytosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Maculopapular cutaneous mastocytosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_25662299[PMID],0,0
Disease,Cutaneous mastocytoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Oculocutaneous albinism type 4,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20301683[PMID],1,1
Clinical subtype,Oculocutaneous albinism type 1B,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,18463683[PMID],1.3,1.3
Disease,Oculocutaneous albinism type 3,<1 / 1 000 000,China,409966,409966,25965,25965,en,Not yet validated,410294,410294,21739261[PMID],0,0
Disease,Oculocutaneous albinism type 3,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Oculocutaneous albinism type 3,<1 / 1 000 000,Japan,409966,409966,25965,25965,en,Not yet validated,410294,410294,21996312[PMID],0,0
Disease,Oculocutaneous albinism type 2,6-9 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,12469324[PMID]_ORPHANET_[EXPERT],58.34,58.34
Disease,Oculocutaneous albinism type 2,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_20301410[PMID],2.55,2.55
Disease,Oculocutaneous albinism type 2,6-9 / 10 000,"Tanzania, United Republic of",409966,409966,25958,25958,en,Validated,410293,410293,3978567[PMID],71.43,71.43
Disease,Oculocutaneous albinism type 2,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,2667743[PMID],2.78,2.78
Disease,Oculocutaneous albinism type 2,1-5 / 10 000,Africa,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7887411[PMID]_3978567[PMID],48.52,48.52
Clinical subtype,Oculocutaneous albinism type 1A,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,18463683[PMID],1.3,1.3
Disease,Hermansky-Pudlak syndrome,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.15,0.15
Disease,Hermansky-Pudlak syndrome,1-5 / 10 000,Puerto rico,409966,409966,25958,25958,en,Validated,410293,410293,7573033[PMID],55,55
Disease,Pseudopseudohypoparathyroidism,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pseudohypoparathyroidism type 1C,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pseudohypoparathyroidism type 1A,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Phakomatosis cesioflammea,,,,,,,,,,,,,
Clinical subtype,Phakomatosis cesiomarmorata,,,,,,,,,,,,,
Clinical subtype,Phakomatosis spilorosea,,,,,,,,,,,,,
Clinical subtype,Griscelli syndrome type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26337734[PMID],13,13
Clinical subtype,Griscelli syndrome type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26337734[PMID],0,0
Clinical subtype,Pemphigus vegetans,1-9 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,27456755[PMID],0.391,0.391
Disease,Pemphigus erythematosus,,,,,,,,,,,,,
Disease,Pemphigus foliaceus,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,27456755[PMID],1.001,1.001
Malformation syndrome,Microcystic lymphatic malformation,,,,,,,,,,,,,
Disease,Pili gemini,,,,,,,,,,,,,
Disease,Brooke-Spiegler syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Dr Neil RAJAN[EXPERT],100,100
Disease,Brooke-Spiegler syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Neil RAJAN[EXPERT],0,0
Malformation syndrome,Macrocystic lymphatic malformation,,,,,,,,,,,,,
Clinical subtype,Verrucous nevus,,,,,,,,,,,,,
Clinical subtype,Inflammatory linear verrucous epidermal nevus,,,,,,,,,,,,,
Clinical subtype,Acanthokeratolytic verrucous nevus,,,,,,,,,,,,,
Disease,Atypical Werner syndrome,,,,,,,,,,,,,
Clinical subtype,Griscelli syndrome type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26960655[PMID],102,102
Clinical subtype,Griscelli syndrome type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26960655[PMID],0,0
Clinical subtype,Griscelli syndrome type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22711375[PMID],20,20
Clinical subtype,Griscelli syndrome type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22711375[PMID],0,0
Disease,Porphyria variegata,<1 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,23114748[PMID],0.008,0.008
Disease,Porphyria variegata,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,23114748[PMID],0.32,0.32
Disease,Porphyria variegata,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.012,0.012
Disease,Porphyria variegata,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.48,0.48
Disease,Porphyria variegata,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.006,0.006
Disease,Porphyria variegata,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.24,0.24
Disease,Porphyria variegata,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.016,0.016
Disease,Porphyria variegata,1-9 / 1 000 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.64,0.64
Disease,Porphyria variegata,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.006,0.006
Disease,Porphyria variegata,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.24,0.24
Disease,Porphyria variegata,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.24,0.24
Disease,Porphyria variegata,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.006,0.006
Disease,Porphyria variegata,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.007,0.007
Disease,Porphyria variegata,1-9 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.28,0.28
Disease,Porphyria variegata,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.004,0.004
Disease,Porphyria variegata,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.16,0.16
Disease,Porphyria variegata,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.011,0.011
Disease,Porphyria variegata,1-9 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.44,0.44
Disease,Porphyria variegata,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.026,0.026
Disease,Porphyria variegata,1-9 / 100 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],1.04,1.04
Disease,Porphyria variegata,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.008,0.008
Disease,Porphyria variegata,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.32,0.32
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],0.46,0.46
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,9151309[PMID],2.2,2.2
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],1.22,1.22
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,9151309[PMID],4.8,4.8
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],0.65,0.65
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,9151309[PMID],3.7,3.7
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 100 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],1.1,1.1
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 100 000,Iceland,409968,409968,25958,25958,en,Validated,410293,410293,9151309[PMID],7,7
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],0.31,0.31
Disease,Juvenile neuronal ceroid lipofuscinosis,1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,9151309[PMID],2,2
Disease,Infantile neuronal ceroid lipofuscinosis,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Infantile neuronal ceroid lipofuscinosis,<1 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],0.07,0.07
Disease,Infantile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,9151309[PMID],0.6,0.6
Disease,Infantile neuronal ceroid lipofuscinosis,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],0.54,0.54
Disease,Infantile neuronal ceroid lipofuscinosis,1-9 / 100 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,9151309[PMID],5,5
Disease,Infantile neuronal ceroid lipofuscinosis,<1 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,9151309[PMID],0.02,0.02
Disease,Adult neuronal ceroid lipofuscinosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Sanfilippo syndrome type A,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],0.32,0.32
Etiological subtype,Sanfilippo syndrome type A,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],1.16,1.16
Etiological subtype,Sanfilippo syndrome type A,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.88,0.88
Etiological subtype,Sanfilippo syndrome type A,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.47,0.47
Etiological subtype,Sanfilippo syndrome type A,1-9 / 100 000,Estonia,409968,409968,25958,25958,en,Validated,410293,410293,22480138[PMID],1.62,1.62
Etiological subtype,Sanfilippo syndrome type A,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1.4,1.4
Etiological subtype,Sanfilippo syndrome type A,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.62,0.62
Clinical subtype,GM1 gangliosidosis type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,70,70
Clinical subtype,GM1 gangliosidosis type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,GM1 gangliosidosis type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Clinical subtype,GM1 gangliosidosis type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,GM1 gangliosidosis type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Clinical subtype,GM1 gangliosidosis type 1,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Classic phenylketonuria,,,,,,,,,,,,,
Clinical subtype,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23351985[PMID],150,150
Clinical subtype,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Clinical subtype,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],1.7,1.7
Clinical subtype,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Pyruvate dehydrogenase phosphatase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Mild phenylketonuria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Biotinidase deficiency,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,1779651[PMID],1.6,1.6
Disease,Biotinidase deficiency,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,1779651[PMID],0,0
Disease,Biotinidase deficiency,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,2314964[PMID],1.5,1.5
Disease,Biotinidase deficiency,1-9 / 100 000,Brazil,409968,409968,25958,25958,en,Validated,410293,410293,9713119[PMID],1.6,1.6
Disease,Biotinidase deficiency,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.6,1.6
Disease,Biotinidase deficiency,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,20224900[PMID],2,2
Disease,Biotinidase deficiency,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID]_3391228[PMID],3.2,3.2
Disease,Biotinidase deficiency,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,11953730[PMID]_3391228[PMID],0,0
Disease,Biotinidase deficiency,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,11388594[PMID],1.4,1.4
Disease,Biotinidase deficiency,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,17185019[PMID],5,5
Disease,Biotinidase deficiency,1-9 / 100 000,Turkey,409968,409968,25958,25958,en,Validated,410293,410293,20333870[PMID],3,3
Disease,Biotinidase deficiency,1-5 / 10 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,31241292[PMID],11.58,11.58
Disease,Galactose epimerase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Classic galactosemia,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],2.1,2.1
Disease,Classic galactosemia,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,15841485[PMID],3,3
Disease,Classic galactosemia,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,8215542[PMID],2.3,2.3
Disease,Classic galactosemia,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,8215542[PMID],4.3,4.3
Disease,Classic galactosemia,1-9 / 1 000 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,6468444[PMID],0.13,0.13
Disease,Classic galactosemia,1-9 / 1 000 000,China,409968,409968,25958,25958,en,Validated,410293,410293,10457302[PMID],0.25,0.25
Disease,Classic galactosemia,1-5 / 10 000,"Iran, Islamic Republic of",409968,409968,25958,25958,en,Validated,410293,410293,23113108[PMID],20.8,20.8
Disease,Classic galactosemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Pyruvate dehydrogenase E2 deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Holocarboxylase synthetase deficiency,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Disease,Holocarboxylase synthetase deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Pyruvate dehydrogenase E1-alpha deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hyperinsulinism due to glucokinase deficiency,,,,,,,,,,,,,
Clinical group,Diazoxide-resistant focal hyperinsulinism,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital bile acid synthesis defect type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Familial LCAT deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],70,70
Clinical subtype,Familial LCAT deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Fish-eye disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Clinical subtype,Fish-eye disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.012,0.012
Disease,Autosomal erythropoietic protoporphyria,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.92,0.92
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.006,0.006
Disease,Autosomal erythropoietic protoporphyria,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.46,0.46
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.007,0.007
Disease,Autosomal erythropoietic protoporphyria,1-9 / 1 000 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.62,0.62
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.018,0.018
Disease,Autosomal erythropoietic protoporphyria,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.54,0.54
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.036,0.036
Disease,Autosomal erythropoietic protoporphyria,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],1.39,1.39
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.003,0.003
Disease,Autosomal erythropoietic protoporphyria,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],2.77,2.77
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.003,0.003
Disease,Autosomal erythropoietic protoporphyria,1-9 / 1 000 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.15,0.15
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.018,0.018
Disease,Autosomal erythropoietic protoporphyria,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.23,0.23
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.035,0.035
Disease,Autosomal erythropoietic protoporphyria,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],1.39,1.39
Disease,Autosomal erythropoietic protoporphyria,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,17994169[PMID],0.033,0.033
Disease,Autosomal erythropoietic protoporphyria,1-9 / 100 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],2.7,2.7
Disease,Autosomal erythropoietic protoporphyria,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,17994169[PMID],2.54,2.54
Disease,Autosomal erythropoietic protoporphyria,1-9 / 100 000,Slovenia,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],1.75,1.75
Clinical subtype,Alpha-N-acetylgalactosaminidase deficiency type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Clinical subtype,Alpha-N-acetylgalactosaminidase deficiency type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Alpha-N-acetylgalactosaminidase deficiency type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Clinical subtype,Alpha-N-acetylgalactosaminidase deficiency type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Alpha-N-acetylgalactosaminidase deficiency type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Clinical subtype,Alpha-N-acetylgalactosaminidase deficiency type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Methylmalonic acidemia with homocystinuria, type cblC",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,500,500
Clinical subtype,"Methylmalonic acidemia with homocystinuria, type cblC",Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Methylmalonic acidemia with homocystinuria, type cblD",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,17,17
Clinical subtype,"Methylmalonic acidemia with homocystinuria, type cblD",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Methylmalonic acidemia with homocystinuria type cblF,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,15,15
Clinical subtype,Methylmalonic acidemia with homocystinuria type cblF,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Sanfilippo syndrome type B,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2013[INST],0.2,0.2
Etiological subtype,Sanfilippo syndrome type B,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.42,0.42
Etiological subtype,Sanfilippo syndrome type B,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.72,0.72
Etiological subtype,Sanfilippo syndrome type B,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.47,0.47
Etiological subtype,Sanfilippo syndrome type B,<1 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.02,0.02
Etiological subtype,Sanfilippo syndrome type B,<1 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.05,0.05
Etiological subtype,Sanfilippo syndrome type C,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.21,0.21
Etiological subtype,Sanfilippo syndrome type C,1-9 / 1 000 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],0.12,0.12
Etiological subtype,Sanfilippo syndrome type C,<1 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.07,0.07
Etiological subtype,Sanfilippo syndrome type C,1-9 / 1 000 000,Czech Republic,409968,409968,25958,25958,en,Validated,410293,410293,20490927[PMID],0.42,0.42
Etiological subtype,Sanfilippo syndrome type C,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],5,5
Etiological subtype,Sanfilippo syndrome type C,1-9 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,25274184[PMID],0.34,0.34
Etiological subtype,Sanfilippo syndrome type D,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,10480370[PMID],0.1,0.1
Etiological subtype,Sanfilippo syndrome type D,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,9918480[PMID],0.1,0.1
Disease,Hereditary coproporphyria,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute intermittent porphyria,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.013,0.013
Disease,Acute intermittent porphyria,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.54,0.54
Disease,Acute intermittent porphyria,<1 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.012,0.012
Disease,Acute intermittent porphyria,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.55,0.55
Disease,Acute intermittent porphyria,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.011,0.011
Disease,Acute intermittent porphyria,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.5,0.5
Disease,Acute intermittent porphyria,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.013,0.013
Disease,Acute intermittent porphyria,1-9 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.59,0.59
Disease,Acute intermittent porphyria,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.018,0.018
Disease,Acute intermittent porphyria,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.81,0.81
Disease,Acute intermittent porphyria,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.014,0.014
Disease,Acute intermittent porphyria,1-9 / 1 000 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.63,0.63
Disease,Acute intermittent porphyria,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.016,0.016
Disease,Acute intermittent porphyria,1-9 / 1 000 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.72,0.72
Disease,Acute intermittent porphyria,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.014,0.014
Disease,Acute intermittent porphyria,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.63,0.63
Disease,Acute intermittent porphyria,<1 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.051,0.051
Disease,Acute intermittent porphyria,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,12372055[PMID],10,10
Disease,Acute intermittent porphyria,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.022,0.022
Disease,Acute intermittent porphyria,1-9 / 1 000 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.99,0.99
Disease,Acute intermittent porphyria,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,23114748[PMID],0.016,0.016
Disease,Acute intermittent porphyria,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,23114748[PMID],0.72,0.72
Disease,Congenital erythropoietic porphyria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,200,200
Disease,Congenital erythropoietic porphyria,<1 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,23114748[PMID],0.065,0.065
Disease,Congenital erythropoietic porphyria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,COG7-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19577670[PMID],8,8
Disease,COG7-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19577670[PMID],0,0
Disease,B4GALT1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11930273[PMID],1,1
Disease,B4GALT1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11930273[PMID],0,0
Disease,MOGS-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24716661[PMID],3,3
Disease,MOGS-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24716661[PMID],0,0
Disease,MGAT2-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22105986[PMID],13,13
Disease,MGAT2-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22105986[PMID],0,0
Disease,ALG9-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26453364[PMID]_28122681[PMID]_28932688[PMID),12,12
Disease,ALG9-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28122681[PMID]_28932688[PMID],0,0
Disease,ALG1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26931382[PMID],57,57
Disease,ALG1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26931382[PMID],0,0
Disease,ALG2-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12684507[PMID],1,1
Disease,ALG2-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12684507[PMID],0,0
Disease,ALG8-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26066342[PMID],15,15
Disease,ALG8-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26066342[PMID],0,0
Disease,ALG12-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22516080[PMID],11,11
Disease,ALG12-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22516080[PMID],0,0
Disease,MPDU1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28122681[PMID]_28940310[PMID],8,8
Disease,MPDU1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28122681[PMID]_28940310[PMID],0,0
Disease,DPM1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27481510[PMID],9,9
Disease,DPM1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27481510[PMID],0,0
Disease,ALG3-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28122681[PMID],15,15
Disease,ALG3-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28122681[PMID],0,0
Disease,ALG6-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25052310[PMID],54,54
Disease,ALG6-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25052310[PMID],0,0
Disease,MPI-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19862844[PMID],25,25
Disease,MPI-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19862844[PMID],0,0
Disease,PMM2-CDG,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,11953730[PMID],1.73,1.73
Disease,PMM2-CDG,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19862844[PMID],0,0
Disease,PMM2-CDG,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,10854097[PMID]_11953730[PMID],0,0
Disease,L-2-hydroxyglutaric aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,L-2-hydroxyglutaric aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],140,140
Disease,D-2-hydroxyglutaric aciduria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],80,80
Disease,D-2-hydroxyglutaric aciduria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Vitamin B12-unresponsive methylmalonic acidemia type mut-,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,450,450
Clinical subtype,Vitamin B12-unresponsive methylmalonic acidemia type mut-,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Vitamin B12-responsive methylmalonic acidemia type cblA,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,60,60
Clinical subtype,Vitamin B12-responsive methylmalonic acidemia type cblA,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Vitamin B12-responsive methylmalonic acidemia type cblB,,,,,,,,,,,,,
Clinical subtype,Progressive familial intrahepatic cholestasis type 1,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Progressive familial intrahepatic cholestasis type 2,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Progressive familial intrahepatic cholestasis type 3,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital bile acid synthesis defect type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9802883[PMID],2,2
Disease,Congenital bile acid synthesis defect type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9802883[PMID],0,0
Disease,Congenital bile acid synthesis defect type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Hair anomaly,,,,,,,,,,,,,
Category,Epidermal appendage anomaly,,,,,,,,,,,,,
Category,Rare disorder with hypertrichosis,,,,,,,,,,,,,
Category,Alopecia,,,,,,,,,,,,,
Category,Other epidermal disorder,,,,,,,,,,,,,
Category,Porokeratosis,,,,,,,,,,,,,
Category,Inherited epidermolysis bullosa,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,20507631[PMID],1.9,1.9
Category,Inherited epidermolysis bullosa,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20507631[PMID],0.8,0.8
Category,Inherited epidermolysis bullosa,1-9 / 1 000 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,2359725[PMID],0.96,0.96
Category,Inherited epidermolysis bullosa,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,20507631[PMID],1.9,1.9
Category,Inherited epidermolysis bullosa,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,20507631[PMID],0.8,0.8
Category,Other genetic epidermal disease,,,,,,,,,,,,,
Category,Erythrokeratoderma,,,,,,,,,,,,,
Category,Ichthyosis,,,,,,,,,,,,,
Category,Hereditary palmoplantar keratoderma,,,,,,,,,,,,,
Category,Acrokeratoderma,,,,,,,,,,,,,
Disease,"3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23564319[PMID],15,15
Disease,"3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23564319[PMID],0,0
Disease,3-phosphoserine phosphatase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9222972[PMID]_14673469[PMID],8,8
Disease,3-phosphoserine phosphatase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9222972[PMID]_14673469[PMID],0,0
Category,Epidermal disease,,,,,,,,,,,,,
Malformation syndrome,"Chondrodysplasia punctata, tibial-metacarpal type",,,,,,,,,,,,,
Malformation syndrome,"Chondrodysplasia punctata, Toriello type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8267015[PMID]_9450859[PMID],3,3
Malformation syndrome,"Chondrodysplasia punctata, Toriello type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8267015[PMID]_9450859[PMID],0,0
Malformation syndrome,Brachytelephalangic chondrodysplasia punctata,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr BAUJAT Geneviève[EXPERT],0,0
Malformation syndrome,Singleton-Merten dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23322711[PMID]_25620203[PMID],22,22
Malformation syndrome,Singleton-Merten dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23322711[PMID]_25620203[PMID],0,0
Malformation syndrome,"Metaphyseal dysplasia, Braun-Tinschert type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Idiopathic juvenile osteoporosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Calvarial doughnut lesions-bone fragility syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Malformation syndrome,Calvarial doughnut lesions-bone fragility syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial expansile osteolysis,,,,,,,,,,,,,
Malformation syndrome,Spondylo-ocular syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11260210[PMID]_16470687[PMID],7,7
Malformation syndrome,Spondylo-ocular syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11260210[PMID]_16470687[PMID],0,0
Disease,Genochondromatosis type 1,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Craniosynostosis-anal anomalies-porokeratosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15924278[PMID]_24095818[PMID]_[EXPERT],9,9
Malformation syndrome,Craniosynostosis-anal anomalies-porokeratosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Dysspondyloenchondromatosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24357493[PMID]_26250472[PMID],16,16
Malformation syndrome,Dysspondyloenchondromatosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Dysspondyloenchondromatosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24357493[PMID]_26250472[PMID],0,0
Malformation syndrome,Genitopatellar syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22265014[PMID]_22265017[PMID],22,22
Malformation syndrome,Genitopatellar syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22265014[PMID]_22265017[PMID],0,0
Malformation syndrome,Ischiovertebral syndrome,,,,,,,,,,,,,
Malformation syndrome,Acropectoral syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22183091[PMID],25,25
Malformation syndrome,Acropectoral syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22183091[PMID],0,0
Malformation syndrome,Keutel syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Malformation syndrome,Keutel syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"X-linked intellectual disability, Abidi type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10398233[PMID],8,8
Malformation syndrome,"X-linked intellectual disability, Abidi type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10398233[PMID],0,0
Clinical subtype,Fetal Gaucher disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Clinical subtype,Fetal Gaucher disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Syndromic X-linked intellectual disability 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10573017[PMID],10,10
Malformation syndrome,Syndromic X-linked intellectual disability 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10573017[PMID],0,0
Malformation syndrome,Microphthalmia-ankyloblepharon-intellectual disability syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"X-linked intellectual disability, Armfield type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10398235[PMID],6,6
Malformation syndrome,"X-linked intellectual disability, Armfield type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10398235[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Cantagrel type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27358180[PMID]_27568816[PMID],30,30
Malformation syndrome,"X-linked intellectual disability, Cantagrel type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27358180[PMID]_27568816[PMID],0,0
Malformation syndrome,Christianson syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Malformation syndrome,Christianson syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Syndromic X-linked intellectual disability due to JARID1C mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,Syndromic X-linked intellectual disability due to JARID1C mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,X-linked intellectual disability-cubitus valgus-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14556244[PMID],5,5
Malformation syndrome,X-linked intellectual disability-cubitus valgus-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14556244[PMID],0,0
Malformation syndrome,MEHMO syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12032729[PMID],8,8
Malformation syndrome,MEHMO syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12032729[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Miles-Carpenter type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2018061[PMID],4,4
Malformation syndrome,"X-linked intellectual disability, Miles-Carpenter type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2018061[PMID],0,0
Malformation syndrome,BRESEK syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24090718[PMID],5,5
Malformation syndrome,BRESEK syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"X-linked intellectual disability, Schimke type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6538752[PMID],4,4
Malformation syndrome,"X-linked intellectual disability, Schimke type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6538752[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Shashi type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12605440[PMID],9,9
Malformation syndrome,"X-linked intellectual disability, Shashi type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12605440[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Siderius type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16199551[PMID],2,2
Malformation syndrome,"X-linked intellectual disability, Siderius type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16199551[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Stocco Dos Santos type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2063914[PMID],1,1
Malformation syndrome,"X-linked intellectual disability, Stocco Dos Santos type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2063914[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Cabezas type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25385192[PMID],24,24
Malformation syndrome,"X-linked intellectual disability, Cabezas type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25385192[PMID],0,0
Disease,X-linked spinocerebellar ataxia type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3470628[PMID],1,1
Disease,X-linked spinocerebellar ataxia type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"X-linked intellectual disability, Wilson type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1357179[PMID],3,3
Malformation syndrome,"X-linked intellectual disability, Wilson type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1357179[PMID],0,0
Malformation syndrome,X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10398239[PMID],3,3
Malformation syndrome,X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10398239[PMID],0,0
Malformation syndrome,X-linked spinocerebellar ataxia type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3614654[PMID],5,5
Malformation syndrome,X-linked spinocerebellar ataxia type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3614654[PMID],0,0
Clinical subtype,"HSD10 disease, atypical type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27306202[PMID],5,5
Clinical subtype,"HSD10 disease, atypical type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ 27306202[PMID],0,0
Disease,X-linked epilepsy-learning disabilities-behavior disorders syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"Deafness-intellectual disability syndrome, Martin-Probst type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,11073537[PMID],0,0
Malformation syndrome,"Deafness-intellectual disability syndrome, Martin-Probst type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_11073537[PMID],3,3
Malformation syndrome,X-linked intellectual disability-macrocephaly-macroorchidism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9863601[PMID],0,0
Malformation syndrome,X-linked intellectual disability-macrocephaly-macroorchidism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9863601[PMID],12,12
Malformation syndrome,X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8574418[PMID],2,2
Malformation syndrome,X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8574418[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Stevenson type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9192265[PMID],4,4
Malformation syndrome,"X-linked intellectual disability, Stevenson type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9192265[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Shrimpton type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10331611[PMID],3,3
Malformation syndrome,"X-linked intellectual disability, Shrimpton type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10331611[PMID],0,0
Disease,"X-linked intellectual disability, Seemanova type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8958326[PMID],4,4
Disease,"X-linked intellectual disability, Seemanova type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8958326[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Pai type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9222958[PMID],1,1
Malformation syndrome,"X-linked intellectual disability, Pai type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9222958[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Turner type",<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12599187[PMID],10,10
Malformation syndrome,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12599187[PMID],0,0
Malformation syndrome,"X-linked intellectual disability, Stoll type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1877628[PMID],4,4
Malformation syndrome,"X-linked intellectual disability, Stoll type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1877628[PMID],0,0
Disease,X-linked intellectual disability-acromegaly-hyperactivity syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2018059[PMID],2,2
Disease,X-linked intellectual disability-acromegaly-hyperactivity syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2018059[PMID],0,0
Disease,X-linked intellectual disability-retinitis pigmentosa syndrome,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"X-linked neurodegenerative syndrome, Hamel type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10051014[PMID],11,11
Disease,"X-linked neurodegenerative syndrome, Hamel type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10051014[PMID],0,0
Disease,"X-linked neurodegenerative syndrome, Bertini type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1605224[PMID],0,0
Disease,"X-linked neurodegenerative syndrome, Bertini type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1605224[PMID],7,7
Malformation syndrome,Fried syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_5054319[PMID],0,0
Malformation syndrome,Fried syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5054319[PMID],1,1
Disease,Oligoarticular juvenile idiopathic arthritis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,20.5,20.5
Disease,Systemic-onset juvenile idiopathic arthritis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],5,5
Disease,X-linked intellectual disability-ataxia-apraxia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1605232[PMID],9,9
Disease,X-linked intellectual disability-ataxia-apraxia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1605232[PMID],0,0
Disease,Rheumatoid factor-negative juvenile idiopathic arthritis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,8,8
Disease,AL amyloidosis,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,22909024[PMID]_1558973[PMID],0.9,0.9
Disease,AL amyloidosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],10,10
Disease,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11567216[PMID]_17527005[PMID]_18073311[PMID],5,5
Disease,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11567216[PMID]_17527005[PMID]_18073311[PMID],0,0
Disease,Wild type ABeta2M amyloidosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2012[INST],4.5,4.5
Disease,AA amyloidosis,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,23148499[PMID],0.1,0.1
Disease,AA amyloidosis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Psoriasis-related juvenile idiopathic arthritis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,4.2,4.2
Disease,Rheumatoid factor-positive polyarticular juvenile idiopathic arthritis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,4.2,4.2
Disease,Enthesitis-related juvenile idiopathic arthritis,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,5.7,5.7
Disease,Hereditary cerebral hemorrhage with amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],350,350
Disease,Hereditary cerebral hemorrhage with amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,X-linked reticulate pigmentary disorder,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,6,6
Disease,X-linked reticulate pigmentary disorder,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,X-linked severe congenital neutropenia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16804117[PMID]_11242115[PMID],45,45
Disease,X-linked severe congenital neutropenia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,DPAGT1-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26033833 [PMID],18,18
Disease,DPAGT1-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26033833 [PMID],0,0
Disease,AGel amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9547007[PMID]_17097682[PMID]_14639586[PMID]_20229579[PMID]_22068858[PMID]_2262277[PMID]_10729296[PMID]_[EXPERT],475,475
Disease,AGel amyloidosis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,ATTRV30M amyloidosis,6-9 / 10 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,8825887[PMID]_24572009[PMID],90,90
Disease,ATTRV30M amyloidosis,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_23425518[PMID],0.1,0.1
Disease,ATTRV30M amyloidosis,1-9 / 100 000,Sweden,409967,409967,25965,25965,en,Not yet validated,410294,410294,8406517[PMID],3.75,3.75
Disease,ATTRV30M amyloidosis,6-9 / 10 000,Sweden,409966,409966,25965,25965,en,Not yet validated,410294,410294,8406517[PMID],97.5,97.5
Disease,ATTRV30M amyloidosis,1-9 / 1 000 000,Cyprus,409967,409967,25958,25958,en,Validated,410293,410293,19291512[PMID],0.69,0.69
Disease,ATTRV30M amyloidosis,1-9 / 100 000,Cyprus,409966,409966,25958,25958,en,Validated,410293,410293,19291512[PMID],3.7,3.7
Disease,ATTRV30M amyloidosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,ATTRV30M amyloidosis,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,3210815[PMID]_12855135[PMID]_24572009[PMID],3,3
Disease,ATTRV122I amyloidosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hereditary amyloidosis with primary renal involvement,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,POMT1-related  limb-girdle muscular dystrophy R11,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Helicoid peripapillary chorioretinal degeneration,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Helicoid peripapillary chorioretinal degeneration,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Benign adult familial myoclonic epilepsy,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,15508931[PMID],2.8,2.8
Disease,Benign adult familial myoclonic epilepsy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Aplasia of lacrimal and salivary glands,,,,,,,,,,,,,
Morphological anomaly,Patella aplasia/hypoplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11857555[PMID],0,0
Morphological anomaly,Patella aplasia/hypoplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11857555[PMID],5,5
Clinical group,Localized lichen myxedematosus,,,,,,,,,,,,,
Disease,Atypical lichen myxedematosus,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Atypical lichen myxedematosus,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial avascular necrosis of femoral head,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],5,5
Disease,Familial avascular necrosis of femoral head,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Lissencephaly type 3-familial fetal akinesia sequence syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8779318[PMID],5,5
Malformation syndrome,Lissencephaly type 3-familial fetal akinesia sequence syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8779318[PMID],0,0
Malformation syndrome,Lissencephaly type 3-metacarpal bone dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11170088[PMID],2,2
Malformation syndrome,Lissencephaly type 3-metacarpal bone dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11170088[PMID],0,0
Clinical group,Lissencephaly with cerebellar hypoplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,18521588[PMID],0,0
Disease,Congenital analbuminemia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Congenital analbuminemia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Chronic lymphoproliferative disorder of natural killer cells,,,,,,,,,,,,,
Disease,Hemolytic anemia due to adenylate kinase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10233365[PMID],7,7
Disease,Hemolytic anemia due to adenylate kinase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10233365[PMID],0,0
Disease,Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7923864[PMID]_9598718[PMID],2,2
Disease,Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Atrichia with papular lesions,,,,,,,,,,,,,
Clinical group,Large granular lymphocyte leukemia,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,27494824[PMID],0.02,0.02
Disease,Acute panmyelosis with myelofibrosis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.06,0.06
Disease,Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Refractory anemia with excess blasts,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Refractory anemia with excess blasts,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.15,0.15
Clinical group,Refractory cytopenia with multilineage dysplasia,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Autosomal recessive epidermolytic ichthyosis,,,,,,,,,,,,,
Disease,Juvenile myelomonocytic leukemia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],0.1,0.1
Disease,"Chronic myeloproliferative disease, unclassifiable",1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.53,0.53
Disease,Chronic neutrophilic leukemia,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Plasmacytoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Plasmacytoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,19016727[PMID]_SEER Surveillance Epidemiology and End Results 1992-2004[INST],0.34,0.34
Disease,Congenital cerebellar ataxia due to RNU12 mutation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27863452[PMID],6,6
Disease,Congenital cerebellar ataxia due to RNU12 mutation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27863452[PMID],0,0
Disease,Splenic marginal zone lymphoma,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medecines Agency 2013[INST],0.5,0.5
Disease,B-cell prolymphocytic leukemia,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.05,0.05
Category,Acute leukemia of ambiguous lineage,,,,,,,,,,,,,
Disease,Myeloid sarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Myeloid sarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Acute basophilic leukemia,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Category,Therapy related acute myeloid leukemia and myelodysplastic syndrome,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Acute myeloid leukaemia with myelodysplasia-related features,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,T-cell large granular lymphocyte leukemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.4,0.4
Disease,T-cell large granular lymphocyte leukemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Aggressive NK-cell leukemia,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,CD4+/CD56+ hematodermic neoplasm,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],12,12
Disease,T-cell prolymphocytic leukemia,,,,,,,,,,,,,
Disease,Nodal marginal zone B-cell lymphoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medecines Agency 2013[INST],1,1
Disease,Lymphomatoid granulomatosis,,,,,,,,,,,,,
Disease,Non-amyloid monoclonal immunoglobulin deposition disease,,,,,,,,,,,,,
Disease,Heavy chain disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Heavy chain disease,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Angioimmunoblastic T-cell lymphoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,16150940[PMID],0.05,0.05
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.12,0.12
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.095,0.095
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.041,0.041
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.006,0.006
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.099,0.099
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.037,0.037
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.097,0.097
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.074,0.074
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.038,0.038
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.008,0.008
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.013,0.013
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.055,0.055
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.053,0.053
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.056,0.056
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.092,0.092
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.128,0.128
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.285,0.285
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.124,0.124
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.226,0.226
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.14,0.14
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.135,0.135
Disease,Nodular lymphocyte predominant Hodgkin lymphoma,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.133,0.133
Disease,Subcutaneous panniculitis-like T-cell lymphoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Primary cutaneous peripheral T-cell lymphoma not otherwise specified,,,,,,,,,,,,,
Disease,Enteropathy-associated T-cell lymphoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,26104061[PMID],0.0111,0.0111
Disease,Enteropathy-associated T-cell lymphoma,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,18618372[PMID],0.1,0.1
Disease,Hepatosplenic T-cell lymphoma,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,21823196[PMID],0.03,0.03
Disease,Hepatosplenic T-cell lymphoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Adult T-cell leukemia/lymphoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2014[INST],3,3
Disease,Extranodal nasal NK/T cell lymphoma,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut National du Cancer 2013[INST],2.25,2.25
Disease,Punctate palmoplantar keratoderma type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2525006[PMID],13,13
Disease,Punctate palmoplantar keratoderma type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2525006[PMID],0,0
Disease,Ichthyosis hystrix of Curth-Macklin,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28405559[PMID]_26538731[PMID],10,10
Disease,Ichthyosis hystrix of Curth-Macklin,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28405559[PMID]_26538731[PMID],0,0
Disease,Cholesterol-ester transfer protein deficiency,,,,,,,,,,,,,
Disease,Hypotonia-failure to thrive-microcephaly syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10896305[PMID],2,2
Disease,Hypotonia-failure to thrive-microcephaly syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10896305[PMID],0,0
Clinical subtype,X-linked congenital generalized hypertrichosis,,,,,,,,,,,,,
Malformation syndrome,Autosomal dominant deafness-onychodystrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],22,22
Malformation syndrome,Autosomal dominant deafness-onychodystrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Malformation syndrome,DOORS syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Malformation syndrome,DOORS syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Punctate palmoplantar keratoderma type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23064416[PMID]_23743648[PMID],35,35
Disease,Punctate palmoplantar keratoderma type 1,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Punctate palmoplantar keratoderma type 1,1-9 / 100 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,8349860[PMID],1.17,1.17
Disease,Punctate palmoplantar keratoderma type 1,1-9 / 100 000,Slovenia,409966,409966,25958,25958,en,Validated,410293,410293,19784524[PMID],3.3,3.3
Clinical group,Autoimmune bullous skin disease,,,,,,,,,,,,,
Clinical subtype,Gardner syndrome,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,17517313[PMID]_24858982[PMID],9.1,9.1
Category,Urogenital tract malformation,,,,,,,,,,,,,
Disease,Autosomal recessive hyperinsulinism due to SUR1 deficiency,,,,,,,,,,,,,
Clinical subtype,Mild hyperphenylalaninemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal recessive hyperinsulinism due to Kir6.2 deficiency,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Scrub typhus,1-9 / 100 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,18362409[PMID],7.2,7.2
Disease,Scrub typhus,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,18362409[PMID],0.3,0.3
Disease,Scrub typhus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Proximal spinal muscular atrophy type 1,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.26,0.26
Clinical subtype,Proximal spinal muscular atrophy type 1,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Murine typhus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Pseudotyphus of California,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Proximal spinal muscular atrophy type 3,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1.1,1.1
Clinical subtype,Proximal spinal muscular atrophy type 3,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Proximal spinal muscular atrophy type 4,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.32,0.32
Clinical subtype,Proximal spinal muscular atrophy type 4,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Proximal spinal muscular atrophy type 2,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,1.23,1.23
Clinical subtype,Proximal spinal muscular atrophy type 2,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Boutonneuse fever,1-5 / 10 000,France,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,24.2,24.2
Disease,Boutonneuse fever,1-9 / 100 000,Portugal,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,9.8,9.8
Disease,Boutonneuse fever,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Epidemic typhus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Rocky Mountain spotted fever,1-9 / 1 000 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.24,0.24
Disease,Rocky Mountain spotted fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Rickettsialpox,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15577753[PMID],800,800
Disease,Rickettsialpox,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Desmoplastic small round cell tumor,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15557784[PMID],300,300
Disease,Desmoplastic small round cell tumor,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Desmoplastic small round cell tumor,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Solitary bone cyst,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Morvan syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27698847[PMID],60,60
Disease,Morvan syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27698847[PMID],0,0
Disease,Narcolepsy type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Narcolepsy type 2,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,11902429[PMID],20.3,20.3
Disease,West-Nile encephalitis,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,23013055[PMID]_Center for Diseases Control and Prevention 2012[INST],0.92,0.92
Disease,West-Nile encephalitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,West-Nile encephalitis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.036,0.036
Disease,West-Nile encephalitis,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.02,0.02
Disease,West-Nile encephalitis,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2012-2015[INST],0.17,0.17
Disease,West-Nile encephalitis,1-9 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.66,0.66
Disease,West-Nile encephalitis,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.16,0.16
Disease,West-Nile encephalitis,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2013[INST],0.07,0.07
Disease,West-Nile encephalitis,1-9 / 1 000 000,Romania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2011-2015[INST],0.12,0.12
Malformation syndrome,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27854409[PMID],62,62
Malformation syndrome,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27854409[PMID],0,0
Malformation syndrome,CAMOS syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11391656[PMID],5,5
Malformation syndrome,CAMOS syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11391656[PMID],0,0
Disease,Thymic aplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Complex regional pain syndrome,1-5 / 10 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,17084977[PMID]_24161450[PMID],26.2,26.2
Disease,Complex regional pain syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Florid cemento-osseous dysplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Regional odontodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,140,140
Disease,Regional odontodysplasia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Microtia,1-5 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,16359491[PMID],38,38
Morphological anomaly,Microtia,1-5 / 10 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,13,13
Morphological anomaly,Microtia,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Microtia,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,21656661[PMID],15.5,15.5
Morphological anomaly,Microtia,1-5 / 10 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,21656661[PMID],0,0
Morphological anomaly,Microtia,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,8933331[PMID],3.7,3.7
Morphological anomaly,Microtia,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,8933331[PMID],0,0
Morphological anomaly,Microtia,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,7666397[PMID],1.2,1.2
Morphological anomaly,Microtia,1-9 / 100 000,Italy,409966,409966,25965,25965,en,Not yet validated,410294,410294,7666397[PMID],0,0
Morphological anomaly,Microtia,1-9 / 100 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,8933331[PMID],2.1,2.1
Morphological anomaly,Microtia,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,8933331[PMID],0,0
Morphological anomaly,Microtia,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,8933331[PMID]_19760683[PMID],22,22
Morphological anomaly,Microtia,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,8933331[PMID]_19760683[PMID],0,0
Morphological anomaly,Microtia,1-5 / 10 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,17548114[PMID],43.4,43.4
Morphological anomaly,Microtia,1-5 / 10 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,17548114[PMID],0,0
Morphological anomaly,Microtia,>1 / 1000,Ecuador,409968,409968,25958,25958,en,Validated,410293,410293,3771073[PMID],174,174
Morphological anomaly,Microtia,6-9 / 10 000,Chile,409968,409968,25958,25958,en,Validated,410293,410293,17186100[PMID],83,83
Malformation syndrome,Congenital primary aphakia,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Glomuvenous malformation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Vulvovaginal gingival syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20373919[PMID],380,380
Disease,Vulvovaginal gingival syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27836748[PMID],8,8
Malformation syndrome,Congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27836748[PMID],0,0
Malformation syndrome,Macrostomia-preauricular tags-external ophthalmoplegia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16854200[PMID],9,9
Malformation syndrome,Macrostomia-preauricular tags-external ophthalmoplegia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16854200[PMID],0,0
Disease,Enteric anendocrinosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24134759[PMID],7,7
Disease,Enteric anendocrinosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24134759[PMID],0,0
Malformation syndrome,LUMBAR syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24259379[PMID],54,54
Malformation syndrome,LUMBAR syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Steroid-responsive encephalopathy associated with autoimmune thyroiditis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Rubella panencephalitis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9103895[PMID],20,20
Disease,Rubella panencephalitis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16691627[PMID],3,3
Malformation syndrome,Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16691627[PMID],0,0
Disease,Eastern equine encephalitis,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention 1989-1996[INST],0.01,0.01
Disease,Eastern equine encephalitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Colorado tick fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute disseminated encephalomyelitis,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.6,0.6
Disease,Acute disseminated encephalomyelitis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Encephalitis lethargica,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mycoplasma encephalitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,La Crosse encephalitis,1-9 / 100 000,Canada,409967,409967,25958,25958,en,Validated,410293,410293,Canada Public Health Agency[INST],1.91,1.91
Disease,La Crosse encephalitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,St. Louis encephalitis,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.38,0.38
Disease,St. Louis encephalitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Western equine encephalitis,<1 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,Center for Diseases Control and Prevention[INST],0.02,0.02
Disease,Western equine encephalitis,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hinman syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Senior-Boichis syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fibronectin glomerulopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,16,16
Disease,Fibronectin glomerulopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Collagen type III glomerulopathy,,,,,,,,,,,,,
Disease,Syndromic diarrhea,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_29527791[PMID]_29868001[PMID]_30397475[PMID],116,116
Disease,Syndromic diarrhea,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT]_30397475[PMID],0,0
Disease,Syndromic diarrhea,1-9 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,23302111[PMID],0.1,0.1
Disease,Idiopathic malabsorption due to bile acid synthesis defects,,,,,,,,,,,,,
Disease,Autosomal recessive spastic paraplegia type 78,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28137957[PMID]_29112700[PMID]_27217339[PMID],7,7
Disease,Autosomal recessive spastic paraplegia type 78,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29112700[PMID],0,0
Disease,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16767100[PMID],2,2
Disease,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16767100[PMID],0,0
Disease,Leukoencephalopathy-spondylometaphyseal dysplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16924009[PMID]_10486082[PMID]_27102849[PMID],11,11
Disease,Leukoencephalopathy-spondylometaphyseal dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16924009[PMID]_10486082[PMID]_27102849[PMID],0,0
Disease,Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28686853[PMID],15,15
Disease,Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28686853[PMID],0,0
Disease,Microcytic anemia with liver iron overload,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16439678[PMID],3,3
Disease,Microcytic anemia with liver iron overload,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16439678[PMID],0,0
Malformation syndrome,Hypomyelination-congenital cataract syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Malformation syndrome,Hypomyelination-congenital cataract syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Camptodactyly-tall stature-scoliosis-hearing loss syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,30,30
Disease,Camptodactyly-tall stature-scoliosis-hearing loss syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Neurogenic scapuloperoneal syndrome, Kaeser type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17439987[PMID],15,15
Disease,"Neurogenic scapuloperoneal syndrome, Kaeser type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17439987[PMID],0,0
Disease,Facial onset sensory and motor neuronopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29781209[PMID],47,47
Disease,Facial onset sensory and motor neuronopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29781209[PMID],0,0
Disease,Addison disease,1-5 / 10 000,Specific population,409967,409967,25958,25958,en,Validated,410293,410293,12788587[PMID],54,54
Disease,Addison disease,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,21164269[PMID]_12788587[PMID]_ [EXPERT],12.5,12.5
Disease,Addison disease,1-5 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,12072049[PMID],14,14
Disease,Addison disease,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,919670[PMID],9.3,9.3
Disease,Bothnia retinal dystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10102298[PMID],0,0
Disease,Cystic leukoencephalopathy without megalencephaly,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Disease,Cystic leukoencephalopathy without megalencephaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Familial encephalopathy with neuroserpin inclusion bodies,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18591508[PMID],6,6
Disease,Familial encephalopathy with neuroserpin inclusion bodies,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18591508[PMID],0,0
Disease,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16227098[PMID]_10733237[PMID],5,5
Disease,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16227098[PMID]_10733237[PMID],0,0
Clinical group,Perineurioma,,,,,,,,,,,,,
Disease,Desmin-related myopathy with Mallory body-like inclusions,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7224095[PMID]_15122708[PMID],5,5
Disease,Desmin-related myopathy with Mallory body-like inclusions,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7224095[PMID]_15122708[PMID],0,0
Disease,Isaac syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],150,150
Disease,Isaac syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hereditary thermosensitive neuropathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9191787[PMID],1,1
Disease,Hereditary thermosensitive neuropathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9191787[PMID],0,0
Malformation syndrome,Endosteal sclerosis-cerebellar hypoplasia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15672385[PMID],4,4
Malformation syndrome,Endosteal sclerosis-cerebellar hypoplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15672385[PMID],0,0
Malformation syndrome,"Craniometadiaphyseal dysplasia, wormian bone type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20684007[PMID],4,4
Malformation syndrome,"Craniometadiaphyseal dysplasia, wormian bone type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20684007[PMID],0,0
Disease,Diaphyseal medullary stenosis-bone malignancy syndrome,,,,,,,,,,,,,
Malformation syndrome,Infantile osteopetrosis with neuroaxonal dysplasia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Astley-Kendall dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9643294[PMID],5,5
Malformation syndrome,Astley-Kendall dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9643294[PMID],0,0
Malformation syndrome,Pseudodiastrophic dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26754439[PMID],13,13
Malformation syndrome,Pseudodiastrophic dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26754439[PMID],0,0
Malformation syndrome,IMAGe syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24624461[PMID],28,28
Malformation syndrome,IMAGe syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24624461[PMID],0,0
Disease,"Microcephalic osteodysplastic dysplasia, Saul-Wilson type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8074143[PMID],4,4
Disease,"Microcephalic osteodysplastic dysplasia, Saul-Wilson type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8074143[PMID],0,0
Malformation syndrome,"Mesomelic dysplasia, Savarirayan type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Familial digital arthropathy-brachydactyly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Craniofacial conodysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7593576[PMID],1,1
Malformation syndrome,Craniofacial conodysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7593576[PMID],0,0
Disease,Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24387990[PMID],18,18
Disease,Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Platyspondylic dysplasia, Torrance type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10053006[PMID]_18076102[PMID],5,5
Disease,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10053006[PMID]_18076102[PMID],0,0
Category,Autosomal anomaly,,,,,,,,,,,,,
Category,Autosomal trisomy,,,,,,,,,,,,,
Category,Total autosomal trisomy,,,,,,,,,,,,,
Category,Partial autosomal trisomy/tetrasomy,,,,,,,,,,,,,
Category,Autosomal uniparental disomy,,,,,,,,,,,,,
Category,Maternal uniparental disomy,,,,,,,,,,,,,
Category,Sex-chromosome number anomaly,,,,,,,,,,,,,
Category,Sex-chromosome structural anomaly,,,,,,,,,,,,,
Category,Paternal uniparental disomy,,,,,,,,,,,,,
Category,Sex-chromosome anomaly,,,,,,,,,,,,,
Category,Chromosome Y structural anomaly,,,,,,,,,,,,,
Category,Chromosome X structural anomaly,,,,,,,,,,,,,
Category,Total autosomal monosomy,,,,,,,,,,,,,
Category,Partial autosomal monosomy,,,,,,,,,,,,,
Category,Rare urinary tract tumor,,,,,,,,,,,,,
Category,Rare digestive tumor,,,,,,,,,,,,,
Category,Rare respiratory tumor,,,,,,,,,,,,,
Category,Rare otorhinolaryngologic tumor,,,,,,,,,,,,,
Category,Rare genetic cardiac disease,,,,,,,,,,,,,
Category,Rare genetic renal disease,,,,,,,,,,,,,
Category,Rare tumor,,,,,,,,,,,,,
Category,Rare disease in plastic and reconstructive surgery,,,,,,,,,,,,,
Category,Rare disease in surgical orthopedic,,,,,,,,,,,,,
Category,Rare nervous system tumor,,,,,,,,,,,,,
Category,Rare gynecological tumor,,,,,,,,,,,,,
Category,Rare surgical neurologic disease,,,,,,,,,,,,,
Category,Diaphragmatic or abdominal wall malformation,,,,,,,,,,,,,
Category,Respiratory or mediastinal malformation,,,,,,,,,,,,,
Category,Central nervous system malformation,,,,,,,,,,,,,
Category,Digestive tract malformation,,,,,,,,,,,,,
Category,Cranial malformation,,,,,,,,,,,,,
Category,"Visceral malformation of the liver, biliary tract, pancreas or spleen",,,,,,,,,,,,,
Category,Rare allergic disease,,,,,,,,,,,,,
Category,Rare genetic disease,,,,,,,,,,,,,
Category,Rare allergic respiratory disease,,,,,,,,,,,,,
Category,Rare infertility,,,,,,,,,,,,,
Category,Rare female infertility,,,,,,,,,,,,,
Category,Rare male infertility,,,,,,,,,,,,,
Category,"46,XY disorder of sex development due to a defect in testosterone metabolism by peripheral tissue",,,,,,,,,,,,,
Category,"Syndrome with 46,XY disorder of sex development",,,,,,,,,,,,,
Category,Autosomal recessive degenerative and progressive cerebellar ataxia,,,,,,,,,,,,,
Category,Autosomal recessive syndromic cerebellar ataxia,,,,,,,,,,,,,
Category,Autosomal recessive metabolic cerebellar ataxia,,,,,,,,,,,,,
Category,Autosomal recessive cerebellar ataxia due to a DNA repair defect,,,,,,,,,,,,,
Category,Autosomal recessive congenital cerebellar ataxia,,,,,,,,,,,,,
Category,Gonadal dysgenesis of gynecological interest,,,,,,,,,,,,,
Category,"46,XY disorder of sex development",<1 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,27603905[PMID],0.06,0.06
Category,"46,XY disorder of sex development",1-9 / 100 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,27603905[PMID],6.4,6.4
Category,"46,XX disorder of sex development induced by androgens excess",,,,,,,,,,,,,
Category,Chronic encephalitis,,,,,,,,,,,,,
Category,Infantile epilepsy syndrome,,,,,,,,,,,,,
Category,Neonatal epilepsy syndrome,,,,,,,,,,,,,
Category,Adolescent-onset epilepsy syndrome,,,,,,,,,,,,,
Category,Childhood-onset epilepsy syndrome,,,,,,,,,,,,,
Clinical group,Progressive myoclonic epilepsy,,,,,,,,,,,,,
Clinical group,Ehlers-Danlos syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005-2012[REG],0.9,0.9
Clinical group,Ehlers-Danlos syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Infectious encephalitis,,,,,,,,,,,,,
Category,Postinfectious encephalitis,,,,,,,,,,,,,
Category,Immunodeficiency-associated lymphoproliferative disease,,,,,,,,,,,,,
Category,Dendritic cell tumor,,,,,,,,,,,,,
Category,Macrophage or histiocytic tumor,,,,,,,,,,,,,
Category,Histiocytic and dendritic cell tumor,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.05,0.05
Clinical group,Hodgkin lymphoma,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.4,2.4
Clinical group,Hodgkin lymphoma,1-5 / 10 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],46.9,46.9
Clinical group,Hodgkin lymphoma,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer Institute 2008[INST]_22835602[PMID],2.8,2.8
Clinical group,Hodgkin lymphoma,1-9 / 1 000 000,Japan,409967,409967,25965,25965,en,Not yet validated,410294,410294,emedicine[OTHER],0.25,0.25
Clinical group,Hodgkin lymphoma,1-9 / 1 000 000,China,409967,409967,25965,25965,en,Not yet validated,410294,410294,emedicine[OTHER],0.25,0.25
Category,Mastocytosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],3,3
Category,Mastocytosis,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,24761987[PMID],9.59,9.59
Category,Mastocytosis,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_24745674[PMID],10,10
Category,Lymphoproliferative disease associated with primary immune disease,,,,,,,,,,,,,
Category,Plasma cell tumor,,,,,,,,,,,,,
Clinical group,Myeloproliferative neoplasm,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.07,3.07
Category,Acute myeloid leukemia with recurrent genetic anomaly,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.11,0.11
Clinical group,Myelodysplastic/myeloproliferative disease,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.29,0.29
Disease,Genetic non-syndromic obesity,,,,,,,,,,,,,
Category,Malformation syndrome with hamartosis,,,,,,,,,,,,,
Category,Combined dystonia,,,,,,,,,,,,,
Category,Congenital myopathy,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,22028225[PMID],3.8,3.8
Disease,Rigid spine syndrome,,,,,,,,,,,,,
Category,Congenital muscular dystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Congenital muscular dystrophy,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,25653289[PMID],0.563,0.563
Disease,GRFoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Neuroendocrine tumor of pancreas,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,18515795[PMID]_National Cancer Institute[INST],0.22,0.22
Category,Neuroendocrine tumor of pancreas,1-9 / 100 000,Japan,409967,409967,25958,25958,en,Validated,410293,410293,24499825[PMID],1.27,1.27
Category,Neuroendocrine tumor of pancreas,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,24499825[PMID],2.69,2.69
Category,Neuroendocrine tumor of pancreas,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,15016750[PMID],0.21,0.21
Category,Neuroendocrine tumor of pancreas,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,15016750[PMID],0.21,0.21
Category,Neuroendocrine tumor of pancreas,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,23237225[PMID]_[EXPERT],27.5,27.5
Category,Neuroendocrine tumor of pancreas,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Mega-cisterna magna,,,,,,,,,,,,,
Malformation syndrome,Pontocerebellar hypoplasia type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],3,3
Malformation syndrome,Pontocerebellar hypoplasia type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Insulinoma,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,2575263[PMID],0.12,0.12
Disease,Insulinoma,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,23430217[PMID],0.25,0.25
Disease,Insulinoma,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,24499825[PMID],0.56,0.56
Disease,Insulinoma,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,PPoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Encephalitis,,,,,,,,,,,,,
Disease,Thyroid lymphoma,Unknown,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,23714679[PMID],0,0
Disease,Somatostatinoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_17645474[PMID],0.0025,0.0025
Disease,Somatostatinoma,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,VIPoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,VIPoma,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Glucagonoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,9113318[PMID],0.005,0.005
Disease,Glucagonoma,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Thymic neuroendocrine tumor,,,,,,,,,,,,,
Disease,Familial papillary thyroid carcinoma with renal papillary neoplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10843148[PMID],2,2
Disease,Carney-Stratakis syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Carney-Stratakis syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Bronchial neuroendocrine tumor,,,,,,,,,,,,,
Category,Rare benign ovarian tumor,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Cardiogenic shock,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2008[INST],40,40
Disease,Kienbock disease,,,,,,,,,,,,,
Disease,Osgood-Schlatter disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Bohring-Opitz syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,29446906[PMID],46,46
Malformation syndrome,Bohring-Opitz syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Thoracic outlet syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Melanoma of soft tissue,,,,,,,,,,,,,
Morphological anomaly,Dural sinus malformation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Panner disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Sinding-Larsen-Johansson disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Persistent placoid maculopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17471331[PMID]_[EXPERT],5,5
Disease,Persistent placoid maculopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Hunter-McAlpine craniosynostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Malformation syndrome,Hunter-McAlpine craniosynostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,ADan amyloidosis,,,,,,,,,,,,,
Clinical subtype,ABri amyloidosis,,,,,,,,,,,,,
Disease,Postencephalitic parkinsonism,,,,,,,,,,,,,
Disease,Pellagra,,,,,,,,,,,,,
Disease,Dementia pugilistica,,,,,,,,,,,,,
Malformation syndrome,Robinow syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],200,200
Malformation syndrome,Robinow syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Caribbean parkinsonism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,"Renal hypoplasia, unilateral",Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,"Renal hypoplasia, bilateral",Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Clinical subtype,Unilateral multicystic dysplastic kidney,1-5 / 10 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,19171687[PMID],23.2,23.2
Clinical subtype,Unilateral multicystic dysplastic kidney,1-5 / 10 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,16053904[PMID],14.8,14.8
Clinical subtype,Unilateral multicystic dysplastic kidney,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,18278521[PMID],45.4,45.4
Clinical subtype,Unilateral multicystic dysplastic kidney,1-5 / 10 000,Japan,409968,409968,25958,25958,en,Validated,410293,410293,11967035[PMID],25,25
Clinical subtype,Unilateral multicystic dysplastic kidney,>1 / 1000,Saudi Arabia,409968,409968,25958,25958,en,Validated,410293,410293,12415373[PMID],108,108
Clinical subtype,Unilateral multicystic dysplastic kidney,1-5 / 10 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,12532949[PMID],24.4,24.4
Clinical subtype,Unilateral multicystic dysplastic kidney,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,7776710[PMID],41,41
Clinical subtype,Unilateral multicystic dysplastic kidney,6-9 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,11683078[PMID],60.3,60.3
Clinical subtype,Unilateral multicystic dysplastic kidney,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Bilateral multicystic dysplastic kidney,,,,,,,,,,,,,
Morphological anomaly,Multiloculated renal cyst,,,,,,,,,,,,,
Etiological subtype,Renal tubular dysgenesis due to twin-twin transfusion,,,,,,,,,,,,,
Etiological subtype,Drug-related renal tubular dysgenesis,,,,,,,,,,,,,
Etiological subtype,Renal tubular dysgenesis of genetic origin,,,,,,,,,,,,,
Malformation syndrome,Right sided atrial isomerism,1-5 / 10 000,France,409968,409968,25958,25958,en,Validated,410293,410293,8308205[PMID],16.67,16.67
Disease,Primary membranous glomerulonephritis,,,,,,,,,,,,,
Malformation syndrome,Maternal uniparental disomy of chromosome 9,,,,,,,,,,,,,
Etiological subtype,Silver-Russell syndrome due to maternal uniparental disomy of chromosome 7,,,,,,,,,,,,,
Malformation syndrome,Maternal uniparental disomy of chromosome 6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27922284[PMID],15,15
Malformation syndrome,Maternal uniparental disomy of chromosome 6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27922284[PMID],0,0
Malformation syndrome,Maternal uniparental disomy of chromosome 4,,,,,,,,,,,,,
Malformation syndrome,Maternal uniparental disomy of chromosome 2,,,,,,,,,,,,,
Malformation syndrome,Ring chromosome 16 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23705081[PMID],10,10
Malformation syndrome,Ring chromosome 16 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23705081[PMID],0,0
Malformation syndrome,Ring chromosome 15 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16267671[PMID],50,50
Malformation syndrome,Ring chromosome 15 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16267671[PMID],0,0
Malformation syndrome,Ring chromosome 13 syndrome,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,7129419[PMID],1.72,1.72
Malformation syndrome,Paternal uniparental disomy of chromosome 6,,,,,,,,,,,,,
Malformation syndrome,Paternal uniparental disomy of chromosome 5,,,,,,,,,,,,,
Malformation syndrome,Maternal uniparental disomy of chromosome 22,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:978-3-642-55287-8[OTHER],4,4
Malformation syndrome,Maternal uniparental disomy of chromosome 22,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:978-3-642-55287-8[OTHER],0,0
Malformation syndrome,Maternal uniparental disomy of chromosome 21,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:978-3-642-55287-8[OTHER],2,2
Malformation syndrome,Maternal uniparental disomy of chromosome 21,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:978-3-642-55287-8[OTHER],0,0
Malformation syndrome,Maternal uniparental disomy of chromosome 20,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26248010[PMID],12,12
Malformation syndrome,Maternal uniparental disomy of chromosome 20,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26248010[PMID],0,0
Malformation syndrome,Maternal uniparental disomy of chromosome 16,,,,,,,,,,,,,
Etiological subtype,Temple syndrome due to maternal uniparental disomy of chromosome 14,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28640239[PMID]_24891339[PMID],64,64
Etiological subtype,Temple syndrome due to maternal uniparental disomy of chromosome 14,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28640239[PMID]_24891339[PMID],0,0
Malformation syndrome,Paternal uniparental disomy of chromosome 20,,,,,,,,,,,,,
Malformation syndrome,Paternal uniparental disomy of chromosome 21,,,,,,,,,,,,,
Malformation syndrome,Paternal uniparental disomy of chromosome 7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17935233[PMID],4,4
Malformation syndrome,Paternal uniparental disomy of chromosome 7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17935233[PMID],0,0
Etiological subtype,Beckwith-Wiedemann syndrome due to paternal uniparental disomy of chromosome 11,,,,,,,,,,,,,
Clinical group,Somatotropic adenoma,,,,,,,,,,,,,
Category,Rare genetic deafness,,,,,,,,,,,,,
Disease,Cushing disease,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency[INST],4,4
Disease,Cushing disease,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,22710101[PMID],0.2,0.2
Malformation syndrome,X small rings,,,,,,,,,,,,,
Category,Polyploidy,,,,,,,,,,,,,
Morphological anomaly,Isolated partial vaginal agenesis,,,,,,,,,,,,,
Malformation syndrome,"49,XXXXY syndrome",1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,7567329[PMID]_[EXPERT]_ ORPHANET,0.55,0.55
Malformation syndrome,"49,XXXXY syndrome",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,"48,XXXY syndrome",1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Malformation syndrome,"48,XXXY syndrome",1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0,0
Clinical subtype,Leydig cell hypoplasia due to partial LH resistance,,,,,,,,,,,,,
Clinical subtype,Leydig cell hypoplasia due to complete LH resistance,,,,,,,,,,,,,
Category,Rare gynecologic or obstetric disease,,,,,,,,,,,,,
Category,Anorectal malformation,,,,,,,,,,,,,
Category,Isochromosome Y,,,,,,,,,,,,,
Etiological subtype,Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26377239[PMID],0,0
Etiological subtype,Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26377239[PMID],37,37
Category,Rare otorhinolaryngological malformation,,,,,,,,,,,,,
Clinical group,Distal arthrogryposis,,,,,,,,,,,,,
Malformation syndrome,Eisenmenger syndrome,1-9 / 1 000 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,19725436[PMID],0.2,0.2
Malformation syndrome,Eisenmenger syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Early-onset schizophrenia,,,,,,,,,,,,,
Disease,Glycogen storage disease due to phosphoglycerate mutase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],50,50
Disease,Glycogen storage disease due to phosphoglycerate mutase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Rippling muscle disease,,,,,,,,,,,,,
Disease,Reducing body myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,4,4
Disease,Reducing body myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Zebra body myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Zebra body myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Riboflavin transporter deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,30793323[PMID]_[EXPERT],109,109
Malformation syndrome,Riboflavin transporter deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30793323[PMID],0,0
Disease,Solar urticaria,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,12975156[PMID]_[EXPERT],3.1,3.1
Disease,Solar urticaria,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30585308[PMID]_27793344[PMID]_[EXPERT],0,0
Disease,Fingerprint body myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Fingerprint body myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare endocrine disease,,,,,,,,,,,,,
Category,Rare immune disease,,,,,,,,,,,,,
Category,Rare hematologic disease,,,,,,,,,,,,,
Category,Rare neurologic disease,,,,,,,,,,,,,
Category,Infectious disease of the nervous system,,,,,,,,,,,,,
Category,Rare neurologic disease with psychiatric involvement,,,,,,,,,,,,,
Category,Rare disease in anaesthesiology,,,,,,,,,,,,,
Category,Rare otorhinolaryngologic disease,,,,,,,,,,,,,
Category,Rare systemic or rheumatologic disease,,,,,,,,,,,,,
Category,Rare headache,,,,,,,,,,,,,
Category,Rare disease with odontological manifestation,,,,,,,,,,,,,
Category,Rare odontologic disease,,,,,,,,,,,,,
Category,Rare circulatory system disease,,,,,,,,,,,,,
Malformation syndrome,Maternal uniparental disomy of chromosome 13,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ISBN:978-3-642-55287-8[OTHER],3,3
Malformation syndrome,Maternal uniparental disomy of chromosome 13,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_ISBN:978-3-642-55287-8[OTHER],0,0
Disease,Congenital renal artery stenosis,,,,,,,,,,,,,
Category,Pseudohypoparathyroidism,1-9 / 1 000 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.67,0.67
Category,Pseudohypoparathyroidism,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,10695258[PMID],0.34,0.34
Category,Pseudohypoparathyroidism,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Disease,Immunotactoid glomerulopathy,,,,,,,,,,,,,
Clinical subtype,Pauci-immune glomerulonephritis without ANCA,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Laure-Hélène NOEL[EXPERT],0,0
Disease,Non-amyloid fibrillary glomerulopathy,,,,,,,,,,,,,
Clinical subtype,Pauci-immune glomerulonephritis with ANCA,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_Dr Laure-Hélène NOEL[EXPERT],0,0
Category,Rare gastroenterologic disease,,,,,,,,,,,,,
Category,Rare cardiac disease,,,,,,,,,,,,,
Clinical subtype,17q11 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16467218[PMID],170,170
Clinical subtype,17q11 microdeletion syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare respiratory disease,,,,,,,,,,,,,
Category,Intestinal malformation,,,,,,,,,,,,,
Category,Gastroduodenal malformation,,,,,,,,,,,,,
Category,Rare ophthalmic disorder,,,,,,,,,,,,,
Category,Rare surgical thoracic disease,,,,,,,,,,,,,
Category,Rare surgical cardiac disease,,,,,,,,,,,,,
Category,Respiratory or thoracic malformation,,,,,,,,,,,,,
Morphological anomaly,Idiopathic isolated micropenis,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21527236[PMID],0,0
Category,Rare precocious puberty,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Posterior hypospadias,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET_25712311[PMID],20,20
Morphological anomaly,Posterior hypospadias,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cytomegalic congenital adrenal hypoplasia,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20301604[PMID],8,8
Disease,Congenital hypothyroidism due to transplacental passage of TSH-binding inhibitory antibodies,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Familial thyroid dyshormonogenesis,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_emedicine[OTHER],2.67,2.67
Disease,Familial thyroid dyshormonogenesis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Disease,Familial thyroid dyshormonogenesis,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,2919526[PMID],4,4
Morphological anomaly,Athyreosis,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3.5,3.5
Category,Primary congenital hypothyroidism without thyroid developmental anomaly,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Congenital hypothyroidism due to developmental anomaly,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],21.3,21.3
Morphological anomaly,Thyroid ectopia,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],14.3,14.3
Category,Acquired premature ovarian failure,,,,,,,,,,,,,
Category,Non-acquired premature ovarian failure,,,,,,,,,,,,,
Disease,Post-traumatic pituitary deficiency,,,,,,,,,,,,,
Category,Pituitary hormone deficiency secondary to storage disease,,,,,,,,,,,,,
Category,Pituitary hormone deficiency secondary to a granulomatous disease,,,,,,,,,,,,,
Disease,Pituitary apoplexy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial adrenal hypoplasia with absent pituitary luteinizing hormone,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2906226[PMID],3,3
Disease,Familial adrenal hypoplasia with absent pituitary luteinizing hormone,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2906226[PMID],0,0
Disease,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.75,0.75
Disease,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Acquired central diabetes insipidus,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Pituitary hormone deficiency of meningeal origin,,,,,,,,,,,,,
Clinical group,Primary hypophysitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Congenital anomaly of hepatic vein,,,,,,,,,,,,,
Category,Congenital anomaly of the coronary sinus,,,,,,,,,,,,,
Category,Acquired pituitary hormone deficiency,,,,,,,,,,,,,
Category,Pituitary hormone deficiency of tumoral origin,,,,,,,,,,,,,
Disease,Adenohypophysitis,,,,,,,,,,,,,
Disease,Panhypophysitis,,,,,,,,,,,,,
Category,Pituitary hormone deficiency of vascular origin,,,,,,,,,,,,,
Category,Atrial appendage anomaly,,,,,,,,,,,,,
Category,Non-acquired pituitary hormone deficiency,,,,,,,,,,,,,
Morphological anomaly,Congenital coronary artery aneurysm,,,,,,,,,,,,,
Category,Arterial duct anomaly,,,,,,,,,,,,,
Morphological anomaly,Aneurysm or dilatation of ascending aorta,,,,,,,,,,,,,
Morphological anomaly,Premature closure of the arterial duct,,,,,,,,,,,,,
Morphological anomaly,Pituitary stalk interruption syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Congenital anomaly of the inferior vena cava,,,,,,,,,,,,,
Category,Congenital anomaly of superior vena cava,,,,,,,,,,,,,
Category,Disease associated with non-acquired combined pituitary hormone deficiency,,,,,,,,,,,,,
Disease,"Combined pituitary hormone deficiencies, genetic forms",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Mesocardia,,,,,,,,,,,,,
Clinical subtype,Congenital aortic valve atresia,,,,,,,,,,,,,
Disease,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,11175288[PMID]_4154794[PMID],0,0
Disease,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET_11175288[PMID]_4154794[PMID],3,3
Disease,Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11960835[PMID],1,1
Disease,Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11960835[PMID],0,0
Morphological anomaly,Tricuspid valve agenesis,,,,,,,,,,,,,
Morphological anomaly,Tricuspid valve prolapse,,,,,,,,,,,,,
Disease,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,1-9 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,21162721[PMID],0.19,0.19
Disease,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,1-9 / 1 000 000,"Taiwan, Province of China",409967,409967,25958,25958,en,Validated,410293,410293,15057820[PMID],0.8,0.8
Disease,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,15057820[PMID],0.189,0.189
Disease,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,1-9 / 1 000 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.19,0.19
Morphological anomaly,Accessory tricuspid valve tissue,,,,,,,,,,,,,
Category,Anomaly of the tricuspid subvalvular apparatus,,,,,,,,,,,,,
Morphological anomaly,Congenital tricuspid stenosis,,,,,,,,,,,,,
Morphological anomaly,Straddling or overriding tricuspid valve,,,,,,,,,,,,,
Clinical subtype,Double-orifice mitral valve,,,,,,,,,,,,,
Category,Univentricular cardiopathy,,,,,,,,,,,,,
Category,Congenital mitral valve insufficiency and/or stenosis,,,,,,,,,,,,,
Morphological anomaly,Cleft mitral valve,,,,,,,,,,,,,
Clinical group,Acute hepatic porphyria,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lissencephaly due to LIS1 mutation,,,,,,,,,,,,,
Clinical group,Chronic hepatic porphyria,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Hepatoerythropoietic porphyria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],40,40
Disease,Hepatoerythropoietic porphyria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,COG8-CDG,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17331980[PMID]_17220172[PMID],2,2
Disease,COG8-CDG,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17331980[PMID]_17220172[PMID],0,0
Disease,Secondary short bowel syndrome,,,,,,,,,,,,,
Clinical syndrome,Acute adrenal insufficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Primary progressive aphasia,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,24108322[PMID],7,7
Disease,Twin to twin transfusion syndrome,,,,,,,,,,,,,
Morphological anomaly,Congenital tracheomalacia,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Angioma serpiginosum,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mills syndrome,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,30631918[PMID],0.12,0.12
Disease,Neuroleptic malignant syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Spondylocostal dysostosis-anal atresia-genitourinary malformation syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7246601[PMID]_9880219[PMID],0,0
Malformation syndrome,Spondylocostal dysostosis-anal atresia-genitourinary malformation syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7246601[PMID]_9880219[PMID],3,3
Disease,"Cerebellar ataxia, Cayman type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spinocerebellar ataxia with axonal neuropathy type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12244316[PMID],0,0
Disease,Spinocerebellar ataxia with axonal neuropathy type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12244316[PMID],9,9
Disease,Recessive mitochondrial ataxia syndrome,,,,,,,,,,,,,
Clinical group,Autosomal dominant cerebellar ataxia type I,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 7,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24374739[PMID],0,0
Clinical group,Autosomal dominant cerebellar ataxia type III,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24225362[PMID],0,0
Clinical group,Autosomal dominant cerebellar ataxia type IV,,,,,,,,,,,,,
Clinical subtype,Anonychia congenita totalis,,,,,,,,,,,,,
Malformation syndrome,Deafness-infertility syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26011646[PMID],3,3
Malformation syndrome,Deafness-infertility syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26011646[PMID],0,0
Malformation syndrome,12q14 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28407409[PMID]_29501611[PMID],22,22
Malformation syndrome,12q14 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28407409[PMID]_29501611[PMID],0,0
Malformation syndrome,Severe intellectual disability-epilepsy-anal anomalies-distal phalangeal hypoplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17351347[PMID],2,2
Malformation syndrome,Severe intellectual disability-epilepsy-anal anomalies-distal phalangeal hypoplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17351347[PMID],0,0
Etiological subtype,15q24 microdeletion syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22359776[PMID],30,30
Etiological subtype,15q24 microdeletion syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22359776[PMID],0,0
Disease,Spondyloepiphyseal dysplasia congenita,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],1,1
Disease,Spondyloepiphyseal dysplasia congenita,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Severe immune-mediated enteropathy,,,,,,,,,,,,,
Malformation syndrome,Partington syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3177452[PMID]_12376949[PMID],2,2
Malformation syndrome,Partington syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3177452[PMID]_12376949[PMID],0,0
Disease,Non-functioning paraganglioma,,,,,,,,,,,,,
Disease,Blue diaper syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Hereditary renal hypouricemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cytophagic histiocytic panniculitis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Cytophagic histiocytic panniculitis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Pseudohypoparathyroidism type 2,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Pseudohypoparathyroidism type 1B,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Ring chromosome 11 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26576288[PMID],20,20
Malformation syndrome,Ring chromosome 11 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26576288[PMID],0,0
Malformation syndrome,Ring chromosome 9 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25722017[PMID],31,31
Malformation syndrome,Ring chromosome 9 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25722017[PMID],0,0
Malformation syndrome,Ring chromosome 3 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11491310[PMID]_27984612[PMID],11,11
Malformation syndrome,Ring chromosome 3 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11491310[PMID]_27984612[PMID],0,0
Malformation syndrome,Ring chromosome 2 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25997743[PMID],18,18
Malformation syndrome,Ring chromosome 2 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25997743[PMID],0,0
Malformation syndrome,Emanuel syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26076791[PMID]_20301440[PMID],350,350
Malformation syndrome,Emanuel syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26076791[PMID]_20301440[PMID],0,0
Malformation syndrome,Koolen-De Vries syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_26306646[PMID],0,0
Malformation syndrome,Monosomy 13q34,,,,,,,,,,,,,
Malformation syndrome,Recombinant 8 syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Non-distal monosomy 20q,,,,,,,,,,,,,
Malformation syndrome,Non-distal monosomy 12q,,,,,,,,,,,,,
Malformation syndrome,Distal monosomy 20q,,,,,,,,,,,,,
Malformation syndrome,Distal monosomy 14q,,,,,,,,,,,,,
Malformation syndrome,Distal monosomy 10q,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Malformation syndrome,Distal monosomy 10q,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal monosomy 12q,,,,,,,,,,,,,
Etiological subtype,Kleefstra syndrome due to 9q34 microdeletion,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22670141[PMID],86,86
Etiological subtype,Kleefstra syndrome due to 9q34 microdeletion,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal monosomy 4q,,,,,,,,,,,,,
Malformation syndrome,Distal monosomy 19p13.3,,,,,,,,,,,,,
Malformation syndrome,Distal monosomy 6p,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23686687[PMID],35,35
Malformation syndrome,Distal monosomy 6p,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal monosomy 7p,,,,,,,,,,,,,
Malformation syndrome,7q11.23 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27617154[PMID],163,163
Malformation syndrome,7q11.23 microduplication syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27617154[PMID],0,0
Malformation syndrome,Monosomy 22,,,,,,,,,,,,,
Malformation syndrome,Non-distal trisomy 9q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 20q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 16q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 13q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 22q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 6q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 5q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 4q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 11q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 10q,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,40,40
Malformation syndrome,Distal trisomy 10q,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Distal trisomy 9q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 8q,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 2q,,,,,,,,,,,,,
Malformation syndrome,3q26 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27549440[PMID],100,100
Malformation syndrome,3q26 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27549440[PMID],0,0
Malformation syndrome,8p inverted duplication/deletion syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],3.9,3.9
Malformation syndrome,8p inverted duplication/deletion syndrome,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,8p inverted duplication/deletion syndrome,1-9 / 100 000,Italy,409968,409968,25965,25965,en,Not yet validated,410294,410294,8644743[PMID],3.9,3.9
Malformation syndrome,4p16.3 microduplication syndrome,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 7p,,,,,,,,,,,,,
Etiological subtype,Beckwith-Wiedemann syndrome due to 11p15 microduplication,,,,,,,,,,,,,
Malformation syndrome,16p13.3 microduplication syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26873618[PMID],27,27
Malformation syndrome,16p13.3 microduplication syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26873618[PMID],0,0
Malformation syndrome,Distal trisomy 1p36,,,,,,,,,,,,,
Malformation syndrome,Mosaic trisomy 22,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 3p,,,,,,,,,,,,,
Malformation syndrome,Distal trisomy 2p,,,,,,,,,,,,,
Malformation syndrome,Mosaic trisomy 4,,,,,,,,,,,,,
Malformation syndrome,Mosaic trisomy 5,,,,,,,,,,,,,
Malformation syndrome,Mosaic trisomy 8,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET,3,3
Malformation syndrome,Mosaic trisomy 8,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Mosaic trisomy 10,,,,,,,,,,,,,
Disease,Idiopathic congenital hypothyroidism,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Congenital thyroid malformation without hypothyroidism,,,,,,,,,,,,,
Morphological anomaly,Thyroid hemiagenesis,1-5 / 10 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,19016002[PMID],25,25
Morphological anomaly,Thyroid hypoplasia,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],3.5,3.5
Morphological anomaly,Levocardia,,,,,,,,,,,,,
Malformation syndrome,Tetrasomy 21,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18372039[PMID],13,13
Malformation syndrome,Tetrasomy 21,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18372039[PMID],0,0
Category,Syndromic renal or urinary tract malformation,,,,,,,,,,,,,
Category,Non-syndromic renal or urinary tract malformation,,,,,,,,,,,,,
Category,Glomerular disease,,,,,,,,,,,,,
Category,Renal or urinary tract malformation,,,,,,,,,,,,,
Etiological subtype,Mixed cryoglobulinemia type III,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Type II mixed cryoglobulinemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Light and heavy chain deposition disease,,,,,,,,,,,,,
Clinical subtype,Heavy chain deposition disease,,,,,,,,,,,,,
Disease,Pediatric systemic lupus erythematosus,,,,,,,,,,,,,
Clinical subtype,AFib amyloidosis,,,,,,,,,,,,,
Clinical subtype,Light chain deposition disease,,,,,,,,,,,,,
Clinical subtype,AApoAI amyloidosis,,,,,,,,,,,,,
Clinical subtype,ALys amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21988333[PMID],7,7
Clinical subtype,ALys amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21988333[PMID],0,0
Histopathological subtype,Dense deposit disease,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20301598[PMID],0.25,0.25
Clinical group,Thrombotic microangiopathy,,,,,,,,,,,,,
Disease,Juvenile polymyositis,,,,,,,,,,,,,
Disease,Polymyalgia rheumatica,,,,,,,,,,,,,
Category,Lysosomal storage disease with skeletal involvement,,,,,,,,,,,,,
Category,Primary bone dysplasia with defective bone mineralization,,,,,,,,,,,,,
Category,Primary bone dysplasia with decreased bone density,,,,,,,,,,,,,
Category,Primary bone dysplasia with increased bone density,,,,,,,,,,,,,
Clinical group,Neonatal osteosclerotic dysplasia,,,,,,,,,,,,,
Clinical group,Chondrodysplasia punctata,,,,,,,,,,,,,
Clinical group,Primary bone dysplasia with multiple joint dislocations,,,,,,,,,,,,,
Category,Patellar dysostosis,,,,,,,,,,,,,
Category,Dysostosis with predominant vertebral and costal involvement,,,,,,,,,,,,,
Category,Dysostosis with predominant craniofacial involvement,,,,,,,,,,,,,
Category,Cleidocranial dysplasia and isolated cranial ossification defect,,,,,,,,,,,,,
Category,Primary bone dysplasia with disorganized development of skeletal components,,,,,,,,,,,,,
Category,Primary osteolysis,,,,,,,,,,,,,
Category,Lethal chondrodysplasia,,,,,,,,,,,,,
Category,Chromosomal disease with overgrowth,,,,,,,,,,,,,
Category,Syndrome with synostosis or other joint formation defect,,,,,,,,,,,,,
Category,Overgrowth syndrome,,,,,,,,,,,,,
Category,Non-syndromic limb reduction defect,,,,,,,,,,,,,
Category,"Non-syndromic polydactyly, syndactyly and/or hyperphalangy",,,,,,,,,,,,,
Clinical subtype,Scheie syndrome,1-9 / 1 000 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,4250044[PMID],0.2,0.2
Clinical subtype,Scheie syndrome,<1 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,18796143[PMID],0.07,0.07
Clinical subtype,Hurler-Scheie syndrome,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,18796143[PMID],0.24,0.24
Clinical subtype,Hurler-Scheie syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Hurler syndrome,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.5,0.5
Clinical subtype,Hurler syndrome,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,18796143[PMID],0.76,0.76
Clinical subtype,Hurler syndrome,1-9 / 1 000 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,16435194[PMID],0.64,0.64
Clinical subtype,Hurler syndrome,1-9 / 1 000 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,18681890[PMID],0.38,0.38
Clinical subtype,Hurler syndrome,1-9 / 1 000 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,18681890[PMID],0,0
Clinical subtype,Hurler syndrome,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,14685153[PMID],1.05,1.05
Clinical subtype,Hurler syndrome,<1 / 1 000 000,"Taiwan, Province of China",409968,409968,25958,25958,en,Validated,410293,410293,19396827[PMID],0.06,0.06
Clinical subtype,Hurler syndrome,1-9 / 1 000 000,Australia,409968,409968,25958,25958,en,Validated,410293,410293,14608657[PMID],0.93,0.93
Clinical subtype,Hurler syndrome,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,ORPHANET_16435194[PMID]_14685153[PMID]_18681890[PMID]_18796143[PMID],0.7,0.7
Clinical subtype,Juvenile sialidosis type 2,,,,,,,,,,,,,
Disease,Genochondromatosis type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17632779[PMID],10,10
Disease,Genochondromatosis type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17632779[PMID],0,0
Clinical subtype,Congenital sialidosis type 2,,,,,,,,,,,,,
Morphological anomaly,Syndactyly type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Syndactyly type 1,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],25,25
Morphological anomaly,Syndactyly type 1,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Morphological anomaly,Syndactyly type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22448207[PMID],4,4
Morphological anomaly,Syndactyly type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22448207[PMID],0,0
Morphological anomaly,Syndactyly type 3,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Syndactyly type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Morphological anomaly,Syndactyly type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,"Brachydactyly-syndactyly, Zhao type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17236141[PMID],2,2
Malformation syndrome,"Brachydactyly-syndactyly, Zhao type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17236141[PMID],0,0
Category,Rare bone disease,,,,,,,,,,,,,
Category,Type 2 collagen-related bone disorder,,,,,,,,,,,,,
Category,FGFR3-related chondrodysplasia,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,22461456[PMID],8.1,8.1
Category,Type 11 collagen-related bone disorder,,,,,,,,,,,,,
Category,Sulfation-related bone disorder,,,,,,,,,,,,,
Category,Perlecan-related bone disorder,,,,,,,,,,,,,
Category,Filamin-related bone disorder,,,,,,,,,,,,,
Category,Ciliopathies with major skeletal involvement,,,,,,,,,,,,,
Category,Multiple epiphyseal dysplasia and pseudoachondroplasia,,,,,,,,,,,,,
Clinical group,Multiple metaphyseal dysplasia,,,,,,,,,,,,,
Clinical group,Spondylodysplastic dysplasia,,,,,,,,,,,,,
Clinical group,Acromelic dysplasia,,,,,,,,,,,,,
Clinical group,Acromesomelic dysplasia,,,,,,,,,,,,,
Clinical group,Mesomelic and rhizo-mesomelic dysplasia,,,,,,,,,,,,,
Clinical group,Campomelic dysplasia and related disorders,,,,,,,,,,,,,
Clinical group,Slender bone dysplasia,,,,,,,,,,,,,
Disease,Spondyloepimetaphyseal dysplasia with multiple dislocations,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spondyloepimetaphyseal dysplasia with joint laxity,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26463668[PMID],27,27
Disease,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26463668[PMID],0,0
Disease,SPONASTRIME dysplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18203204[PMID],16,16
Disease,SPONASTRIME dysplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18203204[PMID],0,0
Etiological subtype,Familial hypocalciuric hypercalcemia type 1,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,21986511[PMID],5.5,5.5
Etiological subtype,Familial hypocalciuric hypercalcemia type 1,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,11353947[PMID],1.3,1.3
Malformation syndrome,Brachydactyly type A6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,4073128[PMID],7,7
Malformation syndrome,Brachydactyly type A6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_4073128[PMID],0,0
Malformation syndrome,Brachydactyly type B,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_18554391[PMID],0,0
Malformation syndrome,Brachydactyly type E,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_18554391[PMID],0,0
Malformation syndrome,Brachydactyly type A1,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18554391[PMID],0,0
Malformation syndrome,Brachydactyly type C,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_18554391[PMID],0,0
Malformation syndrome,Brachydactyly type A2,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Brachydactyly type A2,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18554391[PMID],0,0
Malformation syndrome,Brachydactyly type A7,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,2714013[PMID],1,1
Malformation syndrome,Brachydactyly type A7,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_2714013[PMID],0,0
Malformation syndrome,Brachydactyly type A4,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18554391[PMID],0,0
Morphological anomaly,Myelomeningocele,,,,,,,,,,,,,
Disease,Blepharospasm-oromandibular dystonia syndrome,,,,,,,,,,,,,
Disease,Oromandibular dystonia,,,,,,,,,,,,,
Particular clinical situation in a disease or syndrome,Uremic pruritus,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2010[INST],35,35
Particular clinical situation in a disease or syndrome,Neovascular glaucoma,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2003[INST],24.4,24.4
Morphological anomaly,Humero-ulnar synostosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,5,5
Morphological anomaly,Humero-ulnar synostosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Renier-Gabreels-Jasper syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7077653[PMID],5,5
Malformation syndrome,Renier-Gabreels-Jasper syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7077653[PMID],0,0
Malformation syndrome,Smith-Fineman-Myers syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],11,11
Malformation syndrome,Smith-Fineman-Myers syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Anotia,<1 / 1 000 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,16359491[PMID],0.03,0.03
Morphological anomaly,Anotia,<1 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0.028,0.028
Morphological anomaly,Anotia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Anotia,<1 / 1 000 000,France,409968,409968,25958,25958,en,Validated,410293,410293,8933331[PMID],0.04,0.04
Morphological anomaly,Anotia,<1 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,8933331[PMID],0,0
Morphological anomaly,Anotia,<1 / 1 000 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,7666397[PMID],0.03,0.03
Morphological anomaly,Anotia,<1 / 1 000 000,Italy,409966,409966,25965,25965,en,Not yet validated,410294,410294,7666397[PMID],0,0
Morphological anomaly,Anotia,<1 / 1 000 000,Sweden,409968,409968,25958,25958,en,Validated,410293,410293,8933331[PMID],0.02,0.02
Morphological anomaly,Anotia,<1 / 1 000 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,8933331[PMID],0,0
Morphological anomaly,Anotia,<1 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,8933331[PMID]_19760683[PMID],0.02,0.02
Morphological anomaly,Anotia,<1 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,8933331[PMID]_19760683[PMID],0,0
Morphological anomaly,Anotia,<1 / 1 000 000,Finland,409968,409968,25958,25958,en,Validated,410293,410293,17548114[PMID],0.02,0.02
Morphological anomaly,Anotia,<1 / 1 000 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,17548114[PMID],0,0
Morphological anomaly,Anotia,<1 / 1 000 000,Chile,409968,409968,25958,25958,en,Validated,410293,410293,17186100[PMID],0.05,0.05
Morphological anomaly,Anotia,<1 / 1 000 000,Chile,409966,409966,25965,25965,en,Not yet validated,410294,410294,17186100[PMID],0,0
Malformation syndrome,Chudley-Lowry-Hoar syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3239563[PMID]_[EXPERT],3,3
Malformation syndrome,Chudley-Lowry-Hoar syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Holmes-Gang syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6711605[PMID]_[EXPERT],3,3
Malformation syndrome,Holmes-Gang syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Carpenter-Waziri syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10398237[PMID],6,6
Malformation syndrome,Carpenter-Waziri syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10398237[PMID],0,0
Malformation syndrome,Juberg-Marsidi syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8533845[PMID],16,16
Malformation syndrome,Juberg-Marsidi syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8533845[PMID],0,0
Disease,FG syndrome type 1,,,,,,,,,,,,,
Clinical subtype,Bladder exstrophy,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,11251990[PMID],2.8,2.8
Clinical subtype,Bladder exstrophy,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Bladder exstrophy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Bladder exstrophy,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,8013895[PMID]_15821570[PMID]_17990338[PMID],2.8,2.8
Clinical subtype,Bladder exstrophy,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,19878548[PMID]_ORPHANET,3.05,3.05
Clinical subtype,Isolated epispadias,1-9 / 100 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,19878548[PMID],2.4,2.4
Clinical subtype,Isolated epispadias,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,19878548[PMID],0,0
Clinical subtype,Cloacal exstrophy,1-9 / 1 000 000,Europe,409968,409968,25965,25965,en,Not yet validated,410294,410294,19878548[PMID],0.75,0.75
Clinical subtype,Cloacal exstrophy,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,19878548[PMID],0,0
Clinical subtype,Cloacal exstrophy,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,17990338[PMID],0.6,0.6
Clinical subtype,Cloacal exstrophy,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,11251990[PMID],0.5,0.5
Clinical subtype,Cloacal exstrophy,1-9 / 1 000 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,22002951[PMID],0.54,0.54
Clinical subtype,Midline interhemispheric variant of holoprosencephaly,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Lobar holoprosencephaly,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Alobar holoprosencephaly,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Schwannomatosis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_ISBN:3211695001[OTHER],0,0
Disease,Schwannomatosis,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,ISBN:3211695001[OTHER]_10636128[PMID],0.058,0.058
Morphological anomaly,Familial thyroglossal duct cyst,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16012840[PMID]_19344886[PMID]_17457484[PMID],22,22
Morphological anomaly,Familial thyroglossal duct cyst,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16012840[PMID]_19344886[PMID]_17457484[PMID],0,0
Disease,"X-linked intellectual disability, Hedera type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26467484[PMID]_11782983[PMID],9,9
Disease,"X-linked intellectual disability, Hedera type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26467484[PMID]_11782983[PMID],0,0
Clinical subtype,"X-linked intellectual disability, Sutherland-Haan type",,,,,,,,,,,,,
Clinical subtype,"X-linked intellectual disability, Golabi-Ito-Hall type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],3,3
Clinical subtype,"X-linked intellectual disability, Golabi-Ito-Hall type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Hamel cerebro-palato-cardiac syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Clinical subtype,Hamel cerebro-palato-cardiac syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"X-linked intellectual disability, Porteous type",,,,,,,,,,,,,
Clinical subtype,Laryngotracheoesophageal cleft type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Clinical subtype,Laryngotracheoesophageal cleft type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Laryngotracheoesophageal cleft type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Clinical subtype,Laryngotracheoesophageal cleft type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Laryngotracheoesophageal cleft type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Laryngotracheoesophageal cleft type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Rare renal disease,,,,,,,,,,,,,
Category,Autoinflammatory syndrome,,,,,,,,,,,,,
Clinical subtype,Hemoglobin H disease,1-9 / 100 000,United States,409968,409968,25965,25965,en,Not yet validated,410294,410294,21167500[PMID]_22766612[PMID],8.7,8.7
Clinical subtype,Hemoglobin H disease,1-9 / 1 000 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,21167500[PMID]_[EXPERT],0.1,0.1
Clinical subtype,Hemoglobin H disease,>1 / 1000,South East Asia,409967,409967,25965,25965,en,Not yet validated,410294,410294,20301608[PMID]_ORPHANET,1200,1200
Category,Rare cause of hypertension,,,,,,,,,,,,,
Category,Rare renal tumor,,,,,,,,,,,,,
Clinical subtype,Dent disease type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Dent disease type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Pediatric Castleman disease,,,,,,,,,,,,,
Disease,Juvenile dermatomyositis,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,12794783[PMID]_7551657[PMID],0.295,0.295
Disease,Juvenile dermatomyositis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Unicentric Castleman disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29157611[PMID],0,0
Clinical subtype,Unicentric Castleman disease,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_25120049[PMID],0,0
Category,Rare developmental defect during embryogenesis,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,22939647[PMID],3.3,3.3
Category,Rare developmental defect during embryogenesis,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,22939647[PMID],2.42,2.42
Clinical subtype,Infantile nephronophthisis,,,,,,,,,,,,,
Clinical subtype,Juvenile nephronophthisis,,,,,,,,,,,,,
Category,Familial cystic renal disease,,,,,,,,,,,,,
Clinical subtype,Late-onset nephronophthisis,,,,,,,,,,,,,
Clinical subtype,Primary hyperoxaluria type 1,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,12543880[PMID],0.015,0.015
Clinical subtype,Primary hyperoxaluria type 1,1-9 / 1 000 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,12543880[PMID],0.29,0.29
Clinical subtype,Primary hyperoxaluria type 1,1-9 / 100 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,8808215[PMID],1,1
Clinical subtype,Primary hyperoxaluria type 1,1-9 / 1 000 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,8808215[PMID],0.2,0.2
Clinical subtype,Primary hyperoxaluria type 1,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.83,0.83
Clinical subtype,Primary hyperoxaluria type 1,1-9 / 1 000 000,France,409966,409966,25958,25958,en,Validated,410293,410293,8592622[PMID]_[EXPERT],0.1,0.1
Category,Nephropathy secondary to a storage or other metabolic disease,,,,,,,,,,,,,
Clinical subtype,Congenital thrombotic thrombocytopenic purpura,<1 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_19847791[PMID],0,0
Clinical subtype,Congenital thrombotic thrombocytopenic purpura,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0,0
Clinical subtype,Acquired thrombotic thrombocytopenic purpura,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Acquired thrombotic thrombocytopenic purpura,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,Atypical hemolytic uremic syndrome with anti-factor H antibodies,,,,,,,,,,,,,
Clinical subtype,Distal renal tubular acidosis with anemia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Autosomal dominant distal renal tubular acidosis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Autosomal recessive proximal renal tubular acidosis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Hematological disorder with renal involvement,,,,,,,,,,,,,
Etiological subtype,Cystinuria type B,,,,,,,,,,,,,
Etiological subtype,Cystinuria type A,,,,,,,,,,,,,
Etiological subtype,Xanthinuria type II,,,,,,,,,,,,,
Etiological subtype,Xanthinuria type I,,,,,,,,,,,,,
Clinical subtype,Primary hyperoxaluria type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23167815[PMID],50,50
Clinical subtype,Primary hyperoxaluria type 3,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Primary hyperoxaluria type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23167815[PMID],10,10
Clinical subtype,Primary hyperoxaluria type 2,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Nephrogenic syndrome of inappropriate antidiuresis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22722264[PMID]_[EXPERT],21,21
Disease,Nephrogenic syndrome of inappropriate antidiuresis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Classic Bartter syndrome,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Clinical subtype,Antenatal Bartter syndrome,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Rare renal tubular disease,,,,,,,,,,,,,
Morphological anomaly,Interventricular septum aneurysm,,,,,,,,,,,,,
Morphological anomaly,Laubry-Pezzi syndrome,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Coronary ostial stenosis or atresia,,,,,,,,,,,,,
Morphological anomaly,Abnormal number of coronary ostia,,,,,,,,,,,,,
Morphological anomaly,Malposition of a coronary ostium,,,,,,,,,,,,,
Morphological anomaly,Pulmonary artery hypoplasia,,,,,,,,,,,,,
Morphological anomaly,Peripheral pulmonary stenosis,,,,,,,,,,,,,
Morphological anomaly,Cervical aortic arch,,,,,,,,,,,,,
Morphological anomaly,Right aortic arch,,,,,,,,,,,,,
Morphological anomaly,Dysphagia lusoria,,,,,,,,,,,,,
Morphological anomaly,Persistent fifth aortic arch,,,,,,,,,,,,,
Morphological anomaly,Encircling double aortic arch,,,,,,,,,,,,,
Morphological anomaly,Neuhauser anomaly,,,,,,,,,,,,,
Morphological anomaly,Kommerell diverticulum,,,,,,,,,,,,,
Morphological anomaly,Congenital patent ductus arteriosus aneurysm,,,,,,,,,,,,,
Clinical subtype,Aorto-left ventricular tunnel,,,,,,,,,,,,,
Clinical subtype,Complete atrioventricular canal-tetralogy of Fallot syndrome,,,,,,,,,,,,,
Clinical subtype,Complete atrioventricular canal-ventricle hypoplasia syndrome,,,,,,,,,,,,,
Clinical subtype,Aorto-right ventricular tunnel,,,,,,,,,,,,,
Clinical subtype,Univentricular heart with single atrio-ventricular valve,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15531940[PMID],2,2
Clinical subtype,Univentricular heart with single atrio-ventricular valve,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Straddling and/or overriding mitral valve,,,,,,,,,,,,,
Malformation syndrome,Shone complex,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,DOI: 10.5530/jcdr.2016.3.8[OTHER],100,100
Malformation syndrome,Shone complex,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_DOI: 10.5530/jcdr.2016.3.8[OTHER],0,0
Clinical subtype,Complete atrioventricular canal-left heart obstruction syndrome,,,,,,,,,,,,,
Morphological anomaly,Congenital total pulmonary venous return anomaly,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,18657826[PMID],8,8
Morphological anomaly,Congenital total pulmonary venous return anomaly,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,12084585[PMID],9,9
Morphological anomaly,Inferior vena cava interruption without azygos continuation,,,,,,,,,,,,,
Morphological anomaly,Congenital partial pulmonary venous return anomaly,,,,,,,,,,,,,
Morphological anomaly,Azygos continuation of the inferior vena cava,,,,,,,,,,,,,
Morphological anomaly,Congenital stenosis of the inferior vena cava,,,,,,,,,,,,,
Morphological anomaly,Right inferior vena cava connecting to left-sided atrium,,,,,,,,,,,,,
Morphological anomaly,Persistent eustachian valve,,,,,,,,,,,,,
Morphological anomaly,Coronary sinus stenosis,,,,,,,,,,,,,
Morphological anomaly,Coronary sinus atresia,,,,,,,,,,,,,
Morphological anomaly,Subaortic course of innominate vein,,,,,,,,,,,,,
Morphological anomaly,Agenesis of the superior vena cava,,,,,,,,,,,,,
Morphological anomaly,Persistent left superior vena cava connecting to the roof of left-sided atrium,,,,,,,,,,,,,
Morphological anomaly,Absence of innominate vein,,,,,,,,,,,,,
Morphological anomaly,Right superior vena cava connecting to left-sided atrium,,,,,,,,,,,,,
Morphological anomaly,Persistent left superior vena cava connecting through coronary sinus to left-sided atrium,,,,,,,,,,,,,
Morphological anomaly,Atrial septal aneurysm,,,,,,,,,,,,,
Clinical subtype,"Atrial septal defect, ostium primum type",,,,,,,,,,,,,
Clinical subtype,"Atrial septal defect, sinus venosus type",,,,,,,,,,,,,
Clinical subtype,"Atrial septal defect, coronary sinus type",,,,,,,,,,,,,
Clinical subtype,"Atrial septal defect, ostium secundum type",,,,,,,,,,,,,
Morphological anomaly,Ectasia of the left atrial appendage,,,,,,,,,,,,,
Morphological anomaly,Ectasia of the right atrial appendage,,,,,,,,,,,,,
Morphological anomaly,Juxtaposition of the atrial appendages,,,,,,,,,,,,,
Morphological anomaly,Cor triatriatum sinister,,,,,,,,,,,,,
Morphological anomaly,Cor triatriatum dexter,,,,,,,,,,,,,
Morphological anomaly,Congenital Gerbode defect,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Multiple syringomas,,,,,,,,,,,,,
Disease,Acquired von Willebrand syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,300,300
Disease,Acquired von Willebrand syndrome,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,6-phosphogluconate dehydrogenase deficiency,,,,,,,,,,,,,
Disease,Hemolytic anemia due to erythrocyte adenosine deaminase overproduction,,,,,,,,,,,,,
Disease,Unstable hemoglobin disease,,,,,,,,,,,,,
Malformation syndrome,Microcephaly-cutis verticis gyrata-lymphedema syndrome,,,,,,,,,,,,,
Malformation syndrome,Lymphedema-posterior choanal atresia syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20826270[PMID] _DOI:10.1016/j.mgene.2017.07.006[OTHER],6,6
Malformation syndrome,Lymphedema-posterior choanal atresia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20826270[PMID],0,0
Morphological anomaly,Congenital partial agenesis of pericardium,,,,,,,,,,,,,
Morphological anomaly,Congenital complete agenesis of pericardium,,,,,,,,,,,,,
Morphological anomaly,Pleuro-pericardial cyst,,,,,,,,,,,,,
Malformation syndrome,"48,XYYY syndrome",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28137251[PMID],10,10
Malformation syndrome,"48,XYYY syndrome",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28137251[PMID],0,0
Malformation syndrome,"49,XYYYY syndrome",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28137251[PMID],8,8
Malformation syndrome,"49,XYYYY syndrome",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28137251[PMID],0,0
Etiological subtype,Mosaic monosomy X,,,,,,,,,,,,,
Malformation syndrome,Paternal uniparental disomy of chromosome 13,,,,,,,,,,,,,
Clinical subtype,Familial medullary thyroid carcinoma,,,,,,,,,,,,,
Morphological anomaly,Isolated distichiasis,,,,,,,,,,,,,
Morphological anomaly,Congenital eyelid retraction,,,,,,,,,,,,,
Etiological subtype,Monosomy X,,,,,,,,,,,,,
Malformation syndrome,Kandori fleck retina,,,,,,,,,,,,,
Morphological anomaly,Tarsal kink syndrome,,,,,,,,,,,,,
Morphological anomaly,Epiblepharon,,,,,,,,,,,,,
Morphological anomaly,Euryblepharon,,,,,,,,,,,,,
Morphological anomaly,Isolated congenital ectropion,,,,,,,,,,,,,
Morphological anomaly,Familial combined hyperlipoproteinemia,,,,,,,,,,,,,
Disease,"Primary dystonia, DYT2 type",Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Complete androgen insensitivity syndrome,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,ORPHANET,3,3
Disease,Complete androgen insensitivity syndrome,1-9 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_22698698[PMID],0.83,0.83
Disease,"Spondyloepimetaphyseal dysplasia, Handigodu type",Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7886470[PMID],0,0
Disease,"Spondyloepimetaphyseal dysplasia, Handigodu type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7886470[PMID],234,234
Clinical group,Pituitary adenoma,,,,,,,,,,,,,
Etiological subtype,Turner syndrome due to structural X chromosome anomalies,,,,,,,,,,,,,
Disease,Cheirospondyloenchondromatosis,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_20661403[PMID],0,0
Disease,Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Dermotrichic syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14708109[PMID],0,0
Malformation syndrome,Fried's tooth and nail syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,856958[PMID]_9450885[PMID],12,12
Malformation syndrome,Fried's tooth and nail syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_856958[PMID]_9450885[PMID],0,0
Disease,Leber plus disease,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0.04,0.04
Disease,Pituitary gigantism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_26187128[PMID],0,0
Disease,Mesial temporal lobe epilepsy with hippocampal sclerosis,,,,,,,,,,,,,
Disease,"Obesity, hyperphagia, and severe developmental delay due toTrkB gene deficiency",,,,,,,,,,,,,
Disease,Punctate acrokeratoderma freckle-like pigmentation,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8338755[PMID],7,7
Disease,Punctate acrokeratoderma freckle-like pigmentation,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8338755[PMID],0,0
Clinical subtype,Atypical progressive supranuclear palsy syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Disease,Kostmann syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23351985[PMID],45,45
Disease,Kostmann syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Pontiac fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.048,0.048
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.091,0.091
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.034,0.034
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.054,0.054
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.011,0.011
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.055,0.055
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.046,0.046
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.089,0.089
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.032,0.032
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.046,0.046
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.057,0.057
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.035,0.035
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.051,0.051
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.074,0.074
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.088,0.088
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.051,0.051
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.051,0.051
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.093,0.093
Clinical subtype,Embryonal rhabdomyosarcoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.053,0.053
Clinical subtype,Embryonal rhabdomyosarcoma,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.128,0.128
Clinical subtype,Embryonal rhabdomyosarcoma,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.126,0.126
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.018,0.018
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.054,0.054
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.03,0.03
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.017,0.017
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.009,0.009
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.002,0.002
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.033,0.033
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.085,0.085
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.062,0.062
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.005,0.005
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.021,0.021
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.063,0.063
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.035,0.035
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.029,0.029
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.044,0.044
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.027,0.027
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.045,0.045
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.036,0.036
Clinical subtype,Alveolar rhabdomyosarcoma,<1 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.039,0.039
Disease,Myotonia fluctuans,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Isolated sulfite oxidase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28933809[PMID],50,50
Clinical subtype,Isolated sulfite oxidase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28933809[PMID],0,0
Clinical subtype,Sulfite oxidase deficiency due to molybdenum cofactor deficiency,,,,,,,,,,,,,
Disease,Myotonia permanens,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acetazolamide-responsive myotonia,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,King-Denborough syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12738133[PMID]_18765655[PMID],18,18
Malformation syndrome,King-Denborough syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12738133[PMID]_18765655[PMID],0,0
Malformation syndrome,Amish lethal microcephaly,>1 / 1000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,12376931[PMID],200,200
Malformation syndrome,Amish lethal microcephaly,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301539[PMID],0,0
Category,Rare familial disorder with hypertrophic cardiomyopathy,,,,,,,,,,,,,
Disease,Typhoid,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,15298225[PMID]_[EXPERT]_World Health Organization[INST],3,3
Disease,Typhoid,>1 / 1000,South East Asia,409967,409967,25958,25958,en,Validated,410293,410293,15298225[PMID]_World Health Organization[INST],274,274
Disease,Typhoid,1-5 / 10 000,Latin America,409967,409967,25958,25958,en,Validated,410293,410293,15298225[PMID]_World Health Organization[INST],53,53
Disease,Typhoid,1-5 / 10 000,Africa,409967,409967,25958,25958,en,Validated,410293,410293,15298225[PMID]_World Health Organization[INST],50,50
Disease,Typhoid,1-9 / 1 000 000,North America,409967,409967,25958,25958,en,Validated,410293,410293,15298225[PMID]_World Health Organization[INST],0,0
Disease,Typhoid,1-5 / 10 000,Oceania,409967,409967,25958,25958,en,Validated,410293,410293,15298225[PMID]_World Health Organization[INST],15,15
Disease,Typhoid,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,Institut Pasteur[INST],0.2,0.2
Disease,Typhoid,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Familial focal epilepsy with variable foci,,,,,,,,,,,,,
Disease,Familial temporal lobe epilepsy,,,,,,,,,,,,,
Disease,Landau-Kleffner syndrome,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,23706409[PMID],0.4,0.4
Clinical subtype,"Benign childhood occipital epilepsy, Gastaut type",,,,,,,,,,,,,
Clinical subtype,"Benign childhood occipital epilepsy, Panayiotopoulos type",1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,DOI:10.1136/archdischild-2016-310863.98[OTHER],0.8,0.8
Clinical subtype,Hypohidrotic ectodermal dysplasia with immunodeficiency,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.2,0.2
Clinical subtype,Hypohidrotic ectodermal dysplasia with immunodeficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Paroxysmal exertion-induced dyskinesia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18577546[PMID],50,50
Disease,Paroxysmal exertion-induced dyskinesia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Paroxysmal non-kinesigenic dyskinesia,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,19289562[PMID]_[EXPERT],0.1,0.1
Disease,Paroxysmal kinesigenic dyskinesia,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20301633[PMID],0.6,0.6
Disease,Autosomal dominant dopa-responsive dystonia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Primary dystonia, DYT13 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9120448[PMID],0,0
Disease,"Primary dystonia, DYT13 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9120448[PMID],8,8
Disease,Primary mediastinal large B-cell lymphoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],5,5
Disease,Acute undifferentiated leukemia,,,,,,,,,,,,,
Disease,Acute myeloblastic leukemia without maturation,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Acute myeloblastic leukemia with maturation,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Acute myeloid leukemia with 11q23 abnormalities,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Acute myeloid leukemia with minimal differentiation,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.01,0.01
Disease,Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22),<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Unclassified myelodysplastic syndrome,,,,,,,,,,,,,
Disease,Unclassified myelodysplastic/myeloproliferative disease,,,,,,,,,,,,,
Disease,Refractory anemia,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Chronic myelomonocytic leukemia,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.29,0.29
Disease,Atypical chronic myeloid leukemia,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Desquamative interstitial pneumonia,,,,,,,,,,,,,
Disease,Mast cell leukemia,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mast cell leukemia,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Etiological subtype,Autosomal dominant Emery-Dreifuss muscular dystrophy,,,,,,,,,,,,,
Disease,Indolent systemic mastocytosis,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Aggressive systemic mastocytosis,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,0,0
Disease,Systemic mastocytosis with associated hematologic neoplasm,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Histopathological subtype,"Classic Hodgkin lymphoma, mixed cellularity type",1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.42,0.42
Histopathological subtype,"Classic Hodgkin lymphoma, nodular sclerosis type",1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.28,1.28
Histopathological subtype,"Classic Hodgkin lymphoma, lymphocyte-depleted type",<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.04,0.04
Histopathological subtype,"Classic Hodgkin lymphoma, lymphocyte-rich type",1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.1,0.1
Disease,Intravascular large B-cell lymphoma,,,,,,,,,,,,,
Disease,Lymphomatoid papulosis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Anaplastic large cell lymphoma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2011[INST],2,2
Disease,Southeast Asian ovalocytosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital dyserythropoietic anemia type I,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20665989[PMID]_[EXPERT],0,0
Disease,Congenital dyserythropoietic anemia type I,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital dyserythropoietic anemia type III,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23570799[PMID],60,60
Disease,Congenital dyserythropoietic anemia type III,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23570799[PMID],0,0
Etiological subtype,X-linked Emery-Dreifuss muscular dystrophy,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID],0.13,0.13
Etiological subtype,X-linked Emery-Dreifuss muscular dystrophy,1-9 / 100 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301609[PMID]_Association Française contre les Myopathies[Patient organisation],1,1
Etiological subtype,X-linked Emery-Dreifuss muscular dystrophy,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301609[PMID]_Association Française contre les Myopathies[Patient organisation],1,1
Etiological subtype,Autosomal recessive Emery-Dreifuss muscular dystrophy,,,,,,,,,,,,,
Disease,Charcot-Marie-Tooth disease type 2B1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Familial dysfibrinogenemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Familial afibrinogenemia,,,,,,,,,,,,,
Disease,Hemophilia B,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID]_European Medicines Agency 2018[INST],3,3
Disease,Hemophilia B,1-9 / 100 000,Albania,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1,1
Disease,Hemophilia B,1-9 / 1 000 000,Algeria,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.44,0.44
Disease,Hemophilia B,1-9 / 1 000 000,Argentina,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.54,0.54
Disease,Hemophilia B,1-9 / 1 000 000,Armenia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.2,0.2
Disease,Hemophilia B,1-9 / 1 000 000,Austria,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.665,0.665
Disease,Hemophilia B,1-9 / 1 000 000,Azerbaijan,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.16,0.16
Disease,Hemophilia B,<1 / 1 000 000,Bangladesh,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.015,0.015
Disease,Hemophilia B,1-9 / 1 000 000,Belarus,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.84,0.84
Disease,Hemophilia B,1-9 / 100 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.32,1.32
Disease,Hemophilia B,1-9 / 100 000,Belize,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.155,1.155
Disease,Hemophilia B,<1 / 1 000 000,Bolivia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.045,0.045
Disease,Hemophilia B,1-9 / 1 000 000,Bosnia and Herzegovina,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.265,0.265
Disease,Hemophilia B,1-9 / 1 000 000,Brazil,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.535,0.535
Disease,Hemophilia B,1-9 / 1 000 000,Bulgaria,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.775,0.775
Disease,Hemophilia B,1-9 / 1 000 000,Chile,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.795,0.795
Disease,Hemophilia B,1-9 / 1 000 000,Colombia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.405,0.405
Disease,Hemophilia B,1-9 / 1 000 000,Costa rica,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.645,0.645
Disease,Hemophilia B,1-9 / 100 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.625,1.625
Disease,Hemophilia B,1-9 / 1 000 000,Cuba,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.49,0.49
Disease,Hemophilia B,1-9 / 100 000,Cyprus,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],3.195,3.195
Disease,Hemophilia B,1-9 / 100 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.045,1.045
Disease,Hemophilia B,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.56,1.56
Disease,Hemophilia B,1-9 / 1 000 000,Dominican Republic,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.165,0.165
Disease,Hemophilia B,1-9 / 1 000 000,Ecuador,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.25,0.25
Disease,Hemophilia B,1-9 / 1 000 000,Egypt,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.955,0.955
Disease,Hemophilia B,1-9 / 1 000 000,El Salvador,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.31,0.31
Disease,Hemophilia B,<1 / 1 000 000,Eritrea,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.065,0.065
Disease,Hemophilia B,1-9 / 1 000 000,Estonia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.24,0.24
Disease,Hemophilia B,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.235,1.235
Disease,Hemophilia B,1-9 / 1 000 000,Georgia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.5,0.5
Disease,Hemophilia B,1-9 / 1 000 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.885,0.885
Disease,Hemophilia B,1-9 / 100 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.075,1.075
Disease,Hemophilia B,<1 / 1 000 000,Guatemala,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.075,0.075
Disease,Hemophilia B,1-9 / 1 000 000,Honduras,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.17,0.17
Disease,Hemophilia B,1-9 / 100 000,Hungary,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],2.115,2.115
Disease,Hemophilia B,1-9 / 1 000 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.695,0.695
Disease,Hemophilia B,<1 / 1 000 000,India,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.095,0.095
Disease,Hemophilia B,<1 / 1 000 000,Indonesia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.01,0.01
Disease,Hemophilia B,1-9 / 1 000 000,"Iran, Islamic Republic of",409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.98,0.98
Disease,Hemophilia B,1-9 / 1 000 000,Iraq,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.545,0.545
Disease,Hemophilia B,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.06,1.06
Disease,Hemophilia B,1-9 / 1 000 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.495,0.495
Disease,Hemophilia B,1-9 / 1 000 000,Latvia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.76,0.76
Disease,Hemophilia B,1-9 / 1 000 000,Lithuania,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.57,0.57
Disease,Hemophilia B,1-9 / 1 000 000,Luxembourg,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.235,0.235
Disease,Hemophilia B,1-9 / 100 000,"Macedonia, the former Yugoslav Republic of",409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],3.205,3.205
Disease,Hemophilia B,1-9 / 1 000 000,Malaysia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.5,0.5
Disease,Hemophilia B,1-9 / 1 000 000,Malta,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.77,0.77
Disease,Hemophilia B,1-9 / 1 000 000,Mexico,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.29,0.29
Disease,Hemophilia B,1-9 / 1 000 000,"Moldova, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.37,0.37
Disease,Hemophilia B,1-9 / 1 000 000,Mongolia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.15,0.15
Disease,Hemophilia B,1-9 / 1 000 000,Morocco,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.2,0.2
Disease,Hemophilia B,<1 / 1 000 000,Nepal,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.065,0.065
Disease,Hemophilia B,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.035,1.035
Disease,Hemophilia B,1-9 / 100 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.855,1.855
Disease,Hemophilia B,<1 / 1 000 000,Nigeria,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.005,0.005
Disease,Hemophilia B,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.975,1.975
Disease,Hemophilia B,1-9 / 1 000 000,Pakistan,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.24,0.24
Disease,Hemophilia B,1-9 / 1 000 000,"Palestinian Territory, occupied",409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.84,0.84
Disease,Hemophilia B,1-9 / 1 000 000,Peru,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.24,0.24
Disease,Hemophilia B,1-9 / 1 000 000,Philippines,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.1,0.1
Disease,Hemophilia B,1-9 / 1 000 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.85,0.85
Disease,Hemophilia B,1-9 / 1 000 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.93,0.93
Disease,Hemophilia B,1-9 / 100 000,Qatar,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],2.265,2.265
Disease,Hemophilia B,1-9 / 1 000 000,Russian Federation,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.73,0.73
Disease,Hemophilia B,1-9 / 1 000 000,Saudi Arabia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.15,0.15
Disease,Hemophilia B,<1 / 1 000 000,Senegal,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.04,0.04
Disease,Hemophilia B,1-9 / 1 000 000,Serbia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.715,0.715
Disease,Hemophilia B,<1 / 1 000 000,Sierra leone,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.045,0.045
Disease,Hemophilia B,1-9 / 1 000 000,Singapore,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.545,0.545
Disease,Hemophilia B,1-9 / 1 000 000,Israel,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.995,0.995
Disease,Hemophilia B,1-9 / 1 000 000,Jamaica,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.32,0.32
Disease,Hemophilia B,1-9 / 1 000 000,Jordan,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.745,0.745
Disease,Hemophilia B,1-9 / 1 000 000,Kenya,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.13,0.13
Disease,Hemophilia B,1-9 / 1 000 000,Lebanon,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.33,0.33
Disease,Hemophilia B,1-9 / 1 000 000,Nicaragua,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.33,0.33
Disease,Hemophilia B,1-9 / 1 000 000,Panama,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.585,0.585
Disease,Hemophilia B,1-9 / 1 000 000,Paraguay,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.375,0.375
Disease,Hemophilia B,1-9 / 1 000 000,Romania,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.76,0.76
Disease,Hemophilia B,1-9 / 100 000,Slovakia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.28,1.28
Disease,Hemophilia B,1-9 / 1 000 000,Slovenia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.82,0.82
Disease,Hemophilia B,1-9 / 1 000 000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.525,0.525
Disease,Hemophilia B,1-9 / 1 000 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.765,0.765
Disease,Hemophilia B,<1 / 1 000 000,Sri Lanka,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.065,0.065
Disease,Hemophilia B,1-9 / 1 000 000,Sudan,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.115,0.115
Disease,Hemophilia B,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.85,1.85
Disease,Hemophilia B,1-9 / 100 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.375,1.375
Disease,Hemophilia B,<1 / 1 000 000,Thailand,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.085,0.085
Disease,Hemophilia B,<1 / 1 000 000,Togo,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.02,0.02
Disease,Hemophilia B,1-9 / 1 000 000,Tunisia,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.37,0.37
Disease,Hemophilia B,1-9 / 1 000 000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.31,0.31
Disease,Hemophilia B,<1 / 1 000 000,Ukraine,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.01,0.01
Disease,Hemophilia B,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],2.08,2.08
Disease,Hemophilia B,1-9 / 1 000 000,Uruguay,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.36,0.36
Disease,Hemophilia B,1-9 / 1 000 000,Uzbekistan,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.285,0.285
Disease,Hemophilia B,1-9 / 100 000,Venezuela,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],1.18,1.18
Disease,Hemophilia B,1-9 / 1 000 000,Viet Nam,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.14,0.14
Disease,Hemophilia B,1-9 / 1 000 000,Zimbabwe,409966,409966,25958,25958,en,Validated,410293,410293,21649801[PMID],0.35,0.35
Disease,Hemophilia B,1-9 / 100 000,Worldwide,409968,409968,25958,25958,en,Validated,410293,410293,20301668[PMID],1.665,1.665
Etiological subtype,Bleeding diathesis due to integrin alpha2-beta1 deficiency,,,,,,,,,,,,,
Etiological subtype,Bleeding diathesis due to glycoprotein VI deficiency,,,,,,,,,,,,,
Disease,Congenital dyserythropoietic anemia type II,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,20665989[PMID],0,0
Disease,Adult pure red cell aplasia,,,,,,,,,,,,,
Disease,Transient erythroblastopenia of childhood,,,,,,,,,,,,,
Disease,Hemophilia A,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,19845775[PMID]_ORPHANET,4.85,4.85
Disease,Hemophilia A,1-5 / 10 000,Worldwide,409968,409968,25965,25965,en,Not yet validated,410294,410294,20301578[PMID]_ORPHANET,11.25,11.25
Disease,Hemophilia A,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6.1,6.1
Disease,Hemophilia A,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,20301578[PMID]_19845775[PMID]_ ORPHANET,7,7
Disease,Hemophilia A,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],8,8
Disease,Hemophilia A,1-9 / 100 000,Africa,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID]_ORPHANET,1.58,1.58
Disease,Hemophilia A,1-9 / 100 000,Albania,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],7.6,7.6
Disease,Hemophilia A,1-9 / 100 000,Algeria,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.8,2.8
Disease,Hemophilia A,1-9 / 100 000,Argentina,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.5,4.5
Disease,Hemophilia A,1-9 / 100 000,Armenia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],5,5
Disease,Hemophilia A,1-9 / 100 000,Australia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6.8,6.8
Disease,Hemophilia A,1-9 / 100 000,Austria,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.3,4.3
Disease,Hemophilia A,1-9 / 100 000,Azerbaijan,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],8,8
Disease,Hemophilia A,1-9 / 1 000 000,Bangladesh,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.2,0.2
Disease,Hemophilia A,1-9 / 100 000,Belarus,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],5.1,5.1
Disease,Hemophilia A,1-9 / 100 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6,6
Disease,Hemophilia A,1-9 / 100 000,Belize,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.2,2.2
Disease,Hemophilia A,1-9 / 1 000 000,Bolivia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.1,0.1
Disease,Hemophilia A,1-9 / 100 000,Bosnia and Herzegovina,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.6,2.6
Disease,Hemophilia A,1-9 / 100 000,Brazil,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.7,3.7
Disease,Hemophilia A,1-9 / 100 000,Bulgaria,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6.8,6.8
Disease,Hemophilia A,1-9 / 100 000,Canada,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],7.3,7.3
Disease,Hemophilia A,1-9 / 100 000,Chile,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],5.3,5.3
Disease,Hemophilia A,1-9 / 1 000 000,China,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.2,0.2
Disease,Hemophilia A,1-9 / 100 000,Colombia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.6,2.6
Disease,Hemophilia A,1-9 / 100 000,Costa rica,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3,3
Disease,Hemophilia A,1-9 / 100 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],8.5,8.5
Disease,Hemophilia A,1-9 / 100 000,Cuba,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.7,2.7
Disease,Hemophilia A,1-9 / 100 000,Cyprus,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],5.2,5.2
Disease,Hemophilia A,1-9 / 100 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6.1,6.1
Disease,Hemophilia A,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6.2,6.2
Disease,Hemophilia A,1-9 / 100 000,Dominican Republic,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1.8,1.8
Disease,Hemophilia A,1-9 / 100 000,Ecuador,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.5,2.5
Disease,Hemophilia A,1-9 / 100 000,Egypt,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.4,4.4
Disease,Hemophilia A,1-9 / 100 000,El Salvador,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3,3
Disease,Hemophilia A,1-9 / 1 000 000,Eritrea,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.7,0.7
Disease,Hemophilia A,1-9 / 100 000,Estonia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.8,2.8
Disease,Hemophilia A,1-9 / 100 000,Finland,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.6,4.6
Disease,Hemophilia A,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],5,5
Disease,Hemophilia A,1-9 / 100 000,Greece,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6.5,6.5
Disease,Hemophilia A,1-9 / 100 000,Guatemala,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1,1
Disease,Hemophilia A,1-9 / 100 000,Honduras,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.6,2.6
Disease,Hemophilia A,1-9 / 100 000,Hungary,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],8.3,8.3
Disease,Hemophilia A,1-5 / 10 000,Iceland,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],19.3,19.3
Disease,Hemophilia A,1-9 / 1 000 000,India,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.7,0.7
Disease,Hemophilia A,1-9 / 1 000 000,Indonesia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.1,0.1
Disease,Hemophilia A,1-9 / 100 000,"Iran, Islamic Republic of",409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],5.6,5.6
Disease,Hemophilia A,1-9 / 100 000,Iraq,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1.8,1.8
Disease,Hemophilia A,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],9.2,9.2
Disease,Hemophilia A,1-9 / 100 000,Israel,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],5.4,5.4
Disease,Hemophilia A,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.7,4.7
Disease,Hemophilia A,1-9 / 100 000,Jamaica,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.6,3.6
Disease,Hemophilia A,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.3,3.3
Disease,Hemophilia A,1-9 / 100 000,Jordan,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.5,3.5
Disease,Hemophilia A,1-9 / 100 000,Kenya,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1.1,1.1
Disease,Hemophilia A,1-9 / 100 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3,3
Disease,Hemophilia A,1-9 / 100 000,Latvia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.9,4.9
Disease,Hemophilia A,1-9 / 100 000,Lebanon,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1.5,1.5
Disease,Hemophilia A,1-9 / 1 000 000,Lesotho,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.7,0.7
Disease,Hemophilia A,1-9 / 100 000,Lithuania,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.1,4.1
Disease,Hemophilia A,1-9 / 100 000,Luxembourg,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],5.4,5.4
Disease,Hemophilia A,1-9 / 100 000,"Macedonia, the former Yugoslav Republic of",409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],8.1,8.1
Disease,Hemophilia A,1-9 / 100 000,Malaysia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.3,3.3
Disease,Hemophilia A,1-9 / 100 000,Malta,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.3,3.3
Disease,Hemophilia A,1-9 / 100 000,Mexico,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.2,2.2
Disease,Hemophilia A,1-9 / 100 000,"Moldova, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.7,4.7
Disease,Hemophilia A,1-9 / 100 000,Mongolia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1.4,1.4
Disease,Hemophilia A,1-9 / 100 000,Morocco,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1,1
Disease,Hemophilia A,1-9 / 1 000 000,Nepal,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.6,0.6
Disease,Hemophilia A,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],9.3,9.3
Disease,Hemophilia A,1-5 / 10 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],11,11
Disease,Hemophilia A,1-9 / 100 000,Nicaragua,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.7,3.7
Disease,Hemophilia A,<1 / 1 000 000,Nigeria,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.025,0.025
Disease,Hemophilia A,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6.1,6.1
Disease,Hemophilia A,1-9 / 1 000 000,Pakistan,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.8,0.8
Disease,Hemophilia A,1-9 / 100 000,"Palestinian Territory, occupied",409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.7,2.7
Disease,Hemophilia A,1-9 / 100 000,Panama,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6.6,6.6
Disease,Hemophilia A,1-9 / 100 000,Paraguay,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1.2,1.2
Disease,Hemophilia A,1-9 / 100 000,Peru,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1.6,1.6
Disease,Hemophilia A,1-9 / 1 000 000,Philippines,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.9,0.9
Disease,Hemophilia A,1-9 / 100 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],5.6,5.6
Disease,Hemophilia A,1-9 / 100 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.9,4.9
Disease,Hemophilia A,1-9 / 100 000,Qatar,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],7.9,7.9
Disease,Hemophilia A,1-9 / 100 000,Romania,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],6.4,6.4
Disease,Hemophilia A,1-9 / 100 000,Russian Federation,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.3,3.3
Disease,Hemophilia A,1-9 / 1 000 000,Saudi Arabia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.5,0.5
Disease,Hemophilia A,1-9 / 1 000 000,Senegal,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.8,0.8
Disease,Hemophilia A,1-9 / 100 000,Serbia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.7,3.7
Disease,Hemophilia A,1-9 / 1 000 000,Sierra leone,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.1,0.1
Disease,Hemophilia A,1-9 / 100 000,Singapore,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4,4
Disease,Hemophilia A,1-9 / 100 000,Slovakia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],8.6,8.6
Disease,Hemophilia A,1-9 / 100 000,Slovenia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],8.2,8.2
Disease,Hemophilia A,1-9 / 100 000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3,3
Disease,Hemophilia A,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.8,3.8
Disease,Hemophilia A,1-9 / 1 000 000,Sri Lanka,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.6,0.6
Disease,Hemophilia A,1-9 / 1 000 000,Sudan,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.85,0.85
Disease,Hemophilia A,1-9 / 100 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],7.7,7.7
Disease,Hemophilia A,1-9 / 100 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],7.1,7.1
Disease,Hemophilia A,1-9 / 100 000,Thailand,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1.8,1.8
Disease,Hemophilia A,<1 / 1 000 000,Togo,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.02,0.02
Disease,Hemophilia A,1-9 / 100 000,Tunisia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.2,2.2
Disease,Hemophilia A,1-9 / 100 000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.1,3.1
Disease,Hemophilia A,1-9 / 1 000 000,Ukraine,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],0.35,0.35
Disease,Hemophilia A,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],10.4,10.4
Disease,Hemophilia A,1-9 / 100 000,Uruguay,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.9,4.9
Disease,Hemophilia A,1-9 / 100 000,Uzbekistan,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],3.8,3.8
Disease,Hemophilia A,1-9 / 100 000,Venezuela,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.9,4.9
Disease,Hemophilia A,1-9 / 100 000,Viet Nam,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],1,1
Disease,Hemophilia A,1-9 / 100 000,Zimbabwe,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],2.3,2.3
Disease,Hemophilia A,1-9 / 100 000,Georgia,409966,409966,25958,25958,en,Validated,410293,410293,19845775[PMID],4.4,4.4
Disease,Oculopharyngodistal myopathy,,,,,,,,,,,,,
Disease,Becker muscular dystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],2,2
Disease,Becker muscular dystrophy,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,1673177[PMID],2.7,2.7
Disease,Becker muscular dystrophy,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID]_24780148[PMID]_ORPHANET,3.64,3.64
Disease,Becker muscular dystrophy,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,12495984[PMID],2.5,2.5
Disease,Becker muscular dystrophy,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,emedicine[OTHER],2.4,2.4
Disease,Becker muscular dystrophy,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],2.2,2.2
Disease,Becker muscular dystrophy,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,24780148[PMID],1.53,1.53
Disease,Becker muscular dystrophy,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,10466417[PMID]_24780148[PMID],2.47,2.47
Disease,Becker muscular dystrophy,1-9 / 100 000,Egypt,409966,409966,25958,25958,en,Validated,410293,410293,16210862[PMID]_24780148[PMID],3.94,3.94
Disease,Becker muscular dystrophy,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,1745328[PMID]_24780148[PMID]_ORPHANET,0.91,0.91
Disease,Becker muscular dystrophy,<1 / 1 000 000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,7825085[PMID]_24780148[PMID]_ORPHANET,0.07,0.07
Disease,Becker muscular dystrophy,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,8845721[PMID]_24780148[PMID],1.59,1.59
Disease,Becker muscular dystrophy,1-9 / 100 000,Puerto rico,409966,409966,25958,25958,en,Validated,410293,410293,DOI:10.3233/JND-160147[OTHER],1.42,1.42
Disease,Duchenne muscular dystrophy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],5,5
Disease,Duchenne muscular dystrophy,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,19767415[PMID]_24780148[PMID]_ORPHANET,4.14,4.14
Disease,Duchenne muscular dystrophy,1-5 / 10 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],15.1,15.1
Disease,Duchenne muscular dystrophy,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,12495984[PMID],14,14
Disease,Duchenne muscular dystrophy,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,1733827[PMID],12,12
Disease,Duchenne muscular dystrophy,1-5 / 10 000,Canada,409968,409968,25958,25958,en,Validated,410293,410293,20080524[PMID],10.5,10.5
Disease,Duchenne muscular dystrophy,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,23340516[PMID],9.7,9.7
Disease,Duchenne muscular dystrophy,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,8845721[PMID]_24780148[PMID],8.2,8.2
Disease,Duchenne muscular dystrophy,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,10466417[PMID]_24780148[PMID],1.7,1.7
Disease,Duchenne muscular dystrophy,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,8845721[PMID]_24780148[PMID],4.26,4.26
Disease,Duchenne muscular dystrophy,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,24780148[PMID],4.78,4.78
Disease,Duchenne muscular dystrophy,1-9 / 100 000,Egypt,409969,409969,25958,25958,en,Validated,410293,410293,16210862[PMID]_24780148[PMID],7.66,7.66
Disease,Duchenne muscular dystrophy,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,1745328[PMID]_24780148[PMID]_ORPHANET,3.56,3.56
Disease,Duchenne muscular dystrophy,1-9 / 1 000 000,South Africa,409966,409966,25958,25958,en,Validated,410293,410293,7825085[PMID]_24780148[PMID]_ORPHANET,0.47,0.47
Disease,Duchenne muscular dystrophy,1-9 / 100 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,14678803[PMID]_24780148[PMID]_ORPHANET,2.75,2.75
Disease,Duchenne muscular dystrophy,1-9 / 100 000,Puerto rico,409966,409966,25958,25958,en,Validated,410293,410293,DOI:10.3233/JND-160147[OTHER],2.59,2.59
Disease,Amish nemaline myopathy,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Amish nemaline myopathy,>1 / 1000,Specific population,409968,409968,25958,25958,en,Validated,410293,410293,10952871[PMID],200,200
Clinical subtype,Bilateral perisylvian polymicrogyria,,,,,,,,,,,,,
Disease,Early-onset X-linked optic atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16969871[PMID],4,4
Disease,Early-onset X-linked optic atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16969871[PMID],0,0
Clinical group,X-linked complex spastic paraplegia,,,,,,,,,,,,,
Disease,Congenital muscular dystrophy type 1B,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10677302[PMID],6,6
Disease,Congenital muscular dystrophy type 1B,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10677302[PMID],0,0
Clinical subtype,Periventricular nodular heterotopia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,"Late-onset distal myopathy, Markesbery-Griggs type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15668942[PMID],0,0
Disease,"Late-onset distal myopathy, Markesbery-Griggs type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15668942[PMID],11,11
Disease,Distal myotilinopathy,,,,,,,,,,,,,
Etiological subtype,Presynaptic congenital myasthenic syndromes,,,,,,,,,,,,,
Etiological subtype,Postsynaptic congenital myasthenic syndromes,,,,,,,,,,,,,
Disease,Acute inflammatory demyelinating polyradiculoneuropathy,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT]_European Medicines Agency[INST],3.1,3.1
Etiological subtype,Synaptic congenital myasthenic syndromes,,,,,,,,,,,,,
Disease,Acute motor axonal neuropathy,,,,,,,,,,,,,
Disease,Acute motor and sensory axonal neuropathy,,,,,,,,,,,,,
Disease,Congenital myopathy with excess of thin filaments,,,,,,,,,,,,,
Clinical subtype,Congenital multicore myopathy with external ophthalmoplegia,,,,,,,,,,,,,
Disease,Neutral lipid storage myopathy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26600210[PMID]_28499397[PMID],36,36
Disease,Neutral lipid storage myopathy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26600210[PMID]_28499397[PMID],0,0
Disease,Neutral lipid storage disease with ichthyosis,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Alpha-crystallinopathy,,,,,,,,,,,,,
Disease,Desminopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,"Multiple system atrophy, parkinsonian type",1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,2.4,2.4
Disease,Huntington disease-like 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301701[PMID]_[EXPERT],50,50
Disease,Huntington disease-like 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Miller Fisher syndrome,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Disease,Miller Fisher syndrome,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spinal muscular atrophy with respiratory distress type 1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26709713[PMID],128,128
Disease,Spinal muscular atrophy with respiratory distress type 1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26709713[PMID],0,0
Morphological anomaly,Blake pouch cyst,,,,,,,,,,,,,
Morphological anomaly,Coloboma of choroid and retina,,,,,,,,,,,,,
Malformation syndrome,Colobomatous microphthalmia,1-5 / 10 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,11826019[PMID],19,19
Clinical subtype,Complete cryptophthalmia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16352480[PMID],0,0
Clinical subtype,Complete cryptophthalmia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16352480[PMID],15,15
Clinical subtype,Partial cryptophthalmia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3099574[PMID],0,0
Morphological anomaly,Coloboma of optic disc,,,,,,,,,,,,,
Clinical subtype,Congenital symblepharon,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3099574[PMID],0,0
Morphological anomaly,Coloboma of macula,,,,,,,,,,,,,
Morphological anomaly,Coloboma of eyelid,,,,,,,,,,,,,
Morphological anomaly,Coloboma of eye lens,,,,,,,,,,,,,
Morphological anomaly,Coloboma of iris,,,,,,,,,,,,,
Disease,Climatic droplet keratopathy,,,,,,,,,,,,,
Disease,Gelatinous drop-like corneal dystrophy,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.33,0.33
Disease,Gelatinous drop-like corneal dystrophy,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Epithelial basement membrane dystrophy,,,,,,,,,,,,,
Disease,Lisch epithelial corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,36,36
Disease,Lisch epithelial corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Meesmann corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,250,250
Disease,Meesmann corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Inverse Marcus-Gunn phenomenon,,,,,,,,,,,,,
Disease,Lattice corneal dystrophy type I,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Granular corneal dystrophy type II,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Granular corneal dystrophy type I,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Reis-Bücklers corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,81,81
Disease,Reis-Bücklers corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Thiel-Behnke corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,173,173
Disease,Thiel-Behnke corneal dystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Subepithelial mucinous corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8352693[PMID]_[EXPERT],1,1
Disease,Subepithelial mucinous corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Posterior amorphous corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,301356[PMID]_2314832[PMID]_1582220[PMID]_7573302[PMID]_8600425[PMID]_17273695[PMID]_17300585[PMID]_11862100[PMID],11,11
Disease,Posterior amorphous corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Central cloudy dystrophy of François,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,5305046[PMID]_1083619[PMID]_15734014[PMID]_15534129[PMID]_9258229[PMID]_8776559[PMID]_20337272[PMID],24,24
Disease,Central cloudy dystrophy of François,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Posterior polymorphous corneal dystrophy,1-9 / 100 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,23049806[PMID],1,1
Disease,Posterior polymorphous corneal dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fuchs endothelial corneal dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Schnyder corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19398911[PMID],115,115
Disease,Schnyder corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Macular corneal dystrophy,1-9 / 100 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,21791583[PMID],1,1
Disease,Macular corneal dystrophy,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Fleck corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,139144[PMID]_7950337[PMID]_141212[PMID]_14078376[PMID]_10660318[PMID]_19948560[PMID]_22065932[PMID],30,30
Disease,Fleck corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Chandler syndrome,,,,,,,,,,,,,
Clinical subtype,Cogan-Reese syndrome,,,,,,,,,,,,,
Clinical subtype,Essential iris atrophy,,,,,,,,,,,,,
Disease,Congenital hereditary endothelial dystrophy type I,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,68,68
Disease,Congenital hereditary endothelial dystrophy type I,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Congenital glaucoma,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.6,3.6
Disease,Congenital glaucoma,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.8,5.8
Disease,Congenital glaucoma,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.9,5.9
Disease,Congenital glaucoma,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],4.4,4.4
Disease,Congenital glaucoma,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],2.8,2.8
Disease,Congenital glaucoma,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.8,5.8
Disease,Congenital glaucoma,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],1.6,1.6
Disease,Congenital glaucoma,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],4.7,4.7
Disease,Congenital glaucoma,1-9 / 100 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.3,1.3
Disease,Congenital glaucoma,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],2.3,2.3
Disease,Congenital glaucoma,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.2,3.2
Disease,Congenital glaucoma,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Juvenile glaucoma,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,18214788[PMID],2,2
Morphological anomaly,Axenfeld anomaly,,,,,,,,,,,,,
Clinical subtype,Early-onset anterior polar cataract,,,,,,,,,,,,,
Clinical subtype,Coralliform cataract,,,,,,,,,,,,,
Clinical subtype,Cerulean cataract,,,,,,,,,,,,,
Clinical subtype,Pulverulent cataract,,,,,,,,,,,,,
Clinical subtype,Early-onset sutural cataract,,,,,,,,,,,,,
Clinical subtype,Early-onset zonular cataract,,,,,,,,,,,,,
Clinical subtype,Early-onset partial cataract,,,,,,,,,,,,,
Clinical subtype,Early-onset nuclear cataract,,,,,,,,,,,,,
Clinical subtype,Total early-onset cataract,,,,,,,,,,,,,
Clinical subtype,Early-onset posterior polar cataract,,,,,,,,,,,,,
Disease,Butterfly-shaped pigment dystrophy,,,,,,,,,,,,,
Disease,Reticular dystrophy of the retinal pigment epithelium,,,,,,,,,,,,,
Disease,Adult-onset foveomacular vitelliform dystrophy,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Multifocal pattern dystrophy simulating fundus flavimaculatus,,,,,,,,,,,,,
Disease,Fundus pulverulentus,,,,,,,,,,,,,
Disease,Spastic paraplegia type 7,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,20301286[PMID],4,4
Disease,X-linked Charcot-Marie-Tooth disease type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_17701900[PMID]_20301731[PMID],0,0
Disease,X-linked Charcot-Marie-Tooth disease type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,17701900[PMID]_20301731[PMID],9,9
Disease,Spastic paraplegia type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,100,100
Disease,Spastic paraplegia type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Adult-onset autosomal dominant leukodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Adult-onset autosomal dominant leukodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Congenitally uncorrected transposition of the great arteries with coarctation,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Double outlet right ventricle with subaortic or doubly committed ventricular septal defect with pulmonary stenosis,,,,,,,,,,,,,
Clinical subtype,Double outlet right ventricle with subpulmonary ventricular septal defect,,,,,,,,,,,,,
Clinical subtype,Double outlet right ventricle with non-committed subpulmonary ventricular septal defect,,,,,,,,,,,,,
Malformation syndrome,Pulmonary valve agenesis-intact ventricular septum-persistent ductus arteriosus syndrome,,,,,,,,,,,,,
Morphological anomaly,Abnormal origin of right or left pulmonary artery from the aorta,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24182510[PMID],200,200
Morphological anomaly,Abnormal origin of right or left pulmonary artery from the aorta,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0,0
Morphological anomaly,Pulmonary artery coming from patent ductus arteriosus,,,,,,,,,,,,,
Clinical subtype,Discrete fibromuscular subaortic stenosis,,,,,,,,,,,,,
Clinical subtype,Discrete fixed membranous subaortic stenosis,,,,,,,,,,,,,
Clinical subtype,Valvular pulmonary stenosis,,,,,,,,,,,,,
Clinical subtype,Tunnel subaortic stenosis,,,,,,,,,,,,,
Morphological anomaly,Parachute tricuspid valve,,,,,,,,,,,,,
Morphological anomaly,Congenital anomaly of the tricuspid valve chordae,,,,,,,,,,,,,
Morphological anomaly,Hypoplasia of the mitral valve annulus,,,,,,,,,,,,,
Morphological anomaly,Congenital mitral stenosis,,,,,,,,,,,,,
Morphological anomaly,Congenital unguarded mitral orifice,,,,,,,,,,,,,
Morphological anomaly,Congenital supravalvular mitral ring,,,,,,,,,,,,,
Morphological anomaly,Mitral valve agenesis,,,,,,,,,,,,,
Morphological anomaly,Accessory mitral valve tissue,,,,,,,,,,,,,
Category,EEC syndrome and related disorders,,,,,,,,,,,,,
Category,Rare disorder with conjunctival involvement as a major feature,,,,,,,,,,,,,
Category,Rare disorder of the lacrimal apparatus,,,,,,,,,,,,,
Category,Lacrimal drainage system anomaly,,,,,,,,,,,,,
Malformation syndrome,Syndromic orbital border hypoplasia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14359373[PMID],2,2
Malformation syndrome,Syndromic orbital border hypoplasia,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14359373[PMID],0,0
Category,Congenital alacrima,,,,,,,,,,,,,
Category,Rare eyebrow/eyelash disorder,,,,,,,,,,,,,
Disease,Neurogenic palpebral tumor,,,,,,,,,,,,,
Category,Syndromic telecanthus,,,,,,,,,,,,,
Category,Syndromic outer canthal malposition,,,,,,,,,,,,,
Category,Rare disorder with ptosis,,,,,,,,,,,,,
Category,Rare eyelid malposition disorder,,,,,,,,,,,,,
Category,Congenital ectropion,,,,,,,,,,,,,
Category,Secondary ectropion,,,,,,,,,,,,,
Category,Syndromic epicanthus,,,,,,,,,,,,,
Category,Rare palpebral disorder,,,,,,,,,,,,,
Category,Cryptophthalmia,,,,,,,,,,,,,
Category,Congenital malformation of the eyelid,,,,,,,,,,,,,
Category,Eyelid border anomaly,,,,,,,,,,,,,
Clinical group,Microblepharon-ablephara syndrome,,,,,,,,,,,,,
Category,Syndromic eyelid coloboma,,,,,,,,,,,,,
Category,Syndromic ankyloblepharon filiforme adnatum,,,,,,,,,,,,,
Category,Developmental defect of the eye,,,,,,,,,,,,,
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],8.3,8.3
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],2.9,2.9
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Belgium,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Austria,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],9.8,9.8
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Austria,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],36.4,36.4
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],7.3,7.3
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,France,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],5.8,5.8
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],17.7,17.7
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Hungary,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.6,3.6
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],11,11
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005[REG],25.9,25.9
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Malta,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2005[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],11.1,11.1
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],6.4,6.4
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],2.4,2.4
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Croatia,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],13.1,13.1
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Croatia,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],14.4,14.4
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],12.3,12.3
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Switzerland,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.9,3.9
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],12.9,12.9
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,Ukraine,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Portugal,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],5.2,5.2
Category,Microphthalmia-anophthalmia-coloboma,1-9 / 100 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2008[REG],0,0
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,8921488[PMID]_8179669[PMID]_16007635[PMID]_Center for Diseases Control and Prevention 2004-2006[INST],18,18
Category,Microphthalmia-anophthalmia-coloboma,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,8921488[PMID]_8179669[PMID]_16007635[PMID]_Center for Diseases Control and Prevention 2004-2006[INST],0,0
Category,Syndromic aniridia,,,,,,,,,,,,,
Disease,Autosomal recessive isolated optic atrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,14508503[PMID],5,5
Disease,Autosomal recessive isolated optic atrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_14508503[PMID],0,0
Disease,"Autosomal dominant optic atrophy, classic form",1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET_20301426[PMID],2,2
Disease,"Autosomal dominant optic atrophy, classic form",1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,8689476[PMID],10,10
Disease,"Autosomal dominant optic atrophy, classic form",1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,20417570[PMID],2.86,2.86
Disease,"Autosomal dominant optic atrophy, classic form",6-9 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,21745197[PMID],83.33,83.33
Category,Hereditary optic neuropathy,,,,,,,,,,,,,
Clinical group,Autosomal dominant optic atrophy,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,22776096[PMID],10,10
Clinical group,Autosomal dominant optic atrophy,1-9 / 100 000,United Kingdom,409966,409966,25965,25965,en,Not yet validated,410294,410294,20417570[PMID]_ORPHANET,2.5,2.5
Clinical group,Autosomal dominant optic atrophy,1-9 / 100 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,22776096[PMID],3.3,3.3
Clinical group,Autosomal dominant optic atrophy,6-9 / 10 000,Specific population,409966,409966,25958,25958,en,Validated,410293,410293,21745197[PMID],83,83
Category,Vitreoretinopathy,,,,,,,,,,,,,
Category,Syndromic rod-cone dystrophy,,,,,,,,,,,,,
Category,Color-vision disease,,,,,,,,,,,,,
Category,Lens shape anomaly,,,,,,,,,,,,,
Category,Lens position anomaly,,,,,,,,,,,,,
Category,Lens size anomaly,,,,,,,,,,,,,
Category,Craniofacial anomaly with cataract,,,,,,,,,,,,,
Category,Dentocutaneous disease with cataract,,,,,,,,,,,,,
Category,Musculoskeletal disease with cataract,,,,,,,,,,,,,
Category,Metabolic disease with cataract,,,,,,,,,,,,,
Category,Renal disease with cataract,,,,,,,,,,,,,
Category,Rare lens disease,,,,,,,,,,,,,
Category,Rare disorder with lens opacification,,,,,,,,,,,,,
Category,Syndromic cataract,,,,,,,,,,,,,
Category,Chromosomal anomaly with cataract,,,,,,,,,,,,,
Category,Corneodysgenesis,,,,,,,,,,,,,
Category,Rare disease with glaucoma as a major feature,,,,,,,,,,,,,
Category,Congenital malformation of the eye with glaucoma as a major feature,,,,,,,,,,,,,
Category,Anterior segment developmental anomaly without extraocular manifestations,,,,,,,,,,,,,
Category,Syndromic corneal dystrophy,,,,,,,,,,,,,
Category,Posterior corneal dystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Syndromic keratoconus,,,,,,,,,,,,,
Category,Stromal corneal dystrophy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Category,Superficial corneal dystrophy,1-5 / 10 000,United States,409966,409966,25965,25965,en,Not yet validated,410294,410294,21791583[PMID],13.8,13.8
Category,Superficial corneal dystrophy,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Rare isolated myopia,,,,,,,,,,,,,
Category,Syndromic hyperopia,,,,,,,,,,,,,
Category,Rare hyperopia and astigmatism,,,,,,,,,,,,,
Category,Rare refraction anomaly,,,,,,,,,,,,,
Category,Congenital pulmonary veins anomaly,,,,,,,,,,,,,
Category,Rare atrial defect and interatrial communication,,,,,,,,,,,,,
Category,Noonan syndrome and Noonan-related syndrome,,,,,,,,,,,,,
Category,Congenital arteriovenous fistula,,,,,,,,,,,,,
Category,Neurological muscular channelopathy due to a genetic sodium channel defect,,,,,,,,,,,,,
Category,Genetic neurological muscular channelopathy,,,,,,,,,,,,,
Category,Neurological muscular channelopathy due to a genetic ryanodine receptor defect,,,,,,,,,,,,,
Category,Neurological muscular channelopathy due to a genetic potassium channel defect,,,,,,,,,,,,,
Category,Neurological muscular channelopathy due to a genetic calcium channel defect,,,,,,,,,,,,,
Category,Neurological muscular channelopathy due to a genetic chloride channel defect,,,,,,,,,,,,,
Category,Transposition of the great arteries and conotruncal cardiac anomaly,,,,,,,,,,,,,
Category,Aortic malformation,,,,,,,,,,,,,
Category,Uveitis,1-5 / 10 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,8407119[PMID],17,17
Category,Uveitis,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,8407119[PMID],38,38
Category,Heart position anomaly,,,,,,,,,,,,,
Category,Congenital tricuspid malformation,,,,,,,,,,,,,
Clinical group,Atrioventricular canal defect,,,,,,,,,,,,,
Category,Pulmonary artery or pulmonary branch anomaly,,,,,,,,,,,,,
Category,Atrioventricular valve anomaly,,,,,,,,,,,,,
Category,Ascending aorta anomaly,,,,,,,,,,,,,
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.3,3.3
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,Belgium,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],2.9,2.9
Clinical group,Hypoplastic right heart syndrome,1-5 / 10 000,Denmark,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],19.8,19.8
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,France,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],2,2
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,Germany,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.8,5.8
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,Hungary,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],3.3,3.3
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,Ireland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],3.6,3.6
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,Italy,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],1.4,1.4
Clinical group,Hypoplastic right heart syndrome,1-5 / 10 000,Malta,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2009[REG],24.1,24.1
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],5.8,5.8
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,Norway,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],6.5,6.5
Clinical group,Hypoplastic right heart syndrome,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.5,0.5
Clinical group,Hypoplastic right heart syndrome,1-5 / 10 000,Switzerland,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],12.6,12.6
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],3.9,3.9
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,Ukraine,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2011[REG],9.5,9.5
Clinical group,Hypoplastic right heart syndrome,1-9 / 1 000 000,Spain,409968,409968,25958,25958,en,Validated,410293,410293,EUROCAT European surveillance of congenital anomalies 2010[REG],0.6,0.6
Clinical group,Hypoplastic right heart syndrome,1-9 / 100 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,28009100[PMID],1.68,1.68
Category,Congenital anomaly of the great arteries,,,,,,,,,,,,,
Category,Oculocutaneous or ocular albinism,,,,,,,,,,,,,
Category,Rare disorder with strabismus,,,,,,,,,,,,,
Category,Syndromic disorder with strabismus,,,,,,,,,,,,,
Category,Craniostenosis with strabismus,,,,,,,,,,,,,
Category,Rare oculomotor nerve disorder,,,,,,,,,,,,,
Disease,Congenital trochlear nerve palsy,,,,,,,,,,,,,
Category,Supranuclear eye movement disorder,,,,,,,,,,,,,
Category,Oculomotor apraxia,,,,,,,,,,,,,
Malformation syndrome,Isochromosomy Yq,,,,,,,,,,,,,
Malformation syndrome,Isochromosomy Yp,,,,,,,,,,,,,
Etiological subtype,Angelman syndrome due to paternal uniparental disomy of chromosome 15,,,,,,,,,,,,,
Etiological subtype,Angelman syndrome due to maternal 15q11q13 deletion,,,,,,,,,,,,,
Etiological subtype,Prader-Willi syndrome due to paternal 15q11q13 deletion,,,,,,,,,,,,,
Disease,Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,"Primary dystonia, DYT6 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19345147[PMID]_21110056[PMID],0,0
Disease,"Primary dystonia, DYT6 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19345147[PMID]_21110056[PMID],53,53
Disease,"Primary dystonia, DYT4 type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21956287[PMID],0,0
Disease,"Primary dystonia, DYT4 type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21956287[PMID],22,22
Disease,Autosomal dominant nocturnal frontal lobe epilepsy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301348[PMID],100,100
Disease,Autosomal dominant nocturnal frontal lobe epilepsy,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 27,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],30,30
Disease,Spinocerebellar ataxia type 27,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 14,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301573[PMID]_[EXPERT],20,20
Disease,Spinocerebellar ataxia type 14,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 5,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25142508[PMID],5,5
Disease,Spinocerebellar ataxia type 5,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT]_25142508[PMID],0,0
Disease,Spinocerebellar ataxia type 4,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 8,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 17,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],100,100
Disease,Spinocerebellar ataxia type 17,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 17,<1 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,12116198[PMID]_[EXPERT],0.047,0.047
Disease,Spinocerebellar ataxia type 17,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,16223509[PMID]_[EXPERT],0.16,0.16
Disease,Spinocerebellar ataxia type 12,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301381[PMID]_[EXPERT],40,40
Disease,Spinocerebellar ataxia type 12,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 10,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 19/22,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],12,12
Disease,Spinocerebellar ataxia type 19/22,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 18,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],26,26
Disease,Spinocerebellar ataxia type 18,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 21,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,26813285[PMID],35,35
Disease,Spinocerebellar ataxia type 21,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26813285[PMID],0,0
Disease,Spinocerebellar ataxia type 13,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Spinocerebellar ataxia type 13,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 11,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,21827911[PMID],51,51
Disease,Spinocerebellar ataxia type 11,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_21827911[PMID],0,0
Disease,Spinocerebellar ataxia type 15/16,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,Dr Shinsuke FUJIOKA_Dr Nathaniel WHALEY_Dr Zbigniew WSZOLEK[EXPERT],80,80
Disease,Spinocerebellar ataxia type 15/16,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_[EXPERT],0,0
Category,Neurological channelopathy of the central nervous system due to a genetic glycine receptor defect,,,,,,,,,,,,,
Category,Neurological channelopathy of the central nervous system due to a genetic acetylcholine receptor defect,,,,,,,,,,,,,
Category,Neurological channelopathy of the central nervous system due to a genetic GABA receptor defect,,,,,,,,,,,,,
Category,Autoimmune neurological channelopathy,,,,,,,,,,,,,
Category,Genetic neurological channelopathy of the central nervous system,,,,,,,,,,,,,
Category,Neurological channelopathy of the central nervous system due to a genetic sodium channel defect,,,,,,,,,,,,,
Category,Neurological channelopathy of the central nervous system due to a genetic calcium channel defect,,,,,,,,,,,,,
Category,Neurological channelopathy of the central nervous system due to a genetic potassium channel defect,,,,,,,,,,,,,
Disease,Spinocerebellar ataxia type 1,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20301363[PMID]_[EXPERT],1.5,1.5
Disease,Spinocerebellar ataxia type 2,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.5,1.5
Disease,Spinocerebellar ataxia type 3,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],1.5,1.5
Disease,Spinocerebellar ataxia type 3,1-9 / 100 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,21635785[PMID],1,1
Disease,Spinocerebellar ataxia type 3,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,19169038[PMID],5.5,5.5
Disease,Spinocerebellar ataxia type 6,1-9 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,23331413[PMID],0,0
Disease,Spinocerebellar ataxia type 6,1-9 / 100 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,19169038[PMID],1.7,1.7
Etiological subtype,Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,,,,,,,,,,,,,
Category,Autosomal dominant disease with diffuse palmoplantar keratoderma as a major feature,,,,,,,,,,,,,
Category,Autosomal dominant disease associated with focal palmoplantar keratoderma as a major feature,,,,,,,,,,,,,
Category,Autosomal recessive isolated diffuse palmoplantar keratoderma,,,,,,,,,,,,,
Category,Autosomal recessive disease with focal palmoplantar keratoderma as a major feature,,,,,,,,,,,,,
Category,Male infertility due to obstructive azoospermia,,,,,,,,,,,,,
Disease,Rare idiopathic male infertility,,,,,,,,,,,,,
Category,Autosomal dominant isolated diffuse palmoplantar keratoderma,,,,,,,,,,,,,
Clinical group,Familial partial lipodystrophy,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2016[INST]_29066925[PMID],0,0
Category,Genetic lipodystrophy,,,,,,,,,,,,,
Category,Acquired lipodystrophy,,,,,,,,,,,,,
Category,Laminopathy,,,,,,,,,,,,,
Clinical group,Idiopathic interstitial pneumonia,,,,,,,,,,,,,
Category,Male infertility due to gonadal dysgenesis,,,,,,,,,,,,,
Category,Constitutional megaloblastic anemia due to vitamin B12 metabolism disorder,,,,,,,,,,,,,
Category,Red cell aplasia,,,,,,,,,,,,,
Category,Vitamin B12- and folate-independent constitutional megaloblastic anemia,,,,,,,,,,,,,
Category,Constitutional megaloblastic anemia due to folate metabolism disorder,,,,,,,,,,,,,
Category,Hemolytic anemia due to an erythrocyte nucleotide metabolism disorder,,,,,,,,,,,,,
Category,Hemolytic anemia due to a disorder of glycolytic enzymes,,,,,,,,,,,,,
Category,Hemolytic anemia due to hexose monophosphate shunt and glutathione metabolism anomalies,,,,,,,,,,,,,
Category,Rare constitutional hemolytic anemia due to an enzyme disorder,,,,,,,,,,,,,
Category,Constitutional hemolytic anemia due to acanthocytosis,,,,,,,,,,,,,
Clinical group,Hereditary stomatocytosis,,,,,,,,,,,,,
Category,Rare constitutional hemolytic anemia due to a red cell membrane anomaly,,,,,,,,,,,,,
Category,Rare hemolytic anemia,,,,,,,,,,,,,
Category,Constitutional sideroblastic anemia,,,,,,,,,,,,,
Category,Constitutional anemia due to iron metabolism disorder,,,,,,,,,,,,,
Clinical group,Autoimmune hemolytic anemia,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,2.02,2.02
Clinical group,Autoimmune hemolytic anemia,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_ORPHANET,2.02,2.02
Clinical group,Autoimmune hemolytic anemia,1-5 / 10 000,Denmark,409966,409966,25958,25958,en,Validated,410293,410293,20066507[PMID],11,11
Clinical group,Autoimmune hemolytic anemia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Alpha granule disease,,,,,,,,,,,,,
Category,Dense granule disease,,,,,,,,,,,,,
Category,X-linked syndromic intellectual disability,,,,,,,,,,,,,
Category,Skeletal muscle disease,,,,,,,,,,,,,
Category,Muscular dystrophy,,,,,,,,,,,,,
Category,Idiopathic inflammatory myopathy,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_30073460[PMID],0,0
Category,Metabolic myopathy,,,,,,,,,,,,,
Clinical subtype,Brachydactyly type B1,,,,,,,,,,,,,
Clinical subtype,Blepharophimosis-ptosis-epicanthus inversus syndrome type 2,,,,,,,,,,,,,
Category,Rare coagulation disorder,,,,,,,,,,,,,
Clinical group,Polycythemia,,,,,,,,,,,,,
Category,Secondary polycythemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia,,,,,,,,,,,,,
Disease,Hereditary combined deficiency of vitamin K-dependent clotting factors,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20630065[PMID],30,30
Disease,Hereditary combined deficiency of vitamin K-dependent clotting factors,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20630065[PMID],0,0
Clinical subtype,RFVT2-related riboflavin transporter deficiency,,,,,,,,,,,,,
Clinical subtype,RFVT3-related riboflavin transporter deficiency,,,,,,,,,,,,,
Clinical group,Non-syndromic pontocerebellar hypoplasia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Category,Posterior fossa malformation,,,,,,,,,,,,,
Category,Neurodegenerative disease with dementia,,,,,,,,,,,,,
Category,Late-onset ataxia with dementia,,,,,,,,,,,,,
Category,Early-onset ataxia with dementia,,,,,,,,,,,,,
Malformation syndrome,Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome,,,,,,,,,,,,,
Category,Infectious disease with dementia,,,,,,,,,,,,,
Clinical group,Frontotemporal degeneration with dementia,,,,,,,,,,,,,
Category,Ataxia with dementia,,,,,,,,,,,,,
Malformation syndrome,Blepharophimosis-ptosis-epicanthus inversus syndrome plus,,,,,,,,,,,,,
Clinical subtype,Blepharophimosis-ptosis-epicanthus inversus syndrome type 1,,,,,,,,,,,,,
Category,Rare cerebrovascular dementia,,,,,,,,,,,,,
Category,Cerebral lipidosis with dementia,,,,,,,,,,,,,
Category,Metabolic disease with dementia,,,,,,,,,,,,,
Disease,Infective endocariditis,,,,,,,,,,,,,
Category,Acquired neuromuscular junction disease,,,,,,,,,,,,,
Disease,QRSL1-related combined oxidative phosphorylation defect,,,,,,,,,,,,,
Category,Neuromuscular junction disease,,,,,,,,,,,,,
Disease,Ricin poisoning,,,,,,,,,,,,,
Clinical subtype,HHV-8-associated multicentric Castleman disease,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Idiopathic multicentric Castleman disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_29157611[PMID],0,0
Clinical subtype,Idiopathic multicentric Castleman disease,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,ORPHANET_25120049[PMID],0,0
Disease,Galactose mutarotase deficiency,,,,,,,,,,,,,
Clinical subtype,Transient antenatal Bartter syndrome,,,,,,,,,,,,,
Category,Genetic peripheral neuropathy,1-5 / 10 000,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,22961002[PMID],40,40
Category,Genetic neuromuscular junction disease,,,,,,,,,,,,,
Category,Rare peripheral neuropathy,,,,,,,,,,,,,
Category,Acquired motor neuron disease,,,,,,,,,,,,,
Category,Genetic motor neuron disease,,,,,,,,,,,,,
Category,Motor neuron disease,,,,,,,,,,,,,
Category,Cranial nerve and nuclear aplasia,,,,,,,,,,,,,
Category,Malformation of the cerebellar hemispheres,,,,,,,,,,,,,
Category,Malformation of the cerebellar vermis,,,,,,,,,,,,,
Category,Unclassified rare disease,,,,,,,,,,,,,
Category,Syndromic anorectal malformation,,,,,,,,,,,,,
Etiological subtype,Myopathic intestinal pseudoobstruction,,,,,,,,,,,,,
Disease,Leiomyosarcoma of small intestine,,,,,,,,,,,,,
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.588,0.588
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.517,0.517
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.734,0.734
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.174,0.174
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.308,0.308
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.464,0.464
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.36,0.36
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.574,0.574
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.657,0.657
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.551,0.551
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.724,0.724
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.564,0.564
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.79,0.79
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.265,0.265
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.277,0.277
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.377,0.377
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.788,0.788
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.219,0.219
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.743,0.743
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.462,0.462
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.4,0.4
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.477,0.477
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.76,0.76
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.626,0.626
Disease,Adenocarcinoma of the small instestine,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.679,0.679
Category,Metabolic disease with intestinal involvement,,,,,,,,,,,,,
Category,Rare inflammatory bowel disease,,,,,,,,,,,,,
Category,Rare tumor of intestine,,,,,,,,,,,,,
Clinical group,Intestinal polyposis syndrome,,,,,,,,,,,,,
Category,Rare disease involving intestinal motility,,,,,,,,,,,,,
Clinical group,Short bowel syndrome,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2019[INST],2,2
Category,Congenital enteropathy involving intestinal mucosa development,,,,,,,,,,,,,
Category,Congenital intestinal disease due to an enzymatic defect,,,,,,,,,,,,,
Category,Intestinal disease due to fat malabsorption,,,,,,,,,,,,,
Category,Intestinal disease due to vitamin absorption anomaly,,,,,,,,,,,,,
Category,Congenital intestinal transport defect,,,,,,,,,,,,,
Disease,Undetermined colitis,,,,,,,,,,,,,
Disease,Autoimmune pancreatitis,,,,,,,,,,,,,
Disease,Tropical pancreatitis,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Congenital enterocyte heparan sulfate deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8622507[PMID],3,3
Disease,Congenital enterocyte heparan sulfate deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8622507[PMID],0,0
Disease,Congenital sodium diarrhea,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],15,15
Disease,Congenital sodium diarrhea,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Trehalase deficiency,>1 / 1000,Greenland,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],7700,7700
Disease,Trehalase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Chronic diarrhea due to glucoamylase deficiency,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent,,,,,,,,,,,,,
Disease,Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,,,,,,,,,,,,,
Category,Non-syndromic limb malformation,,,,,,,,,,,,,
Category,Syndrome with limb malformations as a major feature,,,,,,,,,,,,,
Category,Rare intestinal disease,,,,,,,,,,,,,
Category,Arthrogryposis syndrome,,,,,,,,,,,,,
Category,Syndromic respiratory or mediastinal malformation,,,,,,,,,,,,,
Category,Non-syndromic respiratory or mediastinal malformation,,,,,,,,,,,,,
Category,Rare disorder due to toxic effects,,,,,,,,,,,,,
Category,Rare anemia,,,,,,,,,,,,,
Category,Syndrome with a central nervous system malformation as major feature,,,,,,,,,,,,,
Category,Non-syndromic central nervous system malformation,,,,,,,,,,,,,
Category,Non-syndromic diaphragmatic or abdominal wall malformation,,,,,,,,,,,,,
Category,Syndromic diaphragmatic or abdominal wall malformation,,,,,,,,,,,,,
Category,Syndromic intestinal malformation,,,,,,,,,,,,,
Category,Non-syndromic visceral malformation,,,,,,,,,,,,,
Category,Syndromic visceral malformation,,,,,,,,,,,,,
Category,Syndromic esophageal malformation,,,,,,,,,,,,,
Category,Non-syndromic gastroduodenal malformation,,,,,,,,,,,,,
Category,Syndromic gastroduodenal malformation,,,,,,,,,,,,,
Category,Non-syndromic intestinal malformation,,,,,,,,,,,,,
Etiological subtype,Unclassified intestinal pseudoobstruction,,,,,,,,,,,,,
Category,Non-syndromic esophageal malformation,,,,,,,,,,,,,
Category,Periodic fever syndrome,,,,,,,,,,,,,
Category,Immunodeficiency due to a complement cascade protein anomaly,,,,,,,,,,,,,
Category,Rare epilepsy,,,,,,,,,,,,,
Category,Primary immunodeficiency,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,22288591[PMID],0,0
Category,Primary immunodeficiency,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,11202238[PMID],6.8,6.8
Category,Primary immunodeficiency,1-5 / 10 000,France,409966,409966,25958,25958,en,Validated,410293,410293,28732644[PMID],11,11
Category,Primary immunodeficiency,1-9 / 100 000,Spain,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],3.6,3.6
Category,Primary immunodeficiency,1-9 / 100 000,Netherlands,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],2.6,2.6
Category,Primary immunodeficiency,1-9 / 100 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],1.84,1.84
Category,Primary immunodeficiency,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],1.79,1.79
Category,Primary immunodeficiency,1-9 / 100 000,Germany,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],1.38,1.38
Category,Primary immunodeficiency,1-9 / 100 000,Turkey,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],2,2
Category,Primary immunodeficiency,1-9 / 100 000,Poland,409966,409966,25958,25958,en,Validated,410293,410293,22288591[PMID],1.33,1.33
Category,Primary immunodeficiency,1-9 / 100 000,Australia,409966,409966,25965,25965,en,Not yet validated,410294,410294,17588141[PMID],5.6,5.6
Category,Primary immunodeficiency,1-9 / 100 000,New Zealand,409966,409966,25958,25958,en,Validated,410293,410293,17588141[PMID],4.9,4.9
Category,Primary immunodeficiency,1-9 / 100 000,"Korea, Republic of",409966,409966,25958,25958,en,Validated,410293,410293,22787376[PMID],1.1,1.1
Category,Primary immunodeficiency,1-9 / 100 000,Oman,409966,409966,25958,25958,en,Validated,410293,410293,23268475[PMID],4.5,4.5
Category,Rare ataxia,,,,,,,,,,,,,
Category,Rare movement disorder,,,,,,,,,,,,,
Category,Medullar disease,,,,,,,,,,,,,
Category,Neurovascular malformation,,,,,,,,,,,,,
Category,Brain inflammatory disease,,,,,,,,,,,,,
Category,Immunodeficiency predominantly affecting antibody production,,,,,,,,,,,,,
Category,Constitutional neutropenia,,,,,,,,,,,,,
Category,Quantitative and/or qualitative congenital phagocyte defect,,,,,,,,,,,,,
Category,Primary immunodeficiency due to a defect in innate immunity,,,,,,,,,,,,,
Category,Human herpesvirus 8-related disorder,,,,,,,,,,,,,
Category,Unexplained periodic fever syndrome,,,,,,,,,,,,,
Category,Multiple congenital anomalies/dysmorphic syndrome-intellectual disability,,,,,,,,,,,,,
Category,Multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome,,,,,,,,,,,,,
Category,Multiple congenital anomalies/dysmorphic syndrome without intellectual disability,,,,,,,,,,,,,
Category,Rare syndromic intellectual disability,,,,,,,,,,,,,
Clinical group,Classic lissencephaly,,,,,,,,,,,,,
Clinical group,Lissencephaly type 3,,,,,,,,,,,,,
Category,Other syndrome with lissencephaly as a major feature,,,,,,,,,,,,,
Clinical group,Complex hereditary spastic paraplegia,,,,,,,,,,,,,
Clinical group,Pure hereditary spastic paraplegia,,,,,,,,,,,,,
Category,Autosomal recessive limb-girdle muscular dystrophy,,,,,,,,,,,,,
Category,Autosomal dominant limb-girdle muscular dystrophy,,,,,,,,,,,,,
Category,Rickettsial disease,,,,,,,,,,,,,
Category,Autosomal monosomy,,,,,,,,,,,,,
Category,Typhus-group rickettsiosis,,,,,,,,,,,,,
Category,Spotted fever rickettsiosis,,,,,,,,,,,,,
Category,Genetic cardiac rhythm disease,,,,,,,,,,,,,
Morphological anomaly,Anomaly of the mitral subvalvular apparatus,,,,,,,,,,,,,
Disease,Rare non-syndromic intellectual disability,,,,,,,,,,,,,
Category,Rare hepatic and biliary tract tumor,,,,,,,,,,,,,
Category,Rare metabolic liver disease,,,,,,,,,,,,,
Category,Rare biliary tract disease,,,,,,,,,,,,,
Category,Rare vascular liver disease,,,,,,,,,,,,,
Category,Rare parenchymal liver disease,,,,,,,,,,,,,
Category,Rare gastroesophageal disease,,,,,,,,,,,,,
Category,Rare pancreatic disease,,,,,,,,,,,,,
Morphological anomaly,Familial isolated congenital asplenia,,,,,,,,,,,,,
Category,Rare genetic eye disease,,,,,,,,,,,,,
Category,Rare urogenital disease,,,,,,,,,,,,,
Category,Genetic chronic primary adrenal insufficiency,,,,,,,,,,,,,
Category,Acquired chronic primary adrenal insufficiency,,,,,,,,,,,,,
Clinical group,Combined T and B cell immunodeficiency,,,,,,,,,,,,,
Category,Rare eye tumor,,,,,,,,,,,,,
Category,Rare bronchopulmonary tumor,,,,,,,,,,,,,
Category,Rare pulmonary disease,,,,,,,,,,,,,
Category,Pituitary deficiency,,,,,,,,,,,,,
Category,Polyendocrinopathy,,,,,,,,,,,,,
Category,Chronic primary adrenal insufficiency,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.4,0.4
Category,Chronic primary adrenal insufficiency,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,12788587[PMID]_[EXPERT],14,14
Category,Primary adrenal insufficiency,,,,,,,,,,,,,
Category,Rare dyslipidemia,,,,,,,,,,,,,
Category,Rare diabetes mellitus,,,,,,,,,,,,,
Category,Rare thyroid disease,,,,,,,,,,,,,
Category,Rare adrenal disease,,,,,,,,,,,,,
Disease,Autosomal recessive dopa-responsive dystonia,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,50,50
Disease,Autosomal recessive dopa-responsive dystonia,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 25,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],10,10
Disease,Spinocerebellar ataxia type 25,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 26,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15732118[PMID],1,1
Disease,Spinocerebellar ataxia type 26,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15732118[PMID],0,0
Disease,Spinocerebellar ataxia type 28,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 20,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Spinocerebellar ataxia type 20,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spinocerebellar ataxia type 23,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Disease,Spinocerebellar ataxia type 23,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Non-secreting chemodectoma,,,,,,,,,,,,,
Disease,African tick typhus,,,,,,,,,,,,,
Disease,Porphyria cutanea tarda,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,19233912[PMID]_9516680[PMID]_[EXPERT]_ORPHANET,0.6,0.6
Disease,Porphyria cutanea tarda,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],4,4
Disease,Porphyria cutanea tarda,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,19233912[PMID],1,1
Disease,Porphyria cutanea tarda,1-5 / 10 000,Sweden,409966,409966,25958,25958,en,Validated,410293,410293,16191856[PMID],10,10
Malformation syndrome,Pulmonary valve agenesis-tetralogy of Fallot-absence of ductus arteriosus syndrome,,,,,,,,,,,,,
Disease,Charcot-Marie-Tooth disease type 1F,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301366[PMID],0,0
Clinical subtype,X-linked hyper-IgM syndrome,,,,,,,,,,,,,
Disease,Charcot-Marie-Tooth disease type 1A,6-9 / 10 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,20482598[PMID]_24646194[PMID],82.37,82.37
Disease,Charcot-Marie-Tooth disease type 1A,1-5 / 10 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,21984771[PMID],15.2,15.2
Disease,Charcot-Marie-Tooth disease type 1A,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301384[PMID],0,0
Disease,Charcot-Marie-Tooth disease type 1B,1-9 / 100 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301384[PMID],0,0
Disease,Charcot-Marie-Tooth disease type 1C,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Charcot-Marie-Tooth disease type 1D,,,,,,,,,,,,,
Disease,X-linked Charcot-Marie-Tooth disease type 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18458969[PMID],4,4
Disease,X-linked Charcot-Marie-Tooth disease type 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18458969[PMID],0,0
Disease,X-linked Charcot-Marie-Tooth disease type 4,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23217327[PMID],7,7
Disease,X-linked Charcot-Marie-Tooth disease type 4,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23217327[PMID],0,0
Disease,X-linked Charcot-Marie-Tooth disease type 1,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,20301548[PMID],0,0
Disease,X-linked Charcot-Marie-Tooth disease type 2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,1557086[PMID]_1674639[PMID],5,5
Disease,X-linked Charcot-Marie-Tooth disease type 2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_1557086[PMID]_1674639[PMID],0,0
Disease,Charcot-Marie-Tooth disease type 2H,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11166163[PMID],13,13
Disease,Charcot-Marie-Tooth disease type 2H,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11166163[PMID],0,0
Disease,Charcot-Marie-Tooth disease type 2B2,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11112660[PMID],1,1
Disease,Charcot-Marie-Tooth disease type 2B2,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11112660[PMID],0,0
Clinical subtype,Marin-Amat syndrome,,,,,,,,,,,,,
Disease,Autosomal recessive Charcot-Marie-Tooth disease with hoarseness,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Aregenerative anemia,,,,,,,,,,,,,
Clinical subtype,Hyper-IgM syndrome type 3,,,,,,,,,,,,,
Clinical subtype,Hyper-IgM syndrome type 2,,,,,,,,,,,,,
Clinical subtype,Hyper-IgM syndrome type 5,,,,,,,,,,,,,
Clinical subtype,Hyper-IgM syndrome type 4,,,,,,,,,,,,,
Etiological subtype,Familial hypocalciuric hypercalcemia type 2,,,,,,,,,,,,,
Etiological subtype,Familial hypocalciuric hypercalcemia type 3,,,,,,,,,,,,,
Clinical subtype,Congenital aortic valve dysplasia,,,,,,,,,,,,,
Clinical subtype,Familial hypofibrinogenemia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal dominant epilepsy with auditory features,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301709[PMID],0,0
Disease,Congenital stromal corneal dystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24413633[PMID]_20301741[PMID],6,6
Disease,Congenital stromal corneal dystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24413633[PMID]_20301741[PMID],0,0
Clinical subtype,Unilateral hemispheric polymicrogyria,,,,,,,,,,,,,
Clinical subtype,Bilateral frontoparietal polymicrogyria,,,,,,,,,,,,,
Morphological anomaly,Situs inversus totalis,,,,,,,,,,,,,
Morphological anomaly,Cleft hard palate,,,,,,,,,,,,,
Disease,Autosomal dominant spastic paraplegia type 29,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16130112[PMID],1,1
Disease,Autosomal dominant spastic paraplegia type 29,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16130112[PMID],0,0
Disease,Autosomal spastic paraplegia type 30,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22258533[PMID],3,3
Disease,Autosomal spastic paraplegia type 30,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22258533[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 31,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Romano-Ward syndrome,1-5 / 10 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],40,40
Disease,Female restricted epilepsy with intellectual disability,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18234694[PMID]_20830798[PMID],5,5
Disease,Female restricted epilepsy with intellectual disability,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18234694[PMID]_20830798[PMID],0,0
Disease,Transaldolase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23315216[PMID],23,23
Disease,Transaldolase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23315216[PMID],0,0
Clinical subtype,Subependymal nodular heterotopia,,,,,,,,,,,,,
Clinical subtype,Sub-cortical nodular heterotopia,,,,,,,,,,,,,
Disease,Autosomal dominant spastic paraplegia type 3,1-9 / 1 000 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,23609960[PMID],0.14,0.14
Disease,Autosomal dominant spastic paraplegia type 3,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,20862796[PMID]_8649538[PMID]_23609960[PMID],0,0
Clinical group,Autosomal recessive pure spastic paraplegia,,,,,,,,,,,,,
Clinical group,Autosomal recessive complex spastic paraplegia,,,,,,,,,,,,,
Clinical group,Autosomal dominant pure spastic paraplegia,1-9 / 100 000,Norway,409966,409966,25965,25965,en,Not yet validated,410294,410294,22554690[PMID]_ORPHANET,4.4,4.4
Clinical group,Autosomal dominant pure spastic paraplegia,1-9 / 1 000 000,Ireland,409966,409966,25958,25958,en,Validated,410293,410293,22554690[PMID],0.9,0.9
Clinical group,Autosomal dominant pure spastic paraplegia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,Autosomal dominant complex spastic paraplegia,1-9 / 100 000,Norway,409966,409966,25958,25958,en,Validated,410293,410293,19339254[PMID],1,1
Clinical group,Autosomal dominant complex spastic paraplegia,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Cloverleaf skull-asphyxiating thoracic dysplasia syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3499843[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 10,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Autosomal dominant spastic paraplegia type 10,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant spastic paraplegia type 8,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Autosomal dominant spastic paraplegia type 8,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant spastic paraplegia type 6,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Autosomal dominant spastic paraplegia type 6,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive spastic paraplegia type 5A,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal dominant spastic paraplegia type 4,1-9 / 1 000 000,Portugal,409966,409966,25958,25958,en,Validated,410293,410293,23609960[PMID],0.91,0.91
Disease,Autosomal dominant spastic paraplegia type 19,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12112072[PMID],1,1
Disease,Autosomal dominant spastic paraplegia type 19,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12112072[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 20,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28679690[PMID],36,36
Disease,Autosomal recessive spastic paraplegia type 20,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28679690[PMID],0,0
Disease,X-linked spastic paraplegia type 16,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9254866[PMID],1,1
Disease,X-linked spastic paraplegia type 16,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9254866[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 17,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,20,20
Disease,Autosomal dominant spastic paraplegia type 17,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal recessive spastic paraplegia type 14,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10877981[PMID],1,1
Disease,Autosomal recessive spastic paraplegia type 14,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10877981[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 15,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,10,10
Disease,Autosomal recessive spastic paraplegia type 15,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Autosomal dominant spastic paraplegia type 12,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22232211[PMID],27,27
Disease,Autosomal dominant spastic paraplegia type 12,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22232211[PMID],0,0
Disease,Autosomal dominant spastic paraplegia type 13,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10677329[PMID],10,10
Disease,Autosomal dominant spastic paraplegia type 13,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10677329[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 27,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15455396[PMID]_16511635[PMID]_20301682[PMID],10,10
Disease,Autosomal recessive spastic paraplegia type 27,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15455396[PMID]_16511635[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 28,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27216551[PMID],7,7
Disease,Autosomal recessive spastic paraplegia type 28,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27216551[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 25,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12070243[PMID],1,1
Disease,Autosomal recessive spastic paraplegia type 25,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12070243[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 26,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24103911[PMID]_23746551[PMID]_24283893[PMID],10,10
Disease,Autosomal recessive spastic paraplegia type 26,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24103911[PMID]_23746551[PMID]_24283893[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 23,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,7294071[PMID]_6264350[PMID]_6886718[PMID]_4061404[PMID]_12868479[PMID],5,5
Disease,Autosomal recessive spastic paraplegia type 23,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_7294071[PMID]_6264350[PMID]_6886718[PMID]_4061404[PMID]_12868479[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 24,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12499481[PMID],1,1
Disease,Autosomal recessive spastic paraplegia type 24,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12499481[PMID],0,0
Disease,Autosomal recessive spastic paraplegia type 21,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,6024251[PMID]_6024251[PMID]_14564668[PMID]_24451228[PMID],35,35
Disease,Autosomal recessive spastic paraplegia type 21,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_6024251[PMID]_14564668[PMID]_24451228[PMID],0,0
Category,Thyroid carcinoma,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,22033323[PMID]_23894154[PMID],3.65,3.65
Category,Thyroid carcinoma,6-9 / 10 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],61.7,61.7
Category,Thyroid carcinoma,1-5 / 10 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,National Cancer Institute 2010[INST],12.2,12.2
Category,Thyroid carcinoma,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],3.1,3.1
Category,Thyroid carcinoma,1-5 / 10 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,World Health Organization 2008[INST],12.7,12.7
Category,Thyroid carcinoma,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.733,2.733
Category,Thyroid carcinoma,1-5 / 10 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],12.86,12.86
Category,Thyroid carcinoma,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.679,7.679
Category,Thyroid carcinoma,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.74,3.74
Category,Thyroid carcinoma,1-9 / 100 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.921,2.921
Category,Thyroid carcinoma,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],8.329,8.329
Category,Thyroid carcinoma,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.382,6.382
Category,Thyroid carcinoma,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.803,4.803
Category,Thyroid carcinoma,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.375,6.375
Category,Thyroid carcinoma,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.526,5.526
Category,Thyroid carcinoma,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.45,2.45
Category,Thyroid carcinoma,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.563,4.563
Category,Thyroid carcinoma,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],7.905,7.905
Category,Thyroid carcinoma,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.344,6.344
Category,Thyroid carcinoma,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.472,4.472
Category,Thyroid carcinoma,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.488,4.488
Category,Thyroid carcinoma,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],8.628,8.628
Category,Thyroid carcinoma,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.991,3.991
Category,Thyroid carcinoma,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.649,5.649
Category,Thyroid carcinoma,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.162,5.162
Category,Thyroid carcinoma,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.39,6.39
Category,Thyroid carcinoma,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.373,2.373
Category,Adrenal/paraganglial tumor,,,,,,,,,,,,,
Category,Rare parathyroid tumor,,,,,,,,,,,,,
Disease,Primary hepatic neuroendocrine carcinoma,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,8227395[PMID]_24944650[PMID]_ [EXPERT],0.2,0.2
Disease,Primary hepatic neuroendocrine carcinoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Middle ear neuroendocrine tumor,,,,,,,,,,,,,
Category,Thyroid tumor,1-9 / 100 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,21513910[PMID]_ORPHANET,3.2,3.2
Category,Thyroid tumor,1-9 / 100 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,21513910[PMID],5,5
Category,Thyroid tumor,1-9 / 100 000,Italy,409967,409967,25965,25965,en,Not yet validated,410294,410294,23518150[PMID]_ORPHANET,5.7,5.7
Category,Thyroid tumor,1-9 / 100 000,France,409967,409967,25965,25965,en,Not yet validated,410294,410294,21513910[PMID]_ORPHANET,5.35,5.35
Disease,Gallbladder neuroendocrine tumor,,,,,,,,,,,,,
Category,Neuroendocrine tumor with other location,,,,,,,,,,,,,
Category,Thymic tumor,,,,,,,,,,,,,
Clinical syndrome,Carcinoid syndrome,,,,,,,,,,,,,
Category,Gastroenteropancreatic neuroendocrine neoplasm,,,,,,,,,,,,,
Category,Multiple polyglandular tumor,,,,,,,,,,,,,
Disease,Porphyria due to ALA dehydratase deficiency,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,FRAXE intellectual disability,1-9 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,FRAXF syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Bathing suit ichthyosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],20,20
Disease,Bathing suit ichthyosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Etiological subtype,F12-related hereditary angioedema with normal C1Inh,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Hereditary angioedema type 2,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Renin-angiotensin-aldosterone system-blocker-induced angioedema,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Acquired angioedema type 1,,,,,,,,,,,,,
Clinical subtype,Acquired angioedema type 2,,,,,,,,,,,,,
Disease,Semantic dementia,,,,,,,,,,,,,
Disease,Progressive non-fluent aphasia,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22608668[PMID]_European Medicines Agency 2010[INST],2.5,2.5
Disease,Progressive non-fluent aphasia,1-9 / 1 000 000,Europe,409967,409967,25965,25965,en,Not yet validated,410294,410294,22608668[PMID],0.7,0.7
Clinical subtype,Waterhouse-Friderichsen syndrome,,,,,,,,,,,,,
Clinical subtype,Neurogenic thoracic outlet syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Neuroendocrine tumor of stomach,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,25480460[PMID],3.2,3.2
Disease,Neuroendocrine tumor of stomach,1-9 / 100 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,25480460[PMID],1.7,1.7
Disease,Neuroendocrine tumor of stomach,1-9 / 1 000 000,United Kingdom,409966,409966,25958,25958,en,Validated,410293,410293,25480460[PMID],0.7,0.7
Disease,Neuroendocrine tumor of stomach,1-9 / 1 000 000,Japan,409966,409966,25958,25958,en,Validated,410293,410293,25480460[PMID],0.5,0.5
Malformation syndrome,Mosaic trisomy 3,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15386452[PMID],6,6
Malformation syndrome,Mosaic trisomy 3,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15386452[PMID],0,0
Disease,Ileal neuroendocrine tumor,,,,,,,,,,,,,
Disease,Neuroendocrine neoplasm of appendix,,,,,,,,,,,,,
Category,Duodenal neuroendocrine tumor,,,,,,,,,,,,,
Category,Jejunal neuroendocrine tumor,,,,,,,,,,,,,
Disease,Neuroendocrine tumor of anal canal,,,,,,,,,,,,,
Disease,Laryngeal neuroendocrine tumor,,,,,,,,,,,,,
Disease,Neuroendocrine tumor of the colon,,,,,,,,,,,,,
Disease,Neuroendocrine tumor of the rectum,,,,,,,,,,,,,
Clinical subtype,Refractory anemia with excess blasts type 2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Refractory anemia with excess blasts type 1,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Extramedullary soft tissue plasmacytoma,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,19016727[PMID]_SEER Surveillance Epidemiology and End Results 1992-2004[INST],0.1,0.1
Clinical subtype,Primary plasmacytoma of the bone,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,19016727[PMID]_SEER Surveillance Epidemiology and End Results 1992-2004[INST],0.15,0.15
Clinical subtype,Mu-heavy chain disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],35,35
Clinical subtype,Mu-heavy chain disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Gamma-heavy chain disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],120,120
Clinical subtype,Gamma-heavy chain disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Alpha-heavy chain disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],400,400
Clinical subtype,Alpha-heavy chain disease,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Hypocalcified amelogenesis imperfecta,,,,,,,,,,,,,
Clinical subtype,Hypoplastic amelogenesis imperfecta,,,,,,,,,,,,,
Clinical subtype,Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism,,,,,,,,,,,,,
Clinical subtype,Hypomaturation amelogenesis imperfecta,,,,,,,,,,,,,
Disease,Solitary necrotic nodule of the liver,,,,,,,,,,,,,
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type A,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11533914[PMID],20,20
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type A,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11533914[PMID],0,0
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19502294[PMID],37,37
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_19502294[PMID],0,0
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type C,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16429158[PMID]_24354524[PMID],0,0
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type C,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16429158[PMID]_24354524[PMID],35,35
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type D,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10406984[PMID],0,0
Disease,Autosomal dominant intermediate Charcot-Marie-Tooth disease type D,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10406984[PMID],12,12
Morphological anomaly,Esophageal duplication cyst,,,,,,,,,,,,,
Morphological anomaly,Tubular duplication of the esophagus,,,,,,,,,,,,,
Category,Primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies,,,,,,,,,,,,,
Etiological subtype,Hereditary angioedema type 1,1-9 / 100 000,Italy,409966,409966,25958,25958,en,Validated,410293,410293,25758562[PMID]_[EXPERT],1.54,1.54
Etiological subtype,Hereditary angioedema type 1,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Lissencephaly with cerebellar hypoplasia type F,,,,,,,,,,,,,
Malformation syndrome,Lissencephaly with cerebellar hypoplasia type E,,,,,,,,,,,,,
Malformation syndrome,Lissencephaly with cerebellar hypoplasia type B,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11748497[PMID],50,50
Malformation syndrome,Lissencephaly with cerebellar hypoplasia type B,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11748497[PMID],0,0
Malformation syndrome,Lissencephaly with cerebellar hypoplasia type A,,,,,,,,,,,,,
Malformation syndrome,Lissencephaly with cerebellar hypoplasia type D,,,,,,,,,,,,,
Malformation syndrome,Lissencephaly with cerebellar hypoplasia type C,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10594886[PMID]_11748497[PMID],2,2
Malformation syndrome,Lissencephaly with cerebellar hypoplasia type C,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11748497[PMID],0,0
Clinical subtype,ACys amyloidosis,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],9,9
Clinical subtype,ACys amyloidosis,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Intraneural perineurioma,,,,,,,,,,,,,
Clinical subtype,"ABeta amyloidosis, Dutch type",,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],250,250
Clinical subtype,"ABeta amyloidosis, Dutch type",<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Clinical subtype,Reticular perineurioma,,,,,,,,,,,,,
Clinical subtype,Sclerosing perineurioma,,,,,,,,,,,,,
Disease,Extraneural perineurioma,,,,,,,,,,,,,
Clinical subtype,Complex regional pain syndrome type 1,1-9 / 100 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,12749974[PMID],5.46,5.46
Clinical subtype,Complex regional pain syndrome type 1,1-5 / 10 000,United States,409966,409966,25958,25958,en,Validated,410293,410293,12749974[PMID],20.57,20.57
Clinical subtype,Relapsing epidemic typhus,,,,,,,,,,,,,
Clinical subtype,Complex regional pain syndrome type 2,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,12749974[PMID],0.82,0.82
Clinical subtype,Complex regional pain syndrome type 2,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Intermediate DEND syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Brill-Zinsser disease,,,,,,,,,,,,,
Category,Cutaneous myiasis,,,,,,,,,,,,,
Clinical subtype,Apnea of prematurity,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2003[INST],8.5,8.5
Disease,Klatskin tumor,1-9 / 100 000,United States,409967,409967,25965,25965,en,Not yet validated,410294,410294,19638920[PMID]_ORPHANET,1.5,1.5
Disease,Klatskin tumor,1-9 / 100 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.357,3.357
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG],5.42,5.42
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,25320104[PMID]_WHO World Health Organization (GLOBOCAN 2012)[INST],5.2,5.2
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.026,2.026
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.881,3.881
Disease,Squamous cell carcinoma of the esophagus,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.801,0.801
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.79,2.79
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.315,2.315
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.122,3.122
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.325,2.325
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.069,5.069
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.172,4.172
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.215,2.215
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.443,3.443
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.623,2.623
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.896,2.896
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.922,2.922
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.256,1.256
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.706,1.706
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.996,1.996
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.734,3.734
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.866,3.866
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.234,3.234
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.544,3.544
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.778,3.778
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.139,3.139
Disease,Squamous cell carcinoma of the esophagus,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],4.186,4.186
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.264,3.264
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG],5.55,5.55
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,25320104[PMID]_WHO World Health Organization (GLOBOCAN 2012)[INST],0.7,0.7
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.235,1.235
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.918,3.918
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Bulgaria,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.364,0.364
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.485,0.485
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Czech Republic,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.28,1.28
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.305,0.305
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.5,1.5
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,France,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.681,1.681
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.636,1.636
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Iceland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.471,2.471
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],3.736,3.736
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.947,0.947
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.39,0.39
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.526,0.526
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.319,1.319
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Poland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.315,0.315
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.829,0.829
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.578,0.578
Disease,Adenocarcinoma of the esophagus,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.651,0.651
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Switzerland,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],2.612,2.612
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Netherlands,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],5.196,5.196
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],6.592,6.592
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.848,1.848
Disease,Adenocarcinoma of the esophagus,1-9 / 100 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],1.178,1.178
Histopathological subtype,Well-differentiated liposarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22517534[PMID]_[EXPERT],0.51,0.51
Histopathological subtype,Well-differentiated liposarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,Pleomorphic liposarcoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22517534[PMID]_[EXPERT],0.05,0.05
Histopathological subtype,Pleomorphic liposarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,Dedifferentiated liposarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22517534[PMID]_[EXPERT],0.27,0.27
Histopathological subtype,Dedifferentiated liposarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Histopathological subtype,Myxoid/round cell liposarcoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,22517534[PMID]_[EXPERT],0.1,0.1
Histopathological subtype,Myxoid/round cell liposarcoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,O'Sullivan-McLeod syndrome,,,,,,,,,,,,,
Clinical subtype,Atypical teratoid rhabdoid tumor,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,20737418[PMID]_19707161[PMID]_22988546[PMID],0,0
Clinical subtype,Atypical teratoid rhabdoid tumor,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],1.38,1.38
Clinical subtype,Benign recurrent intrahepatic cholestasis type 2,,,,,,,,,,,,,
Clinical subtype,Benign recurrent intrahepatic cholestasis type 1,,,,,,,,,,,,,
Disease,Charcot-Marie-Tooth disease type 4B1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,20301641[PMID]_DOI: 10.1016/j.nmd.2015.06.356[OTHER],11,11
Disease,Charcot-Marie-Tooth disease type 4B1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301641[PMID]_DOI: 10.1016/j.nmd.2015.06.356[OTHER],0,0
Disease,Charcot-Marie-Tooth disease type 4B2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Charcot-Marie-Tooth disease type 4A,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2A2,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,21715711[PMID]_21715704[PMID],0,0
Disease,Charcot-Marie-Tooth disease type 4D,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Charcot-Marie-Tooth disease type 4C,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Charcot-Marie-Tooth disease type 4F,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Charcot-Marie-Tooth disease type 4E,,,,,,,,,,,,,
Disease,Charcot-Marie-Tooth disease type 4H,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,23770104[PMID]_26400421[PMID],15,15
Disease,Charcot-Marie-Tooth disease type 4H,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_23770104[PMID]_26400421[PMID],0,0
Disease,Charcot-Marie-Tooth disease type 4G,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Charcot-Marie-Tooth disease type 4G,1-5 / 10 000,Czech Republic,409966,409966,25958,25958,en,Validated,410293,410293,26822750[PMID],10,10
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2F,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,16087758[PMID],5,5
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2F,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_16087758[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2E,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_20301366[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2I,,,,,,,,,,,,,
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2G,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,3022865[PMID],1,1
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2G,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_3022865[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2K,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18231710[PMID]_19089472[PMID]_20685671[PMID]_21753178[PMID],30,30
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2K,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18231710[PMID]_19089472[PMID]_20685671[PMID]_21753178[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2J,,,,,,,,,,,,,
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2A1,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9409358[PMID],1,1
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2A1,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9409358[PMID],0,0
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2L,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,15021985[PMID],1,1
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2L,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15021985[PMID],0,0
Disease,Idiopathic pulmonary hemosiderosis,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT],0.0425,0.0425
Disease,Idiopathic pulmonary hemosiderosis,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Heiner syndrome,,,,,,,,,,,,,
Clinical subtype,Pleuropulmonary blastoma type 1,,,,,,,,,,,,,
Clinical subtype,Pleuropulmonary blastoma type 2,,,,,,,,,,,,,
Clinical subtype,Pleuropulmonary blastoma type 3,,,,,,,,,,,,,
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2B,,,,,,,,,,,,,
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2C,,,,,,,,,,,,,
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2D,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8872480[PMID]_10732809[PMID]_9879677[PMID]_19329989[PMID],44,44
Disease,Autosomal dominant Charcot-Marie-Tooth disease type 2D,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_8872480[PMID]_10732809[PMID]_9879677[PMID]_19329989[PMID],0,0
Disease,Invasive mole,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Gestational choriocarcinoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Hydatidiform mole,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Placental site trophoblastic tumor,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.02,0.02
Disease,Placental site trophoblastic tumor,1-9 / 1 000 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG],0.86,0.86
Disease,Placental site trophoblastic tumor,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Secondary pulmonary hemosiderosis,,,,,,,,,,,,,
Etiological subtype,Streptococcal toxic-shock syndrome,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,21976764[PMID]_Dr Lina Gérard[EXPERT],0.1,0.1
Etiological subtype,Streptococcal toxic-shock syndrome,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,22534148[PMID]_Dr Lina Gérard[EXPERT],0.2,0.2
Etiological subtype,Streptococcal toxic-shock syndrome,1-9 / 1 000 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,17638193[PMID]_Dr Lina Gérard[EXPERT],0.33,0.33
Etiological subtype,Streptococcal toxic-shock syndrome,1-9 / 1 000 000,Denmark,409967,409967,25958,25958,en,Validated,410293,410293,15815000[PMID],0.23,0.23
Disease,"Theca steroid-producing cell malignant tumor of ovary, not further specified",<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Malignant Sertoli-Leydig cell tumor of the ovary,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0,0
Disease,Maligant granulosa cell tumor of the ovary,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.12,0.12
Disease,Ocular cicatricial pemphigoid,,,,,,,,,,,,,
Clinical subtype,Chronic graft versus host disease,,,,,,,,,,,,,
Clinical subtype,Acute graft versus host disease,,,,,,,,,,,,,
Etiological subtype,Staphylococcal toxic-shock syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Etiological subtype,Staphylococcal toxic-shock syndrome,1-9 / 1 000 000,United States,409967,409967,25958,25958,en,Validated,410293,410293,21860665[PMID]_24188357[PMID],0.58,0.58
Clinical group,Occupational allergic alveolitis,,,,,,,,,,,,,
Disease,Pigeon-breeder lung disease,,,,,,,,,,,,,
Disease,House allergic alveolitis,,,,,,,,,,,,,
Disease,Gynandroblastoma,,,,,,,,,,,,,
Category,Extragonadal non-dysgerminomatous germ cell tumor,,,,,,,,,,,,,
Disease,Malignant dysgerminomatous germ cell tumor of the ovary,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Malignant dysgerminomatous germ cell tumor of the ovary,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.04,0.04
Disease,Acyl-CoA dehydrogenase 9 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24158852[PMID]_26669660[PMID],23,23
Disease,Acyl-CoA dehydrogenase 9 deficiency,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_26669660[PMID],0,0
Disease,Long chain acyl-CoA dehydrogenase deficiency,,,,,,,,,,,,,
Etiological subtype,Streptobacillary rat-bite fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Farmer's lung disease,,,,,,,,,,,,,
Etiological subtype,Spirillary rat-bite fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical group,ACTH-independent Cushing syndrome,,,,,,,,,,,,,
Clinical group,ACTH-dependent Cushing syndrome,1-9 / 1 000 000,Worldwide,409967,409967,25965,25965,en,Not yet validated,410294,410294,20829610[PMID]_18226430[PMID]_15903005[PMID],0.55,0.55
Clinical group,ACTH-dependent Cushing syndrome,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25453225[PMID],0,0
Disease,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25453225[PMID],31,31
Disease,Familial isolated hyperparathyroidism,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,18084346[PMID],100,100
Disease,Familial isolated hyperparathyroidism,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_18084346[PMID],0,0
Disease,Hyperparathyroidism-jaw tumor syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,25511968[PMID],100,100
Disease,Hyperparathyroidism-jaw tumor syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_25511968[PMID],0,0
Disease,Familial parathyroid adenoma,,,,,,,,,,,,,
Disease,Primary parathyroid hyperplasia,,,,,,,,,,,,,
Clinical subtype,Acute megakaryoblastic leukemia in Down syndrome,,,,,,,,,,,,,
Disease,Cushing syndrome due to ectopic ACTH secretion,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Permanent neonatal diabetes mellitus,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,19499210[PMID],0.38,0.38
Disease,Permanent neonatal diabetes mellitus,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,19499210[PMID]_ORPHANET,0,0
Disease,Permanent neonatal diabetes mellitus,1-9 / 1 000 000,United Kingdom,409968,409968,25958,25958,en,Validated,410293,410293,19499210[PMID],0.38,0.38
Disease,Permanent neonatal diabetes mellitus,1-9 / 1 000 000,Poland,409968,409968,25958,25958,en,Validated,410293,410293,19499210[PMID],0.38,0.38
Disease,Permanent neonatal diabetes mellitus,1-9 / 1 000 000,Netherlands,409968,409968,25958,25958,en,Validated,410293,410293,19499210[PMID],0.38,0.38
Disease,Permanent neonatal diabetes mellitus,1-9 / 1 000 000,Slovakia,409968,409968,25958,25958,en,Validated,410293,410293,17213273[PMID],0.46,0.46
Disease,Permanent neonatal diabetes mellitus,1-9 / 1 000 000,United States,409968,409968,25958,25958,en,Validated,410293,410293,23050777[PMID],0.4,0.4
Disease,Permanent neonatal diabetes mellitus,1-5 / 10 000,Oman,409968,409968,25958,25958,en,Validated,410293,410293,10798084[PMID],18,18
Disease,Transient neonatal diabetes mellitus,1-9 / 1 000 000,Europe,409968,409968,25958,25958,en,Validated,410293,410293,[EXPERT],0.3,0.3
Disease,Transient neonatal diabetes mellitus,Unknown,Europe,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Spermatocytic seminoma,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,RARECARE surveillance of rare cancers in Europe[REG],0.03,0.03
Disease,Spermatocytic seminoma,Unknown,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Precursor B-cell acute lymphoblastic leukemia,,,,,,,,,,,,,
Disease,Precursor T-cell acute lymphoblastic leukemia,,,,,,,,,,,,,
Disease,Thymic carcinoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Thymoma,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,[EXPERT]_RARECARE surveillance of rare cancers in Europe 2011[REG],0.14,0.14
Disease,Thymoma,1-9 / 100 000,Europe,409969,409969,25958,25958,en,Validated,410293,410293,22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG],1.22,1.22
Disease,Thymoma,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Thymic neuroendocrine carcinoma,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Glycogen storage disease due to muscle beta-enolase deficiency,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,11506403[PMID],1,1
Disease,Glycogen storage disease due to muscle beta-enolase deficiency,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_11506403[PMID],0,0
Disease,Genetic recurrent myoglobinuria,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Autosomal dominant myoglobinuria,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,9098484[PMID],2,2
Disease,Autosomal dominant myoglobinuria,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_9098484[PMID],0,0
Clinical subtype,Leukocyte adhesion deficiency type II,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24403049[PMID],7,7
Clinical subtype,Leukocyte adhesion deficiency type II,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24403049[PMID],0,0
Clinical subtype,Leukocyte adhesion deficiency type III,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,28827066[PMID],40,40
Clinical subtype,Leukocyte adhesion deficiency type III,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_28827066[PMID],0,0
Disease,Secondary syringomyelia,,,,,,,,,,,,,
Clinical subtype,Idiopathic syringomyelia,,,,,,,,,,,,,
Morphological anomaly,Primary syringomyelia,,,,,,,,,,,,,
Clinical subtype,Ovarioleukodystrophy,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,24808023[PMID]_12707859[PMID]_9153528[PMID],17,17
Clinical subtype,Ovarioleukodystrophy,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_24808023[PMID]_12707859[PMID]_9153528[PMID],0,0
Clinical subtype,Cree leukoencephalopathy,,,,,,,,,,,,,
Disease,Ravine syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10429812[PMID],38,38
Disease,Ravine syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_10429812[PMID],0,0
Disease,Resistance to thyrotropin-releasing hormone syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,19213692[PMID],2,2
Disease,Resistance to thyrotropin-releasing hormone syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,19213692[PMID],0,0
Disease,Yellow fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Yellow fever,<1 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2017[INST],0,0
Disease,Dengue fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Dengue fever,>1 / 1000,Worldwide,409967,409967,25958,25958,en,Validated,410293,410293,22494122[PMID],714,714
Disease,Dengue fever,1-9 / 1 000 000,Europe,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.5,0.5
Disease,Dengue fever,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2015[INST],0,0
Disease,Dengue fever,1-9 / 100 000,Austria,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.14,1.14
Disease,Dengue fever,1-9 / 1 000 000,Belgium,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.98,0.98
Disease,Dengue fever,<1 / 1 000 000,Croatia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.033,0.033
Disease,Dengue fever,1-9 / 1 000 000,Estonia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.58,0.58
Disease,Dengue fever,1-9 / 1 000 000,Finland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.98,0.98
Disease,Dengue fever,1-9 / 1 000 000,France,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.36,0.36
Disease,Dengue fever,1-9 / 1 000 000,Germany,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.96,0.96
Disease,Dengue fever,1-9 / 1 000 000,Hungary,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.14,0.14
Disease,Dengue fever,1-9 / 1 000 000,Ireland,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.32,0.32
Disease,Dengue fever,1-9 / 1 000 000,Italy,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.14,0.14
Disease,Dengue fever,1-9 / 1 000 000,Latvia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.34,0.34
Disease,Dengue fever,1-9 / 1 000 000,Lithuania,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.15,0.15
Disease,Dengue fever,<1 / 1 000 000,Luxembourg,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.04,0.04
Disease,Dengue fever,1-9 / 1 000 000,Malta,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.22,0.22
Disease,Dengue fever,1-9 / 1 000 000,Portugal,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.1,0.1
Disease,Dengue fever,<1 / 1 000 000,Slovakia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.07,0.07
Disease,Dengue fever,1-9 / 1 000 000,Slovenia,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.22,0.22
Disease,Dengue fever,1-9 / 1 000 000,Spain,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.26,0.26
Disease,Dengue fever,1-9 / 100 000,Sweden,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.7,1.7
Disease,Dengue fever,1-9 / 1 000 000,United Kingdom,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0.72,0.72
Disease,Dengue fever,1-9 / 100 000,Norway,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],1.26,1.26
Disease,Dengue fever,<1 / 1 000 000,Greece,409967,409967,25958,25958,en,Validated,410293,410293,European Centre for Disease prevention and Control 2013-2017[INST],0,0
Disease,Crimean-Congo hemorrhagic fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Crimean-Congo hemorrhagic fever,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],0,0
Clinical subtype,Leukocyte adhesion deficiency type I,1-9 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,[EXPERT],0.1,0.1
Etiological subtype,Neuronal intestinal pseudoobstruction,,,,,,,,,,,,,
Disease,LIG4 syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,27717373[PMID],28,28
Disease,LIG4 syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_27717373[PMID],0,0
Clinical subtype,Turcot syndrome with polyposis,,,,,,,,,,,,,
Disease,Familial gestational hyperthyroidism,,,,,,,,,,,,,
Disease,Lassa fever,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Disease,Lassa fever,<1 / 1 000 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,European Medicines Agency 2018[INST],0,0
Disease,Nipah virus disease,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT]_World Health Organization[INST],556,556
Disease,Nipah virus disease,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Marburg hemorrhagic fever,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,[EXPERT],500,500
Disease,Marburg hemorrhagic fever,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Morphological anomaly,Subcortical band heterotopia,,,,,,,,,,,,,
Morphological anomaly,Oligodontia,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Anodontia,,,,,,,,,,,,,
Malformation syndrome,Hemimegalencephaly,Unknown,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Haddad syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,ORPHANET,60,60
Malformation syndrome,Haddad syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Malformation syndrome,Oculootodental syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,12147582[PMID],1,1
Malformation syndrome,Oculootodental syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_12147582[PMID],0,0
Disease,PEHO-like syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,8723564[PMID]_12868478[PMID]_12949965[PMID]_15968934[PMID]_22408680[PMID]_12818526[PMID,10,10
Disease,PEHO-like syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_15968934[PMID]_22408680[PMID],0,0
Etiological subtype,Familial porencephaly,<1 / 1 000 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Clinical subtype,Dentin dysplasia type I,1-9 / 100 000,Europe,409966,409966,25958,25958,en,Validated,410293,410293,17452557[PMID]_[EXPERT],1,1
Clinical subtype,Dentin dysplasia type II,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,10397672[PMID],19,19
Clinical subtype,Dentin dysplasia type II,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET,0,0
Disease,Dentin dysplasia-sclerotic bones syndrome,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,264650[PMID],1,1
Disease,Dentin dysplasia-sclerotic bones syndrome,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_264650[PMID],0,0
Morphological anomaly,Cleft velum,1-5 / 10 000,Europe,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Morphological anomaly,Bifid uvula,Unknown,Worldwide,409966,409966,25965,25965,en,Not yet validated,410294,410294,ORPHANET,0,0
Malformation syndrome,Mosaic trisomy 9,,Worldwide,409970,409970,25958,25958,en,Validated,410293,410293,22249800[PMID],50,50
Malformation syndrome,Mosaic trisomy 9,<1 / 1 000 000,Worldwide,409966,409966,25958,25958,en,Validated,410293,410293,ORPHANET_22249800[PMID],0,0